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P1
Analytical survey of human rabies and animal bite prevalence
during one decade in the province of Kerman, Iran
M Rezaeinasab1, M Rad2
1Rafsanjan University of Medical Sciences, Rafsanjan, Iran; 2Faculty
of Veterinary Medicine, University of Tehran, Iran
Critical Care 2008, 12(Suppl 2):P1 (doi: 10.1186/cc6222)
Introduction In order to find out the frequency rates of domestic
and wild animal bites as well as the evaluation of the prevalence
rates of rabies disease in the human population in the Province of
Kerman, a retrospective study was designed to analyze statistically
the collected recorded data related to this project.
Methods This study was conducted within the framework of
MPVM student research projects by means of collaboration between
University of Tehran, Veterinary Organization of Kerman, Medical
Science University of Kerman and Medical Science University of
Rafsanjan and Networks of Health Centers of the 10 cities of
Kerman Province.
The required data such as the numbers of persons who were bitten
by animals, the distribution of the studied variables such as
geographical locations, age groups of people, jobs and
professional relationships, pre-exposure prophylaxis treatment for
rabies, and topographical conditions of the injured organs of
bodies due to the animal bites, as well as the mortality rates of
individuals resulting from rabies were collected during one decade
from 21 March 1994 to 21 March 2003 in all 10 cities including
the rural areas of the province of Kerman. All data were finally
analyzed by SPSS software (version 11.5).
Results On the basis of recorded statistical analysis, the mortality
cases of human rabies in the province of Kerman during one
decade was 10 persons (eight males and two females). One-half
of them (50%) were bitten by dogs and the others (50%) by foxes.
Among the reported deaths, 40% were from Kahnooj county (Jiroft
region). The reported data indicated that 21,546 persons were
bitten by animals during 10 years in the province of Kerman. The
mean of age of the people who were bitten by dogs was 24.80
years (SD = ±14.6), while the mean age of the people who were
bitten by foxes was 57.25 years (SD = ±1.50). There was a
significant difference between the mean age of these two groups
of the people (P < 0.05). The most frequent rate of injured people
was reported in the age group 10–19 years old and the frequency
rate of males (76.00%) was more than females (24.00%).
Therefore, there was a statistically significant difference between
males and females in this study (P < 0.01). About 60% of all
persons that were bitten by animals were from rural areas and 40%
of them were from urban areas (P < 0.05). Among the people who
were bitten and injured by animals during one decade in the
province of Kerman, 85.70% of them were not treated by the
rabies prophylaxis treatment regimen. Among all of them who were
bitten by animals, 50% were injured through hands and feet, 40%
of them through heads and faces, and 10% of them through
trunks, cervical regions and other organs of the bodies. In the
persons who were bitten by animals in the head region, the mean
latency period for rabies was 33 days (SD = ±12.2 days), while
the mean latency period in the persons who were bitten through
hands and feet was 77 days (SD = ±45.8 days). The P value was
<0.1. The results of this study showed that there is a significant
reciprocal correlation between annual raining level and the
frequency rate of animal bites in the province of Kerman (r = 0.5,
P < 0.01).
Conclusions According to this study, the role of foxes in the
epidemiology of human rabies in the province of Kerman, located in
the southeast of Iran, seems very important. Since most of the
animal bite individuals, during the one-decade survey in this region
of Iran, did not seem aware of the risk of exposure to the viral
infection of rabies through animal bites, the public education of
preventive measurements of rabies seems imperative by the public
health authorities as well as vaccination of animals against rabies,
especially dogs and cats, as well as mass vaccination of wild
animals by means of distribution of oral vaccines in the vast and
scattered forests by helicopters belonging to Veterinary
Organization Authorities being recommended. Collaboration of
intersectional public health relationships of medical science
universities of the province of Kerman as well as all related
authorities to control rabies prevalence in the regional and inter-
regional provinces of the southeast, the southwest and the
neighbor provinces of Fars, Hormozgan, Sistan-Baluchestan and
Yazd is very necessary.
P2
What do people really know about MRSA? A survey of
knowledge and attitudes in the general public and hospital
visitors
A Mclaughlin, J Canavan, E McAdam, R Mcdonagh, H Brar, 
J Hardt, K Sinead, G Fitzpatrick, M Donnelly
Adelaide Meath Hospital, Dublin, Ireland
Critical Care 2008, 12(Suppl 2):P2 (doi: 10.1186/cc6223)
Introduction We set out to assess current understanding of
MRSA among the lay public prior to writing an information booklet
for relatives of patients in the ICU.
Methods Trained researchers approached potential participants in
the hospital entrance and public places to complete the
questionnaire.
Result Of 545 participants who completed the questionnaire, 24
had never heard of MRSA and 521 remained (176 visitors, 345
general public); 4.9% (n = 26) had previously contracted MRSA.
The median age was 37 (21–49) years. The cohort first heard of
MRSA 24 (±18) months previously. The most common sources of
information were television and newspapers. Participants who had
MRSA thought that the shortage of beds contributed to MRSA
S2
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transmission (84% vs 69%). 46.3% of the public versus 16% of
the MRSA group did not expect to acquire MRSA after routine
surgery (P = 0.0095). Most participants (65.3% of the public, 70%
of visitors and 52% of the MRSA group) thought MRSA was
serious. Ninety-two percent of the MRSA group worried about
transmission to family members. 3.6% of the cohort would not
know where to find more information.
Conclusions MRSA is considered serious, information is obtained
through the media, and most participants can obtain further
information.
P3
Intensive care infections: risk factors and mortality
S Silvestri1, L Toma1, F Forfori2, C Mosca2, F Giunta2
1Scuola di specializzazione in Anestesia e Rianimazione, Università
degli Studi di Pisa, Pisa, Italy; 2Department of Surgery, AOUP,
Pisa, Italy
Critical Care 2008, 12(Suppl 2):P3 (doi: 10.1186/cc6224)
Introduction The aim of this study was to elucidate the impact of
ICU-acquired infection on ICU and hospital mortality. The main
determinants of hospital infection onset were investigated and the
role of the most used antibiotics in the ICU was considered a risk
factor for selection of peculiar bacterial species responsible for
ICU pneumonia.
Methods Patients with a longer than 48 hour stay in a teaching
hospital ICU were retrospectively enrolled between January 2005
and December 2006. Risk factors for ICU and hospital mortality
were analyzed with a logistic regression model adjusted for age,
SAPS II, medical or surgical status of the patients. Univariate analysis
permitted one to verify the relation between previous exposition to an
antibiotic therapy and development of ICU pneumonia.
Results Of 343 patients enrolled, 39 had a diagnosis for ICU
infection: 18 had an infection on admission developing a second
infection during ICU stay, and 21 had a primary infection after ICU
admission. Among the patients with ICU-acquired infection, ICU
mortality and hospital mortality were more than doubled (OR =
2.51 (95% CI = 1.05–5.98) and OR = 2.32 (95% CI =
1.10–4.86), respectively). Having more than one infection
demonstrated an ICU mortality risk addiction more than tripled
(OR = 3.36 (95% CI = 1.06–10.61)). Admission severity and an
infection before ICU admission emerged as important risk factors
for ICU-acquired infections (OR = 5.71 (95% CI = 1.19–27.29)
and OR = 3.14 (95% CI = 1.42–6.97), respectively). Previous
fluoroquinolone use demonstrated a clear role in favouring
Pseudomonas aeruginosa pneumonia and linezolid in
Acinetobacter baumannii pneumonia (Table 1).
Conclusions ICU-acquired infections are an independent risk
factor for ICU and hospital mortality. Finally some antibiotic
categories might show up as pneumonia inductors but further
studies are needed to confirm our hypothesis.
Reference
1. Aloush V, Navon-Venezia S: Antimicrob Agents Chemother
2006, 1:43–48.
Table 1 (abstract P3)
Pseudomonas Acinetobacter Stenotrophomonas 
aeruginosa baumannii maltophilia
Fluoroquinolones RR = 2.80 RR = 0.35 RR = 0.47 
(1.03–7.62) (0.04–2.83) (0.05–4.06)
Linezolid RR = 0.38 RR = 6.21 RR = 1.38 
(0.06–2.45) (1.27–30.40) (0.17–11.36)
RR, relative risk (95% confidence interval).
P4
Gram-positive nosocomial infections in a general ICU:
searching for a clue
G Georgiev, S Milanov, V Todorova, M Milanov
Pirogov Emergency Institute, Sofia, Bulgaria
Critical Care 2008, 12(Suppl 2):P4 (doi: 10.1186/cc6225)
Introduction The pattern of nosocomial pathogens has changed
gradually since the mid 1980s and Gram(+) aerobes are the
leading cause of infection in many ICUs today. Despite this trend
there are still no firm recommendations for empiric Gram(+) anti-
microbial coverage in patients with severe nosocomial infections.
Methods A historical cohort study was conducted and included all
cases of documented nosocomial infections in our general ICU for a
1-year period (November 2006–November 2007). Data on demo-
graphic characteristics, primary diagnosis, comorbidity, number of
indwelling devices, previous microbial isolates and current antibiotics
were cross-tabulated according to the presence and type of
Gram(+) pathogens isolated. For the identified most likely risk
factors, separate contingency tables were constructed and analyzed.
Results Sixty-six patients (39.05% of 169 with documented
nosocomial infections) with Gram(+) isolates were identified.
Methicillin-resistant Staphylococcus epidermidis (MRSE) (34.85%)
and Enterococci (25.76%) were most commonly isolated, followed
by methicillin-resistant Staphylococcus aureus (MRSA), methicillin-
susceptible S. epidermidis (MSSE), Streptococci, and methicillin-
susceptible S. aureus (MSSA). In eight (12.12%) of these 66
patients the same pathogen was isolated more than once and in 14
patients (21.21%) more than one Gram(+) pathogen was present
during his/her ICU stay. There were no significant differences
between the groups according to demographic characteristics. The
following independent risk factors for Gram(+) nosocomial infection
were identified – for MRSE, gunshot wound, chronic obstructive
pulmonary disease comorbidity, previous isolation of both Acineto-
bacter spp. and Pseudomonas spp, previous/current treatment with
carbapenem; for Enterococcus spp., billiary peritonitis, previous/
current treatment with the combination cefoperazone–sulbactam; for
MRSA, clinical uroinfection; for MSSE, previous/current treatment
with combination first/second-generation cephalosporin–metronida-
zole; for MSSA, neurologic injury. Surprisingly the number of
indwelling devices was not linked with increased risk of coagulase-
negative staphylococcal infections, nor there was found a long latent
period for their clinical manifestation.
Conclusions Exploratory hypotheses for further larger sample
conformations have been generated. Whether some of these are
pertinent to a particular ICU or could be generalized remains to be
elucidated. Identification of associated risk factors for Gram(+)
nosocomial infections would aid initial antibiotic choice in such
patients at risk.
P5
Descriptive analysis of ICU patients with hospital-acquired,
ventilator-associated, and healthcare-associated
pneumonia at four academic medical centers
DH Kett1, JA Ramirez2, P Peyrani2, JE Mangino3, MJ Zervos4, 
E Cano1, KD Ford5, EG Scerpella5, IMPACT-HAP study group1
1University of Miami/Jackson Memorial Hospital, Miami, FL, USA;
2University of Louisville, KY, USA; 3The Ohio State University
Medical Center, Columbus, OH, USA; 4Henry Ford Health System,
Detroit, MI, USA; 5Pfizer, New York, USA
Critical Care 2008, 12(Suppl 2):P5 (doi: 10.1186/cc6226)
Introduction We developed an ICU performance improvement
project to evaluate patients with ventilator-associated pneumonia
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(VAP), hospital-acquired pneumonia (HAP), and healthcare-
associated pneumonia (HCAP) using the 2005 American Thoracic
Society/Infectious Diseases Society of America guidelines. Below is
a descriptive analysis of the patients enrolled and their outcomes.
Methods Data were collected prospectively. Patients were
classified as VAP, HAP and HCAP. Antibiotics were chosen based
on local antibiograms.
Results The first 158 patients are reported (VAP n = 120, HAP
n = 26 and HCAP n = 12). Patients often had comorbidities;
diabetes (22%), cardiac (22%), respiratory (21%) and renal (16%).
Microorganisms were identified in 78% of patients. One hundred
and twenty-five patients received empiric therapy (ET). ET was
compliant with the guidelines in 31% of these patients. De-
escalation of antibiotic therapy occurred on day 3 in 75% (77/103)
of candidates. Clinical improvement and/or cure were seen in 70%
of patients. Superinfections developed in 37% of the patients. In
patients requiring mechanical ventilatory support, the average days
on the ventilator was 12 ± 17 days. Patients’ average stay (days) in
the ICU* and hospital* differed by group: VAP (17 ± 14 days,
23 ± 19 days), HAP (9 ± 10 days, 13 ± 13 days) and HCAP
(11 ± 19 days, 22 ± 36 days), respectively. *Comparisons with
P < 0.05. See Table 1.
Table 1 (abstract P5)
VAP HAP HCAP
Age 57 ± 19 51 ± 18 64 ± 17
APACHE II score* 21 ± 6 18 ± 6 17 ± 8
Clinical Pulmonary Infection Score* 6.8 ± 2 5.7 ± 2 5.2 ± 2
Day 14 mortality* 19.7% 15.4% 8.3%
*P < 0.05.
Conclusions VAP, as compared with HAP and HCAP, had the
highest severity of illness, mortality, and consumption of ICU and
hospital resources. Published guidelines are not easily translated
into daily practice.
Reference
1. Kett DH, Ramirez JA, Peyrani P, et al.: Am J Respir Crit Care
Med 2005, 71:388-416.
P6
European multicenter survey on antibiotic prophylaxis in
liver transplant patients
E Vandecasteele1, J De Waele1, S Blot1, D Vogelaers1, 
X Rogiers1, D Vandijck1, M Bourgeois2, J Decruyenaere1, 
E Hoste1
1University Hospital, Ghent, Belgium; 2AZ St-Jan, Bruges, Belgium
Critical Care 2008, 12(Suppl 2):P6 (doi: 10.1186/cc6227)
Introduction Infection remains a major problem for patients
undergoing liver transplantation (LT). However, no data regarding
perioperative antibiotic prophylaxis are available. The aim of the
study was to gain insight into prophylactic antibiotic strategies
used in European liver transplant centers.
Methods An electronic and postal survey was sent to all LT
centers, members of the European Liver and Intestine Transplan-
tation Association. The questionnaire asked for the prophylactic
antibiotic regimen used for LT recipients undergoing elective LT,
for LT recipients with acute-on-chronic liver disease, and for LT
recipients with acute liver failure, respectively.
Results A total of 59 centers (46% response rate) from 16
different countries completed the questionnaire. Of all participating
centers, 8.6% reported to perform <25, 37.9% reported 25–50,
27.6% reported 50–75, 10.4% reported 75–100, and 15.5%
reported >100 LTs annually. Antibiotic prophylaxis for recipients
with elective LT consisted of one single antibiotic in 48.3%. In
50%, combination therapy was given; whereas in 1.7%, the
prophylactic regimen rotated from monotherapy to combination
therapy on a 6-month basis. The mean duration of prophylaxis was
3.1 ± 2.0 days. In 19% of the centers prophylaxis was restricted to
1 day only, to the first 2–3 days in 55.2%, and for more than
3 days in 24.1% (one missing answer). Monotherapy consisted of
a first-line antibiotic agent (first-generation and second-generation
cephalosporin, or aminopenicillin) in 42.9%, and of a broad-
spectrum antibiotic (third-generation cephalosporin, piperacillin, or
carbapenem) in 57.1% of centers. For recipients with acute-on-
chronic disease, 73.7% used the same antibiotic regimen as used
for elective LT, while 26.3% changed it (5.3% increased the
duration of prophylaxis, and 21.0% changed the type of antibiotic).
For recipients with acute liver failure, 66.7% used the same
antibiotic regimen as used for elective LT, while 33.3% changed it
(10.5% changed the duration of prophylaxis, and 22.8% changed
the type of antibiotic).
Conclusions Among European LT centers, considerable variation
exists in the antibiotic prophylactic strategies used for liver
transplant recipients, both in terms of antibiotic regimen used and
in duration of therapy. These findings underscore the need for the
development of specific guidelines.
P7
A national survey on current practice of use of selective
digestive decontamination in the United Kingdom
R Shah1, J Louw2, T Veenith2
1Frimley Park Hospital, Surrey, UK; 1Queen Elizabeth Hospital,
Kings Lynn, UK
Critical Care 2008, 12(Suppl 2):P7 (doi: 10.1186/cc6228)
Introduction The incidence of nosocomial pneumonia in patients
in intensive care ranges between 7% and 40%, with a crude
mortality exceeding 50% [1]. One way to reduce the incidence of
ventilator-associated pneumonia in the intensive care is selective
digestive decontamination (SDD). In our clinical experience, SDD
is not used frequently in the UK, despite its evidence.
Methods We conducted a telephonic survey and collected data
on use of SDD. All ICUs in England were included (256 units) and
we obtained a response form 249 units. The average size was 5.8
patients. The response was obtained either from an ICU consultant
or a charge nurse in the intensive care. Before we discussed the
questionnaire, we assessed the suitability of person answering.
We discussed our questionnaire with 73 consultants and 176
charge nurses.
Results We obtained a response from 249 units out of the 256
units. Only 6% (15 units) out of the 249 units used SDD. In 94%
(235) of the units this was not considered for use, and in 4% (12)
of the units this was considered but not deemed suitable. In 0.8%
(two) of the units it is currently being considered for implementation.
Conclusions The oropharynx is the major source of potential
pathogens that cause lower airway infections. The role of SDD is
to eradicate these bacteria from the oropharynx [1]. We found in
our telephonic survey that SDD is not used by most of the ICUs in
England. The main deterring factors were high frequency of MRSA,
drug resistance, lack of incorporation in sepsis bundles, relative
disinterest in the drug companies, cost and difficulty in obtaining
the preparation.
One of the drawbacks of our survey could have been the fact that
we discussed with charge nurses and consultants who were not
part of decision-making for the use of SDD in the ICUs. But the
bottom line is that SDD is not used in the majority of ICUs.
S4
Reference
1. Baxby D, van Saene HKF, Stoutenbeek CP, Zandstra DF:
Selective decontamination of the digestive tract: 13 years
on, what it is and what it is not. Intensive Care Med 1996,
22:699-706.
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Community-acquired and healthcare-related urosepsis: 
a multicenter prospective study
T Cardoso1, O Ribeiro2, A Costa-Pereira2, A Carneiro1, 
A SACiUCI Study Group1
1Hospital Geral Sto António, Porto, Portugal; 2Faculty of Medicine,
University of Oporto, Porto, Portugal
Critical Care 2008, 12(Suppl 2):P8 (doi: 10.1186/cc6229)
Introduction Urinary infections are the third focus of infection in
sepsis. In this study we describe the epidemiology and microbiology
of community-acquired urosepsis, to determine the associated
crude mortality and to identify independent predictors of mortality.
Methods A prospective, multicentered, cohort study on community-
acquired urosepsis cases admitted to Portuguese ICUs from
1 December 2004 to 30 November 2005 with a follow-up until
discharge.
Results Seventeen units entered the study from the north to south
of Portugal, corresponding to 41% of all mixed national ICU beds.
Over this period 4,142 patients were admitted to the study – 897
(22%) had community-acquired sepsis, and of these 65 (7%) had
urosepsis.
Compared with other focuses of infection, urosepsis was more
frequent in women (66% vs 33% in nonurosepsis, P < 0.001), and
associated with shorter ICU length of stay (7 days vs 9 days, P =
0.002). No significant differences were observed regarding
severity of illness (SAPS II, sepsis severity) or crude mortality. The
isolation rate was 68% with 41% positive blood cultures. All
isolations, except one, were Gram-negative and no fungus was
isolated; Escherichia coli dominated the microbiological profile
(63% of all isolations).
Healthcare-related infection (HCRI) was found in 31% of these
patients: E coli represents 58% of all isolations but the resistance
profile was different, with resistance to ciprofloxacin and cotrimoxazol
increasing from 9% (in community-acquired sepsis) to 25% (in
HCRI). The 28-day mortality was higher in the non-HCRI group (29%)
than in the HCRI group (15%), although not statistically significant.
Conclusions Although described as being the focus of infection
with better prognosis we could not confirm this for community-
acquired urosepsis in the present study. HCRI patients are a
particular group with a similar microbiological profile but different
resistance profile requiring a different empirical approach.
Reference
1. Friedman ND, Kaye KS, Stout JE, et al.: Health care-associ-
ated bloodstream infections in adults: a reason to change
the accepted definition of community-acquired infections.
Ann Intern Med 2002, 137:791-797.
P9
Bedside laparoscopy to diagnose intrabdominal pathology
in the ICU
S Matano, M Bonizzoli, A Di Filippo, G Manca, A Peris
Intensive Care and Emergency Service, Florence, Italy
Critical Care 2008, 12(Suppl 2):P9 (doi: 10.1186/cc6230)
Introduction The aim of the study was to evaluate the accuracy of
bedside diagnostic laparoscopy (BDL) in critically ill patients (CIP)
suspected to suffer from intrabdominal pathology compared with
operative laparotomy or diagnostic imaging (CT scan) and to verify
the safety of the procedure. In fact, a delay in the diagnosis of
intrabdominal pathology could worsen the morbidity and mortality
in these patients. In ICU patients treated with prolonged parenteral
nutrition, mechanical ventilation and high-dose opioid analgesics,
acalculous cholecystitis (AC) is a severe complication [1]. Clinical
evaluation of the abdomen is difficult as deep sedation often masks
symptoms, and physical examination is inconclusive so they are
potentially eligible for exploratory laparoscopy after abdominal CT.
Furthermore, performing CT is often impossible because of the
difficulty in safely transporting CIP.
Methods From January 2006 to November 2007 a BDL was
performed in 24 CIP to confirm the clinical diagnosis of AC. Every
day, liver function tests are collected and abdominal ultrasono-
graphy is performed when the suspicion of AC is high. Elevated
liver function tests and ultrasonography signs such as gallbladder
distension or wall thickening (>3–4 mm) with or without perichole-
cystic fluid were the more significant findings of suspected AC and
were considered admission criteria in the study. Twenty-four
patients met the criteria. Ten were trauma victims, three were post-
cardiac surgical patients, and 11 had sepsis of unknown origin.
Fifteen were hypotensive and required haemodynamic support.
BDL was performed with the Visiport. The pneumoperitoneum was
created with a 10–15 mmHg CO2 pressure. The mean procedure
time was 40 minutes.
Results The procedure was done a mean 8 days (range 5–15 days)
after ICU admission. In two patients the BDL was positive for
gangrenous colecystitis (both after cardiac surgery) requiring
laparoscopic cholecystectomies in the operating room. Purulent
peritonitis was found in five patients with sepsis of unknown origin
but microbiological tests on ascites resulted negative in all cases.
The other BDLs resulted negative for intrabdominal pathology.
Conclusions BDL seems to represent an alternative and effective
technique that might be more accurate than a CT scan and less
invasive than laparotomy to obtain a diagnostic evaluation of
intrabdominal pathology in ICU patients.
Reference
1. Rehm CG: Crit Care Clin 2000, 16:101-112.
P10
A potential role for the chest X-ray in the transmission of
resistant bacteria in the ICU
PD Levin, O Shatz, D Moriah, S Sviri, A Or-Barbash, CL Sprung,
C Block
Hadassah Hebrew University Hospital, Jerusalem, Israel
Critical Care 2008, 12(Suppl 2):P10 (doi: 10.1186/cc6231)
Introduction An investigation of infection control practices used by
X-ray technicians during the performance of routine chest X-ray
scans in the ICU, transmission of resistant bacteria to the X-ray
machine, and the effect of an infection control intervention. Up to
20% of patients acquire infections in the ICU, 44% of which may
be transferred on caregivers’ hands. Daily routine chest X-ray
scans are performed sequentially, presenting the potential for
bacterial spread. The degree to which X-ray technicians apply
infection control measures, and the extent to which bacteria are
transferred, is unknown.
Methods Compliance with 14 infection control measures was
measured covertly during the performance of daily chest X-ray
scans. Bacterial surface cultures were taken from the X-ray
machines. An educational intervention (informing the technicians
about resistant bacteria, machine culture results and correct
alcohol and glove use) was instituted. Observations and machine
Critical Care    March 2008 Vol 12 Suppl 2 28th International Symposium on Intensive Care and Emergency Medicine
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cultures were repeated. The appearance of resistant bacteria in
patient cultures was followed.
Results Infection control practices were compared before and
after the intervention. Alcohol hand-rub use before patient contact
increased from 12% to 25% of occasions (P = 0.009), from 0% to
62% prior to touching the X-ray machine (P < 0.001) and from 9%
to 39% (P < 0.001) before touching the next patient. Glove use
also improved significantly.
Resistant Gram-negative bacteria grew in 12/31 (39%) preinter-
vention X-ray machine cultures and 0/29 (0%, P < 0.001) post-
intervention cultures. Cultures with no bacterial growth increased
from 11/31 (33%) to 22/29 (67%, P = 0.002) pre to post inter-
vention.
New occurrences of resistant Gram-negative bacteria in clinical
cultures decreased from 19 in 68 patients (28%) pre intervention
to 8/84 (10%, P = 0.003) post intervention.
Conclusions Resistant Gram-negative bacteria are found
frequently on the X-ray machine, probably being transferred on
technicians’ hands. This represents the potential for patient-to-
patient bacteria transfer. A simple infection control intervention
decreases X-ray machine contamination and is associated with a
decrease in the appearance of resistant bacteria in patient
cultures, although causality is not proven.
References
1. Grundmann H, et al.: Crit Care Med 33:946–951.
2. Pittet D, et al.: Arch Intern Med 159:821–826.
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G Castro1, T Cardoso1, R Carneiro1, O Ribeiro2, 
A Costa-Pereira2, A Carneiro1
1Hospital Geral de Santo António, Porto, Portugal; 2Faculty of
Medicine, University of Oporto, Porto, Portugal
Critical Care 2008, 12(Suppl 2):P11 (doi: 10.1186/cc6232)
Introduction Bacteraemia developing in patients outside the
hospital is categorized as community acquired. Accumulating
evidence suggests that healthcare-related bacteraemia (HCRB)
are distinct from those that are community acquired.
Methods A prospective, observational study of all the patients with
community-acquired bacteraemia sepsis (CABS) admitted to a
tertiary, mixed, 12-bed ICU, at a university hospital, between 1
December 2004 and 30 November 2005. HCRB was defined
according to criteria proposed by Friedman and colleagues [1].
Results Throughout the study period, 160 patients were admitted
with CABS; 50 (31%) had HCRB. In the CABS group the main
focus of infection was respiratory (41%), intra-abdominal (15%)
and endovascular (15%); in the HCRB group respiratory infection
was present in 14 (28%) patients, intra-abdominal in 13 (26%)
patients and urological in 10 (20%) patients (P = 0.227). The
microbiological profile was different between the two groups: in
the non-HCRB the main microbiological agents were Gram-
positive 57 (63%), versus 34 (37%) Gram-negative. In the HCRB
group the Gram-negative dominated the microbiological profile: 26
(65%) versus 34 (37%) (P = 0.003). The ICU crude mortality was
different in both groups (52% in HCRB versus 34% in CABS, P =
0.028) and also hospital mortality (60% vs 39%, P = 0.013).
Conclusions HCRB has a higher crude mortality and a different
microbiological profile was shown in the present study. This
knowledge should prompt the necessity for early recognition of
patients with HCRB that would need a different therapeutic
approach.
Reference
1. Friedman ND, Kaye KS, Stout JE, et al.: Health care-associ-
ated bloodstream infections in adults: a reason to change
the accepted definition of community-acquired infections.
Ann Intern Med 2002, 137:791-797.
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Incidence of nosocomial infection in patients with
nontraumatic or traumatic coma
L Lorente Ramos, J Castedo, R Galván, C García, J Iribarren, 
J Jiménez, M Brouard, L Lorenzo, S Palmero, M Martín, M Mora
Hospital Universitario de Canarias, La Laguna, Tenerife, Spain
Critical Care 2008, 12(Suppl 2):P12 (doi: 10.1186/cc6233)
Introduction To determine the rate of nosocomial infection in
nontraumatic or traumatic coma patients.
Methods A prospective study for 24 months in a medical–surgical
ICU. Infections were diagnosed according to CDC criteria.
Infections were classified based on the diagnosis onset as: early
onset (EO), developed during the first 4 days of ICU stay; and late
onset (LO), developed 5 days after ICU admission.
Results We included 118 patients with nontraumatic coma (31
intracerebral hemorrhage, 30 subarachnoid hemorrhage, 15 brain
infarction, 12 intoxication, nine CNS infection, six status epilepticus
and 15 others), 63 males. The mean age was 55.07 (±16.12
years). The mean APACHE II score was 18.50 (±12.02). A total of
47 patients (39.83%) developed 70 nosocomial infections (28 EO
and 42 LO) and death in 32 patients (27.12%): 33 pneumonias
(18 EO and 15 LO), 25 urinary tract infections (eight EO and 17
LO), five primary bacteremias (two EO and three LO), three
catheter-related bacteremias (three LO), three ventriculitis (three
LO) and one wound surgical infection (one LO). The
microorganisms responsible were: nine Pseudomonas, nine CNS,
eight Escherichia coli, six MSSA, five MRSA, five Haemophillus,
five Candida albicans, four Streptococcus faecalis, four
Streptococcus pneumoniae, four Proteus mirabilis and 11 others.
Included were 67 patients with traumatic coma, 57 males. The
mean age was 38.02 (±17.49 years). The mean APACHE II score
was 18.32 (±12.21). A total of 27 patients (40.29%) developed
38 nosocomial infections (18 EO and 20 LO) and death in 14
patients (20.89%): 27 pneumonias (15 EO and 12 LO), six urinary
tract infections (one EO and five LO), two primary bacteremias
(one EO and one LO), one catheter-related bacteremia (one LO),
one ventriculitis (one EO) and one wound surgical infection (one
LO). The microorganisms responsible were: eight MSSA, one
MRSA, seven Pseudomonas aeruginosa, five CNS, five
Haemophillus influenzae and 12 others.
Conclusions Forty percent of patients with nontraumatic and
traumatic coma developed infections – those with a respiratory
origin being the most frequent.
P13
Comparative study on infection of the central nervous
system in patients with head trauma and spontaneous
cerebral hemorrhage
P Vartzeli, A Yiambides, K Daskalakis, M Moukas, K Schulpis,
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Introduction The emergency neurosurgical procedure, the long
duration of it (>4 hours) and the infected trauma are factors that
have, in studies, been connected with increased probability of
infection of the central nervous system (CNS) during the post-
operative period.
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Objective To study the appearance of infection of the CNS in
patients who have been operated on after sustaining a head injury
or spontaneous cerebral hemorrhage that were hospitalized in the
ICU, over a period of 2 years.
Materials Recordings of 118 patients who were hospitalized in the
ICU during the period 2005–2007. The selection of the patients
was based on the following criteria: the reason for admission to the
ICU was head injury (70 patients) or cerebral hemorrhage (48
patients); all patients had undergone a neurosurgical procedure;
and an infection occurred during hospitalization in the ICU.
Methods All patients out of the 118 that presented fever or
laboratory findings of an infection which could not be attributed to
an infection of any other reason except CNS underwent lumbar
puncture.
Results Twenty-seven patients underwent lumbar puncture
(22.88%). Findings from the lumbar puncture compatible with an
infection of the CNS occurred in six patients (five patients with
cerebral injury and one patient with cerebral hemorrhage) out of
118 patients, 5.08% of all patients (7.14% of head injury and
2.08% of cerebral hemorrhages).
The days that the lumbar puncture was performed were the
4th–19th postoperative days. The mean GCS value during the
admittance to the hospital of the total patients was 8.88 (3–15),
but the mean GCS value of those patients that developed CNS
infection was 7.86 (3–14).
Conclusions The administration of antibiotics from the first day of
admittance to the ICU probably is accountable for the very low rate
of infection of the CNS in patients with head injury or cerebral
hemorrhage. There is no important difference between the
scheduled surgical procedure from the head injury and automatic
cerebral hemorrhage. Further studies are needed for the reduction
and control of the postoperative infections in these patients.
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Introduction Respiratory infection counts for more than one-half of
all admissions to the ICU with sepsis. In this study the
epidemiology and microbiological profile of community-acquired
and healthcare-related (HCR) respiratory sepsis will be described.
Methods A prospective, observational study of all the patients with
community-acquired sepsis (CAS) admitted to our ICU, over 1
year. Respiratory CAS was defined by the presence of respiratory
infection and at least two SIRS criteria at the time of hospital
admission or within the first 48 hours. HCR infection was defined
according to criteria proposed by Friedman and colleagues [1].
Results In the study period, 347 patients were admitted – 149
(43%) with CAS. Respiratory infection was present in 102 patients
(68%). Comparing this group with nonrespiratory CAS, 73%
versus 51% were male (P = 0.01), with a similar median age of 57
years versus 62 years (P = 0.334), more severe sepsis (40% vs
28%) and less septic shock (46% vs 68%) (P = 0.030). Blood
cultures were obtained in 96 (94%) patients, only 8% were
positive versus 39% in nonrespiratory CAS (P < 0.001). Gram-
positive microorganisms represented 51% of all isolations, Gram-
negative 26%, Mycobacterium tuberculosis 6%, atypical 5%, and
fungus represented only 2% of all isolations. Polymicrobian infec-
tions were documented in 5% of the patients. HCR respiratory
infection was present in 17%. Gram-positive microorganisms
represented 50% of all isolations, and Gram-negative 37%. ICU
length of stay (9 vs 8 days, P = 0.595), as well as ICU (35% vs
32%, P = 0.686) and hospital (36% vs 41%, P = 0.559) mortality
were similar between respiratory and non-respiratory CAS.
Conclusions Respiratory CAS is a very important problem in the
ICU, representing 30% of all admissions. Although the
microbiological profile is similar to that described in the literature,
in this population tuberculosis still plays a representative role and
needs to be considered. In this population, no significant
differences in the microbiological profile were seen between CAS
and HCR infection.
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Introduction Antibiotic therapy significantly contributes to health-
care costs and especially to those infections due to multidrug
resistance pathogens. The purpose of the study was to investigate
empiric antibiotic therapy costs compared with the consequent
application of de-escalated therapy.
Methods We prospectively collected data regarding demographics
and antibiotic costs in critically ill ICU patients experiencing
infection. We recorded daily costs of empiric antibiotic therapy on
identification–suspicion of infection as well as the costs after the
pathogen identification and susceptibility.
Results We included 27 critically ill patients (15 males) of mean
age 49.9 ± 4.3 years and illness severity of APACHE II score 15.0
± 1.7, SAPS II 32.4 ± 3.7, and SOFA score 6.0 ± 0.5. Daily costs
of initial empiric antibiotic therapy were significantly higher
compared with those of the therapy guided according to
susceptibility results in confirmed bacteremias. This was applicable
for Gram-positive (€61.0 ± 12.7 vs €130.4 ± 56.3, P = 0.009),
Gram-negative (€181.0 ± 47.8 vs €142.7 ± 42.9, P = 0.0063)
and mixed (€166.0 ± 21.1 vs €96.0 ± 34.0, P = 0.0016)
bacteremias. In patients with other sites of infection the antibiotic
costs did not differ (P = 0.112) between therapy guided according
to susceptibility results compared with empiric therapy (€239.0 ±
49.7 vs €242.0 ± 88.7).
In patients with negative cultures the daily antibiotic cost was
€110.7 ± 31.9. Therapy in those patients was discontinued earlier
and they had a significantly lower length of ICU stay (P = 0.000,
8.7 ± 0.9 days vs 24.6 ± 4.1 days).
Conclusions According to our bacteriologic susceptibility results,
the de-escalation therapy is applicable only in bacteremias which
may lead to decreased antibiotic costs. Such an approach is not
applicable in infections of other sites possibly due to multidrug
resistance pathogens.
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Introduction In the past 10 years different authors have published
higher mortality in severe infection related to inappropriate anti-
biotic therapy (IAT). A systematic review [1] recommends defining
groups of patients that could benefit more with appropriate
antibiotic therapy (AAT).
Methods Two hundred and twenty bacteremic septic patients
admitted during 4 years to a medical–surgical ICU were
considered for place of acquisition (community acquired vs noso-
comial acquired), foci of origin, SAPS II and presence of shock, in
relation to mortality and to the appropriateness of empiric antibiotic
therapy. Mortality was considered during the ICU stay.
Results For 220 septic patients, mortality in 106 patients (48%):
AAT 157 patients (71.4%), mortality in 71 patients (45%); IAT 63
patients (28.6%), mortality in 35 patients (55.5%) (P = 0.2).
Community-acquired bacteremia 153 patients, mortality in 73
patients (47%); nosocomial-acquired bacteremia 67 patients,
mortality in 33 patients (49%) (P = 0.9). Community-acquired
bacteremia 99 patients with SAPS II ≤50: IAT 23 patients, 12
dead; AAT 76 patients, 20 dead (P = 0.03, RR = 1.9). For 54
patients with SAPS II >50 in this group the IAT was not related to
mortality. See Table 1.
Table 1 (abstract P16)
Antibiotic therapy and mortality by foci of origin
Focus n (%) AAT / IAT Mortality
Pulmonary 94 (43) 66/28 (P = 0.8) 25/18 (P = 0.05, 
RR = 2)
Peritoneal 30 (13.6) 17/13 (P = 0.08) 8/5 (P = 0.9)
Vascular 30 (13.6) 26/4 (P = 0.07) 12/1 (P = 0.4)
Urinary 24 (11) 19/5 (P = 0.5) 12/1 (P = 0.1)
Skin 17 (7.7) 13/4 (P = 0.8) 8/3 (P = 0.5)
Unknown 13 (5.5) 5/8 (P = 0.01, 2/6 (P = 0.2)
RR = 3.8)
Meningeo 12 (5.5) 11/1 (P = 0.1) 4/1 (P = 0.4)
Conclusions IAT relates to unknown foci of origin in septic
patients irrespective of the site of acquisition and severity of illness
(P = 0.01, RR = 2.3). Bacteremic pulmonary infections treated
with empirical IAT have a higher attributable mortality (P = 0.02,
RR = 2.9). CA septic patients with SAPS II ≤50, when treated with
IAT, have a significantly higher mortality (P = 0.03, RR = 1.9). We
were not able to document this in more severely compromised
patients (SAPS II >50), probably because the severe septic
condition hides the consequences of the IAT.
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Introduction Patients in ICUs account for the greatest number of
candidemia in most hospitals. Fluconazole prophylaxis has been
used to prevent candida infections in critically ill patients. In order
to examine the effect of fluconazole prophylaxis implementation in
our ICU we reviewed the records of all patients with blood cultures
that grew Candida spp. (albicans and nonalbicans) 1 year before
and after.
Methods In 2006 we started using intravenous fluconazole
administration as prophylaxis (400 mg/day) in selected patients
(surgical, with central venous catheters, receiving broad-spectrum
antibiotics, receiving TPN, requiring hemodialysis, spending more
than 8 days in the ICU) as protocol. We recorded the incidence of
candidemia for 2005 (4.03%) and 2006 (1.7%) as well. We also
recorded the candidemic patient’s age (mean, 47.84 years/51
years), sex (10 men, three women/four men, one woman),
APACHE II score on admission (mean, 11.27/ 12), days spent in
ICU (46 ± 30.30 days/98 ± 68.44 days), median day of candida
isolation (17th day (2nd–50th day)/46th day (23rd–208th day)),
whether they were receiving TPN (30.8%/60%), and outcome. All
candidemic patients were treated with liposomic amphotericin.
Results In 2005, 322 patients were admitted to our ICU – 13 of
them had at least one blood culture that yielded Candida (six C.
albicans, seven Candida spp). None of them received fluconazole
prophylaxis. Seven patients (53.8%) died. In 2006, 291 patients
were admitted – five of them developed candidemia (two C.
albicans, three C. parapsilosis), four were under prophylaxis and
three of them developed C. parapsilosis. Three patients (60%)
died.
Conclusions Although the number of patients is small, it seems
that fluconazole prophylaxis can prevent candidemia in critically ill
patients, but also may promote the development of nonalbicans
species, which are resistant to fluconazole.
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Introduction Candida airway colonisation in patients with a clinical
suspicion of ventilator-associated pneumonia has been associated
with increased mortality in the published literature. The aim of this
study was to investigate whether there is an association between
the presence of Candida spp. in the respiratory secretions of
critically ill adults and ICU mortality, irrespective of the confirmed
presence of ventilator-associated pneumonia.
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Methods A retrospective analysis was performed on patients
admitted to a large mixed ICU in Northern Ireland over a 1-year
period. Data were analysed to determine mortality in patients
whose respiratory secretions had cultured Candida spp. (both with
and without coexisting bacteria), compared with those in whom
cultures were negative for Candida spp. but positive for bacterial
pathogens. Patients with persistently culture-negative respiratory
specimens were excluded from analysis. Statistical significance of
observed differences was evaluated by chi-square testing.
Results In total, 287 patients were analysed. Of these, 202 (70%)
were male. Bacteria only were cultured from respiratory secretions of
208 (72%) patients (the ‘non-Candida’ group). The ‘Candida’ group
consisted of 79 (28%) patients; of these, 39 had Candida spp. only
and 40 had Candida spp. plus bacterial pathogens. Within the ‘non-
Candida’ group, 39 patients died during the ICU episode; in the
‘Candida’ group, 17 died (18.8% vs 21.5%, P = 0.597).
Conclusions The presence of Candida spp. in the respiratory
secretions of this critically ill cohort was not associated with a
significant increase in ICU mortality. It appears, therefore, that
airway colonisation with Candida spp. in the absence of ventilator-
associated pneumonia may not be regarded as a reliable predictor
of ICU mortality.
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Introduction Although a substantial proportion of patients become
colonized with Candida sp. during a hospital stay, only few develop
severe infection. Invasive candidiasis occurs in only 1–8% of
patients admitted to hospitals, but in 10% of patients housed in the
ICU where candida infections represent up to 15% of all noso-
comial infections [1]. Candida sp. isolates from bronchoalveolar
lavage (BAL) cultures in immunocompetent patients are through
contaminants rather than pathogens. The objective of this study is
to research the most important risk factors for lung colonization by
Candida albicans in ICU patients.
Methods Immunocompetent patients admitted to the ICU with C.
albicans isolates from BAL in a 20-month period were retro-
spectively studied. Patients without any microbiological growth
from BAL were also included. The clinical course, therapeutic
decision, potential risk factors and outcome were recorded.
Results The population object of this study is composed of 20
(33.3%) patients with C. albicans isolated from BAL (BAL+) and
of 12 (20%) patients with absent growth in BAL (BAL–).
Significant differences between patients with BAL(+) and patients
with BAL(–) are observed: 80% BAL(+) versus 8.3% BAL(–) was
treated with parenteral nutrition (OR = 44), 90% versus 33.3%
were mechanically ventilated (OR = 20), 65% versus 8.3%
received corticosteroid therapy (OR = 18). See Table 1.
Conclusions Total parenteral nutrition, mechanical ventilation and
treatment with corticosteroids are important risk factors for lung
colonization by C. albicans. The higher risk is attributable to
parenteral nutrition: the risk is twice as high compared with
ventilation and corticosteroid-associated risk.
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Introduction Efungumab (Mycograb®) is a human recombinant
antibody against fungal Hsp90 that, in combination with lipid-
associated amphotericin B, has shown efficacy in patients with
invasive candidiasis (phase 3 data). Eight compassionate-use case
studies of efungumab in combination with antifungal agents in the
treatment of invasive Candida infections are presented.
Methods Efungumab was given to eight patients at 1 mg/kg twice
daily, typically for 5 days combined with standard doses of ampho-
tericin B, caspofungin, flucytosine or fluconazole. Patients were
7–69 years old with culture-confirmed invasive fungal infections,
from which Candida spp. (Candida albicans, Candida krusei,
Candida glabrata) were isolated; five patients had candidal perito-
nitis, one candidaemia, one a subphrenic abscess and candidae-
mia, and one mediastinal, pleural and pulmonary candidiasis; one
patient had neutropenia.
Results Seven out of eight patients responded to 10 doses of
efungumab; one patient (a child with candida peritonitis and
abdominal abscesses associated with a non-Hodgkin’s abdominal
lymphoma) responded but relapsed and required a second course
of treatment, to which he responded. One patient, with mediastinal,
pulmonary and pleural candidiasis associated with ARDS, was
withdrawn after two doses of efungumab, due to blood pressure
fluctuations, impaired gas exchange, increased cardiac output and
fever; in this patient the efungumab was not prefiltered. Three
further patients experienced transient hypotensive or hypertensive
episodes after the first dose, which did not recur with subsequent
doses. One patient experienced nausea and vomiting after the
second dose.
Conclusions This experience with efungumab extends the clinical
trial database. It shows efficacy in poor-prognosis patients who
failed to respond to conventional monotherapy (6–20 days), in
patients with multiple species of Candida, and in candidaemia in a
neutropenic patient. All but one patient tolerated efungumab and
seven patients completed the course without major side effects.
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Odds Standard 95% confidence 
ratio error P > z interval
NTP 44 52.12 0.001 4.31
448.57
Corticosteroid 23.38 0.008 2.166
192.62
VMA 18 17.36 0.003 2.71
119.23
NTP, total parenteral nutrition; VMA, assisted mechanics ventilation.
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Introduction Micafungin (MICA) is an efficacious antifungal
treatment for life-threatening fungal infections [1-4].
Methods We characterised the safety of MICA by analysing
pooled adverse event (AE) data from 17 clinical studies conducted
worldwide. All patients (n = 3,028) received ≥1 dose of intra-
venous MICA; a median daily dose of 100 mg for adults and
1.5 mg/kg for children over a mean duration of 18 and 29 days,
respectively.
Results Median age was 40.5 (range <0.1–92) years, including
296 (9.8%) children (<16 years old) and 387 (12.8%) elderly
patients (≥65 years old). Common underlying conditions were
haematopoietic stem cell or other transplantation (26%), malignan-
cies (21%) and HIV (33%). The most frequently reported MICA-
related AEs were nausea (2.8%), vomiting (2.5%), phlebitis (2.5%),
hypokalaemia (2.1%), pyrexia (2.1%), diarrhoea (2.0%), and
increases in alkaline phosphatase (2.7%), aspartate aminotrans-
ferase (2.3%) and alanine aminotransferase (2.0%). In comparative
studies, the MICA safety profile was superior to liposomal ampho-
tericin B, and similar to fluconazole and caspofungin (Figure 1).
Conclusions This large database with more than 3,000 patients
demonstrated a favourable clinical safety profile for micafungin.
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Introduction Micafungin (MICA) is an antifungal therapy for the
treatment of life-threatening fungal infections. Until this study, the
pharmacokinetics (PK) of MICA in patients with confirmed invasive
candidiasis (IC) or candidaemia (C) had not been studied. We
report here the PK of MICA in this patient population.
Methods We characterised the PK of MICA in neutropenic and
non-neutropenic patients with confirmed IC or C. Patients (n = 20)
received MICA 100 mg daily for ≥14 days. Plasma concen-
tration–time profiles to determine the PK were taken after the first
dose (day 1) and on the last day of treatment.
Results The mean age was 50 years (range: 18–84 years) and
mean weight was 67 kg (range: 48–103 kg). There were 13
Caucasians, three Thais, one Black, one Asian Indian, one Mulatto
and one Cape Coloured. PK parameters are presented in Figure 1.
The mean half-life and mean clearance remained largely
unchanged after repeated daily dosing for 14 or 28 days. There
was no accumulation of MICA between day 1 and the end of
therapy beyond that expected for a drug with linear PK. Systemic
exposure to MICA metabolites was low throughout the study and
therefore they do not contribute to the therapeutic antifungal
effectiveness of MICA.
Conclusions The PK of MICA in these critically ill patients with IC
and C were generally similar to those in earlier studies in healthy
adults [1]. These data support previous studies that show MICA
requires no loading dose.
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Introduction Investigations on the pharmacokinetics and elimina-
tion of amphotericin B (AMB) lipid formulations in liver impairment
have so far been lacking. In the present clinical study the
Available online http://ccforum.com/supplements/12/S2
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Treatment-related adverse events (incidence > 5%) from comparative
studies. Number (%) of patients.
Figure 1 (abstract P22)
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pharmacokinetics of the cholesteryl sulfate complex of AMB was
assessed in critically ill patients with cholestatic liver failure.
Methods Time–concentration profiles were determined in critically ill
patients with cholestatic liver failure and in critically ill patients with
normal hepatic function requiring cholesteryl sulfate complex of AMB
for invasive fungal infections. The lipid-associated and liberated
fraction of AMB were separated by solid-phase extraction and
subsequently quantified by high-performance liquid chromatography.
Results Three patients with impaired and three patients with
normal hepatic function on day 1 of ABCD therapy have so far
been enrolled. After a single dose of ABCD (2.46 ± 0.54 mg vs
2.94 ± 1.47 mg/kg in the impaired-liver group compared with the
control group), the maximum concentration in patients with
impaired liver function was fourfold increased compared with the
control group (1.98 ± 0.61 vs 0.52 ± 0.12 μg/ml for total AMB
(P < 0.05), 1.25 ± 0.58 vs 0.46 ± 0.14 μg/ml for the liberated
fraction (P < 0.05), 0.74 ± 0.05 vs 0.06 ± 0.02 μg/ml for the lipid-
associated fraction (P < 0.05)). The clearance was slower in the
investigational group (0.15 ± 0.09 vs 0.38 ± 0.19 l/hour/kg for
total AMB, 0.22 ± 0.10 vs 0.38 ± 0.19 l/hour/kg for the liberated
AMB fraction (P < 0.05) and 0.52 ± 0.45 vs 17.84 ± 15.45 l/hour/kg
for lipid-associated AMB (P < 0.05)). The volume of distribution at
steady state was significantly decreased (2.17 ± 0.58 vs 9.78 ±
2.99 l/kg for total AMB (P < 0.05), 3.09 ± 0.88 vs 10.39 ± 2.70 l/kg
for liberated AMB (P < 0.05) and 8.18 ± 3.47 vs 83.27 ± 64.98 l/kg
for lipid-associated AMB (P < 0.05)).
Conclusions The elimination of ABCD appears to be delayed in
cholestatic liver failure, particularly that of the lipid-associated
fraction. More pharmacokinetic data are required to establish
reliable dose recommendations for ABCD in patients with liver
failure.
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Introduction Selective decontamination of the digestive tract (SDD)
is an infection prophylaxis regimen that may improve survival in ICU
patients [1]. Antibiotics for SDD are nonabsorbable, are given
enterally and are therefore considered safe to use. The aim of our
study was to determine whether enteral administration of tobramycin
as part of a SDD regimen may lead to detectable and potentially
toxic serum tobramycin concentrations in patients with renal failure.
Methods A prospective, observational study in ICU patients given
SDD treatment for at least 3 days. All patients were on continuous
venovenous hemofiltration with a filtration rate of 35 ml/kg/hour.
Tobramycin serum concentrations were measured every 3 days.
Results Serum samples were taken a median 6 days after the start of
SDD (IQR 3–9 days). Detectable tobramycin levels were found in 12
of 19 patients (63%) and in 15 of 26 serum samples (58%). In four
patients tobramycin concentrations were ≥1 mg/l, and in one of these
patients a toxic concentration of 3 mg/l was found. All patients with
tobramycin levels >1 mg/l had ischemic bowel disease. In contrast,
no patients with lower concentrations had intestinal ischemia.
Conclusions In patients with renal failure treated with continuous
venovenous hemofiltration, administration of SDD can lead to
detectable and potentially toxic tobramycin serum concentrations.
The risk of increased enteral absorption of tobramycin may be
particularly high in patients with intestinal ischemia. We advise
monitoring plasma tobramycin concentrations in patients with renal
failure on prolonged treatment with SDD.
Reference
1. de Jonge E, et al.: Effects of selective decontamination of
digestive tract on mortality and acquisition of resistant
bacteria in intensive care: a randomised controlled trial.
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Introduction Dalbavancin (DAL) is a semisynthetic lipoglyco-
peptide in phase 3 development with activity against Gram-positive
bacteria. Weekly doses (1 g day 1/0.5 g day 8) are being investi-
gated for the treatment of complicated skin and soft tissue infec-
tions. DAL has both renal and nonrenal routes of elimination. A
study was performed to assess the need for dosage adjustments in
patients with hepatic impairment.
Methods Subjects received intravenously 1 g DAL on day 1 followed
by 0.5 g on day 8. Subjects had mild, moderate, or severe hepatic
impairment as defined by Child–Pugh criteria A, B, or C. Age,
gender, and weight-matched controls with normal hepatic function
were also enrolled. DAL plasma concentrations were determined
and pharmacokinetic parameters were calculated. Drug exposure
was calculated as the cumulative area under the concentration–
time curve through day 15; drug clearance and the elimination half-
life were also determined. Safety was assessed by physical
examination and adverse event and laboratory monitoring.
Results Twenty-six subjects were enrolled, received DAL, and had
evaluable pharmacokinetics. The drug was well tolerated with no
serious adverse events. DAL concentrations and exposures were
not increased due to hepatic impairment. The elimination half-life
was not affected by hepatic impairment. Slightly lower exposures
and higher drug clearance were observed for subjects with
moderate and severe hepatic impairment, presumably due to
volume changes secondary to ascites and edema. The DAL
concentrations observed for these subjects were comparable with
the ranges observed in other studies.
Conclusions DAL concentrations are not increased due to hepatic
impairment and no dosage adjustment should be required for
patients with mild, moderate, or severe hepatic impairment.
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Introduction Dalbavancin (DAL) is a novel semisynthetic glyco-
peptide in phase 3 clinical development that has activity against
Gram(+) organisms, including resistant strains. Two doses given 1
week apart have been shown to be effective in complicated skin
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and soft tissue infections. A clinical study was performed to
determine the need for dosage adjustments in subjects with mild to
moderate renal impairment (RI).
Methods Subjects with normal renal function (creatinine clearance
(CrCL) > 80 ml/min), mild RI (CrCL of 50–79 ml/min), or moderate
RI (CrCL of 30–49 ml/min) received DAL as a single intravenous
infusion (1,000 mg). Plasma samples were collected through at
least 14 days after the dose. DAL was assayed using validated LC-
MS/MS methods. Pharmacokinetic (PK) data were analyzed using
noncompartmental methods.
Results Twenty-one subjects were enrolled, received one dose of
1,000 mg dalbavancin, and were included in the PK analysis.
Plasma concentration–time curves through 14 days (AUC0–14)
were similar between subjects with normal renal function and
subjects with mild or moderate RI. An increased concentration was
observed in subjects with moderate RI beyond day 14, at a point in
the profile when concentrations were below 40 m/l (Figure 1).
Conclusions DAL does not require a dosage adjustment for
patients with mild or moderate RI. These results are consistent with
previous clinical and nonclinical PK studies showing that DAL has
dual (both renal and nonrenal) routes of elimination.
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Introduction Dalbavancin (DAL) is a novel, next-generation
lipoglycopeptide with a pharmacokinetic profile that allows weekly
dosing. The safety of DAL in the treatment of complicated skin and
soft tissue infections was demonstrated versus comparators (COMP)
in the phase 2/3 clinical development program.
Methods Safety was assessed by analyzing adverse events (AEs),
laboratory parameters, vital signs, and ECGs. Safety analyses were
conducted on the intent-to-treat (ITT) population, using descriptive
statistics only (consistent with ICH Guidance). COMP included
linezolid, cefazolin, and vancomycin.
Results Of 1,699 patients in the phase 2/3 integrated database,
1126 patients received DAL. Demographic characteristics were
similar between the treatment groups. The majority of patients
were aged <65 years, male (60.2% DAL vs 58.8% COMP), and
Caucasian (71.1% DAL vs 75% COMP). The safety and
tolerability were good and comparable with each of the compara-
tors separately and in toto. No compound-specific or unique
toxicity was identified. The duration of AEs in patients treated with
DAL was similar to that of COMP (median duration, 4 days vs 5.5
days for treatment-related AEs and 3 days vs 4 days for all AEs,
respectively) (Figure 1). There was no hepatotoxic or renal signal in
an examination of abnormalities in ALT, AST, BUN, and creatinine.
The percentage of patients with abnormal hematology values was
low and similar between treatment groups. No QT effect was
demonstrated. Safety in relevant subpopulations (such as elderly,
diabetic patients) was demonstrated.
Conclusions Dalbavancin is a well-tolerated lipoglycopeptide, with
an AE profile similar to comparators in type and duration of AEs.
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Introduction The purpose of this study was to evaluate the
efficacy of telavancin (TLV), a novel bactericidal lipoglycopeptide
with a multifunctional mechanism of action, for the treatment of
surgical site infections due to Gram-positive bacteria, including
methicillin-resistant Staphylococcus aureus (MRSA).
Methods The ATLAS program (assessment of TLV in complicated
skin and skin structure infections (cSSSI)) consisted of parallel,
randomized, double-blind trials including >1,800 patients with
cSSSI who received either TLV 10 mg/kg intravenously every
24 hours or vancomycin (VAN) 1 g intravenously every 12 hours for
7–14 days. This subgroup analysis of ATLAS patients with surgical
site cSSSI compared clinical and microbiologic responses to
treatment with TLV or VAN.
Results One hundred and ninety-four patients (10%) had opera-
tive-site cSSSI (TLV, n = 101; VAN, n = 93). Patient character-
istics were similar between groups. Among all treated patients,
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clinical cure was achieved in 78 (77%) TLV patients and 65 (70%)
VAN patients. The efficacy of TLV was numerically superior to VAN
in SA and MRSA-infected patients (Table 1) but differences did
not reach statistical significance. Incidences of adverse events
were generally similar although nausea (28% TLV, 16% VAN),
headache (10% TLV, 5% VAN) and taste disturbance (20% TLV,
1% VAN) were more common in the TLV group.
Conclusions TLV was at least as efficacious as VAN for treatment
of operative-site MRSA cSSSI and is a potentially useful treatment
option.
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Introduction Telavancin (TLV) is a novel lipoglycopeptide antibiotic
that has a multifunctional mechanism to produce rapid bactericidal
activity. TLV is highly active against Gram-positive bacteria,
including methicillin-resistant and vancomycin (VAN)-intermediate
and VAN-resistant strains of Staphylococcus aureus. The recently
described community-acquired MRSA is known to have virulence
factors associated with multiple lesions and recurrences. The
objective of this study was to determine rates of recurrent skin infec-
tions within 6 months following treatment with TLV versus VAN.
Methods A cohort analysis of outcomes was performed in patients
from a high-volume inner-city emergency department (ED) in New
Orleans, LA, USA. This study was approved by the Human Use
Committee (LSUHSC), and informed consent was obtained for all
patients. The study included patients enrolled in randomized,
double-blind, controlled, phase 2 and 3 multicenter clinical trials.
Eligibility criteria included age ≥18 years and diagnosis of compli-
cated skin and soft tissue infections caused by suspected or con-
firmed Gram-positive organisms. Randomization was 1:1 to receive
TLV or VAN. ED visit records of enrolled patients were reviewed to
determine the number with recurrent skin infections. Data were
analyzed by logistic regression.
Results Ninety-nine patients were randomized and received at
least one dose of study medication; 19 patients were not evaluable
due to adverse events (AEs), loss to follow-up, or lack of response.
Success rates were similar in both analysis populations at the end
of therapy: TLV 40/43 (93.0%) versus VAN 35/37 (94.6%). In 68
patients with S. aureus at baseline, 34/35 (97.1%) were cured in
the TLV group and 32/33 (97.0%) in the VAN group. For 56
MRSA patients, cure rates were 30/30 (100%) for TLV and 25/26
(96.2%) for VAN. A total of 14 baseline MRSA patients initially
cured returned to the ED with a new skin and soft tissue infection:
4/30 (13.3%) patients treated with TLV and 10/26 (38.5%)
patients treated with VAN. In a relative risk analysis, TLV-treated
patients had a 3.34-fold greater chance of not returning with a
recurrent infection than VAN-treated patients (P, 0.04; CI, –1.036,
10.790). The overall incidence of AEs was similar in the two
treatment groups: TLV (30%) versus VAN (32.7%).
Conclusions The results of this study suggest improved long-term
eradication of pathogens by TLV based on recurrence of infection
within 6 months, and support the development of TLV, especially
for infections caused by community-acquired MRSA.
Reference
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Introduction Daptomycin is the first in a class of agents known as
lipopeptides, used for the treatment of Gram-positive infections.
The aim of this study was to evaluate the outcome in patients who
were treated with daptomycin in a 12-month period.
Methods A retrospective review of Onassis Cardiac Surgery
Center medical records. Clinical information, including patient
demographics and clinical outcome, was analyzed. Primary end-
points were resolution of signs and symptoms of infection and
discharge from hospital.
Results Thirty inpatients were treated with daptomycin (27 men,
median age 60.6 years, mean hospital stay 55 days). Seven
patients had bloodstream infection (BSI) (six coagulase-negative
staphylococcus (CNS), one methicillin-susceptible Staphylococcus
aureus (MSSA)), six patients had catheter-related BSI (five CNS,
one vancomycin-resistant enterococcus (VRE)), eight patients had
nonbacteremic catheter-related infection (seven CNS, one VRE),
two patients had wound infection caused by MSSA and one
patient had defibrillator-wire endocarditis caused by CNS. Seven
patients received daptomycin as empiric therapy without laboratory
documentation. All bacterial isolates were tested for susceptibility
to daptomycin (MIC <2 μg/ml was considered sensitive). Most
patients received daptomycin at a dosage of 4–6 mg/kg intra-
venously every 24 hours. The dosing frequency was adjusted to
once every 48 hours or thrice weekly in all patients who had
received hemodialysis. Prior and concomitant antibiotic therapy
had been administered to all patients.
Overall, 22 (73.3%) of the 30 patients improved and were
discharged. Eight patients died of complications of their underlying
medical conditions. CNS was the most common pathogen (19
patients, six of whom died). No adverse events were attributed to
daptomycin.
Conclusions Given the limitations of this registry because of its
retrospective nature, daptomycin appears promising for the
treatment of Gram-positive bacteremia, including catheter-related
BSI by CNS. It has a safety profile similar to other agents
commonly administered. Clinical experience will help define its role
in the treatment of catheter-related BSI, foreign body endocarditis
and multidrug-resistant Gram-positive bacteremia.
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Clinical cure and pathogen eradication rates by treatment group
TLV SA VAN SA TLV MRSA VAN MRSA
Clinical cure, n (%) 41 (85) 33 (70) 18 (86) 15 (71)
Pathogen eradication, n (%) 40 (83) 30 (64) 17 (81) 12 (57)
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Introduction Teicoplanin is a glycopeptide antibiotic. The principle
pharmacodynamic parameter is time dependency.
Methods A total of 16 critically ill patients were enrolled into the
study after informed consent. They were being treated for
suspected or documented Gram-positive infections. We adminis-
trated an initial loading dose of 10 mg/kg every 12 hour for three
doses, followed by a maintenance dose based on therapeutic drug
monitoring and therapy personalization by Bayesian computerized
software. For the maintenance dose we divided patients into two
groups; in the first group teicoplanin was administrated inter-
mittently every 24 hours (control group), in the second group by
continuous infusion (study group). Adequate drug exposure was
defined as a plasma level concentration >10 mg/l or greater. Blood
samples for therapeutic drug monitoring were collected immediately
before teicoplanin administration. When the pathogen agents were
isolated, bacteriostatic and bactericidial properties of the serum
were tested in both groups.
Results No differences between groups were found regarding
mortality and renal damage. In the study group we reached greater
level of teicoplanin despite the same amount of drug (Figure 1). To
reach an adequate plasmatic level we had to increase the amount of
teicoplanin in four patients in the control group, but we halved the
dose in one patient and brought it down to one-quarter in another
one in the study group. Bactericidial serum activity was greater in the
continuous group, although without statistical significance (Figure 1).
Conclusions Our data suggest that the administration of
teicoplanin by continuous intravenous infusion compared with the
intermittent mode might be more efficient in critically ill patients.
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Introduction Nosocomial infections are responsible for significant
morbidity and mortality in ICU patients. This is particularly
important considering the emergence of multidrug-resistant
bacteria. Our aim was to retrospectively study the bacterial
population responsible for colonization and infection of patients
hospitalized in a multidisciplinary seven-bed ICU in a general
hospital, as well as antibiotic resistance, during a 4-year period.
Methods Nine hundred and forty-eight patients were admitted to
the ICU from September 2003 to September 2007. Blood,
bronchial aspirates, urine, pus, drainage fluid (trauma, pleural,
ascitic) and central venous catheter (CVC) tips were cultured for
diagnostic purposes as well as for colonization surveillance.
Results Gram-negative bacteria were most commonly isolated
(59%). The most frequent isolates were Acinetobacter baumannii
(35%) and coagulase-negative Staphylococci (CNS) (30%)
followed by Klebsiella pneumoniae (12%) and Pseudomonas
aeruginosa (12%). Enterococci (6%) and Staphylococcus aureus
(4.6%) were rarely isolated.
Seventy-five percent of S. aureus strains were methicillin resistant,
but all were sensitive to linezolid, teicoplanin and vancomycin.
Ninety percent of CNS strains were methicillin resistant, 1.1% was
resistant to linezolid, 3.3% were resistant to teicoplanin, but all
strains were sensitive to vancomycin. Four percent of
Enterococcus strains were resistant to linezolid, while teicoplanin
and vancomycin resistance was 32.6% and 35.8%, respectively.
Ninety-seven percent and 68% of A. baumannii strains were
resistant to aminoglycosides and carbapenemes, respectively,
while resistance to colimycin showed a significant increase during
the last 2 years (from 5% to 16%). K. pneumaniae strains were
resistant to aminoglycosides in 40%, aztreonam in 57%, and
carbapenemes in 52%, while they were found to have an
increasing resistance to colimycin with time (18% in 2006 to 34%
in 2007). Finally, only one P. aeruginosa strain was found to be
colimycin resistant.
Conclusions Gram-negative resistant strains predominate among
our ICU bacterial population. During the 4-year study period the
overall bacterial resistance, although high, remains relatively stable.
Emerging Gram-negative bacterial resistance to colimycin poses a
potential therapeutic problem for the future.
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Introduction A prospective cohort study was undertaken to
determine the usefulness of surveillance cultures to classify ICU
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infections and to predict the causative agent of ICU-acquired
infections.
Methods A total of 48 community patients (36 men, 11 women,
age 50.17 ± 17.974 years, APACHE II score 13.51 ± 6.153) who
were expected to stay in the ICU for >5 days were included in this
study. Surveillance cultures of the throat and rectum were obtained
on admission and thereafter at days 4, 8 and 12 to look for
potentially pathogenic microorganisms (PPMs) in order to distin-
guish the community acquired from those acquired during the ICU
stay. The epidemiological data and the alteration of carriage state of
the patients during these days were recorded. Total infection
episodes were classified into three categories according to the
carrier state: primary endogenous infection (PEI), caused by PPMs
carried by the patient in surveillance cultures on admission;
secondary endogenous infection (SEI),caused by PPMs of the ICU
environment, yielded both in surveillance and diagnostic cultures;
and exogenous infection (EXI) for those caused by PPMs that did
not yield in surveillance cultures. Statistical analysis was made using
Pearson x2, paired t test, and ROC curve. P value ≤ a, a = 5%.
Results On day 4, colonization was detected by throat and rectum
surveillance cultures in 81.1% and 75% of patients, respectively
(P <<0.05). The most common microorganism isolated in
surveillance cultures from the throat was Acinetobacter baumannii
(22.9%) and that from the rectum was Escherichia coli (15.7%). A
total of 100 infections were described during the patients’ ICU
stay (length of stay: 26.44 ± 17.95) distinguished in 28 PEI, 44
SEI and 25 EXI. ICU-acquired infections were 69% of cases. The
mean day of PEI diagnosis was 6.2 ± 4.7, of SEI was 12.6 ± 8.2
and of EXI was 12.6 ± 7.3. The causative agent could be
predicted in 72% of infections. The sixth day was the cutoff point
to predict the causative microbial agent from the surveillance
cultures (sensitivity 80%, specificity 74.6%). Isolation of A.
baumannii in surveillance cultures had a probability of 92.1% to
cause infection.
Conclusions Our data suggest that surveillance cultures may offer
useful information to improve hygiene in the ICU, to determine the
causative agent of infection and to follow better antimicrobial
policy.
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Introduction The increased incidence of nosocomial infections by
multidrug-resistant Acinetobacter baumannii creates demand on
the application of some combinations of older antimicrobials on
that species. We conducted the present observational study to
evaluate the efficacy of intravenous and aerosolized colistin
combined with rifampicin in the treatment of critically patients with
nosocomial infections caused by multiresistant A. baumannii.
Methods Critically ill patients with nosocomial infections caused
by A. baumannii resistant to all antibiotics except colistin in a
medical ICU were included. Diagnosis of infection was based on
clinical data and isolation of bacteria. The bacterial susceptibilities
to colistin were tested. Clinical response to colistin and rifampicin
was evaluated.
Results There were 26 patients (age 43.58 ± 18.29 years,
APACHE II score 6.35 ± 2.99), of whom were 16 cases of noso-
comial pneumonia treated by aerosolized colistin (1 x 106 IU three
times/day) associated with intravenous rifampicin (10 mg/kg every
12 hours), nine cases of bacteraemia treated by intravenous
colistin (2 x 106 IU three times/day) associated with intravenous
rifampicin (10 mg/kg every 12 hours) in which three cases associa-
ted with ventilator-associated pneumonia, and one case of
nosocomial meningitis treated by intrathecal use of colistin
associated with intravenous rifampicin. The clinical evolution was
favourable for all ill patients. Concerning side effects, we noticed a
moderate hepatic cytolysis in three patients.
Conclusions This is a clinical report of colistin combined with
rifampicin for treatment of A. baumannii infection. Despite the lack
of a control group and the limited number of patients, the results
seem to be encouraging.
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Introduction The aim of the study was to calculate the incidence
of bacteremias due to multidrug-resistant (MDR) Gram-negative
bacteria (GNB) and to detect any emerging trends during a 3-year
period.
Methods A prospective study of bloodstream infections in an ICU
of a tertiary care hospital. The data collected prospectively
included epidemiological and clinical characteristics of all patients
admitted to the ICU from September 2004 to August 2007, the
bacteria isolated from bloodstream infections and their patterns of
resistance. A bacterium was characterized as MDR when it was
resistant to three classes of antibiotics and as MDRc when it was
also resistant to carbapenems. The study was divided into nine 4-
month periods in order to calculate the incidence of MDR
bacteremias in each such period and to evaluate each bacterium
separately.
Results During this study 390 patients were admitted to the ICU,
of whom 60% were male. Their mean age was 65 years, the mean
APACHE score was 17.9 and the mean duration of stay in the ICU
was 18 days. One hundred bacteremias due to MDR GNBs were
recorded. Of the isolated MDR bacteria, 77 were MDRc and 95%
of those 77 were Acinetobacter baumannii (25 isolates), Pseudo-
monas aeruginosa (20 isolates) or Klebsiella pneumoniae (28
isolates). A clear trend emerged for K. pneumoniae, whose
incidence increased exponentially during the study period. Of the
28 isolates of MDRc K. pneumoniae, 7% were recorded during the
first 12 months of the study, 33% during the next 12 months and
60% during the last 12 months. The incidence of A. baumannii
remained relatively stable (36%, 32% and 32% of isolates were
recorded during each 12-month period) and the same was true for
P. aeruginosa (25%, 40% and 35%, respectively).
Conclusions The incidence of bacteremias due to MDR GNBs
that are also resistant to carbapenems is high in our ICU.
Bacteremias due to MDRc K. pneumoniae have risen dramatically
during the past months. Further studies are needed to investigate
the risk factors and develop strategies to confront the problem.
References
1. Kollef M: Chest 2006, 130:1293-1296.
2. Patel G: J Pharm Practice 2005, 18:91-99.
Critical Care    March 2008 Vol 12 Suppl 2 28th International Symposium on Intensive Care and Emergency Medicine
S15
P36
Colonization and infection by potential Gram-negative
multiresistant microorganism in a medical–surgical ICU
L Lorente Ramos, C García, J Iribarren, J Castedo, R Galván, 
J Jiménez, M Brouard, R Santacreu, L Lorenzo, M Martín, M Mora
Hospital Universitario de Canarias, La Laguna, Tenerife, Spain
Critical Care 2008, 12(Suppl 2):P36 (doi: 10.1186/cc6257)
Introduction To determine the rate of colonization/infection by
potential Gram-negative multiresistant microorganisms (pseudo-
monas, stenotrophomonas and acinetobacter) in critically ill patients.
Methods A prospective study for 30 months in the ICU. Throat
swabs, tracheal aspirates and urine were taken on admission and
twice weekly. The infections were classified based on thorat flora
as: primary endogenous (PE), caused by germs that were already
colonizing the throat on ICU admission; secondary endogenous
(SE), caused by germs that were not colonizing the throat on ICU
admission but were acquired during the stay in the ICU; and
exogenous (EX), caused by germs that were not colonizing the
throat. The infections were classified based on the onset as: early
onset (EO), when developed during the first 4 days of ICU stay;
and late onset (LO), when developed 5 days after ICU admission.
Results In total 1,582 patients were admitted. The mean APACHE
II score was 13.95 (±8.93). Mortality was 14.79%. A total of 80
patients had colonization by pseudomonas, 26 patients at ICU
admission and 54 patients during the ICU stay. We documented
46 infections by pseudomonas (nine EO and 37 LO; four PE, 35
SE and seven EX) with death in 13/46 patients (28.26%): 31
pneumonias (six EO and 25 LO; two PE, 24 SE and five EX),
seven urinary tract infections (one EO and six LO; two PE, three
SE and two EX), five primary bacteremias (two EO and three LO;
five SE), two surgical wound infections (two LO and SE) and one
pressure sore infection (one LO and SE). A total of 14 patients had
colonization by stenotrophomonas, one patient at ICU admission
and 13 patients during the ICU stay. We documented eight
infections by stenotrophomonas (two EO and six LO; seven SE
and one EX) with death in 3/8 patients (37.50%): all were
pneumonias. A total of 12 patients had colonization by
acinetobacter, one patient at ICU admission and 11 patients
during the ICU stay. We documented eight infections by acineto-
bacter (two EO and six LO; seven ES and one EX) with death in
2/8 patients (25%): six pneumonias (two EO and four LO; five SE
and one EX) and two bloodstream infection (two LO and two SE).
Conclusions In our series, most of the infections caused by
pseudomona, stenotrophomonas and acinetobacter were pneumo-
nias, had a late onset and were secondary endogenous infections.
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Introduction Over the past two decades, Acinetobacter baumannii
has emerged as an important nosocomial pathogen, and hospital
outbreaks caused by this organism have increased worldwide. Its
extraordinary ability to acquire resistance to almost all groups of
commercially available antibiotics is a clinical problem of great
concern. In fact, most A. baumannii strains isolated in the ICU are
highly resistant to carbapenems, aminogylcosides and β-lactam
antibiotics. The aim of this study is to determine the change in the
resistance pattern of A. baumannii through the years.
Methods Isolates from patients admitted to the ICU in 2003 and
2007 were analyzed. Both colonization and infection isolates were
evaluated. In 2003, 118 isolates from 51 patients and in 2007,
108 isolates from 21 patients were included in the study. The
clinical specimens were sampled from the tracheal aspirate,
abscess, blood, wound, urine, pleura fluid, catheter and ascites.
Susceptibilities to seven antibiotics were determined.
Results Patterns of resistance in 2003 and 2007 were:
54.7%/28.6% sulbactam–cefoperazone, 66.1%/85.7% imipenem,
96.6%/95.2% piperacillin–tazobactam, 66.1%/61.9% cefepime,
4.3%/0% colistin, 76.3%/85% amikacin, and 60.2%/66%
tobramycin, respectively. Even though tobramycin is not on the
market in Turkey, drug resistance has been increased in 4 years.
Conclusions Colistin seems to be the best alternative in our
hospital but, since it is not on the market in our country, the use of
it is limited. Carbepenems are therefore the first choice in the
treatment of multidrug-resistant A. baumannii in our country. This
choice causes increased carbepenem resistance in A. baumannii
isolates. Our hospital’s antibiotic treatment policies and the cyclic
usage of antibiotics must be reconsidered.
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Introduction Which venous catheterization site is associated with
the higher risk of infection remains controversial. In the CDC
guidelines of 1996 and in the latest guidelines of 2002, central
venous catheter (CVC) insertion at the subclavian site is recom-
mended rather than a femoral or a jugular access to minimize
infection risk. The objective of this study was to analyze the
incidence of catheter-related bloodstream infection (CRBSI) of
CVCs according to different accesses.
Methods A prospective and observational study, conducted in a
polyvalent medical–surgical ICU. We included all consecutive
patients admitted to the ICU during 4 years (1 May 2000–30 April
2004). The comparison of CRBSI incidence per 1,000 catheter-
days between the different central venous accesses was
performed using Poisson regression. P < 0.05 was considered
statistically significant.
Results The number of CVCs, days of catheterization duration,
number of bacteremias and the CRBSI incidence density per
1,000 days were: global, 1,769, 15,683, 48 and 3.06; subclavian,
877, 7,805, 8, 1.02; posterior jugular, 169, 1,647, 2 and 1.21;
central jugular, 515, 4,552, 22 and 4.83; and femoral, 208, 1,679,
16 and 9.52. The CRBSI incidence density was statistically higher
for femoral than for central jugular (OR = 1.40, 95% CI =
1.04–infinite, P = 0.03), posterior jugular (OR = 1.99, 95% CI =
1.30–infinite, P < 0.001) and subclavian accesses (OR = 9.30,
95% CI = 4.27–infinite, P < 0.001); for central jugular than for
posterior jugular (OR = 3.98, 95% CI = 1.15–infinite, P = 0.03)
and subclavian accesses (OR = 4.72, 95% CI = 2.27–infinite, P <
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0.001); and there were no significant differences between
posterior jugular and subclavian access (OR = 1.09, 95% CI =
0.43–infinite, P = 0.99).
Conclusions Our results suggest that the order for venous
punction, to minimize the CVC-related infection risk, should be
subclavian or posterior internal jugular as the first option,
subsequently central internal jugular and finally the femoral vein.
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Introduction Catheter-related infections account for a large part of
all nosocomial infections, and clinical studies have suggested that
impregnation of catheters with antiseptics or antibiotics could
decrease the rates of colonization. The purpose of this study was
to assess the efficacy of oligon catheters to reduce bacterial
colonization.
Methods A prospective, randomized clinical study was conducted
among patients admitted to our 16-bed cardiac surgery ICU from 1
December 2006 to 1 December 2007 who required a central
venous catheter after cardiac surgery. A total of 139 patients were
prospectively randomized to receive either an oligon (O group, n =
69) or a standard catheter (S group, n = 70), expected to remain in
place for ≥3 days. Catheter colonization, catheter-related blood-
stream infection and nonbacteremic catheter-related infection were
defined according to the Center for Disease Control and
Prevention. Blood cultures were drawn at catheter removal, and
the removed catheters were analyzed with quantitative cultures.
Catheters were removed aseptically if no longer necessary, the
patient died or there were signs of sepsis.
Results A total of 69 catheters were studied in the oligon group
and 70 in the standard group. Characteristics of the patients, the
insertion site, the duration of catheterization, and other risk factors
for infection were similar in the two groups. Catheter colonization,
3 (4.35%) in O group versus 3 (4.28%) in S group, failed to reach
significance despite the relative long median duration of
catheterization of 9 days versus 8 days, respectively. When
catheter colonization occurred, coagulase-negative staphylococcus
was found most frequently in both groups.
Conclusions Oligon central venous catheters did not significantly
reduce bacterial catheter colonization or the catheter-related
infection rate compared with the standard catheters. This means
that usual preventive measures are the cornerstone to control
catheter-related infections.
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Introduction We conducted a national multicenter randomized
clinical trial to compare the efficacy of a novel anti-infective central
venous catheter (CVC) coated with 5-fluorouracil (5-FU)
(Angiotech Pharmaceuticals, Vancouver, Canada) with a catheter
coated with chlorhexidine and silver sulfadiazine (CH-SS)
(ARROWgard Blue; Arrow International, Inc., Reading, PA, USA) in
preventing catheter colonization, local site infection and catheter-
related bloodstream infection (CRBSI).
Methods Male and nonpregnant female subjects ≥18 years, who
were initially hospitalized in an ICU and required insertion of a
triple-lumen CVC, were randomized (1:1) to receive either the 5-FU
or CH-SS CVCs, implanted for a maximum of 28 days. Upon
removal, catheter tips were cultured using the roll-plate method.
CRBSI was defined as isolation of the same species from
peripheral blood and the catheter tip. Incidence rates of bacterial
catheter colonization between the two treatments were compared
using the Cochran–Mantel–Haenszel χ2 test. To evaluate bacterial
isolates for evidence of acquired 5-FU resistance, isolates cultured
from catheter tips were exposed to 5-FU in vitro for a second time.
Results Of 960 subjects who were randomized, 817 completed
the study. Four hundred and nineteen were randomized to the 5-
FU group and 398 to the CH-SS group. The rate of colonization of
5-FU catheters was 2.9% (n = 12) compared with 5.3% (n = 21)
in the CH-SS-coated catheters (relative reduction in colonization
with 5-FU coating of 46%, P = 0.055). There were no statistically
significant differences (5-FU vs CH-SS) in local site infections
(1.4% vs 0.9%), CRBSI (0% vs 2.8%), and the rate of adverse
events related to the study devices (3.4% vs 3.5%). There was no
evidence for acquired resistance to 5-FU in clinical isolates
exposed to the drug for a second time.
Conclusions The CVC coated with 5-FU is noninferior in its ability
to prevent bacterial colonization of the catheter tip when compared
with catheters coated with CH-SS.
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Introduction The use of systemic aminoglycosides to treat
ventilated patients with Gram-negative pneumonia (GNP) is limited
by their toxicity and poor penetration into the lung. Luyt and
colleagues demonstrated high amikacin epithelial lining fluid (ELF)
concentrations after NKTR-061 twice daily, amikacin 400 mg
(3.2 ml), administration to intubated patients with pneumonia (n =
4) [1]. The present study was conducted to confirm high levels of
NKTR-061 in the ELF in the pneumonic portion of the lung after
400 mg twice daily dosing.
Methods NKTR-061 was delivered via the pulmonary drug delivery
system (PDDS® Clinical; Nektar Therapeutics) in mechanically
ventilated patients with GNP for 7–14 days. The aerosol therapy
was adjunctive to intravenous therapy per ATS guidelines. Twenty-
eight evaluable patients received a daily dose of 800 mg in two
divided doses every 12 hours. On treatment day 3, all patients
underwent bronchoalveolar lavages 30 minutes post aerosol. The
lung fluid was obtained from the infection-involved area of the lung.
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The apparent volume of ELF recovered by bronchoalveolar lavage
was determined using urea as an endogenous marker of dilution.
The same day, the amikacin concentration was determined in
serum collected 0.5, 1, 3, 6, 9, 12, 13, and 24 hours after delivery
of the morning dose.
Results The median ELF amikacin was 976.1 μg/ml (135.7–
16,127.6), whereas the median (range) serum maximum concen-
tration was 0.9 μg/ml (0.62–1.73). The median days of aerosol
treatment was 7 days (2–10).
Conclusions Delivery of aerosolized amikacin using the PDDS
Clinical achieved very high aminoglycoside concentrations in the
ELF, in the pneumonic area of the lung, while maintaining safe
serum amikacin concentrations. The ELF concentrations achieved
always exceeded the amikacin MIC for microorganisms usually
responsible for GNP. The clinical impact of this route remains to be
determined.
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Introduction Intravenous antibiotics (AB) have a clinical cure rate
of ~55% in mechanically ventilated patients (MVP) with pneumonia.
AB inhalation delivers larger lung doses than intravenous AB, but is
problematic in MVP due to inefficient and variable current delivery
systems. NKTR-061, a proprietary amikacin (AMK) aerosolization
system optimized for ventilator circuits, is in clinical development
as an adjunct to intravenous AB therapy for the treatment of
pneumonia.
Methods In a phase II study, MVP (n = 44) received 400 mg every
24 hours or every 12 hours for 7–14 days; serial serum, tracheal
aspirate and urine samples were collected on day 3. The days on
vent and intravenous AB use were monitored. In a separate study,
healthy subjects (n = 14) inhaled a single Technicium 99m-labeled
400 mg dose; serum and urine were collected and lung deposition
was determined with gamma scintigraphy.
Results The AMK lung dose in healthy subjects was 172.2 mg,
43% of the nominal dose. The lung dose in MVP was 112 mg, with
the difference arising from loss of drug in the ventilator circuit. The
predicted peak lung AMK in healthy subjects (Figure 1) ranged
from 75 to 165 μg/g. The peak tracheal aspirate AMK after
NKTR-061 was 16,212 ± 3,675 μg/ml versus 14 ± 4.2 μg/ml after
intravenous (15 mg/kg [1]); the peak serum AMK after NKTR-061
was 3.2 ± 0.5 μg/ml versus 47 ± 4.2 μg/ml after intravenous.
NKTR-061 caused a significant (P = 0.02) dose-dependent
reduction in intravenous AB use, with MVP dosed every 12 hours
requiring half as much concurrent intravenous AB after 7 days of
treatment as those receiving placebo [2].
Conclusions NKTR-061 achieves AMK lung exposures in MVP
much greater than those after intravenous dosing. Greater lung
exposure with concurrent lower overall dose and serum exposure
is expected to increase efficacy, reduce the incidence of AB
resistance and limit systemic AB toxicity.
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Introduction Thoracic empyema remains a serious illness that
usually represents a complication of pneumonia in susceptible
patients. Our exploratory study aims to describe this potentially
fatal disease and identify clinically useful correlations that would
lead to more effective management and treatment.
Methods We performed a retrospective review of patients
hospitalized between the years 1996 and 2006 at Forum Health –
WRCS. Demographics, initial symptoms and signs, underlying
diseases, pleural fluid analysis and cultures, chest CT reports,
length of stay and outcome were reviewed.
Results The charts of 104 patients who filled the above criteria
were reviewed. Their age ranged from 10 months to 87 years;
52% were nonsmokers. The main presenting symptoms were
dyspnea (65%), fever (60%), cough (60%), chest pain (45%)
weight loss (14%) and hemoptysis (9%). Approximately 22% of
the patients had an underlying malignancy. Other underlying
chronic illnesses included chronic obstructive pulmonary disease
(27%), congestive heart failure (24%), and diabetes (21%). Pleural
fluid Gram stain was positive in 25% of the patients and pleural
fluid cultures in 49%. Of those with positive cultures, Gram(+)
aerobes were found in 60%, Gram(–) in 24% and anaerobes in
only 12%. Treatment of the patients included: repeat thoracentesis
(effective in only two patients); intrapleural thrombolysis performed
in five patients, effective in four; and chest tube drainage
(performed in 80% of the patients). Approximately one-half of them
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required further procedures: video-assisted thoracoscopic surgery
was performed in 10 patients (10%), six of whom required subse-
quent thoracotomy; and thoracotomy and decortication (performed
in 46% of the patients). Overall mortality was 9% and surgical
mortality was 2.1%.
Conclusions Clinical suggestions arising from our study are as
follows. Empyema is a fatal complication of pneumonia and should
always be suspected in patients with nonimproving pneumonia.
Early aggressive antibiotic therapy targeting Gram-positive aerobes
should be initiated. An underlying malignancy should be always
considered in the differential diagnosis. Cardiothoracic surgeons
should always be consulted early in the clinical course for
evaluation of a possible video-assisted thoracoscopic surgery or
thoracotomy.
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Introduction The objective of the study was to validate specific
rules and nonspecific scores for prediction of mortality in patients
with severe community-acquired pneumonia (CAP).
Methods The study included 300 patients with CAP admitted to six
ICUs of the city during 2005–2006. On admission each of the
patients was assessed using the specific rules PORT, CURB-65,
CRB-65, SMART-CO, and SOFA and APACHE II scores with
regards to pneumonia severity and mortality. All data were analysed
and processed on receiver operating characteristic curves.
Results See Table 1. The results of analysis demonstrated high
predictive values of the specific rule CAP and SOFA score. The
areas under the receiver operating characteristic curves
(AUROCs) were compared. The APACHE II score did not have
prognostic ability, because the difference in AUROC did not have
statistical significance to the diagonal: 0.71 ± 0.17 (P = 0.2).
PORT and SOFA scores have maximal sensitivity and specificity:
92.3 (63.9–98.7) and 81.0 (65.9–91.4).
Table 1 (abstract P44) 
Score AUROC 95% CI P value
PORT 0.88 0.7 –0.9 <0.01
CURB-65 0.86 0.6–0.9 <0.01
CRB-65 0.84 0.7–0.9 <0.01
SMRT-CO 0.77 0.6–0.9 <0.01
SOFA 0.90 0.8–0.96 <0.01
APACHE-2 0.71 0.4–0.91 >0.05
Conclusions The specific rules PORT, CURB-65, CRB-65,
SMART-CO and SOFA score are comparatively informative and
valuable in predicting short-term mortality in severe CAP. The
APACHE II score is of low specificity and cannot be used for
prediction outcomes.
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Introduction To study the clinical and paraclinical response to
therapy in patients with ventilator-associated pneumonia (VAP).
Methods A prospective, 4-year study of 450 patients ventilated
over 48 hours. Patients were compared according to four age
groups: Group I (<35 years), Group II (35–55 years), Group III
(55–79 years) and Group IV (>80 years). Patients and VAP
characteristics, ICU and hospital lengths of stay (LOSs), duration
of mechanical ventilation (MV)–intubation (TT), patient outcome
and the first day of normalization of each clinical and paraclinical
parameter were studied using Pearson’s chi-square test and one-
way ANOVA.
Results One hundred and thirty-four patients developed VAP.
Twenty-five (18.6%) patients of Group I had (mean ± SD)
APACHE II score 16.5 ± 3.6, MV 19.08 ± 7.8, TT 21.7 ± 8.4, ICU
LOS 25.04 ± 11.5 days, hospital LOS 18.4 ± 10.3 days, ICU
mortality 3 (12%), hospital mortality 0 (0%). Thirty-eight (28.4%)
patients of Group II had APACHE II score 18.5 ± 5.7, MV 24.08 ±
10.8, TT 29.7 ± 10.6, ICU LOS 33.04 ± 12.5 days, hospital LOS
28.4 ± 11.3 days, ICU mortality 5 (20.8%), hospital mortality 6
(21.4%). Sixty (44.8%) patients of Group III had APACHE II score
21.4 ± 5.6, MV 31.1 ± 16.5, TT 32.8 ± 16.8, ICU LOS 37.04 ±
13.8 days, hospital LOS 34.2 ± 14.1 days, ICU mortality 15
(25%), hospital mortality 16 (26.6%). Ten (7.5%) patients of
Group IV had APACHE II score 26.3 ± 4.5, MV 41.6 ± 10.5, TT
45.8 ± 14.7, ICU LOS 49.04 ± 15.2 days, hospital LOS 47.6 ±
18.7 days, ICU mortality 3 (30%), hospital mortality 5 (50%). The
APACHE II score (P < 0.001), duration of MV (P < 0.02) and TT
(P < 0.04), hospital mortality (P < 0.001), hospital LOS (P < 0.01),
and MODS (P < 0.04) differ statistically significantly. ICU mortality
(P < 0.4), CPIS (P < 0.7), and duration of antibiotic treatment (P <
0.6) did not differ significantly. VAP was caused by MDR Gram(–)
microorganisms, except for three cases caused by MRSA (P <
0.8). Time resolution for temperature was 7 days (6.6. ± 1.1, P <
0.1), leucocyte 6 days (5.8 ± 1.2, P < 0.5), hemodynamic stability
5 days (4.8 ± 0.8, P < 0.3), normalization of PaO2/FiO2 4 days
(3.9 ± 0.7, P < 0.07), and microbiological eradication 10 days
(9.3 ± 1.1, P < 0.3). Colonization after VAP resolution was higher
in the elderly patients (P < 0.02).
Conclusions Age does not influence the clinical response to
therapy. Patients in whom the tracheobronchial aspirates were not
sterilized after the resolution of VAP are at higher risk of a longer
time of hospitalization and of dying after discharge from the ICU.
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Introduction To compare the incidence of ventilator-associated
pneumonia (VAP) using an endotracheal tube with a polyurethane
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cuff, designed to reduce channel formation, and subglottic
secretion drainage (ETT-PUC-SSD) versus an conventional
endotracheal tube (ETT-C) with a polyvinyl cuff and without
subglottic secretion drainage.
Methods A clinical randomized trial, between 1 March 2006 and
31 October 2006 in a medical–surgical ICU. Were included
patients requiring mechanical ventilation during more than
24 hours. Patients were randomized into two groups: one group
was ventilated with ETT-PUC-SSD and another group with ETT-C.
Throat swabs and tracheal aspirates were taken at the moment of
admission and twice a week until discharge. The infections were
classified based on thorat flora as: primary endogenous, caused by
germs that were already colonizing the throat on the ICU
admission; secondary endogenous, caused by germs that were not
colonizing the throat on the ICU admission but were acquired
during the stay in ICU; and exogenous, caused by germs that were
not colonizing the throat.
Results There were no significant differences between both
groups of patients in age, sex, diagnosis groups, APACHE II score,
pre-VAP use of antibiotics, paralytic agents, reintubation,
tracheostomy, and days on mechanical ventilation. VAP was found
in 31 of 140 (22.1%) patients in the ETT-C group and in 11 of 140
(7.9%) in the ETT-PUC-SSD group (P = 0.001). Cox regression
analysis showed CET as a risk factor for global VAP (hazard rate =
3.3, 95% CI = 1.66–6.67, P = 0.001), primary endogenous VAP
(hazard rate = 5.12, 95% CI = 1.12–23.38, P = 0.04) and
secondary endogenous VAP (hazard rate = 2.87, 95% CI =
1.20–6.84, P = 0.02); but not for exogenous VAP.
Conclusions The endotracheal tube with a polyurethane cuff and
subglottic secretion drainage is effective to prevent primary
endogenous and secondary endogenous VAP.
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Introduction The objective was to evaluate the effect of con-
tinuous aspiration of subglottic secretions (CASS) on the preven-
tion of ventilator-associated pneumonia (VAP) in mechanically
ventilated patients.
Methods Patients ventilated mechanically in the ICU from October
2004 to April 2006 were randomly divided into two groups: one
group of patients was treated with CASS and the other group of
patients was not (NASS group). The CASS was performed
immediately after admission in the CASS group of patients. The
diagnosis of VAP was made based on the clinical presentations,
and the evaluation of VAP was done using the simplified version of
the Clinical Pulmonary Infection Score. The general status of the
patients, days of ventilated treatment, the volume of daily aspirated
subglottic secretions, the morbidity and timing of VAP, days of stay
in ICU and mortality within 28 days of hospitalization were
recorded.
Results One hundred and one patients were included in the study.
There were 48 patients in the CASS group who were treated with
mechanical ventilation for longer than 48 hours, and 43 patients in
the NASS group. The median volume of aspirated subglottic
secretions within the first 24 hours in the CASS group of patients
(48 cases) was 28.8 ml. The morbidity of VAP in the CASS and
NASS groups of patients was 25.0% and 46.5%, respectively (P =
0.032), and the length of time before the onset of VAP in these two
groups of patients was 7.3 ± 4.2 days and 5.1 ± 3.0 days,
respectively (P = 0.088). There was a significant increase in the
percentage of Gram-positive cocci from the lower respiratory
tracts in the NASS group of patients compared with that in the
CASS group of patients (P = 0.004). In the CASS group of
patients, the volume of the first daily aspirated subglottic
secretions in patients with VAP was significantly less than that in
patients without VAP (P = 0.006). The morbidity of VAP in patients
with the failed early aspiration (volume of first daily aspirated
secretions ≤20 ml) was significantly higher than in patients who
were aspirated effectively (P < 0.01). The length of mechanical
ventilation time in patients with VAP was significantly longer than
that in patients without VAP (P = 0.000). The inhospital mortality in
patients with VAP was significantly higher than that in patients
without VAP (P = 0.009), and mortality in the 28 days after
admission in patients with VAP was significantly higher than that in
patients without VAP (P = 0.035).
Conclusions Effective continuous aspiration of subglottic
secretions could significantly reduce the morbidity of early-onset
VAP, and, accordingly, may decrease the mortality of critically ill
patients.
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Introduction Ventilator-associated pneumonia (VAP) remains a
major complication for patients incubated with ventilators. Most
cases are attributed to increased bacteria flora in the oropharyn-
geal secretion and aspiration of those organisms. Evidence exists
suggesting that oral care could reduce bacterial flora, prevent
aspiration, and subsequently decrease the incidence of VAP for
patients with ventilators. This study aims to evaluate the effective-
ness of a standardized oral care protocol in improving oral hygiene
and reducing the incidence of VAP in a sample of surgical patients
in the ICU (SICU).
Methods Patients newly admitted to the SICU who were under
ventilator support for 48–72 hours and without pneumonia present
were enrolled during March–November 2007 from a tertiary
medical center in Taiwan. Subjects were randomized into the
experimental or control groups and both received a 7-day oral care
protocol. For the experimental group (EG), a standardized 20-
minute oral care protocol was performed using an electronic tooth-
brush to clean and moisturize oral cavity twice daily. For the control
group (CG), a mimic 20-minute protocol involving moisturizing and
attention control was performed for the same intervals. The
incidence of VAP defined by the Clinical Pulmonary Infection
Score and the oral hygiene measured by the Oral Assessment
Guide (OAG) and plaque index were compared between the two
groups. Variables were compared by the analysis of Fisher exact
test, chi-square test, and Mann–Whitney U test. P < 0.05 was
considered significant.
Results Forty-four patients were studied with a mean age of
60.6 ± 16.1 years, 63.6% being males. The results showed that
the cumulative incidence of VAP was significantly lower in the EG,
with 22.7% occurrence in the EG and 77.8% in the CG on day 9
(P < 0.05). In terms of oral hygiene, subjects in the EG performed
significantly better on both OAG scores and plaque index.
Specifically, the OAG decreased from 16.3 ± 1.9 to 14.9 ± 2.6 in
the EG and remained high from 16.5 ± 1.6 to 16.6 ± 2.1 in the
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CG (P < 0.05). The plaque index was decreased from 0.76 ± 0.14
to 0.49 ± 0.18 in the EG and remained high from 0.74 ± 0.13 to
0.75 ± 0.21 in the CG (P < 0.05).
Conclusions The findings support the effectiveness of an oral care
protocol in preventing VAP and improving oral hygiene for patients
admitted to the SICU with ventilator support.
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Soluble triggering receptor expressed on myeloid cells-1
in bronchoalveolar lavage is not predictive for ventilator-
associated pneumonia
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Introduction The aim of the study was to evaluate the usefulness
of soluble triggering receptor expressed on myeloid cells-1
(sTREM-1) as a rapid diagnostic test for ventilator-associated
pneumonia (VAP). To develop a rapid diagnostic test for the diag-
nosis of VAP, a common complication of mechanical ventilation [1],
multiple biomarkers have been evaluated with variable results.
sTREM-1 proved to be a good biomarker for sepsis [2]. For the
diagnosis VAP, however, there have only been a few, relatively
small, studies on the role of this receptor [3].
Methods Retrospectively, 240 bronchoalveolar lavage fluid (BALF)
samples, taken from patients in the ICU of a university hospital, were
tested. sTREM-1 in BALF was measured using a quantitative
sandwich enzyme immunoassay. Two researchers, unaware of the
results of the assay, determined whether a VAP was present.
Clinical suspicion of a VAP was confirmed by the presence of ≥2%
cells containing intracellular organisms and/or a quantitative culture
result of >104 colony forming units/ml in BALF. The disease had to
be acquired after at least 48 hours of mechanical ventilation.
Results The mean concentration of sTREM-1 was significantly
higher in BALF of patients with confirmed VAP compared with
patients without VAP (P = 0.045). The area under the curve was
0.577 (95% CI = 0.503–0.651, P = 0.042). sTREM-1 levels in our
hands proved not to be discriminative for VAP. Choosing a
sensitivity of 95% resulted in a positive predictive value (PPV) of
41% and a negative predictive value (NPV) of 62% in our
population. Taking a specificity of 95% led to a PPV of 67% and a
NPV of 62%. sTREM-1 levels were not different in VAP cases
caused by Gram-positive or Gram-negative bacteria. sTREM-1
levels were higher in nonsurvivors compared with survivors,
regarding inhospital mortality.
Conclusions The results imply that the sTREM-1 assay in BALF is
not discriminative for VAP.
References
1. Jackson WL, et al.: Curr Opin Anaesthesiol 2006, 19:117-121.
2. Bouchon A, et al.: Nature 2001, 410:1103-1107.
3. Gibot S, et al.: N Engl J Med 2004, 350:451-458.
P50
Ventilator-associated pneumonia in an ICU: epidemiology,
etiology and comparision of two bronchoscopic methods
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Introduction Ventilator-associated pneumonia (VAP) is the most
important ICU-acquired infection in mechanically ventilated
patients that appears 48–72 hours after the beginning of
mechanical ventilation. The aim of this study was to evaluate the
incidence and microbiology of VAP and to compare two quanti-
tative bronchoscopic methods – bronchoalveolar lavage (BAL) and
bronchoscopic tracheobronchical secretion (TBS) – for the
diagnosis.
Methods The epidemiological and microbiological etiology of VAP
in a surgical ICU with 65 patients during a 1-year period was
evaluated in this prospective open, clinical study. The patients
were divided into two groups: group I, 30 patients with mechanical
ventilation longer than 48 hours with VAP (the case groups); group
II, 35 patients with mechanical ventilation longer than 48 hours
without VAP (the control group). Two types of quantitative
bronchoscopic methods for identifying the etiological agent were
compared (BAL and TBS).
Results Among 65 long-term ventilated patients, 35 developed
VAP (one more VAPs). VAP was caused predominantly by MRSA
(35%), Pseudomonas aeruginosa (28%), Klebsiella sp. (14%), and
Acinetobacter sp (14%). The treatment of patients with VAP who
were ventilated for a longer period in the ICU took longer
compared with patients without VAP. In our study, we did not find
an increased mortality rate in patients undergoing long-term
ventilation who acquired VAP compared with patients undergoing
long-term ventilation without VAP.
Conclusions The study showed that quantitative analysis for
identifying bacterial etiology of VAP with one of two accessible
bronchoscopic methods (BAL and TBS) produced identical results.
Reference
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Introduction Human metapneumovirus (hMPV) is a paramyxovirus
causing symptoms of the respiratory tract infection comparable
with those of respiratory syncytial virus. The virus can play a
causative role in respiratory tract infection in infants, the elderly and
immunocompromised patients. Analysis of bronchoalveolar lavage
fluid (BALF) samples obtained from patients with hematological
malignancies suspected of pneumonia often do not result in the
identification of a causative infectious organism. To investigate the
potential role of hMPV, we analysed BALF samples of these
patients for the presence of hMPV by means of real-time PCR.
Methods The study was conducted in the ICU and the hematology
ward of the University Hospital Maastricht. All consecutive BALF
samples obtained in the period April 1999–June 2006 from
patients with a hematological malignancy suspected of pulmonary
infection were eligible for inclusion. Data on the BALF total cell
count, differential cell count, quantitative bacterial culture and
detection of viruses, mycobacteria and fungi were noted. All
samples were analyzed by real-time RT-PCR targeting the nucleo-
protein gene of hMPV.
Results A total of 117 BALF samples from 95 patients (82
patients from the hematology ward, 15 ICU patients) were
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included. RNA of hMPV was detected in seven out of 117 (6%)
BALF samples from five patients (three patients from the hemato-
logy ward, two ICU patients). In two out of five hMPV-positive
patients, the underlying disease was non-Hodgkin lymphoma; the
other three patients suffered from multiple myeloma, myelodys-
plastic syndrome and mantle cell lymphoma. In one patient, four
BALF samples were retrieved within 1 month. The first three BALF
samples were hMPV PCR-positive, the fourth (collected 1 month
after the first) was PCR-negative. No other infectious agents were
detected in the hMPV-positive BALF samples. Neither the total cell
count nor the differential cell count was significantly differenced
between the hMPV-positive and hMPV-negative groups.
Conclusions In 6% of BALF samples collected from adult patients
with a hematological malignancy suspected of a pulmonary
infection, hMPV RNA was detected whereas no other infectious
agents were found. hMPV may thus be considered the causative
agent of pulmonary infection in patients with a hematological
malignancy when analysis for other infectious agents is negative.
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Introduction Sepsis, and its complications, is the main causes of
death in the ICU. New preventive measures for nosocomial
infections have been researched as an alternative to antibiotic
administration, such as probiotic usage.
Methods This clinical, randomized trial evaluated 49 patients who
were admitted to the ICU of Hospital Universitário Clementino
Fraga Filho and were mechanically ventilated. The patients were
randomized into one of four groups: control (n = 16), prebiotic (n =
10), probiotic (n = 12) or synbiotic (n = 11). Enteral nutrition,
fibers, and lactobacillus were administered for 14 days. Coloniza-
tion of the gastrointestinal tract, trachea, and the incidence of
nosocomial infections, particularly ventilation-associated pneumonia,
were measured. Other outcomes measured included duration of
mechanical ventilation, length of stay in the ICU, duration of
hospitalization, mortality rates, and development of organ dysfunction.
Results The groups were matched at admission. There was no
difference between the groups in relation to the incidence of
ventilator-associated pneumonia or the incidence of nosocomial
infection. There was a nonsignificant increase in the proportion of
enterobacteria in the trachea at the seventh day in the prebiotic
and probiotic groups compared with the control group. There was
a nonsignificant decrease in the number of bacteria found in the
stomach in the prebiotic, probiotic and synbiotic groups at day 7.
No significant difference with regard to the remaining measured
parameters could be found.
Conclusions Prebiotic, probiotic and synbiotic usage had no
effect in the colonization of the gastrointestinal tract and trachea of
mechanically ventilated patients.
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Introduction It is not yet clear whether surveillance of lower
respiratory tract secretions should be performed routinely and
which method should be used for this. The aim of the present
study is to investigate the value of quantitative (QC-ETA) and
nonquantitative (NQC-ETA) surveillance cultures in predicting the
causative pathogen of ventilator-associated pneumonia (VAP) in
patients receiving antibiotic therapy.
Methods A prospective, observational, cohort study carried out in
medical ICU of a tertiary hospital. One hundred and nine ICU
patients receiving mechanical ventilation for at least 4 days were
included in the study.
Results Concordance and discordance of causative pathogens of
VAP with prior quantitative and nonquantitative surveillance
cultures were assessed. Tracheal surveillance cultures were
obtained routinely at the time of intubation and thrice weekly. Each
sample was processed nonquantitatively and quantitatively (103
and 105 cfu/ml). Diagnosis of VAP was made with microbio-
logically confirmed clinical criteria (CPIS > 6 and growth > 105 cfu/ml
in ETA). Sixty-eight VAP episodes were developed during this
period. Sensitivity (63%, 28%), specificity (78%, 85%), positive
predictive value (82%, 76%), negative predictive value (56%,
41%), false positive (22%, 15%) and false negative (37%, 72%)
results of the NQC-ETA and QC-ETA were calculated, respec-
tively. NQC-ETA and QC-ETA predicted the causative pathogens
3.3 (2.7) days and 2.5( 1.7) days prior to the development of VAP
episodes, respectively.
Conclusions The results of this study suggest that NQC-ETA
would be an acceptable tool in surveillance for and predicting the
causative pathogen of VAP developing in patients who have
already received antibiotic therapy.
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Introduction Prevention of aspiration-induced ventilator-associa-
ted pneumonia (VAP) includes, among other factors, head
elevation‚ appropriate cuff pressure and correct positioning of
nasogastric tubes. The purpose of the study was to identify errors
regarding these prevention measures in critically ill ICU patients.
Methods We included all mechanically ventilated patients
hospitalized in our seven-bed ICU. We prospectively collected the
demographics and positioning of the patients (degrees)‚ cuff
pressures (mmHg) and correct position of the nasogastric tubes in
the stomach at 08:00 every day for six consecutive months.
Results We included 37 patients (25 males) of mean age 66.9 ±
3.3 years and illness severity scores of SAPS II 53.05 ± 1.5 and
SOFA 7.2 ± 0.3. In total we had 267 observations. The mean cuff
pressure was 26.8 ± 0.9 mmHg. The mean slope of the patients’
bed was 29.5 ± 0.4°. The mean volume of the oropharyngeal
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aspirates was 9.9 ± 0.4 ml and of tracheal aspirates was 7.1 ± 0.2 ml.
In 24 and 69 observations‚ tracheal and oropharyngeal aspirates,
respectively, were >10 ml. In 109/267 (40.1%) observations. the
slope of the patients was <30°. All patients had at least one
positioning with a slope <30°. In 64/267 (23.9%) observations,
the cuff pressures were <20.0 mmHg. One-half of the patients had
at least one measurement <20.0 mmHg. In 10 cases, the end of
the nasogastric tube was in the esophagus and in five cases it was
obstructed. Twenty patients developed VAP (20/37‚ 54.1%).
Patients with a large amount of oropharyngeal aspirates (>10 ml)
and low cuff pressures (<20 mmHg) had a significantly higher
incidence of subsequent VAP (72.2% vs 36.8%) compared with
those with a low amount of oropharyngeal aspirates (<5 ml) and
normal cuff pressures (chi-square test‚ P = 0.049; RR = 1.960‚
CI = 1.018–3.774; OD = 4.457‚ CI = 1.110–17.90).
Conclusions Errors regarding specific prevention measures of
VAP are frequently observed. Our data also show the significance
of the amount of oropharyngeal aspirates and cuff pressures for
the subsequent development of VAP. The tightness of the
stomach–oropharyngeal–tracheal axis seems to be a significant
factor influencing the subsequent development of VAP.
Reference
1. Chastre J: Respir Care 2005, 50:975-983.
P55
Clinical predictors for septic shock in patients with
ventilator-associated pneumonia
G Gursel, M Aydogdu
Gazi University School of Medicine, Ankara, Turkey
Critical Care 2008, 12(Suppl 2):P55 (doi: 10.1186/cc6276)
Introduction Ventilator-associated pneumonia (VAP) is one of the
most frequent infections of ICUs, and nearly 50% of patients
develop septic shock during VAP. Septic shock is an independent
predictor for mortality in these patients. The aim of this study is to
investigate the predictors for septic shock in patients with VAP
receiving appropriate antibiotic therapy.
Methods Eighty-nine patients with microbiologically confirmed
VAP and receiving appropriate antibiotic therapy were included in
the study. The patients were divided into two groups according to
the existence of septic shock. Clinical, hematological, biochemical
and microbiological characteristics of the patients were compared.
Results Thirty-one percent of the patients developed septic shock,
and advanced age (OR = 1.07, 95% CI = 1.02–1.13, P = 0.009),
lymphocytopenia <1,000 mm3 (OR = 7.48, 95% CI = 1.91–29,
P = 0.004), high blood glucose levels >120 mg/dl (OR = 4.75,
95% CI = 1.38–16, P = 0.014), and higher Clinical Pulmonary
Infection Scores (OR = 1.64, 95% CI = 1.16–2.33, P = 0.006)
were independent predictors for the development of septic shock.
Conclusions Some clinical parameters such as lymphocytopenia,
advanced age, higher blood glucose levels and Clinical Pulmonary
Infection Scores can predict septic shock during VAP but large
randomized controlled studies are needed to confirm these results.
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Introduction Although the benefit of antibiotic therapy in infectious
inflammatory diseases remains unquestioned [1], little is known
about the effects of these antibiotics on the inflamed
microcirculation independent of their antimicrobial property. The
aim of this study was to evaluate acute effects related to antibiotics
administration upon the intestinal microcirculation, which plays a
crucial role in the pathogenesis of sepsis and subsequent multi-
organ failure [2,3].
Methods Experimental sepsis was induced in 50 Lewis rats using
the colon ascendens stent peritonitis model [4]. Four frequently
used antibiotics were included in the study (20 mg/kg imipenem/
cilastatin (IMI), 25 mg/kg tobramycin (TOB), 70 mg/kg vancomycin
(VAN), 5 mg/kg erythromycin (ERY)). The antibiotics were
administered as a single intravenous bolus following 16 hours of
observation time. The intestinal functional capillary density and
leukocyte–endothelial interactions were evaluated using intravital
microscopy 1 hour following antibiotic treatment. Additional experi-
ments were performed in an abacterial setting with comparable
microcirculatory disturbances (2 hours endotoxemia; n = 50).
Results Acute IMI or TOB administration, respectively, did not
affect the intestinal microcirculation. VAN treatment aggravated the
leukocyte rolling behavior in this acute setting. In contrast, ERY
administration significantly reduced leukocyte activation and
improved the functional capillary density within the intestinal
microcirculation during experimental sepsis. These effects could
be confirmed during endotoxemia, suggesting that ERY exerts anti-
inflammatory effects in addition to its antibacterial action.
Conclusions When choosing antimicrobial agents in septic
conditions, possible effects of the antibiotics within the pathogene-
tically important intestinal microcirculation should be considered. In
conjunction with microbial sensitivity tests, the results of such
studies assist in selecting the appropriate antibiotic therapy.
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sequestration in the lung microvasculature is due to a
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Introduction Intraperitoneal injection of Gram-negative lipopoly-
saccharide (LPS) results in a profound decrease in circulating
leukocyte counts with a significant increase in neutrophil seques-
tration in the lung microvasculature as measured by lung myelo-
peroxidase levels. Mice made deficient in toll-like receptor 4 (TLR4)
are resistant to LPS challenges. Furthermore, it has been demon-
strated that the systemic effects of LPS are due to parenchymal,
possibly endothelial, cells and not due to bone marrow-derived
cells, such as leukocytes.
Methods C57B/6 mice were anesthetized and sacrificed.
Peritoneal lavage using 3 ml PBS followed by a gentle abdominal
massage for 1 minute was performed. Lavage fluid was aspirated
and centrifuged to concentrate the peritoneal cells. Cells were
then treated with normal saline or 10 μg LPS. The treated
peritoneal cells were then injected into the peritoneal cavities of
TLR4-deficient mice (C57B/10ScNJ) for a duration of 4 hours.
Measured outcomes included circulating leukocyte counts and
lung myeloperoxidase (MPO) levels.
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Results Normal saline-treated control C57B/6 mice had circulating
counts of 6.38 ± 0.56 million cells/ml, and the MPO levels in normal
saline-treated peritoneal cells transferred into C57B/6 mice were
5.80 ± 0.73 units. Normal saline-treated peritoneal cells of C57B/6
mice injected into TLR4-deficient mice resulted in circulating counts
of 5.18 ± 0.22 million cells/ml and MPO levels of 4.23 ± 0.73 units.
LPS-treated control C57B/6 mice had circulating counts of 1.94 ±
0.22 million cells/ml, and the MPO levels in LPS-treated peritoneal
cells transferred into C57B/6 mice were 16.52 ± 4.3 units. LPS-
treated peritoneal cells of C57B/6 mice injected into TLR4-deficient
mice resulted in circulating counts of 2.48 ± 0.44 million cells/ml
and MPO levels of 12.06 ± 1.74 units. The liver endothelium was
the only organ activated in this model. Furthermore, this process of
LPS-treated, peritoneal cell-induced neutrophil sequestration in the
lung microvasculature was found to be independent of mast cells
and NKT cells.
Conclusions An as yet to be identified factor, or factors, produced
from the peritoneal lavage cells, can produce neutrophil
sequestration in the lung microvasculature.
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Introduction A recent conference recommended that micro-
circulatory images should be analyzed with several scores that
evaluate density, flow and flow heterogeneity [1]. Following these
recommendations, we analyzed sublingual microcirculatory images
from septic shock patients to determine how these different scores
were correlated with each other and with clinical hemodynamic
and perfusion parameters.
Methods Using side dark-field videomicroscopy (Microscan®;
Microvision Medical) we repeatedly evaluated sublingual micro-
circulation at different time points in septic shock patients. In total,
we performed 17 microcirculatory single-time-point assessments
(3–6 site images/time point), in parallel with hemodynamic and
perfusion measurements (mean arterial pressure (MAP), nor-
adrenaline dose (NA), cardiac index (CI), mixed venous O2 satura-
tion (SmvO2), arterial lactate). Images were analyzed by semi-
quantitative scores of flow (mean flow index (MFI) and proportion
of perfused vessels (PPV)) and density (perfused vascular density
(PVD)) of small vessels (<20 μm). Heterogeneity indexes (Het
Index = maximum – minimum / mean) were calculated for the MFI
and PPV. Correlations between parameters were determined by
the Pearson coefficient and considered significant if P < 0.05.
Results We found that PVD was correlated to PPV (r = 0.55), and
negatively to Het Index PVD (r = –0.54) and Het index PPV (r =
–0.43), but we found no correlation of PVD with any homodynamic
or perfusion parameter. Flow indexes (PPV and MFI) were strongly
correlated with each other (r = 0.81) and inversely with their
respective heterogeneity indexes (PPV and Het Index PPV, r =
–0.88; MFI and Het Index MFI, r = –0.83). In addition, PPV and
MFI were correlated to SmvO2 (r = 0.44 and 0.52), and CI (r =
0.49 and 0.47), and inversely to lactate levels (r = –0.46 and
–0.4). Only the MFI was correlated to MAP (r = 0.5).
Heterogeneity indexes were correlated to lactate (r = 0.40 with
PPV and r = 0.44 with MFI), and inversely to MAP (r = –0.40 with
Het Index PPV and r = –0.64 with Het index MFI). The Het Index
MFI was also correlated to NA (r = 0.5).
Conclusions Higher microcirculatory flow scores, but not density,
are associated with higher CI and better systemic perfusion
parameters. Both MFI and PPV seem equally effective to assess
microcirculatory flow.
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Introduction Iloprost, a prostacyclin analogon, can probably
improve the microcirculation in various tissues. It may have a
positive effect on perfusion and function of the liver, especially in
patients after liver transplantation. We therefore estimated liver
function with the indocyanine green (ICG) plasma disappearance
rate (PDR). We also evaluated iloprost effects on microcirculation
in the oral mucosal tissue.
Methods Sixteen patients after orthotopic liver transplantation
were randomly included in the study. They received either iloprost
(n = 9) or placebo (n = 7). Iloprost was given in a dose of 1 ng/kg/min.
The oral mucosal tissue oxygen saturation, microcirculatory blood
flow and blood flow velocity were measured in a depth of one with
a laser Doppler flowmetry and remission spectroscopy system
(O2C; LEA, Gießen, Germany). The ICG-PDR was determined
with the LIMON (Pulsion, München, Germany). All measurements
were performed 6 hours, 12 hours, 24 hours, 48 hours, 72 hours
and 96 hours postoperatively.
Results We saw a significant increase in the microcirculatory
blood flow and blood flow velocity 6 and 12 hours postoperatively
in the iloprost group in comparison with the placebo group. After
6 hours the blood flow was 156 (minimum, 54; maximum, 460;
without units) in the placebo group and 213 (minimum, 57;
maximum, 456; P < 0.05) in the iloprost group. After 12 hours it
was 175 (minimum, 53; maximum, 483) and 318 (minimum, 86;
maximum, 569; P < 0.05), respectively. The blood flow velocity
was 18 (minimum, 14; maximum, 50) in the placebo group and 29
(minimum, 17; maximum, 51; P < 0.05) in the iloprost group
6 hours postoperatively. Twelve hours postoperatively the velocity
was 21 (minimum, 16; maximum, 52) and 37.5 (minimum, 19;
maximum, 64; P < 0.05). The oral mucosal tissue oxygen saturation
did not change. We could not find any difference in the ICG-PDR
between the two groups.
Conclusions Iloprost improved the microcirculatory blood flow and
blood flow velocity of the oral mucosa in the early postoperative
phase. This effect did not lead to an improved ICG clearance in
patients after liver transplantation.
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Noninvasive monitoring of peripheral perfusion with
physical examination and the peripheral flow index
correlates with dynamic near-infrared spectroscopy
measurements in patients with septic shock
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Introduction Peripheral blood flow can be markedly impaired in
septic shock. Bedside assessment of this derangement has not yet
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been incorporated into routine clinical practice. We hypothesize
that noninvasive monitoring of peripheral perfusion with physical
examination and the peripheral flow index (PFI) derived from the
pulse oximetry signal can reflect sepsis-induced microcirculation
alteration as measured by near-infrared spectroscopy (NIRS) in
patients with septic shock.
Methods NIRS (InSpectra) was used to quantify sepsis-induced
circulatory alterations by calculating the increase rate of tissue
oxygen saturation (slope-StO2) in a standard hyperaemia test
(3 min arterial occlusion followed by rapid reperfusion). The
increase rate of the PFI signal (slope-PFI) following the occlusion
was compared with slope-StO2. We performed a physical
examination of the extremities before arterial occlusion, and
abnormal peripheral perfusion was defined as an increase in the
capillary refill time (>4.5 s). The measurements were registered at
admission after hemodynamic stability was obtained. We
performed regression analysis to study the effect of abnormal
peripheral perfusion on slope-StO2 and to study the relationship
between slope-PFI and slope-StO2.
Results We prospectively studied 20 consecutive septic shock
patients (age 54 ± 15 years; 16 males and four females). The
admission diagnoses were 10 pneumonia, seven abdominal
sepsis, two meningitis and one urosepsis. The slope-StO2 was
significantly different between patients with normal peripheral
perfusion (n = 8; mean = 218%/min; 95% CI = 141–339) and
abnormal peripheral perfusion (n = 12; mean = 92%/min; 95%
CI = 68–123). Regression analysis showed that the slope-StO2 is
138%/min lower in patients with abnormal than in patients with
normal peripheral perfusion, controlled for the possible effects of
central temperature (r2 = 0.42; P < 0.01). We found a strong
association between slope-PFI and slope-StO2 (Pearson
correlation = 0.84; P < 0.001). The effect of slope-StO2 on the
slope-PFI was an increase in slope-StO2 of 90%/min per
1 unit/min slope-PFI (r2 = 0.65; P < 0.001).
Conclusions Peripheral vascular reactivity in patients with septic
shock, as measured by changes in StO2 following an ischemia-
reperfusion challenge, is related to the clinical assessment with the
capillary refill time and PFI.
P61
Effect of intravenous nitroglycerin on the sublingual
microcirculation in patients admitted to the intensive
cardiac care unit
CA Den Uil1, WK Lagrand2, E Klijn1, M Van der Ent1, FC Visser1,
C Ince1, PE Spronk3, ML Simoons1
1Erasmus Medical Center, Rotterdam, The Netherlands; 2Leiden
University Medical Center, Leiden, The Netherlands; 3Gelre
Hospitals, Apeldoorn, The Netherlands
Critical Care 2008, 12(Suppl 2):P61 (doi: 10.1186/cc6282)
Introduction Nitroglycerin (NTG), a nitric oxide donor with
vasodilating effects, is frequently administered to patients with
heart failure. We tested the hypothesis of whether the vasodilating
effects of NTG could be monitored at the bedside.
Methods We included heart failure patients who were admitted to
the intensive cardiac care unit. In each patient, continuous NTG
infusion (2 mg/hour) was started immediately after an intravenous
NTG loading dose of 0.5 mg. Using side-stream dark-field imaging,
sublingual microvascular perfusion was evaluated before NTG
administration (T0, baseline), 2 minutes after the NTG loading
dose (T1) and 15 minutes after T1 (T2). At least three video
sequences of the microcirculation were recorded and analyzed.
Microscan Analysis Software was used to measure the functional
capillary density (FCD), an indicator of tissue perfusion. Capillaries
were defined as the microvessels with a diameter <25 μm. Each
value is represented as the median and interquartile range (P25–P75).
Results Seven patients were included in this study. The mean
arterial pressure decreased during execution of the study protocol:
80 (78–85) mmHg at baseline versus 75 (66–79) mmHg at T2;
P = 0.03. There was a nonsignificant trend to an increase in FCD
throughout the study (10.9 (9.0–12.5) μm–1 at T0 vs 12.3
(11.3–14.0) μm–1 at T2; P = 0.06).
Conclusions We observed a trend to increasing FCD values
during NTG treatment, despite a temporary decrease in the mean
arterial pressure. This finding suggests improvement of
microvascular perfusion by low-dose, intravenously administered
NTG. Based on these interim results, more patients will be
included in the study for final analysis and conclusions.
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Relationship between the sublingual microcirculation and
lactate levels in patients with heart failure
CA Den Uil1, WK Lagrand2, E Klijn1, C Ince1, PE Spronk3, 
ML Simoons1
1Erasmus Medical Center, Rotterdam, The Netherlands; 2Leiden
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Introduction Treatment of patients with severe heart failure aims at
normalizing hemodynamic and metabolic parameters. We tested
whether the sublingual functional capillary density (FCD), an
indicator of tissue perfusion at the microvascular level, correlates
with lactate levels in heart failure patients.
Methods We investigated 12 heart failure patients, treated with
inotropes, within 24 hours after hospital admission. Sidestream
dark-field imaging was used to investigate the sublingual micro-
circulation. At least three video sequences of the microcirculation
were recorded and analyzed. Microscan Analysis Software was
used to measure the FCD, where the FCD was determined as the
total length of perfused capillaries per field of view. Capillaries
were defined as microvessels with a diameter <25 μm.
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Results The mean arterial pressure was 75 (68–78) mmHg,
lactate levels were 1.2 (1.0–1.7) mmol/l and SvO2 was 0.78
(0.65–0.84) mol/mol. The FCD was 11.7 (10.1–12.2) μm–1. The
correlation between lactate and FCD is shown in Figure 1
(regression line: β1 = –0.88, P = 0.05).
Conclusions In this study, FCD correlated with lactate levels. This
finding is indicative for a relationship between global
hemodynamics and the sublingual microcirculation in patients
treated for heart failure. Based on the interim results, more patients
will be included in this study for final analysis and conclusions.
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Introduction Sidestream dark-field (SDF) imaging, a stroboscopic
LED ring-based imaging modality for clinical observation of the
microcirculation, was validated by quantitative and qualitative
comparison with orthogonal polarization spectral (OPS) imaging.
Methods For OPS imaging a Cytocan-II backfocus type device
(Cytometrics, Philadelphia, PA, USA) was used, and for SDF
imaging a MicroScan Video Microscope (MicroVision Medical Inc.,
Amsterdam, The Netherlands) was employed. To validate SDF
imaging, nailfold capillary diameters and red blood cell velocities
were measured in the exact same capillaries using OPS and SDF
imaging. For quantitative comparison of the quality of sublingually
acquired microcirculatory images, an image quality quantification
system was developed to score venular and capillary contrast and
sharpness on scales from 0 to 1.
Results After introduction of a scaling factor to correct for the
slightly higher magnification of the SDF device with respect to the
OPS device, equal quantitative results for capillary diameters and
red blood cell velocities were obtained. Venular contrast and
sharpness were shown to be comparable for OPS and SDF
imaging. Capillary sharpness and contrast, however, were shown
to be significantly higher using SDF imaging (Figure 1). Venular
granularity, in addition, was more clearly observable employing the
SDF device.
Conclusions SDF imaging provided significantly higher image
quality by the use of stroboscopic LED ring-based SDF illumi-
nation. It is anticipated that SDF imaging will serve as a reliable
imaging modality for the clinical assessment of the microcirculation
and will enhance computer-aided image analysis.
Reference
1. Goedhart PT, et al.: Opt Express 2007, 15:15101-15114.
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Introduction Endothelial dysfunction is thought to be an important
mechanism of organ failure in sepsis. We hypothesised that
endothelial function (EF) would be impaired in adult patients with
sepsis; that it would improve with treatment; and that the degree of
its impairment would correlate with disease severity and outcome.
Methods EF was measured using a novel, noninvasive technique
at the bedside (reactive hyperaemia peripheral arterial tonometry
(RH-PAT)) in three groups: patients with sepsis requiring
admission to the ICU (ICU sepsis); patients with sepsis requiring
hospital but not ICU admission (ward sepsis); and control patients
without sepsis. Measurements were taken on days 0, 2 and 7 in
the sepsis patients and at baseline in the control patients.
Results Planned interim analysis was performed on 38 ICU sepsis
patients, 19 ward sepsis patients and 28 control patients. The
mean (95% CI) baseline RH-PAT index was significantly lower in
ICU sepsis (1.56 (1.41–1.71)) than in control patients (2.03
(1.87–2.19)), P = 0.0001. It was intermediate in the ward sepsis
group: baseline RH-PAT index = 1.72 (1.52–1.92) (P = 0.02 cf
controls, not significant cf ICU sepsis). See Figure 1. The RH-PAT
index improved markedly in the ward sepsis patients over the first 2
days (1.72 (1.52–1.92) to 2.29 (2.08–2.57); P = 0.0004); how-
ever, it did not change significantly in the ICU sepsis patients (1.56
(1.41–1.71) to 1.77 (1.56–1.98)).
Conclusions Noninvasive measurement of EF is feasible in sepsis.
EF in sepsis is initially markedly impaired. It improves over the first
2 days in those patients with moderate sepsis but not in those with
Available online http://ccforum.com/supplements/12/S2
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sepsis requiring ICU admission. These data will be further analysed
to explore correlations, and blood samples have been stored for
the measurement of serum arginine and markers of endothelial
activation.
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Microcirculatory investigation in severe trauma injury
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Introduction Disturbances of regional microcirculation do not
correlate with the global indices of perfusion such as the cardiac
index and cardiac output. Research of local regional micro-
circulation must therefore be useful for diagnostic and prognostic
value. The aim of study was to research the diagnostic and prog-
nostic consequence of the microcirculatory indices in severe
trauma injury.
Methods Thirty-four patients with severe trauma injury were
entered into a prospective trial (scale TRISS, excluding patients
with penetrating trauma and severe head injury). The patients were
divided into two groups according to the TRISS scale: group 1
(TRISS 10–15 points, lethal probability 30%, favorable outcome)
and group 2 (TRISS 16–25 points, lethal probability >30%,
unfavorable outcome). The standard of the intensive therapy
included respiratory support, infusion therapy and sedation/muscle
relaxation, and analgesia. We investigated the red blood cell flux by
laser Doppler flowmetry (perfusion unit) – the device was placed
on skin and antral gastric mucosa (LAKK 01, Russia); noninvasive
hemodynamic monitoring with thoracic bioimpedansometry (Diamant
M, Russia) and invasive by PiCCO+ in unstable patients (Pulsion,
Germany). The characteristics of blood gas and oxygen
consumption were evaluated by Bayer RapidLab (Bayer, Germany)
and lactate/pyruvat concentration (Boeringer Mannheim, Germany).
The dates were analyzed by t test, Fisher criteria. P < 0.05 was
considered statistically significant.
Results The serum lactate/pyruvate level was increased in both
groups of patients on day 1 (m ± SD, 3.5 ± 1.2 vs 3.8 ± 1.0 mmol/l;
nonsignificant). According to laser Doppler flowmetry the skin and
the mucosa perfusion were decreased versus the control group
(red blood cell flux 0.45 ± 0.12 in control vs 0.12 ± 0.03 in
perfusion unit; significant). Group 1 was defined as a normalization
of perfusion to day 2, whereas the disturbances of microcirculation
remained in group 2 up to day 2. The microcirculatory index was
not correlated with cardiac index (r = 0.26, nonsignificant). The
extra lung water index by PiCCO+ was correlated with the
microcirculatory index (r = 0.56, P < 0.05): group 1 associated
with a normal index versus group 2 with increased extra lung water
(13 ± 4 vs 23 ± 12; significant).
Conclusions The recovery of the microcirculatory index (red blood cell
flux) is associated with favorable outcome in severe trauma patients.
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Introduction Plasma lactate has been used as a better marker of
tissue hypoperfusion in patients with sepsis. Plasma lactate
elevation can be delayed compared with tissue hypoperfusion.
Microdialysis has been used for an assessment of tissue
hypoperfusion in the area of neurosurgery; however, limited studies
have been published in the area of septic shock. We hypothesized
that septic patients with bacteremia (BA) suffered from more
severe hypoperfusion than those with nonbacteremia (Non-BA).
We therefore investigated subcutaneous lactate and lactate/
pyruvate ratio in cases with BA versus Non-BA for an assessment
of tissue hypoperfusion in both groups.
Methods Cases with septic shock were enrolled between April
2006 and November 2007 in a mixed ICU of a tertiary care
hospital in Japan. Microdialysis (CMA/Microdialysis, Sweden) was
used as in a previous study [1]. Lactate, pyruvate and glucose in
subcutaneous tissue of cases with BA and Non-BA were
measured three times with 8-hour intervals after ICU admission.
Two groups were then compared in terms of above measurements.
All data were reported as medians and interquartile ranges (IQR).
The Mann–Whitney U test was used for statistical analysis and P <
0.05 was considered statistically significant.
Results Fourteen cases were evaluated; the male/female ratio of
BA was 2/5 (age 62–86 years) and Non-BA was 4/3 (age 57–88
years). No difference of APACHE II score was observed (mean:
BA 30 vs Non-BA 29). The lactate level (mmol/l) in BA (median
3.8, IQR 1.9–5.4) was significantly higher than in Non-BA (median
1.9, IQR 1.6–2.6) (P = 0.012). The glucose level (mmol/l) in BA
(median 3.9, IQR 2.6–7.1) was significantly less than that in Non-
BA (median 6.3, IQR 4.9–10.1) (P = 0.004). The lactate/pyruvate
ratio in BA (median 1.8%, IQR 1.4–2.5%) was significantly higher
than those in Non-BA (median 1.4%, IQR 1.2–1.6%) (P = 0.023).
Conclusions Our data suggest that tissue ischemia was more
prominent in septic patients with BA than those with Non-BA.
Microdialysis can be a promising method to differentiate between
septic shock with BA and Non-BA.
Reference
1. Ungerstedt U, et al.: Microdialysis – principles and applica-
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Introduction In sepsis the link between the systemic inflammatory
response and the development of multiorgan failure is represented
by microcirculatory and mitochondrial distress syndrome, which
causes an important cellular deoxygenation not corrigible exclusively
with a restoration of a normal hemodynamic state and a satisfactory
systemic transport of oxygen. We determine the changes caused by
a stagnant ischemia in the tissue oxygenation with near-infrared
spectroscopy (NIRS) in patients with severe sepsis, during therapy
with activated protein C (APC), evaluating whether APC influences
tissue saturation (index of O2ER) and whether alterations of the
hemodynamic state are connected with these changes.
Methods A prospective observational study. We evaluated 10
septic patients (treated with APC) from December 2005 to
September 2007. We carried out evaluation with NIRS of the
tissue oxygen saturation (StO2) with the InSpectra spectrometer
(Hutchinson Technology Inc., MN, USA), putting a probe of 15 mm
into the brachioradialis muscle of the patients. The measurements
were made in five steps: pre-APC, at 24 hours, at 48 hours, at
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72 hours, at 96 hours and 24 hours after the end of the infusion
(post-APC). Each measurement (of the basic StO2 and of the
slope during and after the ischemia) is registered and transformed
from the InSpectra Analysis software. The parameters are studied
with the Wilcoxon nonparametric test for repeated measurement
(P < 0.05).
Results The increase of the basic StO2 during and after the
treatment and its decrease during the arterial occlusion are
statistically relevant (P < 0.05). The increase of the StO2 slope
after arterial occlusion is statistically relevant starting from the
second day of infusion of APC (P < 0.03).
Conclusions There is an improvement of all the NIRS parameters
after the infusion of APC; that is, an increase of O2ER. We have to
verify whether that increase is connected either with a reduced
shunt effect in the microcirculation or with the end of metabolic
downregulation that involves the mitochondrial system. NIRS has
been used in this study for the first time during treatment with APC.
Spectroscopy and videomicroscopy focus our attention on
perfusion and tissue oxygenation, which it is not possible to
separate during the evaluation of severity, of therapeutic choice
and of the treatment response of severe sepsis.
References
1. Skarda et al.: Shock 2007, 27:345-353.
2. Ince C: Crit Care 2005, 9(Suppl 4):S13-S19.
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Introduction Tissue oxygenation (STO2) measured by near-
infrared spectroscopy (NIRS) has been shown to correlate with the
global oxygen delivery index (DO2I) in both humans and animals
during haemorrhagic shock and its fluid resuscitation [1]. This is a
pilot study to determine whether STO2 can be used as a surrogate
marker of DO2I with a view to utilising this simple noninvasive
technique to guide intraoperative haemodynamic therapy.
Methods Eighteen patients undergoing major abdominal surgery
were recruited from a London teaching hospital. All patients
received the same induction and maintenance anaesthesia. Ten
patients were actively haemodynamically optimised to a DO2I
>600 ml/min/kg with fluid resuscitation. The DO2I was determined
using an oesophageal Doppler probe cardiac output monitor
(CardioQ; Deltex Medical, UK). The STO2 of the thenar muscle
was determined using the InSpectra STO2 (Hutchinson
Technology, USA). Paired measurements of the DO2I and STO2
were taken every 20 minutes from the start of surgery.
Results The average patient age was 67 (30–84) years; seven
(39%) were female. A total of 173 paired observations were made.
The median (IQR) for the DO2I and STO2 were 454
(332.5–595.5) and 88 (83–93), respectively. There was no
correlation between the DO2I and STO2 (Figure 1; r = 0.1, P >
0.1). In addition there is no statistically significant difference in
STO2 when the DO2I > 600 ml/min/m2 (paired t test, P = 0.6).
STO2 did not track the changes in DO2I.
Conclusions There is no clear relationship between STO2 and the
DO2I during major abdominal surgery. STO2 in the intraoperative
period cannot currently be used as a surrogate marker for oxygen
delivery in this group of patients.
Reference
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Introduction Crookes and colleagues demonstrated that a
decreased thenar muscle tissue oxygen saturation may reflect the
presence of severe hypoperfusion (shock) in trauma patients better
than traditional hemodynamic parameters [1]. Near-infrared
spectroscopy (NIRS) may be a novel method for rapidly and
noninvasively assessing changes in tissue level oxygenation. The
purpose of this study was to compare and correlate NIRS
measurements (StO2) with central venous blood saturation
measurement (ScvO2) in the setting of compromised systemic
perfusion in critical patients in the emergency department (ED).
Methods A prospective, nonrandomized, observational, study in
patients >18 years, admitted to the critical care area (CAT 1) of
the ED with various complaints classified as cardiovascular,
pulmonary, neurological, trauma or gastrointestinal etiology (n =
500). The NIRS probe was applied to the right thenar eminence
and data were collected and stored for analysis. StO2 and ScvO2
monitoring was performed within 15 minutes of admission to CAT
1, and values were recorded at a single point in time. The ED
physicians were blinded to StO2 values. Exclusion criteria included
the Do Not Resuscitate status, peripheral vascular disease, cardiac
arrest, amputated upper extremities or skin abnormalities in the
monitoring site as well as refusal to participate.
Results StO2 correlation analysis was performed against all
continuous variables. Subsequently, ANOVA was run for all of the
continuous variables allowing pairwise comparisons. For this
cohort of 500 patients, 305 paired data points of StO2 and ScvO2
were compared. StO2 and ScvO2 had a strong linear correlation
that was statistically significant (r = 0.76, P < 0.001). We also
observed that the time spent below an StO2 <75% was
associated with an APACHE score greater than 15 and also was
associated with a higher admission rate to the ICU (P = 0.05).
Conclusions NIRS has demonstrated with significance that there
is a strong correlation with StO2 and ScvO2 in critically ill patients
presenting to the ED. There also appears to be an association
between the time a patient spends below an StO2 <75% with an
increased APACHE score and ICU admission.
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Introduction Ischaemic preconditioning (IP) describes the process
whereby a tissue exposed to brief sublethal periods of ischaemia
becomes protected from longer lethal episodes of ischaemia. One
mechanism by which skeletal muscle may effect protection from
ischaemic insult is to reduce the resting rate of oxygen
consumption (VO2) following a preconditioning stimulus. Tissue
oxygen saturation (StO2) reflects the dynamic balance between
oxygen supply and utilisation. We hypothesised that using near-
infrared spectroscopy to measure thenar eminence StO2 repeated
arterial occlusion of the upper arm would induce an IP effect.
Methods The study was approved by the UCL Research Ethics
Committee and written consent was obtained from 20 healthy
volunteers. StO2 was measured using the InSpectra Tissue
Spectrometer (Model 325; Hutchinson Technology Inc., USA). The
tissue spectrometer probe was attached to the left thenar
eminence and a blood pressure cuff was placed around the left
upper arm. The repeated arterial occlusion forearm ischaemia
model (RAOFIM) consisted of resting measurements and then a
cycle of four cuff inflations (200 mmHg, 3 min) and four deflations
(5 min). Finally the cuff was inflated for 3 minutes on the right
upper arm while the StO2 was measured from the right thenar
eminence. Paired t tests were used to compare rates of oxygen
desaturation; P < 0.05 was considered statistically significant.
Results There was a fall in thenar eminence StO2 during all arterial
occlusions. The rate of decline of StO2 was significantly reduced
during the fourth inflation (0.160%/s) as compared with the first in
the left arm (0.213%/s), P < 0.001. There was an increase in the
rate of StO2 decline in the right arm (0.268%/s) when compared
with the first left occlusion (P < 0.001).
Conclusions The data from this pilot study demonstrate that,
following preconditioning using a RAOFIM, the rate of oxygen
desaturation in resting skeletal muscle during subsequent arterial
occlusion manoeuvres is reduced. This could be explained by a fall
in resting muscle VO2 as a result of the preceding short ischaemic
stimuli and therefore represents evidence of IP in skeletal muscle.
These data do not provide evidence to support a remote IP effect
in the contralateral arm.
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Introduction Near-infrared spectroscopy is a novel method for rapid
and noninvasive assessment of tissue oxygen saturation (StO2). An
association between StO2 and oxygen delivery has been
demonstrated during shock, trauma and resuscitation. We
conducted a pilot observational study in which the aims were to
measure changes in StO2 during the perioperative period for
scheduled cardiac surgery and to explore correlations between
StO2 and routine haemodynamic measures.
Methods The study was approved by the UCLH Joint Research
Ethics Committee. Written informed consent was gained from 74
patients undergoing scheduled coronary artery bypass grafting
(CABG) and valvular surgery requiring cardiopulmonary bypass
(CPB). The thenar eminence StO2 was measured continuously
during the perioperative period for a maximum of 24 hours using
the InSpectra Tissue Spectrometer (Model 325; Hutchinson
Technology Inc., USA). Haemodynamic variables were collected
from patient records. The mean StO2 was calculated for various
time points within the study.
Results The tissue spectrometer performed well throughout the
study. From a baseline of 81.7% the StO2 rose significantly during
induction of anaesthesia to 88.5% (P < 0.001). Prior to and during
CPB the StO2 fell to a minimum of 77.6%, and rose significantly to
83.1% after CPB (P < 0.001). The mean StO2 decreased during
the ICU stay to a minimum of 70.0% at 2 hours post operation.
There was marginal association between StO2 measures and
haemodynamic changes although all analyses resulted in areas
under ROC curves <0.70.
Conclusions The present study demonstrates interesting changes
in tissue StO2 during the perioperative period surrounding
scheduled cardiac surgery. The trends suggest a fall in StO2
throughout CPB and during early recovery in the ICU. Changes in
StO2 may reflect underlying tissue perfusion; therefore the
utilisation of StO2 as both an index for tissue hypoperfusion and as
a therapeutic goal needs further exploration.
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Near-infrared spectroscopy during stagnant ischemia: a
marker of ScvO2–SvO2 mismatch in septic patients with
low cardiac output
H Mozina, M Podbregar
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Introduction Monitoring of oxygen saturation in the superior vena
cava (ScvO2) was suggested as a simpler and cheaper assess-
ment of the global DO2:VO2 ratio and was used successfully as a
goal in treatment of patients with septic shock and severe sepsis
[1]. In patients with low cardiac output (CO) the difference
between SvO2 and ScvO2 is more expressed and problematically
large confidence limits and poor correlation were found between
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the two values [2]. The thenar muscle oxygen saturation (StO2)
measured with near-infrared spectroscopy (NIRS) during stagnant
ischemia (cuff inflation-induced vascular occlusion) decreases
slower in septic shock patients [3]. This may be due to slower
muscle tissue oxygen consumption in sepsis. This phenomenon
possibly contributes to the ScvO2–SvO2 mismatch in patients with
low CO by adding more oxygenated venous blood to flow through
the superior vena cava. The aim of present study was to determine
the relationship between the StO2 deceleration rate and the
ScvO2–SvO2 difference in septic patients with low CO.
Methods In septic patients with low CO and no signs of
hypovolaemia, catheterization with a pulmonary artery floating
catheter was performed. Blood was drawn from the superior vena
cava and pulmonary artery at the time of each StO2 measurement
in order to determine ScvO2 and SvO2. The thenar muscle StO2
during stagnant ischemia was measured using NIRS (InSpectra™)
and the StO2 deceleration rate (StO2%/min) was obtained using
the Inspectra Analysis Program V2.0.
Results Fifty-four patients (47 male, seven female), age 68 ± 13
years, SOFA score 12.2 ± 2.5 points. CI 2.5 ± 0.7 l/min/m2, SvO2
67 ± 10%, ScvO2 77 ± 8%. Lactate 3.5 ± 3.0 mmol/l, CRP 127 ±
78 mg/l. NIRS data: basal StO2 89 ± 8%, deceleration rate
–12.6 ± 4.9%/min, StO2 deceleration rate versus ScvO2–SvO2
0.651, P = 0.001(Pearson correlation, P value).
Conclusions The StO2 deceleration rate during cuffing is inversely
proportional to the difference between ScvO2 and SvO2 in septic
patients with low CO. When using ScvO2 as a treatment goal, this
simple noninvasive NIRS measurement might be useful to discover
those patients with normal ScvO2 but probably abnormally low
SvO2.
References
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Introduction Central venous saturation ScvO2 proved a useful
alternative to mixed venous saturation, and also a reliable
parameter to evaluate the oxygen debt in emergency and intensive
care [1-3]. Under special circumstances of anatomical or
coagulation disorders, however, canulation of the jugular or
subclavian veins are not recommended. In these cases the femoral
vein has to be catheterised. The aim of our prospective study was
to investigate the relationship between the ScvO2 measured in the
superior vena cava (ScvsO2) and in the inferior vena cava (ScviO2).
Methods After local ethics committee approval every ICU patient
with two central venous catheters (one subclavian/internal jugular
and one femoral) entered the study. Parallel blood gas analyses
were performed in random, whenever ScvO2 was requested by the
attending physician. Vital parameters (heart rate, mean arterial
pressure, Glasgow Coma Scale, respiratory parameters) and the
dose of vasopressor and sedative drugs were also recorded.
Results were compared using Wilcoxon test, Pearson correlation
and Bland–Altman plots.
Results In 13 patients 47 matched pairs were compared. Although
ScvsO2 = median 79% (range: 50–85) was significantly higher
than ScviO2 = 71% (45–87), P < 0.001, there was significant
correlation between the two variables (r = 0.690, P < 0.001).
Bland–Altman plots showed a mean bias of 7.6% with lower and
upper levels of agreement of –5.6 and 20.7, respectively. The dose
of vasopressor (norepinephrine) and dose of sedative (propofol)
had a significant influence on the measured difference between the
investigated variables (r = 0.562, P < 0.001; r = 0.538, P < 0.001,
respectively).
Conclusions The preliminary results of this study show that
ScviO2 underestimates ScvsO2 with a low level of agreement and
that this difference is affected by vasopressor support and
sedation. ScviO2 may be useful, however, for monitoring the trend
of ScvsO2.
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Introduction The aim of the present study was to evaluate the
mortality prediction power of central venous oxygen saturation
(ScVO2) in critically ill patients suffering from major trauma and
head trauma.
Methods In an ED, eight-bed, ICU of a teaching hospital from
January 2004 to November 2007, all patients with major trauma
(RTS < 10) and head trauma were included in the study. On the
basis of the severity of head trauma the patients were divided into
two groups: severe (GCS ≤ 8; n = 91) and moderate head trauma
(GCS > 8 ≤ 12; n = 116). Each group was in turn divided into two
other groups: patient survivors and dead patients. In each
subgroup, the age, sex, ISS, SAPS II, worst ScVO2 on the first day
from trauma (emogasanalysis of venous blood sampled by a
catheter inserted in the superior vena cava 2 hours from trauma),
and worst lactate level in circulating blood on the first day from
trauma were compared. Statistics were performed with the
Student t test and the χ2 test.
Results The results showing a significant difference are
summarized in Table 1.
Conclusions ScVO2 seems to be predictive of major outcome in
severe head trauma but not in moderate head trauma. Venous
mixing of the superior vena cava could play a role in this difference.
Reference
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Severe head trauma Moderate head trauma
Survivors Dead Survivors Dead 
(n = 76) (n = 15) (n = 99) (n = 17)
ISS (pt) 30.3 ± 10.7 43.4 ± 18° 27.9 ± 16 41.1 ± 16.3°
ScVO2 (%) 71 ± 7 62 ± 9* 73 ± 7 75 ± 7
Lactate (mmol/l) 3.5 ± 1.9 9 ± 5.4° 2.9 ± 1.6 6.1 ± 4°
Data presented as the mean ± SD. *P < 0.05, °P < 0.01.
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Introduction Benefits of central venous oxygen saturation (ScvO2)
optimization, at early stages of severe sepsis and septic shock,
have been shown [1]. Discontinuous ScvO2 measurement has not
been studied earlier. The purpose of our study was to compare
continuous and discontinuous ScvO2 in terms of the number of
therapeutic interventions in septic patients.
Methods After approval by our institutional ethics committee, 16
patients with severe sepsis or septic shock were included in this
prospective study. Patients were randomly assigned to the
continuous ScvO2 group (central venous catheter; Edwards
Lifescience X3820HS ) or to the discontinuous ScvO2 group.
Blood pressure, heart rates and pulse oxymetry were continuously
monitored and the lactate concentration measured in all patients. In
both groups we noted that the number of therapeutic interventions
due to the ScvO2 value is <70%. Statistical analysis used the
Fisher test exact for qualitative variables and the Student t test
(Mann–Whitney) for quantitative variables. P < 0.05 was considered
significant.
Results There were no significant differences between the groups
with respect to baseline characteristics. The median number of
therapeutic interventions was significantly higher in the continuous
ScvO2 group (13 vs 7, P = 0.016). No significant differences
occurred between the length of stay in the two groups. See Table 1.
Table 1 (abstract P75)
Comparison between continuous and discontinuous central
venous oxygen saturation
Continuous Discontinuous P value
Age 63 ± 17 66.8 ± 5.6 0.64
Weight 63 ± 17 73 ± 8.9 0.44
MODS 6.62 ± 3.9 6.12 ± 1.8 0.87
APACHE I 18.8 ± 7.4 18.1 ± 6.8 0.87
Length of stay 6.1 ± 2.51 10.2 ± 5 0.95
Therapeutic interventions 13 (6–19) 7 (4–12) 0.01*
*Significant at P < 0.05.
Conclusions These preliminary results showed that continuous
ScvO2 measurements increase the number of therapeutic
interventions. We conclude that continuous measurement of
ScvO2 is helpful for early therapeutic interventions. Controlled trials
of sufficient size, however, are needed to confirm these results.
Reference
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Introduction The objective of this study was to evaluate the clinical
outcomes of patients who required intraoperative blood
transfusion, aiming to compare the pretransfusion hematimetric
values with tissue perfusion markers.
Methods A prospective single-center cohort study. Patients were
selected in the operative room of a tertiary hospital. Adult patients
who required blood transfusion during the intraoperative period
were included in the study. Arterial and central venous blood
samples were collected at the moment in which the blood
transfusion decision was made.
Results Sixty-one patients were included, with a mean age of 68
years. The POSSUM score was 36.2 ± 10.3 and the MODS score
was 2.4 ± 1.9. At the time of the blood transfusion the mean
hemoglobin level was 8.4 ± 1.8 g/dl. The overall inhospital
mortality rate was 24.6%. The ScvO2 cutoff point for the ROC
curve was equal to 80% (AUC = 0.75; sensitivity = 80%;
specificity = 65.2%). Patients who received a blood transfusion
and had ScvO2 ≤ 80% (n = 29), in comparison with those with
ScvO2 > 80% (n = 32), had lower mortality rates (12.5% vs
47.1%; P = 0.008) and lower incidence of postoperative compli-
cations (58.9% vs 72.9%; P = 0.06). Blood transfusion with a
ScvO2 ≤ 80% was also associated with reduced use of vaso-
pressors (5.9% vs 36.8%; P = 0.009), lower incidence of
hypoperfusion (17.6% vs 52.6%; P = 0.009) and lower incidence
of infection (23.5% vs 52.6%; P = 0.038) in the postoperative
period.
Conclusions In patients submitted to major surgery, the ScvO2
appears an important variable to be taken into consideration to
decide for or against blood transfusion, since transfusions with
adequate perfusion, reflected by ScvO2 > 80%, are associated
with higher mortality rates and worse clinical outcomes.
References
1. Hebert PC, Wells G, Blajchman MA, et al.: A multicenter,
randomized, controlled clinical trial of transfusion require-
ments in critical care. N Engl J Med 1999; 340:409-417.
2. Vincent JL, Baron JF, Reinhart K, et al.: Anemia and blood
transfusion in critically ill patients. JAMA 2002, 288:1499-
1507.
3. Rivers E, Nguyen B, Havstad S, et al.: Early goal-directed
therapy in the treatment of severe sepsis and septic
shock. N Engl J Med 2001, 345:1368-1377.
P77
Hyperlactatemia and low central venous saturation can
predict prognosis after cardiac surgery
L Hajjar, M Rego, F Maeda, M Sundin, L Sampaio, F Galas, 
J Auler Jr
Heart Institute, Faculdade de Medicina da Universidade de 
São Paulo, Brazil
Critical Care 2008, 12(Suppl 2):P77 (doi: 10.1186/cc6298)
Introduction Hyperlactatemia and low central venous saturation are
commonly encountered in critically ill patients and carry a prognostic
significance in those with sepsis. Few reports, however, have
examined the relationship between these parameters immediately
after cardiac surgery and clinical outcome. We examined the ability
of the arterial plasma lactate concentration and central venous
saturation to predict patient outcome after cardiac surgery.
Methods We performed a consecutive observational study in a
university hospital. A total of 125 patients undergoing cardiac
surgery were studied. Demographic data were analyzed. Samples
of arterial lactate, arterial gases, and central venous saturation
were collected at the time of admission in the ICU, 12 and 24
hours later. Univariate and multivariate analyses were performed.
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Results Of the 125 patients in this study, 115 (92%) patients
survived and 10 (8%) died. The lactate level was higher in
nonsurvivors than in survivors (P < 0.001). A higher lactate level
(>3.3 mmol/l) was an independent predictor of death (OR = 23,
95% CI = 3.9–136), of occurrence of arrhythmias (OR = 5.36,
95% CI = 1.9–15), renal dysfunction (OR = 9.93, 95% CI =
2.9–34), and shock (OR = 67.2, 95% CI = 6.4–710). There were
no relationships of higher level of lactate and longer time of stay in
the ICU, cardiac dysfunction or myocardial ischemia. Low central
venous saturation (<60%) was an independent predictor of
arrhythmias (OR = 12.74, 95% CI = 3.45–47), infection (OR =
6.61, 95% CI = 2.2–19.6), shock (OR = 16.7, 95% CI = 1.8–156),
and need for transfusion (OR = 3.68, 95% CI = 1.25–10.8). There
were no relations of low central venous saturation with cardiac
dysfunction, renal dysfunction or myocardial ischemia.
Conclusions In this observational study, the postoperative plasma
arterial lactate and central venous saturation concentration strongly
and independently predicted the outcome after cardiac surgery.
These findings suggest that these parameters may be markers of
prognosis after cardiac surgery and support the role of
hemodynamic optimization in reducing complications.
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Introduction The purpose of this study was to determine whether
earlobe capillary blood gas sampling, performed by nonmedical
staff, provides a clinically acceptable estimate of the pH, pCO2
and pO2 in critically ill adults.
Methods Paired samples (arterial and capillary) were obtained from
patients aged 16 years and over admitted to the general intensive
therapy unit who had an arterial line in situ. Details of the severity of
illness, use of vasoactive agents and complications were recorded.
Results One hundred and thirty-one paired independent samples
were obtained from 142 patients. Mean age 60 (18–87) years,
mean APACHE II score 20 (5–44). Bland–Altman analysis was
used to compare arterial and capillary pH, pCO2 and pO2,
respectively. See Table 1. The use of vasoconstricting drugs had
no significant effect on the mean differences between arterial and
capillary values for pH, pCO2 or pO2 (P = 0.4, 0.8 and 0.7,
respectively). For high arterial pCO2 tensions (>6.5 kPa), capillary
measurements showed a mean bias of 0.95 kPa with limits of
agreement of –0.22 to 2.12 kPa. For hypoxic patients (PaO2
< 10 kPa), capillary sampling had a mean bias of 0.05 kPa with
limits of agreement of –1.08 to 1.17 kPa. There were no
complications of capillary sampling in terms of bruising, bleeding or
infection. It took significantly longer to obtain capillary samples
than arterial ones (35 s, P < 0.001).
Conclusions Capillary earlobe sampling provides a reliable
estimation of the arterial pH and pCO2 in critically ill patients. For
pO2 estimation, the technique has a higher level of agreement
when the arterial PO2 is below 10 kPa. Capillary earlobe blood
sampling would be a reliable method of monitoring for patients
who do not have an arterial line in situ and can be performed
without complications by nonmedical personnel.
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Introduction Placement of central venous catheters is frequently
associated with serious complications. Arterial puncture is the
most common mechanical complication associated with internal
jugular vein access procedures (IJVAP). The influence of emergent
indication as a sole risk factor for arterial puncture during IJVAP
has not been fully explored. We evaluated the impact of emergent
IJVAP, performed in the operating room, on the carotid arterial
puncture rate.
Methods We analyzed all landmark techniques of guided IJVAP
that were performed by either the anterior or the posterior
approach, using the Seldinger technique in the operating theater
during a 2-year period. All IJVAP were defined either as elective or
emergent. A procedure was defined as emergent if the
anesthesiologist judged that any delay would be harmful. The side
of the puncture site was chosen according to clinical necessity.
The puncture side, number of cannulation attempts, the time
relationship between surgical incision and IJVAP, and the number
of arterial punctures after cannulation were recorded. Correct
placement of the central venous catheter was confirmed by free
venous blood return, free flow of fluid through all ports of catheter
and postinsertion chest X-ray scan.
Results We analyzed 86 IJVAP performed in the operating room
(22 left-sided and 64 right-sided). In 32 cases, IJVAP were
performed as emergent (37.2%). The overall rate of carotid artery
puncture was 9.30%. Arterial puncture following emergent IJVAP
occurred in seven cases (21.87%). After elective IJVAP, accidental
arterial puncture occurred in only one case (1.85%). This
difference was statistically significant (P = 0.003). Emergent IJVAP
were considerably associated with repeated cannulation attempts
(P < 0.001). In 16 cases (50%), emergent IJAVP were performed
after surgical incision, including five cases of unintentional carotid
puncture. Although the arterial puncture frequently occurred after
postincisional emergent IJVAP, the difference was not statistically
significant (31.25% vs 12.15%; P = 0.15).
Conclusions Emergent internal jugular vein cannulation might be
identified as a factor associated with an increased arterial puncture
rate.
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Parameter Mean bias Limits of agreement
pH –0.02 –0.07 to 0.02
pCO2 (kPa) 0.35 –0.62 to 1.33
pO2 (kPa) 1.05 –2.4 to 4.5
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Introduction The placement of a central venous catheter is a
common practice in the ICU and the incidence of mechanical
complications occurs is 5–19% of patients. In this study we
compare the ultrasound approach with classic landmark technique
in terms of reduction of mechanical complications and the number
of attempts needed for the cannulation of the internal jugular vein.
Methods We examined 31 patients admitted to the ICU: in 20 of
them the cannulation of the internal jugular vein was obtained using
real-time ultrasound guidance, while in 11 patients we employed
the landmark technique (axial approach).We recorded the number
of complications and the number of attempts, correlating with the
experience of the operator. All data were statistically examined with
Student’s t test (number of attempts) and Fisher’s test for count of
odds ratio (incidence of complications).
Results We reported 9% of complications in the landmark group
(one accidental arterial puncture) and 6% in the ultrasound group
(one pneumothorax). The odds ratio for these data is 0.5 (95%
CI = 0.006–45.4). We found a statistically significant difference in
the number of attempts performed, with a lower value in the ultra-
sound group (mean ± SD, ultrasound 1.1 ± 0.30 vs landmark
technique 1.7 ± 0.78; P = 0.034). No difference in the number of
attempts was evidenced by the experience of the operator using
the ultrasound approach. See Figure 1.
Conclusions Our data confirm that use of ultrasound for central
venous catheter placement is safer and is associated with a lower
risk of complications than the classical approach, especially for
low-experience operators.
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Introduction Airway pressure limitation is a largely accepted
strategy in neonatal respiratory distress syndrome (NRDS), yet a
lot of debate persists about the exact level of mean airways
pressure (M-PAW) that can be safely used. The aim of the present
study was to examine whether the echocardiographic evaluation of
tricuspid regurgitation (TR) and right ventricular function (RVF) may
help to indirectly solve this problem.
Methods A retrospective study. Thirty preterms were enrolled and
divided into two groups: Group A (control group), 15 patients;
Group B, 15 patients. Mean gestational age 32 ± 1 weeks, body
weight 1.55 ± 0.55 kg, with a diagnosis of NRDS [1]. All of the
patients were treated with surfactant therapy (curosurf 100 mg) for
grade 3 and grade 4 NRDS and with high-frequency pressure-
controlled ventilation: peak pressure according to body weight,
PEEP 3 ± 2 cmH2O, I:E = 1:1.5, breath rate >80 ± 10, FiO2 50 ±
15%. In Group B the M-PAWs were reduced according to our
echocardiographic evaluations. TR and RVF (pulmonary arterial
systolic pressure (PAPs and PAPd), flattening to the left of the
interventricular septum) were monitored daily (SONOS 5500-
Philips echocardiography machine equipped with 8–12 MHz
probes), until beginning weaning from mechanical ventilation.
Results Signs of right ventricular dysfunction (moderate to severe
TR, flattening of interventricular septum, PAPs >36 mmHg) were
observed especially in group A with a M-PAW of 14 ± 3 cmH2O.
The duration of mechanical ventilation was 24 hours longer in
group A than in Group B (P < 0.005 with the Student t test).
Conclusions This small experience shows that RVF worsens while
increasing the M-PAW over 11 cmH2O. This event could increase
the weaning time in those patients. Even though a large number of
patients should be enrolled in our future studies, we believe that
any occurrence of right ventricular dysfunction should be
immediately corrected, reducing M-PAW with the help of
echocardiography.
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Introduction Data investigating the clinical importance of right
ventricular dysfunction (RVD) in liver disease are sparse. The use
of a modified pulmonary artery catheter with a fast-response
thermistor to assess the right ventricular ejection fraction (RVEF)
and right ventricular end-diastolic-volume index (RVEDVI) can aid
in the diagnosis of and guide appropriate therapy for RVD in
critically ill patients. In a previous study, RVD was defined as RVEF
< 52% and RVEDVI > 92 ml/m2 [1]. We aimed to investigate the
prevalence of RVD in a heterogeneous group of patients with
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multiorgan failure and liver disease admitted to a specialist liver
ICU. In addition, differences in right ventricular function were
compared in patients in acute liver failure (ALF) and with acutely
decompensated chronic liver disease.
Methods Over a 24-month period, hemodynamic data for 16
patients were analyzed. Patients with known significant tricuspid
regurgitation and arrhythmias were excluded. Patients were grouped
according to etiology into ALF and acute-on-chronic liver disease
(AoCLD). Comparison of hemodynamic data was performed using
Mann–Whitney U tests.
Results See Table 1. All patients showed evidence of RVD, but
the RVEDVI was higher in patients with AoCLD. The pulmonary
artery occlusion pressure (PaOP) was not different between
groups. The transpulmonary gradient (TPG = MPAP – PaOP) as a
marker of increased pulmonary vascular resistance was higher in
AoCLD patients despite similar pulmonary artery pressures.
Table 1 (abstract P82)
Results of hemodynamic parameters obtained from right heart
catheterisation
ALF patients AoCLD patients 
Parameter All patients (n = 9) (n = 7) P value
RVEF 36.3 36 35 NS
RVEDVI 129.3 114.7 148 <0.005
MPAP 29.5 28.4 31 NS
PAOP 16.1 18.2 13.3 NS
CI 4.4 4.4 4.4 NS
TPG 13.5 10.1 17.9 <0.05
Conclusions RVD is common in patients with liver failure and is
more severe in AoCLD patients. Whether treatment based on
RVEF and RVEDVI monitoring in liver disease can improve patient
outcome still needs to be proven.
Reference
1. Le Tulzo Y, et al.: Intensive Care Med 1997, 23:664-670.
P83
Diastolic function abnormalities in ICU patients with
chronic obstructive pulmonary disease
H Michalopoulou, A Bakhal, J Vaitsis, D Nastou, D Pragastis, 
N Stravodimou
Metaxa Hospital, Athens, Greece
Critical Care 2008, 12(Suppl 2):P83 (doi: 10.1186/cc6304)
Introduction It has been shown from several studies that patients
with right ventricle pressure overload often have left ventricular
(LV) diastolic dysfunction. Our aim was to evaluate LV function in
ICU patients with chronic obstructive pulmonary disease (COPD).
Methods We studied 35 patients (20 males, 15 females), mean
age 65 ± 8.4 years, with COPD and without comorbidities (hyper-
tension, diabetes, coronary heart disease or heart failure). Twenty-
five healthy subjects matched for age and sex were used for
control. Using conventional echocardiography, the LV end diastolic
diameter (LVD), LV ejection fraction (EF%), right ventricle diastolic
diameter (RVD), right ventricle systolic pressure (RVSP), the
maximal velocity of E wave, maximal velocity of A wave, and E/A
ratio were assessed. Using tissue Doppler echocardiography, Em,
Am and Em/Am were calculated.
Results The differences between groups are presented in Figure 1.
The parameters of the diastolic LV function, E/A and Em/Am were
significantly lower in COPD patients in comparison with healthy
subjects. There was also a significant negative correlation between
RVSP and Em/Am (r = –0.74, P < 0.01) and E/A (r = 0.5; P < 0.005).
Conclusions Systolic LV function is well preserved in COPD
patients but we found a severe LV diastolic impairment that might
be due to alterations of the chamber stiffness from the
hypertrophic right ventricle.
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Introduction Rodent models are often studied in critical care
research. Noninvasive cardiac output (CO) measurement is desirable
but often impractical. The present study aimed to compare a
commercially available human CO monitor, USCOM® (USCOM
Ltd, Sydney, Australia), with specialised rodent echocardiography
for noninvasive measurement of rat CO.
Methods With institutional ethics committee approval (UQ AEC
protocol 675/05), 21 anaesthetised, mechanically ventilated male
Sprague–Dawley rats (573 ± 96 g) were studied during
refinement and study of an endotoxic shock model. Pulsed-wave
Doppler echocardiography (15 MHz rodent probe) was used to
measure the left ventricular outflow velocity and to calculate the
stroke volume and CO. USCOM (v1.7, human neonatal algorithm;
2.2 MHz) measurements followed each echocardiographic exami-
nation. USCOM CO was measured by combining continuous wave
Doppler with the predicted outflow tract diameter (OTD-U).
Results Twenty-one paired measurements were analysed. The
mean echocardiographic CO was 113 ml/min (range 46–236).
The mean USCOM CO was 245 ml/min (range 75–553). Paired
echocardiographic and USCOM measurements demonstrated
significant correlations for heart rate (r = 0.92, P ≤ 0.0001) and
CO (r = 0.68, P = 0.001). Bland–Altman analysis of CO demon-
strated a mean bias of –131 ml/min and precision of 52 ml/min.
Linear regression analysis yielded a simple correction factor for
USCOM OTD estimation. Following application of this correction
factor (0.68 x OTD-U), the mean bias improved to –0.1 ml/min with
precision of 38 ml/min.
Conclusions Measurement of rat CO using the USCOM human
neonatal algorithm (v1.7) is not interchangeable with specialised
pulsed-wave Doppler echocardiography. We propose a simple
correction factor that should improve performance of this device in
the rodent laboratory. Incorporation into a rat-specific algorithm
should be evaluated prospectively across a range of potential
applications.
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Introduction Echocardiography is often requested in the manage-
ment and diagnosis of hemodynamically unstable critically ill
patients [1]. Transoesophageal echocardiography (TOE) is often
considered the echocardiographic test of choice in the general
ICU patient population. This is based on studies in which trans-
thoracic echocardiography (TTE) commonly offered inadequate
images [2]. The aim of this study is to assess the quality and
quantity of images obtained in critically ill patients.
Methods Patients were recruited from February 2006 to
December 2007, when the attending consultant requested a TTE
on clinical grounds. A single operator carried out all of the TTE
procedures. Each study was performed in the 45° head-up, left
lateral position. Left ventricular function was assessed either using
Simpson’s biplane model or the 16-segment Wall motion score
index (WMSI). All studies and changes in management were
recorded in the patient’s notes. Demographic, diagnostic and
severity scoring data were collected.
Results Sixty-six TTE procedures were performed. Mean age of
patients was 69 ± 13 years. Eighteen out of 66 studies lacked one
or more basic views. The commonest request was for left
ventricular function, 45% were normal studies, and the commonest
changes in management were fluid boluses, inotrope changes, and
commencement of ACE inhibitor therapy. Five TOE procedures
were requested. The Simpson biplane method was obtained in
65% of the patients. The WMSI was obtained in 73% of studies. In
ventilated patients, the mean positive end-expiratory pressure
(PEEP) in the full studies was 7.7 cmH2O. The mean PEEP was
11.5 cmH2O in the inadequate studies. The parasternal windows
were impaired by high PEEP settings.
Conclusions In 73% of the patients a full study was performed.
Studies may be impaired in patients where their respiratory support
requires PEEP > 10 cmH2O. Changes in management occurred in
60% of the patients within 48 hours. TTE should therefore be
considered the initial and principal echocardiographic investigation
in critically ill patients. In a minority of cases, inadequate views may
require progression to TOE.
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Introduction The purpose of this study was to determine the
efficacy of ultrasonography (US) in the detection of alveolar-
interstitial syndrome and pleural effusion in critically ill patients,
compared with the results of the gold standard computed
tomography (CT).
Methods Twenty-seven consecutive critically ill patients were
enrolled in this study (age = 65 ± 17 years, male/female = 10/17,
APACHE II score = 18.3 ± 6.2 and Lung Injury Score = 1.0 ± 0.7).
Lung US was performed before or after CT within an interval of
20 hours by two independent physicians blinded to the results of
the CT. Ultrasound scanning of the anterior and the lateral chest
was obtained on the right and left hemithorax, from the second to
the fourth–fifth intercostal space from parasternal to midaxillary
line. The results of the US scanning in each intercostal space were
grouped into the respective lobe (superior, mid and inferior for the
right lung, and superior and inferior for the left lung) and were
compared with the findings of the CT in each lobe respectively.
Alveolar-interstitial syndrome was defined as the presence of more
than two comet-tail artifacts perpendicular to the pleural line, and
the pleural effusion was detected as a hypoechoic space above
the diaphragm.
Results The diagnostic sensitivity and specificity of US for the
alveolar-interstitial syndrome were 94.1% and 60% for the right
superior lobe, 93.7% and 100% for the right mid lobe, 76.5% and
90% for the right inferior lobe, 93.3% and 72.7% for the left
superior lobe, and 88.2% and 90% for the left inferior lobe,
respectively. Finally the sensitivity and the specificity of US for
pleural effusion were 94.7% and 100% for the right and 86.6%
and 91.7% for the left pleural effusion, respectively.
Conclusions The preliminary data of this study suggest that US
may provide essential information about the respiratory condition of
the critically ill patient. The fact that lung US is an imaging tool that
can be easily performed at the bedside, that is free of radiation
exposure and that is less costly makes it an attractive and
promising alternative to CT.
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Introduction The present study aimed to investigate the usability
of the vena cava inferior (VCI) diameter as a predictor for acute
blood loss and to compare it with other parameters in patients with
shock.
Methods A total of 78 patients were included in the study. These
patients were divided into two groups, a control group consisting
of 50 healthy individuals and a study group consisting of 28 case
patients. Vital signs of both groups were taken, shock indices were
calculated and the measured VCI diameters of both groups were
compared. Furthermore, VCI diameters were also compared with
shock indices lactate, base excess and bicarbonate, and the
relationships between these parameters and mortality were
investigated.
Results Vena cava inferior expirium (VCIe)-anteroposterior diameter
(AP) was 14.3 ± 3.6 mm in the study group and 29.3 ± 4.8 mm in
the control group (P = 0.000), VCIe-mediolateral diameter (ML)
was 8.9 ± 2.5 mm in the study group and 19.4 ± 3.6 mm in the
control group (P = 0.000), vena cava inferior inspirium (VCIi)-AP
was 10.9 ± 3.6 mm in the study group and 23.8 ± 5.0 mm in the
control group (P = 0.000), and VCIi-ML was 7.0 ± 3.8 mm in the
study group and 15.4 ± 3.2 mm in the control group (P = 0.000).
The VCI diameters of the study and control groups were
significantly different. No correlation was determined between all
VCI diameters and the shock index, heart rate, systolic blood
pressure, diastolic blood pressure, given liquid amount,
hemoglobin, hematocrit, white blood cells and base excess.
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Lactate (r = 55) was correlated with all VCI diameters; however,
this correlation was better for VCIe-ML. The shock index was less
correlated with base excess and lactate (r = 37 and 43, respec-
tively). A significant decrease was found in diastolic blood pressure,
VCIe-ML and VCIi-ML in addition to lactate, bicarbonate and base
excess when dead and alive patients were compared (P < 0.05).
Conclusions The VCI diameter can give more reliable information
compared with the shock index and other parameters, especially in
trauma patients, to determine acute blood loss, and it can be used
as a follow-up parameter of hemorrhagic shock. A decreased VCI
diameter measured on admission in patients with hemorrhagic
shock might be a predictor of high mortality.
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Introduction Although superiority of dynamic parameters compared
with static values of preload is widely accepted, predicting fluid
responsiveness in spontaneously breathing patients is still a
challenging problem. A sudden increase in intrathoracic pressure
during the Valsalva maneuver transiently impairs venous return and,
only in preload-dependent patients, decreases the stroke volume
and arterial pulse pressure (PP). We designed this study to assess
the predictive value of arterial pressure response to a Valsalva maneu-
ver for fluid responsiveness in spontaneously breathing patients.
Methods In 27 spontaneously breathing patients, the Valsalva
maneuver, consisting of a forced expiration through a closed
mouthpiece, was performed. Patients were encouraged to maintain
a constant pressure of 30 cmH2O for 10 seconds. The Valsalva
pulse pressure variation (ΔVPP) was defined using the maximum
PP at the beginning of the strain (PPmax) and the minimum PP
(PPmin) according to the known formula: ΔVPP (%) = (PPmax –
PPmin) / [(PPmax + PPmin) / 2]. A first set of measurements was
obtained at baseline and immediately after the Valsalva maneuver
was performed. Cardiac output (FloTrac/Vigileo™), central venous
pressure, invasive arterial pressure and respiratory pressure were
continuously recorded during the whole strain time. After volume
expansion, new measurements were obtained and the Valsalva
maneuver was performed again post infusion.
Results The volume expansion-induced increase in the stroke
volume index was ≥15% in 10 patients (responders) and <15% in
17 patients (nonresponders). The baseline ΔVPP was higher and
decreased more after volume expansion in responders (P < 0.0001).
The baseline ΔVPP and ΔVPP increase after volume expansion
were statistically correlated with changes in the stroke volume
index (r = 0.83 and r = 0.74, P < 0.0001, respectively). The
baseline ΔVPP accurately predicted changes induced by volume
expansion with a sensibility of 90% and a specificity of 94%. The
area under the ROC curve for ΔVPP was 0.96 (95% CI =
0.81–0.99, P = 0.0001), with a best cutoff value of 50%.
Conclusions Arterial pressure variations induced by a Valsalva
maneuver reliably predict fluid responsiveness in spontaneously
breathing patients.
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Introduction Passive leg raising (PLR) represents a self-volume
challenge that could predict fluid response with less limitations
than other methods as variation of stroke volume and pulse
pressure variation. We hypothesized that the hemodynamic response
to PLR is able to predict fluid responsiveness in mechanically
ventilated patients after cardiac surgery.
Methods A prospective study in a surgical ICU of a university
hospital was performed. We investigated 44 patients in the
immediate postoperative period after cardiac surgery while in
mechanical ventilation with no spontaneous breathing activity.
Fourteen patients had arrhythmias. The hemodynamic status was
evaluated at baseline, after PLR and after volume expansion
(500 ml HAES 130/04 infusion over 10 min). In patients without
arrhythmias, the pulse pressure variation was calculated.
Results In 22 patients (responders), the cardiac index increased
by >15% after fluid infusion. A PLR increase of cardiac index
>15% predicted fluid responsiveness with a sensitivity of 95% and
a specificity of 94%. In patients without arrhythmias, a respiratory
variation in pulse pressure >13% predicted fluid responsiveness
with a sensitivity of 92% and a specificity of 88%.
Conclusions In a group of patients submitted to cardiac surgery,
the changes in cardiac index induced by PLR predict fluid
responsiveness in ventilated patients with higher sensitivity and
specificity than respiratory variation in pulse pressure.
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Introduction We compared thoracic electrical bioimpedance
(TEB) with transpulmonary thermodilution (TT) to evaluate the
accuracy of cardiac index with the ICG (CI-I) and cardiac index
with the PiCCO (CI-P) before and after fluid challenge (FC), to
determine the correlation between intrathoracic blood volume
(ITBV) and corrected flow time (FTc) before and after FC, to verify
the parameters’ response after FC, and to establish the credibility
of total fluid content (TFC) as a pulmonary fluid index in
comparison with extravascular lung water (EVLW).
Methods We recruited 33 patients from May 2006 to July 2007.
Inclusion criteria: instable hemodynamic conditions, mechanic
ventilation. Exclusion criteria: intraaortic balloon pump, aortic
failure. We used 7 ml/kg hydroxyethyl starch 6% in 30 minutes for
the FC. We used the PiCCO (Pulsion Medical Systems AG) and
the ICG (Solar ICG module; GE Medical Systems Technology,
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Milwaukee, USA) to monitor hemodynamic parameters. We
studied the strength of the association between all of the
hemodynamic parameters of the ICG and the PiCCO with the
correlation coefficient (P < 0.005).
Results The correlation coefficient between the differences of CI-I
and CI-P before and after FC is 0.6090 (P = 0.0002). The
correlation coefficient between the differences of EVLW and TFC
before and after FC is 0.1192 (P = 0.51). The correlation
coefficient between the differences of FTc and ITBV before and
after FC is 0.3443 (P = 0.04).
Conclusions The study demonstrates that the ICG can individuate
an increase of cardiac output after FC, but less than the PiCCO.
The correlation coefficient between CI-P and CI-I results is inferior
after FC, so CI-I seems less accurate in identifying the filling
response. There is an agreement between TFC and EVLW before
the FC. The ITBV from the PiCCO demonstrates more clinical
utility in identifying a response to FC. Even if TEB is clinically
useful, it does not represent an available option instead of the TT.
The parameters we studied have less clinical efficacy than the
classic methods of TT, as recent studies of the literature
demonstrate. TEB should be used when catheterization of a central
artery is contraindicated, when there is no other method to monitor
and especially when there is a need for rapid monitoring.
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Introduction Different hemodynamic parameters, including static
indicators of cardiac preload such as the end-diastolic volume
index (EDVI) and dynamic parameters such as the pulse pressure
variation (PPV) have been used in the decision-making process
regarding volume expansion in critically ill patients. The objective of
this study was to compare fluid resuscitation guided by either PPV
or EDVI, after hemorrhagic shock.
Methods Twenty anesthetized and mechanically ventilated pigs
were randomly allocated into two groups: PPV and EDVI. Hemor-
rhagic shock was induced by removing blood to a target pressure
of 40 mmHg and was maintained for 60 minutes. Parameters were
measured at baseline, at the time of the shock (Shock0),
60 minutes after the shock (Shock60), immediately after resusci-
tation with hydroxyethyl starch 6% (130/0.4) (R0), and 1 hour
(R60) and 2 hours (R120) after resuscitation. The endpoint of fluid
replacement was to re-establish the baseline values of PPV or
EDVI. Data were submitted to ANOVA for repeated measures
followed by the Bonferroni test.
Results The resuscitation solution volume was higher in the EDVI
group when compared with PPV (EDVI = 1,305 ± 331 ml and PPV =
965 ± 245 ml; P < 0.05). The time required to reach the endpoint
was also different between groups (PPV = 8.8 ± 1.3 min and EDV =
24.8 ± 4.7 min). The cardiac index decreased after shock (Shock0
and Shock60, P < 0.01) and increased after resuscitation (R0, P <
0.01) in the PPV group. In the EDVI group, the cardiac index
decreased at Shock0 (P < 0.05) and increased during R0 and R60
(P < 0.05). The right atrial pressure and pulmonary artery wedge
pressure decreased after shock in both groups (Shock0 and
Shock60, P < 0.05), reaching baseline values after resuscitation.
Oxygen delivery decreased after shock in both groups (Shock0
and Shock60, P < 0.001), recovered the baseline value at R0 in
both groups, but decreased at R60 and R120 in group PPV and at
R120 in the EDVI group. Lactate increased at Shock60 in both
groups and remained high at R0 in the PPV group and at R0 and
R60 in the EDVI group.
Conclusions After hemorrhagic shock, the resuscitation to an
established endpoint was quicker and required less fluid with PPV
when compared with EDVI.
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Introduction Dynamic indicators derived from the arterial pressure
waveform analysis as systolic pressure variation (SPV) and pulse
pressure variation (PPV) have been shown to be a useful tool to
optimize tissue perfusion in clinical and experimental studies.
These indicators, however, have not been adequately explored in
situations of acute variation of blood viscosity as occurs during
acute normovolemic hemodilution (ANH). The purpose of this
research was to compare the behavior of these dynamic indicators
in a porcine model of ANH with two different solutions.
Methods Fourteen pigs were anesthetized and randomly allocated
into two groups: GI (ANH with 6% hydroxyethyl starch, 1:1) and
GII (ANH with 0.9% saline solution, 1:3). Static and dynamic
hemodynamic parameters were evaluated at baseline (T1),
immediately after ANH (T2), and 1 hour and 2 hours after ANH (T3
and T4). Data were submitted to ANOVA for repeated measures
followed by the Bonferroni test.
Results The cardiac index increased in GI after ANH (T2 and T3,
P < 0.001). The mean arterial pressure was sustained in GI, but
decreased after ANH in GII (T2, T3 and T4, P < 0.05). The right
atrial pressure and pulmonary artery wedge pressure decreased in
GI (T3 and T4, P < 0.05). The PPV increased in GII (T3 and T4,
P < 0.001). The SPV increased in GI (T4, P < 0.05) and GII (T3
and T4, P < 0.001).
Conclusions The fluid responsiveness evaluated by PPV and SPV,
as well as the cardiac index and mean arterial pressure, in animals
submitted to ANH with hydroxyethyl starch showed that the
hemodynamics were better preserved. We can suppose that
starch remains longer in the vessels when compared with normal
saline solution.
Acknowledgements Supported by grants from FAPESP
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Introduction Guyton’s theory on venous return, implying a linear
relationship between blood flow and central venous pressure, was
tested in 12 mechanically ventilated ICU patients during standard
care.
Methods The central venous pressure was changed by applying
four different constant inspiratory plateau pressures over
12 seconds. Mean values of central venous pressure and cardiac
output were measured with pulse contour analysis over the last
3 seconds of this plateau period and were plotted against each
other to construct a venous return curve. During the inspiratory
plateau periods, hemodynamic steady-state circumstances were
met without an observable change in cardiovascular control
mechanisms. Two different volemic states were created: normo-
volemia in the supine position (SUP) and hypervolemia by volume
loading with 0.5 l intravenously (SUP-V).
Results Guyton’s linear venous return pressure–flow relationship
was confirmed. The average slope of the relation during SUP was
not significantly different from the slope during SUP-V. The mean
systemic filling pressures derived from these venous return curves
during SUP and SUP-V were 18.8 ± 4.5 mmHg and 29.1 ± 5.2
mmHg, respectively (P < 0.001). During SUP the calculated total
circulatory mean compliance was 0.98 ml/mmHg/kg and the mean
stressed volume was 1,677 ml.
Conclusions The mean systemic filling pressure, systemic
compliance and stressed volume can be determined in mecha-
nically ventilated patients with intact circulation using inspiratory
pause procedures. These results may imply a physiological tool to
assess the volume state of the circulation as well as fluid
responsiveness of mechanically ventilated patients in the ICU.
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Introduction The aim of this study was to compare the prediction
of fluid responsiveness [1] using the stroke volume variation (SVV)
determined by FloTrac™ (SVV-FloTrac; Edwards Lifesciences,
USA) and PiCCOplus™ (SVV-PiCCO; Pulsion Medical Systems,
Germany).
Methods With ethics committee approval, the SVV-FloTrac, SVV-
PiCCO, pulse pressure variation (PPV), global end-diastolic
volume (GEDV) and stroke volume (SV) were measured before and
after a volume shift induced by body positioning (30° head-up to
30° head-down) in 40 patients after cardiac surgery. A t test,
Bland–Altman analysis, Pearson correlation and area under the
receiver operating curves (AUC) were calculated. P < 0.05 was
considered significant.
Results Body positioning resulted in a significant SV and GEDV
increase, while SVV-FloTrac, SVV-PiCCO and PPV significantly
decreased. Comparably strong correlations between SVV-
FloTrac/SVV-PiCCO and ΔSV were observed (Table 1). The best
AUC was found for SVV-FloTrac (threshold value: 12.1%) and
SVV-PiCCO (threshold value: 9.6%). Mean bias ± 2SD (SVV-
FloTrac – SVV-PiCCO) was –2.5 ± 6.2%, and the correlation
coefficient (r2) was 0.72 (P < 0.01).
Conclusions SVV-FloTrac and SVV-PiCCO showed a comparable
performance in predicting fluid responsiveness. When compared
with SVV-PiCCO, a lower threshold value for SVV-FloTrac has to
be considered.
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Introduction Myocardial dysfunction is one of the most common
organ failures in patients with sepsis characterized by transient
biventricular contractility impairment, as well as systolic and
diastolic dysfunction. The aim of this study is to value early
hemodynamic alterations and myocardial dysfunction in severe
sepsis using the pressure recording analytical method (PRAM).
Methods Patients with severe sepsis or septic shock admitted to
the ICU were enrolled. We studied hemodynamic variations and
cardiac performance measured with PRAM (cardiac output, stroke
volume, systemic vascular resistance, stroke volume variation,
pulse pressure variation, cardiac cycle efficiency (CCE), maximal
rate of rise in the arterial pulse curve (dP/dt max)) for the first
Available online http://ccforum.com/supplements/12/S2
Table 1 (abstract P94)
AUC predicting ΔSV > 25% and Pearson correlation of baseline
indices versus ΔSV
AUC P value r2 value P value
SVV-FloTrac 0.824 0.001 0.426 <0.001
SVV-PiCCO 0.858 <0.001 0.492 <0.001
PPV 0.718 0.011 0.334 <0.001
GEDV 0.509 0.924 0.091 0.580
Figure 1 (abstract P95)
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24 hours. At admission, transthoracic echocardiography (TEC)
was used to value the left ventricular ejection fraction (LVEF%),
E/A ratio and left ventricular end-diastolic surface (LVEDS).
Mortality at 28 days was measured.
Results Eleven patients were included (six severe sepsis, five
septic shock). Mortality was 9%. TEC documented systolic
function preserved in all patients (LVEF > 50%); diastolic
dysfunction (E/A ratio < 1) in five patients and LVEDS reduced in
two patients. Hemodynamic monitoring documented a myocardial
dysfunction as a reduction of CCE and dP/dt max in two patients
that required inotropic support. CCE represents the ratio between
the hemodynamic work and the energetic cost sustained by the
heart [1].
Conclusions PRAM seems to be a valid mini-invasive instrument in
patients with sepsis for early diagnosis of myocardial dysfunction
and to guide therapy. In fact, as shown in Figure 1, despite a
preserved LVEF%, CCE and dP/dt max clearly detected
myocardial dysfunction, because these parameters relate cardiac
function with vascular condition.
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Introduction Omega Critical Care has introduced the truCCOMS
system to address the need for a rapid and accurate cardiac
output monitor. This monitor relates blood flow to the power
required to maintain a fixed temperature difference between a coil
on a pulmonary artery catheter and that of the surrounding blood.
The system was tested to assess their claims of accuracy and
speed.
Methods To test for accuracy, four truCCOMS catheters were
tested against the reference values of a Transonic T201 flowmeter
using pulsatile flow provided by a Syncardia Systems artificial heart
connected to a Donovan mock circulation tank generating flows
between 1 and 8 l/min. Additionally, response time was monitored
for abrupt changes in flow from 3 to 6 l/min and compared with an
Edwards continuous cardiac output catheter.
Results Measured flows from the truCCOMS unit, properly
corrected for thermodynamic differences between blood and the
glycerine used, show accurate correlation with Transonic values as
seen in Figure 1. Figure 2 shows the substantial improvement in
response time provided by the truCCOMS system.
Conclusions Our results show that the principles used in the
truCCOMS monitor can provide accurate measurement of cardiac
output. More importantly, it provides this measurement in near real-
time. Clinical studies should confirm these results. This system
promises to be an accurate and responsive monitor in the clinical
setting.
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Introduction The first evaluation studies of the FloTrac™ device
(Edwards Lifesciences, USA) for cardiac output (CO) measure-
ment revealed conflicting results [1,2]. The initially used software
version may in part be responsible for these findings. The aim of
this study was to compare the CO determined by FloTrac™ using
software versions 1.03 and 1.07 (aFCO and bFCO) with the CO
measured by PiCCOplus™ (Pulsion Medical Systems, Germany)
(PCO) and the CO assessed by intermittent thermodilution (ICO).
Methods With ethics committee approval, CO was assessed after
cardiac surgery. For one set of data (dataset A) aFCO and for one
set (dataset B) bFCO was used. After PiCCO calibration the mean
of triplicate FCO, PCO and ICO values were recorded 15 minutes
after inducing CO changes by different body positions (supine, 30°
Critical Care    March 2008 Vol 12 Suppl 2 28th International Symposium on Intensive Care and Emergency Medicine
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Measured accuracy of the truCCOMS device. CO, cardiac output.
Figure 2 (abstract P96)
Response time: truCCOMS versus Edwards continuous cardiac
output (CCO) catheter.
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head-up, 30° head-down, supine). Statistical analysis was
performed using the t test, ANOVA and Bland–Altman analysis for
absolute values and percentage changes (Δ). P < 0.05 was
considered significant.
Results Data were obtained from 25 patients and 22 patients for
dataset A and dataset B, respectively. Significant changes of FCO,
PCO and ICO between measurement points were observed in
datasets A and B. During dataset A, ΔaFCO was significantly
greater and ΔPCO was significantly smaller than ΔICO induced by
head-down positioning (P = 0.017 and P < 0.001, respectively).
During dataset B no significant difference was observed between
ΔbFCO and ΔICO. ΔPCO was significantly smaller than ΔICO
during dataset B. Increased limits of agreement for aFCO–ICO
and ΔaFCO–ΔICO (dataset A) were found when compared with
PCO–ICO (Table 1). For dataset B the mean bias and limits of
agreement were comparable.
Table 1 (abstract P97)
Bland–Altman analysis of absolute cardiac output (CO) values and
percentage CO changes (Δ)
Dataset CO (l/min) Δ (%)
FCO–ICO A –0.1 ± 2.4 –0.6 ± 48.3
B –0.5 ± 1.1 –0.4 ± 24.8
PCO–ICO A –0.2 ± 1.4 –3.8 ± 28.0
B –0.2 ± 1.3 –1.5 ± 25.3
Conclusions These results indicate that the new FloTrac software
version (reduced time window for vascular compliance adjustment)
improved performance of CO measurement in patients after
cardiac surgery.
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Introduction To evaluate the reliability of continuous cardiac
output monitoring using pulse-contour analysis in critically ill
patients.
Methods We retrospectively analyzed the agreement between
transpulmonary thermodilution cardiac output (TPCO) and pulse
contour cardiac output (PCCO) measured before recalibration of
the TPCO from 34 patients with hemodynamic instability. Logistic
regression analysis was used to identify the independent factors
for the disagreement between TPCO and PCCO, defined as a
relative change >15%.
Results We obtained 261 pairs of measurements. The relative
change in systemic vascular resistance calculated with TPCO
(ΔSVR-TPCO) of over 20% was the only independent factor for
disagreement, while the relative change in systemic vascular
resistance calculated with PCCO (ΔSVR-PCCO) and the time
interval between calibrations had no predictive value of the
reliability of PCCO. See Figure 1.
Conclusions ΔSVR-TPCO > 20% was associated with unreliability
of PCCO measurement. Reliability of PCCO could not be predic-
ted by continuous monitoring parameters, such as ΔSVR-PCCO.
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Introduction Limitations of minimally invasive hemodynamic monitor-
ing devices are important in order to assess when and where these
devices will provide utility. Challenging situations for these devices
occur during extreme hyperdynamic conditions like septic shock,
characterized by extreme loss of vascular tone and high cardiac
output (CO). Identification that a patient has entered this condition
could prove useful for assessing performance of the aforementioned
devices, as well as providing additional information about patient
condition, which should be evaluated for its potential utility.
Methods In a group of 18 patients we evaluated the sensitivity and
specificity for a new peripheral decoupling indicator (PDI) in
assessing moments when physiological patient conditions may be
causing the arterial pressure-derived cardiac output (APCO) to be
underestimated. Comparison was made between a pulmonary
artery catheter (PAC) and an APCO sensor (FloTrac Edwards
Lifesciences, CA, USA). Data were collected over a period of
1,090 hours, providing a total of 196,369 data points for evalua-
tion, with CO values ranging from 2 to 16.
Results The PDI demonstrated specificity of 96.7% and sensitivity
of 82.6%. During these identified periods, FloTrac consistently
exhibited a one-sided bias in its CO value, with a lower CO value
when compared with the PAC. Only two of the patients exhibited
periods of peripheral decoupling. Overall, the PDI indicated ‘on’ for
4,392 of the data points collected, or 2.2% of the time. Figure 1
illustrates the data from one of these patients.
Conclusions The PDI identified moments when patient physiology
led to underestimation of the FloTrac CO value. Additional
research is needed to determine whether the low incidence rate of
extended peripheral decoupling observed in our study is typical in
Available online http://ccforum.com/supplements/12/S2
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septic patients, and whether it could be correlated to patient
condition or treatment. Further research is necessary to determine
any potential prognostic value from the PDI.
Acknowledgement The study was supported by a limited grant
from Edwards Lifesciences.
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Introduction We compared the cross-correlation between esti-
mates of cardiac output (CO) and left ventricular stroke volume
variation (SVV) amongst three commercially available, minimally
invasive devices. (LiDCOplus, FloTrac and PiCCO).
Methods We simultaneously compared continuous and bolus
thermodilution CO measures from a pulmonary artery catheter
(PAC) with simultaneous estimates of arterial pulse contour-
derived CO using the FloTrac®, LiDCOplus® and PiCCO®
measured at one time in 20 cardiac surgery patients during the first
two postoperative hours. We also compared SVV estimates
among the three devices. Mean and absolute values for CO and
SVV across all devices were compared by ANOVA and
Bland–Altman analysis.
Results Mean CO values were not different across devices (5.8 ±
1.6 l/min vs 5.9 ± 1.7 l/min vs 5.8 ± 1.6 l/min for PiCCO, LiDCO
plus and FloTrac, respectively; P = 0.4). The mean PAC CO (5.8 ±
1.6 l/min) was similar to PiCCO and FloTrac estimated CO values,
but less than LiDCO CO values (P < 0.01). Biases between PAC
and PiCCO, LiDCO and FloTrac values were 0.19 ± 0.57 l/min,
–0.35 ± 0.56 l/min and –0.30 ± 1.56 l/min, respectively, and
precision was –1.31 to 0.92 l/min, –1.46 to 0.77 l/min and –2.6 to
2.0 l/min, respectively. LiDCO and FloTrac SVV correlated (r2 =
0.58), however, with a bias of –0.40 ± 6.50% and a precision of
–13 to 7%; whereas FloTrac and PiCCO SVV were not correlated
(r2 = ns), with a bias of 4.0 ± 6.0% and a precision of –8 to 16%.
LiDCO and PiCCO SVV were also not correlated (r2 = ns), with a
bias of –5.4 ± 9.0% and a precision of –22 to 17%. Finally,
PiCCO and LIDCO pulse pressure variation were correlated (r2 =
0.64, P < 0.05), with a bias of 17.0 ± 6.5% and a precision of –10
to 15%.
Conclusions All three arterial pulse contour analysis devices
estimated CO well with a high degree of accuracy and precision.
Furthermore, of the two devices that also report pulse pressure
variation, both gave similar estimates, whereas SVV estimates
correlated well only between LiDCO and FloTrac. The results of
prior studies using LiDCO and PiCCO-derived estimates of SVV
cannot therefore be compared with each other, nor can absolute
values be used to drive similar resuscitation protocols unless
independently validated for that catheter.
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Introduction Assessment of continuous cardiac output using the
arterial pulse wave (APCO) is currently available only with standard
radial artery catheterization (Vigileo System, FloTrac™, Edwards
Lifesciences, Irvine, CA, USA) [1,2]. Many of the studies available
in the literature have compared APCO versus intermittent cardiac
output (ICO) obtained with a pulmonary artery catheter (Intellicath,
Edwards Lifesciences, Irvine, CA, USA) in patients undergoing
cardiac surgery [3]. The aim of this study was to assess the bias
and level of agreement between the APCO and  ICO in patients
undergoing major vascular surgery.
Methods Twenty elective patients undergoing abdominal aortic
aneurysm (AAA) repair were enrolled. Patients with a pre-operative
history of valvular heart disease, preoperative dysrhythmias, or
ejection fraction <40% were excluded from the study. APCO and
ICO measurements were simultaneously collected at the following
steps: Before anesthesia induction (T1), after anesthesia induction
(T2), 30 min after anesthesia induction (T3), at aortic cross-
clamping (T4), 30 min after aortic cross-clamping (T5), 5 (T6), 10
(T7), 30 (T8) min after aortic unclamping, and at the end of surgery
(T9). Statistical evaluation was performed using the Bland and
Altman analysis. The percentage error was calculated according to
the method described by Critchley et al. [4].
Results A total of 360 pairs of APCO/ICO measurements were
analyzed and the bias was 0.09 ± 1.93 l/min/m2 with a percentage
error of 28%. Subgroup analysis revealed that the bias, calculated
without the measurements obtained during the T4 and T5 aortic
cross-clamping periods, was 0.06 ± 1.97 l/min/m2 with a percen-
tage error of 29%, surprisingly similar to the all pairs results.
Conclusions In patients undergoing major vascular surgery,
APCO obtained with the Vigileo System provided a clinically
acceptable bias and agreement with intermittent pulmonary
thermodilution measurements, surprisingly also during the aortic
cross-clamping period. Larger population studies are needed to
confirm these very preliminary data.
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PDI, peripheral decoupling indicator; APCO, arterial pressure-derived
cardiac output; CCO, continuous cardiac output; ICO, intermittent (or
bolus) cardiac output.
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Introduction Knowledge of cardiac output (CO) and vascular
resistance has been shown to influence and direct clinical decisions
in critical care patients [1,2]. The choice of which technology to
measure CO, however, remains troublesome and confusing. The
accuracy and invasiveness of CO measurement technologies are
variable, as are the concepts surrounding whether calibration is
necessary. These issues of invasiveness and accuracy are central
to decisions relating to CO monitor selection and are perceived to
have an inverse relationship. Niccomo™ is a new impedance
cardiography (ICG) algorithm that is noninvasive (‘plug and play’)
and uses no calibration. LiDCO™ is a well validated indicator
dilution (ID) technique. This study compared the accuracy of the
new ICG algorithm versus the LiDCO™ standard.
Methods With consent/assent, 14 critically ill patients were studied.
The ICG monitor was set up and, following two initial ID deter-
minations, CO measurements were recorded from both monitors
simultaneously at one to six time points over 6 hours.
Results Fifty-one paired measurements were obtained from the
ICG and ID monitors. The mean (±SD) COs were 6.11 (1.62)
l/min and 4.67 (1.25) l/min, respectively. The mean bias was
–1.44 l/min with a precision (standard deviation) of ±2.02 l/min.
The lower and upper limits of agreement were –5.48 l/min (mean –
2SD) and 2.61 l/min (mean + 2SD) (P < 0.001). Spearman’s
correlation analysis showed r = 0.149, P = 0.297. On direct
comparison of the initial paired readings, the Niccomo™ estimated
a lower CO than the LiDCO™; however, the differences were
extremely variable.
Conclusions ICG showed both poor agreement and poor
correlation versus ID. The percentage error (53%) lies outside the
graphically derived accepted 30% level [3], and in this patient
population suggests that this ICG algorithm does not have the
required accuracy to drive, or the clinical confidence to make,
haemodynamic management decisions.
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Introduction Intrathoracic blood volume (ITBV) is thought to be a
superior measure of cardiac preload compared with intravascular
pressure [1]. Transpulmonary indocyanine green (ICG) indicator
dilution is regarded as the most reliable method of ITBV measure-
ment but is no longer commercially available. Our previous work
suggests lithium indicator dilution could be used to measure the
ITBV [2].
Methods Patients undergoing cardiac surgery with cardio-
pulmonary bypass who met inclusion criteria were enrolled into a
single-centre, observational study. Perioperative care was
standardised. Comparative ITBV measurements were performed 1,
2, 4 and 6 hours after surgery, using lithium indicator dilution via a
radial artery catheter (LiDCOplus; LIDCO Ltd, UK) and ICG
indicator dilution via a femoral artery catheter (COLD-Z; Pulsion,
Germany). Data were compared by Bland–Altman analysis.
Results Seventeen patients were recruited (age 69 (54–87) years;
Parsonnet score 10 (0–29)), providing a total of 68 paired
measurements. Sixteen ICG measurements were excluded
because of poor-quality indicator dilution curves, leaving 52 paired
comparisons. The mean ITBV measured by lithium dilution was
2,522 ml (±691) and measured by ICG dilution was 1,708 ml
(±432). The mean bias between paired measurements was 813 ml
(limits of agreement (Bland–Altman analysis) ±1,248; P < 0.001).
For the cardiac index, however, the bias between techniques was
only 0.39 l/min/m2 (limits of agreement (Bland–Altman analysis)
±0.9 l/min/m2; P < 0.0001). The discrepancy between the
techniques therefore related to differences in the measurement of
the mean indicator transit time. There was a decreasing trend in
the mean differences in ITBV and mean indicator transit time
(Li-ICG) from 1,014 ml and 16.1 seconds at hour 1 to 466 ml and
10.6 seconds at hour 6 (P = not significant).
Conclusions Poor agreement between ITBV measurements taken
using ICG and lithium indicator dilution appears to be due to
inaccurate measurement of the mean indicator transit time. This
may relate to the use of a radial as opposed to a femoral artery
catheter in patients with poor peripheral perfusion.
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Introduction Optimal monitoring of cardiac preload is essential
during resuscitation from hemorrhagic shock (HSR) to avoid
under-resuscitation and over-resuscitation. The maintenance of
adequate preload by administration of intravenous fluids remains a
primary target to optimize hemodynamics in the early phase of
HSR prior to the arrival of blood products. The central venous
pressure (CVP) is commonly used as a goal to resuscitation;
however, several studies have shown that cardiac filling pressures
are not always accurate indicators of ventricular preload. The
global end-diastolic volume (GEDV) determined at the bedside by
the transpulmonary thermodilution method has been found to
better assess cardiac preload in septic patients than CVP but this
has not been examined in HSR. The present study was designed
to assess the value of GEDV measured by transpulmonary
thermodilution as an indicator of cardiac preload in HSR.
Methods Twenty anesthetized swine underwent a grade V liver
injury and bled without resuscitation for 30 minutes. Animals were
then resuscitated with study fluid to, and maintained at, the
preinjury mean arterial pressure. Hemodynamic parameters were
evaluated in triplicate by the transpulmonary thermodilution
technique: before and immediately after the liver injury and
spontaneous hemorrhage; and 30 minutes after hemorrhage,
immediately before and after resuscitation to the preinjury mean
arterial pressure.
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Results Changes in the GEDV index were more highly correlated
with changes in stroke volume (SV) as compared with changes in
CVP versus changes in SV (Figure 1).
Conclusions In this porcine model of traumatic hemorrhagic shock
and resuscitation, the GEDV in contrast to the CVP behaved as an
indicator of cardiac preload.
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Introduction The study investigated the prognostic value of the
extravascular lung water index (EVLWI) determined by the single
transpulmonary thermodilution technique and its relationship with
physiologic indexes of lung injury in critically ill patients with septic
shock in the ICU.
Methods The EVLWI was determined using a PiCCO monitor, and
the daily fluid balance, oxygenation ratio (PaO2/FiO2), pulmonary
vascular index (PVI), lung compliance and lung injury score (LIS)
were recorded. The final outcome was assessed at day 28. Data
(mean ± SD) were compared using Student’s t test for continuous
variables and by the chi-squared test for discrete variables. The
correlations were estimated using Pearson’s coefficient. P < 0.05
was regarded as statistically significant.
Results Thirty patients with septic shock were admitted
prospectively. Fourteen (47%) patients died before day 28. At day
1 and day 3 the EVLWI was correlated to PaO2/FiO2 (r = –0.4 and
r = –0.47, respectively; P < 0.05) and to LIS (r = 0.47 and r =
0.43, respectively; P < 0.05). No correlation was found, however,
between the EVLWI and lung compliance and fluid balance. The
average EVLWI at baseline was 12 ± 5 ml/kg, and the difference
was not different between survivors and nonsurvivors; P = 0.14.
The EVLWI and PVI for day 3 in nonsurvivors were significantly
higher than in the survivors (13.7 ± 4.5 vs 8.6 ± 2.6 ml/kg; P =
0.001 and 2.69 ± 0.98 vs 1.93 ± 0.65; P = 0.01, respectively).
ROC statistics using the highest EVLWI value at day 3 in each
individual revealed an area under the curve of 0.868 ± 0.128; P =
0.001 with a cutoff point >11.5 ml/kg. At day 3, the hospital
mortality of patients with EVLWI >11.5 ml/kg was significantly
higher than those with EVLWI <11.5 ml/kg (77% vs 19%; P =
0.02) with sensitivity of 77% and specificity of 80%. During the
course of illness, the EWLI, PVI and fluid balance decreased from
days 1 to 3 only in the survivors (P < 0.05).
Conclusions In human septic shock, the EVLWI demonstrated
moderate correlation with markers of the severity of pulmonary
aggression. Dynamic observation of the EVLWI can be one of the
factors for predicting the prognosis of patients with septic shock. A
reduction of the EVLWI at early treatment was associated with a
better prognosis.
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Introduction Traumatic brain injury (TBI) is one of the most important
causes of death in young adults. Treatment aims at controlling the
intracranial pressure (ICP) in order to maintain an adequate cerebral
blood flow, to reduce the risk of secondary ischemic damage.
Abnormal blood flow in the middle cerebral artery in patients with TBI
was previously associated with poor outcome. Because perfusion of
the brain shares a common origin with blood flow in the conjunctiva,
we hypothesized that conjunctival microcirculation is altered after
TBI in comparison with healthy subjects.
Methods We used sidestream dark-field (SDF) imaging for
evaluation of the readily accessible microcirculation of the bulbar
conjunctiva as a noninvasive research site. Conjunctival micro-
circulation was studied in eight patients with TBI requiring sedation
and continuous ICP monitoring. In addition, we investigated eight
age-matched healthy control individuals. Using MAS software we
determined the functional vascular density (FVD) as the total length
of perfused vessels per field of view as well as the microvascular
flow index (MFI).
Results Data are presented as the median (interquartile range).
The TBI patients had an ICP of 20 (15–25) mmHg and a cerebral
perfusion pressure of 61 (53–77) mmHg. The conjunctival MFI in
TBI patients was 2.94 (2.88–3.00) in comparison with 2.93
(2.79–3.00) in healthy controls. The FVD was 7.78 (7.54–8.14)
and 8.53 (7.60–9.97) in TBI patients and healthy controls, respec-
tively. There was no significant difference in microcirculatory
parameters found between the groups.
Conclusions We found that the FVD and MFI did not differ
between healthy subjects and patients with TBI. Based on these
interim results, further research will focus on the effect of an
elevated ICP on conjunctival microvascular blood flow.
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Introduction Major head injury is a common reason for admission
to the ICU. Knowledge of factors that predict mortality provides
clues to the pathophysiology of head injury, how clinicians’
interventions can be most effective, allows audit between different
units or time points and provides objective data with which to
communicate with patients’ relatives. Several established risk
prediction models exist in the ICU; however, they have been shown
to have suboptimal discrimination and calibration in this patient
group [1]. Our aim was therefore to develop a novel model to
predict mortality specifically for head injury.
Methods A literature review was undertaken to identify variables
predictive for mortality after severe head injury. The ICNARC Case
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Mix Programme, containing multiple data from 374,594 admissions
to 171 critical care units in England, Wales and Northern Ireland
from 1995 to 2005, was searched for head injury patients with a
primary diagnosis of ‘primary brain injury’, ‘subdural haematoma, or
‘extradural haematoma’. Each variable that could be supported by
the database was entered into a stepwise logistic regression
model with mortality as the outcome. Calibration of the risk
prediction model was assessed by the area under the receiver
operating characteristic curve, discrimination by the Hosmer–
Lemeshow C statistic and overall fit by Brier’s score.
Results A total of 10,937 admissions with head injury were
identified. A prediction model was constructed using 14 variables
and shown to have a superior discrimination and calibration to
APACHE II, SAPS II and MPM II. A simplified model consisting of
only three variables also performed better than existing models.
Conclusions We present two novel prediction models for mortality
after head injury requiring intensive care. Both models, even the
simplified model of only three variables, had superior discrimination
and calibration to existing ICU risk-prediction models.
Reference
1. Hyam JA, Welch CA, Harrison DA, Menon DK: Case mix,
outcomes and comparison of risk prediction models for
admissions to adult, general and specialist critical care
units for head injury: a secondary analysis of the ICNARC
Case Mix Programme Database. Crit Care 2006, 10(Suppl
2):S2.
P108
Changes in cerebral physiology following cranioplasty: 
a 15oxygen positron emission tomography study
M Abate, D Chatfield, J Outtrim, G Gee, T Fryer, F Aigbirhio, 
D Menon, J Coles
Wolfson Brain Imaging Centre, University of Cambridge, UK
Critical Care 2008, 12(Suppl 2):P108 (doi: 10.1186/cc6329)
Introduction Patients with skull defects report symptoms, which
improve with cranioplasty (CP). We used 15O positron emission
tomography (PET) to examine whether this resulted from improve-
ments in cerebral physiology.
Methods Seven patients were imaged 6–12 months post craniec-
tomy with PET to derive maps of cerebral blood flow (CBF),
oxygen metabolism (CMRO2), and oxygen extraction fraction
(OEF) before and after CP. PET maps were coregistered with
magnetic resonance images and segmented into grey matter (GM)
and white matter (WM). Physiology was quantified in mixed GM +
WM, GM and WM regions of interest (ROIs) underlying the
craniectomy and in whole-brain GM, WM and GM + WM ROIs.
Results See Figure 1. There were no significant changes in CBF,
CMRO2 or OEF following CP, even within ROIs underlying skull
defects. Individual patients showed increases in CBF and CMRO2
and decreases in OEF, but all values were above ischemic
thresholds [1].
Conclusions Although individual subjects demonstrate improve-
ments in physiology following CP, there were no systematic
changes. Future studies will assess changes in individuals and
relate these to metabolic changes within specific brain regions.
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Introduction The study objective was to analyse what kind of
dynamic interrelations exist between brain tissue oxygenation (PbtO2)
and corresponding fast modifications of arterial blood pressure
(ABP), cerebral perfusion pressure (CPP) and intracranial pressure
(ICP) in transient events.
Methods We reviewed retrospectively 325 computer recordings
of PbtO2, invasive ABP and ICP waveforms from 23 head-injured
patients. All patients were sedated, paralysed and ventilated. All
signals were digitised, and recorded using ICM+ software. We
divided the events into two groups, depending on whether ABP
(Group 1) or ICP (Group 2) was the first parameter to change.
Group 1 was further subdivided based on whether the vascular
autoregulation was intact (ABP-ICP negative correlation) or was
impaired (ABP-ICP positive correlation).
Results Group 1 (n = 255): intact cerebral autoregulation (n =
179): during hypotension PbtO2 decreased with delay with
respect to CPP (48.5 s; SEM 92.1) and ICP (39.9 s; SEM 91.4),
and during hypertension PbtO2 increased with a delay of 58.1
seconds (71.9 SEM) with respect to CPP and 52.2 seconds (72.2
SEM) with respect to ICP; impaired cerebral autoregulation (n =
76): PbtO2 modified following ABP changes, with a delay of 56.8
seconds (SEM 59.3) with respect to CPP and 54.2 seconds (58.8
SEM) with respect to ICP. Group 2 (n = 61): plateau waves and
isolated gradual increases in ICP caused CPP to lower, followed
by a PbtO2 decrease. The delay in PbtO2 reaction was 23.1
seconds (55.7 SEM, n = 23) with respect to ICP and 18.4
seconds (54.9 SEM, n = 24) to CPP.
Conclusions Transient events were observed in PbtO2 related to
ABP or ICP modifications. Changes in PbtO2 were present
irrespective of the state of autoregulation or the origin of the event
(haemodynamic or ICP related). Generally PbtO2 followed the CPP
direction. PbtO2 usually changed with a delay relative to the
pressure parameters. The CPP-PbtO2 delay was significantly
shorter in the events characterized by primary ICP modification
(Group 2) in comparison with the ABP-led events (Group 1),
irrespective of the state of autoregulation. These findings should
be taken into account to evaluate the validity of indices assessing
cerebral autoregulation using PbtO2.
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Introduction We measured the fatty acid binding protein (H-
FABP) and tau levels in the cerebrospinal fluid (CSF) of patients
after subarachnoid hemorrhage (SAH): to evaluate the relationship
between SAH severity and H-FABP/tau values; to test the
hypothesis that H-FABP/tau might help in the diagnosis of
vasospasm; and to evaluate their association with outcome.
Methods We studied 38 SAH patients, whose severity was
assessed by the Glasgow Coma Scale (GCS). Serial CSF
samples were obtained in every patient starting on the day of SAH
and up 2 weeks post-SAH. H-FABP/tau levels were measured by
ELISA. Vasospasm was defined as neuro-worsening (loss of at
least one point of the motor component of GCS and/or appear-
ance of a new focal deficit) + angiographic confirmation. The 6-
month outcome was assessed by the dichotomized Glasgow
Outcome Score (GOS): good (GOS 4–5) and bad (GOS 1–3).
Multiple logistic regression analyses were performed to assess the
association between H-FABP/tau values and GOS.
Results H-FABP and tau increased after SAH. We observed a
significant association between the peak H-FABP/tau values and
admission mGCS (Spearman r = –0.581, P = 0.0001 and r =
–0.582, P = 0.0001, respectively). Eight patients underwent brain
death. Within the survivors we observed vasospasm in 11 patients.
Both proteins were significantly higher in this group compared with
those without ischemia (H-FABP = 15,958 ± 21,736 pg/ml vs
2,527 ± 2,427 pg/ml, P < 0.05; tau = 5,821 ± 3,774 pg/ml vs
1,118 ± 1,547 pg/ml, P < 0.05). The H-FABP rise preceded
clinical recognition of vasospasm in seven patients and was
simultaneous in four patients. Tau increased before clinical
recognition of vasospasm in five patients. Patients with bad out-
come showed higher peak levels of both proteins than patients
with good outcome: respectively, H-FABP = 23,977 ± 25,593 pg/ml
and 3,374 ± 2,549 pg/ml, P < 0.001; tau = 6,756 ± 4,544 pg/ml
and 1,591 ± 1,639 pg/ml, P < 0.001. Logistic regression showed
that, after correction for age, sex and SAH severity, the peak value
of tau protein was an independent predictor of outcome.
Conclusions The H-FABP and tau increase following SAH and
might add complementary information for the diagnosis of
vasospasm. There is an association between their CSF values and
outcome following SAH.
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Introduction Active smokers comprise 35–55% of patients
admitted with acute spontaneous subarachnoid hemorrhage (SAH).
Transdermal nicotine replacement is sometimes prescribed to these
patients to prevent a withdrawal syndrome, but the safety of
exogenous nicotine during the acute period after SAH is unknown.
Methods We conducted a prospective, observational study from
2001 to 2007 in the neurological ICU of a major academic medical
center. All active smokers admitted with SAH were included in the
analysis, but we excluded patients who died within 7 days of
admission to remove those whose death was due to discon-
tinuation of life support. The primary endpoint was 3-month
mortality. Secondary endpoints were delayed cerebral ischemia
(DCI) and clinical vasospasm.
Results One hundred and ninety-two active smokers, including
104 (54%) who received transdermal nicotine, were well matched
on demographics, gender, age, Hunt and Hess grade, SAH sum
score, aneurism size, and smoking pack-year history, but a higher
percentage of current heavy smokers (>10 cigarettes daily)
received nicotine (67%, P < 0.001). There was no association of
nicotine replacement and clinical vasospasm or DCI. After
controlling for disease severity and cerebral edema on head CT
(OR = 13.9, CI = 1.5–125.3), multivariable logistic regression
revealed that heavy smokers were more likely than light smokers to
die (OR = 6.0, CI = 1.11–32.7). Smokers who received nicotine
had lower mortality (OR = 0.26, CI = 0.68–0.98), an effect that
seemed on secondary analysis to be driven by high mortality
among heavy smokers who did not receive nicotine.
Conclusions Transdermal nicotine replacement is not associated
with clinical vasospasm or DCI in smokers admitted with SAH, and
is associated with lower mortality, particularly among smokers of
more than 10 cigarettes daily. This may be due to prevention of the
physiological derangements associated with nicotine withdrawal.
Nicotine replacement after acute SAH is probably safe, and should
be given to active heavy smokers at the time of admission. More
research is needed to verify these findings and define the
therapeutic role of nicotine in the ICU.
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Introduction Statins have neuroprotective properties including
improved vasomotor reactivity, reduced platelet activation and anti-
inflammatory effects [1]. A prospective observational controlled
study was conducted to evaluate the impact of pravastatin on the
development of delayed ischemic disease (DID) and ICU mortality
after aneurysmal subarachnoid hemorrhage (aSAH).
Methods A total of 98 patients (20–80 years old) with aSAH were
randomized to receive either pravastatin 40 mg (n = 40) or
nonstatin treatment (n = 58) within 24 hours after the ictus. Primary
endpoints, incidence of DID and extent of disability measured by the
Glasgow Outcome Scale; secondary endpoint, ICU mortality.
Results Groups were comparable with respect to age (54.2
(50.3–58.3) vs 53.2 (49.8–56.7) 95% CI), grade of aSAH
(Hess/Hunt) (2.6 (2.17–3.03) vs 3.06 (3.00–3.80) 95% CI) and
stroke severity (Glasgow Coma Scale 10.9 (9.4–12.4) vs 10.5
(9.3–11.8) 95% CI). There was a trend towards less DID in the
statin group (37.5% vs 60.3% nonstatin; standard error of the
difference of the means 9.8 (3.64–28.00) 95% CI). The extent of
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disability between the groups, however, was not different
(Glasgow Outcome Scale 3.65 (3.16–4.14) statin vs 3.39
(3.00–3.80) nonstatin 95% CI). Mortality was unchanged as well
(22.5% statin vs 22.4% nonstatin).
Conclusions These results are in line with a recently published
study demonstrating reduced vasospasm-related DID in patients
treated with pravastatin after aSAH [2]. We could not confirm the
benefit of statin treatment regarding mortality as mentioned in the
cited trial since our study was not powered to detect a difference
in mortality. So it is to be hoped that the Statins for Aneurysmal
Hemorrhage STASH trial will clarify this topic.
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Introduction We studied the induction of Pentraxin 3 (PTX3), a
prototypic long pentraxin protein induced by proinflammatory
signals in subarachnoid hemorrhage (SAH) patients, to investigate
a possible relation with SAH-associated ischemic brain damage.
Methods PTX3 was measured in the plasma and cerebrospinal
fluid (CSF) of 38 SAH patients admitted to the neuroscience ICU,
who were divided into three groups: occurrence of vasospasm,
defined as neuro-worsening (loss of at least one point of the
Glasgow Coma Scale motor component and/or appearance of a
new focal deficit) and angiographic confirmation of vasospasm;
presence of an early hypodense lesion, defined as the appearance
of a new hypodense lesion at CT scan following endovascular or
surgical treatment, or around the initial intracerebral hematoma;
and absence of a hypodense lesion. Arterial and CSF samples
were obtained every 12 hours starting on the day of SAH and up 2
weeks post SAH.
Results PTX3 was induced in the plasma and CSF of SAH
patients. CSF peak concentrations were significantly higher in
patients with vasospasm (21.5 ± 5.1 ng/ml) compared with those
with no CT hypodense lesion (5.8 ± 4.5 ng/ml, P < 0.05). Patients
with an early hypodense lesion showed a peak concentration that
was intermediate between the other two groups (12.4 ± 5.2 ng/ml).
No difference was observed in plasma levels among the three
groups. The temporal pattern of CSF PTX3 in patients with
vasospasm was triphasic: there was an initial increase of PTX3
during the first 48 hours following SAH (acute phase, up to 17.2 ±
5.2 ng/ml), followed by a subsequent decrease in the next 48–96
hours (subacute phase, up to 1.2 ± 0.3 ng/ml, P < 0.01 compared
with the acute phase). With the appearance of vasospasm, a
secondary peak of PTX3 was detected (up to 7.1 ± 1.4 ng/ml, P <
0.01 compared with the subacute phase). No changes were
detectable in plasma.
Conclusions PTX3 is induced in the CSF and in plasma following
SAH; however, the CSF but not plasma levels are directly related
to the degree of brain injury. In addition the data show that PTX3
measured in the CSF might be a reliable marker of vasospasm
following SAH, and suggest that measurements of PTX3-CSF
levels associated with clinical evaluation could improve early
diagnosis of vasospasm in these patients.
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Introduction Cerebral blood flow (CBF) disturbances at focal
lesions of the hypothalamopituitary system and brain stem structures
are one of the unexplored and pressing questions of modern
neurosurgery [1]. Transcranial duplex sonography (TCDS) is a
widely used method for determination of the cerebral blood-flow
velocity (FV) in neurosurgical patients.
Methods We studied characteristics of cerebral hemodynamics by
TCDS after hypothalamic and brain stem tumor excision in 186
patients. The data obtained were compared with CT-MRI data,
clinical parameters and factors of neurohumoral regulation.
Results Our study showed that FV disturbances were observed in
82% of patients after surgery for hypothalamic and brain stem
lesion. The revealed FV disturbances were evaluated as vasomotor
spasm of different degrees of manifestation; distress of FV was
caused by a thrombosis of branches of cerebral vessels, hyper-
perfusion, hypoperfusion and infringements of venous outflow and
CBF autoregulation. Stable neurological disorders were observed
in 100% of patients at FV <40 cm/s and >200 cm/s. At FV
>120 cm/s we observed 61% of patients with transient
neurological disorders and 24% with stable, and at FV >150 cm/s
22% with transient and 78% with stable neurological disorders.
Middle cerebral artery (MCA)/internal carotid artery ratio >3.0 and
FV >120 cm/s and basilar artery (BA)/external vertebral artery ratio
>2.0 with BA velocities >85 cm/s was associated with 92%
sensitivity and 97% specificity for vasospasm in the MCA and BA
accordingly. In 87% of patients with FV in MCA >185 cm/s we
observed focal ischemic brain lesions verified on CT scan. Fixed
pathologic interactions between degrees of FV and factors of
neurohumoral regulations suggest existing pathogenetic mechanisms
of CBF disturbances in focal lesions of the hypothalamic pituitary
system and brain stem. The dependence of FV disturbances and
vasopressin plasma level was established. The revealed FV
disorders allowed us to develop algorithms for therapy and
preventing secondary ischemic brain lesions.
Conclusions The investigation of FV by the TCDS method at focal
brain lesions, together with MRI and neurological research, has
allowed us to specify pathogenic mechanisms of CBF
disturbances and algorithms for their therapy.
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Introduction Most commonly, transcranial duplex sonography
(TCDS) is used to evaluate the flow velocity (FV). The main signs
of cerebral blood flow disturbances in head injury are olygemia,
hyperemia and vasospasm [1], which are closely connected with
traumatic brain injury and dynamics of the disease. The influence of
FV values measured by TCDS on the course and outcome of head
injury of different severity is of special importance.
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Methods FV was measured using an ultrasound triplex system in
83 patients with head injuries. The traumatic brain injury substrate
was verified by CT and nuclear MRI. Mean values for FV were
registered in the MCA every 48 hours. The hemispheric index (HI)
was measured to differentiate a vasospasm (HI = mean MCA /
mean ICA).
Results Depending on values of CFV, all patients were divided into
three groups: Group I, 22 patients with FV < 70 cm/s; Group II, 23
patients with FV 70–120 cm/s and HI < 3; Group III, 38 patients
with FV > 120 cm/s and HI > 3.0. Severity of cerebral lesions in
Group I was caused by unilateral intracranial haematomas in six
cases, contusion of type 1–2 in nine cases and diffuse axonal
injury (DAI) in 12 cases. Patients in Group II and Group III revealed
bilateral intracranial haematomas combined with type 2 and 3
contusions and DAI; patients in Group II showed contusion
predominance, and patients in Group III had concomitant brain
damage predominance (that is, intracranial haematomas combined
with type 2–3 contusions and post-traumatic SAH). Outcome
analysis in Group I revealed a GOS score of 1–2 in 13 patients, of
3 in seven patients and of 4 in two patients. In Group II the GOS
score was 1 or 2 in 17 patients, 3 in four patients and 4 in two
patients. In Group III the GOS score was 1 or 2 in 12 patients, 3 in
14 patients and 4 in six patients, and mortality was marked in five
patients.
Conclusions The performed analysis allowed us to conclude that
there existed a close relationship between the severity of traumatic
brain damage and the character of FV disturbances. Marked
traumatic brain injuries presented by multiple contusions and
intracranial haematomas, DAI of type 2–3 and combined with SAH
resulted in development of vasospasm in the MCA. Low values of
FV as well as development of vasospasm in the cerebral middle
artery are regarded as unfavourable prognosis for patients in the
acute period of severe head injury.
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Introduction Many assumptions have been proposed to explain
the confinement of red blood cells infested by Plasmodium
falciparum in the cerebral capillaries (cell adherence, rosetting),
involving an increase in blood viscosity and a deceleration in blood
flow inside capillaries.
Methods In this study, 10 nonimmune adults were included with
serious malaria according to the WHO classification. All of them
had one or more criteria of gravity. A Quantitative Buffy Coat
malaria test, a microscopic examination of thick and thin blood
smear and transcranial Doppler were carried out from entry. We
compared the transcranial Doppler findings, the pulsatility index
(PI), with the degree of parasitemia. Data are expressed as the
mean, standard deviation, extremes and percentage.
Results The age of the patients was 40 ± 13 (SD) years (19–62).
The sex ratio was 0.9. SAPS II was 34.3 ± 10 (SD) (20–53). The
Glasgow Coma Scale score was 10 ± 4 (SD) (14–3). The
parasitemia was 12.2 ± 16.9% (SD) (0.01–50). The PI (by averaging
the two middle cerebral arteries’ PI) was 1.9 ± 2.5 (0.8–9). The
correlation coefficient between parasitemia and the PI was 0.86.
Conclusions Some studies, carried out in children, demonstrated
the interest in monitoring cerebral perfusion pressure and
transcranial Doppler in prognostic evaluation of cerebral malaria
[1]. In the adult, the interest in monitoring cerebral perfusion
pressure was also demonstrated [2]. Nevertheless, measurement
of intracranial pressure is related with hemorrhagic risk because of
homeostasis disorder usually observed during serious malaria. We
know there is no exact correlation between the degree of
parasitemia and the quantity of red blood cells confined in cerebral
capillaries. Nevertheless, in our preliminary study, there is a
correlation between the degree of parasitemia and disturbance of
the cerebral flow. Indeed, the PI rises when parasitemia increases.
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Introduction Invasive devices are the ‘gold standard’ for measure-
ment of intracranial pressure (ICP). Their placement, however, can
be challenging (coagulation disorders, lack of surgical availability).
Noninvasive sonography of the optic nerve sheath diameter
(ONSD) has been proposed to detect elevated ICP [1,2]. How-
ever, this method needs further validation. This study was per-
formed to assess the relationship between the ONSD and ICP in
neurocritical care patients.
Methods After approval from the local ethics committee, 37 adult
patients with severe traumatic brain injury (n = 22), subarachnoidal
hemorrhage (n = 6), intracranial hematoma (n = 8) and stroke (n =
1) requiring sedation and ICP monitoring (intraparenchymal probe
in the frontal lobe; Codman, Johnson & Johnson) were included.
For each optic nerve, two measurements of ONSD were made
using a 7.5 MHz linear probe (HP Sonos 5500®; Hewlett Packard)
(2D mode, 3 mm behind the globe, one measure in the sagittal and
one in the transverse plane). The mean value for both eyes was
retained. The ONSD and ICP were measured simultaneously once
a day during the first 2 days after ICP probe placement and in
cases of important changes in ICP.
Results There was a significant linear relationship between the
ONSD and ICP (Spearman correlation ρ = 0.75, P < 0.0001;
Figure 1a). Changes in ICP (delta) were also significantly
correlated with ONSD variations (ρ = 0.78, P < 0.001; Figure 1b).
The ONSD cutoff for detecting ICP > 20 mmHg was 5.8 mm (area
under ROC curve = 0.91). The negative likelihood ratio of this
cutoff was 0.07.
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Relationship between intracranial pressure (ICP) and the optic nerve
sheath diameter (ONSD).
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Conclusions There is a significant relationship between the ONSD
and ICP in neuro-ICU patients. Changes in ICP are accurately
detected by the ONSD. The probability of having high ICP when
the ONSD is below 5.8 mm is very low. This noninvasive method
could be used to check the absence of raised ICP.
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Introduction Intracranial hypertension (ICH) caused by brain
oedema is a frequent complication of the acute aneurismal sub-
arachnoid haemorrhage (SAH) [1]. The only adequate method of
diagnosis and assessment of ICH degree is its continuous
monitoring that is necessary for efficient and timely anti-edematous
therapy [2].
Methods The authors report 75 patients with SAH and risk of ICH.
Intracranial pressure (ICP) monitoring was performed by ‘Codman’
sensors in 35 patients (Group 1). In 32 of them ICP monitoring
was performed using subdural sensors, and in three of them using
intraventricular sensors. In seven cases ICP monitoring was carried
out in the preoperative period, and in 28 cases after AA exclusion.
In 40 patients without ICP monitoring (retrospective material –
Group 2) the basic methods of diagnosis were neurological
examination and computed tomography (CT). Both groups were
identical by sex, age, time of operative intervention, methods of
intensive therapy and severity of state. The basic difference was
the starting time of anti-edematous therapy.
Results Cerebral ischemia and marked neurological deficits were
more frequently observed in Group 1 compared with Group 2
(80% and 17% correspondingly, P < 0.05). Favourable outcome
was 65.7% (GCS, GOS Y-IY) in Group 1 and 17.5% in Group 2.
Unfavourable outcome was 34.3% (GOS III-1) in Group 1 and
77.5% in Group 2; mortality made up 25% and 22.9%
correspondingly, and brain oedema was 90% and 25%
correspondingly. The mortality rate was as follows: in Group 1
eight patients (22.9%) died, two of them of brain oedema, which
made up 25% of all mortality cases in this group, and six patients
(75%) died of SAH recurrence. In Group 2 10 patients (25%)
died, one of them (10%) died of SAH recurrence and nine patients
died of brain oedema, which made up 90% of all mortality cases in
this group.
Conclusions ICP monitoring in patients with aneurismal SAH
allow one to reveal ICH in the early stage and to determine the
cause of the increased ICP according to CT data. Besides, ICP
monitoring in the acute stage of the aneurismal SAH allows timely
adequate intensive care and thus evidence-based outcome
improvement (P < 0.05).
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Introduction This study aimed at investigating the advantages of
brain function monitoring in patients with subdural haematoma or
spontaneous haemorrhage. We hypothesized that the reactivity of
the EEG signal to stimuli could aid in the assessment of the
condition of the brain and prediction of the outcome. We were also
interested in the EEG patterns and features induced by midazolam
in these critically ill patients as there are only a few studies on this
subject in the literature.
Methods Twenty-three patients with subdural haematoma and four
patients with spontaneous haemorrhage were incorporated in the
study. Midazolam and fentanyl were used as sedative agents. The
EEG signal from four channels (C3, C4, Fp1, Fp2) was recorded
for at least 24 hours following the surgery. Every 4–6 hours, on
average, a well standardized sequence of stimuli (voice, noise,
TOF, tetanic) was applied. Reactions to the stimuli were carefully
annotated by the study nurse. Segments of the EEG signal from
20 seconds before up to 40 seconds after each stimulus were
extracted. The segments were further divided into 10-second sub-
segments overlapping by 5 seconds. The modulation of alpha
activity (8–13 Hz) by the phase of the delta rhythm (0.5–4 Hz) was
estimated for each subsegment.
Results The averaged results are shown grouped by the response
of the patient to the stimuli (Figure 1). Deviation of the curves from
a straight line indicates modulation. The lowermost curves corres-
pond to the first subsegment (–20 to –10 s relative to the stimulus)
and the uppermost curve to the last subsegment (30–40 s).
Conclusions Slight modulation of alpha activity by the delta rhythm
can be seen. In cases where clinical response was noted, the
modulation is stronger but tends to disappear at about 5–15
seconds post stimulus, indicating desynchronization. Further
analysis is needed to draw final conclusions.
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Introduction This study attempts to compare the effects of
mannitol and melatonin on traumatic secondary brain damage with
magnetic resonance imaging (MRI) findings.
Methods In this study we used 12 New Zealand rabbits whose
weight range was 2,000–2,500 g. After the subjects were injected
with anesthesia, they were subjected to head trauma with the
Feeney method. Three hours after the trauma, their MRI scans
were taken. The subjects were divided into two groups as the
mannitol group and the melatonin group. After the first MRI results
were taken, 20% mannitol at the rate of 2 g/kg was given to the
mannitol group and melatonin at a rate of 100 mg/kg was given to
the melatonin group. Thirty-six hours after the trauma, the MRI
findings were taken again. The MRI images before and after the
trauma were compared. The 36-hour MRI results of the melatonin
and mannitol groups were also compared against each other.
Results When the findings of 36-hour MRI results were compared
with those taken 3 hours after the trauma in the melatonin group, it
was found that the ventricular pressure and parenchyma edema,
the parenchyma protrusion developed, and those contusion
findings got heavier. The symptoms in the MRI images taken 36
hours later in the mannitol group were found to have developed
slightly. A significant difference was found between the melatonin
and mannitol groups’ findings in the MRI images taken 36 hours
after the trauma.
Conclusions In decreasing traumatic secondary brain damage,
mannitol is better than melatonin.
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Introduction We analyze information on brain-injured patients’
monitoring and care provided by a powerful information system.
Methods We analyzed 543 hours on 11 patients, limited to 72
hours per patient when available: mean arterial pressure (MAP),
intracranial pressure (ICP) and cerebral perfusion pressure (CPP)
values were plotted against guideline thresholds, respectively 90
mmHg, 20 mmHg and 60 mmHg. The data were sampled every 2
seconds. Extraction was performed using a 3 teraflops
supercomputer. We developed a method to detect periods of
abnormal values.
Results The calculated CPP and monitored CPP differed despite
a good correlation (r = 0.91, P < 0.0001). Fifty-seven percent,
40% and 27% of the recorded MAP, ICP and CPP values reached
thresholds. The time distributions of abnormal CPP, ICP and MAP
values are detailed in Table 1: 51.7% of the MAP periods, 48.8%
of the ICP periods, 51.8% of the calculated CPP were short
episodes (<30 min). Mortality was associated with CPP < 60
(OR = 4.13 – logistic regression model, P < 0.0001) and inversely
associated with MAP drops and IC hypertension episodes (OR
0.58 and 0.45, respectively). The mean time spent in each episode
was higher in the NS group (76 ± 6 vs 48 ± 5 min). Caregivers’
actions are perceptible on a CPP distribution chart.
Conclusions Monitoring artifacts should be better identified when
monitoring-based targets are used to guide therapy. Computer-
based data analysis shows evidence of frequent episodes
requiring therapeutic actions according to published guidelines,
assuming that multimodal monitoring is not limited to the three
studied parameters. Caregivers need new tools for data
management to provide a better quality of care.
Acknowledgements Project funded by the EC and Martinique
country.
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Introduction A reduction in mortality of severe head injury patients
is associated with the development of evidence-based protocols
[1,2]. This audit studies the adherence to the neurointensive care
unit (NICU) protocol for the management of respiratory parameters
in severely head injured patients in the first 24 hours.
Methods A random case note review was undertaken of 50
patients intubated prior to admission to NICU, between March
2005 and April 2007. All data in the first 24 hours was compared
with protocol targets.
Results There were 170 severely head injured patients admitted to
the NICU in the defined period. Patients reviewed were 39 males,
11 females; median age 34 years, range 17–74 years. The median
presenting GCS was 7. Eighteen patients had thoracic pathology
on admission, these included seven spinal fractures, four
haemothoraces, one sternal fracture, six rib fractures, six aspiration
pneumonitis and one collapsed lung. Admission ventilation targets
and their compliance were measured. The results were ventilation
mode (SIMV) 98% compliance, tidal volume (6–10 ml/kg) 96%,
FIO2 (30–40%) 38%, respiratory rate (12–16) 30%, I:E ratio (1:2)
78% and PEEP (5–10 cmH2O) 94%. See Table 1.
Conclusions Overall our audit detected only 18 protocol
deviations out of 311 interventions regarding maintenance of
adequate oxygenation and tight PaCO2 control (6%). There were
78 episodes out of 397 samples taken where the protocol should
have been activated for the management of PaCO2 control (20%).
Critical Care    March 2008 Vol 12 Suppl 2 28th International Symposium on Intensive Care and Emergency Medicine
Table 1 (abstract P121)
Detected abnormal episodes
CPP ICP MAP
5–15 min 53 42 58
15–30 min 25 41 60
30–60 min 17 27 44
60–120 min 6 18 26
>120 min 13 17 40
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Protocols can reduce mortality but knowledge of adherence to
protocols is necessary to improve clinical practice.
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Introduction c-Jun N-terminal kinase (JNK) is a regulator of many
cellular events, including programmed cell death (apoptosis). The
JNK pathway is activated in several models of brain injury and its
inhibition confers neuroprotection. The role of JNK following
traumatic brain injury (TBI) is unclear. We tested the hypothesis
that JNK might be a relevant pathway following TBI in humans and
in a model of cerebral contusion, and evaluated the neuro-
behavioral and histological effects of its pharmacological inhibition
by the administration of DJNKI-1, a peptide that selectively
prevents the binding between JNK and its substrates.
Methods JNK activation was investigated by western blot analysis
performed on brain samples obtained from four TBI patients who
underwent surgical removal of a cerebral contusion, and on injured
cortex and hippocampus of mice subjected to anesthesia followed
by controlled cortical impact brain injury at 1, 4 and 48 hours post
injury. In addition, at 10 minutes post injury, animals randomly
received an intraperitoneal administration of either DJNKI-1
(11 mg/kg) or an equal volume of saline (100 μl). A second group
of mice received identical anesthesia, surgery without injury, and
saline to serve as uninjured controls. Neurobehavioral motor
outcome was evaluated at 48 hours and 7 days post injury by
performing the Neuroscore. Cell death was quantified by the
histochemical TUNEL technique at 48 hours post injury and the
contusion volume was evaluated at 7 days post injury.
Results We observed a robust activation of the JNK pathway both
in the human pericontusional brain tissue and in the injured cortex
and hippocampus of mice at 1, 4 and 48 hours post injury. At
48 hours and 7 days post injury, mice receiving DJNKI-1 showed a
better motor performance compared with mice receiving saline
(P < 0.05 at both time points). Moreover, mice receiving DJNKI-1
showed a significant reduction of TUNEL-positive cells in the
hippocampus compared with mice receiving saline at 48 hours
post injury (P < 0.05) and a reduced contusion volume at 7 days
post injury (P < 0.01).
Conclusions JNK is activated following human and experimental
TBI. The administration of the inhibitor DJNKI-1 to injured mice
induced an amelioration of neurobehavioral deficits and histological
damage following controlled cortical impact brain injury.
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Introduction In spite of dramatic recent achievements in neuro-
endocrine immunology and neuroprotection, an adequate treat-
ment strategy for interrupting molecular cascade reactions in
severe brain damage is not quite clear. The role of daily monitoring
of the hormone and cytokine levels in these patients in the ICU is
not quite understood and so far recognized.
Methods Two hundred and eighty-two patients with severe
traumatic brain injury (GCS < 8 at admission), 226 patients with
aneurismal subarachnoid haemorrhage and 325 operated patients
with brain tumors were studied. Prolactin (as immunomodulator),
free and total thyroxine and triiodothyronine (FT4, T4, FT3 and T3),
and cytokines (IL-6, sIL-2R, NT-proBNP) were assayed in blood
and CSF by RIA kits and chemiluminescent analysis (Immulite
2000). The obtained data were compared with clinical,
neurological and neuroimaging data.
Results Independent of causation and gender, an abrupt serum
prolactin level decrease (P < 0.001) started 2–3 days before
respiratory and brain inflammatory complaints were verified by
roentgenogram. Significant decreases, especially T3 and FT3 to
undetected values (P < 0.05), were characterized for worsening
patient conditions (brain ischemia/hypoxia and brain edema
increasing, consciousness depression (r = –0.239, P < 0.000415)).
Simultaneously there were marked significantly increased sIL-2R,
IL-6, and NT-proBNP levels in blood and CSF in comparison with
normal values (P < 0.001). The highest values were found in
patients with unfavourable outcomes.
Conclusions Serum and CSF hormone and cytokine level daily
monitoring in critically ill patients with severe brain damage, ARDS,
haemodynamic disturbances, sepsis and polyorgan deficit strictly
reflects the patient condition (upregulation and downregulation of
neuroendocrine and immune systems and its roles in
neurosystemic and systemic inflammatory responses) and allows
immediate prognosis of the disease process. The ‘brain low T3
syndrome’ earlier proposed by us for severe neurosurgical patients
serves as a basis for brief thyroid hormone substitution therapy in
addition to conventional therapy, taking into account the crucial
role of T3 in neurogenesis in the adult brain and its important
influences on endothelium and cardiodynamics.
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Blood gas analysis
Protocol target Total samples Total interventions Protocol deviations Episodes when protocol not activated 
PaO2 > 11 kPa 397 138 1 5
PaCO2 4–4.5 kPa 397 173 17 78
S50
P125
Is the ratio of lactated to pyrostaphylic acid in cerebral
tissue a prognostic index for the outcome of patients with
intracerebral hemorrhage?
G Paraforos1, E Mavromatidi1, A Chovas1, T Paraforou1, 
K Katselou2, V Christodoulou1, A Komnos1
1General Hospital Larisa, Greece; 2University Hospital of Larisa,
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Introduction The objective was to correlate the ratio of lactated to
pyrostaphylic acid (L/P) with the outcome of patients with intra-
cerebral hemorrhage, according to the Glasgow Outcome Scale
(GOS).
Methods ICU patients with spontaneous intracerebral hemor-
rhage, diagnosed with a brain CT, were enrolled in the study. The
inclusion criterion was a GCS on admission <8. An intracranial
microdialysis catheter was inserted in cerebral tissue and
extracellular brain fluid sample was collected every 2 hours for
analysis. A CMA 600 Microdialysis Analyzer was used for
measurements. Patients were divided into two groups according to
their GOS score 6 months later, group A (GOS 4–5, good
outcome) and group B (GOS 1–3, poor outcome). The variable of
L/P was dichotomized and a value that was statistically significant
correlated to the outcome was investigated. Comparison of the
mean value of L/P between the two groups was carried out at a
significance level of 95%.
Results There were 29 patients enrolled in the study, with a mean
age of 62 years (±9.86). Six months later there were six patients in
group A (mean L/P value: 34.13 ± 2.64) and 23 patients in group
B (mean L/P value: 41.21 ± 16.39). There was a borderline
correlation between the L/P value and the outcome between the
two groups. Group A with a good outcome had a lower mean L/P
ratio value (P = 0.059). All patients with a good outcome had an
L/P value lower than 37, whereas all patients with an L/P value
greater than 37 had a poor outcome, as is shown in Table 1.
Table 1 (abstract P125)
Correlation between L/P ratio and GOS scale
L/P ratio GOS 4–5 (n = 6) GOS 1–3 (n = 23)
L/P < 37 6 11
L/P ≥ 37 0 12
Fisher’s exact test P = 0.028
Conclusions According to our results, the lactated to pyro-
staphylic acid ratio is correlated to the outcome of patients with
intracerebral hemorrhage, 6 months after admission to the ICU.
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Coagulopathy predicts poor outcome in traumatic brain
injury
G Fuller, H Pattani, A Chalmers, D Sperry, P Yeoman
Queen’s Medical Centre, Nottingham, UK
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Introduction Cerebral damage arising from traumatic brain injury
(TBI) can occur primarily at the time of injury or can occur
secondarily at a temporally distant time point post insult [1].
Abnormal clotting occurs in 10–20% of head-injured patients and
may exacerbate secondary brain injury [2,3]. It may also be a
marker of the degree of the primary injury. Brain tissue is rich in
thromboplastin, and activation of clotting pathways following TBI is
thought to occur leading to abnormal coagulation. This may result
in disseminated intravascular coagulation, cerebral microthrombi
and ischaemia, or exacerbation of intracranial haemorrhage [4,5].
We have studied the admission International Normalised Ratio
(INR) in moderate to severe TBI patients, examining its role as a
prognostic indicator in these patients.
Methods All patients admitted to the Queens Medical Centre from
1993 to 2002 with a recorded Glasgow Coma Score of 12 or less
within 48 hours of a TBI were included in the Nottingham Head
Injury Register. The INR and outcome at 1 year were recorded on
the register. We looked at the strength of the association between
the admission INR and the outcome at 1 year.
Results Data were available on 497 patients. Their mean age was 36
years (range 16–91). Seventy-five per cent of the patients were male.
Of the 497 patients, 199 died at 1 year. The INR was increased in
60% of patients. Linear regression and logistic regression after group
division into dead versus alive and good versus poor outcome were
significant for the whole range of increased INR, but particularly
striking and clinically relevant outcome difference was found where
INR > 1.5 (chi-squared P < 0.001).
Conclusions A prolonged INR was observed in patients
presenting with moderate or severe TBI and was associated with
unfavourable outcome. An admission INR > 1.5 is a statistically
significant indicator of poor prognosis in moderate to severe TBI
patients and may be a useful prognostic marker in these patients.
This may be a valuable addition to prognostic scoring systems.
References
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Alteplase for acute ischemic stroke: 2 years in a
community hospital without previous experience in stroke
thrombolysis
A Estella, A Sainz de Baranda, E Moreno, MJ Galan, E Leal, 
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Introduction Intravenous administration of recombinant tissue
plasminogen activator (rt-PA) remains the most beneficial proven
intervention for emergency treatment of stroke. The objective of the
present study was to assess the implementation of the ‘Stroke
code’ in routine clinical care at our center in the last 2 years and to
describe the clinical outcome of patients who received treatment
with intravenous rt-PA.
Methods The aim of the ‘Stroke code’ is the early recognition of
selected patients with a suspected stroke who may be treated with
thrombolysis therapy. Prehospital emergency medical services,
critical care, radiology and neurology departments are implicated.
Inclusion criteria for intravenous administration of rt-PA (0.9 mg/kg)
were: age 18 years or greater, measurable neurological deficit,
NIHSS >4 and <25, onset of symptoms <3 hours before begin-
ning treatment, CT without a multilobar infarction (hypodensity
>1/3 cerebral hemisphere).
Results Fifty-five ‘Stroke codes’ were activated from November
2005 to November 2007. rt-PA was administered in 27 patients
(49%), 21 patients were males and six females. The mean age was
64 years. APACHE II (admission) score was 8.8 ± 3.5 points. ICU
length of stay was 3.5 ± 1.5 days. Eighty-eight percent of patients
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had vascular risk factor, 33.3% were receiving aspirin at stroke
onset.
Post-treatment study imaging was performed 48 hours after
thrombolysis: three patients developed CT haemorrhagic infarct
type 1 (asymptomatic small petechiae along the margins of the
infarct). Two patients died, because of cerebral infarction with
cerebral edema. The median NIHSS score was 12.8 points at
admission and 10.2, 8 and 7.2 at 2 hours, 24 hours and 48 hours
after treatment, respectively.
Conclusions In selected patients rt-PA is effective when used
within 3 hours of stroke onset [1]. rt-PA is safe in routine clinical
use despite limited prior experience of thrombolysis for acute
stroke [2].
References
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Introduction Acute lung injury (ALI) may complicate neurological
illness, but the mechanisms and outcomes of ALI in this setting are
poorly understood. We hypothesized that ALI is linked to severity
of neurological illness, mechanical ventilation (MV) parameters, and
outcomes in brain-injured patients.
Methods We identified consecutive patients admitted over a 2-
year period to a tertiary hospital neurosciences critical care unit
and requiring MV for >48 hours. ALI was determined using AECC
criteria. Univariable and multivariable predictors of ALI and of
mortality were assessed.
Results We evaluated 124 patients with head trauma (34
patients), intracerebral hemorrhage (29 patients), subarachnoid
hemorrhage (25 patients), ischemic stroke (12 patients), and other
brain disorders (24 patients). The primary indication for MV was
neurological (impaired consciousness, seizures, intracranial hyper-
tension) in 89 patients, respiratory failure in 22 patients, surgery in
10 patients, and other in three patients. ALI developed in 36
patients (29%) a mean (SD) of 2.7 (1.8) days after initiation of MV.
Neither ALI risk factors (pneumonia, aspiration, sepsis, trauma,
transfusion, pancreatitis) or neurological insult severity (Glasgow
Coma Scale on admission, absence of brainstem reflexes) were
significantly associated with ALI. Tidal volumes and positive end-
expiratory pressures on days 1 and 2 of MV were not significantly
different in patients with and without ALI. Fifty-two patients (42%)
died during hospitalization, and independent predictors of death
were admission with intracerebral hemorrhage (OR = 4.3, 95% CI =
1.5–12.2), absence of corneal reflex (OR = 5.0, 95% CI =
1.2–20.0), and circulatory shock (OR = 6.2, 95% CI = 1.9–20.9).
There was no independent association between ALI and mortality.
Conclusions ALI developed in nearly one-third of patients
undergoing MV following either traumatic or nontraumatic brain
injury. The postulated relationships between ALI and MV
parameters, neurological severity of illness, and short-term mortality
were not confirmed in this population.
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Introduction We discuss prognostic criteria of hemodynamic
changes in patients after hypothalamic and brain stem surgery. We
hope that better understanding of mechanisms of adaptive
disorders in local brain lesions will help to optimize postoperative
management of these patients. This study was based on the
interdisciplinary neurocardiologic approach [1].
Methods Cardiac output measured by the echocardiographic
method as well as hemodynamic and humoral parameters were
investigated in 139 patients with pituitary adenomas and cranio-
pharyngiomas and in 148 patients with brain stem tumors.
Results We consider that unfavorable hemodynamic changes may
be used as prognostic criteria of severe damage of regulatory
centers in the hypothalamus or brain stem. It is clear that a
favorable type of hemodynamic change is a kind of postoperative
stress reaction. The reaction after pituitary tumor surgery was
reduced or delayed and grew to its peak by the third day after brain
stem surgery. The main unfavorable type of hemodynamics was
decreased cardiac output (CO). However, the causes of this
decrease are quite different. In damage of the hypothalamus,
decrease of CO was connected with decreased blood volume and
the latter was connected with a decrease of vasopressin secretion.
Our research has shown that patients with lesions of different
structures of the hypothalamus and brain stem revealed specific
changes of various neurohumoral systems. In damage of the
dorsomedial part of the medulla oblongata, the decease of CO
was caused by primary neurogenic cardiac insufficiency. In
damage of hypothalamic structures, we see increased amplitude
power spectral density of the respiratory period of heart rate
variability (HRV), a decrease of the amplitude of the low-frequency
peak and a very high degree of coherence between HRV and
respiratory variability. In brain stem structure damage, we can see
low-frequency components only on the power spectral density of
HRV. We postulate that the revealed distinctions of power spectral
density of HRV showed that with hemodynamic disturbance in
hypothalamic and brain stem lesions a different pathological type
of cerebral regulation of hemodynamics forms.
Conclusions Disorders of a humoral regulation at focal lesions of
the hypothalamus and brain stem are specific. Intensive care
should therefore be carried out taking into account that these
changes should be directed to regeneration of a normal humoral
pattern.
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Introduction The purpose of this study was to define the
prevalence and outcome of diabetes insipidus (DI) in the early
post-traumatic brain injury (TBI) period in ICU patients. Inadequate
Available online http://ccforum.com/supplements/12/S2
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antidiuretic hormone secretion, which results in DI, is a well
recognized complication of TBI, owing to post-traumatic posterior
pituitary dysfunction.
Methods This prospective study was performed in 73 ICU-TBI
patients (with or without multisystem trauma) admitted to a general
ICU at a tertiary center between December 2005 and November
2007. Patients had suffered severe TBI, according to the initial
GCS score (≤8). DI was diagnosed if plasma sodium exceeded
145 mmol/l in the presence of inappropriate dilute urine with 24-
hour urine volume >30 ml/kg body weight, urine specific gravity
<1,005 or urine osmolality <300 mOsm/kg with a simultaneous
plasma osmolality ≥300 mOsm/kg. The age, gender, GCS, Injury
Severity Score (ISS), onset of DI, peak recorded plasma sodium
and outcome were noted. Statistical analysis was computed by t
test and Fischer exact test. P < 0.05 was considered statistically
significant.
Results Twenty-one ICU-TBI patients (28.7%) developed acute
DI. Comparison was made between two groups of these patients:
Group A, nine survivors and Group B, 12 nonsurvivors of TBI.
There was no statistical significance between them with respect to
age, gender (P > 0.05). Group B had a lower GCS (4.5 ± 1.5) as
compared with Group A (7.8 ± 3, P = 0.003). The ISS was
significant greater in Group B: 38 ± 8 versus 17 ± 7 in Group A,
P < 0.001. Peak plasma sodium was significantly greater in Group
B: 167 ± 4 mmol/l versus 156 ± 3 mmol/l in Group A, P < 0.05.
The mean onset time of DI in Group B (1.7 ± 0.9 days) was shorter
than in Group A (7.4 ± 3.3 days), P = 0.004. Overall mortality was
57.1%. The mortality rate for the development of DI within the first
3 days after TBI was 90% versus 27.2% if DI occurred later.
Nonsurvivors died from brain death and not as a result of their
associated injuries.
Conclusions Our results demonstrate that DI is common,
following severe TBI. ICU-TBI patients presenting with features of
DI have an overall high mortality. This study shows that the
development of DI within the first 3 days of TBI is associated with
high mortality rate and impending brain death. On the contrary,
ICU-TBI patients who develop DI later have a better prognosis.
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Introduction Hypernatremia (HyperNa) carries on an increased
risk of death in critically ill patients [1]. It is not known, however,
whether this is true also in patients with severe traumatic brain
injury (TBI).
Methods We analyzed prospective data from all patients admitted
for severe TBI (GCS < 8) to a trauma ICU over a 3-year time
period. We collected demographics, clinical variables, complica-
tions, and the available laboratory data for each day of ICU stay.
Major outcomes were ICU and hospital mortality, and ICU length of
stay (LOS). We used Cox proportional-hazards regression models
with time-dependent variates designed to reflect the exposure to
the varying sodium (Na) levels over time during the ICU stay. The
same models were adjusted for age, gender, and Na levels at
admission as baseline covariates.
Results We included in the study 130 TBI patients (mean age
52 years, SD 23, range 18–96; males 74%; median GCS 3, range
3–8; mean SAPS II 50, SD 14, range 9–84; all mechanically
ventilated; tracheostomy in 64/130, 49%). ICU mortality was
36/130 (27.7%), hospital mortality was 42/130 (32.3%). Follow-
up included a total of 1,334 patient-days (average of 2.9 measure-
ments of serum Na/day). Serum Na values were computed as the
daily average, which was 140 mmol/l (range 133–153); the patient
average of the daily maximum Na levels was 143 mmol/l (range
131–164). Twenty-six percent of the days in the ICU were compli-
cated by HyperNa (that is, at least one value of Na > 145 mmol/l),
with 70% of the patients showing this abnormality. The average
time of first occurrence of HyperNa was 5 days from ICU
admission, while only five patients had HyperNa at ICU admission.
A daily increase from the cumulative patient-average by 1 SD unit
(about 2.4 mmol/l Na) was associated with a 2.15 times increase
hazard of death (95% CI = 1.28–3.59; P = 0.004). Adjustment for
the daily use of hypertonic solutions did not change our findings.
HyperNa was slightly associated with increased ICU LOS.
Conclusions Our study suggests a strong relation between
increased Na levels and mortality in patients with severe TBI.
Although these results do not prove a causal relation between
increased Na levels and death, we urge for interventional studies to
ascertain the safety of treatment strategies that might increase
serum Na levels in patients with severe TBI.
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Introduction Following severe brain injury most patients require
intubation and ventilation. Gastric tubes, whether nasogastric or
orogastric, allow the stomach to be decompressed, which can aid
mechanical ventilation, reduce the risk of aspiration and provide a
route for drug administration and subsequently nutrition.
Methods A 4-month prospective audit was carried out on patients
admitted to the ICU of a regional neurosurgical centre following
severe brain injury. Patients were included following primary
intracerebral haemorrhage or traumatic brain injury.
Results All patients (n = 25) were admitted to the ICU from an
Emergency Department. All had a Glasgow Coma Score of 3 on
admission to the ICU and were intubated and ventilated prior to
arrival. The mean time from accident to arrival in the ICU was
15 hours. Only 32% of patients had a gastric tube in situ on arrival
in the ICU; 16% had a nasogastric tube and 16% had an oro-
gastric tube in situ. Only 16% of patients had the gastric tube
inserted at the time of rapid sequence intubation. Thirty-five
percent of patients who required gastric tube insertion after
admission to the ICU had documented changes in management or
complications as a consequence of the procedure. These included
the need for bolus sedation and muscle relaxant use, with ensuing
hypotension requiring inotrope support; delay in commencement of
enteral feeding and the need for extra chest radiographs to confirm
the tube position.
Conclusions Instrumentation to pass a gastric tube may cause a
rise in intracranial pressure or induce hypertension, which may
precipitate rebleeding in patients with intracerebral haemorrhage.
Transfer times to regional neurosurgical units can be long. Optimal
management of the brain-injured patient should include insertion of
gastric tubes at the time of initial rapid sequence intubation. This is
not current practice in the emergency department and improved
awareness of the need to place gastric tubes early in brain-injured
patients may avoid unnecessary complications.
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Introduction The study objective was to determine whether there
is a significant difference in the pattern and severity of injury
sustained during falls in patients who have consumed alcohol and
those who have not. To determine how the pattern and severity of
injury correlates with the blood alcohol level (BAL).
Methods A prospective quasi-randomised controlled study
between November 2001 and July 2002. All healthy adults
between 16 and 60 years old who had fallen from standing height
were included. A systematic history and examination allowed
calculation of injury severity scores as per the abbreviated injury
scale update 1998. BALs were obtained from intoxicated patients
with consent.
Results Three hundred and fifty-one healthy adult patients were
included in the study, there were 238 in the no alcohol group, 113
had consumed alcohol, and blood alcohol levels were obtained for
47 patients. The alcohol group had a higher incidence of head
injuries (46 (48%) vs 22 (9%)) with a lower incidence of limb
injuries (39 (39%) vs 183 (76%)) than the no alcohol group. There
was a significant difference in the pattern of injury between the
alcohol and no alcohol groups (χ2, P < 0.001) and there was a
significant difference in the injury severity scores (P < 0.001,
Z –2.5). In the alcohol group, the severity and pattern correlated
with the alcohol level at the time of injury. Patients with an alcohol
level <200 mg/dl had mostly soft-tissue limb injuries (58%),
200–250 mg/dl mostly significant limb fractures (55%) and
>250 mg/dl mostly significant head injuries (90%).
Conclusions Alcohol-related falls are more often associated with
severe craniofacial injury. The severity of both limb and head injury
is greater and correlates directly with the BAL.
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Introduction Microalbuminuria (MA) is considered a risk factor in
the hypertensive and diabetic population. The presence of MA
during the evolution of acute coronary syndrome (ACS) is a bad
prognosis criterion.
Methods We studied the presence of MA by 24-hour urine test in
396 hospitalized patients with ACS consecutively. During their
hospitalization period blood samples were taken in the first 24
hours for all of them (leukocyte recount, hemoglobin and hemato-
crit levels, troponin I, total cholesterol, LDL-cholesterol, fibrinogen,
ultrasensible C-reactive protein (US-CRP), glucose and
glycosylated hemoglobin (HbA1) serum levels). The left ventricular
function was determined in all cases through echocardiography.
We made a follow-up of 2.5 years.
Results One hundred and forty-seven patients presented MA
(37%). We found this group was also the one with older age (P =
0.001), higher hypertension level (P = 0.001) and more diabetes
(P = 0.0001), strokes (P = 0.04), periferal arteriopathy (P =
0.0001) and chronic renal failure (P = 0.0001) cases. Thirty-seven
percent of patients were hospitalized in Killip >I stage (P =
0.0001). This group was characterized to have poor left ventricular
ejection function (51% vs 46%, P = 0.001), worse renal function
(P = 0.001) and higher glycemic levels (P = 0.0001). Patients with
MA presented a high intrahospital mortality ratio (9% vs 4%; P =
0.004), more heart failure development (45% vs 21%; P = 0.0001),
atrial fibrillation (25% vs 12%; P = 0.004), abnormalities of
conduction syndromes (15% vs 7%; P = 0.02), and strokes (4%
vs 1%; P = 0.02). In the follow-up, the mortality rate in the MA
group rose to 15% (P = 0.0001). In the multivariant analysis due to
age, gender, left ventricular ejection function, troponin-I serum
levels, existence of anemia and creatinine clearance, MA was
found to be an independent risk factor of heart failure (OR = 1.75;
95% CI = 1.02–3.01; P = 0.04) and of mortality (OR = 2.6; 95%
CI = 1.05–6.41).
Conclusions The presence of MA during evolution of ACS is
associated with high-profile vascular risk and is a powerful short-
term and long-term prognostic factor.
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Introduction Over the past several years, nonoperative manage-
ment (NOM) has increasingly been recommended for the care of
selected blunt abdominal solid organ injuries. No prospective study
has evaluated the rate of NOM of blunt abdominal trauma in the
northwest of Iran. The objective of our study was to evaluate the
success rate of this kind of management in patients who do not
require emergency surgery.
Methods This prospective study was performed in Imam Khomeini
Hospital (as a referral center of trauma) at Tabriz University of
Medical Sciences, Iran, between 20 March 2004 and 20 March
2007. All trauma patients who had sustained injury to a solid
abdominal organ (kidney, liver, or spleen) were selected for initial
analysis, using the student’s t test or chi-square test.
Results During the 3 years of the study, 98 patients (83 male and
15 female) with blunt trauma were selected for NOM for renal,
hepatic and splenic injuries. Mean age was 26.1 ± 17.7 years
(range, 2–89) and the mean injury severity score (ISS) was 14.5 ±
7.4. The success rate of NOM was 93.8%. Fifty-one patients (43
men, eight women; mean ISS, 14.2 ± 5.8) underwent NOM of
splenic trauma, 38 patients (33 men, five women; mean ISS,
12.9 ± 8.2) hepatic trauma, and nine patients (seven men, two
women; mean ISS, 22.2 ± 7.6) renal trauma. Six patients
underwent laparotomy due to the failure of NOM. The success
rates of this treatment were 94.1%, 94.7% and 88.8% for the
spleen, liver and kidney injuries, respectively. Female gender and
ISS were significant predictors of the failure of NOM (P = 0.005
and P = 0.039, respectively).
Conclusions We suggest that NOM can be undertaken
successfully for the hemodynamically stable patients with solid
organ blunt trauma. The study indicates that the rates of NOM vary
in relation to the severity of the organ injury. These suggest that
this approach to the care of blunt injury in abdominal solid organs
is being led by trauma centers.
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Introduction The present study investigates the presence of
intestinal epithelial cell damage in multitrauma patients on admis-
sion. In trauma patients, the development of SIRS and sepsis are
important determinants of clinical outcome. Intestinal damage is
considered to play an important role in development of these
inflammatory syndromes. However, clinical evidence remains
scarce. Previously, in a rat model of hemorrhagic shock, we
demonstrated that interventions reducing intestinal damage
strongly attenuated the inflammatory response. In order to explore
potential applicability of such therapies in trauma patients, the
presence of early intestinal damage is assessed after trauma.
Methods Trauma patients (n = 95) admitted to the emergency
room (ER) were divided into four groups regarding the Injury
Severity Score (ISS) and the presence of abdominal injury (+AI or
–AI): ISS < 25 +AI (n = 27); ISS > 25 +AI (n = 26); ISS < 25 –AI
(n = 24) and ISS > 25 –AI (n = 18). Plasma was obtained directly
after admittance to the ER. Intestinal fatty acid binding protein
(I-FABP), a cytosolic protein constitutively present in mature
enterocytes and released after cellular damage, was measured by
ELISA. Circulating procalcitonin (PCT), representing inflammation,
was assessed by Kryptor assay.
Results On admission, concentrations of I-FABP (1,395 ± 438 pg/ml)
were significantly (P < 0.05) elevated in patients with ISS > 25
+AI compared with all other groups on admission (ISS > 25 –AI:
309 ± 67 pg/ml; ISS < 25 +AI: 531 ± 202 pg/ml; ISS < 25 –AI:
221 ± 46 pg/ml) (MWU). Noteworthy, I-FABP was significantly
increased in patients without AI (ISS > 25) in comparison with 76
healthy volunteers (102 ± 12 pg/ml). On admission, I-FABP levels
were correlated positive with ISS (Pearson r2 = 0.28; P < 0.0001).
Furthermore, I-FABP concentrations at ER correlated to PCT levels
on day 1 (Pearson r2 = 0.50; P < 0.0001).
Conclusions This is the first study to provide evidence for rapid
development of intestinal epithelial cell damage in severe multi-
trauma patients with and without abdominal trauma. The extent of
early intestinal damage is associated with the inflammatory
response present at 24 hours. Further studies are needed to
determine whether therapies aimed at reduction of intestinal
damage improve clinical outcome of patients with severe trauma.
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Introduction ICU injured patients often experience a condition of
tissue hypoperfusion due to low cardiac output and oxygen
delivery (DO2). The imbalance between oxygen demand and DO2
could be responsible for an anaerobic metabolism that is
correlated with poor outcome. Several authors demonstrated that
traditional (that is, serum lactate, base deficit) and oxygen-derived
and carbon dioxide-derived parameters of anaerobiosis are helpful
indicators of bad outcome in trauma patients. We aimed to identify
predictors of morbidity in our ICU trauma patients.
Methods Data for 175 adult trauma patients (age mean 50 ± 18.5
years) admitted to our ICU were prospectively collected from May
2006 and April 2007. Seventy hemodynamic, ventilatory, and
metabolic parameters were evaluated within 3 hours after ICU
admission. Accordingly to the GIVITI (Italian Group for the
Evaluation of Interventions in ICU) database definitions, complica-
tions were defined as one or more organ dysfunctions or failures
occurring during the ICU stay. Multivariate and receiver operating
characteristic (ROC) curve analyses were applied.
Results Morbidity was 40.5%. The Simplified Acute Physiology
Score II, a high CO2 production (VCO2), and a low DO2/VCO2
ratio were significant in the multivariate analysis (Table 1). The
DO2/VCO2 ratio was the best predictor of morbidity. Its cutoff
value for morbidity was 3, and its area under the ROC curve was
0.87 (sensitivity 82%, specificity 75%). The ICU stay was longer
for complicated patients (4.4 vs 14.5 days, P < 0.001), and
mortality was higher (9% vs 22%, P < 0.001).
Table 1 (abstract P137)
Multivariate analysis results
OR 95% CI P value
DO2/VCO2 1.9 1.35–2.9 0.012
VCO2 1.7 1.2–2.3 0.03
SAPSII 1.2 1.01–2.1 0.04
Conclusions This study demonstrated that the DO2/VCO2 ratio
correlated well with morbidity. This ratio represents the imbalance
between oxygen demand and delivery. The ratio might be
continuously monitored in critically ill patients to assess an
anaerobiosis state. This ratio together with the SAPS II ratio could
predict complications in trauma patients.
Reference
1. Husain FA, et al.: Serum lactate and base deficit as predic-
tors of mortality and morbidity. Am J Surg 2003, 185:485-
491.
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Introduction Survival and the length of ICU stay (LOS) of severely
ill or injured patients are dependent on demographic (for example,
age, gender) and organizational factors as well as pre-existing
diseases and the degree of physiological abnormalities. Different
scores allow one to predict hospital mortality of general ICU
patients. Such scores (for example, APACHE II or SAPS II) are
developed by multivariate statistical methods. Burned patients,
however, have been excluded in the development of most scoring
systems. We are interested in finding relevant risk factors
concerning hospital mortality and LOS.
Methods Patients with >10% burned surface area (BSA) admitted
to the burn unit of the University Hospital Zurich between 1997
and 2006 were retrospectively analysed. Relevant epidemiologic
and clinical parameters were included in a univariate analysis and
subsequently in a multivariate analysis with either hospital mortality
or LOS as endpoints.
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Results Six hundred and sixty-two burned patients were treated
between 1997 and 2006. Four hundred and eighty-nine patients
having a BSA > 10% were included. One hundred and forty-one
(28.8%) died and the median LOS was 19 days in survivors. There
were no changes in overall mortality, gender distribution, surgical
treatment ore intensive care throughout the whole study period.
Conclusions We could confirm age, burned surface area, male
sex, inhalation injury, diabetes mellitus and psychiatric illness of any
kind as important risk factors for mortality. Additionally, suicide
attempts were included in the model but did not reach statistical
significance. LOS in survivors was correlated with burned surface
area, inhalation injury and the presence of suicide attempt.
References
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Introduction Hemorrhagic shock is associated with adrenergic
discharge that has been linked to neurohumoral and immune
inflammatory responses, vasoconstriction and end-organ perfusion
deficits. Our goal is to characterize the sympathetic activity to
hemorrhage in tissues with a rich supply of sympathetic nerves
(deferens duct).
Methods Seventy anesthetized male Wistar rats were submitted to
femoral artery and vein catheterization for mean arterial pressure
(MAP) measurement and blood withdrawal to reach a MAP of
40 mmHg. Deferens ducts were removed from rats after 10 minutes,
30 minutes and 60 minutes, and were placed in isolated organ
baths between two platinum electrodes for transmural electrical
stimulation (TES) (0.1–20 Hz, 1 ms, 60 V). This technique allows
the evaluation of neurotransmissors released by sympathetic
nerves (noradrenaline and ATP).
Results Controls maintained a MAP of 105 ± 3 mmHg in all
experimental groups. Hemorrhaged rats presented a MAP of 39 ±
3 mmHg after 10, 30 or 60 minutes. The contraction profile after
ATP and noradrenaline after TES were similar between controls
and hemorrhaged rats. The amplitude was greater, however, for the
three hemorrhaged groups. The addition of tetrodotoxin abolished
contractions induced by TES, confirming the neurogenic nature of
those contractions. The ATP-mediated contraction was blocked by
the selective P2 purinoreceptor antagonist suramin. Noradrenalin-
mediated contraction was blocked by the prazosin, a selective α-
adrenoreceptor.
Conclusions We conclude that, based on the increased amplitude
contraction induced by both noradrenaline and ATP, sympathetic
nerve activity is increased in hemorrhagic shock animals.
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Introduction Indirect calorimetry (IC) can be useful in the
evaluation of metabolic status from critical care patients, especially
during weaning from mechanical ventilation (MV) when energy
expenditure can increase. The goals of this study were to compare
the energy expenditure (EE) from patients during weaning from
MV, comparing pressure support ventilation (PSV) and T tube (TT)
using IC, as well as to compare these findings with results
calculated with Harris–Benedict equation.
Methods Patients clinically ready to discontinue MV support were
evaluated from August 2006 to January 2007. They were studied,
in a random order, during PSV and TT. Measurements from EE
were registered during 20 minutes in both methods. Indirect calori-
metry was registered using a specific metabolic monitor (Datex-
Ohmeda/M-COVX). EE was also estimated using the Harris–
Benedict equation with and without an activity factor. Results are
shown as the mean ± standard deviation. Statistical analysis was
performed with the paired t test, Pearson’s correlation coefficient
and the Bland–Altman test. The significance level was P < 0.05.
Results Forty patients were enrolled. The mean age was 56 ± 16
years, APACHE II score was 23 ± 8 and the majority of patients
were male (70%). The mean EE during TT was 14.43% greater
than during PSV (P < 0.001). The mean EE estimated by the
Harris–Benedict equation was 1,455.05 ± 210.4 kcal/24 hours,
and considering the activity factor 1,608 ± 236.14 kcal/24 hours.
Both calculated values showed correlation with that measured by
indirect calorimetry during PSV (r = 0.647) and TT (r = 0.539). The
agreement limits comparing measured and estimated EE with the
Bland–Altman analysis suggest that the Harris–Benedict equation
underestimates EE during TT.
Conclusions Comparing EE during PSV and TT, using IC, we
observed that during TT there was, as expected, an increase in EE
(14.43%). The results also suggest that the Harris–Benedict
equation underestimates energy expenditure during TT.
References
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Introduction While implementation of protocols for nutritional
support is associated with less energy deficit [1,2], the impact of
hypocaloric feeding on clinical relevant outcomes is more
controversial: recent studies suggested both positive [3,4] and
negative effects [5] in patients receiving the recommended intakes.
The aim of this study was to assess the incidence and magnitude
of hypocaloric feeding in an ICU without explicit nutrition protocols
together with standardized mortality ratios.
Methods A retrospective analysis of data from all patients staying
>72 hours in a mixed medical–surgical 30-bed university hospital
ICU in 2006.
Results Data from 562 patients (medical 270 patients, surgical
292 patients) were analyzed. The lengths of ICU and hospital stay
were 9 ± 9 days and 27 ± 25 days. The age was 61 ± 16 years,
weight 77 ± 17 kg, BMI 26 ± 5 kg/m2, and APACHE II and SAPS
scores 24 ± 8 and 50 ± 17. Daily energy and protein intake were
302 ± 33 kcal and 12 ± 1 g (recommended amount of energy and
protein intake according to the European Society of Parenteral and
Enteral Nutrition: 1,549 ± 34 kcal and 114 ± 2 g). Patients were
mechanically ventilated during 7 ± 8 days. ICU mortality was 14%
(expected by APACHE II and SAPS II: 50% and 46%), and
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hospital mortality was 22%. The total caloric deficit per patient was
9,820 ± 1,126 kcal. The distribution of the acquired energy deficit
was: 0–5,000 kcal (20%), 5,000–7,500 kcal (31%), 7,500–
10,000 kcal (20%), 10,000–20,000 kcal (22%), 20,000–30,000
kcal (4%), >30,000 kcal (3%).
Conclusions Most patients with an ICU stay >72 hours acquired a
substantial caloric deficit during the study period when compared
with recommendations. Despite this, mortality was relatively low for
the measured APACHE II and SAPS II scores. Nutrition protocols
should be used and their impact on both the delivered calories and
clinically relevant outcome parameters be monitored.
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Introduction Early enteral nutrition has been shown to have a
beneficial effect on intestinal integrity and motility, immuno-
competence, and patient outcome. Generally, circulatory stability is
needed for the introduction but, because there is no precise
definition, we might miss the right time to begin. In the present
study we attempted to establish early enteral nutrition for patients
with cardiogenic shock with a ventricular assist device.
Methods Ten postoperative patients with cardiogenic shock under
percutaneous cardiopulmonary support were included. An enteral
feeding tube was placed beyond the pylorus within 36 hours of
operation under the observation of an upper gastrointestinal
fiberscope. We estimated the mobility rate of the stomach by
counting the number of vermiculation for 3 minutes at the pylorus. We
assessed the movement of the intestine by observing the X-ray film to
see whether the contrast medium we injected 3 hours before had
moved or not. If the medium had moved rapidly to the colon, enteral
formula was started at the rate of 20 ml/hour. The serum prealbumin
concentration was measured every 7 days. Other laboratory data was
compared with five control TPN patients retrospectively.
Results The mobility rate of the stomach was decreased to 4.6 ±
3.2 times/3 minutes, but contrast media moved rapidly to the
ascending colon in two patients, to the transverse colon in three
patients, to the sigmoid colon in one patient, and to the rectum in
three patients. One patient needed to stop enteral nutrition
transiently because of reflux, but for the other nine patients enteral
nutrition was well established. The prealbumin level also rose to 13
± 3.5, 14.1 ± 4.9, 22 ± 2.8 weekly, but it was difficult to compare
with control TPN patients because many of them died early. Serum
ALP, total bilirubin, and direct bilirubin concentration 1 week after
in survivors was lower in ED patients (ALP 437 ± 248 vs 566 ±
300, P = 0.57; total bilirubin 2.5 ± 2.5 vs 3.1 ± 1.0, P = 0.09; and
direct bilirubin 1.5 ± 1.8 vs 2.1 ± 0.8, P = 0.09). Seven (70%) of
the ED patients survived over 90 days (all five patients died in the
TPN group).
Discussion If mesenteric circulation were stable, enteral nutrition
could not be contraindication. Even an improvement in patient
outcome can be expected in the view of avoiding complications
such as bacterial translocation.
Conclusions Intestinal mobility is fairly maintained in patients with
cardiopulmonary support, and early enteral nutrition can be
established under close observation.
P143
Nutritional activation of the cholinergic pathway after
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Introduction This study investigates the effects of lipid-enriched
nutrition administered early after hemorrhagic shock. Previously we
have shown that high-lipid feeding effectively inhibits systemic
inflammation and preserves intestinal integrity when given before
hemorrhagic shock by stimulation of the cholinergic anti-inflam-
matory pathway via activation of CCK receptors. Control of the
inflammatory status of trauma patients forms a major clinical
problem since the inflammatory cascade is already ongoing upon
presentation. The anti-inflammatory effects of high-lipid intervention
after shock are therefore examined.
Methods Hemorrhagic shock in rats was induced by extracting
30–40% of the circulating volume. Animals were subsequently
fasted or given enteral feedings containing high or low concen-
trations of lipids at 30 and 180 minutes after shock (n = 8). CCK-
receptor antagonists were administered 10 minutes before feed-
ing. Tissue and plasma were collected 4 hours after shock to
assess inflammation and intestinal integrity.
Results Administration of lipid-enriched nutrition early after shock
significantly reduced plasma levels of IFNγ at 4 hours (0.39 ± 0.06
ng/ml) compared with low-lipid treated (0.77 ± 0.09; P < 0.01)
and fasted animals (1.38 ± 0.11; P < 0.001). Enterocyte damage,
expressed as circulating levels of ileal lipid binding protein, was
prevented by high-lipid feeding compared with animals that
received a low-lipid composition or were fasted (3.7 ± 0.3 vs 4.9 ±
0.5 vs 8.0 ± 1.1 pg/ml; P < 0.05 respective P < 0.0001). Further-
more, early post-shock intervention with lipid-enriched feeding
significantly reduced translocation of bacteria to distant organs
(69.7 ± 6.4 vs low lipid: 100.9 ± 9.2 CFU/g tissue; P < 0.05).
Blockage of CCK receptors abrogated the anti-inflammatory
effects of high-lipid nutrition (IFNγ 1.18 ± 0.15 vs vehicle 0.58 ±
0.14 ng/ml; P < 0.05).
Conclusions Administration of lipid-enriched nutrition after
hemorrhagic shock reduces inflammation and preserves intestinal
integrity. This study implicates lipid-enriched nutrition as a potential
therapeutic option in settings in which inflammation and tissue
damage are already present, such as in trauma patients.
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Inflammatory response in patients requiring parenteral
nutrition: comparison of a new fish-oil-containing emulsion
(SMOF®) versus an olive/soybean oil-based formula
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Klinikum Ludwigshafen, Germany
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Introduction Lipid emulsions are an essential part of parenteral
nutrition (PN), such as energy supply and source of essential fatty
acids. It has been shown that the composition of cell membranes is
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influenced by the fatty acid profile of dietary lipids, and may there-
fore be responsible for modulations in immune response. The aim
of this study was to assess the effects of a new lipid emulsion
based on soybean oil, medium-chain triglycerides, olive oil and fish
oil (SMOF®) compared with a lipid emulsion based on olive and
soybean oil (ClinOleic®) on the inflammatory response in post-
operative ICU patients.
Methods A prospective randomised study. After approval from the
ethical committee, 44 postoperative surgical patients with an
indication for PN were included in this study. Nonprotein calories
were given as 60% glucose and 40% lipid emulsion. The total
energy intake per day was calculated as 25 kcal/kg body weight.
The sedation regimen was standardized, excluding propofol
administration. Patients were thus allocated to one of two nutrition
regimens: group A (n = 22) received SMOFlipid® 20%, and group
B (n = 22) a lipid emulsion based on olive and soybean oil
(ClinOleic® 20%). Lipid emulsions were administered during 5 days
postoperatively, corresponding to the observation time. IL-6, TNFα,
and soluble E-selectin levels (sE-selectin) were measured before the
start of infusion (d0), at day 2 (d2) and at day 5 (d5) after the start of
administration. The significance level was defined at P < 0.05.
Results There were no significant differences between the two
groups in the inflammatory response at d0 and d2. But at d5,
significantly lower IL-6 (group A: 73 ± 58 vs group B: 123 ± 107
pg/ml), TNFα (group A: 15.2 ± 7.9 vs group B: 22.6 ± 12.9 pg/nl),
and soluble E-selectin concentrations (group A: 21.5 ± 13.7 vs
group B: 32.6 ± 21.2 ng/ml) were seen in patients receiving
SMOF® compared with patients administered ClinOleic®.
Conclusions The administration of SMOFlipid® within a PN
regimen led to a significantly reduced inflammatory response at
day 5 of the nutrition regimen compared with a lipid emulsion
based on olive and soybean oil, including measurements of IL-6,
TNFα, and soluble E-selectin values.
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Introduction The present study investigates the nutritional activation
of the cholinergic anti-inflammatory pathway. Lipid-enriched nutrition
effectively attenuates systemic inflammation and prevents gut barrier
failure by stimulation of the cholinergic pathway via cholecystokinin
(CCK) receptors. This study investigates whether enteral lipids
activate the autonomic nervous system via local stimulation of CCK
receptors on the afferent vagus or by activation of receptors within
the central nervous system via circulating CCK.
Methods Sprague–Dawley rats were subjected to hemorrhagic
shock. Before shock, animals were fasted or fed a lipid-enriched
oral nutrition at 18 hours, 2 hours and 45 minutes. Peripheral
activation of the autonomic nervous system was determined by
performing deafferentations with perivagal application of capsaicin
prior to shock. Central activation of the autonomic nervous system
by circulating levels of CCK was studied by infusion of high levels
of sulfated CCK8 starting 30 minutes prior to shock until sacrifice
in fasted animals. Plasma and tissue samples were collected
90 minutes after shock to assess the inflammatory status and gut
barrier function.
Results Deafferentation significantly abrogated the inhibitory effect of
dietary fat on TNFα (133.7 ± 31.6 pg/ml vs 45.3 ± 12.9 pg/ml
(sham); P < 0.001) and IL-6 (168 ± 14 pg/ml vs 69 ± 9 pg/ml
(sham); P < 0.001). Preservation of gut barrier function was hindered
by vagal deafferentation, expressed as increased leakage of HRP in
ileal segments (6.1 ± 0.3 μg/ml vs 2.7 ± 0.3 μg/ml (sham); P <
0.001) and bacterial translocation (113 ± 20 CFU/g tissue vs 33 ± 4
CFU/g tissue (sham); P < 0.001). Infusion of sulfated CCK8 (arterial
levels: 13 ± 2 pM at shock and 19 ± 4 pM at sacrifice) failed to
attenuate inflammation and improve gut barrier function.
Conclusions Our study shows for the first time that lipid-enriched
nutrition attenuates systemic inflammation and improves intestinal
integrity via local activation of the afferent vagus nerve. The
presence of enteral lipids is essential to exert these protective
effects. Clinically, nutritional activation of this potent anti-inflam-
matory pathway could provide a novel therapeutic treatment for
patients prone to develop excessive inflammation.
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Introduction The aim of this study was to assess the clinical
efficacy of glutamine dipeptide-supplemented total parenteral
nutrition (TPN), defined by the occurrence of nosocomial infections
or new organ failure as clinical endpoints.
Methods Patients received a glutamine dipeptide-supplemented
TPN (Glu-TPN) or a standard TPN (S-TPN). Entry criteria: adult
patients in the ICU requiring TPN for 3 days or more and APACHE
II score >12. Exclusion criteria: malnutrition or obesity, chronic
renal or hepatic failure, immunocompromised patients and poor life
expectancy. Both groups received isonitrogenous and isocaloric
TPN. Nutritional needs were calculated: 0.25 g N/kg/day and
25 kcal/kg/day. The Glu-TPN group received 0.5 g/kg/day glutamine
dipeptide and the S-TPN group a similar amount of amino acids.
Vitals, sepsis and septic shock on admission, type of patient, daily
SOFA score, daily calories administered, nosocomial infections
based on CDC criteria, ICU and hospital lengths of stay and ICU
mortality were recorded. Intent-to-treat and per-protocol analyses
were done. Infections rates were compared using density rates
and the ΔSOFA score was analyzed using ANOVA.
Results One hundred and seventeen patients received any
intervention, 53 assigned to Glu-TPN and 64 to S-TPN. Baseline
characteristics were similar in both groups. Less new infections
occurred in Glu-TPN patients: nosocomial pneumonia 8.04 versus
29.25 episodes-‰ days of mechanical ventilation (RR = 1.4; 95%
CI = 1.2–1.7; P = 0.02), and urinary tract infections 2.5 versus
16.7 episodes-‰ days of urinary catheter (RR = 1.6; 95% CI =
1.3–2.1; P = 0.04). There were no differences in the incidence of
catheter-related sepsis, primary bacteremias and intra-abdominal
infections. There was a trend to improved ΔSOFA score in patients
receiving Glu-TPN: ΔSOFA 72 hours (1.9 ± 2.4 vs 2.6 ± 2.7, P =
0.07). There were no differences in ICU and hospital lengths of
stay or ICU mortality (15% vs 18%).
Conclusions Glu-TPN used in critically ill patients for longer than 3
days significantly reduces the incidence of nosocomial pneu-
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monias and urinary tract infections, and decreases the severity of
organ failures.
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model of normotensive endotoxemia without attenuating
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Introduction Sepsis and septic multiorgan failure are still
associated with a high mortality. Recent pathophysiological studies
could show that a substantial depletion of the semi-essential amino
acid arginine occurs during sepsis. However, the effects of a high-
dosed supplementation of L-arginine on the microcirculation have
not been well characterised. This study addresses the effect of an
intravenous L-arginine application on the microcirculation in a well-
established model of normotensive endotoxemia.
Methods In a dorsal skinfold chamber preparation in male Syrian
golden hamsters, normotensive endotoxemia was induced by
intravenous lipopolysaccharide (LPS) administration (Escherichia
coli, 2 mg/kg BW). Before and 30 minutes, 3 hours, 8 hours and
24 hours after LPS application, arteriolar and venular leukocyte
rolling and adhesion as well as functional capillary density as a
parameter of microvascular perfusion injury were quantified by
intravital microscopy. In the treatment group, animals received
intravenous L-arginine (50 mg/kg BW, n = 5) 15 minutes before
LPS administration. Animals infused with the stereo isomer D-
arginine (n = 4, 50 mg/kg BW) or sodium chloride (NaCl 0.9%,
vehicle) served as controls.
Results Administration of LPS markedly increased leukocyte rolling
and adherence in control animals (P < 0.01 vs baseline). L-Arginine
induced a significant reduction of leukocyte rolling (P < 0.05) and
adherence (P < 0.01) in postcapillary venules, whereas D-arginine
did not lead to significant differences when compared with vehicle
controls. Interestingly, despite its effect on leukocyte/endothelial cell
interaction, L-arginine did not attenuate capillary perfusion failure.
Conclusions L-Arginine supplementation results in a significant
reduction of LPS-induced leukocyte/endothelial cell interaction in
this in-vivo microcirculation model (dorsal skinfold chamber). The
lack of improvement in capillary perfusion has to be further
characterised in additional studies.
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Introduction Evidence shows that in critical illness antioxidant
defences are overwhelmed by a massive increase in reactive
oxygen species [1]. Antioxidant supplementation may be beneficial
in these patients. We quantified antioxidant intake from enteral
nutrition by our patients and compared this with the dietary
reference value (DRV) for the healthy population [2].
Methods Data were collected from a retrospective case note
review during January 2007. Patients’ volume and type of feed
delivered was recorded each day. Antioxidant intake was
calculated from the volume of feed and the feed nutritional data.
Results Antioxidant intake of vitamins and traces elements was
assessed for the enterally fed patients over the first 7 days in the
ICU or part thereof. This amounted to 117 days of feeding. The
mean intake per day and the intake as a percentage of DRV are
presented in Table 1.
Conclusions There is no evidence to recommend an optimal
intake of antioxidants, but doses of antioxidants used in clinical
trials with beneficial outcomes have been up to 10–20 times the
DRV [3]. Antioxidant intakes in our patients were much lower than
this. The present audit shows that beneficial antioxidant
supplementation is unlikely to be met by standardised feed
delivery, and additional supplementation will be required.
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Introduction Hyperglycemia at the moment of hospitalization is
associated with a worse prognosis in patients with acute coronary
syndrome (ACS). We introduce a study about the influence of
glycemic levels at hospital admission in patients with ACS.
Methods We studied glycemic levels of 611 patients with ACS at
hospitalized admission consecutively. We established three groups
based on the glycemic levels results: Group 1, <114 mg/dl; Group
2, 114–163 mg/dl; Group 3, >163 mg/dl. The clinical and
evolution characteristics were evaluated and we made a median of
3 years follow-up.
Results Group 3 presented significantly older age, higher hyper-
tension levels and more diabetes, peripheral arteriopathy and
chronic renal failure cases. During the follow-up we found in Group
3 the worst Killip stage at the moment of hospitalization, a higher
rate of heart failure (44%) and atrial fibrillation and a minor survival
rate at the end of the pursuit (Group 1, 92%; Group 2, 89% and
Group 3, 82%, P = 0.03).
Conclusions High levels of glycemia at the first determination in
ACS patients are a long-term prognostic factor. It is necessary to
know the influence of glycemic levels for ACS prognosis when a
correct control of the level is obtained during the ACS acute phase.
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Intake of antioxidants
Vitamin A Vitamin C Vitamin E Selenium Copper Zinc
Mean intake 806.9 μg 98.6 mg 13.6 mg 56.9 μg 1.7 mg 12.2 mg
Percentage of DRV 119% 248% 158% 79% 150% 137%
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Introduction Tight blood glucose control (TBGC) results in a
decrease in the infection rate in critically ill patients. In 2002 a
retrospective analysis of 38 postoperative patients in our cardiac
surgical ICU revealed that most of the patients had a high serum
glucose level upon arrival and remained so throughout their stay
irrespective of their diabetes status. Additionally it was noted that
the number of infections exceeded the international accepted rate.
Methods Based on those findings, we initiated a prospective
observational study implementing a continuous insulin intravenous
infusion protocol as recommended internationally in our patients,
both diabetic and nondiabetic, to achieve a blood glucose level
(BGL) between 4 and 8 mmol/l. Our sample study population
included 116 patients, mean age 54 (±17.9) years, 65 (56%) were
males, 62 (53%) received coronary artery bypass grafting and 46
(40%) were diabetic. Initially there was resistance to implement
this protocol and compliance was poor. We therefore embarked on
a nursing and physician education program for more than 1 year.
We initiated a new prospective study in 2006–2007. The study
included 270 patients, mean age 52 years (±15.8), 155 (57%)
were males, 136 (50%) received coronary artery bypass grafting
and 97 (36%) were diabetic.
Results The demographics of the study patients were similar. The
mean admission BGL, highest BGL, lowest BGL and discharge
BGL for 2003 and 2006–2007 were 8.1/13/7.9/11 mmol/l and
7.8/12.8/4.6/8.3 mmol/l, respectively. A comparison of wound
infection rates before and after full implementation of TBGC
showed a decrease in the rate from 7.25% in 2002 to 3.3% in
2007 (P = 0.02). The blood stream infection rate, however, did not
showed any statistical significant change, 2% in 2003 versus
1.9% in 2007 (P = 0.4).
Conclusions Our study showed that implementing TBGC in
cardiac surgical patients decreases surgical wound infection but
does not change significantly the bloodstream infection.
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Introduction Strict blood glucose control with intensive insulin
therapy reduces mortality and morbidity of critical illness, including
newly acquired kidney injury [1-3].
Methods To study the underlying mechanisms, we independently
manipulated blood glucose (G) and insulin (I) to normal (N) or high
(H) levels in our rabbit model of prolonged critical illness [4],
resulting in four experimental groups: NI/NG, HI/NG, NI/HG and
HI/HG.
Results Plasma creatinine levels were elevated in the two HG
compared with the two NG groups. Light microscopy showed
severe renal structural abnormalities in HG rabbits, with formation
of tubular casts. These effects of blood glucose control on kidney
function and structure were not explained by an effect on blood
flow or oxygen delivery to the kidney. In contrast, in the renal cortex
of HG rabbits, the activities of the mitochondrial respiratory chain
enzymes were reduced to below 50% to 30% of the values
observed in controls and NG rabbits, a finding that was indepen-
dent of insulin. No significant correlations were found between
respiratory chain complex activities and blood flow or oxygen
delivery to the cortex. Strongly significant inverse correlations were
found between the enzyme activities and plasma levels of
creatinine, suggesting that mitochondrial protection by intensive
insulin therapy mediated at least part of the prevention of kidney
injury. The glucose content in the renal cortex was more than four-
fold higher in the HG than the NG groups and correlated directly
with creatinine levels and inversely with enzyme activities, suppor-
ting glucose toxicity as the mediator of renal mitochondrial damage.
The dicarbonyls glyoxal, methylglyoxal and 3-deoxyglucosone were
elevated in plasma of the HG groups and strongly correlated with
glucose in the cortex and plasma creatinine, suggesting a possible
contribution of these toxic metabolites of glucose.
Conclusions Intensive insulin therapy during critical illness confers
renal protection by prevention of hyperglycemia-induced
mitochondrial damage rather than by improving perfusion and
oxygen delivery.
References
1. Van den Berghe et al.: N Engl J Med 2001, 345:1359.
2. Van den Berghe et al.: N Engl J Med 2006, 354:449.
3. Schetz M, et al.: J Am Soc Nephrol, in press.
4. Ellger et al.: Diabetes 2006, 55:1096.
P152
Complement activation after uncomplicated coronary
artery bypass grafting: role of strict glucose control
C Hoedemaekers1, M Van Deuren1, T Sprong1, P Pickkers1, 
TE Mollnes2, I Klasen1, J Van derHoeven1
1Radboud University Nijmegen Medical Centre, Nijmegen, The
Netherlands; 2Rikshospitalet, Oslo, Norway
Critical Care 2008, 12(Suppl 2):P152 (doi: 10.1186/cc6373)
Introduction The complement system is a key component in the
SIRS response after cardiac surgery. The aim of this study was to
investigate whether strict glucose control modifies complement
activation in this setting and to analyze the route of complement
activation.
Methods We performed a randomized trial in 20 adult patients
after coronary artery bypass grafting (CABG). Patients were
assigned to receive intensive or conventional insulin treatment
immediately after admission to the ICU. Components of the
complement system were determined by ELISA. Changes in
complement levels over time were analyzed with one-way ANOVA
repeated measures.
Results Blood glucose levels were significantly lower in the
intensive treatment group (P < 0.003). Serum concentrations of
terminal complement complex were increased on admission to the
ICU in both groups (2.80 ± 1.45 AU/ml vs 3.21 ± 2.17 AU/ml, P =
0.817) and declined significantly thereafter. All complement
activation pathways converge at the point of C3 activation. The
C3bc concentration was strongly increased on admission in both
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groups (78.9 ± 36.7 AU/ml vs 103.4 ± 68.0 AU/ml, P = 0.355)
and declined in the following hours with a second peak at 8 hours
after admission (P = 0.005). C3bBbP (alternative pathway
activation) was increased on admission in both groups (106.44 ±
42.72 AU/ml vs 144.44 ± 73.51 AU/ml respectively, P = 0.199),
followed by a significant decline in the following hours (P < 0.001).
C1rs–C1inh complexes (classical pathway) were increased on
admission in both groups (38.00 ± 12.27 AU/ml vs 40.78 ± 16.41
AU/ml, P = 0.690), followed in time by a gradual decrease and
later by an increase (P < 0.001). No differences in C4bc
(combined classical and lectin pathway) concentrations were
measured between the treatment groups, and the concentrations
remained constant during ICU stay. MBL (lectin pathway)
concentrations were comparable in both treatment groups and did
not change significantly during the 24-hour follow-up.
Conclusions Strict glucose regulation does not alter the
concentration of complement components or route of activation.
Complement activation after CABG shows a biphasic pattern.
Initially complement is activated trough the classical/lectin pathway
and augmented by the alternative pathway. In a second phase,
complement is activated by the classical/lectin pathway to the
point of C3b formation without production of terminal complement
complexes, indicating inhibition beyond C3b.
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Introduction The aim of this study was to investigate the
relationship between blood glucose level measured on admission
and hospital mortality with the Glasgow Coma Score (GCS) in
ischemic and hemorrhagic stroke patients.
Methods Those patients who experienced ischemic and
hemorrhagic stroke and who arrived at the hospital within the first
3 hours after the beginning of the symptoms were included in the
study. On arrival the GCS was detected. Blood glucose levels
were determined for each patient. The patients were allocated as
ischemic and hemorrhagic stroke groups on admission. In addition,
ischemic and hemorrhagic stroke groups were allocated as GCS
≤ 8 and GCS ≥ 9 groups. The patients were observed in terms of
mortality during their stay in the hospital. The data were compared
using Kruskal–Wallis variance analysis and the Mann–Whitney U
test with Bonferroni correction. P ≤ 0.05 was considered significant.
Results We enrolled 113 patients (26 hemorrhagic, 87 ischemic
stroke) in the study. The mean blood glucose level in the ischemic
stroke and GCS ≤ 8 group (25 patients) was 189 ± 69.23 mg/dl on
admission. The mean blood glucose level for the ischemic stroke and
GCS ≥ 9 group (62 patients) was 165 ± 79.8 mg/dl. The mean
blood glucose level of the hemorrhagic stroke and GCS ≤ 8 group
(16 patients) was 291.7 ± 162.63 mg/dl. On admission, the mean
blood glucose level of the hemorrhagic stroke and GCS ≥ 9 group
(10 patients) was 141.8 ± 35.46 mg/dl. The mean blood glucose
level of dead patients (n = 35) was 236.25 ± 128.88 mg/dl. A
significant reverse relationship was found between GCS and blood
glucose level (P = 0.00). A significant reverse relationship was found
between GCS and blood glucose level for dead patients (P = 0.00).
Conclusions In patients with ischemic and hemorrhagic stroke
who referred to the emergency clinic within the first 3 hours after
the stroke developed, a measured high glucose level on admission
could be an indicator of bad prognosis and high hospital mortality.
References
1. Perttu J, et al.: Stroke 2004, 35:363-364.
2. Martini SR, et al.: J Cerebral Blood Flow Metab 2007, 27:
435-451.
P154
Significance of the suppression of blood glucose variability
in acutely ill severe patients with glucose intolerance
evaluated by means of bedside-type artificial pancreas
M Hoshino1, Y Haraguchi2, I Mizushima3, S Kajiwara1, 
M Takagi1
1Shisei Hospital, Saitama, Japan; 2National Hospital Organization
Disaster Medical Center, Tokyo, Japan; 3Tokyo Police Hospital,
Tokyo, Japan
Critical Care 2008, 12(Suppl 2):P154 (doi: 10.1186/cc6375)
Introduction We hereby report the usefulness of continuous use
of an artificial pancreas (AP) to control blood glucose (BG)
clinically. In this report we analyzed the significance of BG stability,
or variability under strict control of BG, by the use of an AP.
Methods BG control was performed by an AP, STG22. Patients
were evaluated at early (E) phase and late (L) phase (1 week after
the E phase). Based on the daily mean BG (BGm), basically
calculated by 24 data obtained hourly, patients were classified into
two groups. Patients with BGm <200 mg/dl and those with BGm
>200 mg/dl were denoted as group B and group A, respectively.
Each group was classified into two subgroups based on the daily
BG difference (BGd), or 100 mg/dl, high and low variability
subgroups. Group B patients with BGd <100 mg/dl were denoted
BL, and group B patients with BGd >100 mg/d as BH. Subgroups
AL and AH were classified similarly. The parameters studied were
BGm, BGd, SOFA score and mortality.
Results (1) Group A had BGm in the E phase and L phase of 231
± 24 (n = 11) and 220 ± 19 (n = 7), respectively. Group B had
BGm in the E phase and L phase of 175 ± 19 (n = 35) and 166 ±
21 (n = 42), respectively. (2) Relationship between BGm and
BGd: (E phase) group A had the tendency of higher BGd as
compared with group B (101 ± 60 vs 68 ± 46, P < 0.10); (L
phase) group A had significantly higher BGd as compared with
group B (109 ± 43 vs 66 ± 46, P < 0.025). (3) Relationships
between BGd and SOFA score, mortality: (E phase) group AH had
the tendency of higher mortality as compared with group AL
(100%, n = 3 vs 50%, n = 8); (L phase) group BH had the
tendency of higher SOFA score and mortality as compared with
group BL (8.0 ± 6.7, 80%, n = 5 vs 6.7 ± 5.7, 38%, n = 37).
Conclusions Although this is a preliminary study, based on the
precise data measured by the AP, the following conclusions were
suggested. High BG variability or unstability supported high
morbidity and mortality. BG control aimed at the suppression of
BG variability, or BGd lower than 100 mg/dl, may therefore
improve the outcome as well as the improvement of BGm.
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Introduction In two randomised controlled trials (RCTs) on the
effect of intensive insulin therapy (IIT) in a surgical ICU (SICU) and
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a medical ICU (MICU), IIT reduced the incidence of critical illness
polyneuropathy and/or myopathy (CIP/CIM) and the need for
prolonged mechanical ventilation (MV ≥ 14 days). Here we investi-
gated whether these effects are present in daily practice when IIT
is implemented outside a study protocol.
Methods We retrospectively studied all electronically available
electrophysiological data (electroneuromyography (ENMG)) from
patients in the SICU and MICU before and after implementation of
IIT in routine practice (omitting data obtained during the two
RCTs). All ENMGs were performed because of clinical weakness
and/or weaning failure. As in the RCTs, CIP/CIM was diagnosed
by the presence of abundant spontaneous electrical activity
(fibrillation potentials or positive sharp waves). Baseline and out-
come variables were compared using Student’s t test, chi-square
test or Mann–Whitney U test when appropriate. The effect of
implementing IIT on CIP/CIM and prolonged MV were assessed
using univariate analysis and multivariate logistic regression analysis
(MVLR) correcting for baseline and ICU risk factors.
Results ENMGs were performed in 193 long-stay ICU patients
before and 494 after implementing IIT. This population comprised
4.6% of all patients before and 5.6% after IIT implementation in the
MICU and 4.0% before and 3.9% of all patients after IIT
implementation in the SICU. With IIT, mean glycemia was
significantly lowered (median 142 (130–153) to 106 mg/dl
(100–113)). IIT implementation significantly reduced ENMG
diagnosis of CIP/CIM in this population (71.6% to 48.7% (P <
0.0001)). MVLR identified implementing IIT as an independent
protective factor (P < 0.0001, OR = 0.24 (95% CI = 0.14–0.43)).
MVLR confirmed the independent protective effect of IIT on
prolonged MV (P = 0.03, OR = 0.55 (95% CI = 0.31–0.95)). This
effect was explained by the reduction in CIP/CIM (P = 0.009,
OR = 1.13 (95% CI = 1.65–2.42)).
Conclusions Implementing IIT in daily practice evokes a similar
beneficial effect on neuromuscular function, as observed in two
RCTs. IIT significantly improves glycemic control and significantly
and independently reduces the electrophysiological incidence of
CIP/CIM. This reduction explains the beneficial effect of IIT-
prolonged MV.
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Introduction The purpose of this study was to investigate the
performance of a newly developed prototype decision support
system for the establishment of tight glycaemic control in patients
in the medical ICU for a period of 72 hours.
Methods The study was conducted as a single-center, open,
noncontrolled clinical investigation in 10 mechanically ventilated
patients at the Medical University Graz. After admittance to the
ICU, arterial blood glucose values were monitored and the CS-1
Decision Support System (interacting infusion pumps with
integrated algorithm eMPC and user interface) was used to adjust
the infusion rate of intravenously administered human soluble
insulin to normalize arterial blood glucose. The efficacy and safety
were assessed by calculating the percentage within the target
range (4.4–6.1 mM), the hyperglycaemic index (HGI), mean glucose
and the number of hypoglycaemic episodes (<2.2 mM).
Results The percentage of readings within the target range was
47.0% (±13.0). The average blood glucose concentration and HGI
were 6.08 mM (±0.73) and 0.54 mM (±0.52), respectively. No
hypoglycaemic episode (<2.2 mM) was detected. Several
technical malfunctions of the device, such as repetitive error
messages and missing data in the data log owing to com-
munication problems between the new hardware components, are
shortcomings of the present version of the device. Owing to these
technical failures of system integration, treatment had to be
stopped ahead of schedule in three patients.
Conclusions For the first time a decision support system fully
integrated into an infusion pump system was tested clinically.
Despite technical malfunctions, the performance of this prototype
system of the CS-1 Decision Support System device was, from a
clinical point of view, already effective in maintaining tight
glycaemic control. Accordingly, and with technical improvement
required, the CS1 system has the capacity to be further improved
in the next phase of the development process and to serve as a
reliable tool for routine establishment of glycaemic control for
critically ill patients.
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Introduction Recent data suggest that a tight glucose control by
intensive intensive therapy (TGCIIT) may improve survival of
critically ill patients. The optimal target for blood glucose (BG),
however, is a matter of debate and controversy, and the constraints
associated with the implementation of TGCIIT are considerable.
Methods The present study surveyed the current practice of
glucose management. We sent a multiple-choice questionnaire to
120 Belgian ICUs, on behalf of the Belgian Federal Board for
Intensive Care.
Results Fifty-two ICUs (43%) answered. A total of 489 patients
were staying in the ICUs when the questionnaire was filled. The
number of glucometers per ICU bed averaged 0.6 ± 0.4 and the
nurse/patient ratio averaged 0.6 ± 0.3. Glucose control is felt to be
an important issue by all participants, while 96% are aware of the
results of the landmark 2001 study of Van den Berghe and
colleagues. Ninety percent changed their practice following this
study. Fifty percent of the responders use TGCIIT for every patient,
while others restricted TGCIIT to long-stayers, septic or diabetic
patients. An algorithm is used for glucose control by 98% of the
participants. The BG target is 80–110 mg/dl and 110–140 mg/dl
for 27% and for 56% of the responders, respectively. BG is
checked systematically two to eight times per day (five to eight
times for 54%), on blood and capillary samples. Prior to the
achievement of the target BG, checks are performed hourly (60%)
or every 2 hours (28%). Once the target BG is reached, checks
are performed six times (45%) to 12 times (36%) a day. The
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amount of glucose supplied per day ranged from 50 g to more than
200 g, with 55% of the participants providing 75–150 g. For 81%
of the responders, patients are discharged from the ICU with
subcutaneous insulin therapy. Finally, 98% of the responders are
waiting for recommendations concerning TGCIIT.
Conclusions In spite of an awareness of TGCIIT, the current
practice is largely variable among ICUs. The need for practical
recommendations, including the type of patients, the equipment
required and the optimal BG target, is underlined by these data.
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Introduction Hyperglycaemia is often associated with the hyper-
metabolic response to burn injury. It is perceived that glycaemic
control can be difficult in a burns population. The aims of this study
are to define the level of glycaemic control and the incidence of
severe hypoglycaemia since the introduction of a nurse-led
intensive insulin programme in a tertiary referral burns intensive
therapy unit (BITU).
Methods A retrospective analysis of blood glucose levels following
the introduction of a tight glycaemic target range (4.4–6.1 mmol/l)
in November 2003. The study period was 42 months. All patients
were admissions to the BITU. Insulin therapy was initiated once
glucose levels were outside the defined range and were adjusted
by nursing staff according to a regularly revised glucose/insulin
sliding scale. Glucose levels were obtained by whole blood
analysis using an onsite blood gas analyser (Chiron Diagnostics,
Novartis, USA) subjected to daily calibration.
Results In total, 24,602 blood glucose measurements were
recorded within the study period. For 146 adult admissions (mean
age = 47.7 years, mean% burn = 42.25%), there were 19,723
measurements. Median blood glucose = 7.1 mmol/l (IQR ± 2.2).
Of these measurements, 22.6% were within the target range.
Thirty per cent were >8.0 mmol/l. Incidence of severe hypo-
glycaemia was 0.21%. For 85 paediatric (age ≤ 16 years) admis-
sions (mean age = 6.9 years, mean% burn = 43.5%), there were
4,879 recorded blood glucose measurements. Median = 6.8 mmol/l
(IQR ± 2.2); 29.1% of measurements were within the target range,
and 23.5% were >8.0 mmol/l. The incidence of severe hypo-
glycaemia was 0.22% (see Figure 1).
Conclusions The defined management strategy did not achieve
tight glycaemic control; however, the majority of measurements
were less than 8.0 mmol/l, as recommended by the Surviving
Sepsis Campaign [1]. Paediatric patients had more results within
the defined range compared with adult patients. The rate of severe
hypoglycaemia was only 0.2%. Given the potential morbidity of
severe hypoglycaemia and the uncertain benefit of intensive insulin
therapy, this approach has produced an acceptable level of
glycaemic control.
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Introduction Hyperglycemia is common in critically ill patients and
is associated with increased mortality. The aim of our study was to
test the efficacy of intensive insulin therapy in maintaining blood
glucose levels within the target range.
Methods During a 2-month period, three patients (mean age: 67.6
years; mean APACHE II score: 13) were included in our study. The
goal of the procedure was to maintain blood glucose levels below
150 mg/dl. Insulin intravenous dosages (continuous infusion and
push) were adjusted by the ICU nurses based on ABG glucose
levels, also according to nutritional support and the glucose levels
trend algorithm.
Results During this period, 547 ABG samples were performed
overall for the patients. The number of samples per patient per day
was 7.5 ± 1.6 (mean ± SD): minimum 5, maximum 12. The blood
glucose value per patient per day was 123.6 ± 25.7 (mean ± SD),
minimum 13.5, maximum 196.33. The insulin dosage per patient
per day was 86.34 ± 76.86 (mean ± SD) minimum 13.5, maximum
334. We recorded eight episodes of hypoglycemia (1.46% of all
measurements), all successfully treated after 30% dextrose
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infusion. Within the target range were 427 blood glucose levels
(78.06%), while the higher glucose values were associated with
the initial hyperglycemia correction. The regration between glucose
values and insulin dosage was not linear but rather polynomial,
while the higher values of insulin dosage correlated with both the
higher and the lower glucose levels.
Conclusions The blood glucose level target is difficult to achieve
with intensive insulin therapy in a population of ICU patients with
high severity score on admission. In our study, the glycemic control
target below 150 mg/dl was achieved in more than two-thirds of
measurements using a high insulin dosage. On the other hand, the
rate of hypoglycemia was high in our study (1.46%), probably
because of application failure of the insulin dosage algorithm
during nutritional interruption. We suggest that application of an
intensive insulin therapy protocol adjusted to nutritional support
and the glucose levels trend will achieve glycemic control in clinical
practice, while minimizing the risk of hypoglycemia.
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Introduction Intensive insulin therapy (IIT) reduces mortality and
morbidity of critically ill patients [1]. The ‘original IIT protocol’ as
used by the group of van den Berghe (Leuven, Belgium) is a simple
text-based protocol aiming for blood glucose values between 4.4
and 6.1 mmol/l. We conducted a postal survey amongst intensive
care physicians and nurses in February 2007. As part of this
survey, respondents were asked to send in a copy of their protocol
on glycemic control (GC).
Methods All Dutch ICUs with ≥5 beds available for mechanical
ventilation received a questionnaire on GC policies, in particular
thresholds for blood glucose values to start insulin, and the targets
of GC. Respondents were explicitly asked to send in their GC
protocol too, when available.
Results Of 71 ICUs responding to the questionnaire, 46 (65%)
sent in their GC protocol. Formats of the glucose control protocol
varied widely, four different types of protocol formats could be
recognized: ‘flow chart’ based (n = 17), ‘sliding scales’ based (n =
16), ‘text’ based (n = 7), and ‘others’ (n = 5). In three ICUs the GC
protocol was computer based. In only 11 GC protocols (24%)
were blood glucose targets between 4.4 and 6.1 mmol/l. In the
majority of GC protocols (87%), the lower target for blood glucose
was <4.5 mmol/l; in only one-half of GC protocols (43%), the
upper target for blood glucose was <6.1 mmol/l. In four GC
protocols, the thresholds for starting insulin were unclear.
Conclusions There is large variability in the presently used GS
protocols in The Netherlands. In only 24% did the GC-protocol
targets reflect those of the original IIT protocol as used by van den
Berghe.
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Introduction Insulin resistance and hyperglycemia are important
features of the care of the critically ill. They are part of the
metabolic pathophysiology of acute conditions [1,2]. In septic
patients, insulin resistance is linked to the synergic effect of
cytokines, bacterial products and catecholamines [3]. Laboratory
findings include elevated C-peptide and serum insulin-like growth
factor binding protein 1 (IGFBP-1) [4]. This is secreted by the liver
and its secretion is inhibited by insulin. In the insulin-resistant
patient, a rise in insulin fails to reduce its plasma levels. We dosed
serum IGFBP-1 in samples of patients with sepsis and compared it
with glycemia and serum C-peptide.
Methods Only patients with a definite diagnosis of sepsis were
included. Five blood samples were taken from each patient at the
time of their entrance and every 24 hours for the next 96 hours. For
each sample, glycemia, C-peptide and IGFBP-1 were dosed and
their values compared.
Results C-peptide levels constantly remained high, even in
normoglycemic patients. Higher glycemias were associated with
raised serum IGFBP-1 levels. Insulin increases could not inhibit
IGFBP-1 and, hence, the worse the insulin resistance, the higher
the glycemia, the higher the IGFBP-1. The relation between C-
peptide and IGFBP-1 showed that higher levels of circulating
insulin were associated with higher levels of IGFBP-1. This was
thought as a direct sign of the existing insulin-resistant state.
Conclusions IGFBP-1 can be used to asses insulin resistance in
septic critical patients, particularly compared with glycemia. Its
correlation with C-peptide might better define the severity of insulin
resistance and, thus, of the underlying sepsis.
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Introduction With insulin use increasing to treat ICU hyper-
glycemia, we wished to determine whether insulin is cytoprotective
in the presence of deformation-induced lung cell injury.
Methods A549 epithelial cells were grown in full growth media for 24
hours on deformable six-well culture plates coated with type 1
collagen. Cells were then grown in glucose concentrations of
1.26 g/l, 4.26 g/l and 7.26 g/l for an additional 24 hours. After
2 hours of serum starvation, cells were exposed to 100 nM insulin for
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30 minutes, followed by stretching for 2 minutes at 8 Hz, 30% strain
amplitude and 140%/s strain velocity in the presence of 1% FITC
solution, a marker of plasma membrane injury and reseal. Following
stretching, the cells were incubated with 1% PI, a marker of cell
death, with quantification of death performed by confocal microscopy.
Results In undeformed cells the rate of cell death was 0.8%, 0.5%
and 1.2% at 1.26 g/l, 4.26 g/l and 7.26 g/l glucose, respectively.
In undeformed cells treated with 100 nM insulin, cell death was
0.2%, 1.3% and 2.1%. Deformation increased the percentage of
cellular death to 3%, 5% and 2% compared with undeformed
cells. Deformation increased the percentage of death in cells
treated with 100 nM insulin to 15%, 15%, and 8% as compared
with undeformed cells treated with insulin and deformed cells
grown in glucose alone. Cell death did not differ from control at
insulin concentrations ranging up to 100 nM but doubled and
plateaued, with concentrations of 100–300 nM.
Conclusions Insulin increases deformation-induced death in lung
cells. This is consistent with a previously published multivariate
analysis of patients with respiratory failure showing that the amount
of infused insulin and the mean glucose level were independent
risk factors for increased mortality. Our findings may have
important implications for the use of insulin therapy in critically ill
and ventilated patients. The mechanism by which insulin influences
lung cell death after deformation is not yet known.
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Factors influencing accuracy of blood glucose
measurements in critically ill patients
J Peng, Y Liu, Y Meng, X Song, L Weng, B Du
Peking Union Medical College Hospital, Beijing, China
Critical Care 2008, 12(Suppl 2):P163 (doi: 10.1186/cc6384)
Introduction Rapid and accurate blood glucose measurement is
essential for treatment of critically ill patients. This prospective
observational study, performed in a nine-bed medical ICU, was
designed to evaluate factors affecting the accuracy of different
methods of blood glucose measurement.
Methods A total of 29 consecutively admitted patients were
included. Blood glucose was measured with a glucometer
(Lifescan surestep™, capillary and arterial), a blood gas analyzer
(Radiometer ABL-735, arterial), and a central laboratory (Olympus
AU5400, arterial). Each value was compared with the reference
laboratory result. Discrepancy was defined as the percentage of
paired values not in accordance (>0.83 mmol/l difference for
laboratory values <4.12 mmol/l, and >20% difference for values
≥4.12 mmol/l). Patient demographics, and clinical data including
the presence of peripheral edema, vasopressor dependence,
hematocrit, arterial pH and PaO2 were also recorded. Binary
logistic regression analysis was used to determine the inde-
pendent factor of discrepancy of blood glucose measurements.
Results Discrepancy occurred in 46% (152/332) of blood
glucose measurements. Independent factors of discrepancy are
presented in Table 1.
Conclusions Decreased hematocrit, poor oxygenation, and use of
glucometer significantly increased the risk of discrepancy of
glucose measurements in critically ill patients.
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Evaluation of a noninvasive blood glucose monitoring
device for critically ill patients
O Amir1, D Dvir2, B Grunberg2, J Cohen2, E Gabis1, P Singer2
1OrSense Ltd., Nes Ziona, Israel; 2Rabin Medical Center, Petach
Tikva, Israel
Critical Care 2008, 12(Suppl 2):P164 (doi: 10.1186/cc6385)
Introduction The purpose of this study was to evaluate the feasibility
of the NBM device (OrSense Ltd) for noninvasive continuous glucose
monitoring in critically ill patients. Critically ill patients frequently
experience abnormalities in carbohydrate metabolism and a severe
insulin resistance state. Hyperglycemia is a negative predictor of
outcome in these patients, as high blood glucose (BG) values are
associated with an increased risk of morbidity and mortality. Current
BG monitoring methods do not provide the continuous glucose
monitoring needed to implement tight glucose control protocols.
Methods The NBM uses a sensor shaped like a ring, placed on the
base of thumb. Red/near-infrared occlusion spectroscopy detects
and analyzes BG and hemoglobin concentrations. A study was
conducted on 14 patients (seven females, seven males, ages
34–92 years) in the ICU of the Rabin Medical Center. The NBM
probe performed noninvasive continuous glucose monitoring for up
to 24 hours, with readings every 10 minutes. There were a total of
22 sessions, with two excluded due to insufficient calibration. NBM
results were compared with arterial blood samples taken through an
arterial line every 30–60 minutes and were analyzed with a blood
gas machine (ABL 700; Radiometer). In all sessions there was
good patient compliance and no adverse effects were identified.
Results A prospective analysis based on a uniform model with
personal calibration was performed on the NBM readings, for a
total of 195 paired data points. The calibration phase lasted 3 hours
utilizing reference BG values taken at t0+0:30, t0+1:30, t0+2:30,
and t0+3:30. The reference BG range was 62–369 mg/dl. The
median relative absolute error was 7.6%. A Clarke error grid
analysis showed that 95.9% of the measurements fell within zones
A (66.7%) and B (29.2%). Furthermore, the NBM and ABL 700
showed comparable estimates for the average percentage of time in
hypoglycemia (8% ABL 700, 11% NBM), euglycemia (25% ABL
700, 26% NBM), and hyperglycemia (49% ABL 700, 57% NBM).
Conclusions This study indicates the potential use of the
noninvasive NBM as a device for continual, accurate, safe, and
easy-to-use BG evaluation for the ICU. Consequently, it will improve
patient care and survival, as well as reducing staff workload. The
device has the promise for trend analysis, hypoglycemia detection
and closed-loop systems enabling automatic glycemic control.
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Evaluation of a near-infrared automated blood glucose
monitor for use in critical care settings
S Hendee, S Vanslyke, F Stout, M Borrello, D Welsh, A Ross, 
A Fettig, S Martha, A Truong, R Robinson, R Thompson
Luminous Medical, Inc., Carlsbad, CA, USA
Critical Care 2008, 12(Suppl 2):P165 (doi: 10.1186/cc6386)
Introduction Luminous Medical (Carlsbad, CA, USA) is develop-
ing an automated, patient-attached system that uses near-infrared
spectroscopy to measure glucose in whole blood. The system
under development will aid caregivers in achieving tight glycemic
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Independent factors of discrepancy of blood glucose measurements
Factor OR 95% CI P value
Hematocrit 0.93 0.89–0.98 0.006
PaO2 0.98 0.98–0.99 0.003
Assay
Laboratory 1.0
ABG 2.4 1.1–4.9 0.021
Glucometer 7.5 3.6–15.6 0.000
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control in critical care patients. Luminous Medical conducted a
pilot study to characterize system performance in terms of auto-
mated blood access and glucose measurement accuracy.
Methods Four volunteers with type 2 diabetes (mean BMI = 32)
participated in an IRB-approved study of the Luminous Medical
Automated Glucose Monitor (AGM). Two subjects were enrolled
for 24-hour sessions, and two for 48-hour sessions. Two AGM
systems were used in the study. A standard peripheral intravenous
catheter was placed in the subject’s arm to provide venous access.
The AGM was attached to the catheter via a sterile, patient-
dedicated, disposable tubing set. The system was configured to
automatically draw a blood sample through a flow cell integrated
into the disposable set at 30-minute intervals. Near-infrared
transmission spectra were collected as blood was drawn through
the flow cell. After measurement, the system reversed flow to
return the blood to the subject and to flush the circuit with saline.
Glucose measurements were determined from collected spectra
using partial least-squares regression applied in subject-out cross-
validation. Simultaneous blood samples collected and analyzed
with a YSI 2700 Select provided reference glucose values.
Results The Luminous Medical AGM systems collected 283 blood
glucose measurements during 144 hours of operation. The system
operated with a single disposable set without interruption during
each of the four sessions, infrequently requiring only minor
operator interventions (such as slight adjustment of the arm
position). Glucose values ranged from 75 to 340 mg/dl. Bland–
Altman analysis showed good agreement between Luminous
Medical AGM glucose measurements and paired reference values,
with a mean difference of 4.15 mg/dl, 95% confidence limits of
–18.8 to 10.5 mg/dl, and R2 = 0.97.
Conclusions Luminous Medical’s AGM provides reliable access to
peripheral venous blood samples in volunteers with type 2
diabetes, and accurately measures glucose in these samples.
Luminous technology holds considerable promise for providing an
improved critical care glucose monitoring solution over currently
available methods.
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Comparison of accuracy of three point-of-care
glucometers in an adult ICU
A Roman, C Hanicq, P Flament, T El Mahi, F Vertongen, 
E Stevens
CHU Saint-Pierre, Brussels, Belgium
Critical Care 2008, 12(Suppl 2):P166 (doi: 10.1186/cc6387)
Introduction Obtaining accurate blood glucose levels at the
bedside is mandatory to titrate insulin infusions in ICU patients
under tight glycemic control. We evaluated concurrently the
performance of three point-of-care devices – one blood gas
analyzer and two glucometers – in an adult ICU.
Methods Simultaneously, arterial blood glucose was measured
with RapidLab 1265, the Accu-chek Aviva, the Nova StatStrip and
in the central laboratory as reference using the hexokinase method.
The Bland–Altman approach and a modified Kanji approach [1]
were used.
Results A total of 330 matched analysis were randomly performed
in 275 patients. The mean SOFA score was 4.5 (minimum 0;
maximum 21). The range of laboratory glucose was 34–526 mg/dl.
One patient showed 1,025 mg/dl and was not included in
statistical analysis as glucometers all indicated a high out-of-range
value. No patient was receiving peritoneal dialysis with icodextrin,
and none had a paracetamol overdose. Biases are defined as
point-of-care minus laboratory glucose values. These mean biases
were –2.9 mg/dl for the RapidLab 1265 blood gas analyzer,
–1.2 mg/dl for the Accu-Chek Aviva and –0.3 mg/dl for the Nova
StatStrip. The analysis of the 20% discrepancy showed, respec-
tively, zero cases, five cases and one case in the study, while
another 22 cases, 40 cases and 19 cases revealed more than
10% discrepancy. See Table 1.
Conclusions The very low biases and the low rate of significant
(>20%) discrepancy appear sufficient for safe tight glucose
control monitoring in the adult ICU.
Reference
1. Kanji S, et al.: Crit Care Med 2005, 33:2778-2785.
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Accuracy of point-of-care blood glucose measurements in
the medical ICU
Y Liu, D Wu, X Song, Y Meng, L Weng, B Du
Peking Union Medical College Hospital, Beijing, China
Critical Care 2008, 12(Suppl 2):P167 (doi: 10.1186/cc6388)
Introduction Accurate blood glucose measurement is essential for
strict glycemic control. We evaluated four methods of point-of-care
blood glucose measurement in critically ill patients.
Methods In this prospective observational study, blood glucose
was measured with the Roche Accu-Chek (capillary and arterial),
the Radiometer ABL-700 analyzer (arterial), and in the central
laboratory (arterial). Each value was compared with the reference
laboratory result. Discrepancy was defined as the percentage of
paired values not in accordance (>0.83 mmol/l difference for
laboratory values <4.12 mmol/l, and >20% difference for values
≥4.12 mmol/l).
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Table 1 (abstract P166) 
Mean bias n >10% n >20% 
n (mg/dl) SD discrepancy discrepancy
RapidLab 1265 329 –2.9 5.6 22 (6.6%) 0
Accu-Chek Aviva 329 –1.2 7.7 45 (13.6%) 5 (1.5%)
Nova StatStrip 329 –0.4 5.6 20 (6.0%) 1 (0.3%)
Table 1 (abstract P167) 
Mean ± SD (mmol/l) Bias (mmol/l) r2 (95% CI) Cb Discrepancy (%)
Reference 7.7 ± 2.8 NA NA NA NA
Accu-Chek, capillary 9.3 ± 2.7 1.6 ± 1.4 0.874 (0.818–0.914) 0.848 65.3 (62/95)
Accu-Chek, arterial 9.1 ± 2.6 1.4 ± 1.5 0.835 (0.758–0.889) 0.867 59.8 (52/87)
ABL-700, arterial 8.7 ± 3.0 1.1 ± 1.1 0.925 (0.890–0.950) 0.930 35.8 (34/95)
Laboratory, arterial 8.3 ± 2.8 0.6 ± 1.2 0.908 (0.864–0.938) 0.978 21.5 (20/93)
r2, Pearson correlation coefficient; Cb, bias correction factor
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Results The mean value, bias, agreement and discrepancy are
presented in Table 1.
Conclusions Our findings suggest that capillary blood glucose
measured by a glucometer is inaccurate in critically ill medical
patients. Fingerstick measurements should be interpreted with
great caution to avoid hypoglycemia.
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Tight glycemic control: comparison of a real-time
continuous interstitial tissue glucose monitoring system
with arterial plasma glucose measurement in critically ill
patients
A Vlkova, F Musil, P Dostal, Z Zadak, A Smahelova, V Cerny
University Hospital Hradec Kralove, Czech Republic
Critical Care 2008, 12(Suppl 2):P168 (doi: 10.1186/cc6389)
Introduction The purpose of the study was to compare the results
of interstitial glucose measurements obtained by the Guardian
Real-time system and arterial plasma glucose concentration in
mechanically ventilated, critically ill patients. The Guardian Real-
time continuous glucose monitoring system is an external device
that uses a subcutaneous microsensor that measures the concen-
trations of glucose in interstitial fluid.
Methods Ten mechanically ventilated critically ill patients with tight
glycemic control based on arterial blood glucose measurements
admitted to the six-bed multidisciplinary ICU of a tertiary care
hospital, with no clinical and laboratory signs of inadequate tissue
perfusion, were included in this single-center study. Interstitial
glucose concentrations were measured by the Guardian Real-time
monitoring system and compared with a standard reference
method of plasma glucose measurement. The Guardian Real-time
system was calibrated against the arterial plasma glucose
measurement every 8 hours. Arterial blood glucose concentrations
were measured every 60 minutes (glucose oxidation reaction) and
the Guardian Real-time data were downloaded and paired with
plasma glucose. Data were analyzed using the Bland–Altman
method and the correlation coefficient was calculated.
Results Two hundred and seventeen paired results were obtained
and analyzed. Correlation between both methods was reasonable,
but not perfect (correlation coefficient r = 0.6930, P < 0.0001).
This was confirmed by Bland–Altman analysis (Figure 1), demon-
strating broad limits of agreement: +2.3 and –3.1 mmol/l.
Conclusions The observed, clinically unacceptable broad limits of
agreement do not support the use of the Guardian Real-time
system for tight glycemic control management in mechanically
ventilated, critically ill patients.
Acknowledgement Supported by MZO 00179906.
Reference
1. Aussedat B, et al.: Am J Physiol Endocrinol Metab 2000,
278:E16-E28.
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Lactate measurement by the capillary method in shocked
patients
O Collange, F Cortot, A Meyer, B Calon, T Pottecher, P Diemunsch
Strasbourg University Hospital, Strasbourg, France
Critical Care 2008, 12(Suppl 2):P169 (doi: 10.1186/cc6390)
Introduction Arterial blood lactate is a reliable indicator of tissue
oxygen debt and is of value in expressing the degree and
prognosis of circulatory failure. Compared with arterial measure-
ment, capillary lactate measurement is easier, faster, cheaper and
lowers the incidence of arterial puncture complications. Capillary
lactate measurement has been already validated to assess fetal
well-being. The aim of this study was to compare arterial and
capillary lactate in adult shocked patients.
Methods Consecutive shocked patients hospitalized in a university
hospital surgical ICU were simultaneously tested for arterial and
capillary lactate measurements. Arterial lactate was measured by
the usual method described by Marbach and Weil, capillary lactate
was measured using a micromethod device (Lactate Pro* LT1710;
Arkray, KGK, Japan). Lactate levels were compared by linear
regression, calculation of Pearson’s correlation coefficient R2 and
using a Bland–Altman plot.
Results In total, 60 simultaneous measurements of capillary and
arterial blood lactate concentrations were performed in 16 patients
with shock. A good linear correlation was found between capillary
lactate (CapL) and arterial lactate (ArtL) concentrations: CapL =
0.85ArtL + 1.61; r = 0.8 (P < 0.0001). The mean difference was
0.78 ± 2.3 mmol/l. See Figure 1.
Conclusions These preliminary findings suggest that capillary
lactate values could be used to assess the severity and guide
therapy during shock.
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Influence of Stewart acid–base variables on plasma pH in
critically ill patients
A Marcelli, L Bucci, A Pochini, L Errico, RA De Blasi, M Mercieri
Università La Sapienza di Roma, Rome, Italy
Critical Care 2008, 12(Suppl 2):P170 (doi: 10.1186/cc6391)
Introduction The study objective was to determine and quantify
the influence of strong-ion approach variables on the plasma pH in
critically ill patients.
Methods A retrospective analysis of clinical records for 284
consecutive patients admitted to the medical adult ICU of a
university hospital. Analysis was made of plasma acid–base data
for 5,172 blood samples collected at admission and throughout
hospitalization (one sample per patient). By substituting bicar-
bonate with the apparent strong-ion difference (SID), the weak
acid anionic component (A–) and unmeasured ions (UI) in the
Henderson–Hasselbalch equation, and after selecting samples
having at least one variable within the normal range, we determined
possible linear relationships between the study variables. We then
compared our results with those calculated using derivatives of the
simplified strong-ion equation.
Results In samples with normal UI and PaCO2, the SID had a
strong correlation with plasma pH (r2 = 0.84), yielding a δpH/δSID
ratio of +0.013 (strong-ion acidosis/alkalosis) (Figure 1). In
samples with normal SID and PaCO2, UI also correlated strongly
with pH (r2 = 0.69), yielding a δpH/δUI ratio of –0.014 (uncompen-
sated metabolic acidosis) (Figure 2). Hypoalbuminemia caused a
compensatory reduction in SID of about 3 mEq/l per g/dl, thereby
also influencing the pH (δpH/δalbumin ratio of –0.040). In samples
with normal SID and UI, PaCO2 correlated strongly with pH (r2 =
0.85), yielding a δpH/δPaCO2 ratio of –0.01 (pure acute respira-
tory acidosis/alkalosis) (Figure 3).
Conclusions The SID correlates strongly with changes in pH, thus
identifying a strong-ion acidosis or alkalosis. The changes in pH
related to the SID, total nonvolatile weak anions and PaCO2 in
critically ill patients almost match those calculated using the
Stewart’s simplified strong-ion equation.
Reference
1. Constable PD: J Appl Physiol 1997, 83:297-311.
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Value of postoperative C-reactive protein and leukocyte
count after elective thoracoabdominal aneurysm surgery
GB Brunnekreef1, E Scholten2, LJ Bras2, MA Schepens2, 
LP Aarts3, EP Van Dongen2
1University Medical Centre, Utrecht, The Netherlands; 2St Antonius
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Centre, Leiden, The Netherlands
Critical Care 2008, 12(Suppl 2):P171 (doi: 10.1186/cc6392)
Introduction There are many causes for a systemic inflammatory
response after thoracoabdominal aortic aneurysm (TAAA) repair.
The aneurysm itself, the surgical trauma, ischemia-reperfusion
injury and reactions to graft material can all cause an inflammatory
response. This makes it difficult to identify postoperative infection.
A PubMed search revealed no study on how to discern between
normal postoperative levels of inflammation and postoperative
infection after TAAA repair.
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Figure 2 (abstract P170)
Correlation between UI and pH (patients with normal SID and PaCO2).
Figure 3 (abstract P170)
Correlation between the PaCO2 and pH (patients with normal UI and SID).Figure 1 (abstract P170)
Correlation between the SID and pH (patients with normal UI and PaCO2).
S68
Methods In this prospective single-centre study we included 34
patients. They underwent elective surgical TAAA repair. Immuno-
compromised patients and patients using immunosuppressive
agents were excluded. C-reactive protein (CRP) levels and
leukocyte count were measured in the operating room and on
every postoperative day until discharge from the ICU, with a
maximum of 14 days. We also determined the occurrence of fever.
Results Five patients (15%) suffered a postoperative infection:
three pulmonary infections, one bacteraemia of unknown origin and
one patient suffered a septic period without positive cultures. In all
patients there was a postoperative rise in CRP with a maximum on
the second and third postoperative day. The median CRP was
229 mg/l on the second day and 221 mg/l on the third
postoperative day. CRP declined towards preoperative levels
during the first 2 weeks after surgery. The leukocyte count
continued to rise postoperatively to 13 x 109/l on day 14. There
was no correlation between fever or leukocyte count and infection.
In only three of five patients with postoperative infection was a
second rise in CRP noted.
Conclusions This study shows the CRP levels and leukocyte
count that can be expected in the ICU after TAAA surgery.
Surprisingly the leukocyte count continued to rise. This may be
caused by the fact that patients with infection tend to stay longer in
the ICU. The median CRP level on day 14, however, was only
22 mg/l. Not all postoperative infections caused a rise in the
already high CRP levels. So in some cases CRP, leukocyte and
temperature may be of no clinical value. Clinical evaluation
combined with positive cultures may be the only method to
diagnose postoperative infection in this group of patients.
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Role of inflammation in nonhemorrhagic strokes
H Michalopoulou, A Bakhal, J Vaitsis, D Nastou, 
N Stravodimou, D Pragastis
Metaxa Hospital, Athens, Greece
Critical Care 2008, 12(Suppl 2):P172 (doi: 10.1186/cc6393)
Introduction In recent years considerable interest has been
focused on the role of inflammation in the pathophysiology of acute
coronary syndromes. There are limited data, however, about its
participation in the pathogenesis of strokes. We investigated
whether inflammation markers are increased in the acute phase of
strokes.
Methods We studied consecutively 54 patients aged 55 ± 8 years
old (32 males) that were hospitalized in the ICU from June 2005 to
December 2007 with the diagnosis of nonhemorrhagic stroke
proven by computed (CT) or magnetic (MRI) tomography. Within
24 hours of their admission, C-reactive protein (CRP), IL-6 and
fibrinogen values were determined in all patients. Seventy patients,
who were comparable as regards their age and sex, were used as
a control group.
Results See Figure 1.
Conclusions Inflammation markers are increased in the acute
phase of ischemic strokes. Further studies are needed to show
whether this increase is secondary to or contributes itself in the
pathogenesis of ischemic strokes.
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Biomarkers that might improve prognostic accuracy in ICU
patients
M Karvouniaris, M Stougianni, A Tefas, D Lagonidis
General Hospital of Giannitsa, Thessaloniki, Greece
Critical Care 2008, 12(Suppl 2):P173 (doi: 10.1186/cc6394)
Introduction There is often a discrepancy between physician
prediction of mortality and clinical prediction scores, and the
accuracy of the latter is rather moderate. Nevertheless, it is
tempting to just measure a biochemical parameter – a biomarker –
to find prognostic information. Serum lipoproteins, for example, can
mirror inflammatory activity and prognosis as well.
Methods A prospective study of 29 patients that stayed in the ICU
for at least 4 days and had the following characteristics: age 62.28
± 16.92 years, length of stay in the ICU 15.55 ± 10.51 days and
APACHE II score 21.28 ± 7.83. C-reactive protein (CRP), total
cholesterol and high-density lipoprotein (HDL) were measured on
admission and on day 4 in the ICU. First, we correlated these
parameters with the length of stay in the ICU using Pearson’s
correlation method. Secondly, we compared the means between
survivors and nonsurvivors after 6 months with an independent-
samples’ t test. We finally performed receiver operating curves of
the above parameters according to mortality.
Results CRP both on admission and on day 4 was positively
correlated with length of stay in the ICU (P < 0.05). Mortality in
6 months was 18/29 (62%). According to the independent-
samples’ t test, statistical significance (P < 0.05) was only found
for CRP on admission. On admission, the values of areas under the
curve (AUC) were: CRP = 0.793, HDL = 0.667, total cholesterol =
0.604. Furthermore, on day 4 the values of AUC were: CRP =
0.629, HDL = 0.712 and cholesterol = 0.629. Using a cutoff CRP
value on admission of ≤0.87 mg/dl, there was a better chance of
survival with a sensitivity of 63.6% and a specificity of 94.44%
(95% CI = 72.6–99.1). In addition to that, a cutoff HDL value on
day 4 of ≥28.4 mg/dl predicts survival with a sensitivity of 63.6%
and a specificity of 83.3% (95% CI = 46.5–90.2).
Conclusions Serial measurements of CRP and HDL are both easy
to perform and can add prognostic information. On the other hand,
total cholesterol seems not to have any prognostic significance.
Reference
1. Schuetz et al.: Curr Opin Crit Care 2007, 13:578-585.
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Plasma C-reactive protein and albumin as predictors of
readmission to intensive care
N Al-Subaie, T Reynolds, R Sunderland, A Myers, P Morgan,
RM Grounds, A Rhodes
St Georges Hospital, London, UK
Critical Care 2008, 12(Suppl 2):P174 (doi: 10.1186/cc6395)
Introduction Readmission to intensive care is associated with
poor outcome. C-reactive protein (CRP) and low albumin are asso-
ciated with systemic inflammation, and this study aims to assess
their usefulness in predicting readiness for discharge from the ICU.
Methods An observational study based in a London teaching
hospital mixed medical/surgical ICU. Plasma CRP and albumin on
the day of ICU discharge and patients’ demographic and outcome
data were collected.
Results Seven hundred consecutive patients were identified, of
which 125 were excluded as they were not suitable for readmission.
Eleven patients did not have plasma CRP and albumin data on the
day of discharge or the outcome was unknown. Of the 564 patients
Critical Care    March 2008 Vol 12 Suppl 2 28th International Symposium on Intensive Care and Emergency Medicine
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included, 53.1% were males, the median age was 64 (16–97)
years and 38.1% were medical admissions. In the 55 patients who
were readmitted to the ICU (9.8%), there was a significant
difference in their median CRP (70.2 vs 128.4, P = 0.036) and
median albumin (19 vs 21, P < 0.001) compared with the remaining
patients. See Figure 1. The areas under the ROC curve for plasma
CRP and albumin are 0.583 and 0.313, which precludes use of this
biochemical marker as a useful predictor of readmission to the ICU
in our population.
Conclusions Plasma CRP and albumin are of limited clinical value
in predicting successful ICU discharge despite the significant
difference of their values in patients who were subsequently
readmitted to the ICU compared with the others. We are currently
validating these results by collecting the data prospectively.
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Role of the leukocyte antisedimentation rate in prediction
of early recognition of post-stroke infection
T Molnar, A Peterfalvi, L Bogar, Z Illes
University of Pecs, Hungary
Critical Care 2008, 12(Suppl 2):P175 (doi: 10.1186/cc6396)
Introduction Patients with stroke are more susceptible to bacterial
infections that indicate early immune responses, especially those
by leukocytes. The leukocyte antisedimentation rate (LAR), a
simple test to detect activation of leukocytes, was therefore serially
examined and correlated with high-sensitivity C-reactive protein
(hsCRP), S100b, procalcitonin (PCT) and outcome in patients with
acute ischemic events.
Methods Venous blood samples were taken serially for measuring
the LAR, S100b, hsCRP and PCT within 6 hours after the onset of
first symptoms (T0), at 24 hours (T24) and at 72 hours (T72). After
24 hours, enrolled patients were categorized into acute ischemic
stroke (AIS) and transient ischemic attack (TIA) groups, based on
clinical and imaging data. The LAR and hsCRP were also obtained in
61 healthy volunteers. For statistical analysis, the Wilcoxon test, Spear-
man correlation, ROC analysis and Mann–Whitney U test were used.
Results The LAR measured on admission (T0) was significantly
higher in patients with acute ischemic events (AIS, n = 38 and TIA,
n = 11) compared with healthy controls (median, IQR: 0.329,
0.212 vs 0.159, 0.218 vs 0.060, 0.069, respectively; P < 0.001,
P = 0.002). In addition, the LAR was significantly higher at T0 in
AIS patients compared with patients with TIA (median, IQR: 0.338,
0.204 vs 0.149, 0.168, P < 0.05). When the LAR was serially
analyzed in the AIS group, a significant decrease in the LAR at T24
was found in 10 patients complicated by post-stroke infections
(P = 0.028). The cutoff value of the LAR at T24 differentiating
patients with high risk of post-stroke infections was found to be
25.6% with a sensitivity of 81.5% and a specificity of 60% (AUC:
0.728, P = 0.035). The cutoff value of LAR24 for predicting poor
outcome (defined by Glasgow Outcome Scale ≤ 3) was found to
be 26.4% with a sensitivity of 84.2% and a specificity of 53%
(AUC: 0.728, P = 0.020). We also observed a positive correlation
between S100b and the LAR, hsCRP at 72 hours (P < 0.05).
Conclusions The simple LAR test was capable of separating
individuals with definitive ischemic stroke from those with TIA
within 6 hours after onset of symptoms and to select patients with
AIS at T24 who are at high risk for post-stroke infection. Our
results indicate a very early and rapid activation of innate immune
responses in stroke correlating with the size of infarct, and suggest
that lack of elevation in the LAR could be related to an increased
risk of infection due to a dysregulated activation of leukocytes.
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Identifying sepsis in the emergency room: the best clinical
and laboratory variables
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Introduction Early diagnosis, antibiotics and supportive therapy are
essential in sepsis. The diagnostic value of clinical and laboratory
variables were evaluated in a prospective observational study.
Methods A cohort of 404 adult patients admitted to the Department
of Infectious Diseases from the emergency room (ER) for suspected
severe infection was studied. A bacterial infection requiring antibiotic
treatment was diagnosed in 306 patients (pneumonia 130 patients,
urinary tract infection 80 patients, skin/soft tissue 43 patients, other
bacterial infections 53 patients). Nonbacterial infections or
noninfectious conditions were diagnosed in 82 patients. Significant
bacteremia was detected in 68 patients (most common isolates:
pneumococci 19, Escherichia coli 18, Staphylococcus aureus eight,
β-haemolytic streptococci seven). Physiological variables recorded
were temperature, heart rate, blood pressure, respiratory rate (RR),
oxygen saturation, urine output, cerebral status. Laboratory variables
were C-reactive protein (CRP), lactate, bicarbonate, creatinine, urea,
hemoglobin (Hb), white blood cells (WBC), neutrophils, platelets,
International Normalized Ratio, D-dimer, albumin, bilirubin, pro-
calcitonin (PCT), IL-6 and LPS binding protein (LBP).
Results The value of each variable in identifying patients with
bacteremic sepsis or bacterial infections requiring antibiotics was
evaluated. In a univariate analysis, PCT, IL-6, LBP, CRP, bilirubin and
maximum RR during the first 4 hours (RRmax 0–4 h) was significantly
associated with bacteremia with P < 0.001 and CRP, PCT, IL-6,
LBP, WBC, neutrophils, RRmax 0–4 h and Hb was associated with a
bacterial infection with P < 0.001. In a multivariate logistic
regression, PCT, RRmax 0–4 h, bilirubin and CRP each contributed
significantly to the accurate prediction of bacteremia. To predict a
bacterial infection, CRP, WBC, Hb and RRmax 0–4 h contributed
significantly. If patients with pneumonia were excluded, the RR still
contributed significantly to the prediction of bacteremia.
Conclusions The studied patients have a high level of suspicion of
a serious infection. The patients without bacterial infections often
have other inflammatory processes, sometimes mimicking sepsis.
This is indeed a challenging population for a diagnostic variable to
prove its value but also one where it would be most needed. The
results show that the RR is the best discriminatory physiological
variable and that PCT is best fitted to predicting bacteremia
whereas CRP best predicts bacterial infections.
P177
Procalcitonin, cytokine and NOx in diabetic ketoacidosis
S Suwarto, R Noer, M Oemardi, S Waspadji, K Inada
Ciptomangunkusumo, Jakarta, Indonesia
Critical Care 2008, 12(Suppl 2):P177 (doi: 10.1186/cc6398)
Introduction Procalcitonin (PCT), cytokine and NOx concentra-
tions are different in patients with systemic inflammatory response
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syndrome (SIRS) and sepsis. Diabetic ketoacidosis (DKA) is
frequently accompanied by SIRS, and inflammatory cytokines can
increase in the absence of infection. The aim of this study was to
determine PCT, IL-6, IL-8, IL-10 and NOx between patients with
SIRS and sepsis in DKA patients.
Methods Patients with DKA admitted to Dr Cipto Mangunkusumo
Hospital Jakarta, between 1998 and 1999, were retrospectively
reviewed. Plasma IL-6, IL-8, and IL-10 levels were measured by
commercially available kits based on ELISA. Nitrate and nitrite
(NOx) levels were measured by Griess reagent. PCT
concentrations were measured by the immunoluminometric
method (PCT LIA; BRAHMS Aktiengesellschaft GmbH, Germany).
Results Patients characteristic are presented in Table 1. Clinical
characteristics were similar in both groups. PCT and IL-6 on
admission were higher in septic groups compared with SIRS
groups. The mean of PCT was 0.1 ± 0.1 in SIRS groups and 26.5
± 25.9 in sepsis groups (P < 0.05). IL-6 in SIRS groups ranged
from 10 to 38 (median 24.7) and in sepsis groups ranged from
15.9 to 562.1 (median 46.2, P < 0.05). Serum IL-8, IL-10 and NOx
did not differ in both groups.
Table 1 (abstract P177)
Characteristics of 22 patients with DKA
SIRS Sepsis
Glucose 362.8 ± 49.5 372.9 ± 63.8
pH 7.2 ± 0.1 7.1 ± 0.2
Temperature 37.8 ± 0.8 37.7 ± 0.9
Leukocyte 16.7 ± 7.0 19.5 ± 8.0
Conclusions Most cases of DKA had signs of SIRS. PCT and IL-6
are a useful marker to differentiate between SIRS and sepsis in
ketoacidosis patients.
References
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reactive protein as early markers of sepsis in patients with
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Assessment of procalcitonin values in deep mycosis
associated with high β-D-glucan values
S Kikuchi, Y Suzuki, G Takahashi, M Kojika, N Sato, S Endo
Iwate Medical University, Morioka, Japan
Critical Care 2008, 12(Suppl 2):P178 (doi: 10.1186/cc6399)
Introduction Measurement of serum β-D-glucan values has come
into widespread use in routine clinical practice as a means of
diagnosing deep mycosis. We have previously reported on the
usefulness of measuring procalcitonin (PCT) as a means of diag-
nosing infections and sepsis and assessing the severity of
mycoses, and the fact that PCT values do not increase in deep
mycoses that are single infections.
Methods In the present study we made simultaneous measure-
ments of the PCT values of patients with hyper-β-D-glucanemia and
assessed the results.
Results Fungi were isolated from every patient by local or blood
culture. In 16 patients with β-D-glucan values of 100 pg/ml or more
it was also possible to continuously measure both β-D-glucan
values and PCT values, and six of them had β-D-glucan values that
exceeded 1,000 pg/ml. There were eight patients with fungal
infections alone, and all of them had PCT values below 0.5 pg/ml.
There were four patients with mixed infections caused by fungi and
Gram-negative bacteria, and three of them had PCT values of 0.5
pg/ml or more. There were also five cases of mixed infection by
fungi and Gram-positive bacteria, and in three of them the PCT
value exceeded 0.5 pg/ml. When there was a fungal infection
alone, the PCT value never rose, even when the β-D-glucan value
exceeded 1,000 pg/ml. No significant correlation was found
between the β-D-glucan values and the PCT values.
Conclusions Simultaneous measurement of β-D-glucan values and
PCT values was shown to be useful in making the differential
diagnosis between mycoses alone and mixed infections.
P179
Elevation of procalcitonin in chronic dialysed patients
H Brodska, K Malickova, A Kazda, J Lachmanova, J Uhrova, 
T Zima
University Hospital, Prague, Czech Republic
Critical Care 2008, 12(Suppl 2):P179 (doi: 10.1186/cc6400)
Introduction In some chronic dialysed patients, without signs of
infection, increased values of procalcitonin (PCT) are found. The
aim of our work was to determine the relations of PCT with other
markers of inflammation.
Methods Heparinized plasma of 35 chronically dialysed patients
without infection were analysed before and after 4 hours of
dialysis. Parameters were daily diuresis, diabetes mellitus (yes/no),
secondary hyperparathyroidism (yes/no), IL-10, IL-12 (flow cyto-
metry), calprotectin (spectrophotometry), PCT (ELFA; Brahms), C-
reactive protein (CRP) (turbidimetry; Modular). Statistics involved
the Spearman correlation coefficient and the nonparametric
Mann–Whitney test.
Results The PCT level was above 0.5 μg/l in seven patients and the
maximal value was 4.9. The median, lower and upper quartiles were
calculated before and after dialysis. During dialysis the values of PCT
were not statistically different; similarly the value of IL-10, IL-12, CRP
and calprotectin. Calprotectin was significantly elevated in
hemodialysed patients in comparison with blood donors (P < 0.001).
Reference ranges: IL-10, 10–35%; IL-12, 20–40%; calprotectin,
0–12 μg/ml; CRP, <7 mg/l; PCT, <0.5 μg/l. See Table 1
Conclusions No significant change of IL-10, IL-12 and of
calprotectin during dialysis indicates no activation of monocytes,
nor of polymorphonuclear cells. An elevated level of calprotectin
confirms chronic persisting inflammation. There was no correlation
between PCT and all other markers of inflammation. Elevation of
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Table 1 (abstract P179)
Markers of inflammation: statistical parameters
PCT PCT IL 10 IL 10 IL 12 IL 12 Calprotectin Calprotectin CRP CRP 
before after before after before after before after before after
Median 0.23 0.23 11.1 9.3 26.7 25.7 25 29.6 6.0 6.0
First; third quartiles 0.13; 0.375 0.11; 0.397 6.8; 21.9 4.4; 18 18.9; 38.6 14.7; 32.8 11.6; 41.1 18.2; 68.3 3.0; 26 3.0; 22
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PCT in chronic dialysed patients is not caused by infection systemic
inflammation. We also found no correlation of elevation of PCT with
diuresis, diabetes mellitus and secondary hyperparathyroidism.
P180
Role of procalcitonin in diagnostics of acute adrenal
insufficiency
K Popugaev, I Savin, L Astafieva, O Gadjieva, V Tenedieva
NN Burdenko, Russian Academy of Medical Sciences, Moscow,
Russian Federation
Critical Care 2008, 12(Suppl 2):P180 (doi: 10.1186/cc6401)
Introduction Acute adrenal insufficiency (AAI) with refractory
arterial hypotension (RAH) is a rare but life-threatening complica-
tion after neurosurgery. Clinical and laboratory diagnostics of AAI
are difficult and its treatment must be begun immediately. Hyper-
thermia, leukocytosis and increased C-reactive protein (CRP) are
commonly revealed in these patients. RAH and the other
abovementioned symptoms are also typical for patients with septic
shock onset. These delayed the timely beginning of adequate
therapy. We undertook a pilot study to elucidate the role of
procalcitonin (PCT) in diagnostics of AAI.
Methods RAH developed in three patients postoperatively: one
patient had an aneurism of the anterior cerebral artery, one patient
cavernoma of the midbrain, and one patient clival chordoma. After
hemodynamic insult, clinical blood analysis was performed. PCT
(LUMItest PCT; BRAHMS), CRP, electrolytes, glucose and cortisol
were investigated. X-ray investigation, urine and liquor examina-
tions were performed.
Results Patients had hyperthermia (>38°C), increased CRP
(>90 mg/l), leukocytosis (>11 x 109/l) in two patients and leuco-
penia in one case. Two patients had PCT < 0.5 ng/ml and
1–1.3 ng/ml (in 2 days after hydrocortisone administration, PCT
was 0 ng/ml). There were no revealed sites of infection.
Hyponatremia, normoglycemia and tendency to hyperkalemia were
founded. Cortisol was normal in two patients and low in one
patient. Patients received a stress dose of hydrocortisone with
sympathomimetics and infusion. The hemodynamics was stabilized.
In 2–3 days patients were weaned from the sympathomimetics.
There were no indications for antibiotics.
Conclusions PCT is normal in patients with AAI despite the
presence of hyperthermia, leukocytosis and increased CRP. The
results show PCT helps in timely diagnostics and treatment of AAI.
P181
Use of procalcitonin as an aid to antibiotic prescribing in
intensive care
A Fletcher, P Moondi
The Queen Elizabeth Hospital, Kings Lynn, UK
Critical Care 2008, 12(Suppl 2):P181 (doi: 10.1186/cc6402)
Introduction Procalcitonin (PCT) is increasingly used as a specific
marker for bacterial infection and sepsis. It has been shown to
increase the accuracy of sepsis diagnosis at an early stage. PCT
levels are low in viral infections, chronic inflammatory disorders or
autoimmune processes. PCT levels in sepsis are generally greater
than 1–2 ng/ml and often reach values between 10 and 100 ng/ml.
An audit was carried out to ascertain whether a change in antibiotic
prescribing occurred when PCT results were used in conjunction
with white cell count (WCC) and C-reactive protein (CRP).
Methods The audit was carried out over a 1-month period. All
patients with suspected infection had their WCC, CRP and PCT
measured. The consultant intensivist was blinded to the PCT result
and asked for their management plan on the basis of all other
blood tests and clinical assessment. The PCT result was then
revealed and the management plan was then re-evaluated.
Results A total of 100 PCT tests were carried out on 30 patients.
The PCT result did change management 26% of the time. The
PCT result led to an omission of antibiotics, which would otherwise
have been given in eight out the 30 tests. The PCT result also led
to continuation of antibiotics, which otherwise would have been
changed in 10 out of 16 tests. The number of continuations of
antibiotics was higher after PCT (65 post PCT and 52 pre PCT)
but this is related to the fact that 10 of these would have had
alteration of antibiotics. See Figure 1.
Conclusions The use of PCT had a useful role in changing
antibiotic prescribing in 26% of instances. Most commonly it leads
to patients not having antibiotics initiated or reducing the change in
antibiotics once started.
References
1. Tang et al.: Accuracy of procalcitonin for sepsis diagnosis.
Lancet Infect Dis 2007, 7:210-217.
2. Uzzan et al.: Procalcitonin as a diagnostic test for sepsis in
crtically ill adults. Crit Care Med 2006, 34:1996-1920.
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Procalcitonin to guide length of antibiotic therapy in
surgical intensive care patients
S Schroeder, M Hochreiter, T Koehler, T Von Spiegel
Westkuestenklinikum Heide, Germany
Critical Care 2008, 12(Suppl 2):P182 (doi: 10.1186/cc6403)
Introduction The development of resistance by infective bacterial
species is an encouragement for us to reconsider the indication
and administration of the available antibiotics. Proper recognition
of the indication and the correct duration of therapy are particularly
important for the use of highly potent substances in intensive care.
There has as yet been no clinical chemical parameter that is
capable of specifically distinguishing a bacterial infection from a
viral or noninfectious inflammatory reaction. It now appears that
procalcitonin (PCT) offers this possibility [1-3]. The present study
is intended to clarify whether PCT can be used to guide antibiotic
therapy in surgical intensive care patients.
Methods One hundred and ten patients in a surgical intensive care
ward receiving antibiotic therapy after confirmed infection or a
high-grade suspicion of an infection were enrolled in this study. In
57 of these patients a new decision was reached each day as to
whether the antibiotic therapy should be continued after daily PCT
determination and clinical judgement. The control group consisted
of 53 patients with a standardised duration of antibiotic therapy
over 8 days.
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Results Demographic and clinical data are comparable in both
groups. In the PCT group, however, the period of antibiotic therapy
is significant shorter compared with controls (5.9 ± 1.7 vs 7.9 ± 0.5
days, P < 0.001) without unfavourable effects on clinical outcome.
Conclusions The daily determination of PCT for intensive care
patients shortened the duration of antibiotic therapy. There were
no unfavourable effects on the outcome.
References
1. Christ-Crain M, Müller B: Swiss Med Wkly 2005, 135:451-460.
2. Harbarth S: Am J Respir Crit Care Med 2001, 164:396-402.
3. Oberhoffer M Clin Chem Lab Med 1999, 37:363-368.
P183
Validation of procalcitonin measurement to the side of the
stream bed as marking infection in intensive therapy
patients
M Vaisman, R Lima, C Filho, M Dourado, A Castro, H Torres, 
I Barbosa, D Castro, J Machado
Samaritano Hospital, Rio de Janeiro, Brazil
Critical Care 2008, 12(Suppl 2):P183 (doi: 10.1186/cc6404)
Introduction Elevation of the serum concentration of procalcitonin
(PCT) has been proposed as a marker of disease severity and is
associated with systemic infection. This association has led to the
proposed use of PCT as a novel biomarker for bacterial sepsis. We
sought to evaluate the PCT measurement with culture samples to
quickly ratify the sepsis and rapidly begin the use of antibiotics.
Methods Between September 2006 and March 2007 we
evaluated 82 blood samples from 82 patients – 48 males (80.33 ±
10.55 years old) and 34 females (81.17 ± 13.83 years old) – with
sepsis or SIRS in the adult ICU of a tertiary hospital. The PCT
levels were measured by a quantitative imunoturbidimetry method
(PCTL) in ng/ml (Lumitest PCT; Brahms, Germany) and the results
compared with a sample culture (blood, urine, tracheal secretion
and others).
Results With the cutoff of PCT levels at 2 ng/ml and positive or
negative sample cultures, the analysis found that sensitivity is 37%,
specificity is 92%, positive predictive value is 0.84, negative
predictive value is 0.40, positive likelihood ratio is 4.62 and
negative likelihood ratio is 0.68. With the cutoff of PCT levels at
0.5 ng/ml and positive or negative sample cultures, the analysis
found that sensitivity is 72%, specificity is 33%, positive predictive
value is 0.54, negative predictive value is 0.48, positive likelihood
ratio is 1.07 and negative likelihood ratio is 0.84.
Conclusions This preliminary analysis suggests that PCT can be
used to accurately early identify sepsis only at levels above 2 ng/ml
and then decide to rapidly begin the use of antibiotics. In patients
with PCT < 2 ng/ml we cannot use PCT to exclude the diagnosis of
sepsis. With the cutoff of 0.5 ng/ml we found the same result. Other
studies with more samples are necessary to confirm this conclusion.
Reference
1. Giamarellos-Bourboulis EJ, Mega A, Grecka P, et al.: Procal-
citonin: a marker to clearly differentiate systemic inflam-
matory response syndrome and sepsis in the critically ill
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Prognostic value of raised procalcitonin when combined
with routine biomarkers of sepsis among critically ill
patients
J Louw, T Veenith, P Moondi
Queen Elizabeth Hospital, Kings Lynn, UK
Critical Care 2008, 12(Suppl 2):P184 (doi: 10.1186/cc6405)
Introduction In sepsis the timing of treatment is vital in survival of
the patients. Procalcitonin (PCT) by itself cannot reliably differen-
tiate sepsis from other noninfective causes [1]. PCT, however, may
help to identify the critically ill patients with poor prognosis when
used in combination with other markers, such as C-reactive protein
(CRP) and white cell count (WCC). The aim of this retrospective
study was to look at prognosis of patients admitted to the ICU with
a raised PCT >10 ng/ml. A novel approach for prediction of
prognosis and severity may be to combine the biomarkers with
PCT.
Methods We looked at all the patients with a raised PCT (PCT
> 10 ng/ml), admitted to a general ICU in a district general hospital
over a period of 17 months. The total number of patients admitted
over this time was 976 (surgical patients 67% and medical
patients 33%) with a corresponding unit mortality of 16% and a
hospital mortality of 21%. The corresponding WCC and CRP were
noted. Our patients had similar SOFA and IPS scores so they were
comparable with each other.
Results The overall mortality of patients with a PCT > 10 ng/ml
was 28%, compared with our ICU mortality of 16%. When the
biomarkers are combined, the mortality of patients with all
biomarkers raised (> 3 markers – abnormal WCC, increased CRP,
increased PCT) was 30%. The mean length of stay in patients with
all biomarkers raised was 10.5 days, compared with the length of
stay in patients with an isolated marker of 6.5 days (isolated raise
of WCC or CRP).
Conclusions These results support the use of PCT as prognostic
marker in the critically ill, but also emphasize the role of CRP for
added accuracy in predicting mortality. The WCC seems to have
less significance as a predictive indicator. This may even be
important in an inpatient setting to identify the high-risk patients for
early intervention.
Reference
1. Tang et al.: Accuracy of procalcitonin for sepsis diagnosis
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Procalcitonin in elective colorectal surgery and its
predictive value for an early discharge of fast-track
patients
A Chromik1, W Uhl1, A Thiede2, H Reith2, U Mittelkötter1
1St Josef University Hospital, Bochum, Germany; 2University
Hospital of Würzburg, Germany
Critical Care 2008, 12(Suppl 2):P185 (doi: 10.1186/cc6046)
Introduction Procalcitonin (PCT) is regarded as a specific
indicator of bacterial infection. Infectious complications in patients
after colorectal surgery are a common cause of morbidity and
mortality. The aim of this study was to investigate whether PCT
could serve as a negative predictive marker for postoperative
complications, and whether in patients with elevated PCT levels a
preemptive treatment with the third-generation cephalosporin
ceftriaxone is superior to antibiotic treatment starting later on the
appearance of clinical signs and symptoms of infection.
Methods By screening 250 patients with colorectal surgery we
identified 20 patients with PCT serum levels >1.5 ng/ml on at least
two of the first three postoperative days. The remaining 230
patients were followed up for the occurrence of infectious
complications. The 20 patients with elevated PCT were included in
a prospective randomised pilot study comparing preemptive
antibiotic treatment with ceftriaxone versus standard treatment.
Results The negative predictive value of PCT for systemic
infectious complications was 98.3%. In patients receiving
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preemptive antibiotic treatment (ceftriaxone), both the incidence
and the severity of postoperative systemic infections were
significantly lower compared with those in a control group
(Pearson’s chi-squared test P = 0.001 and P = 0.007,
respectively). Major differences were also observed with respect to
the duration of antibiotic treatment and the length of hospital stay.
Conclusions PCT is an early marker for systemic infectious
complications after colorectal surgery with a high negative
predictive value. A significant reduction in the rate of postoperative
infections in patients with elevated PCT serum concentrations was
achieved by means of preemptive antibiotic treatment.
P186
Endotoxin adsorption method may affect serum
procalcitonin
T Ikeda, K Ikeda, T Ueno, S Suda
Tokyo Medical University, Hachioji Medical Center, Tokyo, Japan
Critical Care 2008, 12(Suppl 2):P186 (doi: 10.1186/cc6407)
Introduction When septic patients progress to endotoxin shock,
they present a high mortality rate. The mortality rate of septic patients
with multiple organ failure has been reported to be 30–80%. The
endotoxin adsorption method (PMX-DHP: Toray Industries, Inc.,
Tokyo, Japan) has been used for treatment of patients with severe
sepsis and septic shock primarily caused by Gram-negative
infections in Japan. We also reported that PMX-DHP removed
plasma endotoxin and improved hemodynamic parameters in clinical
trials [1]. The purpose of this study was to assess the changes of
procalcitonin (PCT) values during PMX-DHP.
Methods The retrospective study was carried out in our ICU. In
this study, 68 septic patients who had multiple organ failure due to
intra-abdominal infection were treated with PMX-DHP. Sepsis was
diagnosed according to the criteria of the ACCP/SCCM Consen-
sus Conference Committee. These patients were separated into
two groups: those who survived for at least 28 days after the start
of PMX-DHP therapy (S group; 49 patients), and those who did
not (nonsurvival group; 19 patients). Background factors and
inflammatory mediators were examined in each group. PCT was
measured by immunoluminometric assay before and after PMX-
DHP and 24 hours later. The luminometer used was an Autolumat
LB953 (Berthord, Bad Wildbad, Germany). Endotoxin (kinetic
turbidimetric method) was also measured just before and
immediately after PMX-DHP.
Results The 28-day survival rate was 72.1% (49 survivors, 19
nonsurvivors). The APACHE II scores were 22.0 ± 8.3 and 28.3 ±
7.0 and the Sequential Organ Failure Assessment scores were
9.1 ± 3.9 and 11.1 ± 2.8 in the survival and nonsurvival groups,
respectively, showing significantly higher scores in the nonsurvival
group. PCT before PMX-DHP in all patients was 59.1 ± 97.2
ng/ml and tended to decrease 54.7 ± 81.7 ng/ml after PMX-DHP.
PCT was 59.4 ± 109.4 ng/ml before PMX-DHP and significantly
decreased to 42.2 ± 67.4 ng/ml at 24 hours after PMX-DHP in the
survival group, but it did not change significantly in the nonsurvival
group. There was a significant correlation between endotoxin and
PCT (r = 0.527, P < 0.001).
Conclusions Our results may suggest that PMX-DHP can reduce
systemic inflammatory cytokines and serum PCT in the survival
group.
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Discriminative procalcitonin values for diagnosis of
systemic inflammatory response syndrome and sepsis in
the ICU
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Introduction No study has found a procalcitonin level that
distinguishes between systemic inflammatory response syndrome
(SIRS) and sepsis [1]. The goal of our study was to determine a
cutoff value of serum procalcitonin concentration for diagnosis of
SIRS and sepsis.
Methods In this prospective and observational study, we included
all patients admitted to the ICU. The procalcitonin level was
determined on day 0, day 2, day 4 and day 7 of hospitalization using
the immunoluminometric method (PCT-lumin; Brahms Diagnostica,
Berlin, Germany). Normal values are < 0.1 ng/ml. The detection limit
was 0.3 ng/ml. P < 0.05 was considered significant. Time points
were defined as the procalcitonin concentrations measured at
different times in all patients. Time points were associated with
SIRS, sepsis and septic shock (SS) according to the established
ACCP/SCCM consensus definition. Statistical analysis was
performed using SPSS software for windows version 10.
Results A total of 70 patients were included in our study. Two
hundred and sixty-five time points were categorized into three
groups (SIRS, sepsis and SS). The mean IGS II score was 32 ±
14; the mean APACHE II score 15 ± 7. The median procalcitonin
levels in the SIRS group and the sepsis + SS group were,
respectively, 0.325 and 1.115 ng/ml (P < 0.001). The area under
the ROC curve to distinguish the presence or absence of sepsis
was 0.745 (0.685–0.805). A cutoff value of 1.3 has a specificity
and a sensitivity of 89% and 45%, respectively. If we exclude
patient patients with SS, a cutoff value of 1.3 has the same
specificity (89%) and was less sensitive (58%). A cutoff value of
0.265 had a specificity of 58% and a sensitivity of 80%.
Conclusions According to these preliminary results a procalcitonin
level between 0.265 and 1.3 ng/ml cannot distinguish between
SIRS and sepsis. This can be explained by the fact that we
considered different time points in the same patients and by the
fact that we did not separate medical and surgical patients.
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Measurement of procalcitonin in bronchoalveolar lavage
and serum as early predictors in acute respiratory distress
syndrome
A Abdel Razek, E Abdel Moneim Arida, A Deghady
Alexandria Faculty of Medicine, Alexandria, Egypt
Critical Care 2008, 12(Suppl 2):P188 (doi: 10.1186/cc6409)
Introduction Procalcitonin (PCT) is a diagnostic for identifying
severe bacterial infections and reliably indicating complications
secondary to systemic inflammation. PCT levels increase in cases
of sepsis, septic shock and in severe systemic inflammatory
reactions. The early pathological features of acute respiratory
distress syndrome (ARDS) are generally described as diffuse
alveolar damage, which can be diagnosed by cytological
examination of bronchoalveolar lavage fluid (BAL) [1]. The aim of
this study was to evaluate the value of PCT measurement in BAL
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and serum in the early diagnosis, and to faciliate reliable follow-up
of the clinical course of ARDS.
Methods This study included 35 patients admitted to the Critical
Care Department at Alexandria Hospital. Patients were allocated
into two groups, the study group (25 cases) and the control group
(10 cases). A plain X-ray scan was performed, and the hypoxic
index (PaO2/FiO2) was calculated daily. PCT in BAL and blood
was measured on days 0, 3 and 6 from the diagnosis of ARDS in
the patient group using an automated immunofluorescent assay
(KRYPTOR BRAHAMS PCT). Disease severity was assessed daily
during the stay of the patient using the Acute Lung Injury Score
and the Multiple Organ Failure Score (MODS).
Results In the ARDS group the mean serum PCT was higher than
the control, 6.86 ± 3.34, and increased insignificantly after 3 days
to 8.06 ± 7.21 (P = 0.195) and after 6 days to 8.60 ± 9.49 (P =
0.232). On the other hand, there was no significant change
between the study and control groups for BAL PCT. There was a
significant direct correlation between serum PCT and the Murray
score on diagnosis of ARDS, on day 3 and day 6. All were
significantly higher in nonsurvivors, compared with survivors.
Conclusions Serum PCT is helpful in the diagnosis of ARDS, but
there was no significant change in the value of BAL PCT. A direct
correlation exists between serum PCT, the MODS and the Murray
score in ARDS patients.
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Introduction The ability to stratify patients with evidence of sepsis
and to determine appropriate ICU admission is often hampered by
inadequate history and a paucity of physical examination findings.
The literature is replete with multiple markers used to determine the
presence and severity of sepsis. Among the proposed biomarkers,
procalcitonin (PCT), C-reactive peptide (CRP) and recently the
endotoxin activity assay (EAA) have been proposed as tools to aid
in the diagnosis of sepsis from various etiologies. The purpose of
this current investigation is to compare baseline EAA levels with
PCT and CRP in their ability to correlate with ICU admission above
specified levels.
Methods This is a secondary analysis of a prospective
observational study of patients qualifying for early goal-directed
therapy for severe sepsis. Emergency department patients enrolled
were >18 years old, with at least two SIRS criteria and evidence of
infection. From a total of 95 patients (25 nonsevere sepsis and 70
severe sepsis (lactate >4 mmol/l)) who were enrolled, 92 had
complete data. Descriptive statistics are provided for ICU and non-
ICU patients. Non-normally distributed data for disposition and
values for EAA, PCT and CRP were analyzed by Spearman
correlation. An alpha level <0.05 was considered statistically
significant.
Results Mean EAA value for patients = 0.54 (SD = 0.23, n = 92),
PCT = 19.72 (SD = 54.82, n = 91) and CRP = 122.29 (SD =
94.14, n = 86). Based upon baseline values for EAA (>0.6), PCT
(>5 ng/ml) and CRP (>5 mg/l), no statistically significant
correlations were found between an elevated EAA, PCT or CRP
and ICU admission (P = 0.67, 0.16 and 0.67, respectively).
Similarly, the combination of EAA (>0.6) and lactate (>2.0 mmol/l)
did not correlate with a significantly higher rate of ICU admissions
(P = 0.86). When the maximum level of EAA was followed
throughout the first 72 hours of evaluation and treatment, however,
there was a trend towards higher ICU admission (P = 0.054).
Conclusions In this analysis, baseline levels of EAA, PCT and
CRP of patients with severe sepsis showed no statistically
significant correlation with ICU admission. Evaluation of the
maximum value of EAA did display a trend towards higher ICU
admission. Possible explanations of this discrepancy may point to
heterogeneity in infectious etiologies and presence of
comorbidities that complicate interpretation of biomarker data.
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Introduction The aim of the present study was to evaluate the
clinical utility of endotoxin activity (EAA) measurement in critically ill
septic shock (SS) patients.
Methods From January 2007 to August 2007 in an eight-bed
general ICU, we performed a prospective analysis of the EAA level
on 29 critically ill patients within 24 hours of SS diagnosis (CDC
criteria). The EAA level was assessed by a new and rapid assay
based on neutrophil-dependent chemioluminescence. The EAA
level (defined as low, intermediate and high, respectively, for values
<0.40, 0.40–0.60, and ≥0.6) was then correlated with severity of
illness and ICU mortality.
Results The clinical profile of SS patients is shown in Table 1. The
EAA level was low in a minority of SS patients (13%), and
intermediate and high EAA levels were evidenced in 31% and
56% of SS patients, respectively (Table 2). Our results seem to
evidence a good correlation between EAA levels and severity of
illness (Table 2). The EAA level seems to correlate with ICU
mortality, which was 0% in low EAA patients, and 17% and 37% in
intermediate and high EAA patients.
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Table 1 (abstract P190)
Clinical profile of septic shock patients
Age (years) 58.6 ± 16.4
PCR (mg/dl) 27 ± 10
VAM / CRRT 90% / 22.5%
SOFA / SAP SII 12.3 ± 3 / 47 ± 9
Gram-positive / Gram-negative 24% / 17%
Table 2 (abstract P190)
Endotoxin activity (EAA) level and severity of illness
EAA < 0.4 0.4 < EAA < 0.6 EAA > 0.6
MAP (mmHg) 86.8 ± 4.7 80.5 ± 5.8 79.3 ± 17.1
NEu (kg/min) 0.36 ± 0.21 0.43 ± 0.36 0.68 ± 0.53
Lac (mmol) 3.0 ± 1.5 3.9 ± 3.7 6.4 ± 5.8
SOFA 9.7 ± 5 10.1 ± 3. 12.6 ± 3.8
CI (l/min/m) 3.78 ± 1.26 4.16 ± 1.14 3.64 ± 2.10
S75
Conclusions Although our sample is too small to reach statistical
significance, the EAA level could be a good marker of severity in
SS patients. A high level of EAA seems to correlate with worse
prognosis in SS patients.
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Introduction Endotoxin scattering photometry (ESP) is a newly
developed endotoxin assay. The mechanism of ESP is the same as
for the turbidimetric method, which is a conventional endotoxin
assay in Japan; however, ESP enables one to detect a very small
amount of endotoxin within 1 hour. This is because ESP can detect
the clotting enzyme product coagulin, which is the first appearance
of limulus amebocyte lysate cascade evoked by endotoxin [1].
Methods For measurement of clinical samples of endotoxin with
ESP, three groups of patients were examined. The three groups
were normal healthy volunteers (n = 14), patients with elective
surgery (n = 10) and patients with sepsis (n = 19) who were
admitted to the ICU between February and September 2007.
Sepsis is defined by the American College of Chest Physicians/
Society of Critical Care Medicine as systemic inflammatory
response syndrome resulting from infection.
Results Using endotoxin measurement with ESP, the value was
higher in patients with sepsis (median, 20.7 pg/ml (interquartile
range, 5.1–64.1 pg/ml)) than in patients with elective surgery
(0.259 pg/ml (0.050–0.875 pg/ml)) and in normal healthy
volunteers (0.073 pg/ml (0.031–0.345 pg/ml)).
Conclusions Endotoxin could be detectable in every clinical
sample by ESP, even though the turbidimetric method could detect
positive for only 15% of patents with sepsis. These data suggest
the potential value of measuring endotoxin with ESP for hunting
down a hidden infection or an early manifestation for Gram-
negative infection.
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Introduction Anaemia is a common problem in critically ill patients.
The pathophysiology of anaemia involves altered iron metabolism
and impaired erythropoiesis. In this study we compared the iron
metabolism in septic and nonseptic patients on admission and
during their stay in the ICU.
Methods Sixty polytrauma patients under mechanical ventilation
were studied, 34 septic patients (Group I) and 26 nonseptic
patients (Group II). The mean age of all patients was 51 ± 19
years, APACHE II score 13 ± 6, ISS 24 ± 11, and the mean ICU
stay 25 ± 8 days. Blood samples were collected on admission, on
the 7th day or the day of the onset of sepsis, and on the 15th day,
and were tested for serum iron (Fe), ferritin (Ft), transferrin (Tf), and
soluble transferrin receptor (sTfR). The measured inflammatory
parameters were white blood cell count, C-reactive protein and
procalcitonin. Statistical analysis involved Student’s t test and
linear regression analysis.
Results In Group I the mean values were Fe 22 μg/dl (12–78), Ft
877 ng/dl (85–4,797), and Tf 128 mg/dl (61–212). In group II the
mean values were Fe 43 μg/dl (23–97), Ft 377 ng/dl (36–1,127)
and Tf 151 mg/dl (69–216). There was a statistical difference
between the two groups (P < 0.05). No difference was observed for
sTfR: 1.08 mg/dl (0.44–2.16) vs 0.94 mg/dl (0.6–1.49) between the
two groups. No correlation could be established between any of the
markers of the iron metabolism and the patient outcome. For all
patients C-reactive protein was weakly correlated with Ft (r = 0.43, P
< 0.001) and inversely with Tf (r = –0.39, P < 0.001).
Conclusions The iron metabolism is altered in patients who
develop sepsis in the ICU but this does not seem to outline patient
outcome.
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Introduction There are three forms of translocation phenomena in
sepsis: translocation in a proximal way to the small intestine, in the
lymphatic way to peritoneal exudates and lymphatic collectors, and
to the portal vein and hepatic circulation. Such factors of sepsis
evolution are called decompartmentalization. The aim of our study
was to investigate the prognostic value of several biochemical
markers in peritoneal exudates in abdominal sepsis.
Methods One hundred and four patients with general peritonitis
and abdominal sepsis were examined. According to the Consensus
Conference ACCP/SCCM (1992), the patients were divided into
three groups: the sepsis group (n = 34, the focus of infection and
two SIRS symptoms; APACHE II 5 ± 1; SOFA 1.0 ± 0.5); severe
sepsis (n = 50, sepsis + multiorgan dysfunction; APACHE II 15 ±
2; SOFA 4.5 ± 2.5); and septic shock (n = 20, severe sepsis +
vasopressor agents; APACHE II 25 ± 6; SOFA 7.6 ± 3.5). We
researched the markers of SIRS in blood serum and in peritoneal
exudates: TNFα (ELISA; DPC Biermann, Bad Nauheim, Germany),
IL-1 (ELISA, LIA; Sangtec Medical, Bromma, Sweden), lactoferrine
(Vector Best, Russia). The data were analyzed by t test, Fisher
criteria. P < 0.05 was considered statistically significant.
Results The sepsis group was characterized by a brief increase of
TNF and IL-1 levels in blood serum on the first day (mean ± SD:
TNF, 0.24 ± 0.1 pg/ml vs 0.1 ± 0.06 pg/ml; IL-1, 0.34 ± 0.12
pg/ml vs 0.1 pg/ml, significant). The severe sepsis group was
characterized by an increase of TNF and IL-1 levels in blood serum,
the considerable increase of TNF level in peritoneal exudates
(severe sepsis 0.56 ± 0.21 pg/ml vs sepsis 0.12 ± 0.08 pg/ml,
significance), and a significant increase of lactoferrine level in
peritoneal exudates. The septic shock group was characterized by
the low level of proinflammatory cytokines in blood serum, the
increase of the IL-1 level in peritoneal exudates (septic shock
0.78 ± 0.24 pg/ml vs severe shock 0.54 ± 0.25 vs sepsis 0.18 ±
0.09 pg/ml, significant), and the low concentration of lactoferrine in
peritoneal exudates.
Conclusions The nonfavourable outcome in abdominal sepsis was
associated with the increase of TNFα and IL-1 levels, and the
decrease of the lactoferrine level in peritoneal exudates.
Available online http://ccforum.com/supplements/12/S2
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Introduction To reduce the mortality rates of patients with sepsis,
rapid diagnosis and therapeutic decision are required. We have
therefore discovered the soluble CD14 subtype (sCD14-ST),
which is specific for sepsis and is elevated at an early stage during
the disease progression [1]. Additionally, we have been
researching a novel fusion protein, MR1007, which consists of the
modified light chain of interalpha inhibitor and the anti-CD14
antibody as an anti-sepsis agent.
Methods We developed an ELISA using two rat monoclonal
antibodies against N-terminal and C-terminal peptide sequences of
rabbit sCD14-ST, respectively, to determine sCD14-ST concen-
trations in rabbit plasma. Survival rates and the time course of
plasma levels of sCD14-ST, IL-6, and D-dimer were examined in a
rabbit cecal ligation and puncture (CLP) model. Blood bacterial
counts were also determined as colony-forming units.
Results The plasma sCD14-ST levels in seven dead animals
clearly increased at 2 hours or later together with blood bacterial
counts, reached the peak at 3 hours, and then gradually decreased
at 4–8 hours, whereas those in one surviving animal did not. The
induction phase was about 24 minutes and the half-life ranged
from 4 to 5 hours. Additionally, the plasma IL-6 and D-dimer levels
in dead animals clearly increased at 3 hours or later, whereas
those in one surviving animal did not. Intravenous administration of
MR1007 with an antibiotic, latamoxef sodium, following the
observation of increases in sCD14-ST levels and blood bacterial
counts, improved the survival and the plasma D-dimer levels in a
rabbit CLP model (n = 9, P < 0.05).
Conclusions Plasma sCD14-ST levels were elevated earlier than
IL-6 and D-dimer along with occurrence of blood bacteria in a
rabbit CLP model. Therapy with an anti-sepsis agent such as
MR1007 following the elevation of sCD14-ST improved the
outcome in the CLP model. These results suggest that sCD14-ST
is useful to determine the earlier initiation of anti-sepsis therapy.
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Introduction In the present study we investigated the early prog-
nostic value of the serum levels of the main proinflammatory and anti-
inflammatory cytokines and soluble cytokine inhibitors for mortality
and late complications such as sepsis and multiorgan failure (MOF)
in a well-defined population of patients with severe trauma.
Methods A total of 62 previously healthy immunocompetent
patients with severe multiple trauma (ISS > 16) admitted to the
Emergency Room and aged less than 65 years were included
during a period of 18 months. Sixty-four healthy individuals served
as controls. Sera for sequential cytokine determination from
patients were obtained on admission, 12 hours and 24 hours after
trauma. We used an ELISA kit for quantitative determination of a
wide spectrum of proinflammatory and anti-inflammatory cytokines
simultaneously (TNFα, IL-1β, IL-6, IL-10, sTNFR type I and type II,
IL-1ra and TGFβ). All patients were evaluated clinically and
microbiologically and were followed up for clinical outcome until
discharge from the hospital.
Results The patient characteristics (57 men and five women) were
age 34.51 ± 11.65 years and ISS 22.16 ± 12.43. They had a
mortality rate of 11.29%, MOF 22.58%, ARDS 8.06% and sepsis
33.87%. On admission, trauma patients had significantly higher
levels of IL-6, IL-10, sTNFRII, IL-1ra and TGFβ than did controls.
Among the various cytokines, IL-6 (admission, 12 hours, 24 hours)
and IL-10 (24 hours) were more closely related to the severity of
trauma and the ISS (P < 0.001). Elevated serum IL-6 (24 hours),
TGFβ (admission) and IL-1ra (24 hours) were associated with
intrahospital death, whereas higher levels of IL-6 (24 hours), IL-10
(24 hours), sTNFRI (24 hours), sTNFRII (12 hours and 24 hours)
and IL-1ra (24 hours) were detected in patients who developed
later sepsis and higher levels of IL-6 (admission, 12 hours and
24 hours), IL-10 (12 hours and 24 hours) and IL-1ra (12 and
24 hours) were detected in patients who developed later MOF. In
the multivariate analysis, higher values of IL-6 (12 hours and
24 hours) were detected in sepsis and MOF (P = 0.006 and P =
0.029, respectively). In addition a significant decline in IL-10 at
12 hours and 24 hours was observed in patients without sepsis
and MOF, as well as a decline in IL-1ra at 24 hours in survivors.
Conclusions The levels of IL-6 as well as a sustained IL-10 and
IL-1ra production may predict death and late complications as
early as into the first 24 hours following severe trauma.
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Introduction Dysregulation of innate immunity may contribute to
both the initiation and progression of acute respiratory distress
syndrome (ARDS) [1]. The deactivation of alveolar macrophages
(AMs), which is expressed by reduced HLA-DR surface molecules,
was associated with higher mortality rate in patients with acute
lung injury [2]. Our aim was to investigate the immune status in the
lungs and systemically in early ARDS, by evaluating the AM and
peripheral blood monocyte (PBM) HLA-DR expression.
Methods Forty-one mechanically ventilated patients, 34 with early
ARDS and seven without lung disease (control), were studied. On
the third day after the onset of ARDS, all patients underwent
fiberoptic bronchoscopy. Bronchoalveolar lavage fluid was
obtained, and, besides the cell differential analysis, evaluation of
AM HLA-DR expression was performed. At the same time,
peripheral blood samples were obtained for evaluation of HLA-DR
expression on PBMs. The three-step immunoperoxidase method
was applied using the streptavidin–biotin complex Kit and the
monoclonal mouse anti-human HLA-DR antigen. Levels of HLA-DR
Critical Care    March 2008 Vol 12 Suppl 2 28th International Symposium on Intensive Care and Emergency Medicine
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expression were determined from the percentages of cells with
positive cytoplasmic staining to the total number of cells.
Results Patients were characterized as having direct ARDS (group
A, 17 patients) and indirect ARDS (group B, 17 patients), respec-
tively. In both groups, percentages of polymorphonuclear cells and
lymphocytes were higher, while AM percentages were lower in
comparison with the control group. HLA-DR expressions on AMs in
both ARDS groups were lower than in controls (19.9 ± 11.4%
(group A), 32.1 ± 10.4% (group B) vs 56.4 ± 10.5% (control),
respectively; P < 0.05). AM HLA-DR expression in group A was
lower than in group B (P < 0.05). PBM HLA-DR expressions in
both ARDS groups were lower than in controls (38.06 ± 15.7%
(group A), 27.5 ± 12.6% (group B) vs 54.1 ± 15.4% (control),
respectively; P < 0.05). PBM HLA-DR expression in group B was
lower than in group A (P = 0.01).
Conclusions In early ARDS, HLA-DR expressions on AMs as well
as on PBMs were low. In direct ARDS, however, local immuno-
paralysis was more profound, while more intense peripheral
monocyte deactivation was observed in the indirect syndrome. The
understanding of the immune dysfunction in ARDS may allow the
assessment of novel treatments in an attempt to modify lung injury.
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Introduction Transforming growth factor beta (TGFβ) is a pleo-
trophic cytokine that promotes a CD4 Th1 response to infection.
We examined the gene expression of TGFβ by quantitative RT-
PCR in three study groups: 10 healthy controls, 15 patients with
Gram-negative bacteraemia but without severe sepsis, and 58
patients with severe sepsis.
Methods Blood samples were collected from healthy controls at
one time point. In bacteraemic patients, blood sampling was carried
out within 24 hours of the positive blood culture being reported. In
58 patients presenting with severe sepsis, blood sampling was
carried on day 1 of intensive care admission and on day 7 in
survivors. Mononuclear cells were isolated and TGFβ mRNA was
quantified using the technique of quantitative QRT-PCR. All values
are stated as the median and interquartile range. Between-group
comparisons were performed by Wilcoxon rank sum test.
Results TGFβ mRNA copy numbers were significantly reduced in
the bacteraemic group (1.99 x 106; 2.22 x 106–1.92 x 106)
compared with controls (3.8 x 106; 4.1 x 106–2.9 x 106), P = 0.01,
and was significantly reduced in the sepsis group (1.97 x 106;
2.8 x 106–0.76 x 106) compared with the control group, P = 0.009.
While median TGFβ copy numbers were similar in sepsis and
bacteraemia groups, 18 of 58 (30%) patients with sepsis had
TGFβ copy numbers less than the lowest of the bacteraemic group
(P = 0.02). In the sepsis group, 19 patients died. There was no
association between TGFβ mRNA copy numbers and outcome
measures such as mortality, the presence of shock after prolonged
sepsis, duration of vasopressor support, duration of mechanical
ventilation and duration of intensive care stay.
Conclusions The human host response to infection is related to a
distinct pattern of TGFβ gene transcription, with deficient TGFβ
gene transcription related to the occurrence of infection and onset
of septic shock rather than recovery from a shocked state or
survival. This information could be used to structure genomic
studies in sepsis and infection.
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Introduction Oxidative stress plays an important role in the course
and eventual outcome of a majority of patients admitted to the ICU.
Markers to estimate oxidative stress are not readily available in a
clinical setting. Recently, advanced glycation endproducts (AGEs),
compounds that accumulate with age and play an important role in
the development of end organ damage in several conditions, have
emerged as one of the very few stable end products of oxidative
stress. Skin autofluorescence (AF) is a validated marker of tissue
content of AGEs, and can be rapidly and noninvasively measured.
We hypothesized that AGEs, measured by AF accumulate in ICU
patients, are a prognostic factor for outcome.
Methods Skin AF was measured using an AGE reader in 40
consecutive ICU patients (with a small subgroup of five diabetic
patients), age >18 years. As a comparison, historical data of a non-
diabetic control group (n = 231) and a diabetic control group (n =
973) were also used to calculate age-adjusted AF levels (AF-adj).
Values are expressed as the median and interquartile range
(P25–P75). Differences between groups were tested by the Mann–
Whitney U test. P < 0.05 was considered statistically significant.
Results AF-adj values were higher in nondiabetic ICU patients
(0.333 (0.002–0.676)) than in nondiabetic controls (–0.070
(–0.290 to 0.240); P < 0.001). AF-adj values were also higher in
diabetic ICU patients (0.770 (0.566–0.892)), compared with
diabetic controls (0.000 (0.000–0.000); P < 0.001). No differences
in skin AF were observed between acute or planned admissions,
nor was skin AF related to severity of disease as estimated by the
APACHE II score, length of ICU and hospital stays or mortality.
Conclusions Acute AGE accumulation occurs in ICU patients,
probably reflecting oxidative stress. The group was too small to allow
any conclusions on the possible predictive value of skin AF for
prognosis for patients on the ICU. Further studies should reveal
whether AGE accumulation will be a useful parameter in ICU patients.
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Introduction The objective was to study the parameters of free
radical processes and cholesterol metabolism in sufferers with
severe multiple trauma (SMT).
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Methods The investigation included 77 persons. The patients
were divided into two groups in relation to the outcome of disease:
group I, nonsurvivors; group II, survivors. The concentrations of
lipid metabolic parameters, total antioxidant status (TAOS) and a
number of biochemical plasma parameters were determined on the
biochemical analyzer on days 1, 3, 5, 7 and 15. Very low-density
lipoprotein and low-density lipoprotein (LDL) cholesterols were
calculated. 8-Hydroxy-2-desoxyguanosine was determined using
the method of gel electrophoresis of isolated blood cells.
Results The study indicated normal levels of 8-hydroxy-2-
desoxyguanosine in group II in the early period after SMT. There
was a rise of this parameter on days 5 and 7 in group I. The TAOS
was decreased in comparison with the normal range in both
groups and has a tendency to decrease later. The level of total
cholesterol was decreased in both groups during the first week
after the SMT. A rise of total cholesterol occurred in group II on
day 15 (4.48 ± 1.81 mmol/l). At the same time, this parameter
remained decreased in group I. The content of LDL cholesterol in
the first week after trauma tended to increase in group II and to
decrease in group I. The study findings suggest that a level of LDL
cholesterol lower than 2.0 mmol/l during the first week after SMT
with a decreased (<3.2 mmol/l) level of total cholesterol are
unfavourable prognostic factors of disease. There was a reduction
of high-density lipoprotein cholesterol in the early period after
trauma. This parameter, however, tended to increase in group II
and to decrease in group I. There was a rise of GGT in group I,
although the total protein tended to decrease. Enhanced alkaline
phosphatase activity was observed in both groups, and on day 15
was in 1.5–2 times higher than the normal range.
Conclusions The dynamics of changes of total cholesterol, LDL
cholesterol, total protein, GGT and 8-hydroxy-2-desoxyguanosine
can be used as a prognostic factor in sufferers in the early period
after SMT.
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Introduction Free thiolic group (SH) and reactive oxygen
metabolite (ROM) determination could provide helpful information
on the balance between oxidative damage and antioxidant capacity
[1]. In previous work we reported the change of the relationship
between ROMs and SHs in a group of patients with severe sepsis
[2]. In this work we show the values of ROMs and SHs of patients
in the ICU divided into three groups according to the gravity of
sepsis to investigate a possible relationship between these
parameters and the clinical state.
Methods Sixty patients admitted to the ICU were divided into three
groups (sepsis, severe sepsis, septic shock). At least three
determinations of ROMs and SHs for patient were assayed in 2–3
weeks. Control cases: 20 surgical patients without complications.
The blood for ROM and SH determinations was drawn during
24 hours after surgery. SH groups were assayed in plasma by
Ellman’s reaction with spectrophotometric methods applied to an
automatic instrument (OLYMPUS AU 460) [3]. The plasmatic
ROM values were assayed by a DIACRON-Italia kit, applied to an
automatic instrument (OLYMPUS AU 640).
Results The results obtained show a significant reduction of both
plasma SHs and ROMs in the three groups according to their level
of sepsis. The analysis of variability (CV) of ROMs shows a clear
CV increase in the three groups of patients (CV 40–60%) in
comparison with the relatively low values in the control group (CV
20%). If the septic shock patients are divided in two groups
according to their ROM levels (lower and higher than 150 Ucarr),
the frequency of deaths in the group of low ROM values (12/20) is
decidedly higher than that observed in survivors patients during the
observation time (3/17).
Conclusions This last result suggests that plasma ROM levels
decrease significantly when the clinical situation gets worse, and
allows one to hypothesize a possible diagnostic use of this
parameter as a prognostic index.
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Introduction Although changes in lipoprotein levels occur in a
variety of inflammatory disorders, little is known about lipoprotein
metabolism among septic patients. This study investigated the
dynamics of plasma apolipoprotein A1 (apoA1), as well as other
inflammatory markers, in ICU patients with and without sepsis.
Methods Sixty patients (34 with sepsis and 26 without) on
mechanical ventilation, mean age 51 ± 19.6 years, mean ICU stay
24 ± 18.8 days, APACHE II score 13 ± 6.8, admitted directly to
our ICU were enrolled in our study. Three blood samples were
collected on day 0, on day 7 or the day of sepsis onset and on day
15 for the determination of plasma apoA1, C-reactive protein and
serum amyloid A levels by the nephelometric technique
(BNProSpec; Dade-Behring).
Results Among septic patients apoA1 levels decreased from
81.9 ± 28.3 on day 0 to 56.2 ± 16.0 mg/dl the on day of sepsis
onset (63.2 ± 14.4 and 50.6 ± 15.4 mg/dl for survivors and non-
survivors, respectively). On day 15, surviving patients demon-
strated increasing values (79.3 ± 16.4 mg/dl); the opposite was
true for nonsurvivors (30.3 ± 15.4 mg/dl on the third sample).
Among nonseptic patients, the apoA1 values corresponded to
92.8 ± 26.2 on day 0, 85.2± 19.3 on day 7, and 87.2 ± 20.9
mg/dl on day 15. Significantly different levels (paired Student’s t
test, P < 0.05) were detected between septic and nonseptic
patients on day 7 or on the day of sepsis onset, between surviving
sepsis and nonsurviving sepsis patients on the same day, and
between surviving sepsis and nonsurviving sepsis patients on day
15. C-reactive protein and serum amyloid A concentrations
showed no difference between patients who survived and those
who passed away (second or third sample).
Conclusions Among ICU patients with sepsis, the apoA1
concentrations decrease rapidly, but not in nonseptic patients. Low
apoA1 levels on the day of onset of sepsis appear to be a
predictive factor for adverse outcome.
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Introduction Although previous studies of severe sepsis (SS)
patients found coagulopathy quite common, little is known of
coagulopathy in infection with lesser degrees of illness severity.
Methods In a 28-center prospective cohort study (GenIMS) of
patients presenting to US emergency departments with community-
acquired pneumonia, we measured serum coagulation markers (INR,
partial thromboplastin time, platelets, antithrombin, D-dimer, factor IX,
prothrombin activator-inhibitor (PAI) and thrombin–antithrombin (TAT))
on emergency department presentation. We stratified the proportion
of subjects with abnormal values by illness severity (APACHE III),
subsequent development of SS, and 90-day mortality. We
hypothesized coagulation abnormalities would increase with illness
severity and be greater in those with poor outcomes.
Results Of 1,895 hospitalized subjects, 31% developed SS and
11% died by day 90. The proportion with abnormal initial coagulation
marker values increased with initial illness severity (Figure 1). Yet,
even among the least ill (APACHE III mean (SD), 31 (7); ICU
admission rate 6%), coagulation abnormalities were common. Day 1
percentage abnormal PAI and TAT were greater in those that
developed SS, while day 1 PAI, TAT, partial thromboplastin time, D-
dimer were more often abnormal in those dying by day 90. Many
subjects that either did not develop SS or died had evidence of
coagulopathy at presentation (see table in Figure 1).
Conclusions Coagulation abnormalities are common in hospitalized
community-acquired pneumonia patients, increasing with illness
severity and poor outcome. Abnormalities were seen even in the
least ill, however, and differences between groups were not large.
Therapeutic manipulation of coagulation in infection will probably
require a carefully titrated approach.
Acknowledgement Supported by NIGMS R01GM61992.
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Introduction This study evaluated anti-activated protein C (anti-
APC) antibody (Ab) development in drotrecogin alfa (activated)
(DAA) (recombinant human APC)-treated adult patients with
severe sepsis.
Methods Serum and plasma samples were collected for anti-APC
Ab testing from patients in the PROWESS, EVBF (ENHANCE
substudy), ADDRESS and XPRESS trials at baseline (BL) and on
days 14, 28 and 60 (except PROWESS). PROWESS and
ADDRESS were placebo-controlled studies. All patients in EVBF
and XPRESS were DAA-treated. An ELISA detecting anti-APC
IgA/IgG/IgM Abs (sensitivity: 0.26 μg/ml) was used to screen all
serum samples from patients who had a BL sample and at least
one post-BL sample. Confirmed positive samples (binding inhibited
≥50% with 50 μg/ml exogenous DAA) were titered by twofold
serial dilutions. IgG isolated from plasma of positive samples was
tested for neutralizing activity against DAA-induced prolongation of
aPTT. Positive anti-APC Ab was analyzed on an ‘as treated’ basis.
Results The proportions of patients who tested negative for BL
and positive for post-BL anti-APC Abs in all studies are presented
in Figure 1, and were similar in the DAA and placebo cohorts at
each sampling time. Twenty-five DAA patients and 24 placebo
patients had a negative BL but positive post-BL anti-APC Abs; all
were alive at day 28 and all but two in each group were alive at
hospital discharge, including all eight with positive neutralizing Abs.
No thrombotic events were reported. No relationship between the
titer of anti-APC Abs and neutralizing Abs was observed. In
PROWESS, no difference in markers of coagulopathy between
Ab-positive and Ab-negative patients was observed.
Conclusions The proportion of patients with anti-APC or neutra-
lizing Ab was low and was similar between the 1,855 DAA patients
and 1,493 placebo patients tested. No relationship between anti-
APC Ab development and adverse reactions was observed. There
was no evidence that the anti-APC Abs detected represented a
specific immune response to DAA therapy.
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Introduction Multicentre studies have demonstrated that early
infusion of recombinant human activated protein C (rhAPC) improves
survival of patients suffering from severe sepsis. The objective of this
study was to demonstrate the benefit of early infusion of rhAPC on
the number of years lost due to premature death (YLPD).
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Figure 1 (abstract P203)
Patients with negative BL and positive post-BL anti-APC Abs. *DAA
not given.
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Methods This case–control study included 146 patients suffering
from severe sepsis admitted to the ICU from January 2003 to
December 2006. Patients were divided into three groups based on
the initiation time of rhAPC after the diagnosis of severe sepsis:
Group I (GI): patients who received rhAPC within the first 24 hours
of severe sepsis (n = 53), Group II (GII): patients who received
rhAPC after 24 hours from diagnosis of severe sepsis (n = 41), and
Group III (GIII): patients with severe sepsis who did not receive
rhAPC (n = 52). Dependent variables included age, gender,
APACHE II score, and the number of organs with acute failure at the
time of admission, YLPD and mortality. Four follow-up time periods
were established: Time (T) I: from initiation of infusion to day 4 of
infusion of rhAPC, T2: from completion of infusion to day 8, T3: from
day 9 to day 30, and T4: from day 30 to the end of the study period
(December 2006). Descriptive statistics were performed to identify
the variable distribution. Chi-square analysis was used to determine
the association between mortality and therapy. The number of YLPD
was calculated according to conventional equations.
Results There were no differences between groups in age and
APACHE II score at admission. There were statistical differences
in the number of organs in acute failure; GI 2 (1–5), GII 3 (2–5)
and GIII 2 (1–4) (median, minimum and maximum) (P = 0.03). At
T1, mortality was 7.5% GI, 26.8% GII and 23.1% GIII (P = 0.03),
and YLPD were 81.82 years GI, 226.65 years GII and 189.6 years
GIII. Within T2, mortality was 4% GI, 23% GII and 7.5% GIII (P =
0.017), and YLPD were 20 years GI, 102.63 years GII and 54.89
years GIII. Within T4, mortality was 28.3% GI, 70.7% GII and
48.1% GIII (P = 0.000), and YLPD were 244 years GI, 529.7
years GII and 369.24 years GIII.
Conclusions Early infusion of rhAPC improves survival and
decreases the YLPD in patients suffering from severe sepsis.
P205
Extended drotrecogin alfa (activated) therapy in patients with
persistent requirement for vasopressor support after 96-hour
infusion with commercial drotrecogin alfa (activated)
J Dhainaut1, M Antonelli2, P Wright3, M Belger4, 
M Cobas-Meyer4, M Mignini4, J Janes4
1Cochin University, Paris, France; 2A Gemelli University, Rome,
Italy; 3Moses Cone Memorial Hospital, Greensboro, NC, USA; 4Eli
Lilly & Co. Ltd, Windlesham, UK
Critical Care 2008, 12(Suppl 2):P205 (doi: 10.1186/cc6426)
Introduction In the European Union, drotrecogin alfa (activated)
(DAA) is licensed (intravenous infusion, 96 hours) for adults with
severe sepsis with multiple organ failure. In the PROWESS trial,
DAA treatment was associated with significant mortality reduction
and more rapid improvement in cardiovascular function over 7 days
(decreased need for vasopressors). But 22% of DAA-treated
patients remained on vasopressors at end infusion. The primary
aim of this study was to investigate, in severe sepsis patients with
persistent vasopressor dependency at the end of 96-hour
commercial DAA treatment, whether continued administration of
DAA for up to a further 72 hours results in more rapid resolution of
vasopressor dependency compared with placebo (no DAA after
commercial DAA infusion). Secondary objectives were mortality,
biomarker changes, and safety.
Methods A multicentre, double-blind, randomized, placebo-
controlled study. Owing to slower than anticipated recruitment, the
planned sample size was reduced from 275 to 200.
Results Two hundred and one patients (64 centers, nine
countries) were entered, 199 randomized, 193 received study
medication for any length time (ITT population). There were
clinically relevant differences in baseline characteristics, with more
DAA patients having a cardiovascular SOFA score of 4 compared
with placebo (78.7% vs 64.3%, P = 0.03), having higher median
doses of norepinephrine (0.26 μg/kg/min vs 0.16 μg/kg/min, P =
0.03) and tending to have lower protein C levels (66.8% vs 72.9%,
P = 0.23). There was no statistically significant difference for
primary endpoint resolution of vasopressor dependency (log-rank
P = 0.42), nor in the proportion of resolvers (34.0% DAA vs
40.4% placebo, P = 0.36). Day 28 mortality was 39.8% in the
DAA group, 32.3% in the placebo group (P = 0.28). The DAA
group had significantly lower percentage change in D-dimers
(21.9% vs 63.2%, P < 0.001), driven primarily by a larger increase
in the placebo group. By end infusion, protein C levels were similar
(81.7% DAA vs 79.4% placebo, P = 0.23). One serious bleeding
event occurred during the infusion period in each group.
Conclusions Continued DAA for up to a further 72 hours after
commercial drug administration did not result in more rapid resolution
of vasopressor-dependent hypotension, despite anticipated effects on
D-dimer and protein C levels, and was associated with an acceptable
safety profile. The reduction in the planned sample size combined with
baseline imbalances in protein C levels and vasopressor requirements
may have limited our ability to show clinical benefit.
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Introduction Drotrecogin alfa (DA) is an effective treatment in
sepsis-induced MODS. Optimum duration of treatment is 96 hours
of infusion. It is unclear whether stopping DA before 96 hours, in
patients in whom organ dysfunction rapidly resolves, ultimately
affects the 30-day mortality. We performed a prospective study to
evaluate this concept.
Methods We evaluated patients with severe sepsis having three or
more organ failures (OF) who received DA within 24 hours of
onset. We stopped DA before completion of 96 hours of infusion,
assuring complete resolution of OF. All of these patients were
monitored for reappearance of OF until discharge from hospital.
Results Six patients with APACHE II score 25 ± 1.89 were
evaluated. All six patients recovered completely from MODS and
were discharged to home. Reappearance of OF was not seen in
any of them. See Table 1.
Conclusions DA can be safely stopped before 96 hours in
patients who show rapid reversal of organ dysfunction.
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Patient data
APACHE Shock ARDS Duration of ICU 
Patient II reversal reversal drotrecogin stay 
number score (hours) (hours) alfa (hours) (days)
1 28 70 48 72 16
2 25 No shock 66 72 7
3 23 48 20 76 8
4 23 56 70 72 6
5 25 76 40 76 9
6 26 56 100 90 10
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Introduction Both plasminogen activator inhibitor-1 (PAI-1) and
soluble E-selectin (sES) are substances activated by cytokines under
strong inflammation. PAI-1 is a rapid inhibitor of tissue plasminogen
in vivo. PAI-1 is known as one of the markers of systemic
inflammatory response syndrome, which is followed by multiple
organ dysfunctions. sES is an adhesion molecule that is expressed
from endothelial cells activated by TNF. It is reported that elevation of
sES is followed by respiratory failure, which causes acute respiratory
distress syndrome. But it is not clear whether their plasma levels
affect the mortality and morbidity of critically ill patients. We therefore
divide patients into two groups by the plasma levels of PAI-1 and s-
ES and evaluate the mortality respectively.
Methods We compared the levels of PAI-1 and sES in survivors with
those in nonsurvivors. We examined 29 patients admitted to our
surgical ICU in the hospital of Kagoshima University. High levels of
PAI-1 are known to be accompanied by hemorrhage after surgery.
To evaluate, we therefore use the values of PAI-1 and sES on the
admission day (day 1), day 2 and the day when hemorrhage is
controlled. The plasma levels of PAI-1 and sES are measured by the
latex agglutination assay with an automatic analyzer (LPIA-NV7;
Mitsubishi Kagaku Iatron Co., Tokyo, Japan). For statistical analysis, a
two-sided Fisher exact probability test was used to analyze the
difference in the mortality. P < 0.05 indicated statistical significance.
Results Among the patients examined, 11 patients showed
elevated tPAI levels (>50 ng/ml) (PE group) and 18 patients
showed normal tPAI levels (≤50 ng/ml) (PN group). Fourteen
patients showed elevated sES levels (>30 ng/ml) (EE group) and
15 patients showed normal sES levels (<30 ng/ml) (EN group).
Mortality is significantly higher in the PE group (9/11, 81.8%) and
EE group (8/14, 57.1%) than in the PN group (1/18, 5.5%) (P <
0.0001) and EN group (2/15, 13.3%) (P < 0.0209), respectively.
Conclusions Both the levels of PAI-1 and sES are useful for
evaluating prognosis of critically ill patients in the surgical ICU.
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Introduction Severe burn injury is characterized by the activation
of coagulation, decreased fibrinolytic activity and decreased
natural anticoagulant activity. The aim of our study was to investi-
gate the effect of antithrombin administration on the coagulation
status and on organ function in the early postburn period.
Methods Thirty-one patients admitted to the burn ICU were
randomized into two groups, antithrombin-treated (n = 15) and
control (n = 16), for four consecutive days after thermal injury. The
clinical data, coagulation parameters and fibrinolysis parameters
were compared and the adverse effects were monitored.
Results Significant differences in the time trend of D-dimers and
thrombin–antithrombin complexes were observed between anti-
thrombin-treated and control groups (decrease in the antithrombin-
treated group and increase in the control group). According to the
International Society on Thrombosis and Hemostasis criteria,
disseminated intravascular coagulation (DIC) diagnosis was set for
28 from 31 patients. The presence of overt DIC was associated with
mortality (P = 0.002). The Sequential Organ Failure Assessment
score time trend differed significantly between the two investigation
groups (decreased in the treated group and did not change in the
control group). Antithrombin-treated patients had an absolute
reduction in 28-day mortality of 25% compared with the control
group (P = 0.004). No treatment-related side effects were observed.
Conclusions Treatment with antithrombin seems to affect the
coagulation status and to reduce multiple organ failure incidence
and mortality in the early postburn period.
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Introduction Thromboembolic events have been reported in
marathon athletes during competition. We tested the hypothesis
that activation of coagulation and platelets depends on the type of
endurance sport and running fraction.
Methods After ethic committee approval, 68 healthy athletes
participating in a marathon (MAR, running 42 km, n = 24), a
triathlon (TRI, swimming 2.5 km + cycling 90 km + running 21 km,
n = 22), and long-distance cycling (CYC, 151 km, n = 22) were
included in the study. Blood samples were taken before and
immediately after competition. Rotational thrombelastometry was
performed (ROTEM; Pentapharm, Germany). The coagulation time
(CT) and maximum clot firmness (MCF) after intrinsic activation
was assessed. Platelet aggregation was tested using a multiple
platelet function analyzer (Multiplate; Dynabyte, Germany) by
activation with ADP as well as thrombin-activating peptide 6 and
expressed as the area under the curve (AUC). Statistics used the
Wilcoxon signed rank test, P < 0.05.
Results Complete datasets were obtained in 59 athletes (MAR: n =
21, TRI: n = 19, CYC: n = 19). The CT significantly decreased in
MAR (from 172 ± 15.3 s to 155 ± 18.3 s), TRI (from 168.1 ± 12.9
s to 154.2 ± 11.3 s), and CYC (from 164.7 ± 17.7 s to 152.5 ±
13.0 s) without differences between groups. In parallel, the MCF
increased in all groups (MAR: from 58.1 ± 3.9 mm to 62.4 ± 3.8
mm, TRI: from 56.1 ± 3.2 mm to 59.5 ± 3.1 mm, CYC: from 59.3 ±
5.0 mm to 64.2 ± 4.2 mm). Platelets were only activated during the
MAR and TRI, however, as indicated by an increased AUC during
TRAP activation in the MAR (from 919 ± 149 to 1,074 ± 290) and
an increased AUC during ADP activation in the MAR (from 532 ±
184 to 827 ± 262) and TRI (from 505 ± 205 to 799 ± 329).
Conclusions As shown before, coagulation is activated during
physical activity. We observed significant platelet activation during
a marathon and to a lesser extent during a triathlon. We conclude
that prolonged running may increase platelet activity. Moreover, we
speculate that direct mechanical stress during running contributes
to the observed effect. Running therefore activates both coagula-
tion and platelet activity, resulting in an increased risk of thrombo-
embolic incidents in running athletes.
Reference
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rinolysis 2007, 18:435-440.
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Introduction Abnormal platelet counts are common findings in ICU
patients. Thrombocytopenia is associated with a poor outcome [1].
Conversely, thrombocytosis may be associated with an improved
outcome [2]. We therefore conducted a retrospective observa-
tional study in our own unit to investigate this further.
Methods All patients admitted to the ICU of a large district general
hospital (Royal Cornwall Hospital) from January 2002 to April
2005 were included in this retrospective study. We collected data
on age, sex, admission category, platelet count, APACHE II score,
APACHE II predicted mortality, and hospital mortality. The platelet
value was taken as the lowest platelet count obtained within the
first 24 hours of ICU admission. The primary outcome was hospital
mortality. Statistical analysis was conducted with SPSS version
15.0 using logistical regression models.
Results A total of 1,767 patients were admitted during the study
period. We excluded 119 patients with no recorded platelet data.
We found a strong negative correlation between the admission
platelet count and mortality, which was significant (P = 0.001,
logistic regression). To test this relationship with actual hospital
mortality we divided the cohort into deciles of platelet count and
plotted the data against mortality. Those with platelet counts below
67 had a mortality rate of 57.2%. This was substantially higher then
the remaining deciles (P = 0.0001, Fisher’s exact test). We did not
demonstrate any significant reduction in mortality in patients with
thrombocytosis (P = 0.523, Fisher’s exact test). We compared
medical versus surgical patients and found that, for any given
platelet value, the predicted outcome for surgical patients was
better (P = 0.008, t test). We analysed a model that included
platelets as an additional indicator for outcome. In binary logistic
regression analysis there was a significant association between
platelet count and mortality (coefficient = 0.998, CI = 0.996–
0.999). This association remained significant in a multiple logistic
regression model, which included APACHE II (P < 0.001). A
model including both APACHE II and platelet count improved the
proportion of deaths correctly predicted from 69.5% with
APACHE II alone to 71.3% with platelets included.
Conclusions We confirmed previous findings that there is a
correlation between low platelet counts and adverse outcome, and
we have further demonstrated that the correlation between platelet
count and predicted mortality exists across the spectrum of platelet
values. In addition we have demonstrated a difference in mortality
between medical and surgical patients for any given admission
platelet values. Finally, we have demonstrated that platelet values
provide additional prognostic information above the APACHE II score.
References
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Introduction Animal studies of acute lung injury (ALI) suggest
nebulized heparin may limit damage from fibrin deposition in the
alveolar space and microcirculation. We therefore undertook a trial
to assess the safety and tolerability of nebulized heparin in patients
with ALI.
Methods An open-label phase 1 trial of four escalating doses of
nebulized heparin was administered over 2 days. A total of 16
ventilated patients with ALI were studied. Each dose was assessed
in four patients. The first group was administered 50,000 U/day,
the second 100,000 U/day, the third 200,000 U/day and the
fourth 400,000 U/day. We measured the arterial to inspired oxygen
ratio (PaO2/FiO2), lung compliance, the alveolar dead space
fraction, the blood thrombin clotting time and the activated partial
thromboplastin time (APTT). Bronchoalveolar lavage (BAL) fluid
was collected and the prothrombin fragment and tissue plasmino-
gen activator levels assessed.
Results There was no difference between groups in the
PaO2/FiO2, lung compliance or the alveolar dead space fraction
over the study period. A trend to reduced prothrombin fragment
levels in BAL fluid was present with higher doses of nebulized
heparin (P = 0.1). Nebulized heparin did not increase tissue
plasminogen activator levels in BAL fluid. A trend to increased
blood thrombin clotting time and APTT levels was present with
higher doses of nebulized heparin (P = 0.1 and P = 0.09,
respectively). For the highest dose, the APTT reached 64 seconds.
Conclusions Nebulized heparin can be administered safely to
ventilated patients with ALI. At higher doses, nebulized heparin
may limit coagulation activation in the lungs and increase systemic
APTT levels.
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Introduction Thromboelastography (TEG) is a point-of-care
monitoring tool that could help in managing coagulopathy in the
critically ill. This may be beneficial in reducing the length of stay in the
ICU, guide blood product transfusion and improve patient outcome.
Methods We conducted a retrospective analysis of the use of TEG
in a busy district general hospital ICU. We included all 100 patients
in whom TEG was performed over 1 year. They required >4 units
blood intraoperatively or >2 units blood on the ICU, abdominal
aortic aneurysm repair or had sepsis. TEG was performed on 212
occasions, in parallel with routine coagulation studies.
Results We transfused 656 units of packed RBCs, 27 units of
cryoprecipitate, 180 units of FFP and 130 units of platelets,
incurring an expenditure of £722,682. The cost of running TEG for
that year was £1,845. Two hundred and twelve clinical decisions
were made following TEG along with clotting results. We identified
174 (82.08%) abnormal TEG results, of which 88 (50.57%) were
accompanied by abnormal clotting. One hundred and eighty-seven
(88.21%) clinical decisions were influenced by the TEG result. In
this group, 171 (91.44%) were related to guiding transfusion of
blood products. Fifteen (8.02%) resulted in a change of medical
management, guiding activated protein C administration, renal
replacement therapy, invasive procedures and starting secondary
anticoagulation prophylaxis.
Conclusions Standard coagulation assays do not provide any
information on platelet function or fibrinolysis [1]. TEG can replace
clotting studies and the assessment of platelet function [2]. TEG
can guide blood product transfusion in cardiac surgery [1]. TEG
can be done with a fraction of the total costs of transfusion and
provides confidence during the management of coagulopathy.
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Ongoing research should focus on establishing clear guidelines for
the appropriate use of the thromboelastograph.
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Introduction Preeclamptic conditions are often associated with a
natural inhibitor consumption. Many studies have evidenced validity
of antithrombin (AT) treatment during preeclamptic conditions. The
aim of the study is to restore a congruous coagulation imbalance
with administration of AT under the guide of thromboelastographic
monitoring (TEG).
Methods Ten preeclamptic pregnant women in the 24th–30th
weeks with diastolic blood pressure >90 mmHg and urinary protein
level 24 hours >0.3 g were included. All patients were submitted
to a complete study of coagulation function: prothrombin time (PT),
activated partial thromboplastin time (aPTT), International
Normalization Ratio (INR), fibrinogen C, D-dimer, AT and TEG at
the beginning, after every administration of AT, weekly until
caesarean section, and daily for 1 week in the postoperative
period. AT was administered every time the AT plasmatic level was
less than 80% to restore the plasmatic level to more than 120%
using the following algorithm: (120% – AT plasmatic level) x kg. At
the beginning, only seven patients were treated with AT.
Results At the beginning, all patients showed AT consumption and
a hypercoagulation TEG (Figure 1), but the INR and aPTT were in
the normal ranges. Patients treated with AT at the beginning did
not need a new administration. The remaining patients were
treated at the 31st, 33rd and 34th weeks, respectively. In all
patients, AT administration determined a normalization of TEG
without any modification of the PT and aPTT or bleeding. All
patients were submitted to caesarean section between the 36th
and 39th weeks.
Conclusions AT administration could play a central role in
preeclampsia treatment. TEG monitoring evidenced, in real time,
coagulation changes that common laboratory tests could not
show.
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Introduction Thrombocytopenia is inversely related to survival in
critical care patients [1]. The objective of the present study was to
evaluate the prevalence of thrombocytopenia in patients of an ICU
and to determine whether it might be a significant predictor of
outcome.
Methods A prospective observational cohort study was performed
from April to September 2007 in a 24-bed medical–surgical ICU.
All patients admitted to the ICU during the period of observation
were included in the study. Patients were prospectively studied until
14 days from admission, discharge from the ICU, or death. Patients
who had thrombocytopenia on admission or spent less than 48
hours in the ICU were excluded from the patient population.
Results During the period of observation, 215 patients were
admitted to the ICU (57.5% male), with a median age 65.0 years
(IQR 54–77) and APACHE II score 14.0 (IQR 10.0–19.0). One
hundred and seventy-six subjects (81.9%) were alive after a 14-
day follow-up. Seventy patients (32.6%) developed thrombocyto-
penia during the study. Patients who ever developed thrombocyto-
penia had a higher ICU mortality (28.6% vs 13.0%, respectively;
P < 0.006) and a higher consumption of blood products (24% vs
2%, P < 0.0001). However, both groups had the same APACHE II
score (15.15 ± 6.1 vs 15.15 ± 7.2, P = 0.99) and ICU stay (8.2 ±
7.1 vs 8.4 ± 12.8, P = 0.93).
Conclusions Even in an ICU sample with a low risk of death
predicted by the APACHE II score, thrombocytopenia was highly
associated with higher mortality and consumption of blood
products.
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Introduction One of the causes of obstetric hemorrhages is toxicosis
in the second half of pregnancy accompanied by a chronic form of
disseminated intravascular coagulation syndrome, hypercoagulation
and increased aggregation activity of platelets.
Methods To assess the functional state of the hemostasis system
we used our devised test with local ischemia of the upper
extremity. The analysis of the coagulation, vascular and thrombo-
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Figure 1 (abstract P213)
Thromboelastographic monitoring at admission.
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cytic components of hemostasis and fibrinolysis was made on the
basis of parameters of the blood aggregate state obtained using
the method of haemoviscoelastography.
Results We examined 30 healthy pregnant women in the age
range 20–31 years (control group), and 30 pregnant women with
revealed late toxicosis of different severity degree (nephropathy of
II degree, 10 women; nephropathy of III degree, 20 women). While
analyzing the functional state of the hemostasis system in healthy
pregnant women we distinguished two types of response to the
test: compensated type (1) in 30% and subcompensated type (2)
in 70%. The pregnant women suffering from late toxicosis were
registered to have a subcompensated type of the hemostasis
system response (3) in 20% of cases and a decompensated type
(4) in 80% of cases. The functional test in group 1 resulted in
decreased aggregation activity of platelets, reduced activity of the I
and II phases of blood coagulation (elevation of r and k) and
activation of the fibrinolytic system. Group 2 is noted to have
enhanced aggregation activity of platelets, enhanced thrombin
activity and acceleration of the thrombin formation and activation of
II and III coagulation phases. The total fibrinolytic blood activity was
reduced by 42%.
Conclusions Late toxicosis is therefore accompanied by changes
in the hemostasis system, causing exhaustion of compensatory
potentials of the regulation system of the blood aggregate state
and promoting a high risk of thrombohemorrhagic complications
during delivery and in the postpartum period.
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Introduction Endothelial cell activation and injuries are important
causes of multiorgan failure. Altered fibrinolysis promotes fibrin
deposition and may create microvascular alterations during
inflammation. C-reactive protein (CRP) is correlated with an
increased risk of MOF [1] and CRP may inhibit fibrinolysis [2]. We
aimed to determine whether plasma fibrinolysis is related to the
SOFA score and von Willebrand factor (vWF antigen), as a marker
of endothelium dysfunction, in critically ill patients at ICU admission.
Methods A cross-sectional study in an adult medicosurgical ICU.
Patients were 49 consecutive patients (31 nonseptic and 18
septic). Plasma fibrinolysis was assessed by the euglobulin clot
lysis time (ECLT) at ICU admission [3].
Results The ECLT was significantly longer in septic than in nonseptic
patients (1,219 ± 574 min versus 701 ± 224 min, P = 0.001).
Significant correlation between the ECLT and CRP (R = 0.67, P <
0.001) and between the ECLT and SOFA score (R = 0.36, P =
0.009) were observed. CRP was weakly correlated with vWF (R =
0.29; P = 0.04). The vWF was not correlated either with the ECLT
(R = –0.06, P = 0.65) or the SOFA score (R = –0.02, P = 0.88).
Conclusions The ECLT measurement could be a marker of organ
dysfunction and a prognosis factor in critically ill patients. Further
studies with measurement of plasma fibrinolysis by the ECLT
should be investigated in ICU patients.
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Introduction Despite the evidence of perioperative hypercoagula-
bility in cancer patients, there are no consistent data evaluating the
extent, duration, and specific contribution of platelets and
procoagulatory proteins by in vitro testing. This study compared
the efficacy of haemoviscoelastography (HVG) versus thrombo-
elastography (TEG) for monitoring coagulation imbalance.
Methods In 108 patients undergoing surgery for abdominal cancer
we examined the efficacy of a variety of coagulation tests. A
complete coagulation screening, TEG and HVG were performed
before and at the end of surgery.
Results We calculated the elastic shear modulus of standard
maximum amplitude (MA) (Gt) and HVG MA (Gh), which reflect the
total clot strength and procoagulatory protein component, respec-
tively. The difference was an estimate of the platelet component
(Gp). There was a 14% perioperative increase of standard MA,
corresponding to a 48% increase of Gt (<0.05/J) and an 80–86%
contribution of the calculated Gp to Gt. We conclude that serial
standard TEG and HVG viscoelastic tests may reveal the
independent contribution of platelets and procoagulatory proteins to
clot strength. The results showed that some components of the TEG
failed to identify hypercoagulation (r < 0.2, P > 0.75). All compo-
nents of the HVG test reflected postoperative coagulopathies.
Conclusions Hypercoagulability is not reflected completely by
standard coagulation monitoring and TEG, and seems to be
predominantly caused by increased platelet reactivity. HVG
provides a fast and easy-to-perform bedside test to quantify in vitro
coagulation, and may be useful in determining the coagulation
status of cancer patients perioperatively.
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Introduction In recent years there has been increasing evidence
that resuscitation strategies with different fluids can have widely
divergent impacts on the immune response and neutrophil
activation. This study was undertaken to determine the neutrophil’s
oxidative burst in a swine model during the acute normovolemic
hemodilution (ANH) procedure with hydroxyethyl starch (HES),
normal saline solution (NSS) or gelatin (GEL).
Methods Twenty-four pigs were anesthetized, instrumented and
randomized into four groups: Control, ANH + HES, ANH + NSS
and ANH + GEL. Animals in the ANH group were submitted to
acute normovolemic hemodilution to a target hematocrit of 15%
with volume replacement performed with HES 130/0.4 and GEL at
a 1:1 ratio and NSS at a 3:1 ratio. The withdrawn blood was
returned to the animals 120 minutes after the end of hemodilution.
Neutrophil oxidative burst was performed with blood samples
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collected from the femoral vein at the following time points: before
ANH (baseline), after instrumentation (INST), immediately after
ANH (H), 60 minutes after ANH (60H), 120 minutes after ANH
(120H), 60 minutes after blood infusion (60BI) and 120 minutes
after blood infusion (120BI) and determined with a flow cytometer.
A t test was performed to evaluate differences between groups.
P < 0.05 was considered statistically significant.
Results Between groups there were significant differences at time
point H between Control (25.75 ± 8.45) and HES (60.61 ± 10.49;
P < 0.01), between Control and NSS (55.94 ± 10.38; P < 0.05),
and between Control and GEL (68.42 ± 27.83; P < 0.01). At time
point 60H, the differences were between Control (34.48 ± 8.11)
and HES (54.15 ± 12.49; P < 0.01). In 120H, Control (29.05 ±
9.39) and HES (45.20 ± 5.80; P < 0.05) and NSS (46.18 ± 9.42;
P < 0.05) showed significant differences. Sixty minutes after blood
infusion, only HES (38.57 ± 7.89; P < 0.05) was different from
Control (26.46 ± 7.54).
Conclusions Fluid replacement immediately after induced ANH
increased inflammation expressed by oxidative burst activity
without significant differences among them.
Acknowledgements Performed at LIM 08. Supported by grants
from FAPESP (05/58987-9).
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Introduction In many trauma patients, blood loss is the major
cause of anaemia. Subsequent increased production of red blood
cells is reflected by increased reticulocyte numbers (R). Measure-
ment of the R might be useful in predicting the recovery of
hemoglobin (Hb), especially since current transfusion guidelines
accept lower Hb levels. The value of the modern fully automated
measurement of R in assessing recovery of Hb after blood loss has
not been investigated in this context. We therefore investigated the
temporal relation of Hb and R in a cohort of trauma patients.
Methods Over a 10-month period all patients with trauma admitted
to our hospital were analysed. Patients were grouped by
comorbidity and reason for admission. When an Hb was routinely
measured, a R measurement was also performed in the same
sample. Both Hb and R (reference range 8–26 promille) were
determined in EDTA-anticoagulated blood in the central laboratory
with a Sysmex XE-2100. Before further pooled analysis, values for
individual patients were averaged or interpolated to daily values.
Red blood cell (RBC) transfusions were administered according to
modern restrictive transfusion guidelines, with a Hb threshold of
4.3 mmol/l in otherwise healthy patients. Hb and R were analyzed
for a maximum of 30 days post-trauma, and were related with age,
sex and the presence of comorbidity.
Results Two hundred and forty-one patients with a mean ± SD
age of 52 ± 21 years were studied. The mean length of stay was
15 days (range 1–110). In 107 patients (44%), important
comorbidity was present. In 28 patients (12%), one or more RBC
transfusions were administered with a mean of 2.2 RBCs (range
1–4). Hb decreased from a mean level of 7.6 ± 1.5 mmol/l at
admission to 6.8 ± 1.3 on day 3. R slowly rose from 16 ± 11 at
admission to 38 ± 21 promille on day 13. The highest R value
observed was 121 promille. Nadir Hb values and maximum R
values were inversely related upon univariate analysis (Pearson R =
–0.62, P < 0.001). Multivariate analysis with the variables minimal
Hb, maximum R, age, sex, and the presence of comorbidity
showed that only minimal Hb was a significant determinant of R
(R = 0.63).
Conclusions There is a strong relationship between minimal Hb
and maximum R in trauma patients. The measurement of
reticulocytes may be helpful in predicting the recovery in Hb after
acute blood loss due to trauma and to assist in deciding whether a
patient needs to be transfused.
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Introduction Serious bleeding is the most feared adverse effect of
vitamin K antagonists (VKA) such as warfarin. VKA-treated patients
who are bleeding (or found to have a supratherapeutic INR value)
can be managed by administering one or more of the following:
vitamin K, fresh frozen plasma, recombinant activated factor VII, or
prothrombin complex concentrates. Current guidelines and review
articles addressing this subject are discordant. We tested the
hypothesis that significant clinical practice differences exist
between North America and the rest of the world for reversal of
VKA-associated coagulopathy.
Methods A survey containing three hypothetical clinical cases was
presented to attendees at a meeting of the International Society of
Thrombosis and Haemostasis in July 2007. The respondents were
primarily physicians with experience in anticoagulant management.
The cases involved patients with an elevated INR value and either
intracerebral bleeding, gastrointestinal bleeding, or no clinical
evidence of bleeding. For each case, the attendee was asked to
choose the intervention they would most probably order at their
institution.
Results A total of 119 surveys were distributed and 46 were
completed. See Table 1. For patients with intracerebral or
gastrointestinal bleeding who required urgent reversal of VKA-
associated coagulopathy, there was significantly greater use of
fresh frozen plasma and recombinant activated factor VII in North
America and significantly greater use of prothrombin complex
concentrates in the rest of the world. For patients with an elevated
INR but no bleeding, there was no significant difference in practice
by geographic region; vitamin K was used consistently in all cases.
Conclusions Significant geographical differences exist in the way
clinicians urgently reverse VKA-associated coagulopathy in
bleeding patients. This suggests that randomized trials are needed
to define optimal management strategies.
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Comparison by region of respondents recommending prothrombin
complex concentrates for each case
North America Other 
(%) (n = 10) (%) (n = 36) P value
Intracerebral bleeding 10 81 <0.0001
Either 10 86 <0.001
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Introduction Anticoagulation, coagulation disorders and
haemorrhage are causing considerable morbidity and mortality in
surgical patients. Reversal of vitamin K anticoagulants and
treatment of perioperative coagulopathy can be achieved by
prothrombin complex concentrates (PCC). However, the effects on
coagulation parameters, and any side effects on organ function,
have yet to be determined.
Methods Patients of the surgical department were analysed during
1 year retrospectively by reviewing patient charts and documen-
tation in a case-note review. Patients with vitamin K antagonist
reversal (reversal group: n = 12) were compared with patients
receiving PCC for management of severe bleeding (bleeding group,
n = 38). Coagulation was assessed using thromboplastin times
(INR/Quick’s value). Serum bilirubin and creatinine concentrations
at day 3 after PCC application served as safety variables.
Results Both patient groups were comparable in terms of age
(reversal: 67.3 ± 4.1 years vs bleeding: 66.1 ± 1.8 years) and
body temperature (37.2 ± 0.2°C vs 36.8 ± 0.3°C). Thromboplastin
times (INR) before PCC treatment were significantly higher in the
reversal group (reversal: 2.4 ± 0.2 vs bleeding: 1.5 ± 0.2; P <
0.001), whereas anaemia occurred significantly more frequently in
bleeding patients (haemoglobin: reversal 11.8 ± 0.6 g/dl vs
bleeding: 8.2 ± 0.3 g/dl; P < 0.001). Both groups showed a highly
significant decrease in INR values over time (reversal: 1.3 ± 0.2 at
180 ± 31 min after PCC application vs bleeding: 1.2 ± 0.2 at 147
± 15 min after treatment; INR: P < 0.001 vs baseline, time: not
significant). Creatinine and bilirubin concentrations at day 3 were
not significantly increased in either group (P > 0.05), indicating no
significant effect on renal and hepatic function.
Conclusions Patients of the reversal group showed significant
differences when compared with bleeding patients in terms of
baseline INRs and cardiocirculatory situation (data not shown). Our
results demonstrate that PCC can effectively improve INR in
nonhypothermic surgical patients requiring coumarin reversal or
experiencing severe bleeding. In almost all patients, this
improvement in plasmatic coagulation was judged to be clinically
significant, and allowed operative and/or interventional procedures.
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Introduction Postoperative bleeding reflects haemostatic
alterations associated with cardiopulmonary bypass (CPB), which
may lead to inflammatory response (IR). We evaluated the efficacy
of different doses of tranexamic acid (TA) (before versus before
and after CPB) for IR and postoperative bleeding.
Methods We performed a randomized, double-blind study with
consecutive Caucasian adult patients undergoing elective CPB
surgery from January 2006 to January 2007 in a 24-bed ICU at a
university hospital. From 209 consecutive patients, 49 met the
criteria for exclusion. After obtaining informed written consent,
patients were randomized to receive coded infusions of a single
pre-CPB dose (40 mg/kg) of TA (n = 80), and 40 mg/kg TA before
and after (twice) CPB (n = 80). We performed an analysis,
comparing IR incidence (defined as core body temperature higher
than 38ºC (100.4ºF) in the first 4 hours after intervention, systemic
vascular resistance index <1,600 dyn·s·cm–5·m–2 and cardiac
index higher than 3.5 l·min–1·m–2) and postoperative 24-hour
bleeding. We also analyzed several biological parameters related
to inflammation, coagulation, fibrinolysis and hemoderivative
requirements. SPSS version 15 was used.
Results The incidence of post-CPB IR was significantly lower in
the twice-TA group than in the single-TA group (7.5% vs 20%; P =
0.037). The twice-TA group had lower D-dimer at 4 and 24 hours
after CPB (both, P < 0.001). The twice-TA group lost less blood at
24 hours after CPB than the single-TA group: 670 (95% CI =
543–798) ml vs 827 (95%CI = 704–950) ml (P = 0.007). No
differences in blood transfusions were observed.
Conclusions We observed a significant reduction of IR and
postoperative bleeding with lower postoperative fibrinolysis in the
group of CPB patients who received TA before and after CPB.
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Introduction There is considerable interest in the potential use of
recombinant activated factor VIIa (rFVIIa) as adjunctive therapy in
major haemorrhage; to date, however, only a single RCT supports
its use as rescue treatment [1]. Previous efforts have been made to
establish which patients are most likely to benefit from rFVIIa using
scoring systems, but the optimal circumstances remain unclear
[2,3]. The purpose of this study was to investigate potential factors
influencing response to rFVIIa (in terms of subsequent packed red
cell (PRBC) transfusion) and survival in a cohort of nonhaemophiliac
patients treated with rFVIIa for haemorrhage in our region.
Methods We performed a retrospective analysis of the records of
40 nonhaemophiliac critically ill adults treated at seven hospitals in
the Cheshire and Mersey region with rFVIIa for haemorrhage
resistant to conventional management. The influence of potential
factors on post-rFVIIa PRBC transfusion and ICU survival were
evaluated using the Mann–Whitney U test and Fisher’s exact test,
respectively.
Results The 40 patients were surgical (21 patients), trauma (11
patients), obstetric (three patients), cardiothoracic (three patients)
and medical (two patients). The median age was 53.5 years, 26
patients were male. A median single dose of 90 μg/kg rFVIIa was
administered after a median 14.5 units PRBC. Fifty-three per cent
of patients survived to ICU discharge. Factors influencing PRBC
transfusion in the 24 hours post rFVIIa administration and ICU
survival are presented in Tables 1 and 2.
Conclusions While the optimal circumstances for rFVIIa
administration remain unclear, it seems easier to focus on the
question ‘Who is unlikely to benefit?’ pH ≤ 7.1 at the time of
administration of rFVIIa was associated with significantly increased
PRBC transfusion and 100% mortality. Hypothermia (temperature
≤35°C) and cardiac arrest prior to rFVIIa administration were also
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associated with significantly increased PRBC transfusion.
Although there have been previous reports of survival following
rFVIIa administration for haemorrhage in the presence of pH < 7.1,
such profound acidaemia provides a strong indication that rFVIIa is
likely to be futile.
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Introduction Postpartum haemorrhage (PPH) is a major cause of
global maternal morbidity and mortality. The use of haemostatic
drugs in the therapeutic management of patients is mainly empirical.
A rationale for an early treatment with fibrinogen, however, has been
recently suggested [1].
Methods A multicentre, noncontrolled, phase 2 study was
performed to assess the efficacy and the safety of a new triple-
secured fibrinogen concentrate (FGT1; LFB, Les Ulis, France) in
the treatment of PPH. A single median dose of 30 mg/kg was
administered in addition to standard care. Patients were followed
until 6 weeks after the inclusion. Failure of treatment was defined
when ultimate resources (that is, invasive hæmostatic intervention
or treatment with activated recombinant factor VII) were required to
stop the hæmorrhage, or in case of massive transfusion or death.
Other clinical criteria included the course of haemorrhage and
investigator’s assessment using a four-point scale. Laboratory
assessments were changes in fibrinogen plasma levels and in the
FibTEM A15 parameter (RoTEM®). Safety included adverse events
and vital signs.
Results Sixteen patients were included with a median (range)
volume of haemorrhage of 1,667 (800; 3,160) ml at baseline.
FGT1 succeeded in controlling the haemorrhage in 75% of the 12
patients who were clinically assessable. A convergence was
observed for all efficacy criteria used. The median fibrinogen incre-
mental recovery was 10.0 (g/l)/(g/kg) with a 7% concomitant
median increase of A15 FibTEM. Biological ranges were also very
large. Higher incremental recovery and relative increases of
FibTEM A15 were associated with clinical success. FGT1 was well
tolerated in all patients. Among the 14 adverse events reported,
only one was serious, but all were reported as not related to FGT1.
No thrombosis or allergic reaction to the study drug occurred.
Conclusions This exploratory study suggests efficacy of FGT1 to
control PPH in cases of failure of first-line treatments. Most severe
PPH may require higher doses than used in this study. These
results are to be confirmed by larger controlled trials.
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Introduction Thrombin, the key enzyme of blood clotting, is
responsible for the conversion of fibrinogen to fibrin, and for the
activation coagulation factors and platelets. Sufficient thrombin
generation (TG) is therefore crucial for hemostasis. In an experi-
mental dilutional coagulapathy in pigs with subsequent bone or
spleen injury, the effect of a substitution therapy with prothrombin
complex concentrate (PCC) (Beriplex P/N; CSL Behring) or
autologous porcine fresh frozen plasma (pFFP) on TG and
hemorrhage was evaluated.
Methods A dilutional coagulopathy was induced in 44 anaes-
thetized pigs. Erythrocytes were retransfused, the lost volume was
replaced by hydroxyethyl starch. Animals were randomized to the
following two study groups – A: bone injury, (1) placebo (n = 7),
(2) PCC 25 U/kg (n = 7), (3) 15 ml/kg pFFP (pFFP15, n = 7), or
(4) 40 ml/kg pFFP (pFFP40, n = 4); B: spleen injury, (1) placebo
(n = 7), (2) PCC 25 U/kg (n = 6), or (3) 15 ml/kg pFFP (n = 6). A
3 mm bone injury was performed by drilling a hole into the femur
neck. A spleen incision was created by a scalpel blade. Blood loss
(BL) and the time to hemostasis (TH) were determined. TG, the
prothrombin time (PT) and coagulation factor levels were measured.
Results The dilutional coagulopathy led to a decrease in
circulating coagulation factors, a prolonged PT and a decreased
TG. The substitution with PCC and pFFP normalized the impaired
PT, but only PCC could normalize the TG. PCC but not pFFP
could restore the decreased plasma levels of coagulation factors of
the prothrombin complex to sufficiently high levels. In the placebo
group, TH and BL after bone injury were 90.0 ± 27.4 minutes and
625 ± 330 ml, and were 82.8 ± 24.5 minutes and 757 ± 251 ml
after spleen injury. After substitution therapy with PCC, a
significantly faster TH of 39.6 ± 9.8 minutes (P = 0.0004) and a
decreased BL of 191 ± 119 ml (P = 0.0127) was observed after
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Table 1 (abstract P223)
Median post-rFVIIa PRBC transfusion in the presence or absence
of factor
PRBC transfusion (units)
Factor Present Absent P value
pH ≤ 7.1 6 3 0.050*
Temperature ≤ 35°C 8 3 0.001*
Prior cardiac arrest 10 3 0.034*
Prior PRBC transfusion ≥ 20 units 4.5 3 0.062
INR ≥ 1.5 3 3 0.621
Platelet count ≤ 50 x 109/l 4.5 3 0.609
*Significant at P < 0.05.
Table 2 (abstract P223)
Survival in the presence or absence of factor
Survival (%)
Factor Present Absent P value
pH ≤ 7.1 0 63 0.003*
Temperature ≤ 35°C 44 65 0.711
Prior cardiac arrest 33 56 0.398
Prior PRBC transfusion ≥ 20 units 47 56 0.745
INR ≥ 1.5 42 61 0.342
Platelet count ≤ 50 x 109/l 25 56 0.331
*Significant at P < 0.05.
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bone injury. After spleen injury, TH was 45.3 ± 9.1 minutes (P =
0.0129) and BL was 356 ± 175 ml (P = 0.0152). Neither dose of
pFFP could correct hemorrhage.
Conclusions Substitution with PCC but not FFP could normalize
TG and provide sufficient coagulation factors to reduce hemor-
rhage. In both models of either venous or arterial injury, TH and BL
were significantly decreased by PCC. It was concluded that the
correction of TG correlates with hemostasis from a trauma injury.
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Introduction As a part of a clinical trial to evaluate the potential
benefits of inline filtration on reducing major complications of paediatric
ICU (PICU) patients (Clinical Trials.gov ID NCT 00209768), we
examined the physical aspects and chemical composition of par-
ticles captured by inline microfilters. Additionally we investigated
the inflammatory and cytotoxic effects of particles on human endo-
thelial cells and macrophages in vitro.
Methods We analysed 22 filters used by critically ill children with
electron microscopy and energy dispersion spectroscopy. The
average number of particles on the surface as well as their
composition was examined. In the in vitro model, human
endothelial cells and murine macrophages were exposed to
different solutions of glass particles and the cytokine levels
assayed to assess their immune response. Levels of IL-1β, IL-6,
IL-8, and TNFα were measured.
Results The average number of particles found on the surface of a
filter membrane was 542/cm2 and energy dispersion spectroscopy
analysis confirmed silicon as one of the major particle constituents.
When human endothelial cells and murine macrophages were
exposed to different solutions of glass particles (according to the
particles found on the filter membranes), levels of IL-1β, IL-6, IL-8,
and TNFα were found to be significantly suppressed.
Conclusions Inline filtration prevents the infusion of potentially
harmful particles. The suppression of macrophage and endothelial
cell cytokine secretion by particles in vitro suggests that the
infusion of microparticles may also contribute to immune
compromisation, which is often seen in vivo in the clinical course
of PICU patients. These findings and their effect on the clinical
outcome of our PICU patients may be further elucidated.
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Introduction The use of filter needles to prepare medication is
suggested as a way of preventing particulate contamination of
infusions, which is regarded as a source of infection or inflammation
in critical care patients [1]. To assess the impact of such needles
purely on bacterial contamination we carried out a comparison of
the retention of four bacterial pathogens through a standard 25-swg
needle (BD), a standard fill needle with 5 μm filter (BD) and the filter
of an Epidural minipack system (Portex). Comparisons were made
at high and then low (‘real world’) bacterial contamination levels.
Methods We prepared four bacterial suspensions mixed together
in peptone saline to produce Staphylococcus aureus (2.35 x 106
colony-forming units (cfu)/ml, Bacillus cereus (5.77 x 105 cfu/ml),
Escherichia coli (4.38 x 106 cfu/ml) and Pseudomonas aeruginosa
(3.86 x 106 cfu/ml) per 10 ml test fluid. This volume was then
injected through each type of needle and the epidural filter, after
which the filtrate was taken for culture. Small standard amounts
were plated on Columbia blood agar while the remainder of the
sample (9.9 ml) was mixed with double-strength nutrient broth to be
incubated for 24 hours at 37°C. This was repeated with three sets
of needles and filters. We then prepared a low-density inoculate of
1 ml equating to a total density of 2.63 x 102 cfu of an equal mix of
the above bacteria. This was injected through six sets of the devices
in question, and both quantitative counts and cultures were
performed. Student’s t test was used to compare counts.
Results No bacteria could be cultured following the use of the 0.2
μm epidural filter either from Columbia blood agar or from broth at
high or low contamination levels. In contrast, it was easy to isolate
all four pathogens from both needles. In quantitative counts there
was no difference in the mean counts (175 cfu/ml vs 190 cfu/ml)
between filtered and unfiltered needles.
Conclusions In terms of preventing bacterial transmission where
an infusion is contaminated (even at low levels), the use of a 5 μm
filter needle is no better than a normal needle. In contrast a 0.2 μm
filter is highly efficient at preventing transmission, at least when
resisting a single challenge.
Reference
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Introduction Morbidity and mortality in patients suffering from
systemic inflammatory response syndrome (SIRS) remain high. The
present study was carried out because proteins might serve as
promising agents to reduce mortality in SIRS patients. We
therefore investigated the effects of a plasma-protein solution
containing immunoglobulins on serum cytokine levels and survival.
Methods This prospective, double-blind, randomized, controlled
trial was performed in the medical ICU of a university hospital.
Forty consecutive patients with SIRS were randomized to receive
either a commercially available standardized plasma-protein solution
(Biseko®; Biotest, Dreieich, Germany) [1] consisting of all impor-
tant transport and inhibitor proteins as well as immunoglobulins or
a 5% albumin solution. Plasma/albumin was given intravenously at
a volume of 1,000 ml on the first day and 500 ml/day during the
following 4 days. Serum cytokine levels of IL-1β and IL-6 were
measured on days 1–6, TNFα and TNF-R levels were determined
on days 1 and 14 and at day 28. Survival was assessed on day 28
and on day 180.
Results Eighteen patients received Biseko®, 20 patients received
albumin. Two patients died before receiving the complete study
medication. During days 1–6 of the study period, serum levels of
IL-1β were significantly lower in patients with Biseko® therapy
compared with patients receiving albumin (IL-1β AUC 65 ± 71
days.pg/ml vs 111 ± 157 days.pg/ml, P = 0.03). No statistically
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significant difference could be found in serum levels of IL-6, TNFα
and TNF-R between both groups. While a not statistically
significant trend towards better survival could be observed in the
Biseko® group on day 28, the survival rate on day 180 was
significantly higher in the Biseko® group (50% (9/18)) vs the
albumin group (10% (2/20), (P < 0.008)).
Conclusions The data suggest that Biseko® therapy was
associated with significantly lower IL-1β plasma concentrations
(days 1–6) and with improved survival rates.
Reference
1. Keller E, et al: Comparison of fresh frozen plasma with a
standardized serum protein solution following therapeutic
plasma exchange in patients with autoimmune disease.
Ther Apher 2000, 4:332-337.
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Introduction In colon surgery for malignancy, tissue oedema as a
result of increased capillary permeability – due both to operational
stress response and the perioperative fluid therapy – may contribute
not only to the systemic consequences, but also to anastomotic
dehiscence with questionable end results for the patient. The use of
albumin is considered the gold standard for prevention of this
complication, being at least theoretically combined with
hypoalbuminaemia; however, in recent years its use has become
controversial. On the other hand, after the acknowledgement of the
pharmacokinetic advantages of synthetic colloids, there has been
an ongoing shift towards their use as perioperative fluid therapy in
major elective surgery, too. We aimed to investigate the effect of
colloids as a postoperative regimen against routinely given human
albumin in patients subjected to colectomy for cancer. Thirty-day
morbidity, including anastomotic leakage, abdominal wound
infection and dehiscence, as well as organ-specific and systemic
infections, sepsis and septic shock, were assessed.
Methods Fifty colon cancer patients with actual indication for early
postoperative albumin treatment were randomized to receive either
human albumin (100 ml/day) or 6% HES 130/0.4 (Voluven;
Fresenius AG) (500 ml/day), for six consecutive days. Patients
were then followed up for the next 30 days.
Results In the albumin and Voluven groups, anastomotic leakage
was prominent in three patients and one patient, respectively;
wound infection in three patients and one patient, respectively;
systemic infection in five patients and four patients, respectively;
and sepsis in two patients and zero patients, respectively. One
patient finally died from sepsis in the albumin group.
Conclusions We conclude that, in our study, patients receiving
Voluven against albumin as a perioperative 6-day treatment
exhibited lower morbidity rates. However, further research is
required.
References
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Introduction The aim of the study was to evaluate the effects of
hydroxylethyl starch (HES) solutions in patients with severe brain
injury dependently of cerebral blood flow (CBF) type.
Methods One hundred and twenty-six patients (female/male ratio,
32/94) with severe brain injury GCS < 8 were included. 76.2%
patients passed surgery due to depressed skull fracture or
intracerebral hemorrhage. CBF was assessed by transcranial
Doppler ultrasonography (insonation of M1–2 segments of the
middle cerebral artery (MCA) with assessment of linear blood
velocity (LBV)). Patients were divided into three groups: I, with
brain hyperemia (BH) (n = 42); II, with cerebral vasospasm (CVS)
(n = 58); III, with brain hypoperfusion (BHP) (n = 26). All patients
received volume replacement with 6% HES 200/0.5.
Results Infusion of HES in group I causes a statistically significant
increase of the cerebral blood volume, a rise of intracranial pressure
(ICP) and central venous pressure (CVP) and leads to more deep
depression of consciousness. In group II, HES provided some
reduction of LBV in MCA and improvement of consciousness.
Increasing CVP was statistically significant. In group III, increasing
CVP and LBV in the MCA were observed. See Table 1.
Conclusions Volume replacement with HES during severe
traumatic brain injury gives best results in patients with CVS and
BHP. HES in patients with BH is not expedient as it may increase
ICP and CVP and lead to more deep depression of consciousness.
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hydroxylethyl starch 130/0.4 (Voluven®) in patients
suffering from symptomatic vasospasm after
subarachnoid haemorrhage
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Introduction Patients suffering from symptomatic cerebral artery
vasospasm (CAV) after subarachnoid haemorrhage (SAH) develop
alterations in sodium and fluid homeostasis, and the effects of fluid
Available online http://ccforum.com/supplements/12/S2
Table 1 (abstract P230) 
Data BH initial BH after 4 hours CVS initial CVS after 4 hours BHP initial BHP after 4 hours
GCS 7.8 ± 0.4 5.7 ± 0.5* 7.6 ± 0.6 8.8 ± 0.7 5.4 ± 0.4 5.9 ± 0.4
LBV in MCA (cm/s) 148.2 ± 11.4 165.3 ± 13.5* 156.6 ± 15.2 139.3 ± 14.8 63.2 ± 5.8 81.2 ± 7.1*
CVP (cmH2O) 9.6 ± 3.5 11.3 ± 5.9* 5.6 ± 2.4 7.3 ± 3.7* 7.2 ± 4.1 9.1 ± 5.3*
ICP (mmHg) 109.4 ± 5.8 132.3 ± 6.2* 101.3 ± 3.1 108.1 ± 4.9 180.3 ± 9.4 168.4 ± 7.2
*P < 0.05.
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infusion are uncertain. Since their fluid management is contro-
versial, we assessed the effect of a single colloid infusion on global
haemodynamics and fluid balance.
Methods In a prospective study, 500 ml of 130/0.4 hydroxylethyl
starch (HES) was administered over 30 minutes in patients with
CAV after SAH. The mean arterial pressure (MAP), central venous
pressure (CVP), fluid balance, cardiac index (CI), intrathoracic
blood volume (ITBV), and extravascular lung water (EVLW) were
measured immediately before, and 60, 120, 180 and 360 minutes
after HES by transpulmonary thermodilution (PiCCO; Pulsion).
Patients increasing CI by more than 10% were considered as
responders (R), versus nonresponders (NR). Comparisons were
made between groups by one-way ANOVA, and at various time
points by two-way ANOVA (P < 0.05 significant, mean ± SD).
Results After HES, the CI changed from –14% to +62%.
Considering all patients (n = 20), the CI increased at 60 minutes
(4.3 ± 0.7 vs 4.8 ± 0.9 l/m2/min, P < 0.05) but returned to
baseline value at 120 minutes (4.6 ± 0.9 l/m2/min) and thereafter.
There was no difference in the MAP, CVP, ITBV and EPLW over
time. Ten patients were R and 10 were NR. Baseline MAP, CVP,
CI, ITBV and EPLW were not different between R and NR. The
norepinephrine infusion rate was higher in NR than in R (18 ± 12
vs 6 ± 9 μg/min, P < 0.05). The CI increased in R from 60 to 180
minutes, and returned to baseline at 360 minutes (respectively 4.0
± 0.6, 5.2 ± 1.1, 4.9 ± 1.1, 4.8 ± 1.0, and 4.2 ± 1.1 l/m2/min). The
evolution of fluid balance was different between R and NR: it
remained unchanged in R, while it was negative at 360 minutes in
NR (–0.60 ± 0.87 vs –0.04 ± 0.47). The MAP, CVP, ITBV and
EPLW were not different between R and NR throughout.
Conclusions By transpulmonary thermodilution, the haemo-
dynamic effects of a short HES infusion were variable and
unpredictable. In R, the increase in cardiac output lasted 3 hours.
In NR, fluid infusion fluid therapy should be considered with
caution, since it may be associated with a negative fluid balance,
probably due to cerebral salt wasting. Our data suggest that fluid
therapy should be closely monitored in this population of patients
with altered homeostasis.
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Introduction The pathological renal mechanisms of hydroxy-
ethylstarch (HES) are not identified. We designed an isolated renal
perfusion model in which we try to identify possible mechanisms of
injury between different HES preparations.
Methods After approval of the local animal protection committee,
24 porcine kidneys in an isolated renal perfusion model of 6 hours
duration were studied. We compared three different infusion
solutions: 10% HES 200/0.5 (HES200) versus 6% HES 130/0.42
(HES130) versus Ringer’s lactate (RL). Infusion was supplied to
achieve a stable hematocrit of 0.2. Tubular damage was assessed
with N-acetyl-β-D-glucosaminidase (β-NAG). After immunohisto-
logical staining, proliferation (proliferating nuclear antigen (PCNA))
and macrophage activation (ED-1+macrophages (ED-1)) were
analyzed as positive cells/visual field. Effects of infusion solution and
time were statistically analyzed by ANOVA for repeated measure-
ments. The histological changes were analyzed using ANOVA.
Results β-NAG was significantly different between groups (P <
0.001) (Figure 1). For ED-1 there were significant differences
between HES200 and HES130 (1.3 ± 0.4 vs 0.17 ± 0.04, P =
0.044). Proliferation was significantly greater in the HES200 versus
the HES130 group (18.8 ± 3.2 vs 7.2 ± 0.8, P = 0.008). Subanalysis
of PCNA showed that these differences occurred in the interstitium
and not in the glomerulus (18.0 ± 0.3 vs 6.5 ± 0.1, P = 0.006).
Conclusions For the first time we identified proliferation and macro-
phage activation as the pathomechanism causing renal injury after
HES application. Furthermore, the degree of renal injury in our model
was significantly lower using HES130 compared with HES200.
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Introduction In several clinical studies it has been shown that
hydroxyethyl starch (HES) may be as effective and safe but less
expensive as albumin when used for perioperative plasma volume
replacement in children. The new third-generation HES 130/0.42
solution was designed to reduce adverse drug reactions (ADR)
and improve safety while maintaining efficacy. In this prospective
multicentric observational postauthorization safety study, therefore,
the perioperative application of HES 130/0.42 was examined in
children with a focus on possible ADR.
Methods In the first year approximately 300 pediatric patients
aged up to 12 years with risk score ASA I–III undergoing peri-
operative application of HES 130/0.42 (Venofundin 6%; Braun,
Germany) should be included. According to statistics, this number
of patients is sufficient to show a 1% occurrence of ADR. After
approval of a local ethic commission, patient data and those
relating to the application of HES 130/0.42, the performed
procedure, anaesthesia-related data and ADR were documented
with focus on cardiovascular stability, hemodilution, acid–base
balance, renal function, blood coagulation and hypersensitivity.
Results Three hundred and sixteen children (ASA I–III, age 3 (SD
3.4, range day of birth–12) years, body weight 13 (SD 10.5, range
1.1–60) kg) were studied in five centres in Germany, Austria and
Italy until August 2007. Forty-five percent of the patients
underwent abdominal, 12.4% urological, 11.4% thoracic, 7.6%
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N-acetyl-β-D-glucosaminidase over time for the three infusion solutions.
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orthopedic and 7% cardiac surgical procedures. The mean volume
of infused HES 130/0.42 was 11 (SD 4.8, range per day 5–42)
ml/kg. Cardiovascular stability was maintained in all cases. After
HES infusion, values of hemoglobin (11.5 vs 10.25 g/dl), base
excess (–2 vs –2.7 mmol/l), anion gap (12.9 vs 11.17 mmol/l) and
strong ion difference (34.3 vs 31.4 mmol/l) decreased and chloride
(105.7 vs 107.8 mmol/l) increased significantly (P < 0.05). No
serious ADR (i.e. bleeding, renal insufficiency, hypersensitivity)
were observed.
Conclusions Moderate doses of HES 130/0.42 help to maintain
cardiovascular stability and lead to only moderate changes in
haemoglobin concentration and acid–base balance in children. The
probability of serious ADR is lower than 1%. HES 130/0.42/6:1
for plasma volume replacement therefore seems to be safe and
effective even in neonates and small infants.
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Introduction The purpose of the present study was to directly
compare the impact of two different hydroxyethylstarch solutions
(HES 6% 130/0.4, Voluven® 6%; and HES 10% 200/0.5,
Hemohes® 10%) and a balanced crystalloid (Sterofundin® ISO) on
the colloid-osmotic pressure (COP) and renal function in fulminant
ovine endotoxemia.
Methods Thirty healthy ewes received a continuous infusion of
Salmonella typhosa endotoxin started at 5 ng/kg/min, which was
doubled every hour until the mean arterial pressure fell below
65 mmHg. Thereafter, sheep were randomized (each group n =
10) to either receive repeated bolus infusions of 5 ml/kg HES 130
or HES 200, or 10 ml/kg crystalloid to increase the central venous
pressure (8–12 mmHg), pulmonary arterial occlusion pressure
(12–15 mmHg) and mixed-venous oxygen saturation (≥65%).
Following infusion of the maximum colloid dose (20 ml/kg), all
groups received only crystalloid infusions (10 ml/kg), if necessary.
Animals surviving the 12-hour intervention period were
anesthetized and killed. Data are expressed as means ± SEM.
Statistics were performed using two-way ANOVA with Student–
Newman–Keuls post-hoc comparisons.
Results The colloid groups needed less total fluids than the
crystalloid group. Apart from significantly higher systemic oxygen
delivery index and stroke volume index in sheep treated with HES
130, the hemodynamics were comparable between groups. COP
was higher in both colloid-treated groups as compared with the
crystalloid group (12.5 ± 0.6 and 14.7 ± 1.0 vs 8.4 ± 1.7; P <
0.05 for HES 130 and HES 200 vs crystalloids). However, there
was no significant difference in COP between the two colloid
groups (P = 0.429). Urinary output was markedly reduced in the
HES 200 group (2.5 ± 0.9 vs 5.7 ± 1.3 and 7.2 ± 1.2 ml/kg/hour;
P < 0.05 for HES 200 vs HES 130 and crystalloids). Plasma
creatinine was highest in sheep treated with HES 200 (1.4 ± 0.1
vs 1.0 ± 0.0 and 1.0 ± 0.1 mg/dl; P < 0.05 for HES 200 vs HES
130 and crystalloids).
Conclusions In ovine endotoxemia, treatment with HES 200 may
compromise oxygen transport and renal function as compared with
HES 130 and crystalloids. The underlying mechanisms remain to
be elucidated but appear to be independent of COP.
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Introduction Patients with a long ICU stay (>7 days) are prone to
develop anemia due to high severity of disease, repeated flebo-
tomies and inflammatory status with altered erythropoiesis. They
are also more prone to receive a blood transfusion. The aim of our
study was to assess the hemoglobin (Hb) transfusion trigger and
the influence of blood transfusion on outcome in critically ill
patients with an ICU length of stay (LOS) >7 days.
Methods The prospective noninterventional study was performed in a
mixed 19-bed ICU of a tertiary care university hospital and included all
patients with an ICU LOS > 7 days admitted during 1 year. Patients
were divided into two groups: patients never transfused (NT group),
and patients ever transfused (ET group). Collected data were
demographic data, severity scores, Hb transfusion trigger, transfusion
data, ICU LOS and outcome. Statistical analysis was conducted
using the Student t test and multinomial logistic regression.
Results The study enrolled 132 patients (NT, 54 patients; ET, 78
patients) with a mean ICU LOS 12.9 days, a mean worst APACHE
II score 22.8 and a mean worst SOFA score 9.3. Anemia (Hb
< 12 g%) was present in 83.3% patients at ICU admission and in
95.4% at ICU discharge. In the ET group the transfusion trigger
Hb was 7.8 ± 2.3g%. In the ET group a total of 228 red blood cell
units were transfused on 154 different occasions with a median of
2 (1–16) units/patient. The mortality was significantly different in
the ET group (51 patients, 65.3%) versus the NT group (11
patients, 20.7%). Mortality significantly correlates with worst SOFA
score (P = 0.041) and mostly with transfusion status (P = 0.002).
See Table 1.
Table 1 (abstract P235)
Patient data
Variable NT group ET group P value
Patients, n (%) 54 (40.9%) 78 (59.1%) NS
Worst APACHE score 23.2 ± 9.5 22.2 ± 9.8 NS
Worst SOFA score 8.9 ± 3.6 9.8 ± 4.4 NS
ICU mortality 11 (20.7%) 51 (65.3%) 0.0004
Conclusions The incidence of anemia in critically ill patients with a
long ICU stay is high (83% at ICU admission, 95% at ICU
discharge). The transfusion trigger Hb was 7.8g%, a value that
matches the actual restrictive policy. Blood transfusion was an
independent risk factor for increased mortality in the ET group.
P236
Outcome of surgical patients who needed blood
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Introduction Blood transfusions are associated with immune
modulation, a higher postoperative infection rate, transmission of
infectious diseases and higher hospital costs. Measures are
necessary to avoid blood transfusion both intraoperative and post-
Available online http://ccforum.com/supplements/12/S2
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operative in surgeries with a major blood loss. This study aimed to
verify the practices of blood transfusion in surgical patients.
Methods A prospective cohort study, with a follow-up of 10
months, in a surgical center of a tertiary hospital. Inclusion criteria
were age above 18 years, need for blood transfusion in the
intraoperative period. Exclusion criteria were patients who refused
to receive blood transfusion due to religious reasons, coronary
artery disease, acute brain injury. Blood transfusion decision-taking
was the charge of the surgical team.
Results Eighty patients were included, with mean age 68.3 ± 13.1
years, 55% female. The POSSUM and MODS scores were equal
to 36.2 ± 10.3 and 2.4 ± 1.9, respectively. Eighty-two percent of
the surgeries were elective, with mean length 6.3 ± 3.2 hours. The
basal hemoglobin level was 12.3 ± 1.6 g/dl, and at the moment of
the blood transfusion it was 8.4 + 1.8 g/dl. Patients were
transfused, on average, 2.3 ± 0.9 units packed red cells, stocked
for 16.8 ± 11.8 days. Hospital mortality rate was 24.6%. Patients
who had a higher mortality rate (death vs discharge) were elderly
(77.3 ± 8.1 vs 66.2 ± 13.4 years old; P = 0.005), had higher
POSSUM (44.2 ± 10.6 vs 33.4 ± 9.1; P = 0.001) and MODS
(3.4 ± 1.9 vs 2.1 ± 1.7; P = 0.02) scores, and had any of the
following complications in the first 28 days postoperative (92.9%
vs 39.5%; P < 0.001), such as infections, tissue hypoperfusion,
shock, neurologic disturbances, ARDS, ARF, and digestive fistulae,
in decreasing values.
Conclusions The mean hemoglobin level used to trigger blood
transfusion in surgical patients was 8.4 ± 1.8 g/dl, and patients were
transfused 2 units packed red cells on average. Age, POSSUM and
MODS scores, urgent surgeries, and 28-day postoperative
complications determined a worse outcome in this population.
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Introduction We should perform red cell blood transfusion therapy
(RC-BTF) only after crossmatching to decrease the whole risks of
this treatment, particularly ABO-incompatible transfusion. In a rapid
catastrophic bleeding condition, however, we often have to do this
treatment without crossmatching and without establishment of
ABO blood type. Our BTF manual (2002) states that the ABO
blood type is confirmed only after double examinations, usually the
first examination in the routine examination at admission or first visit
to the hospital and the second in the procedure of crossmatching.
Most of our medical staff have been afraid that type O RC-BTF
was unacceptable for patients and their families. The aim of this
study is to establish safety in the procedure of immediate RC-BTF
without crossmatching and to clarify how we explain this safety to
medical staff, patients and their families.
Methods We examined the medical records of the patients who
underwent immediate RC-BTF without crossmatching for the past
5 years in our Critical Care and Emergency Center. Data were the
number of requested and used packed red cells (PRC) without
crossmatching, adverse events of transfusion, and incidents
concerning RC-BTF therapy.
Results In 5 years in our Critical Care and Emergency Center,
1,036 units PRC were used for 109 cases without crossmatching.
Type O RC-BTF without crossmatching before blood type
detection was performed in 30 cases. These 109 patients
underwent 9.42 units (mean) PRC without crossmatching. For
patients who underwent RC-BTF without crossmatching at first
and with crossmatching successively, 6.10 units (mean) of non-
crossmatched PRC were transfused. On the other hand, for
patients who underwent repeated RC-BTF without crossmatching,
we required 7.03 units (mean) at first and excessive non-
crossmatched units successively. In total, we actually used 85% of
requested units of noncrossmatched PRC in immediate RC-BTF.
No incompatible RC-BTF was performed, and eight incidents were
noticed (error in sampling of blood, labeling on the examination
tube, entering the data, and detecting the blood type).
Conclusions Our manual for transfusion therapy is safe and useful.
In immediate RC-BTF without crossmatching, we should use type
O PRC, and we can make this therapy acceptable to medical staff
in the hospital and patients and their families for step-by-step
education.
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Introduction Bleeding occurs in about 20% of cardiac surgery
and is associated with significant morbidity. In this context, red cell
transfusions are used to augment the delivery of oxygen to avoid
the deleterious effect of oxygen debt. However, blood cell trans-
fusions are associated with morbidity and mortality in clinical
studies with critically ill patients. The purpose of this study was to
evaluate the relationship between blood transfusion in the
operative room and clinical outcomes after cardiac surgery.
Methods We performed a consecutive observational study in a
university hospital. A total of 125 patients undergoing elective
coronary artery bypass graft surgery or valve surgery were studied.
Demographic data were analyzed. Postoperative cardiac dysfunc-
tion was defined as low cardiac output or hemodynamic instability
requiring inotropic support for >24 hours. Renal dysfunction was
defined as >50% increase in serum creatinine from baseline.
Univariate and multivariate analyses were performed.
Results Of 125 patients, 41 (32.8%) received blood transfusion in
the intraoperative room. Patients who received blood transfusion
had more postoperative complications than those who did not (P <
0.001). Intraoperative blood transfusion was a risk factor for low-
output syndrome (P = 0.02), renal dysfunction (P < 0.003),
infection (P < 0.008) and longer stay in the ICU (P = 0.01). In a
multivariate analysis, blood cell transfusion increased independently
the risk of renal dysfunction (OR = 5.5, 95% CI = 1.5–16.9).
Conclusions In this observational study, intraoperative blood cell
transfusion predicted the outcome after cardiac surgery, resulting
in more postoperative complications. These findings suggest that
the criteria for perioperative blood transfusion should be revised,
considering potential risks.
Reference
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Introduction This study was undertaken to determine the inci-
dence, type, and severity of acute transfusion reactions observed in
a tertiary care pediatric ICU.
Methods All transfusions of blood product administered to
consecutive patients admitted to our pediatric ICU, between
February 2006 and February 2007, were prospectively recorded.
For each transfusion, the bedside nurse recorded the patient’s
status before, during, and up to 4 hours after the transfusion, as
well as the presence of any new sign or symptom suggesting an
acute transfusion reaction.
Results A total of 651 transfusions were administered during the
study period. Sixty-one febrile nonhemolytic transfusion reactions
(9.4%) were recorded. No allergic and hypotansive reactions and
transfusion-related acute lung injury were seen. Seventy-seven
percent (n = 47) of the febrile reactions were recorded during the
red blood cell transfusions.
Conclusions The incidence of febrile nonhemolytic reactions was
higher when compared with similar studies. Possible cause may be
not using leuko-reduced components. Transfusion-related acute
lung injury is not common in critically ill pediatric patients. These
estimates are useful for decisions concerning transfusion therapy,
and for evaluating efficacy of interventions to reduce risk in
critically ill pediatric patients.
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Introduction Hemorrhagic shock is a frequent encountered entity
in a critical situation. The initial treatment for hemorrhagic shock is
rapid replacement of massive extracellular fluid (ECF); however,
sufficient oxygen transportation to peripheral tissue cannot be
obtained only by ECF replacement. Lately, using state-of-the-art
nanotechnology, an artificial oxygen transporter with the ribosome
inclusion body (hemoglobin endoplasmic reticulum (HbV)) has
been developed. In this study, measuring the serum lactate level
and tissue lactate level, we investigated the effect of HbV on the
peripheral oxygen metabolism by the microdialysis method in a
fatal rat (Wister rat) model with hemorrhagic shock.
Methods Cannulation was placed in the femoral vein of a rat and
probes for measurement of the tissue oxygen partial pressure and
microdialysis method were inserted into subcutaneous tissue of
the abdominal wall. A shock model was made by exsanguinations
from the femoral vein by 60% of the total body blood volume until
the mean arterial pressure decreased to 25 ± 5 mmHg. We
classified this shock model into two arms at random; ECF
replacement arm (n = 10) and HbV arm (n = 8). The mean arterial
pressure, plasma oxygen pressure, plasma lactate (p-lac), tissue
partial oxygen pressure and tissue lactate (t-lac) of this shock
model were measured every 50 minutes after exsanguinations until
250 minutes elapsed.
Results Elevation of p-lac and t-lac was observed in each arm after
exsanguinations. In both arms, p-lac elevated rapidly and then
decreased after exsanguinations. While p-lac in the ECF arm re-
elevated, that in the HbV arm decreased steadily. The p-lac in the
HbV arm showed a significantly lower value than that in the ECF
arm at each measured point (P < 0.05). After exsanguinations, t-lac
elevated rapidly and then steadily elevated thereafter in the ECF
arm, while t-lac in the HbV arm decreased. Similarly, t-lac in the
HbV arm showed a significantly lower value than that in the ECF
arm at each measured point (P < 0.05). In conclusion, the HbV
arm significantly decreased p-lac and t-lac compared with the ECF
arm in a fatal rat model with hemorrhagic shock.
Conclusions Our study showed that HbV had better outcomes
than ECF in terms of oxygen metabolism in peripheral tissue.
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Introduction Postoperative low cardiac output (PLCO) remains a
serious complication after cardiopulmonary bypass (CPB). Our aim
was to determine the incidence and clinical outcome of PLCO.
Methods We performed a cohort study in consecutive patients
who underwent CPB surgery in a period of 8 months. PLCO was
defined as dobutamine requirements >5 μg/kg/min at least longer
than 4 hours after optimized pulmonary capillary wedge pressure =
18 mmHg, to achieve a cardiac index higher than 2.2 l/min/m2. We
recorded the preoperative left ventricular function, postoperative
haemodynamic parameters, and clinical outcomes (postoperative
arrhythmias, length of mechanical ventilation, ICU and hospital
stays, and mortality). SPSS version 15 was used.
Results We studied 166 patients, 50 (30.1%) women and 116
(69.9%) men, mean age 67 ± 1 years. Surgical procedures were
92 (55.4%) coronary artery bypass grafting, 55 (33.1%) valvular,
16 (9.5%) combined surgery and three (1.8%) other procedures.
The preoperative left ventricular function was 65 ± 10%, and there
was no difference between patients regarding PLCO. Thirty-nine
(23.5%) patients developed PLCO. Aortic clamping and CPB time
showed no differences. According to the type of surgery, valvular
procedures had 19 (48.7%), coronary artery bypass grafting 14
(35.9%) and combined surgery six (15.4%) PLCO (P = 0.037).
According to the type of valvulopathy, PLCO was associated with
16 (59.3%) mitral valvulopathy versus 11 (40.7%) other
valvulopathies (P = 0.011). Patients with PLCO needed longer
mechanical ventilation (15 (7–37) hours versus 7 (5–10) hours
(P < 0.001)), ICU stay (5 (3.5–12.5) days versus 3 (2–4) days
(P < 0.001)) and hospital stay (20 (15–28) days versus 24
(18–37) (P = 0.022)). We observed 50 postoperative arrhythmias,
and in 22 patients were associated with PLCO (P < 0.001). There
were nine deaths, seven of them had PLCO (P < 0.001).
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Conclusions PLCO was associated with valvular procedures,
particularly mitral valvulopathy. PLCO had a higher incidence of
arrhythmias, longer ICU and hospital stays, longer mechanical
ventilation and higher mortality.
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Introduction Large clinical trials have revealed that renal dys-
function (RD) is a common problem and one of the major negative
predictors of survival in patients with acute heart failure (AHF);
however, the influence of different degrees of RD on prognosis has
been less well defined.
Methods We studied 82 patients (mean age 69 ± 11 years, 64
male patients) admitted to our unit for AHF from July 2005 to
November 2006. Fifty-eight percent of them (48 patients) met the
criteria for RD. The aim of our study was to evaluate whether
creatinine clearance (Cr-C) values calculated by Cockroft’s formula
[(140 – age (years)) x weight (kg)] / [72 x plasma creatinine level
(mg/dl)] adjusted by sex correlated with inhospital mortality in this
ICU population with AHF. We analyzed four subgroups of patients
according their Cr-C: ≥90 ml/min, 89–60 ml/min, 59–30 ml/min
and <30 ml/min. Kidney failure was defined as Cr-C < 60 ml/min.
The etiology of AHF was mainly ischemic heart disease (68%) and
mean the left ventricular ejection fraction was 31.6 ± 12.7%. We
compared baseline characteristics and used a multivariable model
to adjust and compare inhospital all-cause mortality across the Cr-
C groups.
Results Lower Cr-C was significantly related to older age, female
gender, lower blood pressure and ischemic etiology. Cardiogenic
shock was more frequent in patients with reduced Cr-C. Inhospital
total mortality was significantly higher in RD patients than in those
without RD (10% vs 3.3%), P < 0.0001. Mortality was 3.3% in
patients with Cr-C ≥ 90 ml/min, 13.4% in patients with Cr-C
between 89 and 60 ml/min, 24.2% in patients with Cr-C between
59 and 30 ml/min, and 62.5% in patients with Cr-C < 30 ml/min.
OR = 3.2 (2.23–4.58), P < 0.001.
Conclusions Among patients with AHF, RD is a frequent finding
and a major risk factor for inhospital mortality. Even mild degrees of
Cr-C impairment showed higher mortality rates than normal values.
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Introduction Acute myocardial infarction (AMI) is one of the most
common cardiovascular emergencies. Studies about old female
patients with AMI are much more frequent than those about
younger patients. The objective of our study is to analyze the risk
factors and prognoses of female patients younger than 60 years
old with AMI.
Methods Seventy-five female patients younger than 60 years old
with AMI were compared with 440 male patients regarding
hypertension, hyperlipemia, diabetes, smoking, occupation, body
mass index, complications and hospital mortality.
Results The morbidity of hyperlipemia and the ratios of mental
labors and smoking in female patients were significantly lower than
those in male patients (P < 0.001, P < 0.05, P < 0.001, respec-
tively); the morbidity of hypertension and the ratios of physical
labors in female patients were significantly higher than those in
male patients (P < 0.001, all); the morbidity of diabetes and body
mass index were similar in both sexes. The incidence of
complications in female patients was significantly higher than that
in male patients (P < 0.05), and the hospital mortality was similar in
both sexes.
Conclusions The incidence of AMI in female patients younger than
60 years old was much less than that in male patients, which
probably related to lower blood fat and more physical labors in
female patients. Hypertension played a more important role in
female patients younger than 60 years old with AMI as compared
with male patients. The prognoses in female patients were worse
than those in male patients, probably owing to the higher morbidity
of hypertension in female patients.
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Introduction Multiple organ dysfunction syndrome (MODS) is one
of the leading causes of inhospital mortality after acute myocardial
infarction (AMI) in the elderly. The identification of patients at
increased risk of MODS in the immediate postmyocardial infarction
period could therefore aid in targeting more aggressive treatment,
thereby leading to improved outcomes in these patients.
Methods Eight hundred patients 60 years of age and older, who
presented after onset of symptoms and had either ST elevation in
any two contiguous leads or new left bundle branch block, were
admitted to the Chinese PLA General Hospital from 1 January
1993 to 30 June 2006. Patients were divided into two groups,
based on the patients with or without MODS in the immediate
postmyocardial infarction period. Data were obtained from case-
record forms. The clinical characteristics, risk factors, clinical
presentation, and complications were analyzed. All statistical tests
were two-sided and nominal P values with a threshold of 0.05
were used in these exploratory analyses. All baseline variables on
univariate analyses with P < 0.05 were included as candidate
variables in the multivariable models.
Results Of the 800 patients enrolled, 27 patients (3.4%)
developed MODS within 30 days after AMI. Patients with MODS
had higher mortality rates (55.6% vs 11.6%, P < 0.001) and more
complications of cardiogenic shock (25.9% vs 6.2%, P < 0.001),
heart failure (59.3% vs 18.2%, P < 0.001), arrhythmia (44.4% vs
26.4%, P < 0.05) and pneumonia (55.6% vs 16.3%, P < 0.001) at
30 days, compared with patients without MODS. From multivariate
logistic regression analysis using MODS as the dependent variable
and the major acute symptoms during AMI, risk history, inhospital
complication and so on as the independent variables, the major
determinants of the MODS secondary to AMI inhospital were
shortness of breath (OR = 2.64, 95% CI = 1.13–6.16), heart rate
on the first day of admission (OR = 1.74, 95% CI = 1.14–2.64),
inhospital complication of heart failure (OR = 3.03, 95% CI =
1.26–7.26) and pneumonia (OR = 2.82, 95% CI = 1.18–6.77).
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Conclusions These findings demonstrate that the heart rate on the
first day of admission and inhospital complication of heart failure
and pneumonia were the independent impact factors of MODS
complicating AMI in the elderly.
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Introduction Acute myocardial infarction (AMI) may be accom-
panied by acute, severe, concomitant, noncardiac conditions. The
most common concomitant condition was pneumonia. The study
objective was to investigate the impact factors of pneumonia in
hospitalized patients with AMI.
Methods A total of 1,443 patients admitted with an AMI were
prospectively enrolled in Chinese PLA General Hospital between
January 1993 and June 2006. Patients were divided into two
groups, based on whether or not the patient was ill with pneumonia
within 30 days in hospital. The clinical characteristics, risk factors,
clinical treatment and complications were analyzed.
Results From multivariate logistic regression analysis using
pneumonia as a dependent variable and the history, inhospital
complications and so on as independent variables, the major
determinants of pneumonia were age (OR = 1.983, 95% CI =
1.499–2.623), history of coronary heart disease (OR = 1.566,
95% CI = 1.034–2.371), heart rate (OR = 1.823, 95% CI =
1.452–2.287) and white blood cell count (OR = 1.409, 95% CI =
1.071–1.853) at admission, and complications of heart failure
(OR = 3.264, 95% CI = 2.130–5.002), ventricular tachycardia or
fibrillation (OR = 2.347, 95% CI = 1.231–4.476), anemia (OR =
2.292, 95% CI = 1.482–3.543) and percutaneous coronary
interventions (OR = 0.519, 95% CI = 0.327–0.824).
Conclusions These findings demonstrate that aging, history of
coronary heart disease, heart rate and white blood cell count at
admission, and complications of heart failure, ventricular tachycardia
or fibrillation, anemia and percutaneous coronary interventions are
independent impact factors of pneumonia complicating AMI.
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Introduction The TEI index (myocardial performance index), an
indicator of combined ventricular systolic and diastolic function, is
defined as the ratio of the sum of the isovolumic relaxation time and
the isovolumic contraction time. The TEI index is independent of
ventricular geometry, and is not significantly affected by heart rate
or blood pressure. We sought to determine whether there was
association with postoperative atrial fibrillation (AF) after
cardiopulmonary bypass surgery.
Methods We performed a preoperative and the postoperative first
hour comparison between flow and tissue Doppler imaging
analyses in patients who underwent cardiopulmonary bypass
surgery. The Doppler sample volume was placed at the tips of the
mitral leaflets to obtain the left ventricular inflow waveforms from
the apical four-chamber view and just below the aortic valve to
obtain the left ventricular outflow waveforms from the apical long-
axis view, sequentially. All sample volumes were positioned with
ultrasonic beam alignment to flow. Tissue Doppler imaging was
obtained with the sample volume placed at the lateral and septal
corner of the mitral annulus from the apical four-chamber view. We
analyzed the mean of five consecutive measures. We compared
the result according to the presence of postoperative atrial
fibrillation. SPSS version 15 was used.
Results We studied 166 patients, 50 (30.1%) women and 116
(69.9%) men, mean age 67 ± 1 years. Surgical procedures were
92 (55.4%) coronary artery bypass grafting, 55 (33.1%) valvular,
16 (9.5%) combined surgery and three (1.8%) other procedures.
The onset of postoperative AF was 38 ± 5 hours. We observed a
higher preoperative lateral-mitral tissue Doppler TEI index (0.87 ±
0.43 versus 0.68 ± 0.32, P = 0.017) and preoperative septal-
mitral tissue Doppler (0.96 ± 0.45 versus 0.67 ± 0.31, P = 0.004)
in patients who developed postoperative AF. The flow Doppler TEI
index showed no differences between both groups. The
postoperative tissue Doppler TEI index showed no differences:
lateral-mitral, 0.76 ± 0.42 versus 0.71 ± 0.43 and septal-mitral,
0.76 ± 0.45 versus 0.78 ± 0.44, and the postoperative flow TEI
index showed similar values, 0.66 ± 0.30 versus 0.64 ± 0.27.
Conclusions Higher values of the preoperative tissue Doppler TEI
index, which reflects a worse global ventricular function, were
associated with postoperative AF.
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Introduction Quantification of left ventricular (LV) dyssynchrony is
important for heart failure patients with left bundle branch block to
assess the effectiveness of cardiac resynchronization therapy (CRT).
We tested the hypothesis that LV contraction dyssynchrony and the
impact of CRT on restoration of efficient synchronous contraction
could be quantified from discordant regional radial strain.
Methods Seven open-chest dogs had grayscale mid-LV short axis
echo images. Right atrial (RA) and right ventricular (RV) to simulate
left bundle branch block, and LV free wall (LVf) and apical LV (LVa)
pacing leads were placed to create CRT. Regional radial strain was
analyzed by custom software (Toshiba Corp.) for color-coded
speckle tracking in six radial sites during four different pacing modes:
RA, RA–RV, RA–RV–LVf (CRTf) and RA–RV–LVa (CRTa).
Dyssynchrony was assessed as the maximum time difference
between the earliest and latest time to peak segmental strain. RA
pacing was used as minimal dyssynchrony and RA–RV pacing as
maximal dyssynchrony. For each pacing mode, the global efficient
strain was calculated as the area under the curve (AUC) of the global
positive strain. During RA–RV we calculated the global negative
strain as the sum of AUCs of negative individual segment strains.
Results Baseline dyssynchrony during RA pacing control was
minimal (58 ± 40 ms). RV pacing increased dyssynchrony (213 ±
67 ms, P < 0.05 vs control) and reduced LV stroke work (89 ± 46
mJ, P < 0.05 vs RA). Radial dyssynchrony was improved by both
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CRTf and CRTa (116 ± 47 ms, 50 ± 34 ms, respectively, P < 0.05
vs RV). RV pacing displayed early septal wall thickening and
opposing wall thinning with a lower efficient strain compared with
RA (257 ± 124%/ms vs 129 ± 80%/ms, P < 0.05), whereas both
CRTf and CRTa restored efficient strain to RA pacing levels
(205 ± 78%/ms and 223 ± 76%/ms). During RA–RV, the global
efficient strain and negative global strain were similar (230 ±
88%/ms vs 257 ± 123%/ms, P < 0.05) and correlated (r2 = 0.96)
with RA global efficient strain.
Conclusions LV contraction efficiency and cardiac performance
can be quantified by speckle tracking radial strain analysis.
RA–RV-induced decreased efficiency and improved efficiency with
both CRTa and CRTf can be characterized by summed regional
strain changes.
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Introduction Lipopolysaccharides (LPSs) trigger the development
of sepsis by Gram-negative bacteria and cause a variety of
biological effects on host cells including alterations in ionic
channels. As heart rate variability is reduced in human sepsis and
endotoxemia, we hypothesized that LPS affects the pacemaker
current If in the human heart, which might – at least in part –
explain this phenomenon.
Methods Isolated human myocytes from right atrial appendages
were incubated for 6–10 hours with LPS (1 μg/ml and 10 μg/ml),
and afterwards used to investigate the pacemaker current If. The If
was measured with the whole-cell patch-clamp technique (at 37°C).
Results Incubation of atrial myocytes with 10 μg/ml LPS was
found to significantly impair If by suppressing the current at
membrane potentials positive to –80 mV and slowing down current
activation, but without effecting maximal current conductance.
Furthermore, in incubated cells (10 μg/ml) the response of If to β-
adrenergic stimulation (1 μM isoproterenol) was significantly larger
compared with control cells (the shift of half-maximal activation
voltage to more positive potentials amounted to 10 mV and 14 mV
in untreated and treated cells, respectively). Simulations using a
spontaneously active sinoatrial cell model indicated that LPS-
induced If impairment reduced the responsiveness of the model
cell to fluctuations of autonomic input.
Conclusions This study showed a direct impact of LPS on the
cardiac pacemaker current If. The LPS-induced If impairment may
contribute to the clinically observed reduction in heart rate
variability under septic conditions and in cardiac diseases like heart
failure where endotoxin could be of pathophysiological relevance.
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Introduction Cardiac cycle efficiency (CCE) can be calculated by
the pressure recording analytical method (PRAM), a less invasive
pulse-contour system that can provide beat-to-beat monitoring of
cardiac output (CO). CCE is an innovative parameter that ranges
from –1 to +1, with –1 being the worse and +1 the best possible
efficiency of the cardiac cycle (that is, better ventricular–arterial
coupling). Pro-BNP-type natriuretic peptide (pro-BNP) is
predominantly secreted from the cardiac ventricles in response to
increases in ventricular wall stress (VWS). Pro-BNP has been
shown to correlate with myocardial hypertrophy and dysfunction
[1]. We studied the feasibility of the CCE by PRAM when
compared with pro-BNP to monitor the VWS and myocardial
impairment and recovery in cardiac surgery.
Methods Ten patients with myocardial hypertrophy undergoing
aortic valve replacement were studied. Plasma pro-BNP concen-
trations were obtained 15 minutes after the induction of anesthesia
(t0), 15 minutes after myocardial reperfusion (t1), and 24 hours
after surgery (t2). CCE measurements were acquired at the same
times and correlations with pro-BNP levels were assessed.
Results CCE values ranged from –0.38 to +0.44. CCE decreased
from 18% to 42% at t1 with respect to t0 (P < 0.05). Also, at t1 a
decrease of CO from 10% to 25% with respect to t0 was
observed (P < 0.05). The t2 and t0 intervals showed similar values
for CCE (+0.37 ± 0.08 vs +0.35 ± 0.11) and CO (5.0 ± 0.9 vs
4.8 ± 1.1 l/min). Pro-BNP was 1,270 ± 1,560 pg/ml at t0,
increased moderately at t1, and peaked significantly at t2 (2,839 ±
873 pg/ml; P < 0.001). Overall, a negative correlation between
CCE and pro-BNP values was found (r = –0.89, P < 0.01). At
each time of the study, correlations between CCE and pro-BNP
were –0.91, –0.83, and –0.88 (t0, t1, and t2, respectively; P < 0.01).
Conclusions This study demonstrated an inverse correlation
between CCE and pro-BNP values. The feasibility of PRAM to
assess VWS, myocardial impairment and recovery during various
phases of surgery sounds good. This new pulse-contour system
seems a valuable tool that, together with pro-BNP measurements,
may provide new insights into cardiac and hemodynamic
assessment of patients scheduled for cardiac surgery.
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Introduction The Bradford Acute Coronary Syndrome (BACS) study
was set up after the introduction of 24-hour primary percutaneous
coronary intervention (pPCI) service in a tertiary centre, the Leeds
General Infirmary (LGI), approximately 15 miles away from the
initial site of presentation. This paper reviews the process, the
demographics and the challenges faced with the introduction of
pPCI in a tertiary centre remote from our hospital, the Bradford
Royal Infirmary (BRI). The BRI is an urban hospital serving a
population of about half a million people, and our busy emergency
department (ED) sees in excess of 110,000 new patients per year.
Methods Data from all acute coronary syndromes presenting to
the ED at the BRI are stored prospectively on a database. The
BACS study reviewed patients presenting between 22 May 2005
and 21 May 2007, 1 year before and 1 year after the introduction
of 24-hour pPCI, which commenced on 22 May 2006. A
structured analysis of the database was performed for the purpose
of this paper. Data concerning treatment modalities, times to
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achieve treatments and all the complications were tabulated and
presented graphically.
Results The study looked at 161 patients who had presented in the
year prior to the introduction of pPCI, and 156 patients who had
attended the ED at the BRI in the year after pPCI was introduced.
After the introduction of 24-hour pPCI, 87 (56%) patients had primary
angioplasty at the LGI, 24 (15%) had angiogram only at the LGI, two
(1.3%) had primary angioplasty at the BRI, eight (5%) were
thrombolysed at the BRI, three (2%) were thrombolysed at the LGI,
one (0.7%) was thrombolysed prehospitally, 26 (17%) had medical
management at the BRI and five (3%) patients had medical
management at the LGI. Of 119 patients transferred to the LGI, 87
(73%) had primary angioplasty, 24 (20%) had only angiogram, three
(2.5%) were thrombolysed, and five (4.5%) were managed medically.
Conclusions pPCI is the gold standard for the management of
acute myocardial infarction. This paper by the BACS study group
reviews the processes, the demographics of patients, and the
complications that can occur in patients who present with acute
myocardial infarctions and need to be transferred to a tertiary
centre where onsite 24-hour pPCI service is available.
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Introduction Postoperative atrial fibrillation is one of the most
frequent complications after cardiopulmonary bypass (CPB)
surgery. We evaluated the value of preoperative transthoracic
echocardiography and tissue Doppler imaging (TDI) analysis of the
mitral annulus and the incidence of postoperative new-onset atrial
fibrillation (NOAF) in CPB surgery.
Methods A cohort of CPB surgery patients underwent a
preoperative transthoracic echocardiography. The annular TDI
waveforms were obtained from the apical four-chamber view. The
sample volume was located at the septal and lateral side of the
mitral annulus. Early (E´) and late (A´) diastolic mitral annulus
velocities and the ratio of early to late peak velocities (E´/A´) were
obtained. SPSS version 15 was used.
Results We studied 166 patients, 50 (30.1%) women and 116
(69.9%) men, mean age 67 ± 1 years. Surgical procedures were 92
(55.4%) coronary artery bypass grafting, 55 (33.1%) valvular, 16
(9.5%) combined surgery and three (1.8%) other procedures.
Postoperative NOAF developed in 37 (74%) patients out of 50
patients with postoperative atrial fibrillation. There were no differences
in preoperative left ventricular function between groups. We found a
higher distance of the left atrium in systole and diastole in patients
with NOAF (P = 0.005 and P = 0.038, respectively) and a higher D
pulmonary vein peak velocity (52 ± 18 cm/s versus 41 ± 14 cm/s,
P = 0.02). Patients with NOAF had a higher TDI E/A septal ratio
(0.90 ± 0.33 versus 0.74 ± 0.29, P = 0.22). Attending to
preoperative diastolic filling patterns, patients with NOAF had nine
(24.3%) normal pattern, 19 (51.3%) abnormal relaxation, eight
(21.6%) pseudonormal pattern and one (2.7%) restrictive pattern
(P = 0.11), but NOAF patients were prompted to have an alteration in
the diastolic filling pattern (28 (75.7%) versus 9 (24.3%), P = 0.028).
Conclusions Higher size of the left atrium, preoperative D
pulmonary vein peak velocity and TDI E/A ratio together with any
degree of alteration of preoperative diastolic filling pattern were
associated with postoperative NOAF in CPB surgery.
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Introduction The authors decided to estimate the risk of death for
patients admitted to general surgery units dependent on the
suggested risk factor comprised in the description of basic
diagnosis (according to International Classification of Diseases
(ICD-10)).
Methods The study was a retrospective analysis of mortality in
general surgery units located at three university hospitals: N.
Barlicki University Hospital No. 1 in Lodz, WAM University Hospital
No. 2 in Lodz and B. Szarecki University Hospital No. 5. The study
comprised 26,020 patients treated in these units from 1 January
2003 to 31 December 2006. One of the distinguished death risk
factors – malignant neoplasm, suspicion of malignant neoplasm,
acute diffuse peritonitis, paralytic ileus, acute pancreatitis, other
inflammatory conditions, bleeding from digestive tract, acute
vascular disorders of intestines (included in basic diagnosis),
states with peritoneal obliteration, perforation or peritonitis
(included in basic diagnosis), states with acute hepatic failure or
cirrhosis (included into basic diagnosis) or lack of death risk factor
– is ascribed to each basic diagnosis of patients hospitalised in
one of the selected units (after modification of the structure). The
death risk groups formed in this way were subjected to further
statistical analysis in order to estimate the occurrence of significant
differences in mortality between the group without the risk factor
and the groups containing determined risk factors.
Results Among the risk factors subjected to analysis, only one
(malignant neoplasm) demonstrated a significant difference in
mortality in relation to the group of diagnoses without a risk factor
in every general surgery unit subjected to analysis. Three risk
factors (paralytic ileus, acute vascular disorders of intestines,
states with peritoneal obliteration, perforation or peritonitis)
manifested a significant difference in mortality in relation to the
group of diagnoses without a risk factor in one of the three surgical
units subjected to analysis.
Conclusions 1. A patient hospitalised in a general surgery unit
with basic diagnosis (according to ICD-10) comprising malignant
neoplasm is a patient at increased risk of death (high-risk factor). 2.
A patient hospitalised with basic diagnosis comprising paralytic
ileus, acute vascular disorders of intestines or states with
peritoneal obliteration, perforation or peritonitis is a patient with
moderately increased risk of death (low-risk factor). 3. A patient
hospitalised with basic diagnosis comprising acute diffuse
peritonitis and the states with acute hepatic failure or cirrhosis
requires further studies (necessity for increase of the sample size).
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Introduction Venous thromboembolism (VTE) is the most frequent
complication following surgery in cancer patients. This complica-
tion becomes more serious in complicated surgery. The morbidity
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and mortality associated with VTE remains unacceptably high. The
surgeon may not perceive VTE as a significant problem and would
not be aware of the effects of prophylaxis. The aim of the work is to
evaluate a different modality for prophylaxis against VTE among
patients with complicated, major surgery, for cancer treatment.
Methods One hundred and seventy-four patients admitted to the
surgical ICU with complicated (unexpected long duration (more
than 6 hours) or vascular injury) major surgery for cancer treatment,
in the period from January 2006 to June 2007, were included. The
patients were randomized to receive enoxaparin, 40 mg/12 hours
(group (E)), intermittent pneumatic compression (group (PC)) or
enoxaparin 40 mg/24 hours + intermittent pneumatic compres-
sions (group (E + PC)). All patients underwent duplex venous
ultrasonography examination on day 0; at discharge and at clinical
suspicion of deep vein thrombosis (DVT) or pulmonary embolism
(PE) (complaint of chest discomfort or shortness of breath, change
on ECG), a same-day chest X-ray scan and ventilation-perfusion
scan was obtained, to confirm PE. The incidence of DVT, PE and
bleeding was recorded.
Results Calf DVT was only recorded in one patient in group (E).
The incidence of proximal DVT was significantly higher in group
(E), 3.6%, compared with group (PC), 1.7%, and group (E + PC),
1.6%. No significant difference occurred in the incidence of clinical
PE between the three groups, but the incidences of total and fatal
PE were higher in group (PC), 3.4% and 1.7%, respectively. The
bleeding complication was recorded in three patients in group (E),
5.5%, one patient in group (PC), 1.7%, and one patient in group (E
+ PC), 1.6%. The total incidence of mortality in the 174 patients
admitted to the surgical ICU was 5.75%, 30% of deaths were
ascribed to PE, 20% were sudden cardiac deaths (which
undoubtedly included some undiagnosed PE). Fifty percent were
due to surgical complication and cancer, of which 60% were
considered due to respiratory failure, which may also have included
some deaths due to PE.
Conclusions In high-risk patients with complicated surgery the use
of multimodality (intermittent pneumatic compression plus LMWH)
provided excellent and safe prophylaxis against VTE.
Reference
1. Patiar S, et al.: Br J Surg 2007, 94:412-420.
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Introduction Pleural space hyperthermic perfusion with cisplatin
(hyperthermic intrathoracic chemotherapy (HIC)) in the
multimodality treatment of malignant mesothelioma is a relative
modern procedure [1]. Published data are related to postoperative
lung function and medium–long-term outcome. To our knowledge,
no study describes the effects of HIC on cardiovascular and
metabolic parameters. We aimed to evaluate the influence of the
HIC on cardiac output (CO) and oxygen delivery (DO2) in thoracic
surgery patients.
Methods Ten patients (mean age 67 years) undergoing thoracic
surgery for malignant mesothelioma were studied. HIC was applied
with 3 l of 0.9% saline solution warmed at 42.5°C, containing
cisplatin (100 mg/m2), and infused in 60 minutes. CO, DO2 and
systemic vascular resistance (SVR) were calculated with a pulse
contour system called the pressure recording analytical method
(PRAM) [2]. PRAM parameters were blinded to the anaesthesiolo-
gists who based their management (for example, fluids and/or
vasoactive drugs) on standard protocols. Data were retrieved
before, during and after the HIC.
Results When the HIC started, the mean arterial pressure (MAP)
and SVR decreased from 81 to 51 mmHg, and from 1,500 to
1,050 dyne*s/cm5, respectively (P < 0.05). The MAP quickly went
up to pre-HIC values before the end of HIC (within 10 min).
Conversely, SVR achieved pre-HIC values after 3 hours. CO and
DO2 decreased from 4.6 to 2.6 l/min, and from 610 to 370 ml/min,
respectively (P < 0.05). They increased after the end of HIC and
reached the pre-HIC values after 2 hours. Serum lactates peaked
during the HIC from 0.9 to 2.8 mmol/l (basal vs on-HIC values, P <
0.01) and slowly decreased to reach pre-HIC values after 3 hours.
Conclusions The hemodynamic and metabolic state of patients
undergoing thoracic surgery is severely affected by HIC. Standard
monitoring may not disclose the intraoperative hemodynamic
changes of patients undergoing HIC. Furthermore, it does not
provide key information about oxygen delivery with the hazard of an
imbalance between tissue oxygen demand and consumption. We
believe that a beat-to-beat hemodynamic monitoring should be
used whenever a HIC is scheduled for thoracic surgery patients to
avoid the risk of a low output state, tissue hypoperfusion, and bad
outcome.
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Introduction In the current practice of lung transplantation (LT),
donor and recipient genders are neither directly considered nor
matched. However, donor female gender has been suggested as a
significant risk factor for mortality in recipients after solid organ
transplantation. The purpose of this study was to evaluate the early
mortality (30 days) in LT recipients according to the donor gender
(male or female).
Methods We analysed the potential effect of donor gender on
early survival in all lung transplant recipients performed in our
institution between January 1999 and December 2006. The curves
of survival were calculated by the Kaplan–Meier method and the
comparison among curves was made by the log-rank method.
Results During the study period 153 LT procedures were
performed in 150 patients. There was a total of 99 male donors
and 54 female donors. The study groups were found to be
homogeneous with regard to the major preoperative risk factors
(etiology, status at transplantation, donor and recipient age, total
ischemic time). The mean age of recipients was 54 ± 10 years
(range 14–70). Indications included chronic obstructive pulmonary
disease in 49%, idiopathic pulmonary fibrosis in 40%, and other in
11%. The 30-day survival was 86% (95% CI, 77–91%) for
recipients who received male donor lungs and 80% (95% CI,
Critical Care    March 2008 Vol 12 Suppl 2 28th International Symposium on Intensive Care and Emergency Medicine
S99
66–88%) for recipients who received female donor lungs. No
differences were observed between both curves of survival
according to the log-rank test (P = 0.983). A Cox proportional
hazards analysis for overall survival at 30 days showed a hazard
ratio of 0.99 (95% CI, 0.63–1.58; P = 0.98) in recipients who
received male donor lungs.
Conclusions Even though previous reports suggest that gender
negatively affects survival, this factor proved to have no influence
on the early outcome of the present series.
Reference
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Introduction Lung transplantation (LT) has been increasingly
applied to patients over 60 years. The outcome of LT recipients in
this age group has not been analyzed systematically. The purpose
of this study was to evaluate the early mortality (30 days) in LT
recipients older than 60 years according to the type of procedure
(single vs bilateral LT).
Methods We retrospectively reviewed our experience with older
recipients between January 1999 and August 2007. The curves of
survival were calculated by the Kaplan–Meier method and the
comparison among curves was made by the log-rank method.
Results During the study period 167 LT procedures were
performed in 164 patients, of which 51 (30.5%) were aged 60
years and older (range 60–70, mean 63.3 ± 2.4 years). Thirty-
seven of the recipients 60 years and older received a single LT and
14 a bilateral LT. Indications included chronic obstructive pulmonary
disease in 51% (26/51), idiopathic pulmonary fibrosis in 43%
(22/51), and other in 6% (3/51). The 30-day survival was 84%
(95% CI, 67–92%) for patients who underwent a single LT and
93% (95% CI, 59–99%) for patients who underwent a bilateral LT.
No differences were observed between both curves of survival
according to the log-rank test (P = 0.896). A Cox proportional
hazards analysis for overall survival at 30 days showed a hazard
ratio of 1.05 (95% CI, 0.46–2.38; P = 0.897) in the unilateral LT
group.
Conclusions The early survival of lung transplant recipients 60
years of age or older who underwent bilateral versus single LT is
comparable. The type of procedure is not a predictor of mortality in
this age group. In carefully selected recipients ≥60 years of age, LT
offers acceptable early survival.
Reference
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Introduction Acute mesenteric ischemia (AMI) is a catastrophic
disorder of the gastrointestinal tract with high mortality. Owing to
recognition in advanced stages and late treatment of patients with
AMI, this disease is still considered a highly lethal condition. There
are few data on characteristics of this disease in Iran, so this study
was conducted to determine characteristics of this disease in the
population.
Methods In a retrospective study, all patient records of public and
private hospitals in Shiraz, Southern Iran, with an impression of
acute abdomen, bowel gangrene or abdominal pain, and patients
with risk factors for this disease, who were admitted from March
1989 to March 2005, were reviewed, and those with AMI were
identified, analyzed and compared with other research.
Results Among the 10,000 patient records studied, 105 patients
with AMI were identified. The mean age of patients was 57 years.
The most common symptoms were abdominal pain (98.09%),
vomiting (68.5%) and constipation (36.1%). Heart diseases were
seen in 44.7% of cases. The mortality rate in patients with AMI was
50.5%. The mortality rate was lower in patients undergoing
mesenteric angiography (P = 0.014). In those patients in whom the
site of lesion was exactly defined, 41.9% of cases were due to
venous thrombosis, 25.7% due to mesenteric arterial emboli, 19%
due to mesenteric arterial thromboses, and 8.5% were of
nonocclusive types.
Conclusions AMI is a relatively common cause of acute abdomen
especially in old patients referred to Shiraz hospitals, with venous
thrombosis being the most common type. Early diagnosis
especially with early use of mesenteric angiography and treatment
may decrease the mortality from AMI.
References
1. Brandt LJ, Boley SJ: Intestinal ischemia. In: Sleisenger and
Fordtran’s Gastrointestinal and Liver Disease. 7th edition.
Philadelphia, PA: W.B Saunders, Co.; 2002.
2. Williams LF Jr: Mesentric ischemia. Surg Clin North Am
1988, 68:331-353.
3. Benjamin E, Oropello JM, Iberti TJ: Acute mesenteric
ischemia: pathophysiology, diagnosis and treatment. Dis
Mon 1993, 39:131-210.
4. Luther B, Bureger K, Sellentin W: Acute occlusion of the
intestinal ateries – diagnosis and surgical therapy. Zen-
tralbl Chir 1997, 112:1411-1419.
P258
Systemic inflammatory response syndrome post cardiac
surgery: a useful concept?
NS MacCallum, SE Gordon, GJ Quinlan, TW Evans, SJ Finney
NHLI, Imperial College, London, UK
Critical Care 2008, 12(Suppl 2):P258 (doi: 10.1186/cc6479)
Introduction Systemic inflammatory response syndrome (SIRS) is
the leading cause of morbidity and mortality in the critically ill. It is
associated with a 50% reduction in 5-year life expectancy. SIRS is
defined as two of the following criteria: heart rate >90 beats/min,
respiratory rate >20 breaths/min or pCO2 <4.3 kPa, temperature
<36°C or >38°C, white cell count <4 x 109/l or >12 x 109/l. These
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criteria are used to stratify patients for specific therapies and in
research to define interventional groups. Cardiac surgery is
associated with systemic inflammation. We undertook to describe
the incidence of SIRS post cardiac surgery and relate this to
outcome.
Methods We retrospectively analysed prospectively collected data
from 2,764 consecutive admissions post cardiac surgery (coronary
artery bypass grafting 1,425 admissions, valve 763 admissions,
combined 252 admissions, other 324 admissions). The number of
criteria met simultaneously within 1-hour epochs was recorded for
the entire admissions.
Results Totals of 96.4%, 57.9% and 12.2% of patients met at
least two, three or four criteria respectively within 24 hours of
admission (Table 1). The ICU mortality was 2.67%. The length of
stay (LOS) exceeded 3 days in 18.5% of patients. The temperature
criterion was least often fulfilled. Scoring and outcome data are
presented. Simultaneous presence of more criteria was associated
with greater mortality and more prolonged ICU stay, P < 0.0001.
Table 1 (abstract P258)
Scoring and outcome variables associated with meeting SIRS
criteria (n = 2,764)
SIRS criteria >2 (96.4%) >3 (57.9%) 4 (12.2%)
APACHE II score 15.2 ± 4.7 15.8 ± 5.1 17.1 ± 5.9
SOFA score (day 1) 5.5 ± 2.2 5.7 ± 2.3 6.3 ± 2.6
ICU mortality (%) 2.78 4.25 10.42
LOS (days) 3.2 ± 7.0 4.0 ± 8.5 6.8 ± 14.0
Conclusions Nearly all patients fulfilled the standard two-criteria
definition of SIRS within 24 hours of admission. This definition
does not adequately define the subgroup of patients with greater
systemic inflammation, mortality or LOS. Thus, some clinical
manifestations of inflammation are very common following cardiac
surgery, although not necessarily prognostic. The presence of
three or more criteria was more discriminatory of death and
prolonged ICU stay. We propose that three SIRS criteria is a more
appropriate threshold that defines those patients with clinically
significant inflammation post cardiac surgery.
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Introduction Ischaemic preconditioning provides endogenous
protection against ischaemia and also inflammation resulting from
ischaemia reperfusion injury. A number of exogenous pharma-
cological substances including adenosine, bradykinin, noradrenaline
and inhalational halogenated anaesthetic agents are recognised
triggers of preconditioning.
Methods The investigation was approved by the Royal Brompton,
Harefield & NHLI research ethics committees. Patients scheduled
for first-time coronary artery bypass grafting (CABG) surgery with
triple-vessel coronary artery disease and at least moderate left
ventricular function were recruited. Exclusion criteria included: age
>80 years; unstable angina; noninsulin-dependent diabetes
mellitus treated with KATP channel blockade; use of nicorandil or
nitrate use within 24 hours of surgery. Preoperative risk variables
were compared using the EuroSCORE. Patients were randomised
to anaesthesia facilitated using halogenated inhalational agents or
total intravenous anaesthesia (TIVA) (propofol). The surgical
technique was standardised as far as possible. All cases
necessitated the use of cardiopulmonary bypass. Inflammation was
assessed up to 72 hours postoperatively using a combination of
physiological and biochemical parameters. Physiological assess-
ment consisted of the development of systemic inflammatory
response syndrome (SIRS). Biochemical assessment consisted of
measurement of plasma IL-6, myeloperoxidase and C-reactive
protein. Blood samples were obtained preoperatively and at 5, 24,
48 and 72 hours postoperatively.
Results SIRS was reduced in patients who received TIVA (P <
0.05, Fisher’s exact test; n = 13 TIVA, n = 8 inhalational; Figure 1).
Plasma IL-6, myeloperoxidase and C-reactive protein were
elevated postoperatively although levels were unaffected by the
mode of anaesthesia (P = not significant, two-way ANOVA; n = 13
TIVA, n = 8 inhalational).
Conclusions We have demonstrated a protective benefit of TIVA
on the development of SIRS postoperatively in patients undergoing
CABG surgery. A larger double-blind randomised controlled trial is
required to confirm these results.
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Introduction Goal-directed therapy has been used for critically ill
patients. The purpose of this study was to evaluate the ability of
intraoperative perfusion parameters in predicting outcome after
cardiac surgery.
Methods A total of 98 patients undergoing cardiac surgery were
prospectively evaluated. Samples of lactate, arterial gases, and
central venous saturation (SVO2) were collected 60 minutes after
beginning surgery, 120 minutes after and at the end of the
procedure. Univariate and multivariate analyses were performed.
Results Factors associated with cardiac dysfunction were
previous low ejection fraction (P = 0.035), surgery with pump (P =
0.001), longer duration of pump (P = 0.003), low initial intra-
operative central venous saturation (P = 0.001) and high level of
initial gapCO2 (P = 0.02). A low intraoperative SVO2 was
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Figure 1 (abstract P259)
Systemic inflammatory response syndrome (SIRS) post coronary artery
bypass grafting.
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independently associated with a sevenfold increase (95% CI,
2–21) and a initial high level of CO2gap with a 4.5-fold increase
(95% CI, 1.6–12) in cardiac dysfunction after cardiac surgery.
Associated factors with renal dysfunction were age (P = 0.045),
longer duration of pump (P = 0.01) and low initial intraoperative
central venous saturation (P = 0.001). A low intraoperative SVO2
was associated with a 12-fold increase and a low level of initial
base excess with a 27-fold increase in rates of infection after
cardiac surgery. A high level of final arterial lactate predicted a
longer time of mechanical ventilation (OR, 4.56; 95% CI,
1.4–11.2). There were no relations of perfusion parameters with
longer time of stay in the ICU or mortality.
Conclusions In this observational study, a low intraoperative level
of SVO2 is an independent predictor of cardiac dysfunction, renal
failure and infection after cardiac surgery and a high level of lactate
is associated with a longer time of mechanical ventilation. These
findings suggest that these parameters may be markers of
prognosis after cardiac surgery.
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Introduction Prostacyclin inhalation is increasingly used to treat
acute pulmonary hypertension (PHT) and right ventricular (RV)
failure. Prostacyclins not only affect vasomotor tone, but may also
have cyclic adenosine 3′,5′-monophosphate-mediated positive
inotropic effects and modulate autonomic nervous system (ANS)
tone. We studied the role of these different mechanisms in the
overall hemodynamic effects produced by iloprost (ILO) inhalation
in an experimental model of acute PHT.
Methods Twenty-six pigs were instrumented with biventricular
conductance catheters, a pulmonary artery (PA) flow probe and a
high-fidelity PA-pressure catheter. The effects of 50 μg inhaled ILO
were studied in healthy animals with and without blockade of the
ANS, and in animals with acute hypoxia-induced PHT.
Results ILO had minimal hemodynamic effects in healthy animals
and produced no direct effects on myocardial contractility after
pharmacological ANS blockade. During PHT, ILO resulted in a
51% increase in cardiac output when compared with placebo (5.6
± 0.7 vs 3.7 ± 0.8 l/min, P = 0.0013), a selective reduction of RV
afterload (effective PA-elastance (PA-Ea): from 0.6 ± 0.3 vs 1.2 ±
0.5 mmHg/ml; P = 0.0005) and a significant increase in left
ventricular (LV) end-diastolic volume (91 ± 12 vs 70 ± 20 ml, P =
0.006). Interestingly, RV contractility was reduced after ILO (slope
of preload recruitable stroke work: 3.4 ± 0.8 vs 2.2 ± 0.5 mW/ml;
P = 0.0002), while ventriculovascular coupling remained essentially
preserved (ratio of RV end-systolic elastance over PA-Ea: 0.97 ±
0.33 vs 1.03 ± 0.15).
Conclusions In acute PHT, ILO improved global hemodynamics
primarily via selective pulmonary vasodilation and a restoration of
LV preload. The reduction of RV afterload was associated with a
paradoxical decrease in RV contractility. This appears to reflect an
indirect mechanism serving to maintain ventriculovascular coupling
at the lowest possible energetic cost, since no evidence for a
direct negative inotropic effect of ILO was found.
Reference:
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Introduction Enthusiasm for application of dobutamine has
retreated after the introduction to clinical practice of new medica-
tions such as levosimendan. Such treatment, however, is rather
expensive as well as remote outcomes still being under discussion.
Owing to this, dobutamine still has an appropriate place in the
treatment of patients with complicated acute myocardial infarction
(AMI) where signs of acute heart failure and pulmonary
hypertension should be treated immediately. The study objective
was to evaluate the hemodynamic effect of dobutamine using the
pulmonary artery catheterization technique in patients with AMI
complicated by cardiogenic shock and pulmonary hypertension.
Methods Dobutamine was infused continuously for patients with
AMI complicated by cardiogenic shock and with verified pulmonary
hypertension. Only low doses not exceeding 4 μg/kg/min
dobutamine were continuously infused. Data were obtained using
a pulmonary artery catheter. Hemodynamic indices including the
cardiac output (CO), pulmonary pressures and pulmonary artery
capillary wedge pressure (PAWP) were measured.
Results Nineteen patients were investigated according to the
study protocol, 11 (57.9%) men and eight (42.1%) women.
Average age was 65.1 ± 11.2 years. Anterior AMI was diagnosed
for 14 (73.7%) patients, inferior for five (26.3%). The inhospital
mortality rate was 52.6% (10 patients). The initial CO was 3.3 ±
0.9 (range from 1.8 to 5.4 l/min), the mean pulmonary artery
pressure (MPAP) was 34.8 ± 13.4 mmHg (maximum 50 mmHg),
and the PAWP was 25.7 ± 10.4 mmHg (maximum 42 mmHg).
After the first day of continuous dobutamine infusion, the CO was
4.2 ± 1.2 (range from 2.5 to 6.4 l/min), the MPAP was 31.1 ± 7.9
mmHg (maximum 43 mmHg), and the PAWP was 16.2 ± 3.8
mmHg (maximum 21 mmHg). After the termination of dobutamine
(after 48 hours), the CO was 4.2 ± 0.9 (range from 3.1 to 6.1
l/min), the MPAP was 30.2 ± 8.1 mmHg (maximum 46 mmHg),
and the PAWP was 16.4 ± 3.4 mmHg (maximum 21 mmHg). The
increase of the initial CO and reduction of PAWP after the first day
of continuous dobutamine infusion were statistically significant
(P < 0.05).
Conclusions Application of dobutamine showed a positive benefit
in reduction of pulmonary hypertension and pulmonary capillary
wedge pressure as well as in the increase of cardiac output for
patients with AMI complicated by cardiogenic shock and
pulmonary hypertension.
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Introduction Catecholamines have been shown to modulate
various immunological functions. In previous experiments we
demonstrated that dobutamine pretreatment protects T cells from
staurosporin-induced apoptosis [1]. In the current study we
planned to investigate whether antioxidative properties of the
dobutamine molecule might be responsible for its protective effect.
Methods Jurkat T-cell passages 1–12 were used.
Results Experiments with a caspase-activity assay confirmed
previous results: pretreatment (4 hours) with dobutamine 0.1 mM
and 0.5 mM decreased staurosporin-induced apoptosis in Jurkat T
cells from 14.0% to 11.6% and 8.7%, respectively (P < 0.01).
Other catecholamines such as epinephrine and norepinephrine
had no protective effect. To investigate whether production of
ROS could be measured, Jurkat T cells were loaded with CM-
H2DCFDA. After washing steps, the cells were exposed to 0 μM,
1 μM, 10 μM and 100 μM H2O2 for 6 hours. The fluorescence
signal (ex 480/em 520 nm) measured was 36.7 U, 37.7 U, 38.1 U
and 54.3 U, respectively, demonstrating the relation between ROS
and the fluorescence signal. Next, production of ROS due to
staurosporin treatment (2 μM) was measured: ROS production
increased minimally after exposure for 2 hours. Only after 6 hours
of staurosporin treatment, the ROS signal increased from 36.7 U
to 42.1 U (P < 0.05). Subsequently, the ROS-scavenging effect of
dobutamine was investigated. CM-H2DCFDA-loaded cells were
exposed to staurosporin (2 μM) for 2 hours, with or without
dobutamine pretreatment (0.1 mM and 0.5 mM): the ROS-
scavenging effect was very pronounced in the 0.1 mM group
(decrease in fluorescence signal from 56.1 U to 22.5 U, P < 0.01),
and increased further in the 0.5 mM group (17.8 U, P < 0.01).
Control experiments with unstained cells showed that addition of
dobutamine did not change the autofluorescence signal.
Conclusions These experiments demonstrate that dobutamine
acts as a ROS scavenger. Whether this scavenging effect is
responsible for the protective properties of dobutamine against
staurosporin-induced apoptosis is currently under investigation.
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Introduction Levosimendan is a positive inotropic drug agent that
increases the sensibility of contractile proteins to calcium [1]. The
drug is used in patients with decompensated low-output heart failure
[2]. The aim of our study is to analyze the hemodynamic effects of
levosimendan in patients with refractory cardiogenic shock.
Methods After approval by our institutional ethics committee, 16
patients who had a refractory cardiogenic shock after myocardial
infarction (n = 10), peripartum cardiomyopathy (n = 3) and
cardiomyopathy (n = 3) were prospectively included in our study.
Levosimendan was added to conventional inotropic agents
(dobutamine) with a bolus dose of 12 μg/kg for 30 minutes
followed by a continuous infusion at a rate of 0.1 μg/kg/min for
24 hours. Hemodynamic data (continuous cardiac output and
venous oxygen saturation) were obtained by a Swan–Ganz
catheter at T0, 30 minutes, 90 minutes, 2 hours, 4 hours, 8 hours,
12 hours, 24 hours and 48 hours. A transoesophageal
echocardiography was performed at T0, day 1, day 2, day 7 and
day 15. SPSS version 10 was used for all statistical analyses.
Results After levosimendan administration, a significant reduction
of pulmonary and vascular resistances values was followed by a
significant increase of the cardiac index and venous oxygen
saturation. Changes in heart rates and mean arterial blood
pressure were not significant. The left ventricular ejection fraction
was increased from 24% (T0) to 40% (day 2).
Conclusions This study showed that levosimendan improves
hemodynamic parameters and left ventricular ejection fraction in
patients with cardiogenic shock. Controlled trials of sufficient size
are needed, however, to confirm these results.
References
1. Figgitt DP, Gillies PS, Goa KL: Drugs 2001, 61:613-627.
2. Follath F, Cleland JGF, Just H, et al.: Lancet 2002, 360:196-
202.
P265
Levosimendan does not improve resuscitation success
after hypovolemic cardiac arrest
E Semenas, L Wiklund
Uppsala University Hospital, Uppsala, Sweden
Critical Care 2008, 12(Suppl 2):P265 (doi: 10.1186/cc6486)
Introduction Resuscitation from hemorrhagic shock and
subsequent cardiac arrest (CA) is a major clinical challenge in the
care of trauma patients. Levosimendan, a new calcium sensitizer,
exerts positive inotropic and lusitropic effects in failing human
myocardium without increase in energy expenditure [1]. The aim of
this study was to evaluate possible beneficial effects of
levosimendan in combination with vasopressin in hypovolemic CA
and subsequent cardiopulmonary resuscitation.
Methods Five anesthetized male piglets (26.5 ± 1.1 kg) were bled
(25.1 ± 3.4% of calculated total blood volume) to a mean arterial
blood pressure of 35 mmHg during 12.9 ± 0.2 minutes. After-
wards the piglets were subject to 4 minutes untreated ventricular
fibrillation followed by 12 minutes open-chest cardiopulmonary
resuscitation (CPR). At 5 minutes of CA, 0.4 U/kg vasopressin and
12 μg/kg levosimendan were given intravenously and an infusion of
3 ml/kg hypertonic saline and dextran (7.5% saline, 6% dextran
70) was given in 20 minutes. Internal defibrillation was attempted
from 7 minutes of CA to achieve restoration of spontaneous
circulation (ROSC). If necessary, at 8 minutes of CA, 0.4 U/kg
vasopressin was repeated intravenously. Hemodynamic variables,
continuous cerebral cortical blood flow and blood gas parameters
were measured during CPR and up to 180 minutes after ROSC.
Blood samples for 8-iso-PGF2α, 15-keto-dihydro-PGF2α, protein S-
100β and troponin I were taken.
Results ROSC was achieved in two out of five piglets. Only one of
these piglets survived the whole experiment. Another piglet died
60 minutes after ROSC due to a new episode of ventricular
fibrillation. It was difficult to achieve ROSC due to persistent
ventricular fibrillation during CPR. The mean number of defibril-
lation attempts was 14.2 (range: 8–21). The mean coronary per-
fusion pressure was 19–21 mmHg during CPR. Piglets that
achieved ROSC needed a constant dobutamine infusion for
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hemodynamic stability. Concentrations of troponin I continuously
increased after ROSC, reaching maximum levels at the end of the
study. During the very early reperfusion phase (5–15 min after
ROSC) the cerebral cortical blood flow was 18–47% greater than
baseline values. Thereafter, it remained elevated about 18% at 30
minutes, and was decreased to baseline level during the remainder
of the experiment.
Conclusions A combination of levosimendan and vasopressin did
not improve resuscitation success. A combination of levosimendan
and vasopressin produced ventricular fibrillation resistant to
defibrillation attempts in a hypovolemic cardiac arrest model. Further
studies are necessary in order to evaluate effects of vasopressin and
other inotropic agents in hypovolemic animal models.
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Introduction After cardiac surgery, most children require inotropic
support. Dobutamine, dopamine and milrinone are not always
effective, however, and in some cases these drugs are associated
with significant adverse effects. Levosimendan, a new calcium-
sensitizing agent, may be an alternative to treatment of this
syndrome, with positive inotropic effects, vasodilating properties
without cathecolamine release. We sought to investigate the effect
of levosimendan in children after cardiac surgery.
Methods A prospective open-label study was carried out in 18
children. Their mean age was 42 months (5 days–18 years), the
mean ejection fraction was 31% and all of them required one or
more inotropic drug for more than 24 hours before receiving
levosimendan. Levosimendan was administered without bolus
dose, in an intravenous infusion of 0.2 μg/kg/min over 24 hours.
Echocardiographic assessments of ventricular function were made
before and 3–5 days after levosimendan infusion.
Results The heart rate, systolic pressure, diastolic pressure, mean
blood pressure, and central venous pressure were unchanged
during and after levosimendan administration. Levosimendan
allowed for discontinuation of catecholamines in 10 patients and a
dose reduction in five patients. The dose of dobutamine was
reduced from 8.4 μg/kg/min prelevosimendan to 3 μg/kg/min on
day 5 (P < 0.01). The ejection fraction for the group improved from
31% to 40.5% (P < 0.01).
Conclusions Levosimendan can be safely administered to infants
and children with low-output syndrome after cardiac surgery.
Levosimendan allowed for significant reduction in catecholamine
infusions and also produced an objective improvement in
myocardial performance in children after cardiac surgery without
significant adverse effects.
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Introduction Levosimendan, a calcium sensitizer, improves cardiac
output in patients with acute decompensated heart failure (ADHF).
Its effect in patients with cardiogenic and septic shock remains
unknown. We hypothesized that levosimendan improves cardiac
output similarly in patients with ADHF (group A), cardiogenic
(group C), and septic shock (group S).
Methods Sixty consecutive patients were enrolled in this
prospective observational study. Levosimendan infusion was
started in all patients at 0.05 μg/kg/min intravenously, without a
bolus dose, and was increased by 0.05 μg/kg/min every 30
minutes to a maximum of 0.2 μg/kg/min intravenously, at which
time levosimendan infusion was continued for 24 hours. The
thermodilution cardiac output and central venous saturation
(ScvO2) were measured at baseline and every 4 hours thereafter
for a total of 48 hours. Hypotension (mean arterial pressure
< 65 mmHg) was treated with norepinephrine, titrated to mean
arterial pressure ≥ 65 mmHg.
Results APACHE II scores were 15 ± 7, 18 ± 7, and 22 ± 7 (P =
0.01) and median (IQR) ICU length of stay was 5 (3.9), 8 (6.23),
and 11 (7.21) days (P < 0.01) for groups A, C, and S, respectively.
During the first 48 hours, the cardiac index increased within each
group (P = 0.01) but there were no differences in cardiac index
between the study groups (P = 0.58), and the ScvO2 did not
change significantly within and between study groups (Figure 1).
Group S received more norepinephrine than did the other groups
(P < 0.05).
Conclusions Levosimendan has similar hemodynamic effects
when administered to patients with ADHF, cardiogenic, and septic
shock. It did not appear to have a significant effect on ScvO2.
Available online http://ccforum.com/supplements/12/S2
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Changes in central venous saturation (ScvO2).
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Introduction The most important goal during mechanical
ventilation in the ICU is to achieve patient comfort and patient–
ventilator synchrony. Once proper analgesia has been established,
an infusion of a sedative should be added. The goal of this study
was to investigate whether continuously awake sedation during
mechanical ventilation (MV) decreased the days of ventilation and
complications.
Methods All patients with MV – based on the abovementioned
criteria – were included (age: 20–70 years; community-acquired
pneumonia; two quadrant infiltrates; PaO2/FiO2 < 200; no other
organ dysfunction). From June 2001 to February 2004, patients
with MV received deep sedation (midazolam 0.03–0.20 mg/kg
body weight/hour and propofol 0.5–2.0 mg/kg body weight/hour).
This is the ‘sedatonarcosis’ group. From March 2004 to July 2007,
patients were treated with ‘awake sedation’ (alprasolam 1.5–2.0
mg/day).
Results All of the patients received low tidal volume ventilation, de-
escalation antibiotics, continuous correction of homeostasis,
management of enteral feeding and pulmonary physiotherapy. In
both groups we applied noninvasive respiratory therapy after
extubation. It was possible to mobilise patients earlier – before the
extubation – in the awake sedation group. See Table 1.
Conclusions Adopting awake sedation during MV (compared with
continuous sedatonarcosis) decreased the days on ventilation, and
the lengths of ICU and hospital stay.
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Introduction A problem for patients submitted to extended
sedation is evidence of a liver dysfunction. We wanted to verify
whether this dysfunction is either correlated with the splanchnic
hypoperfusion or with the extended administration of drugs.
Methods During March–September 2007, four patients with pure
cranial trauma (age 34–50 years) were treated with midazolam,
propofol, sodium thiopental and fentatienil. Parameters evaluated:
burst suppression ratio (BSR) with electroencephalography
(Aespect; GE Health Care), functional capillary density (FCD) and
mean velocity with Microscan and MAS (MicroVision Medical,
Amsterdam, The Netherlands), plasma disappearance ratio (PDR)
with Pulsion LIMON (SEDA; Milano), intramucosal pH and regional
PCO2 with Tonocap (GE Health Care), electrocardiography, mean
arterial pressure and hematochemical examinations (transaminases,
γ-glutamyl transpeptidase (GGT), serum bilirubin, serum amylases,
serum lactates and drugs dosages). Exclusion criteria: hepatopathy
at admission, age <18 years and >60 years, BMI > 30, clinical
factors favouring splanchnic hypoperfusion. All the parameters are
analysed at t0 (admission to the ICU) and then every 48 hours
during the sedation (t1, t2, t3) and at its end (t4, t5) through the
Friedman test (P < 0.05) and the Spearman test (P < 0.05 and
R > 0.6).
Results Increase of transaminases at the end of sedation in three
of the four patients. Earlier increase of GGT in all patients. Serum
bilirubin always in range. Increase of serum amylases in three of the
four patients is correlated to propofol dosage. PDR always
>16%/ml (cutoff of hepatic hypoperfusion). BSR always >0%
during t1, t2, t3. FCD always steady and mean velocities always
high. Hepatic cytonecrosis indexes, GGT, serum amylases are well
correlated to splanchnic perfusion indexes (serum lactates, FCD
and regional PCO2) so their increase apparently is not due to
splanchnic hypoperfusion. Patient 1 (propofol, fentatienil early
replaced with sodium thiopental, midazolam), increase of trans-
aminases when midazolam was stopped. Because of the beginning
of an epileptic status, the patient was eliminated from the study.
Patient 2 (propofol, midazolam, fentatienil), increase of trans-
aminases associated with the paradoxical increase of splanchnic
perfusion. Patient 3 (propofol, midazolam, fentatienil), increase of
transaminases and serum amylases is not associated with the
splanchnic hypoperfusion. Serum amylases increase according to
the increase of propofol dosage. Patient 4 (propofol, fentatienil),
late increase of transaminases, serum amylases and GGT is
associated with the propofol dosage.
Conclusions Drugs used for the analgosedation seem responsible
for the increase of transaminases but not for the decrease of
splanchnic perfusion. This study has to be confirmed by other
studies recruiting more patients and with more precise exclusion
criteria.
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Introduction With the approval of the anaesthetic conserving
device (AnaConDa®), inhalative sedation in the ICU has become
feasible [1]. Isoflurane has been investigated in postoperative and
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Results 
MV Length of ICU stay Length of hospital stay Died Exclusion 
Patients (n) (average, days) (average, days) (average, days) (n) (n)
Sedatonarcosis group (n = 21) 6.37 9.06 18.66 4 1
Awake sedation group (n = 23) 4.38 7.22 15.16 3 2
t0.05 1.8357 1.28725 1.2940
P value <0.05 <0.05 <0.05 Not significant
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critically ill patients using AnaConDa® [2,3], whereas sevoflurane
sedation has only been reported in small observations [4,5]. This
randomised, single-blinded, BIS-controlled study was to evaluate
for the first time sevoflurane via AnaConDa® compared with
propofol, with regard to recovery, sedation quality and consump-
tion of anaesthetics.
Methods Seventy patients scheduled for elective coronary artery
bypass graft surgery were randomised at admission to the ICU to
either receive sevoflurane (n = 35) or propofol (n = 35) for post-
operative sedation. The primary endpoint was recovery time from
termination of sedation (extubation time, spontaneous eye opening
and hand grip). Sedation quality (using the Richmond Agitation
Sedation Scale, RASS), sevoflurane consumption, duration of ICU
and hospital stays, and adverse side effects were documented.
Results Median recovery times were significantly shorter (P <
0.002) with sevoflurane than with propofol (extubation time:
21.5 min (2–259) vs 150.5 min (22–910)). Mean sevoflurane
consumption was 3.2 ± 1.4 ml/hour to obtain end-tidal concen-
trations of 0.5–1 vol%; mean administration of propofol was 2.4 ±
1.1 mg/kg/hour. Sedation quality was comparable in both groups
(RASS –3 to –4), and no serious complications including
haemodynamics related to either sedative drug occurred. Length of
stay in the ICU was similar in both groups, whereas patients
receiving sevoflurane were discharged significantly (P < 0.03)
earlier from hospital (10.6 ± 3.3 days vs 14 ± 7.7 days).
Conclusions Sevoflurane administration via AnaConDa® is an
efficacious and easy titratable way to provide postoperative
sedation in the ICU. Recovery from sedation was facilitated with
sevoflurane compared with propofol, and resulted in a shorter
ventilation time. Sevoflurane sedated patients left hospital a mean
3 days earlier compared with a propofol-based regimen.
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Introduction Surgery of upper abdominal organs is painful and
mutilating, joined with possible serious postoperative complica-
tions – pulmonary, abdominal (anastomoses related), cardiological,
and thromboembolic.
Methods During past year 100 patients had upper abdominal
surgery. According to analgesia type they were divided into two
groups. The first group (G1) was administered a first dose of local
anesthetic (bupivacain 0.25% 5 ml) prior to total anesthesia
through a thoracic epidural catheter. After that they underwent
classical total anesthesia (midazolam, diprivan, fentanil, relaxant),
followed by anesthesia with diprivan 6 mg/kg/hour and analgesia
with local anesthetic epidurally. Postoperatively they were
administered through the thoracic epidural catheter a combination
of opioids (morphine 2 mg) and local anesthetic (bupivacain
0.125% 6–8 ml) every 8 hours. The other group (G2) underwent
classical total anesthesia followed by classical proportion of oxidul
and oxygen, and analgesia by fentanyl, with postoperative systemic
analgesia by nonsteroid anti-inflammatory drugs, paracetamol, and
metamisol sodium. The parameters followed during surgery were
arterial tension, heart rate, gas analysis, diuresis, and operating
field bleeding. The postoperatively followed parameters were
Visual Analog Scale, arterial tension, heart rate, gas analysis,
beginning of peristalsis, and pulmonary complications.
Results Thoracic epidural analgesia during surgery provides better
hemodynamic patient stability and lower blood loss due to
intraoperative bleeding, statistically and clinically significantly better
analgesia in the first postoperative 72 hours, compared with
systemic analgesia (Visual Analog Scale, G1 < 8 in movement vs
G2 > 30 in movement), reduces the period of postoperative ileus
(for 1.06 days), reduces pulmonary and cardiologic complications,
provides early patient mobilization and decreases the number of
intensive postoperative care days (for 3.9 days).
Conclusions Our experience shows that thoracic epidural
analgesia is the right choice, because it provides effective pain relief
in patients, prevention of postoperative complications, provides
early patient mobilization and reduces the length of stay in the ICU.
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Introduction Use of etomidate in cardiopulmonary bypass (CPB)
surgery is usual practice during the anesthetic induction. The
objective of this study was to determine the incidence of relative
adrenal insufficiency (RAI) in CPB patients after etomidate
administration and the impact on hemodynamic status.
Methods A prospective cohort study was performed on CPB
patients who received etomidate or not during the anesthetic
induction. Patients were excluded if they had received systemic or
inhaled corticosteroids or immunosuppressants, and active
preoperative infection. RAI was defined as a rise in serum cortisol
≤9 μg/dl after the administration of 250 μg cosyntropin. Cortisol
levels were measured preoperatively, immediately before and
30 minutes, 60 minutes and 90 minutes after the administration of
cosyntropin (250 μg). We used SPSS version 15.
Results We studied 65 patients (74% men), mean age 68 ± 11
years. The incidence of RAI was 89.4% in these patients compared
with 50% in patients who did not receive etomidate (P = 0.01) (Table
1). Higher postoperative cortisol levels were associated with lower
doses of norepinephrine at 4 hours post CPB. Levels of cortisol in
etomidate patients were inversely proportional to the needs of
norepinephrine. Finally the maximum increase of cortisol levels after
ACTH stimulation was directly associated with the systemic
resistance index in nonetomidate patients at four postoperative hours.
Table 1 (abstract P272)
Incidence of relative adrenal insufficiency
RAI Etomidate (n = 47) Others (n = 18) P value
Yes (%) 89.4 50 0.01
No (%) 10.6 50
Conclusions The use of etomidate was associated with RAI post
CPB surgery. Cortisol levels were related to the postoperative
hemodynamic profile and the need for vasopressor drugs.
Available online http://ccforum.com/supplements/12/S2
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Introduction Hospitals are increasingly forced to consider the
economics of technology use. We estimated the incremental cost-
consequences of remifentanil-based sedation (RS) versus conven-
tional sedation (CS) in ICU patients with an anticipated mechanical
ventilation (MV) time of 2–3 days for Germany.
Methods A probabilistic Markov model was utilized that describes
the patient flow on the ICU using eight model states: MV – main-
tenance, MV– eligible start weaning, MV – actual weaning started,
MV– eligible for extubation, ICU – extubated, ICU – eligible for
discharge, Discharged from ICU, and Death. At every hour,
patients stay at the current state, move to the next state, or die. The
respective transition probabilities and the utilization of sedation
drugs were derived from UltiSAFE, a Dutch open-label trial with
205 critically ill patients. In UltiSAFE, patients either received CS
(predominantly morphine or fentanyl combined with propofol or
midazolam) or RS (remifentanil, combined with propofol if
required). Unit prices for drugs and total costs per ICU-hour with
and without MV were collected in one 12-bed adult mixed ICU in a
general German hospital. Material, staff and overhead costs were
considered. All costs were measured from a hospital perspective
with 2006 as the reference year. According to the UltiSAFE target
population, only patients who started weaning within 72 hours of
the start of treatment were included.
Results The average duration of MV and of ICU stay was shorter,
0.9 and 0.8 days respectively, in the RS group compared with the
CS group, while the average costs per patient were €6,157 in the
RS group versus €7,160 in the CS group. The savings caused by
the shorter length of stay therefore more than offset the additional
drug acquisition costs, leading to €1,003 savings per patient in
the RS group. The probability of RS being cost-saving was
estimated at 91%.
Conclusions RS seems to be the economically preferred option
for patients with an anticipated MV time of 2–3 days: RS
decreases the length of stay in the ICU, the total costs per patient
and the duration of MV, which is a risk factor for ventilator-
associated morbidity.
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Introduction Although disposition of propofol has been extensively
studied in different populations of adult and paediatric age, data
are still very limited. Preliminary data in neonates suggested that
propofol clearance is significantly different compared with toddlers
and children, with important interindividual variability in propofol
clearance in neonates [1]. We therefore wanted to document
covariates that contribute to interindividual variability in propofol
pharmacokinetics in preterm and term neonates.
Methods Population pharmacokinetics were estimated (nonlinear
mixed effects model) based on arterial blood samples collected in
(pre)term neonates after intravenous bolus administration of
propofol (3 mg/kg, 10 s). Covariate analysis included post-
menstrual age (PMA), postnatal age (PNA), gestational age, weight
and creatinaemia.
Results Two hundred and thirty-five arterial concentration–time
points were collected in 25 neonates. The median weight was
2,930 (range 680–4,030) g, PMA 38 (27–43) weeks and PNA 8
(1–25) days. In a three-compartment model, PMA was the most
predictive covariate for clearance (P < 0.001) when parameterized
as [CLstd x (PMA / 38)11.5]. The standardized propofol clearance
(CLstd) at 38 weeks PMA was 0.029 l/min. The addition of a fixed
value in neonates with a postnatal age ≥10 days further improved
the model (P < 0.001) and resulted in the equation [CLstd x
(PMA / 38)11.5 + 0.03] for neonates ≥10 days old. Values for the
central volume (1.32 l), peripheral volume 1 (15.4 l) and peripheral
volume 2 (1.29 l) were not significantly influenced by any of the
covariates (P > 0.001).
Conclusions PMA and PNA contribute to the interindividual
variability of propofol clearance with very fast maturation of
clearance in neonatal life. This implicates that preterm neonates
and neonates in the first week of postnatal life are at an increased
risk for accumulation during either intermittent bolus or continuous
administration of propofol.
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Introduction New strategies for sedation in mechanically ventilated
(MV) patients have yielded improvements in patient outcomes,
including acute brain dysfunction, but the differential effect of
sedation regimens across patient diagnosis categories is not
known. In this pilot project, we evaluated the impact of sedation
using dexmedetomidine versus lorazepam, in an a priori determined
subgroup of septic patients enrolled in the MENDS trial [1].
Methods The MENDS study enrolled 103 adult medical/surgical
MV patients and excluded those with neurological disease, severe
liver failure, active coronary ischemia, and seizures. Patients were
randomized in a double-blind fashion to receive dexmedetomidine
(DEX)-based (maximum 1.5 μg/kg/hour) or lorazepam (LZ)-based
(maximum 10 mg/hour) sedation for up to 5 days, titrated to a
target Richmond Agitation-Sedation Scale score. Patients were
monitored for delirium daily with the Confusion Assessment
Method for the ICU.
Results Thirty-nine patients in the MENDS study were admitted
with sepsis, with 19 in the DEX group and 20 in the LZ group.
Baseline demographics, ICU type and admission diagnoses of this
septic subgroup were balanced between DEX and LZ, with the
median (interquartile range) age being 57 (49, 66) vs 55 (44, 65)
years, P = 0.66 and APACHE II scores of 30 (24, 32) vs 28.5 (25,
32), P = 0.86, respectively. The median DEX dose was
0.9 μg/kg/hour and the median LZ dose was 3 mg/hour. DEX
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patients had greater delirium and coma-free days (8 (4, 10) vs 1.5
(0.7, 5) days, P = 0.002), delirium-free days (10 (7.5, 11) vs 7.4 (4,
8.2) days, P = 0.007), MV-free days (9.5 (0, 11.6) vs 2 (0, 8.5)
days, P = 0.037) and a reduction in the risk of dying at 28 days
(hazard ratio 0.3 (0.1, 0.9), P = 0.036) as compared with the LZ
patients.
Conclusions In this subgroup analysis of severe sepsis patients
from the MENDS trial, sedation incorporating dexmedetomidine
reduced the duration of delirium and coma and the length of time
on the ventilator, and decreased the risk of dying as compared with
lorazepam. This serves as a hypothesis-generating analysis to help
direct further prospective study in such patients.
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Introduction Noninvasive ventilation (NIV) reduces the intubation
and mortality in patients with acute on chronic respiratory failure.
NIV is associated with a large number of failures, and with patient
refusal. The purpose of the study was to assess the feasibility and
safety of dexmedetomidine-based sedation during NIV.
Methods In this prospective, randomised controlled study, patients
on NIV support with agitation and ventilatory discomfort were
included. The patients were allocated randomly into two groups:
dexmedetomidine (Dex) and control. In the Dex group, the infusion
rate was 0.2–0.7 μg/kg/hour to reach a Ramsey sedation score
(RSS) between 3 and 4. Haemodynamic and respiratory
characteristics, and the RSS were documented at 1 minute, 10
minutes, 30 minutes, 1 hour, 4 hours and 24 hours after Dex infu-
sion was started. When additional sedation was needed
0.02–0.03 mg/kg intravenous midazolam was used. Spontaneous
ventilation and NIV support durations, the total infusion time
(hours), the total Dex consumption, the reason for infusion therapy
cessation, additional sedative agent requirements, and the duration
of the mechanical ventilation were documented.
Results Thirty patients under NIV support with agitation and
ventilatory discomfort were included in this study. The results in the
Dex group are summarized in Table 1. Additional sedative agent
requirement was significantly higher in the control group. Side
effects such as hypotension and hypoglycemia were found in the
Dex group.
Conclusions Dexmedetomidine is safe and effective for the
sedation of the patients under NIV support.
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Introduction Perioperative managements for endovascular
neurosurgery require some considerations such as minimizing
hemodynamic changes and especially avoiding blood pressure
elevation accompanying extubation, immobilizing the trunk and
lower limbs until bleeding from the site of femoral artery sheath
removal has stopped, and monitoring patients in the ICU for at
least 12 hours to notice neurological deterioration promptly. The
aim of this study was to assess the usefulness of dexmedetomidine
as a postoperative sedative drug for endovascular neurosurgery.
Methods The study included 182 patients with endovascular
neurosurgery admitted to the ICU in 2006. The authors evaluated
the postoperative sedative state and hemodynamics with the
Richmond Agitation Sedation Scale (RASS) [1], heart rate (HR)
and mean arterial pressure (MAP). To examine the time-dependent
changes of the RASS, MAP and HR, data were collected from
medical records, including at the start and end of dexmedeto-
midine infusion and at the time of extubation.
Results The surgical indications in patients with endovascular
neurosurgery were unruptured cerebral aneurism (57%), sub-
arachnoid hemorrhage (20%), arteriovenous malformation (5%),
arteriovenous fistula (3%) and others (15%). One hundred and
eighteen patients (85.3%) received dexmedetomidine. The RASS
showed patients with dexmedetomidine experienced RASS –1 to
–3 states, which was arousable with verbal stimulation. There were
no dexmedetomidine-induced HR and MAP deteriorations; further-
more, dexmedetomidine prevented the blood pressure elevation
accompanying extubation. The overall morbidity and mortality rates
relating to endovascular neurosurgery were 1.6% and 0.54%,
respectively.
Conclusions Application of sedative drugs for the postoperative
management for neurovascular disease may be controversial;
however, the use of dexmedetomidine facilitates postoperative
management of endovascular neurosurgery. Compared with the
reported endovascular neurosurgery morbidity (3.7–5%) and
mortality (1.1–1.5%), our morbidity and mortality rate showed that
dexmedetomidine did not cause neurological deteriorations.
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Introduction An intravenous formulation of paracetamol is
available, but remains off-label in patients below 10 kg although
pharmacokinetics during repeated intravenous administration were
Available online http://ccforum.com/supplements/12/S2
Table 1 (abstract P276)
Respiratory, haemodynamic characteristics and Ramsey sedation
score variables
1 minute 1 hour P value
PaO2/FiO2 159 ± 47 239 ± 80 <0.01
SaO2 95.8 ± 4 98.8 ± 1 <0.05
PaO2 83.6 ± 27 130 ± 31 <0.05
Respiratory rate 30.4 ± 5 24.5 ± 6 <0.05
Mean arterial pressure 86.6 ± 12 77.7 ± 11 <0.01
Heart rate 108 ± 23 98.9 ± 18 <0.05
RSS 1.0 ± 0 2.6 ± 0.8 <0.01
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documented and dosing regimes suggested [1,2]. We therefore
retrospectively evaluated aspects of the administration of
intravenous paracetamol in neonates.
Methods A single-centre retrospective study. Data were collected
in neonates born and admitted between 1 January 2006 and 1
October 2007 to whom intravenous paracetamol was adminis-
tered. In these patients, clinical data (age, duration of treatment,
switch to oral treatment, liver enzymes during and up to 2 days
after intravenous treatment) were retrieved. Correlations (Spear-
man rank) of hepatic enzymes with duration of treatment (hours)
and differences in liver enzymes during/after (Mann–Whitney U
test) were investigated.
Results Information on 2,360 administrations in 189 cases
(postmenstrual age 38 (range 30–55) weeks, postnatal age 5
(1–182) days) was available. The median duration of administration
was 48 (6–480) hours. The indication for initiation of intravenous
paracetamol was postoperative analgesia in about 50% of cases,
of whom the most frequent surgical interventions were cardiac
surgery (39 cases), abdominal surgery (31 cases), thoracic surgery
(16 cases) or neurosurgery (seven cases). Switch to oral treatment
was only documented in 68/189 cases, end of paracetamol
administration in 84 cases and insufficient analgesia (unscheduled
initiation of opioids) in 23 cases. Six hundred and forty-nine
observations on liver enzymes (ALT 280, AST 284, γGT 85) during
and 174 (74, 75 and 25, respectively) after intravenous
administration were available. No significant correlations between
liver enzymes and duration of administration were observed and
there was no significant difference in liver enzymes during versus
after intravenous administration.
Conclusions The current observations in 189 (pre)term neonates
suggest that intravenous paracetamol does not alter hepatic
enzymes profiles during or after intravenous administration in this
specific population, and therefore seems to be a safe drug. The
switch to oral treatment has only been observed in a relatively
limited number of patients, probably reflecting the need to
implement strategies to facilitate this switch.
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Introduction Interindividual variability in drug metabolism is based
on constitutional, environmental and genetic factors but mainly
reflects ontogeny in early neonatal life. We therefore wanted to
document determinants of O-demethylation activity in critically ill
neonates and young infants.
Methods Tramadol (M) and O-demethyltramadol (M1) concen-
trations were determined in 24-hour urine collections in neonates
in whom continuous intravenous tramadol was administered [1].
Samples were analysed by a HPLC methodology described earlier
[2]. The log M/M1 in 24-hour urine collections was calculated and
correlations with clinical characteristics and CYP2D6 poly-
morphisms were investigated.
Results Based on 86 urine collections, a significant correlation
between urine log M/M1 (0.98, SD 0.66) and postmenstrual age
(PMA) (r = –0.69) was observed. One-way analysis of variance
documented a significant decrease in log M/M1 with an increasing
number of active CYP2D6 alleles. In a forward multiple regression
model, PMA and the number of active CYP2D6 alleles remained
independent determinants of the urine log M/M1.
Conclusions Both ontogeny (PMA) and CYP2D6 polymorphisms
already contribute to the interindividual variability of phenotypic O-
demethylation activity of tramadol in critically ill (pre)term neonates
and young infants. The current observations are of pharmaco-
dynamic relevance. In addition, we hereby are the first to illustrate
the simultaneous impact of both age and genetic polymorphisms
on drug metabolism in early life.
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Introduction The presence of spontaneous breathing (SB) activity
may improve gas exchange during mechanical ventilation. Pressure
support ventilation (PSV) is one of the most frequently used modes
of assisted mechanical ventilation, but little is known about the
mechanisms of improvement of lung function during PSV. To shed
light into this issue, we evaluated the regional distribution of
aeration and pulmonary blood flow (PBF) during controlled and
assisted mechanical ventilation with PSV in experimental acute
lung injury.
Methods In five anesthetized, controlled mechanically ventilated
pigs, acute lung injury was induced by surfactant depletion. The
ventilatory mode was switched to biphasic intermittent positive
airway pressure ventilation and the depth of anesthesia reduced to
resume SB. When SB represented 20% of the minute ventilation,
animals were ventilated with PSV during 1 hour. Measurements of
lung mechanics, gas exchange and hemodynamics, as well as
whole lung computed tomography at mean airway pressure, were
obtained at baseline, injury and during assisted ventilation with
PSV. In addition, PBF was marked with intravenously administered
fluorescent microspheres and spatial cluster analysis was used to
determine the effects of interventions in the distribution of PBF.
Statistical analysis was performed with Wilcoxon’s test and P <
0.05 was considered significant.
Results In injured lungs under controlled mechanical ventilation,
impairment of oxygenation was associated with a significant
increase of poorly aerated and nonaerated areas in dependent lung
regions. Resuming of SB and assisted mechanical ventilation with
PSV led to a decrease in mean airway pressures and improvement
in oxygenation, but not in total and dependent lung aeration.
However, redistribution of PBF toward well aerated nondependent
regions was observed.
Conclusions The improvement of oxygenation during PSV seems
not to result from recruitment of dependent lung areas, but rather
from redistribution of PBF from dependent, less aerated lung zones
toward better aerated, nondependent lung regions.
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Introduction We hypothesized that the time course of the slow
pressure drop after interruption of inspiratory flow contains
information about the underlying lung disease. Respiratory data
obtained from repetitive inspiratory flow interruption manoeuvres
was compared between mechanically ventilated patients without
pulmonary disease and with acute respiratory distress syndrome
(ARDS) and was analyzed using a model describing the Newtonian
and viscoelastic properties of the lung.
Methods Inspiratory airflow was repetitively interrupted for 3
seconds after inflation of 100 ml volume steps up to a maximum
plateau pressure of 45 mbar by means of an automated super
syringe manoeuvre (Evita 4Lab; Dräger Medical, Lübeck, Germany).
Twelve patients with healthy lungs and 20 patients suffering from
ARDS were investigated. We determined the Newtonian and
viscoelastic unit of a model (Figure 1a) [1,2] by mathematical fitting
the model to segments of the pressure curve (Figure 1b). The slow
pressure drop was described by viscoelasticity (resistance R2,
compliance C2).
Results Analysis of time constant T of the viscoelastic unit revealed
no differences between ARDS and healthy patients (Figure 2a).
However, compliance C2 (Figure 2b) and resistance R2 (Figure 2c)
of the viscoelastic unit were significantly different. C2 was lower
and R2 was higher in ARDS patients. The time constant as well as
C2 and R2 showed a significant dependency on pressure.
Conclusions The time constant of the viscoelastic unit determines
the decay of the pressure curve after airflow interruption. Identical
time constants mean that there is no significant difference in the
decay between health and ARDS. Only the model-based analysis
revealed the significant difference in viscoelasticity that is
associated with ARDS.
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Introduction Recruitment maneuvers (RM) attempt mechanical
homogenization and improvement of V/Q matching in the hetero-
geneous acute respiratory distress syndrome (ARDS) lung in a
short time. Apart from the postulated beneficial effect, their
performance carries a risk for serious adverse events.
Methods The study included 17 consecutive ARDS patients
placed on baseline ventilation with standardized ventilatory para-
meters. Pressure-controlled ventilation RM was then applied for
2 minutes and consisted of: peak inspiratory pressure = 45 mbar,
respiratory rate = 10/min, I:E = 1:1, positive end-expiratory
pressure (PEEP) = 20 mbar for the first minute, 25 mbar for the
remaining time. Predefined safety criteria were used for premature
RM termination. Patients with a minimum of 30% PaO2/FiO2
increment on the fifth minute after the RM completion were judged
responders. Those with prematurely terminated RM and non-
responders were excluded from the subsequent study. In the
remaining group, a decremental PEEP trial was then conducted.
ECG, SpO2, invasive systemic arterial pressures, Paw, exhaled
Vt/MV and total respiratory system compliance (Ctot) were
continuously monitored and their representative values were
recorded for different time periods. Arterial blood samples for
blood gas analysis were taken immediately before the RM, on the
fifth minute and on the sixth hour after the RM completion. Twenty-
four hours after the RM, a bedside chest X-ray was conducted for
extraalveolar air detection.
Results Six patients (35.3%) were considered nonresponders,
and in one of them RM was prematurely terminated. In the
responders’ group there was statistically significant PaO2/FiO2
Available online http://ccforum.com/supplements/12/S2
Figure 1 (abstract P281)
(a, left) Newtonian (R1, C1) and viscoelastic unit (R2, C2). (b, right) Data fit.
Figure 2 (abstract P281)
Results for the viscoelastic unit. (a, left) Time constant T; (b, middle) compliance C; (c, right) resistance R.
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increment on the fifth minute after the RM, which was preserved on
the sixth hour. The PaO2/FiO2 increment was significant in the
nonresponders’ group too, but with smaller magnitude. There was
also a significant increase in Ctot and PaCO2 decrement in the
responders’ group on the sixth hour. No significant changes in
PaCO2 and Ctot in the nonresponders’ group were noted. PaO2/
FiO2 in the fifth minute after the RM was not significantly different
between responders and nonresponders, but PaCO2 and Ctot
were. None of the monitored hemodynamic parameters changed
significantly at any time in both groups. Clinical or radiographic
signs of barotrauma were not found.
Conclusions The described pressure-controlled ventilation RM
and decremental PEEP titration increased arterial oxygenation
efficacy in the short term. Surrogate markers for alveolar
recruitment were also influenced. RM showed good tolerability
regarding hemodynamic stability and barotrauma potential.
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Introduction The objective was to evaluate the effect of frequency
on the prevention of ventilation-induced lung injury during high-
frequency oscillation ventilation (HFOV) in a sheep acute
respiratory distress syndrome (ARDS) model.
Methods Twenty-four adult sheep (38.3 ± 2.3 kg) were randomly
divided into four groups (n = 6): three HFOV groups (3 Hz, 6 Hz, 9
Hz) and a conventional mechanical ventilation (CMV) group. After
induction of the ARDS model (PaO2 < 60mmHg) by repeated NS
lavage, step-by-step lung recruitment was performed in all groups,
optimal alveolar recruitment as a PaO2 > 400 mmHg. After this
recruitment procedure, the optimal mean airway pressure was
selected by decreasing 2 mmHg every 5 minutes until the PaO2
decreased below 400 mmHg, and ventilation was continued for 4
hours. Hemodynamics, respiratory mechanics and gas exchange
were measured throughout the experiment, and lung histopatho-
logical changes, lung wet/dry weight ratio, lung myeloperoxidase
activity, lung and plasma IL-6 expression (ELISA) were determined.
Results The heart rate, mean arterial pressure, cardiac output,
central venous pressure and pulmonary arterial wedge pressure
did not differ among the four groups in experiment (P > 0.05). The
mean pulmonary arterial pressure was significantly higher in the
HFOV group after 4 hours than in the CMV group (P < 0.05). After
lung recruitment, sustained improvements in the oxygenation index
were observed in all groups. Lung compliance and the
intrapulmonary shunt (Qs/Qt) were significantly improved in the 6
Hz and 9 Hz HFOV groups after 4 hours of ventilation (P < 0.05).
The amplitude of alveolar pressure was significantly lower in the 9
Hz HFOV group during the experiment (P < 0.05). Histologically,
the lung injury score was significantly lower in the 9 Hz HFOV
group than the other groups (P < 0.05). The lung wet/dry weight
ratio did no differ among the four groups (P > 0.05). The lung
MPO activity and expression of IL-6 in lung tissue and blood
plasma significantly reduced in the 6 Hz and 9 Hz HFOV-treated
animals (P < 0.05).
Conclusions Compared with CMV and low frequency in HFOV,
the higher frequency in HFOV results in less lung injury. HFOV may
be an optimal lung-protective strategy.
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Introduction Adherence to the ARDS Network low-stretch ventila-
tion protocol [1] is recommended as standard of care in the VALID
study, a randomised double-blind mortality study of rSP-C surfac-
tant (Venticute®) in intubated and mechanically ventilated patients
with severe respiratory failure due to pneumonia or aspiration. Ten
Hungarian study sites have recruited about 9% of patients in the
VALID study to date.
Methods The VALID study is conducted in more than 140 medical
centers in 23 countries. Adherence to ARDS Network ventilation
standards was assessed after 200 patients were randomised.
Subsequently, an intensified training program to promote low-
stretch ventilation was conducted during site visits and investigator
meetings, through letters and emails, by distributing training
material, and by discussing ventilation settings prior to enrolment
of individual patients. In Hungary, data are available from 24
patients enrolled prior to implementation of training measures and
from 45 patients enrolled thereafter. Tidal volumes (VT) and peak
inspiratory pressures (PIP) at baseline were assessed.
Results In Hungary, the median VT at baseline decreased from
8.2 ml/kg predicted body weight (PBW) prior to initiation of intensi-
fied training measures to 7.3 ml/kg PBW thereafter (P < 0.001,
Wilcoxon, two-sided). Concurrently, the overall study median VT
decreased from 7.8 ml/kg PBW (Patient 1 to Patient 200) to
7.0 ml/kg PBW (Patient 201 to Patient 776). The two Hungarian
sites with the highest enrolment decreased the median VT from 8.2
to 7.5 ml/kg PBW and from 9.1 to 6.6 ml/kg PBW. The median PIP
at baseline decreased from 30.8 to 29.0 cmH2O in Hungary and
from 29.5 to 28.5 cmH2O in the VALID study overall.
Conclusions In response to training measures, Hungarian
investigators participating in a multinational multicenter intensive
care trial of lung surfactant in ventilated patients have decreased
VT and PIP, thereby improving adherence to the global standards
of the ARDS Network ventilation protocol.
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Introduction An analysis of clinical experience of patients treated
with high-frequency oscillatory ventilation (HFOV) was performed.
This alternative technique of mechanical ventilation is used as
‘rescue’ therapy for patients with severe acute respiratory distress
syndrome (ARDS) when it is not possible to provide adequate
oxygenation and ventilation by conventional methods.
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Methods A prospective review of all patients treated with HFOV
(SensorMedics 3100B) in the ICU during 2004–2006. The data
(patient demographics, aetiology of ARDS, gas exchange,
ventilator settings before and after initiation of HFOV, duration of
HFOV, complications, outcome at 30 days, etc.) were obtained
and statistical analysis was performed (mean ± SD, %, t test). For
all analyses P < 0.05 was considered significant.
Results Values given as mean ± SD. Thirty-one patients (13
women and 18 men, age 42.8 ± 16.1 years; APACHE II score,
22.1 ± 4.9) with severe ARDS (PaO2/FiO2, 72.0 ± 14.7; oxygena-
tion index (OI), 44.0 ± 16.5) were connected to HFOV (38 trials)
after previous conventional ventilation (CV) for a duration of 6.8 ±
4.1 days with ventilator settings (plateau, 39.3 ± 5.1 cmH2O;
PEEP, 14.5 ± 3.6 cmH2O; mPaw, 26.5 ± 6.3 cmH2O). Patients
were treated with HFOV for 4.7 ± 2.1 days. The 30-day mortality
rate was 70.9%. Of the patients 51.6% were treated with steroids,
and 22.6% of patients underwent prone positioning. Survivors/
nonsurvivors: 6/9 women, 3/13 men; age 27.4 ± 4.9/49.0 ± 16
years; duration of CV 4.4 ± 3.1/7.8 ± 4.0 days; ventilator settings
– plateau 41.2 ± 4.3/38.5 ± 5.2 cmH2O, PEEP 16 ± 1.9/13.9 ±
4.0 cmH2O, mPaw 26.6 ± 3.4/26.4 ± 7.1 cmH2O; duration of
HFOV 6.4 ± 1.4/4.0 ± 1.9 days.
Conclusions We found significant improvement in PaO2/FiO2, the
OI and reduction in paCO2 within 12 hours of transition to HFOV.
The age of patients and days on CV were significantly higher in
nonsurvivors (49 years; 7.8 days) than in survivors (27 years; 4.4
days). Early treatment with HFOV can help to bridge the most
critical period of respiratory failure and improve the mortality rate.
Timing of HFOV initiation is the most important factor; that is, early
intervention may improve outcome.
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Introduction Preparation of lungs for transplantation includes
perfusion with lung protection solution, typically by flushing the
organ within short time periods leading to high fluidic (arterial)
pressures. In an isolated porcine lung model we analyzed the
influence of perfusion pressure during anterograde perfusion on
the pulmonary edema formation during mechanical ventilation.
Methods Isolated porcine lungs were ventilated in the volume
control mode (SV 900 C; Siemens-Elema, Solna, Sweden) with a
tidal volume of 3 ml/kg BW and with two positive end-expiratory
pressure (PEEP) levels, 4 cmH2O and 8cmH2O. After awaiting
stationary ventilation conditions, flush perfusion with nutrition
solution (PERFADEX; Vitrolife, Göteborg, Sweden) was applied at
different fluidic (hydrostatic) pressures that were achieved by
height differences between the lung and fluid reservoir of 100 cm
(high level) or 55 cm (low level), respectively.
Results During high-level perfusion, the maximal fluidic pressure
reached 50 mmHg and lung mass increased by 130%. During low-
level perfusion, the fluidic pressure reached 28 mmHg and lung
mass increased only by 91% at PEEP of 4 cmH2O. Histological
examination of the lung tissue confirmed that this increase in lung
mass corresponded to an increase of interstitial edema. Using a
PEEP of 8 cmH2O at low-level perfusion reduced the relative
increase in lung mass to 30%. With increased PEEP the relative
increase of lung mass caused by flush perfusion was reduced.
Conclusions Flush perfusion at high fluidic pressure amplitudes
leads to an increased lung mass compared with low fluidic
pressure amplitudes. Edema formation in isolated lungs caused by
flush perfusion is reduced using low-perfusion pressures in
combination with high PEEP. Low flush perfusion pressures might
be advantageous for preparation of lungs for transplantation.
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Introduction The aim of the study was the evaluation of efficacy to
limit loss in functional residual capacity (FRC) of endotracheal
suction with a closed system (ESCS) versus endotracheal suction
with an open standard system (ESOS) in patients needing
ventilation with PEEP > 10 cmH2O.
Methods After IRB approval and obtaining consent, 15 patients
admitted to the ICU for acute respiratory failure were connected
and adapted to the Engstrom Carestation (GE Healthcare – 2006)
by the closed suction system Cathy (Vygon – 2006). We
performed ESCS and ESOS in an alternate randomization
sequence at a distance of 2 hours for the first from the second.
FRC measurements (based on evaluation of nitrogen washin and
washout by the COVX metabolic module – Engstrom Carestation
Lung FRC INview) were made at baseline, 5, 10 15, 20, 25, and
30 minutes after suction. The PaO2 was measured at baseline,
immediately after the suction and 30 minutes after suction. Loss in
FRC was considered as the difference between the basal value
and values obtained after suction, and the time to FRC recovery
after suction was considered as the minutes to return to the basal
value. Data are shown as the mean ± SD; FRC was measured in
millilitres, time in minutes, PaO2 in mmHg; intergroup variables
were analysed with the Mann–Whitney test. P < 0.05 was taken as
statistically significant.
Results Basal values of all studied parameters did not show
significant differences between the two groups categorized by
suction methods. Loss in FRC 5, 10 and 15 minutes after ESCS
was significantly lower than after ESOS (5 minutes ESCS =
–250 ± 483, ESOS = –740 ± 567, P = 0.002; 10 minutes ESCS =
–36 ± 388, ESOS = –211 ± 188, P = 0.006; 15 minutes ESCS =
–89 ± 489, ESOS = –268 ± 148, P = 0.046; 20 minutes ESCS =
–157 ± 569, ESOS = –125 ± 176, not significant; 25 minutes
ESCS = –167 ± 570, ESOS = –89 ± 133, not significant;
30 minutes ESCS = +216 ± 246, ESOS = +22 ± 81, not
significant). Time to recovery of FRC basal value after ESCS was
significantly lower than after ESOS (ESCS = 9 ± 5, ESOS = 21 ± 7,
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P < 0.0001). PaO2 reduction was significantly lower after ESCS
than after ESOS (ESCS = 151 ± 18, ESOS = 119 ± 9, P = 0.048)
Conclusions ESCS in patients needing mechanical ventilation
with PEEP > 10 cmH2O for acute respiratory failure reduces signi-
ficantly the loss of FRC, the reduction on PaO2 and a time to
recovery of loss after suction greater than standard open suction.
In this way it could be possible to avoid pulmonary overdistension
made by recruitment manoeuvres, often necessary after suction
with an open system to recover the loss in FRC and PaO2.
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Introduction Melatonin is a hormone with antioxidant and immuno-
modulatory effects. We studied the effects of melatonin treatment
on lung damage, inflammation and oxidative stress in a model of
ventilator-induced lung injury (VILI).
Methods Forty-eight Swiss mice were randomized into three
experimental groups: control, low-pressure ventilation (peak pressure
15 cmH2O) or high-pressure ventilation (peak pressure 25 cmH2O).
Within each group, eight mice were treated with melatonin
(10 mg/kg) and eight mice with placebo. After 2 hours, lung injury
was evaluated by gas exchange and histological analysis. Tissue
levels of malondialdehyde and IL-6 and IL-10 were measured as
indicators of lipid peroxidation and inflammation. Variables were
compared using a two-way ANOVA. P < 0.05 was considered
significant.
Results See Table 1. Ventilation with high pressures induced
severe lung damage and release of IL-6. Treatment with melatonin
improved oxygenation and decreased histological lung injury, but
significantly increased oxidative stress quantified by
malondialdehyde levels. The increase of IL-10 observed after
melatonin treatment could be responsible for the differences. There
were no differences in IL-6 caused by melatonin.
Conclusions Melatonin reduces VILI by increasing the anti-
inflammatory response. The combination of high pressure and
melatonin increased oxidative stress.
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the transdifferentiation of alveolar epithelial type II cells
into type I cells
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Introduction The alveolar epithelium is comprised of type I (ATI)
and type II (ATII) cells. ATI cells are incapable of cell division, with
epithelial repair achieved by proliferation of ATII cells and
transdifferentiation of ATII cells into ATI cells. We have previously
shown that hyperoxia inhibits the transdifferentiation of ATII cells in
vitro [1]. The objective of these studies was to determine the effect
of hyperoxia on the transdifferentiation of ATII cells in vivo.
Methods Rats (n = 9) were anaesthetised and Staphylococcus
aureus or saline (controls) instilled into the distal airways. Animals
recovered in air for 72 hours and were then randomised to
normoxia (air) or hyperoxia (FiO2 ~0.9) for 48 hours. Lung sections
were stained with combinations of cell-selective antibodies,
immunofluorescent images obtained using confocal microscopy
and the proportion of the alveolar surface covered with ATII
(RTII70/MMC4-positive), ATI (RTI40-positive) and transitional
(RTI40/MMC4-positive) cell-staining membrane determined by
quantification of binary masks.
Results In control lungs, 94 ± 2% of the alveolar surface was lined
by ATI, 2 ± 1% by ATII and <1% by transitional cell-staining
membrane. In S. aureus-instilled lungs exposed to normoxia alone,
there was a decrease in ATI cell-staining membrane (84 ± 3%)
with an increase in ATII (8 ± 1%) and transitional (12 ± 4%) cell-
staining membrane consistent with ATI cell necrosis, ATII cell
hyperplasia and transdifferentiation of ATII cells into ATI cells. In S.
aureus-instilled lungs exposed to hyperoxia, there was a decrease
in ATI cell-staining membrane (73 ± 5%, P < 0.05) with a marked
increase in ATII cell-staining membrane (16 ± 1%, P < 0.001) and
less transitional cell-staining membrane (3 ± 1%, P < 0.05). As
hyperoxia is proapoptotic and inhibits ATII proliferation [2,3], these
data suggest persistent ATII cell hyperplasia and reduced ATII cell
transdifferentiation.
Conclusions Hyperoxia impairs epithelial repair by inhibiting the
transdifferentiation of ATII cells into ATI cells in a model of
resolving S. aureus-induced pneumonia.
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Introduction Previous animal studies revealed that administration
of statins ameliorates lung injury following endotoxin exposure or
ischemia-reperfusion. In this experiment, we endeavored to investi-
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Control, Control, PIP 15 cmH2O, PIP 15 cmH2O, PIP 25 cmH2O, PIP 25 cmH2O, 
placebo melatonin placebo melatonin placebo melatonin
PaO2/FiO2 349 ± 38 441 ± 61 333 ± 49 322 ± 54 127 ± 14#,† 380 ± 86*
Histological score 0.8 ± 1.3 1 ± 1.6 1.9 ± 2.8 2.1 ± 1.8 6.3 ± 3.3 2.7 ± 3.1
IL-10 (pg/mg protein) 221 ± 156 438 ± 236 208+102 513+202* 123+191 457+270*
Malondialdehyde (nmol/mg protein) 7 ± 1.5 7.5 ± 0.9 8.8 ± 2.1 7.3 ± 1.1 10.1 ± 3.4 13.8 ± 3.4#,†,*
Data are mean ± SEM. P < 0.05 compared with #control, †PIP 15 cmH2O or *melatonin.
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gate whether pretreatment with atorvastatin confers protection
from lung injury caused by high-pressure/high-tidal-volume ventilation.
Methods Twenty-four isolated sets of normal rabbit lungs were
utilized. Treated animals received atorvastatin (20 mg/kg body
weight/day per os) for 3 days before surgery. All isolated lungs
were perfused (constant flow, 300 ml/min) and ventilated for
1 hour with pressure control ventilation at either 23 cmH2O (high-
pressure, injurious ventilation) or 11 cmH2O (low-pressure,
noninjurious ventilation) peak static pressure and positive end-
expiratory pressure of 3 cmH2O. Four groups of six lung sets each
were examined: HPC (high pressure, no statin), HPS (high
pressure, statin pretreatment), LPC (low pressure, no statin), and
LPS (low pressure, statin pretreatment). Changes (from baseline to
the end of ventilation) in the ultrafiltration coefficient (ΔKf,c;
pulmonary capillary permeability), weight gain (ΔW; edema
formation) and histological lesions (hemorrhage) were used as
indices of lung damage.
Results At baseline, the compared groups did not differ with
regard to Kf,c (P = 0.3). At the end of ventilation, the HPC group
suffered greater ΔKf,c (P < 0.001) and greater ΔW (P < 0.001)
than both the LPC and LPS groups. In contrast, the HPS group did
not differ from both the LPS and LPC groups regarding these
variables (P > 0.4). In the HPC and HPS groups, lungs with as
opposed to those without statin pretreatment experienced a
significantly lower ΔKf,c (–0.013 ± 0.016 versus 1.723 ± 0.495
g/min/cmH2O/100 g; P = 0.0006) and lower ΔW (4.62 ± 1.50
versus 17.75 ± 4.71 g; P = 0.007). This was also the case for the
histological lesions.
Conclusions In an ex vivo model of ventilator-induced lung injury,
pretreatment with atorvastatin attenuates lung injury following high-
pressure/high-tidal-volume ventilation.
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Introduction In mechanically ventilated (MV) brain-injured patients,
pulmonary complications appear to be the leading cause of non-
neurological morbidity, suggesting that the local and systemic
inflammatory responses associated with brain damage and/or the
mechanical ventilation itself may contribute to the pulmonary injury
(that is, one or two hit model). We recently provided evidence for
lung inflammation in brain-injured, mechanically ventilated patients
with neither acute lung injury nor sepsis [1]. We now investigate
whether positive end-expiratory pressure (PEEP) application in the
same cohort (27 MV brain-injured subjects) is associated with
systemic inflammatory changes that could probably contribute to
the lung inflammation observed in these patients.
Methods Patients were ventilated with 8 ml/kg tidal volume and
were put on either zero PEEP (ZEEP, n = 12) or 8 cmH2O PEEP
(PEEP, n = 15). The following markers of systemic inflammation
were recorded or measured in blood, on the first, third, and fifth
days of MV: temperature, leukocyte and neutrophil counts, albumin,
soluble triggering receptor expressed on myeloid cells (sTREM-1),
C-reactive protein, procalcitonin, IL-10, IL-1β, IL-6, IL-8, IL-12p70,
and TNFα.
Results Upon entry, the two groups were well balanced clinically
and demographically. Significant differences between the two
patient groups were observed in leukocyte counts, IL-6 and
sTREM-1; all three parameters were constantly higher on ZEEP
(P < 0.05; two-way ANOVARM), while the former two markers
decreased with time in both groups (P < 0.05).
Conclusions In our population of MV brain-injured patients, ZEEP
is associated with increases in systemic inflammatory markers that
are present early on and throughout the first 5 days of MV. Our
findings suggest that PEEP application influences the systemic
inflammatory response observed in the absence of sepsis and
acute lung injury, and probably points to significant IL-6 and
sTREM-1 roles in the systemic and pulmonary inflammation
observed in this patient setting.
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Introduction Recently, so-called label-free quantitative proteomic
methods have gained acceptance for protein expression analysis via
mass spectrometry (MS). These methods allow better experiment
design by circumventing the need to establish pair-wise
comparisons required by popular stable isotope dilution methods (for
example, isotope coded affinity tag, isobaric tags for relative and
absolute quantitation and stable-isotope labelling by amino acids in
cell culture) and are thus fundamentally better suited for proteome
studies where sample number is large. Here we discuss the use of
shotgun proteomics (that is, no prior protein fractionation) and label-
free quantitative methods to characterize human bronchoalveolar
lavage fluid (BALF) proteomes of six normal healthy volunteers and
three patients with acute respiratory distress syndrome (ARDS) [1].
Methods Our proteomic profiling technology for BALF involves: (i)
removal of cells by centrifugation followed by precipitation of the
remaining soluble protein, (ii) denaturation and proteolysis of
soluble proteins, (iii) analysis in quadruplicate of each sample by
LC-MS/MS using Fourier transform-mass spectrometry (FT-MS),
(iv) identification of proteins by database search of tandem mass
spectra (MS2 data), and (v) extraction of changes in protein
relative expression directly from peptide ion intensity values (MS1
data) as recently described [2]. Notably, data for each sample are
acquired independent of all other samples, allowing any patient’s
data to be compared directly with all others in silico. We also
measured levels of several proteins of interest (identified in LC-
MS/MS experiments) by ELISA in ARDS BALF from 69 patients
ranging from those at risk to 14 days post diagnosis and six
normals. Enriched functional categories within BALF proteins
relative to the entire human proteome were determined using
Expression Analysis Systematic Explorer (EASE) software [3].
Results Using BALF from three patients, we identified a total of
870 different proteins, a nearly 10-fold increase from previous
reports. Among the proteins identified were known markers of lung
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injury, such as surfactant, proteases, and serum proteins. We also
identified several biologically interesting proteins not previously
identified in patients with ARDS, including insulin-like growth
factor-binding protein-3 (IGFBP-3). Immunoassay showed elevated
levels of IGFBP-3 and IGF-I in at-risk patients and those with early
ARDS, whereas normal controls had low levels of IGFBP-3. The IGF
pathway, acting through the type 1 IGF receptor, repressed
apoptosis of lung fibroblasts but not lung epithelial cells. Further-
more, depletion of IGF in ARDS BALF led to enhanced fibroblast
apoptosis. Additionally, normal human BALF was profiled from six
volunteers. From these analyses a total of 167 unique proteins were
detected with >100 proteins detected in each of the six individual
BAL samples, 42 of which were in common to all six subjects.
Conclusions Our data suggest that the IGFBP-3/IGF pathway is
involved in the pathogenesis of lung injury, illustrating the power of
shotgun proteomics to catalog proteins present in complex
biological fluids, such as BALF, from which hypotheses can be
developed and tested. From the normal BALF proteome data, gene
ontology analysis demonstrated enrichment of several biological
processes in the lung that reflects its expected role in gas
exchange and host defense as an immune organ. The same
biological processes were enriched compared with either human
plasma proteome or total human genome calculated proteome,
suggesting an active enrichment of plasma proteins in the lung
rather than passive capillary leak.
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Introduction Determination of extravascular lung water (EVLW) by
transpulmonary thermodilution predicts progression to acute lung
injury (ALI). Early identification of patients at risk for developing ALI
may impact clinical decision-making. Measurement of EVLW,
however, is invasive, requiring central venous and arterial
catheters. We asked whether less invasive clinical parameters and
markers of severity of lung injury could be used to estimate lung
water, obviating the need for the more invasive determination.
Methods Eighteen patients at risk for ALI due to massive aspiration
(n = 1), sepsis (n = 16), massive transfusion (n = 1), and/or trauma
(n = 2) were studied prospectively. The PaO2/FiO2 ratio, central
venous pressure (CVP), Vd/Vt, fluid balance, Cs, and Lung Injury
Scores (LIS) were compared with the EVLW measured on the
same day by linear regression analysis (Figure 1).
Results Poor correlation of EVLW with the PaO2/FiO2 ratio (r2 =
0.0061), CVP (r2 = 0.1261), fluid balance (r2 = 0.0903), Vd/Vt
(r2 = 0.0135), Cs (r2 = 0.0014), and LIS (r2 = 0.0837) was seen
(Figure 1).
Conclusions The clinical parameters examined in this study do not
accurately reflect the EVLW and should not be used as surrogates
for it.
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Introduction Large tidal volumes and transpulmonary pressures
play a central role in pathogenesis of ventilator-induced lung injury.
Moderate tidal volumes are considered safe in healthy lungs [1].
Recent studies suggested that insults like endotoxin [2] or surgery
[3] sensitize the lung to injury by priming for an exaggerated
response to a second stimulus. Our aim was to investigate how
animals sensitized to lung injury by previous anesthesia and
surgery respond to mechanical ventilation (MV).
Methods Twenty-two male adult Sprague–Dawley rats instru-
mented surgically under ether anesthesia with vascular catheters
on the previous day were anesthetized, tracheostomized and
randomly allocated to two mechanically ventilated groups – MVLP
group (FiO2 1.0, respiratory rate 60/min, tidal volume 10 ml/kg,
PEEP 2 cmH2O, n = 8) and HVZP group (FiO2 1.0, respiratory
rate 20/min, tidal volume 30 ml/kg, PEEP 0 cmH2O, n = 8) – and a
no MV group C (n = 6). After randomization (C group) or after
2 hours of MV, rats were sacrificed, the P–V curve of the
respiratory system constructed, and bronchoalveolar lavage fluid
(BALF) and aortic blood samples obtained.
Results Comparison of P–V curves suggested derecruitment of
the lung in the MVLP group, but no significant difference in airway
pressures at maximal lung volume (14 ml) was observed between
groups. Total protein (μg/ml) in BALF was similar in both the MVLP
and HVZP groups (0.21 (0.16, 0.30) and 0.22 (0.18, 0,50), P =
0.366) and lower in the C group (0.13 (0.07, 0.16), P < 0.05)
versus both MV groups. Similar results were obtained for IL-6
levels (pg/ml) in BALF (102.0 (93.4, 111.8) and 120.0 (53.7,
130.0) for the MVLP and HVZP groups, P = 0.628 and 48.5 (43.4,
56.4) pg/ml for the C group, P < 0.05 vs both MV groups).
Conclusions Both moderate and high tidal volumes induce a
similar elevation of lung injury markers in mechanically ventilated
animals sensitized to injury by previous anesthesia and surgery.
Acknowledgement Supported by Research Project MZO
00179906.
Critical Care    March 2008 Vol 12 Suppl 2 28th International Symposium on Intensive Care and Emergency Medicine
Figure 1 (abstract P293)
S115
References
1. Ricard J-D, et al.: Eur Respir J 2003, 22(Suppl 42):2s-9s.
2. Schreiber T, et al.: Anesthesiology 2006, 104:133-141.
3. Kaneko A, et al.: J Surg Res 2006, 134:215-222.
P295
Effects of an open lung approach following the ARDS
Network ventilatory strategy in patients with early acute
lung injury/acute respiratory distress syndrome
V Rotman1, F Bozza2, A Carvalho3, R Rodrigues4, J Castro1, 
J Pantoja1, F Saddy1, D Medeiros1, W Viana1, E Salgueiro1, 
CRR de Carvalho5
1Copa Dor Hospital, Rio de Janeiro, Brazil; 2Oswaldo Cruz
Foundation, Rio de Janeiro, Brazil; 3University Clinic Carl Gustav
Carus, Dresden, Germany; 4Federal University of Rio de Janeiro,
Brazil; 5São Paulo University, São Paulo, Brazil
Critical Care 2008, 12(Suppl 2):P295 (doi: 10.1186/cc6516)
Introduction The beneficial effects of the institution of high levels
of positive end-expiratory pressure (PEEP) after recruitment
maneuvers are controversial. We aim to compare the effects of the
ARDS Network (ARDSNet) ventilatory strategy and open lung
approach (OLA) applied in a sequential way, in patients with acute
lung injury/acute respiratory distress syndrome (ALI/ARDS).
Methods Ten patients fulfilling criteria for early ALI/ARDS were
recruited. For definitive selection, blood gas collected after
30 minutes application of 5 cmH2O PEEP and tidal volume (VT) =
10 ml/kg had to demonstrate PaO2/FIO2 < 300 mmHg. The
patients were initially ventilated for 24 hours according to the
ARDSNet protocol. After this period, if the PaO2/FIO2 was
≤350 mmHg, a recruitment maneuver was performed (sequential
5 cmH2O increments in PEEP starting from 20 cmH2O, until
PaO2/FIO2 > 350 mmHg) and an additional 24 hours of ventilation
according to the OLA (VT = 6 ml/kg and PEEP to achieve a
PaO2/FIO2 > 350 mmHg) was applied. Whole lung computed
tomography images (1.0 mm thickness with 10 mm gap) were
acquired after 24 hours of each strategy.
Results The institution of OLA was necessary in nine of the 10
studied patients. The PEEP was significantly higher during OLA (17
cmH2O (17–19) vs 8 cmH2O (8–11); P = 0.007) and resulted in a
significant improvement of oxygenation sustained for 24 hours of
follow-up, with no significant differences in plateau pressure, static
compliance, minute ventilation, PaCO2 and pH (P > 0.1). OLA
resulted in a significant reduction of the fraction of nonaerated
regions as compared with the ARDSNet protocol (13% (10–23) vs
37% (33–42); P = 0.018) without a significant increase in the
percentage of hyperinsufflation (5% (1–13) vs 2% (0–7); P =
0.149). No significant differences were observed in the infused
doses of vasopressors, fluid balance and arterial blood pressure.
Conclusions When compared with the ARDSNet protocol OLA
improved oxygenation, reducing the fraction of nonaerated regions
without significant increase in hyperinflated areas with comparable
levels of hemodynamics and fluid balance.
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Introduction The therapeutic measures of lung-protective
mechanical ventilation used in treatment of acute lung injury (ALI)
and acute respiratory distress syndrome (ARDS) have revived the
interest in high-frequency ventilation (HFV). The reduction of the
tidal volume during the conventional ventilation (CV) in terms of
low-tidal-volume ventilation is not unboundedly feasible. However,
HFV allows a further reduction of tidal volume. Established HFV
techniques are high-frequency oscillation (HFO), high-frequency
percussive ventilation (HFPV) and superimposed high-frequency
jet ventilation (SHFJV). The aim of this study was to evaluate the
amelioration of the oxygenation index (OI).
Methods Twenty-four patients with ALI/ARDS admitted to an ICU
were involved. Haemodynamic parameters, blood gas analysis,
ventilation pressures (positive end-expiratory pressure (PEEP),
plateau and mean airway pressures) were measured. The use of
HFV was indicated if the OI was still lower than 200 under CV. The
initial parameters (plateau and mean airway pressure, PEEP, I:E
ratio, ventilation frequency and FiO2) were chosen as the latest
setups of the CV. We randomly used one of the abovementioned
techniques to treat patients with ALI/ARDS. The clinically relevant
parameters were proved every 4 hours and ventilation was
adopted.
Results All patients treated with HFV showed an amelioration of
OI within 24 hours after the start (Figure 1). Furthermore, we
registered a significant increase of OI after 24 hours compared
with basis CV (Figure 1). However, we did not measure any
significant changes between the three HFV techniques at this time
point. We observed less/no haemodynamic disturbances with
SHFJV and HFPV compared with HFO. It was therefore important
to clinically stabilize the patients.
Conclusions We achieved a significant amelioration of the OI
using HFV rather than with CV. Each of the HFV techniques,
however, needs a period of a few hours to predict that the
technique is responding or nonresponding.
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Introduction The study objective was to investigate the relation-
ship of stress index and positive end-expiratory pressure (PEEP) in
Available online http://ccforum.com/supplements/12/S2
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patients with acute respiratory distress syndrome (ARDS). To
determine the relationship of the stress index, lung recruitment,
oxygenation and respiration mechanics.
Methods Fourteen patients with ARDS were enrolled in the study.
During volume control ventilation with constant inspiratory flow, the
pressure–time (P–t) curve was fitted to a power equation: P = a x
timeb + c, where coefficient b (stress index) describes the shape
of the curve: b = 1, straight curve; b < 1, progressive increase in
slope; and b > 1, progressive decrease in slope. PEEP was set to
obtain a b value between 0.9 and 1.1 after application of a
recruiting maneuver (RM). PEEP was changed to obtain 0.6 < b <
0.8 and 1.1 < b < 1.3. The experimental conditions sequence was
random. The recruited volume (RV) was measured by the static
pressure–volume curve method. The hemodynamics, pulmonary
mechanics and gas exchange were observed at the same time.
Results The PEEPs at b < 1, b = 1 and b > 1 were 8.3 ± 1.5
cmH2O, 15.0 ± 1.9 cmH2O and 18.4 ± 1.9 cmH2O, respectively,
which were significantly different (P < 0.001). At b = 1 and b > 1,
the partial arterial oxygen tension (PaO2/FiO2) (350.1 ± 113.0
mmHg, 338.3 ± 123.8 mmHg) was higher than that (165.1 ± 59.9
mmHg) of pre-RM (P < 0.05). The plateau pressures (Pplat) at b =
1 (29.0 ± 3.5 cmH2O) and b > 1 (32.9 ± 7.3 cmH2O) post-RM
were significantly higher than that at b < 1 (21.9 ± 4.3 cmH2O)
(P < 0.05). The Pplat at b > 1 was higher than that (25.3 ± 15.9
cmH2O) pre-RM (P < 0.05). Compared with the static pulmonary
compliance (Cst) at b = 1 (38.6 ± 10.9 ml/cmH2O), the Cst at b >
1 (26.4 ± 6.5 ml/cmH2O) decreased significantly (P < 0.05). The
RV at b = 1 and b > 1 (401.6 ± 204.0 ml, 588.3 ± 269.1 ml) were
significant higher than that at pre-RM and b < 1 (135.9 ± 111.1
ml, 175.2 ± 122.4 ml) (P < 0.05). At pre-RM, b < 1, b = 1 and b >
1, the HR, mean arterial pressure and lactate were not significantly
different (P > 0.05).
Conclusions The stress index at post-RM could be a good method
of PEEP titration for ARDS patients.
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Pulmonary homogenicity changes during recruitment
maneuvers and positive end-expiratory pressure in dogs
with acute respiratory distress syndrome
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Introduction The objective of the study was to investigate
pulmonary homogenicity changes during recruitment maneuvers
(RM) and positive end-expiratory pressure (PEEP) in dogs with
pulmonary acute respiratory distress syndrome (ARDSp) or
extrapulmonary acute respiratory distress syndrome (ARDSexp).
Methods After induction of saline lavage–injured ARDS (ARDSp,
n = 8) or oleic-acid-injured ARDS (ARDSexp, n = 8), PEEP was
set at 20 cmH2O and RM were performed (40/30-maneuver). RM
were repeated every 5 minutes until reaching sufficient alveolar
recruitment (PaO2/FiO2 > 400 mmHg), and then the tidal volume
was set at 10 ml/kg and PEEP was lowered by 2 cmH2O in every
10 minutes. Optimal PEEP was defined at 2 cmH2O above the
PEEP where PaO2/FiO2 dropped below 400 mmHg. Computed
tomography (CT) scans were done before and after induction of
ARDS and at each pressure level. By the changes in the CT
values, the lung was divided into hyperinflated, normally aerated,
poorly aerated and nonaerated regions. Lung volumes were
calculated by Pulmo software.
Results After RM, the total lung volume and air volume were
significantly increased before and after induction of ARDS in the
two models (P < 0.05). At optimal PEEP, poorly aerated and
nonaerated lung areas decreased and normally aerated lung areas
increased sharply but were accompanied by significant alveolar
hyperinflation in the two models (P < 0.05). Compared with
ARDSexp models, the changing of hyperinflated lung areas was
markedly greater in ARDSp models at optimal PEEP (P < 0.05).
After three-dimensional renderings of CT scans, alveolar
hyperinflation occurred mainly in nondependent lung regions,
whereas alveolar recruitment occurred in dependent regions.
Conclusions The alveolar hyperinflation increase and pulmonary
heterogeneity climb during RM and at optimal PEEP. A focal
distribution of lung injury in ARDSp may be more susceptible to
alveolar hyperinflation with optimal PEEP.
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Positive end-expiratory pressure-induced changes of the
vibration response image
S Lev, I Kagan, M Grinev, J Cohen, P Singer
Rabin Medical Center, Beilinson Hospital and Sackler School of
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Introduction Vibration response imaging (VRI) is a new modality that
reflects the distribution of vibration in the lung during the respiratory
process. The VRI dynamic and functional image has been proved to
be sensitive to changes in ventilator settings, including changes in
mode of mechanical ventilation. In the present study, we assess the
changes of the VRI image and quantification data as a function of
positive end-expiratory pressure (PEEP) changes.
Methods Thirty-four ventilated patients were consecutively enrolled
in this study. PEEP levels (0–15 cmH2O) were assigned according
to level of oxygenation and blood pressure. A change in vibration
distribution of more than 10% in one of the six lung segments was
considered major. One hundred and thirteen recordings were
performed sequentially in 21 patients at the same level of PEEP in
order to assess the reproducibility of the measurement.
Results One hundred and sixty VRI recordings were completed.
Sixty-eight percent showed major changes in the VRI measurement
when changing the PEEP. These changes were detectable for a
PEEP change of 5 cmH2O or less in 17 patients and for 10 cmH2O
for six patients. Among most VRI responders, an optimal PEEP
range could be detected, in the range 5–10 cmH2O (Figure 1).
Ninety-six percent of the sequential recordings performed on the
same patient at a given PEEP level exhibited less than 10% change.
Conclusions VRI measurements respond rapidly to PEEP
changes, and can provide the optimal vibration distribution at
different PEEP levels.
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Effect of positive end-expiratory pressure application on
inflammation in acute respiratory distress syndrome
patients during pressure–volume curve maneuver
T Adanir, A Sencan, T Aydin, M Koseoglu
Ataturk Training and Research Hospital, Izmir, Turkey
Critical Care 2008, 12(Suppl 2):P300 (doi: 10.1186/cc6521)
Introduction There are several studies indicating that low-tidal-
volume ventilation causes less damage to the alveoli than a high
tidal volume [1], but this strategy may facilitate alveolar de-
recruitment and deterioration of gas exchange [2]. Recruitment
maneuvers may improve gas exchange, but inflating the lungs to
nearly vital capacity might be harmful due to stretch stress
imposed on the pulmonary parenchyma. Alveolar macrophages
liberate inflammatory cytokines in response to stretch [3]. The
pressure–volume (PV) curve is a physiological tool proposed for
diagnostic or monitoring purposes during mechanical ventilation in
acute respiratory distress syndrome (ARDS). This maneuver effect
is similar to recruitment maneuver. We study the hypothesis that
the systemic level of proinflammatory cytokines may be affected by
a PV curve maneuver in ARDS patients, and positive end-expiratory
pressure (PEEP) application may affect these levels.
Methods This prospective, interventional clinical trial was per-
formed in the ICU of a teaching hospital. Twenty-two consecutive
mechanically ventilated patients with clinical and radiological signs
of ARDS were included in the study. A single PV curve maneuver
was performed by elevating the airway pressure to 40 cmH2O for
7 seconds with (group 2) (n = 10) or without PEEP (group 1) (n =
12) application. Plasmatic concentrations of IL-6, TNFα and
antioxidant capacity, arterial blood gases and respiratory changes
were measured immediately before and 5 minutes, 1 hour and
5 hours after the PV curve maneuver.
Results The PV curve maneuver caused a minor but nevertheless
significant improvement of oxygenation (P = 0.015) in both groups. In
addition, plasma concentrations of TNFα of both groups were similar,
but the IL-6 level was higher in the group without PEEP application
than in the group with PEEP after the maneuver (P = 0.000).
Conclusions The PV curve maneuvers with or without PEEP
improved oxygenation slightly. But if the PV curve maneuvers were
applied with PEEP, this did not modify systemic inflammatory
mediators in mechanically ventilated ARDS patients.
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Airway pressure release ventilation: an alternative ventilation
mode for pediatric acute respiratory distress syndrome
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Introduction The purpose of the present data is to determine
whether airway pressure release ventilation (APRV) can improve
oxygenation in pediatric patients with acute respiratory distress
syndrome relative to pressure-controlled ventilation (PCV).
Methods Data about the patients with acute respiratory distress
syndrome whose oxygenation was not improved with conventional
ventilation and switched to APRV were collected retrospectively.
Results Five patients were switched from conventional ventilation to
APRV. Of these five, three patients responded to APRV with
improvement in oxygenation. The mean age of the responders was
5.8 ± 1.3 (4.3–7.4) months. The fractional oxygen concentration
decreased from 96.6 ± 2.3% for PCV to 68.3 ± 11.5% for APRV,
the peak airway pressure fell from 36.6 ± 11.5 cmH2O for PCV to
33.3 ± 5.7 cmH2O for APRV, the mean airway pressure increased
from 17.9 ± 5.9 cmH2O for PCV to 27 ± 2.6 cmH2O for APRV and
the release tidal volume increased from 8.3 ± 1.5 ml/kg for PCV to
13.2 ± 1.1 ml/kg for APRV at the first hour (Table 1). Of the two
nonresponders, both had primary acute respiratory distress
syndrome and one of them had prior ventilation history. We
suggested that the lungs of the nonresponders were not recruitable.
Conclusions APRV may improve oxygenation in pediatric ARDS
patients when conventional ventilation does not work. APRV modality
may provide better oxygenation with lower peak airway pressure. The
recruitability of the lungs may affect the response to APRV.
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Conventional ventilation versus APRV
APRV time (hours)
Pre-enrollment to APRV T1 T24 T48 T72
PIP/Phigh (cmH2O) 36.6 ± 11.5  33.3 ± 5.7 30.3 ± 5.5 29 ± 1.4 25.5 ± 2.1
MAP (cmH2O) 17.9 ± 5.9 27 ± 2.64 24.6 ± 4.16 23.5 ± 0.7 21.6 ± 2.3 
PEEP/Plow (cmH2O) 13.3 ± 1.5 0 0 0 0
Thigh (sec) 3.6 ± 0.5 3.7 ± 0.4 3.8 ± 0.2 3.65 ± 0.21
Tlow (sec) 0.73 ± 0.2 0.76 ± 0.11 0.9 ± 0 0.75 ± 0.21
VTe (mL/kg) 8.3 ± 1.5 13.2 ± 1.1 12 ± 1.7 11.0 ± 1.41 9.5 ± 6.7
Set FiO2 (%) 96.6 ± 2.3 68.3 ± 11.5 60.0 ± 5 57.5 ± 3.5 52.5 ± 3.5
T4 T24 T48 T72
pH 7.23 ± 9.7 7.32 ± 9.5 7.35 ± 6.42 7.34 ± 4.9 7.39 ± 1.41
pCO2, mmHg 72.3 ± 21.4 63.4 ± 16.8 61.4 ± 7.85 56.4 ± 6.43 57.0 ± 12.7
PIP, peak airway pressure; MAP, mean alveolar pressure; PEEP, positive end expiratory pressure; VTe, expiratory tidal volume; FiO2, fractional oxygen
concentration; T, time 
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Influence of rhDNAse on the duration of mechanical
ventilation in intensive care patients
N Deschner, B Friedrich, W Brehm, R Vonthein, J Riethmueller
University Hospital Tuebingen, Germany
Critical Care 2008, 12(Suppl 2):P302 (doi: 10.1186/cc6523)
Introduction rhDNase is effective in the treatment of children with
cystic fibrosis [1]. Significant reduction of the duration of
ventilation by rhDNAse has been reported in children following
cardiac surgery [2]. The goal of the present study was to
investigate whether rhDNase is able to reduce the duration of
ventilation in adult mechanically ventilated intensive care patients.
Methods After approval of local ethics committees we conducted a
double-blind, placebo-controlled, randomised, multicentre national
trial. Patients were stratified into two subgroups depending on their
status as surgical or nonsurgical. The trial was started within 48
hours after the start of mechanical ventilation and lasted until
weaning was successful. Patients in the treatment group received
2.5 ml rhDNase endotracheally twice a day. Patients in the placebo
group received the same amount of normal saline.
Results One hundred and twenty-three surgical and 162
nonsurgical patients were included in the study. Factors such as
gender, weight, smoking habit, chronic pre-existing diseases and
prevalence of chronic obstructive pulmonary disease were
distributed equally in both groups in surgical patients. In
nonsurgical patients, more smokers were randomized to the
rhDNase group. Acute burn patients were randomized to the
rhDNase group only. Twelve patients (two surgical) died in the
rhDNase group versus 16 (four surgical) in the placebo group. In
surviving surgical patients, the median duration of ventilation was
16.6 days (95% CI 11.5–21 days) in the rhDNase group and
11.7 days (95% CI 8.4–15.6 days, P = 0.39) in the placebo group.
In surviving nonsurgical patients, the median duration of ventilation
was 7.8 days (95% CI 6–9.3 days) in the rhDNase group and
12.6 days (95% CI 7.9–16.9 days; P = 0.038) in the placebo
group without adjustment for smoking habits.
Conclusions In adult nonsurgical intensive care patients, rhDNase
significantly shortens the duration of ventilation. This effect is not
seen in surgical patients. The hypothesis that especially pneumonia
that requires mechanical ventilation responds favourably to
treatment with rhDNase should be investigated.
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Introduction Chronic obstructive pulmonary disease (COPD) is
predicted to be the third leading cause of death in the United
States by 2020. Approximately 125,000 people die yearly from
acute exacerbations of the disease. Once intubation and
mechanical ventilation become necessary, the death rate
increases. To avoid the need for ventilator use we have developed
a new device (the Hemolung), which is an integrated pump/
oxygenator that functions at low blood flow rates (250–500 ml/min)
equivalent to those used in renal dialysis. The small priming volume
(190 ml), reduced membrane surface area (0.5 m2), and use of a
percutaneously inserted dual lumen venous catheter (15 Fr) to
provide blood inflow and outflow make the entire system suitable
for repetitive use in patients with hypercapnic acute respiratory
failure. We report here 7-day animal data stressing the
hemocompatibility and gas exchange capabilities of the device.
Methods The venous catheter was inserted into the right exterior
jugular vein of four adult sheep and connected to the saline-primed
Hemolung circuit. Hollow fiber membranes were coated with
siloxane and heparin to prevent plasma wetting and to increase
biocompatibility. Animals were minimally anticoagulated with
heparin (ACT 150). Blood flow, CO2 exchange, blood gases and
key hematological parameters were measured over 7 days.
Necropsy was performed on termination.
Results Removal of CO2 remained steady over 7 days, averaging
72 ± 12 ml/min at blood flows of 384 ± 18 ml/min. As the venous
PCO2 rose or fell, so did the level of CO2 removal. No changes
were necessary in the system and no plasma wetting was noted
over the 7 days. Hematocrit remained stable and no blood
products were required. Initial platelet counts dropped to
221,000 ± 58,000/μl by the second day, but recovered to base-
line values on day 4 and remained stable. Necropsy showed no
signs of thromboembolism or organ damage.
Conclusions A simple alternative to mechanical ventilation for
patients with COPD and hypercapnic respiratory failure has been
successfully tested in animals. Human trials are planned for 2008
to determine what role ‘respiratory dialysis’ will have in this patient
population.
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Effect of the inspiratory flow pattern on inspiration/
expiration transition of lung vibrations in mechanically
ventilated patients
S Jean, I Cinel, R Dellinger
Robert Wood Johnson School of Medicine, UMDNJ, Cooper
University Hospital, Camden, NJ, USA
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Introduction Mechanical ventilation can be performed using
different inspiratory flow patterns. We used vibration response
imaging (VRI) technology to ascertain the intensity of lung vibration
with different inspiratory flow patterns during various modes of
mechanical ventilation.
Methods VRI was performed in succession during volume control
ventilation with a square and decelerating inspiratory flow
waveform, a pressure control waveform and a pressure support
waveform. The total lung vibration energy transmitted to the
posterior thorax (from 36 sensors) was plotted over time and the
transition of vibrations from inspiration to expiration noted.
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Results During volume control ventilation with a square inspiratory
flow waveform, peak inspiratory flow (PIF) is immediately followed
by peak expiratory flow (PEF) and, as such, the separation of peak
inspiratory (I) and expiratory (E) lung vibrations as transmitted to the
chest wall surface was minimal or absent consistently (Figure 1a).
During pressure support ventilation, PIF and PEF are separated –
resulting in a consistent separation of I and E peak lung vibration
(Figure 1b). During pressure control ventilation with sufficient I time
to allow inspiratory flow to return to a baseline as near-baseline
level, the valley was consistently widened between the peak I and E
lung vibration energy, reflecting the decrease in vibration energy
associated with lower end-inspiratory airflow (Figure 1c).
Conclusions When the flow-time waveform recorded between the
patient and the ventilator is compared with the vibration waveform
summed from surface sensors, two patterns emerge: as the time
between PIF and PEF increases, the separation of peak I and E
lung vibration energy increases; and as end-inspiratory flow
decreases, the valley between peak I and E vibration deepens. The
decelerating flows that gradually diminish to zero will therefore
produce the greatest separation in respiratory vibrations. There
could be clinical relevance as to the effect of the inspiratory flow
waveform on vibration transition in the chest.
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Introduction Assisted ventilation with pressure support (PS) is
one of the most commonly used ventilation modes; however, there
is no agreement about the most adequate method to set an
optimal level of PS. The aim of our study is to analyze the effect of
different pressurization ramps on the work of breathing. This was
estimated by the airway occlusion pressure in the first 100 ms of
inspiration (P0.1) and by the breathing pattern: the respiratory rate
(RR) and tidal volume (TV).
Methods We carried out an interventional prospective study in a
group of 15 patients mechanically ventilated after acute respiratory
failure (ARF), with different initial causes at the beginning of assisted
ventilation. The initial PS level was equal to the plateau pressure, and
this was decreased in order to keep the patient comfortable and the
P0.1 lower than 3 cmH2O. The PEEP level used in controlled
ventilation was maintained and subsequently we changed the
inspiratory rise time in three ranks: 0.0, 0.2 and 0.4 seconds. After
keeping the patient respiratorily and haemodynamically stable we
measure the RR, TV and P0.1. We compare data using statistical
analysis with nonparametric tests. Results are presented as the
mean ± standard deviation at 0.0, 0.2 and 0.4 seconds.
Results The cause of ARF was acute respiratory distress syn-
drome (ARDS) in nine patients and acute on chronic respiratory
failure in six patients. Mean age: 61.2 ± 14.02 years. The mean
level of PS and PEEP was 17.93 ± 7.10 and 6 ± 1.69 cmH2O.
Decreasing the inspiratory ramp was associated with the
significantly highest P0.1 levels (1.25 ± 0.8, 1.47 ± 1, 1.96 ± 1.24,
P = 0.01), whereas the RR and TV did not significantly change
(RR: 22.66 ± 9.38, 21.73 ± 7.05, 22 ± 6.67; TV: 534.46 ± 162.59,
541.8 ± 168.5, 522.73 ± 157.09). There were no significant
differences in the P0.1 levels between acute respiratory distress
syndrome and acute on chronic respiratory failure.
Conclusions The parameters frequently used to estimate the
breathing pattern do not necessarily reflect the changes in the
work of breathing. The availability of automatic measurements in
some respirators can help to optimize the ventilatory mode used.
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Introduction A closed-loop system for automated control of
mechanical ventilation, Autopilot-BT, will be enhanced [1]. It must
be able to adapt to diverse disease patterns. The Autopilot-BT is
based on fuzzy logic, which can model complex systems using
expert knowledge. The expert knowledge was acquired by a
specifically designed questionnaire (Figure 1a).
Methods Exemplarily we will focus on the respiratory rate (RR)
controller, responsible for the arterial partial pressure of carbon
dioxide/end-tidal carbon dioxide pressure (etCO2) control. The
etCO2 values are classified into seven different fuzzy sets ranging
from ‘extreme hyperventilation’ to ‘extreme hypoventilation’. For
different diseases such as chronic obstructive pulmonary disease
or acute respiratory distress syndrome (ARDS), every clinician
assigns given etCO2 values to a ventilation status. By averaging
over all assignments of the clinicians, new targets and limits for
each disease are obtained. Afterwards the new target and limit
areas were implemented in a new fuzzy system controlling the RR.
Available online http://ccforum.com/supplements/12/S2
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(a) Questionnaire for ARDS. (b) Membership functions for “healthy” and “ARDS”.
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Results Sixty-one of the anaesthesiologists filled the questionnaire
completely, two did not answer. Figure 1b exemplarily shows the
different classifications of etCO2 (membership functions) in
‘healthy’ and ARDS derived from the questionnaire. The member-
ship areas of ‘normal state’, ‘moderate’, ‘strong’ and ‘extreme hypo-
ventilation’ in the ARDS fuzzy system are shifted to the right. Also the
basis of the target area ‘normal state’ ranges in the ARDS system
from 30 to 60 mmHg etCO2. One of the limits in the fuzzy system
therefore shifts more to the hypoventilated area and the system
tolerates etCO2 values up to 60 mmHg as the normal state range.
Conclusions Disease-specific expert knowledge derived from the
questionnaire greatly modifies the performance of the RR
controller. The developed disease-specific adaptive controller
provides better mechanical ventilation support to patients.
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P307
Use of chest sonography to estimate alveolar recruitment
in general anesthesia
B Serretti1, B Ferro1, L Gargani2, F Forfori3, R Mori3, C Mosca3,
F Giunta3
1Scuola di Specializzazione in Anestesia e Rianimazione, Università
degli Studi di Pisa, Pisa, Italy; 2Institute of Clinical Physiology,
National Research Council, Pisa, Italy; 3AOUP, Pisa, Italy
Critical Care 2008, 12(Suppl 2):P307 (doi: 10.1186/cc6528)
Introduction Chest sonography evaluates extravascular lung water
as the number of ultrasound lung comets (ULC). The goal of this
study was to assess the potential role of chest sonography to
detect lung reaeration after alveolar recruitment maneuvers (RM)
using the PaO2/FiO2 ratio as reference parameter.
Methods Chest sonography and arterial blood gas (ABG) analysis
were independently performed in eight anesthetized and
mechanically ventilated patients after abdominal surgery, before RM
(achieved with positive end-expiratory pressure at 35 cmH2O for
30 s) and 5 and 60 minutes later. A total of 11 anterior and lateral
chest regions were studied. For each chest region, lung patterns
were scored as: 0 = normal, 1 = B lines ≥7 mm, 2 = B lines <7 mm,
3 = white lung, 4 = alveolar consolidation. A global ULC score for
each patient was calculated adding the score of the 11 chest
regions. Using the PaO2/FiO2 ratio as reference parameter, we
calculated the sensitivity, specificity and positive predictive value of
the lung ultrasound. The baseline ULC score was compared with
the basal PaO2/FiO2 ratio, and furthermore the variation of eco
score was compared with the variation of the PaO2/FiO2 ratio.
Results Chest sonography shows a sensitivity of 50–100%, a
specificity of 75% and a positive predictive value of 67–88%. A
linear correlation between the PaO2/FiO2 ratio and eco score was
found (Figures 1 and 2).
Conclusions Chest sonography is a promising, simple and bedside
tool to estimate the efficacy of alveolar recruitment maneuvers.
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Introduction The optimal setting of positive end-expiratory
pressure (PEEP) during mechanical ventilation in the ICU is still an
open problem [1]. Recruitment processes are important influence
factors that are difficult to measure in patients [2,3]. It is proposed
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(Left) Isolated lung during experiment. (Middle) Crackle as a wave form. (Right) Power spectrum.
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to use lung sound analysis to identify recruitment during mechanical
ventilation.
Methods A special low-noise microphone and amplifier has been
developed (Figure 1, left) and integrated into a standard stetho-
scope. A series of experiments were performed to obtain sound
data from isolated animal lungs. A standard protocol was
implemented using the Evita4Lab equipment (Dräger Medical,
Lübeck, Germany). After preparation of the lung, a low-flow
manoeuvre was performed as a first inflation to open the atelectatic
lung. Visual inspection allows us to identify the amount of
recruitment. At most two more low-flow manoeuvres were per-
formed while recording the lung sounds until the whole lobe below
the stethoscope was opened. Finally, a PEEP wave manoeuvre
was used to record normal breaths at different PEEP levels starting
from zero PEEP up to a peak pressure of 50 mbar.
Results Crackle sounds (Figure 1, right) could be identified and
analysed in the recorded sound data offline using Matlab
(Mathworks, Natick, MA, USA) for the analysis and visualization.
With a window technique, the power of the sound signal in a
specific frequency range for crackles (700–900 Hz) was
determined. At the beginning of the low-flow manoeuvre, trains of
crackles were found that increased in intensity with pressure. At
higher pressure levels the crackle intensity decreased, especially in
the second and third manoeuvres.
Conclusions Sound analysis in isolated lungs can reliably detect
increasing crackle activities that seem to correlate with visually
observable opening of atelectasis.
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Introduction Congestive heart failure (CHF), chronic obstructive
pulmonary disease (COPD) and asthma patients typically present
with abnormal auscultatory findings on lung examination. The aim
of this study was to evaluate in detail the distribution of respiratory
sound intensity in CHF, COPD and asthma patients during acute
exacerbation.
Methods Respiratory sounds throughout the respiratory cycle were
captured and displayed using an acoustic-based imaging technique.
The breath sound distribution was mapped to create a gray-scale
sequence of two-dimensional images based on the intensity of
sound (vibration). Consecutive CHF (n = 23), COPD (n = 12) and
asthma (n = 22) patients were imaged at the time of presentation to
the emergency department. Geographical area of the images and
respiratory sound patterns were quantitatively analyzed.
Results In healthy volunteers, CHF, COPD and asthma patients,
the mean geographical area of the vibration energy image in an
inspiratory maximal energy frame was 76.2 ± 4.5, 67.6 ± 6.7,
72.2 ± 7.6 and 52 ± 11.7 kilo-pixels, respectively (P < 0.01). In
healthy volunteers, CHF, COPD and asthma patients, the ratio of
vibration energy values at peak inspiration and expiration (peak I/E
ratio) were 6.3 ± 5.2 and 5.6 ± 4, 2.8 ± 2.2 and 0.3 ± 0.3,
respectively (P < 0.01). Mathematical analysis of the timing of
vibration energy peaks of right lungs versus left lungs showed that
the time between inspiratory peaks was 0.03 ± 0.04 seconds and
between expiratory peaks was 0.14 ± 0.09 seconds in
symptomatic asthmatic patients. There were no significant
differences in the timing of vibration energy peaks in healthy
volunteers, CHF and COPD patients.
Conclusions Compared with healthy volunteers, the geographic
area of the image in CHF is smaller, there is no difference in the
peak I/E vibration ratio and there is no peak energy asynchrony
between two lungs; In COPD, there is no difference in the
geographic area of the image and no asynchrony in peak energy
between two lungs but there is a significant decrease in the peak
I/E vibration ratio; In asthma, the geographic area of the image is
much smaller, and the peak I/E ratio is even further decreased and
there is asynchrony in peak energy between the two lungs. These
characteristics may be helpful in distinguishing acute
symptomology due to CHF, COPD or asthma.
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Introduction Mechanical energy from the beating heart is
transferred to the lung, inducing variations in the airway pressure
signal called cardiogenic oscillations (COS), which we hypothesize
reflect intratidal nonlinear lung mechanics. However, during high
flow rate, as characteristic for passive expiration, the analysis of
lung mechanics is impractical since COS are almost suppressed
and the quantity is low.
Methods Five piglets with atelectasis were investigated during
constant inspiratory flow mechanical ventilation with positive end-
expiratory pressure of 0, 5, 8, 12 and 16 mbar. The airflow rate,
airway pressure, pleural pressure and ECG were recorded (sample
frequency 100 Hz). The expiratory airflow rate was limited using
two switchable tubes of different lumen. Signals were separated
and compared by each breath.
Results Compared with passive expiration COS in decelerated
expiration became clearly distinguishable (Figure 1). COS
amplitudes were increasing with decreasing airflow rate.
Conclusions By decelerating the expiration, COS become
distinguishable and therefore analyzable. With this method, lung
mechanics can be determined separately in expiration.
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Introduction Heartbeats transfer mechanical energy to the lung,
inducing variations in local compliance (dV/dP) [1], which translate
to cardiogenic oscillations (COS) in the pressure-volume (PV)
loop. We hypothesized that the COS-related local dV/dP change
reflects intratidal nonlinear lung mechanics modulated by positive
end-expiratory pressure (PEEP).
Methods Ten piglets with atelectasis were investigated during
constant inspiratory flow mechanical ventilation with PEEP of 0, 5,
8, 12 and 16 mbar, respectively. The airflow rate, airway pressure
and ECG were recorded (sample frequency: 100 Hz). The
inspiratory limb of the PV loop was partitioned into segments
confined by two consecutive ECG R-peaks and containing one
COS. Local compliances were analyzed as the local slope (dV/dp)
within consecutive volume windows of 50 ml size.
Results The COS-related local compliances depend on the PEEP
level as shown in one representative animal (Figure 1). They are
maximal at PEEP levels of 5 and 8 mbar and are minimal at zero
PEEP and at high PEEP levels of 12 and 16 mbar, and they
decrease with increasing inspired volume.
Conclusions COS-related local compliances reflect nonlinear lung
mechanics. The information obtained by COS corresponds to what
can be learnt from the sigmoid PV loop of a quasistatic manoeuvre
with low compliance at low pressure, high compliance at
intermediate pressure and again low compliance with
overdistension. The intratidal pattern of COS-related compliances
possibly reflects the nonlinearity of pulmonary volume distensibility,
which, among others, is modulated by PEEP. Analysis of COS-
related local compliances may open a window towards lung
mechanics determination in spontaneous breathing.
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Introduction The level of positive end-expiratory pressure (PEEP) is
important to avoid ventilator-induced lung injury (VILI) by preventing
alveolar collapse and alveolar overdistension. One of the mecha-
nisms of application of optimal PEEP could be measurement of the
functional residual capacity or end-expiratory lung volume (EELV) in
mechanically ventilated patients. Recently, GE Healthcare intro-
duced a multibreath open-circuit nitrogen technique to measure the
EELV during mechanical ventilation. The aim of this study was to
measure the EELV levels at three different PEEP levels in ventilated
patients with different diseases.
Methods We examined 45 sedated mechanically ventilated
patients in a mixed ICU of a university hospital. Patients were
divided into three groups: normal pulmonary function (group N),
respiratory failure due to primary lung disorders (group P) and
respiratory failure due to secondary lung disorders (group S). In all
patients the EELV measurements were performed at three PEEP
levels (15 cmH2O, 10 cmH2O, 5 cmH2O). Arterial blood gases
were also obtained at each PEEP level.
Results Figures 1 and 2 show the EELV data and PaO2/FiO2 (PF)
ratio data, respectively.
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Conclusions We conclude that the EELV values decreased
significantly after stepwise reduction of the PEEP levels from 15 to
5 cmH2O, whereas the PaO2/FiO2 ratio did not change. This
indicates that monitoring a patient’s lung function could be a
prerequisite to find the optimal PEEP in order to prevent VILI.
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Critical Care 2008, 12(Suppl 2):P313 (doi: 10.1186/cc6534)
Introduction The ability to track the functional residual capacity
(FRC) volume for a patient treated with ventilator therapy may be
useful for guidance in improving or preserving gas exchange and
for avoiding ventilator-associated injury to the lung. We tested the
repeatability of the FRC measurement at the bedside for
mechanically ventilated patients in the ICU.
Methods All data needed for the FRC measurement were
collected using a volumetric capnography system (NICO2;
Respironics, Wallingford, CT, USA), which had been modified to
contain a fast, on-airway oxygen sensor. The nitrogen washout and
washin method was used to calculate the FRC for 13 ICU patients.
The protocol for a measurement set called for increasing the FIO2
from the clinically determined baseline to 100% for 5 minutes,
returning the FIO2 to the baseline level for 5 minutes, and then
repeating the FIO2 change. After approximately 1 hour, the
measurement set was repeated. The differences between the first
and second measurements in each set were analyzed.
Results Bland–Altman analysis yielded a bias between repeated
measurements of 85 ml (2.8%) and a standard deviation of the
differences of ±278 ml (9.0%). The r2 of the repeated measure-
ments was 0.92 (n = 28). See Figure 1.
Conclusions We have previously verified the FRC measurement
accuracy of this system in bench tests and volunteer studies. The
satisfactory repeatability demonstrated in this study suggests the
system is clinically viable in the ICU.
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Introduction Pulmonary atelectasis and hypoxemia are significant
events after cardiac surgery. The aim of the present study was to
determine the efficacy of alveolar recruitment in different ventilation
modes after cardiac surgery.
Methods We evaluated 480 patients submitted to cardiac surgery
after arrival in the ICU. Groups were randomly allocated to one of
eight groups: group 1 – volume controlled (8 ml/kg), respiratory
rate if 12/min, PEEP = 5 cmH2O with no recruitment, FiO2 = 0.6;
group 2 – volume controlled (8 ml/kg), respiratory rate if 12/min,
PEEP = 5 cmH2O, FiO2 = 0.6 and recruitment with three
maneuvers (PEEP 30 cmH2O for 30 seconds); group 3 – volume
controlled (8 ml/kg), respiratory rate if 12/min, PEEP = 10 cmH2O,
with no recruitment, FiO2 = 0.6; group 4 – volume controlled
(8 ml/kg), respiratory rate if 12/min, PEEP = 10 cmH2O, FiO2 =
0.6 and recruitment with three maneuvers (PEEP 30 cmH2O for
30 seconds); group 5 – pressure controlled (to achieve 8 ml/kg),
respiratory rate if 12/min, PEEP = 5 cmH2O with no recruitment,
FiO2 = 0.6; group 6 – pressure controlled, respiratory rate if
12/min, PEEP = 5 cmH2O, FiO2 = 0.6 and recruitment with three
maneuvers (PEEP 30 cmH2O for 30 seconds); group 7 – pressure
controlled, respiratory rate if 12/min, PEEP = 10 cmH2O, with no
recruitment, FiO2 = 0.6; and group 8 – pressure controlled,
respiratory rate if 12/min, PEEP = 10 cmH2O, FiO2 = 0.6 and
recruitment with three maneuvers (PEEP 30 cmH2O for 30
seconds). The primary outcome was the ratio of arterial tension to
inspired oxygen fraction measured after 4 hours of ventilation and
the time for extubation.
Results Oxygenation was higher in recruitment groups (P < 0.01),
and pressure-controlled ventilation resulted in better oxygenation
than volume-controlled ventilation (P < 0.05). Patients of groups 6
and 8 (pressure controlled with recruitment maneuvers) presented
a lower time for extubation than the other modes (280 min vs 476
min, P < 0.01).
Conclusions After cardiac surgery, pressure-controlled ventilation
with recruitment is an effective method to reduce hypoxemia, and
results in a reduction of length in mechanical ventilation.
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Introduction After induction of anaesthesia and during abdominal
surgery, homogeneity of ventilation is influenced by different
factors such as compression and absorption atelectasis and
change in abdominal pressure [1]. To assess the spatial change in
Available online http://ccforum.com/supplements/12/S2
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ventilation by applying positive end-expiratory pressure (PEEP), we
employed the dynamic centre of gravity index ycog [2], which is a
new mathematical feature of electrical impedance tomography
(EIT) measurement in a clinical study.
Methods After approval of the local ethics committee and informed
consent we prospectively randomized 32 consecutive patients
(ASA physical status I/II) scheduled to undergo elective laparo-
scopic cholecystectomy. The patients were randomly assigned to
the PEEP group (10 cmH2O) or ZEEP group (0 cmH2O). Patients
obtained volume-controlled ventilation (8 ml/kg bw) and the minute
volume was adjusted by increasing the respiratory rate but
maintaining a PaCO2 level between 35 and 45 mmHg. EIT (EIT
evaluation KIT; Dräger Medical, Lübeck, Germany/GoeMF II
system; University of Göttingen, Germany) was performed at an
intercostal level of Th 6 in the supine position. Measurements were
carried out preoperatively and intraoperatively at five different time
points (T0–T4). We calculated the ventral/dorsal lung ycog [2] to
investigate the differences in homogeneity of pulmonary ventilation.
EIT data and gas exchange parameters were compared between
the randomized groups. A t test and variance analysis by the GLM
repeated-measures procedure (Greenhouse–Geisser) method
were used for statistical analysis.
Results Both study groups showed no differences in their
preoperative characteristics. After induction of anaesthesia,
oxygenation was reduced in the ZEEP group compared with the
PEEP group and also the PaO2/FiO2 ratio was lower during
anaesthesia compared with T0 measurements. The PEEP-
ventilated patients showed higher values of respiratory compliance.
The ZEEP-ventilated patients showed a lower gravity index
compared with the PEEP group (P = 0.018). Ventilation with PEEP
showed no difference in ycog at T0.
Conclusions The dynamic change of the homogeneity of
ventilation after induction of anaesthesia and during surgery can be
characterized by the calculation of the gravity index, which is a
result of mathematical calculation of noninvasive EIT
measurements. ZEEP ventilation resulted in a prominent reduction
of oxygenation and a shift of the dynamic centre of gravity index
compared with preoperative measurements and ventilation with
PEEP. To optimize ventilation in anaesthetized patients, this new
index can be of fundamental help.
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Introduction High postoperative mortality in patients after open
elective aortic abdominal aneurysm (AAA) repair is thought to be
the effect of ischemia-reperfusion organ injury followed by Multiple
Organ Dysfunction Score. Neutrophils appear to be predominant
leukocytes that are important in mediating ischemia-reperfusion
injury and organ damage. Growth-related oncogene alpha (GROα)
(CXCL1) is the chemokine with potent chemotactic activity for
neutrophils. The aim of this study was to determine changes in
serum GROα concentrations in the course of ischemia-reperfusion
during AAA repair.
Methods Blood samples were taken before surgery (Preop),
before unclamping of the aorta (Pre-Xoff), 90 minutes after
unclamping (90min-Xoff) and 24 hours after surgery. GROα serum
concentrations were measured with the ELISA technique.
Results Seventeen patients, all men, with median age 65 (range
44–76) years undergoing AAA repair and a control group
comprised of 11 volunteers, all men, were included in the study.
Nine patients made an uncomplicated recovery, eight (47%)
developed complications and four of them (24% of all) died.
During AAA repair the GROα level decreased from 79 pg/ml at
Preop and 76 pg/ml at Pre-Xoff to the lowest value of 61 pg/ml at
90min-Xoff (P = 0.308 vs Preop), followed by an increase to 100
pg/ml 24 hours after operation (P = 0.055 vs 90min-Xoff).
Contrary to the uncomplicated group, in death and complicated
cases there was no depletion of GROα levels during surgery, but
the rise of its level to 137 pg/ml (P = 0.144 vs Preop) and 133
pg/ml (P = 0.86 vs Preop), respectively, was observed 24 hours
after surgery. There was significant positive correlation between
GROα level and Multiple Organ Dysfunction Score (r = 0.417),
calculated on the second day after AAA repair.
Conclusions Serum GROα concentrations decreased in the
course of ischemia-reperfusion during AAA repair in uncomplicated
patients. The lack of depletion of the chemokine level during
surgery and its high value after AAA repair were associated with
the development of postoperative organ dysfunction and death.
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Introduction The 50–50 criteria (serum bilirubin (SeBi) > 50
μmol/l, serum prothrombin index (PI) < 50%) on postoperative 5
day is a predictor of mortality after liver transplantation [1]. The aim
of this study was to analyse the perioperative causes,
consequences and outcome of early excretion liver dysfunction.
Methods In 96 liver transplanted patients the graft dysfunction
was defined in PI > 50% and SeBi > 50 μmol/l. The multiorgan
donation data including liver biopsies results were recorded.
During and after liver transplantation, volumetric hemodynamic,
global oxygenation and regional splanchnic perfusion parameters
were measured. The hepatic and renal functions were analysed.
Based on the postoperative fifth-day SeBi levels, the patients were
divided in two groups: group A (SeBi < 50 μmol/l, n = 47) and
group B (SeBi > 50 μmol/l, n = 49). The postoperative
complications bleeding, renal and respiratory failure, infection were
noticed and mortality was recorded. Statistical analyses were
performed with the Wilcoxon signed rank test, chi-squared test
and Kaplan–Meyer model.
Results Before organ retrieval, more group B donors received
dopamine (P < 0.04), compared with group A donors who
received noradrenalin (P < 0.004). The occurrence of donors’ fatty
liver was the same in both groups. In group B, more Child–Pugh C
recipients (P < 0.004) with higher Model for End-Stage Liver
Disease (MELD) score (P < 0.001) had longer transplantations
(P < 0.05). Worse volumetric hemodynamic (intrathoracic blood
volume index, cardiac index, p < 0.03), global oxygenation (oxygen
delivery index, P < 0.04) and regional splanchnic perfusion para-
meters (intramucosal gastric pH; P < 0.02) were found in group B
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only after portal and arterial reperfusion. In group B the occurrence
of continuous renal replacement therapy and sepsis were higher
(P < 0.02), the ICU therapy was longer (P < 0.02), and the 1-year
mortality was 47% compared with 4% of group A (P < 0.004).
Conclusions Early billiary injury after liver transplantation can be
connected with the vasopressor therapy of the donor, the severity
of cirrhosis, and the worse oxygenation and hemodynamic
parameters after reperfusion.
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Introduction Without past history or clinical signs of cirrhosis, the
diagnosis of portal hypertension (PHT)-related digestive haemor-
rhage (DH) is often delayed until upper intestinal endoscopy
performance, thus delaying specific medical treatment such as
vasoactive drugs. As the liver stiffness measurement (LSM) is
correlated to hepatic fibrosis [1] and PHT, it could be therefore
useful for the diagnosis of cirrhosis in this situation. The aim of this
study was to assess the predictive value of LSM by FIBROSCAN®
for the diagnosis of cirrhotic PHT-related DH.
Methods Between January and May 2006, all consecutive patients
referred for DH in two ICUs were prospectively included. In all
patients a LSM and an upper gastrointestinal endoscopy were
performed simultaneously at admission, each operator blinded to
the result of the other examination. Exclusion criteria were the
presence of ascitis or portal thrombosis without cirrhosis.
Results Sixty-two patients were included (mean age: 60.2 ± 14.2
years; males: 40/62 (65%); BMI: 24.0 ± 11.3 kg/m2; SAPS II: 26.0
± 19.3): 27/62 (44%) had non PHT-related DH (gastroduodenal
ulcer, 16 cases; oesophagitis, seven cases; others, four cases);
35/62 (56%) had PHT-related DH (oesophageal varicose, 100%).
All of these 35 patients had cirrhosis, either previously known or
clinically obvious (18/35, 51%) or biopsy-proven later. The median
LSM was significantly higher in patients with PHT-related DH (54.6
kPa (45.0–65.7) vs 5.2 kPa (4.3–6.3), P < 10–6). The AUROC for
the diagnosis of PHT-related DH was 0.97 ± 0.03. A threshold of
13.7 kPa was chosen with specificity and a positive predictive value
at 100% (sensitivity, 93%; negative predictive value, 94%).
Conclusions LSM is a powerful noninvasive tool for the instant
diagnosis of PHT-related DH. Performed at admission, it could
allow the rapid onset of specific medical management. The
prognostic value assessment of LSM in these patients is ongoing.
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Introduction We investigated the small bowel transit time and
pathophysiological changes using a video capsule in ICU patients
with head injuries. The gut was only recently recognized as pivotal
in the disease process of critical illness; hence, work is needed to
improve our understanding of how bowel dysfunction impacts
healing. We hypothesized that new diagnostic technology such as
wireless capsule endoscopy, which allows real-time investigation
of the small bowel, will show that the small bowel transit time is
increased in critically ill patients with brain injuries.
Methods We recruited 32 patients older than 18 years in this
prospective, controlled, IRB-approved trial. Their authorized
representatives gave written, informed consent. Sixteen of them
were neuro-ICU patients with mild-to-moderate brain injury (GCS
6–14) who required a feeding tube. The control group consisted of
16 ambulatory patients. A small capsule containing a video camera
(PillCam™) was positioned in each patient’s proximal small
intestine at the time of endoscopic feeding tube insertion. Sensors
on the patient’s abdomen picked up signals the capsule trans-
mitted to allow real-time video recording of the gut. Two indepen-
dent observers analyzed the data.
Results The average small bowel transit time for neuro-ICU
patients ranged from 144 to 480 minutes (median 344 min, mean
338 min). For the ambulatory patients, the range was 228–389
minutes (median 250 min, mean 279 min). All five patients with
small bowel transit times greater than 400 minutes were neuro-ICU
patients. The mean difference between the groups was 59 minutes
(95% CI: –17 to 135), and according to a Mann–Whitney rank-
sum test P = 0.184.
Conclusions The current results suggest that the small bowel
transit time is not significantly increased in our critical care
patients.
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Introduction It is often difficult to manage optimal ventilation
parameter settings in patients with low chest wall compliance, as in
an obese patient. This case report demonstrates options to
ventilate such difficult patients.
Methods A 34-year-old obese woman was transferred to our
academic ICU to solve difficult ventilation and oxygenation
problems in the context of septic shock following urinary tract
infection. This patient was transferred to an Avea ventilator (Viasys
Healthcare) and an 8 Fr esophageal balloon catheter was inserted
in the lower third of the esophagus. An expiratory airway occlusion
maneuver, described by Baydur and colleagues [1], was performed
to confirm correct positioning. We performed an inspiratory hold to
obtain and compare the airway plateau pressure (Pplat) and
transpulmonary plateau pressure (Ptpplateau), and an end-
expiratory hold to obtain and compare airway total positive end-
expiratory pressure (PEEPt) and transpulmonary total PEEP
(PtpPEEP). Transpulmonary pressures were used to change
ventilator parameter settings.
Results The patient had a BMI of 58.6. Arterial blood gas showed
metabolic and respiratory acidosis (pH: 7.18, paCO2: 53, HCO3:
19) and hypoxemia (paO2: 75, SpO2: 94% with 1.0 FiO2) that
persisted for 4 days prior to the installation of an esophageal
balloon. The Pplat was 52.6 cmH2O and PEEPt was 24.8 cmH2O,
with a set PEEP of 8 cmH2O. The Ptpplateau was 14.3 cmH2O
and PtpPEEP was –4.4 cmH2O. The set PEEP was increased to
25 cmH2O, which resulted in a PtpPEEP of –1.4 cmH2O.
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Hemodynamic parameters remained unchanged. Within 24 hours,
FiO2 was decreased down to 0.35 (pH: 7.34, paCO2: 35, HCO3:
18, paO2: 165, SpO2: 99%), and the patient was extubated 3 days
later.
Conclusions As demonstrated in acute lung injury patients [2], this
case study also showed a clinical benefit of measuring
transpulmonary pressures to adjust ventilator parameter settings,
especially the PEEP to recruit the lung, as it should be observed in
patients with very abnormal chest wall compliance.
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Introduction During controlled mechanical ventilation the
diaphragm’s passive mechanical characteristics contribute to the
respiratory system’s impedance, reflecting predominantly a part of
thorax compliance. We focus here on the passive mechanical
properties of the diaphragm. We hypothesize that changes in
diaphragm compliance can be quantitatively assessed with our
new bioreactor setup [1].
Methods Isolated diaphragms of wildtype rats were placed inside
the bioreactor on an elastic membrane building the deformable
wall of a pressure chamber of 5.5 ml volume. By increasing the
pressure inside the chamber, the membrane and the diaphragms
were deflected following the shape of a spherical cap. By analysis
of the pressure–volume relationship inside the pressure chamber
we calculated the mechanical properties (that is, compliance of the
passive diaphragms) at certain points in time.
Results Two diaphragms were investigated for 24 hours after
explantation. Courses of compliance over time of the cultivated
diaphragms showed characteristic courses reflecting relaxation,
onset and end of rigor mortis and breakup of tissue structure
(Figure 1).
Conclusions We attribute the increase in compliance to time-
dependent changes of mechanical tissue properties of the
diaphragms after explantation. We conclude that our method
allows investigation of changes in mechanical characteristics of
biological tissue during application of strain. In combination with
histological and molecular–biological examinations, our method
could give new insights into processing of mechanically evoked
development of inflammation, apoptosis, necrosis or physiological
reactions (for example, muscle fatigue). To our knowledge, this is
the fist setup that allows repeated measurement of mechanical
tissue properties at the same sample. We therefore further
conclude that with our method the number of animal experiments
could be reduced.
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Introduction Abdominal compartment syndrome (ACS) is mani-
fested by elevated intra-abdominal pressures (IAP) and associated
hemodynamic, lung, or renal dysfunction. ACS may develop in
trauma, pancreatitis, or burn patients. Abdominal closure after
laparotomy, using negative pressure therapy (NPT) via a reticulated
open-cell foam-based dressing, provides indirect negative
pressure to the abdominal wall and viscera. We hypothesize that
NPT improves hemodynamic, lung, and renal function as compared
with a dressing-covered open abdomen without NPT.
Methods Pigs (25–37 kg) were anesthetized and ventilated. After
laparotomy, the superior mesenteric artery was occluded for
30 minutes. The cecum was perforated and a fecal clot was
created to induce severe sepsis. Animals received isotonic fluid
resuscitation titrated to mean arterial pressure (MAP) > 60 mmHg.
Critical Care    March 2008 Vol 12 Suppl 2 28th International Symposium on Intensive Care and Emergency Medicine
Figure 1 (abstract P321)
Table 1 (abstract P322)
Data from T24 through T48 
Hemodynamics Lung function Intestinal edema Renal function 
MAP Cardiac output Plateau pressure Bladder pressure Creatine Urine output 
(mmHg)† (l/min)† (cmH2O)† (cmH2O)† Wet/dry† (mg/dl)† (ml/hour)†
NPT  65 ± 1.3 3.00 ± 0.08 19 ± 0.46 11 ± 1.33 5.99 ± 0.20 1.08 ± 0.06 135 ± 17
No NPT  59 ± 2.3 1.70 ± 0.07 23 ± 1.34 18 ± 1.14 8.22 ± 0.67 1.7 ± 0.22 45 ± 11
Data are mean ± SE. †P < 0.05 between groups.
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The abdomen was closed at the time of injury, then reopened 12
hours later and the animals were randomized to receive either NPT
at –125 mmHg (n = 3) or no NPT (n = 3). Parameters were
recorded hourly for 48 hours or until premature death.
Results The hemodynamics, lung, and renal function were similar
prior to application of NPT (T0–T11). The parameters improved
after placement of the NPT device (Table 1).
Conclusions NPT improved physiologic parameters in a clinical
model of ACS. NPT is an effective strategy for the treatment of
ACS in a severe sepsis model.
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Introduction Aggressive resuscitation in disease processes such
as sepsis, peritonitis, and bowel ischemia can result in elevated
intra-abdominal pressure (IAP), leading ultimately to abdominal
compartment syndrome (ACS). Clinically, ACS causes organ
dysfunction with oliguria, increased airway pressures, reduced oxy-
genation, and a fall in cardiac output (CO). There are currently no
animal models that adequately mimic the complex pathophysiology
associated with ACS. We have developed a clinically applicable
porcine model that closely mimics the pathology seen in human
patients.
Methods Pigs (n = 3) weighing 25–28 kg were anesthetized and
placed on mechanical ventilation. Bladder, venous, systemic and
pulmonary arterial catheters were placed for hemodynamic
monitoring, infusion of fluids and drugs, blood sampling, and to
measure bladder pressure (IAP). The injury model consists of ‘two
hits’: through a midline laparotomy, the superior mesenteric artery
was occluded for 30 minutes then released to create intestinal
ischemia/reperfusion injury; and the cecum was perforated, and
stool collected (0.5 ml/kg) and mixed with blood (2 ml/kg) to form
a fecal clot that was placed in the right lower quadrant of the
peritoneal cavity. Following injury the laparotomy was closed and
animals received vigorous fluid resuscitation to maintain the mean
arterial pressure (>60 mmHg) and urine output (UOP)
(>0.5 cm3/kg/hour), and wide-spectrum antibiotics (ampicillin 2 g
and flagyl 500 mg) were administered. The abdomen was
reopened 12 hours after injury, and passively drained to mimic
current clinical treatment.
Results See Figure 1.
Conclusions This model accurately mimics the development of
human ACS as indicated by an increasing IAP and plateau pressure
(Ppl) with a decrease in oxygenation (P/F ratio), CO, and UOP.
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Introduction The intra-abdominal pressure (IAP) may increase in
critically ill ventilated patients inducing abdominal compartment
syndrome with irreversible intra-abdominal organ ischemia. Increases in
positive end-expiratory pressure (PEEP) induce an increase in plateau
pressure (Pplat) and in intrathoracic pressure, which lead to hemo-
dynamic changes and may also increase IAP by pressure trans-
mission through the diaphragm. The aim of this study was to evaluate
the relation between Pplat changes induced by PEEP and IAP.
Methods During a 6-month period, 278 measurements were pros-
pectively performed in 27 ICU patients. Pplat and IAP were
measured 20 minutes after changes in the PEEP level. IAP
measurement was performed using an intravesical pressure
monitoring method by clamping the Foley urinary tube after
injection of 30 ml normal saline, under sterile conditions. Statistical
analysis was performed using parametric and nonparametric tests,
as appropriate, and correlation tests. See Figure 1.
Results Twenty-seven patients (22 males, five females) were
included with a mean age of 58.2 years. The overall relation
between Pplat and IAP was significant (r2 = 0.143, P < 0.001).
Conclusions Our study shows that ventilatory pressure is a factor
of the increase in IAP. In patients with high risk of intra-abdominal
hypertension, therefore, IAP monitoring using a vesical pressure
method may be useful before and after each PEEP adjustment.
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Introduction Unsuccessful extubation (the need for reintubation)
occurs in up to 20% of patients within 24–72 hours of planned
extubation. Factors that appear to increase the risk are age >70
years, higher severity of illness at weaning onset, use of intra-
venous sedation, and longer duration of mechanical ventilation
prior to extubation [1]. Reintubation is associated with increased
hospital stay and mortality [2]. Noninvasive positive pressure
ventilation (NIPPV) has been proposed in the management of
acute respiratory failure occurring in the postextubation period. The
use of NIPPV to prevent postextubation respiratory failure must
therefore be considered.
Methods Thirty high-risk patients for postextubation failure were
enrolled in this study, and were divided into two groups. Group A
received standard medical therapy just after extubation, while in
group B NIPPV is applied just after extubation.
Results Reintubation and NIPPV were applied in 8/15 patients
(55.33%) in group A, while in group B it was 2/15 patients
(13.33%). The improvement in oxygen extraction in group B after
48 hours of the study was greater than in group A (25.32 ± 0.69%
and 27.89 ± 1.82%, respectively) (P = 0.004). The shunt fraction
was significantly different (P = 0.001) after 48 hours between
group A and group B (3.55 ± 0.35 and 2.92 ± 0.37, respectively).
Conclusions NIPPV is an efficient means to prevent
postextubation respiratory failure in high-risk patients when applied
immediately after extubation.
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Introduction Adaptive support ventilation (ASV) is a minute
ventilation-controlled mode governed by a closed-loop algorithm.
The combination of target tidal volume and respiratory rate is
continuously adjusted with the goal of maintaining the patient in
isominute ventilation, and thus reducing the work of breathing. A
recent study demonstrated a reduction in time to extubation in
patients ventilated in the ASV mode compared with those
ventilated in synchronized intermittent mandatory ventilation (SIMV)
followed by a pressure support mode [1]. This might be explained
by a delay in switching the patient from SIMV to the pressure
support mode. Pressure-regulated volume control (PRVC) with
automode is a better comparator as it delivers pressure control
breaths in the absence of triggering and automatically switches to
pressure support breaths when triggered. We compared ASV with
PRVC in the duration of intensive care ventilation in 50 patients
after elective coronary artery bypass surgery.
Methods Patients were randomized to either ASV or PRVC on
arrival in the ICU. Respiratory weaning progressed through three
phases: phase 1 (start of intensive care ventilation to recovery of
sustained spontaneous breaths), phase 2 (end of phase 1 to peak
airway pressures <15 cmH2O during spontaneous breaths), phase
3 (T-piece trial). Following a successful T-piece trial, patients were
extubated. The primary outcome was the duration of intensive care
ventilation. Secondary outcomes were the time from intensive care
admission to extubation, duration of phases 1–3, number of
patients failing to wean, arterial blood-gas samples and ventilator
setting changes made prior to extubation.
Results Forty-eight patients completed the study. The duration of
intensive care ventilation was significantly shorter in the ASV than
the PRVC group (165 (120–195) vs 480 (360–510) min; P <
0.001). The observed reduction in intubation time was mainly a
result of shortening of phase 1 (21 (6–41) min in the ASV group vs
60 (24–153) min in the PRVC group) and of phase 2 (147
(91–171) min in the ASV group vs 357 (163–458) min in the
PRVC group) (P < 0.001). Seventeen patients in the PRVC and
three patients in the ASV group did not reach the protocol criteria
for a T-piece trial within 8 hours but were successfully extubated.
There were no significant differences in the number of arterial
blood-gas samples taken or ventilator setting changes between the
groups.
Conclusions ASV is associated with earlier extubation, without an
increase in clinician intervention, when compared with PRVC in
patients undergoing uncomplicated cardiac surgery.
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Introduction Discontinuing patients from mechanical ventilation is
an important problem in ICUs. The aim of this study is to compare
the effectiveness between a spontaneous breathing trial with a
low-pressure support protocol and a liberal or nonprotocol-
directed method.
Methods We conducted a retrospective cohort study involving
577 patients who were arranged and appropriate for weaning from
mechanical ventilation on a general surgical ICU in an academic
university-affiliated hospital between 1 July 2003 and 30 June
2007. Two hundred and twenty-two patients (Liberal group) had
weaning process orders that depended on their physicians. Three
hundred and fifty-five patients underwent a once-daily spontaneous
breathing trial with a low-pressure support protocol. Patients
assigned to this protocol had the pressure support level decreased
to 5–7 cmH2O for up to 2 hours each day. If signs of intolerance
occurred, assisted control ventilation was reinstituted for 24 hours.
Patients who tolerated a 2-hour trial without signs of distress were
extubated. We collected demographic data, cause of ICU
admission, APACHE II score at arranged time of weaning, the
weaning process time, ventilator days and ICU length of stay.
Results There were no statistical differences between liberal and
protocol groups in age (59.2 ± 19.3 vs 55.6 ± 19.8 years; P =
0.03), gender (male 74.3 vs 67.9%; P = 0.2) and APACHE II
score at arranged time of weaning (14.7 ± 7.4 vs 15.3 ± 6.3; P =
0.2). The mean duration of the weaning process was 72.1 ± 101.3
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hours in the liberal group and 7.7 ± 16.8 hours in the protocol
group (P < 0.01). The mean ventilator days and length of ICU stay
were statistically different between the liberal and protocol groups
(5.7 ± 2.8 vs 2.7 ± 2.3; and 7.3 ± 7.1 vs 4.4 ± 3.4 days,
respectively; P < 0.01) (Figure 1).
Conclusions The spontaneous breathing trial with a low-pressure
support protocol for liberation from the mechanical ventilator was
effective in the general surgical ICU.
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Introduction Failure in weaning from mechanical ventilation (MV) is
frequent (25–30%) and associated with high mortality. Indexes
predicting success can be helpful clinically. However, their
predictive capacity can be low. The goal from this study is to
evaluate weaning predictor indexes in patients during weaning
from MV.
Methods We included patients under MV for at least 48 hours,
submitted to a spontaneous breathing trial (SBT) for 30 minutes,
extubated according to clinical decision and followed for 48 hours.
They were evaluated concerning age, sex, clinical characteristics,
length of hospital and ICU stays and length of MV. At the first and
30th minutes from the SBT we analyzed: arterial blood gases,
hemodynamic and respiratory parameters such as respiratory rate
(f), tidal volume (VT), rapid shallow breathing index (f/VT), maximal
inspiratory and expiratory pressures. Comparisons were made
between two groups of patients: success vs failure, defining failure
as return to MV in the first 48 hours.
Results Four hundred and fifty-eight patients were studied. The
overall mortality rate was 14%. Return to MV occurred in 21%. The
most important differences comparing success with failure groups
were: lower age (56 ± 19 vs 62 ± 17 years, P < 0.01), lower
mortality rate (10% vs 31%, P < 0.001), shorter length of ICU stay
(15 ± 12 vs 19 ± 13 days, P < 0.01), higher oxygen saturation at
the first and 30th minutes (97 ± 3 vs 96 ± 6 and 95 ± 4 vs 94 ± 4,
P < 0.05), lower f at the first and 30th minutes (24 ± 6 vs 26 ± 6
bpm and 25 ± 6 vs 28 ± 7 bpm, P < 0.001), lower f/VT at the first
minute and principally in the 30th minute (56 ± 32 vs 69 ± 38 and
62 ± 39 vs 84 ± 55, P < 0.001), and lower increase in f/VT (4 ±
28 vs 12 ± 38, P < 0.05) during the test.
Conclusions In this group of patients a great number failed in the
weaning process, showing, as expected, a higher mortality rate.
Parameters related to failure were higher age, longer length of ICU
stay, lower level of oxygenation, higher f and f/VT and higher
increase in f/VT during the test.
Acknowledgements Members of the Weaning Study Group: R
Wickert, LG Borges, ME Alves, ACT Silva, R Condessa, CE Hahn,
L Cassel, MB Blom, R Zancanaro, F Callefe, KB Pinto, K
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Introduction The threshold can be used as a physiotherapy tool in
order to increase muscle strength. This effect can be useful in
weaning patients. However, there are still controversies
considering its advantages during weaning from mechanical
ventilation (MV). This study aims to evaluate the effects of the
threshold in such situations.
Methods Patients under MV for more than 48 hours and prone to
weaning were randomly assigned to the control group or to the
threshold group (trained twice daily). They were followed until
extubation, tracheotomy or death. All cardiorespiratory variables,
maximal inspiratory and expiratory pressures (MIP and MEP),
length of weaning and success or failure were registered.
Statistical analysis was performed using ANOVA, Mann–Whitney
U test and chi-square test, where appropriate. A level of 0.05 was
considered significant.
Results Eighty-six patients were studied (52% men, mean age
63 ± 17 years, 48% with chronic obstructive pulmonary disease).
No differences were observed when comparing initial versus final
cardiorespiratory variables in both groups, with the exception of the
MIP (varied from –33.72 ± 13.5 cmH2O to –40.81 ± 12.67 cmH2O
in the threshold group and from –37.67 ± 10.49 cmH2O to
–34.19 ± 10.85 cmH2O in the control group, P < 0.001), the MEP
(varied from 25.47 ± 12.48 cmH2O to 29.65 ± 12.02 cmH2O in
the threshold group and from 29.65 ± 11.97 cmH2O to 26.86 ±
11.6 cmH2O in the control group, P < 0.05) and tidal volume
(varied from 386.16 ± 236.56 ml to 436.16 ± 228.39 ml in the
threshold group and from 361.91 ± 168.81 ml to 357.14 ±
121.35 ml in the control group, P < 0.05). No differences were
observed in the length of weaning (1.36 days in the threshold
group versus 1.98 days in the control group, P > 0.05) and
weaning success (83.7% in the threshold group versus 76.7% in
the control group, P > 0.05).
Conclusions The threshold during weaning from MV can cause an
increase in MIP, MEP and tidal volume. In this group of patients,
however, it was not associated with a decrease in the length of
weaning or with an increase in weaning success.
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Introduction Delayed discontinuation of mechanical ventilation is
associated with increased mortality. The Sixth International
Consensus Conference on Intensive Care Medicine recommends
spontaneous breathing trials (SBT) as best practice for mechanical
ventilation weaning. Daily spontaneous awakening trials (SAT) are
also correlated with reduced ventilation duration and ICU length of
stay. The aim of our study was to implement the SBT and SAT as
best practices in the ICU and to assess the outcome of using the
SAT and SBT combined.
Methods We collected information on medical ICU patients for
12 weeks in 2006 after implementing a SBT protocol and in 2007
after adding a SAT protocol to the SBT. We compared the
likelihood of passing the SBT, extubation after a complete SBT,
reasons for not extubating after a passed SBT, and the median
ventilator days. Statistical comparison included the chi-square test
and Mann–Whitney test (two-tailed with P < 0.05 considered
significant).
Results Fifty-three patients were enrolled in the SBT-only group
and 44 patients were included in the SAT + SBT group. In the SAT
+ SBT group the likelihood of passing both a safety screen (38%
vs 47%; P < 0.05) and 30-minute SBT (73% vs 85%, P < 0.05)
were lower than in the SBT-only group. The decreased likelihood
of passing the safety screen in the SAT + SBT group was
associated with an increased incidence of physician override to the
protocol. The number of SBT trials performed decreased from 6.1
to 5.7 per patient with the addition of the SAT. The likelihood of
extubation following a complete SBT increased in the SAT + SBT
group versus the SBT-only group (42% versus 29%, P = 0.143).
The likelihood of not extubating following a passed SBT due to
sedation is decreased in the SAT + SBT group (10% vs 36%, P =
0.002). The median ventilator days was reduced in the SAT + SBT
group versus the SBT-only group (5 days versus 6 days, P = 0.18).
Conclusions Implementation of a best practice protocol for SAT to
an SBT in the medical ICU improved patient outcome by
decreasing the days on the ventilator and increasing the likelihood
of extubation.
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Introduction This study was conducted to compare early versus
late tracheotomy in ICU patients.
Methods A total of 103 patients (81 men, 22 women) were
included in this study. They were classified into two groups: Group
A – early tracheotomy (≤7 days) included 36 patients (mean age
55.14 ± 17.698 years), and Group B – late tracheotomy (>7 days)
included 67 patients (mean age 56.55 ± 19.078 years). We
studied the impact of timing of tracheotomy on the duration of
mechanical ventilation, duration of weaning, length of stay in the
ICU (LOS), outcome in 28 days, incidence of ventilator-associated
pneumonia (VAP), and days of sedation administration. Severity of
illness and organ dysfunction were assessed by APACHE II, SAPS
and SOFA scores. Statistical analysis was performed using the
Pearson x2, independent t test, Levene significance control,
Mann–Whitney U test, and paired t test. The control criterion was
P (significance) ≤ a (significance level), a = 5%.
Results The two groups were comparable in terms of age,
APACHE II score and SAPS. There was a statistically significant
difference in the admission SOFA score (P << a), the SOFA score
of the tracheotomy day (P = 0.003) and in SOFA max (P << a), as
well as the total days of mechanical ventilation (Group A 18.36 ±
12.059 vs Group B 24.19 ± 14.27, P = 0.05) and the LOS
(Group A 16.75 ± 7.038 vs Group B 22.51 ± 10.726, P = 0.007).
No difference was observed regarding the days of weaning after
tracheotomy (Group A 7.56 ± 6.135 vs Group B 9.19 ± 9.24) and
mortality (25% vs 23.9%, respectively). The prevalence of VAP
was evaluated in 58 patients. In Group A VAP developed in
23.1%, vs 76.9% of patients in Group B (P = 0.099). There was
no difference in the day VAP was diagnosed (P = 0.959). A
significant difference in the days of sedative administration before
and after tracheotomy was observed in both groups (before:
7.49 ± 5.34 days, after: 4.76 ± 8.05 days, P = 0.005). Days of
sedative administration before tracheotomy were significantly differ-
ent (Group A 4.32 ± 2.083 vs Group B 9 ± 5.690, P = 0.003).
Conclusions Our results reinforce the findings of previous studies
showing that early tracheotomy decreases significantly the duration
of mechanical ventilation, ICU LOS and total days of sedative
administration, and may provide a benefit in reducing the
occurrence of VAP.
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Introduction The main purpose of our study was to assess whether
precocious tracheotomy, compared with prolonged intubation,
reduces the duration of ventilation, the frequency of nosocomial
pneumopathy, the duration of hospitalization and the mortality.
Methods A retrospective and comparative study between two
groups who present a neurologic or respiratory pathology and
require mechanical ventilation for more than 3 weeks. The study
covered 7 years and was about 60 patients divided into two
groups: tracheotomy group (TG, n = 30), where the tracheotomy
was realized between the eighth day and the 15th day, after the
first period of intubation; and intubation group (IG, n = 30), where
the patients are still intubated during the whole period of
hospitalization until extubation or death. We determined the
duration of ventilation, the frequency of nosocomial pneumopathy,
the mean duration of hospitalization and the mortality. The
statistical study was based on the chi-squared test for qualitative
variables and on Student’s test for quantitative variables. P < 0.05
was considered significant. The two groups contain a similar
number of cases that have the same diagnosis. They have the
same data about age, the sex and the gravity score: SAPS II and
APACHE II score.
Results There was a significant statistical decrease of the whole
duration of mechanical ventilation for the TG, 27.03 ± 3.31 days
versus 31.63 ± 6.05 days for the IG, with P = 0.001. However,
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there was no significant difference between the two groups for the
frequency of nosocomial pneumopathy (P = 0.18). The mean
duration of hospitalization did not differ between the two groups,
and was about 30.96 ± 9.47 days for the TG versus 34.26 ± 9.74
days for the IG with P = 0.10. The study of the evolution shows
that there was no statistically significant difference between the
two groups regarding the mortality, 26.7% in the TG versus 46.7%
for the IG with P = 0.10.
Conclusions It seems that precocious tracheotomy in the
resuscitation of patients leads to a decrease of the duration of
ventilation and delayed the incidence of nosocomial pneumopathy
without a modification of the frequency of the mean duration of
hospitalization in the resuscitation ward, or of death.
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Introduction Percutaneous tracheostomy (PcT) has reached a
high level of safety; however, significant perioperative
complications still occur. The most feared complication is posterior
tracheal wall injury during insertion of the dilational device into the
trachea applying downward pressure. Ciaglia Blue Dolphin (CBD)
is a new technique for PcT using radial balloon dilation, thereby
eliminating downward pressure during insertion and dilation.
Methods An observational, clinical trial was conducted in 20 adult
ICU patients undergoing elective PcT with the CBD technique
(Cook Inc., Bloomington, IN, USA). After a 15 mm skin incision,
tracheal puncture, and predilation of the puncture channel with a
14 F punch dilator, a balloon-cannula apparatus was passed over a
guidewire until the tip of the balloon mounted at the distal end of
the apparatus was seen in the trachea. The balloon was inflated
with saline solution to 11 atm for a few seconds, then deflated, and
the 8.0 mm ID tracheostomy tube preloaded onto a customized
stylet, which formed the proximal portion of the apparatus, was
placed by advancing the entire apparatus further into the trachea.
The apparatus and guidewire were then removed, leaving only the
cannula in place.
Results Twenty patients underwent CBD PcT under broncho-
scopic control. All procedures were successfully completed in a
mean time of 3.8 ± 1.7 minutes. Even though six patients were
under continuous therapeutic anticoagulation therapy, blood loss
was classified as ‘none’ (n = 14), ‘marginal’ (n = 5), or ‘moderate’
(n = 1). In the latter patient, bleeding occurred from a sub-
cutaneous vein, but ceased without further intervention once the
tracheostomy tube was in place. No other complications of either
medical or technical nature were noted.
Conclusions Based on the data of this first clinical report, the new
CBD device allows for quick, reliable, and safe dilation and
subsequent cannula placement with one single apparatus. Even
though the operators had no previous experience with CBD, no
complications were noted. Randomized trials need now to be
conducted to confirm the promising results of our study and to
determine both advantages and disadvantages of the CBD
technique when compared with other techniques of PcT.
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Introduction Percutaneous tracheostomy techniques are gaining
greater popularity in ICUs. Refinement of the percutaneous
tracheostomy technique has made this a straightforward and safe
procedure in appropriately selected patients. Generally, coagulo-
pathy is a relative contraindication for surgical tracheotomy. We
sought to determine its usage in high-risk patients with
documented coagulopathy.
Methods Twenty critically ill patients with coagulopathy (Inter-
national Normalized Ratio (INR) ≥ 1.5) underwent elective per-
cutaneous tracheostomy using a Portex percutaneous tracheos-
tomy kit (Ultraperc). The Ciaglia Blue Rhino single-stage dilator set
was used in all cases and the same intensivists performed all of the
tracheotomies
Results There were 17 patients with an INR > 1.5, two patients
were on a heparin drip, and one patient had a platelet count
<20,000. One patient included in the study met requirements for
two categories with a platelet count of 17,000 and an INR of 1.7.
The procedural times ranged from 3 to 5 minutes. Apart from minor
bleeding episodes during and after the procedures in three
patients, which were controlled promptly, no other complications
occurred; average estimated blood loss was around 5–10 ml.
Conclusions In trained hands with careful precautions, we believe
that percutaneous tracheostomy is safe even in patients with
documented coagulopathy.
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Introduction Percutaneous tracheostomy (PDT) has been
established as a safe technique in the critically ill, with an equivalent
complication rate to surgical tracheostomy (ST). However, PDT
insertion may result in unrecognised hypercarbia, and has been
associated with an increased perioperative complication rate. We
therefore decided to audit current practice within our ICU.
Methods Over a 3-month period, prospective data were collected
on 25 patients within a 14-bed regional ICU. A single observer
collected data on staff present, cardiovascular recordings and end-
tidal carbon dioxide.
Results PDT was performed on 15 patients within the ICU, and ST
was performed on 10 patients. Indication for tracheostomy was
prolonged mechanical ventilation in 16 patients, poor neurological
status in eight patients and sputum retention in one patient.
Cardiovascular instability, defined as a greater than 20% deviation
from normal blood pressure, occurred in nine (60%) patients
during PDT. For ST, eight (80%) patients were cardiovascularly
unstable. Hypercarbia, as detected by an end-tidal CO2 rise of
more than 20%, occurred in six (40%) patients during PDT and in
one (10%) patient during ST. See Table 1.
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Conclusions This audit has shown that assistance for PDT is
inferior to that provided in the operating theatre, and this has
potential safety implications particularly when junior staff are
anaesthetising. Perioperative complication rates were similar
overall, confirming the safety of PDT as a technique. Hypercarbia
occurred relatively frequently during PDT, however, which may
have deleterious effects in the brain-injured patient. From this audit,
we would recommend that within our ICU more attention be
focused on adequate staffing during the performance of this
operative procedure on critically ill patients. Also, end-tidal carbon
dioxide should be monitored carefully and treated if elevated.
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Introduction Percutaneous dilatational tracheostomy (PDT) is
considered a safe alternative to open surgical tracheotomy, with
comparable complication rates. Major complications are reported
to be <1.5%, with a mortality rate of 0.3% [1].
Methods A 52-year-old male was admitted to our ICU following
craniotomy for an intracranial hemorrhage. Prior history revealed
hypertension and morbid obesity (BMI 46).
PDT was performed on the fourth day after intubation, because of
persisting low Glasgow Coma Score and failure to clear
secretions. PDT was performed with a Seldinger technique. With
bronchoscopic guidance, endotracheal placement was confirmed.
Initial airway pressure was high, but normalized quickly. Although
oxygenation was maintained, saturation was 84% at the end of the
procedure.
Results After 3 days a subcutaneous swelling occurred around the
tracheostomy tube (TT), compromising the airway. An abscess was
expected but could not be confirmed by stab incision or CAT scan.
A rise of airway pressure with loss of tidal volume was seen in the
next hours. On oral and transtracheostomy bronchoscopy, a
diffusely swollen larynx with narrowing of the proximal trachea was
seen. The TT was exchanged for a Bivona TT.
On retrospection, the CAT scan revealed a dislocated cuff
visualized as a double bubble. This was caused by tissue swelling,
gradually enlarging the distance between skin and trachea. In this
morbid obese patient, the standard TT was too short and
dislocation could occur. A second CAT scan confirmed an
adequate position of the Bivona TT. After 1 week, a TT with
increased skin-to-trachea length was inserted and the patient was
successfully weaned from ventilation.
Conclusions Since the complication rate is increased when
performing a PDT in the obese [2], we suggest the following. First,
PDT should be guided by fiberoptic bronchoscopy. Second, a TT
of adequate diameter and length should be used. Inadequate skin-
to-trachea length of the TT can result in improper placement with
cuff dislocation not necessarily resulting in air leak with ventilation.
An experienced team should perform the procedure: one person
doing a bronchoscopy, another placing the TT.
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Introduction One of the common postoperative complications is
sore throat and cough. A number of factors may be responsible,
namely direct trauma by the airway, the endotracheal tube, and
mucosal damage caused by pressure by the cuff hyperinflated by
N2O. This complication is minor but distressing to an otherwise
healthy patient; different strategies have been proposed to prevent
it. They include changes in the technique of intubation, in the
endotracheal tube material, and lower cuff pressure.
Methods Eighty female patients ASA status I and II, scheduled for
elective caesarean sections, were divided randomly into two
groups. See Table 1. The same anaesthetist performed all the
intubations and extubations. The patients were interviewed on the
day of operation and on the following 2 days about cough and sore
throat. See Table 2.
Results The frequency of postoperative sore throat and cough was
greater with the use of the polyvinylchloride endotracheal tube.
Conclusions The study demonstrates that the use of a poly-
vinylchloride endotracheal tube was associated with a significantly
higher incidence of postoperative sore throat and cough.
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Table 1 (abstract P335)
Staff involved in PDT and ST
PDT (%) ST (%)
Assistants ≥2 8 (53) 10 (100)
Operator SpR3+ 12 (80) 4 (40)
Anaesthetist SpR3+ 6 (40) 9 (90)
Table 1 (abstract P337)
Demographic data
Tube Number Mean age (years) Mean weight (kg)
Polyvinylchloride 40 25.2 67.27
Armoured 40 28.8 65.95
Table 2 (abstract P337)
Frequency of cough and sore throat
Tube Cough Sore throat P value
Armoured 10 (12.5%) 26 (32.5%) 0.0704
Polyvinylchloride 26 (32.5%) 58 (72.5%) 0.0129
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Introduction Both retrospective and prospective cohort studies of
routine chest radiographs after uncomplicated dilational percu-
taneous tracheostomy have showed a low pick up rate of clinically
important new data [1,2]. It was felt that the true level of complica-
tions on insertion was much less than the reported rate of between
3% and 18% [3]. We decided to undertake a retrospective
analysis of the last 100 percutaneous tracheostomies from our ICU
population, looking at the utility of a postprocedural radiograph in
terms of new data added.
Methods Percutaneous tracheostomies were performed consis-
tently by the Portex Blue Rhino™ (Portex, UK) dilational method
under direct bronchoscopic control. At the end of the procedure
the tip–carina distance was measured with the fibroscope and
recorded. The bronchoscope logbook was examined to identify
patients. Patients were excluded if aged under 18 or they could not
be identified on the electronic radiographic database. The report
on the postprocedural radiograph was compared with the previous
report for data that could not be detected clinically or
bronchoscopically.
Results Two hundred and two records were examined to give 100
procedures. Of these, 89 could be identified on the radiology
database. Eighty-three reports (93.25%) showed no new data. In
three cases the tube tip was reported as close to the carina, which
was not correct on direct vision. No radiograph showed any
serious complication of the procedure.
Conclusions In this series the pneumothorax rate was 0%, and
over 93% of radiographs added no new clinical data. This
evidence does not support the use of a routine radiograph, and we
recommend them only if indicated clinically.
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Introduction The tracheal wall pressure (TWP) exerted by a tracheal
tube cuff should normally be kept between 20 and 30 cmH2O. This
protects against mucosal injury whilst allowing ventilation without
an audible air leak [1]. The Portex Soft Seal high-volume low-
pressure (HVLP) cuff has a working intracuff pressure of
30 cmH2O, providing a safe TWP of the same value because there
is no tension in the cuff wall material. There are, however, folds
within the cuff wall that allow passage of subglottic fluid to the
tracheobronchial tree below, increasing the risk of ventilator-
associated pneumonia [2]. The Lotrach endotracheal tube was
designed to prevent this leakage at an equivalent TWP to that of
correctly inflated HVLP cuffs [3]. Each Lotrach cuff is individually
calibrated to transmit only 30 cmH2O to the tracheal wall, yet
because of the lack of folds in the cuff wall it has been shown to
prevent of aspiration of subglottic contents [4]. Although
extensively tested in benchtop models and pig tracheas, we
wished to demonstrate that the Lotrach cuff had an identical
sealing pressure, and therefore TWP, as the HVLP cuff in normal
clinical practice.
Methods One hundred and two ventilated patients were intubated
with either the Lotrach (n = 54) or the Portex Soft Seal (n = 48)
tubes. Both the Lotrach and Portex Soft Seal cuffs were inflated to
their working pressures. Whilst undertaking staged recruitment
manoeuvres (up to 40 cmH2O), the positive end-expiratory
pressure at which laryngeal air leak occurred was noted.
Results The seal pressures (TWP) are presented in Table 1.
Table 1 (abstract P339)
Seal pressures for the Lotrach and Portex Soft Seal cuffs
Number of Mean (SD) 
Type of tube measurements TWP (cmH2O)
Portex (30 cmH2O) 73 (in 54 patients) 32.4 (3.0)
Lotrach (80 cmH2O) 100 (in 48 patients) 30.0 (3.8)
Conclusions Both the Portex Soft Seal and Lotrach cuffs exert an
equal and safe TWP when inflated to their recommended working
pressures.
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Introduction During mechanical ventilation the resistance of the
endotracheal tube (ETT) causes a noticeable pressure drop
between the airway pressure and the tracheal pressure. Analysis of
lung mechanics requires knowledge of the tracheal pressure.
Available online http://ccforum.com/supplements/12/S2
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Besides methods for calculation of the tracheal pressure [1,2],
direct measurement of the tracheal pressure was suggested [3].
We hypothesized that the measure probe significantly increases the
ETT’s resistance and therefore is inappropriate for continuous
monitoring of the intratracheal pressure in the presence of pediatric
ETTs. In a laboratory study we investigated the pressure drop across
pediatric ETTs with and without an intraluminal sensor probe.
Methods A physical model consisting of a special tube connector
for insertion of the sensor probe (Samba Preclin 420 LP; Samba
Sensors, Västra Frölunda, Sweden), the anatomically curved ETTs
of inner diameter 2.0–4.5 mm, and an artificial trachea was
ventilated with sinusoidal gas flow with an amplitude of 240 ml/s
and a ventilation rate ranging from 20 to 50 cycles/min. The airway
pressure (proximal to the ETT) was measured at the proximal end,
and the tracheal pressure at the distal end of the ETT.
Results We found that placement of the intraluminal sensor
significantly increased the pressure drop across the ETT (P <
0.05) for all sizes of ETT. Figure 1 shows the pressure–flow
relationship of a 2-mm-ID tube. The relative increase of this
pressure drop caused by the intraluminal sensor was more
prominent for smaller ETTs.
Conclusions Measurement of tracheal pressure using intraluminal
sensors results in an increased ETT resistance and thus in an
additional increase of work of breathing. We conclude that direct
tracheal measurement is inappropriate for continuous bedside
monitoring of tracheal pressure in small children.
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Introduction The telemedicine system from ambulance to hospital
is not popular in emergency medical service (EMS) systems in the
world. In this study we investigated the effect of telemedicine from
ambulance to hospital in a suburban EMS.
Methods From June 2007 to October 2007, 2,934 patients
enrolled in our study. The emergency patient information from the
ambulance was transferred to the emergency medical information
center and emergency center by the code-division multiple access
(CDMA) transfer system. In the emergency medical information
center, the patient data were stored and analyzed. The transferred
data were the patient’s ECG, blood pressure, respiration rate,
pulse oxymetry, and body temperature. We analyzed the effect of
the using the telemedicine system in our suburban EMS.
Results Of the 2,934 patients, 351 patients (12%) used the
telemedicine system from ambulance to hospital (group 1). The
other 2,583 patients (88%) did not use the telemedicine system
(group 2). The rate of medical control was increased in group 1
(100%) compared with group 2 (0%). The severity of patients was
more increased in group 1 than group 2. The time to treatment in
prehospital was longer in group 2 (6.3 ± 5.3 min) than group 1
(5.6 ± 4.7 min). The transfer time was longer in group 1 (21 ± 10.4
min) than group 2 (15.7 ± 8.9 min). The rate of using the
telemedicine was increased in paramedics (24.6%) compared with
EMT-intermediate (9.6%) or EMT-basic (4.0%).
Conclusions Our telemedicine system from ambulance to hospital
is the effective system for medical control and prehospital care in a
suburban EMS.
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Introduction The purpose of this work was to test, in a bench
study, the performance of a modified Boussignac continuous
positive airway pressure (CPAP) system, aimed at avoiding the
drop in inspired oxygen fraction (FiO2) during high inspiratory
patient peak flows.
Methods We modified a Boussignac system (Bssc), inserting
between the valve and the face mask a T-piece, connected with a
1.5 l reservoir balloon, supplemented with oxygen independently
from the valve itself. During inspiration, the patient inhales oxygen
from the reservoir, diminishing the blending with atmospheric air
and keeping the FiO2 higher. The performance of the system was
evaluated in a bench study, applying a CPAP face mask to a
plexiglass cylinder connected with an active lung simulator (ASL
5000; IngMar Medical, USA) generating tidal volumes with
increasing inspiratory peak flow rates (V′insp). Two positive end-
expiratory pressure (PEEP) levels were tested for the Bssc,
SUPER-Boussignac with 10 l/min (SB10) and 30 l/min (SB30)
supplementary oxygen flows. The FiO2 was continuously recorded
and the lowest value reached during each tidal volume (FiO2) was
averaged over 20 breaths.
Results With all systems the FiO2 increased with increasing PEEP
levels and decreased at higher V′insp. SB10 and, to a greater extent,
SB30 allowed one to reach greater FiO2 values, and decreased the
drop in FiO2 due to increasing V′insp. See Tables 1 and 2.
Conclusions The SUPER-Boussignac is simple and effective in
increasing (up to 30%) the FiO2, and limiting the drop related to
V′insp during noninvasive CPAP.
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Figure 1 (abstract P340)
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Introduction Numerous studies have confirmed that using non-
invasive continuous positive airway pressure (nCPAP) for chronic
obstructive pulmonary disease and congestive heart failure
improves the respiratory rate, heart rate (HR), and work of
breathing. We hypothesize that early application of nCPAP with
concomitant medical therapy to patients with acute undifferentiated
shortness of breath (SOB) will improve objective measures of
respiratory distress. Specifically, early application of nCPAP can
improve the tidal volume (TV), end-tidal carbon dioxide (EtCO2) and
Rapid Shallow Breathing Index (RSBI), and reduce intubations over
the standard of treatment alone in 15 minutes or less.
Methods Fifty-two patients were randomized equally to either
CPAP + standard of care (nCPAP group) or to standard of care
(standard group) for acute undifferentiated SOB. nCPAP was
applied for 15 minutes. Subject enrollment was randomized and
demographic data were recorded upon enrollment. Volumetric
measures were obtained by breathing through the EtCO2/Flow
sensor for 30 seconds at 5-minute intervals along with vital signs.
Inclusion criteria were adults >18 years, with acute respiratory
distress, admitted to the resuscitation room of the emergency
department, respiratory rate > 25 bpm, SpO2 > 75%, Glasgow
Coma Score > 8, HR > 60/min, and systolic blood pressure
> 90 mmHg. Exclusion criteria were respiratory arrest and/or cardiac
arrest, suspected pulmonary embolism, pneumothorax, myocardial
infarction, temperature >38.5°C, or refusal to participate.
Results All tests were two-sided and assessed at the 0.05 type-I
error rate. The gender distribution was equal for both groups.
There was no difference in baseline characteristics except for age,
HR and diastolic blood pressure (P < 0.05). Subjects in the
nCPAP group had a greater improvement for various parameters
compared with the standard group including TV (0.8 l, 0.3 l),
EtCO2 (30 mmHg, 38 mmHg) and RSBI (39, 150), respectively.
The nCPAP group also had a shorter hospital and ICU length of
stay compared with the standard group (4 vs 5 days, and 2 vs 3
days, respectively). Finally, the rate of intubations was higher in the
standard group (n = 8, n = 3) than the nCPAP group (P < 0.01).
Conclusions The early application of nCPAP in patients with acute
undifferentiated SOB improves their volumetric parameters and
vital signs in as early as 5 minutes. This pilot study provides
objective support for the notion that early application of nCPAP
can lead to measurable improvement in TV, EtCO2, RSBI and
reductions in intubations.
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Introduction Treatment of patients with acute respiratory failure
(ARF) involves mechanical ventilation via endotracheal intubation
(INV). Noninvasive positive pressure ventilation (NIV) using the Bi-
level positive airway pressure (BiPAP) can be safe and effective in
improving gas exchange. The aim of the study is to assess NIV
(BiPAP) as an alternative method for ventilation in ARF and to
determine factors that predict the successful use of BiPAP.
Methods Thirty patients with ARF (type I and type II) were enrolled
and divided into two groups. Group I included 10 patients
subjected to INV ventilation. Group II included 20 patients
subjected to NIV using BiPAP. Both groups were compared
regarding arterial blood gases (ABG) on admission, 30 minutes
after beginning of ventilation, at 1.5 hours and then once daily.
Complications, namely ventilator-associated pneumonia (VAP),
skin necrosis and carbon dioxide narcosis, static compliance and
resistance, were measured at day 1 and day 2.
Results Compared with group I, group II patients were associated
with similar improvement in ABG at 30 minutes and at
discontinuation of ventilation. Group II patients showed lower
incidence of VAP (20% vs 80%), a shorter duration of ventilation
(3 ± 3 vs 6 ± 5 days, P < 0.01), with shorter length of hospital stay
(5.8 ± 3.6 vs 8.9 ± 2.7 days, P < 0.01) when compared with
group I. Skin necrosis and carbon dioxide narcosis occurred in
group II only. Group II patients showed a difference change in
compliance and a change in resistance from day 1 to day 2 when
compared with group I. On a univariate basis, parameters were
analyzed to choose those associated with the outcome under
concern (successful NIV). The following parameters were
identified: level of consciousness, pH (7.3 ± 0.03 vs 7.26 ± 0.1,
P = 0.009), PCO2 (69.16 ± 13.14 vs 100.97 ± 12.04) on
admission, 1.5 hours after NIV, pH (7.37 ± 0.03 vs 7.31 ± 0.17,
P = 0.005), PCO2 (53.98 ± 8.95 vs 77.47 ± 5.22, P = 0.0001) in
whom NIV succeeded and failed, respectively. The variable
identified was PCO2 after 1.5 hours in the two models with 100%
specificity.
Conclusions In patients with ARF, NIV was as effective as
conventional ventilation in improving gas exchange, associated
with fewer serious complications and shorter stay in intensive care.
A 1.5-hour trial with NIV can predict success with BiPAP, as
shown by an improvement in pH and PCO2 and the overall clinical
picture. PCO2 after 1.5 hours could be the sole predictor of
successful NIV with 100% specificity.
Available online http://ccforum.com/supplements/12/S2
Table 1 (abstract P342)
FiO2 values at PEEP 7 cmH2O
V′insp 30 l/m 60 l/min 90 l/min
Bssc 84 ± 0.3 61 ± 0.6 51 ± 0.4
SB10 91 ± 0.4 72 ± 0.3 58 ± 0.4
SB30 92 ± 0.4 93 ± 0.2 77 ± 0.3 
Table 2 (abstract P342)
FiO2 values at PEEP 13 cmH2O
V′insp 30 l/min 60 l/min 90 l/min
Bssc 90 ± 0.2 72 ± 0.4 59 ± 0.4
SB10 91 ± 0.7 81 ± 0.5 68 ± 0.5
SB30 92 ± 0.4 93 ± 0.2 83 ± 0.3 
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Introduction The Rapid Shallow Breathing Index (RSBI) is derived
by dividing the respiratory rate by the tidal volume. Previous work
by this group has shown an association between an elevated RSBI
(>105) and the need for noninvasive ventilation. Hypothesis: an
improvement in RSBI, defined as a decrease from baseline (that is,
ΔRSBI) can predict whether patients will develop respiratory failure
either when receiving conventional therapy (non-CPAP) or
continuous positive airway pressure (CPAP).
Methods A secondary analysis of a prospective randomized
controlled trial of patients receiving CPAP plus conventional
therapy (CPAP group) versus conventional therapy alone (non-
CPAP group) for undifferentiated dyspnea. The tidal volume was
determined utilizing volumetric capnography with an end-tidal
carbon dioxide flow sensor while receiving treatment. There were
26 patients in each group (CPAP and non-CPAP). Comparisons of
ΔRSBI between the CPAP and non-CPAP groups were made.
Simple t tests were performed to compare ΔRSBI values between
groups. All tests were two-sided and assessed at the 0.05 type-I
error rate.
Results The mean ΔRSBI in the CPAP group at t = 0–5 minutes,
0–10 minutes, and 0–15 minutes were 79.1, 96.2, and 93.6,
respectively. For the time period t = 5–10 minutes the mean
ΔRSBI was 15.8, and for t = 10–15 minutes the mean was –2.5. In
the non-CPAP group the mean ΔRSBI for t = 0–5, t = 0–10, t =
0–15, t = 5–10 and t = 10–15 minutes were 6.7, –30.2, –5.4,
–36.9, and 11.4, respectively. Patients randomized to CPAP had a
greater improvement in ΔRSBI compared with patients receiving
conventional therapy. Change from 0 to 5 minutes (P = 0.01), from
5 to 10 minutes (P = 0.03) and from 10 to 15 minutes (P = 0.42).
The largest improvement in RSBI was seen in the first 10 minutes.
There were more intubations in the non-CPAP (n = 8) group
compared with the CPAP group (n = 4).
Conclusions ΔRSBI may be used as a noninvasive technique to
predict respiratory failure in patients receiving CPAP. The largest
improvement in respiratory function in this group occurred during
the first 10 minutes of treatment with CPAP. Further studies are
needed to compare ΔRSBI with conventional predictive
techniques.
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Introduction As the tertiary centre in Northern Ireland, severely
injured patients are transferred to Royal Victoria Hospital (RVH)
regional ICU for further definitive management. Minimum radiology
should be performed before transfer.
Methods ICU transfers from the emergency department (ED), RVH
and district general hospital (DGH), to the trauma centre were
prospectively audited over 4 months.
Results Thirteen patients were admitted from RVH ED, 25 from a
DGH ED. Spinal injury was diagnosed in 7.7% in the RVH group
versus 28% from the DGH ED. The median time to clear the
cervical spine was 24 hours (RVH) versus 48 hours (DGH), and
the thoracolumbars was 34 hours (RVH) versus 48 hours (DGH).
See Tables 1 and 2.
Conclusions Despite Advanced Trauma Life Support guidelines,
plain X-ray scans of the lateral cervical spine, chest and pelvis are
not routinely performed in all trauma patients. Not all spinal injuries
are being detected by radiology performed in EDs. Significant
delays in clearance of spinal injuries occur despite a protocol in
place, exposing patients to other potential risks. The development
of a critical care network in Northern Ireland should allow the
standardisation of pre-ICU management of trauma patients.
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Introduction Needlestick injuries are an occupational hazard for
junior doctors, especially in emergency medicine. The emergency
department is involved in the management of injuries both in the
hospital setting and in the community. The setting was in an inner-
city area with a high incidence of intravenous drug abuse, HIV,
hepatitis B and hepatitis C. The study was to highlight areas for
improvement in management.
Methods A retrospective review of all emergency notes coded as
needlestick injury for a 12-month period from 1 July 2001 to 1 July
2002. Information recorded included times, from incident, arrival at
department, to be seen by doctor and to get postexposure
prophylaxis (PEP) if indicated. Also the number of tetanus toxoid,
hepatitis B immunoglobulin/vaccine, and HIV PEP given as well the
number indicated. Risk of injury and exposure were assessed and
follow-up was checked.
Results There were 73 needlestick injuries, 35 (48%) presented
during normal working hours (9–5 pm) and 38 (52%) outside
these hours. Twenty-six (34%) were healthcare workers, 51(66%)
were nonhealthcare workers. The average time from incident to
arrival was 1.4 hours for healthcare workers and 22.6 hours for
nonhealthcare workers. The median time from arrival in the
department to being seen by a doctor was 90 minutes. Ten
(13.7%) injuries were high risk. Antiretroviral agents were given to
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Table 1 (abstract P347)
Plain radiological investigations performed
Cervical 
Cervical spine Thoraco-
spine antero- lumbar Pelvis 
Chest (%) lateral (%) posterior (%) (%) (%)
RVH 100 100 100 53.8 38.5
DGH 96 88 88 68 32
Table 2 (abstract P347)
Injuries identified prior to ICU admission
Brain Cervical Thoracolumbar Chest 
(%) spine (%) spine (%) (%)
RVH 53.8 0 0 38.5
DGH 76 8 8 28
S137
15 (20.1%) patients and the average time from door to HIV PEP
was 141 minutes.
Conclusions Emergency medicine staff should be aware of the
risks of blood-borne viral transmission as they have greater
exposure than other healthcare groups. They are at higher risk of
percutaneous injury and therefore should adopt universal
precautions; shield and sheath devices would also reduce the risk
of sharp injury. The HIV PEP is effective if given early, so these
patients must be assessed urgently and antiretroviral agents given
as soon as possible if indicated. Emergency medicine has had an
increasing role in management of needlestick injuries in healthcare
workers occurring outside working hours, out-of-hospital injuries
and other attendances for HIV PEP. Greater education of
emergency staff, other healthcare workers and the general public is
required for optimal management of needlestick injuries.
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Introduction The issues of pandemic preparedness and the use of
critical care resources in a pandemic have been of increased
interest recently [1]. We assessed the effect of a proposed
pandemic critical care triage tool [2] on admissions to the ICU. The
tool aims to identify patients who will most benefit from admission
to the ICU and excludes patients considered ‘too well’, ‘too sick’,
or with comorbidities likely to limit survival in the shorter term.
Methods To assess the impact of the pandemic tool on our current
practice, we performed a retrospective observational study of the
application of the pandemic triage tool described by Christian and
colleagues [2] to all admissions to our 14-bed general medical–
surgical ICU over a 1-month period.
Results One hundred and nineteen patients were admitted to the
ICU. Using the pandemic triage tool, 91 of these patients (76%)
did not meet the triage inclusion criteria on admission. As required
by the triage tool, patients were reassessed at 48 and 120 hours,
with only one of the 91 patients becoming eligible for admission on
reassessment. Further assessment of the 29 patients (24%) who
met the triage inclusion criteria revealed that 17 of these met the
triage exclusion criteria, leaving 12 patients (10%) from the original
119 as qualifying for ICU. One of these 12 was deemed ‘too sick’
by the triage tool and therefore was also excluded, leaving 11
patients (9%).
Conclusions Application of this triage tool to our current ICU
patient population would radically change practice, and would
generate substantial capacity that could be used in the situation of
a pandemic. In addition, as the triage tool aims to exclude patients
who are less likely to benefit from admission to the ICU, these
results also have implications for ICU resource management in the
nonpandemic situation.
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Introduction Our rural 10-bed ICU serves a 167-bed hospital
situated in a small town at the centre of the Australian Continent.
The hospital is utilised mainly by Indigenous patients. We were
interested to estimate the Pneumonia Severity Index (PSI) among
all patients presenting to our emergency department (ED) with
community-acquired pneumonia (CAP) during 2006 to ascertain
whether this scoring system could be validated among our unique
patient population and to ascertain whether the score could have
been helpful to support a clinical decision to transfer patients to
the medical ward or ICU.
Methods All patients presenting to the ED during 2006 were
identified and their demographic and parameters details noted to
calculate their PSI scores, which were performed retrospectively.
Triage was performed clinically by the ED doctors. The following
complications were noted: requirement for artificial ventilation,
septic shock, acute renal failure, requirement for percutaneous
tracheostomy and mortality. All patients transferred to tertiary
centres because of staff or bed shortages were also noted. Micro-
biological data were collected on all ICU patients and most of the
ward patients.
Results Four hundred and seventy-six CAP patients presented to
the ED in 2006, of which 91% (436/476) were Indigenous and
12% (57/476) were transferred to the ICU. Admission charac-
teristics of ICU patients revealed high incidences of alcoholism
(76%) and chronic illness (70%). Artificial ventilation rates of these
57 patients were defined according to PSI severity: no patient with
a score <91 required artificial ventilation, whereas 64% of patients
with a score of 91–130 and 75% of patients with a score >130
required artificial ventilation. Using PSI < 91 for predicting
absence of the need for artificial ventilation, specificity of 100%
and sensitivity of 91% were demonstrated.
Conclusions The CAP rate among the central Australian
Indigenous population is unacceptably high. This high rate is
associated with high incidences of alcoholism, chronic ill health
and poor social conditions. The PSI has been validated in this
study, accurately predicting mortality and the need for artificial
ventilation. The PSI could be a useful tool to support a clinical
decision to transfer patients from the ED to the general medical
wards (PSI < 91) or to the ICU (PSI ≥ 91).
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Introduction Although it is widely recognized that physical
restraint of violent persons can result in death or serious injury,
formal reports documenting the incidence or rate of such injuries
are lacking. The rate and nature of injuries for emotionally disturbed
patients brought in police custody to a major urban emergency
department (ED) were therefore recorded.
Methods All medical records of persons brought by police to the
public hospital ED for a large metropolitan county (population 2.5
million) are electronically marked for subsequent rapid searches.
Excluding those arriving following commission of a crime or for
evaluation of medical conditions or sexual assaults, all patients
brought with the transport assistance of paramedic crews to the
ED in police custody for psychiatric evaluation as an emotionally
disturbed person from 12 December 1999 through 31 August
2003 were studied. Patients were classified specifically as
‘agitated’ if they were described as violent, psychotic, aggressive,
combative, hostile, threatening, homicidal or dangerous.
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Results Of the total 24,895 police custody visits, 17,733 met the
inclusion criteria for receiving psychiatric evaluation as emotionally
disturbed persons. Of these, 10,173 (57%) could be classified as
agitated. A potentially lethal weapon was confiscated in 447
cases. Of the 17,733 studied, 511 (3.3%) sustained injuries – 398
(78%) of which were self-inflicted stab wounds, wrist lacerations
and hangings. Mace exposure resulted in 34 minor injuries, while
none were attributable to conductive electrical devices. Overall,
the rate of self-inflicted injuries over 3 years and 9 months was
2.2% (n = 398) while it was 0.6% (n = 113) for those inflicted by
others. Only four of these patients (approximately one per year)
required admission to a surgical service. Of note, 29% of injuries
sustained by agitated patients were not self-inflicted, compared
with 13.6% in nonagitated patients (70/238 vs 37/273, P =
0.0001).
Conclusions With the assistance of transporting paramedics,
police officers were able to restrain violent, emotionally disturbed
patients with a very low risk of serious injury.
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Introduction We compared the reliability and validity of two four-
level emergency triage systems: the ETS1, used in our emergency
department (ED); and the ETS2, a triage algorithm derived from the
Emergency Severity Index [1].
Methods This is an observational retrospective study of 189
patients admitted to our ED in 2 weeks of October 2006. Triage
scenarios were designed with medical records. Ten trained triage
nurses were randomly assigned either to training in ETS2, or to
refresh the ETS1. They independently assigned triage scores to
the scenarios, at time zero and after 6 months. Both triage systems
have four urgency categories (UC): UC1 = immediate response;
UC2, UC3, UC4 = assessment within 20, 60, 120 minutes. We
collected demographic and clinical characteristics, nurse triage
category, admission status and site, nurse triage forms with
presenting complaint, mode and time of arrival, past diseases, vital
signs, and pain score. For each scenario we considered ‘true
triage’ the mode of the UC assigned by the nurses. Weighted
kappa (Κ) was used to calculate inter-rater and intra-rater reliability
in each of the two groups of nurses. The relationships between the
‘true triage’ and admission, and admission site were assessed.
Results The UCs assigned were similar in two groups: 20%
versus 21% with UC4, 50% versus 48% with UC3, 28% versus
28% with UC2, 2% versus 3% with UC1. A complete disagree-
ment in UC was found in 3% and 5% cases of ETS1 and ETS2; a
complete agreement in 52% and 56% cases of ETS1 and ETS2.
Inter-rater reliability among nurses using ETS1 and ETS2 was Κ =
0.73 (95% CI: 0.59–0.87) and Κ = 0.79 (95% CI: 0.65–0.93),
respectively; intra-rater reliability was: Κ = 0.82 (95% CI:
0.67–0.96) and Κ = 0.78 (95% CI: 0.62–0.93) in ETS1 and
ETS2. Hospital admission by ETS1 and ETS2 was similar for UC2
(39% vs 37%), UC3 (5% vs 8%), and UC4 (3% vs 0%); 100% of
patients with UC1 in ETS1 and 60% in ETS2 were admitted to the
ICU.
Conclusions The two emergency triage systems showed similar
reliability and validity. ETS2 is easier to consult but worse in
prediction of ICU admission. To our knowledge this is the first
study on the intra-rater reliability of two four-level emergency triage
systems.
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Introduction Emotionally disturbed persons brought to the emer-
gency department (ED) are at risk of surgical and medical illness.
The patterns of medical and surgical illness for emotionally
disturbed patients brought in police custody to a major urban ED
were recorded.
Methods Our electronic ED medical records include the chief
complaint, final diagnosis and disposition. A smaller number have
detailed nursing notes. All patients with detailed nursing notes who
were brought between 1 December 1999 and 31 August 2003 in
police custody for psychiatric evaluation were studied. Patients
were classified as ‘agitated’ if they were described as violent,
psychotic, aggressive, combative, hostile, threatening, homicidal or
dangerous.
Results In total, 17,733 were brought for psychiatric evaluation. Of
these 6,432 had complete nursing notes. Rates of injury and
illness were low. Of 1,985 nonagitated patients, 194 (9.8%) were
injured: 180 (93%) self-inflected and none was attributed to a
restraint process. For 4,447 agitated patients, 227 (3.5%) were
injured, 160 (70%) were self-inflicted and 39 (0.9%) were
attributed to the restraint process. Of these, 31 were exposed to
mace, six had minor head or soft-tissue injuries, one had a
pneumothorax, and one had an airway injury. For the subgroup self-
inflicted injuries included lacerations (245), head injuries (60),
hangings (13), penetrating wounds (10), hand fractures or
infection (three), and other minor (nine). Overall 2,903 (45.8%)
were admitted to a psychiatric service, 110 (1.7%) to a medical
service and seven (0.12%) to a surgical service. Admitted surgical
diagnoses were abdominal stab wound (one), tibial fracture (two),
pneumothorax (one), airway injury (one), infected human bite (one),
complicated lacerations (three), and penile foreign body (one). The
predominant medical admission diagnoses were alcohol
withdrawal (16 patients), overdose (24 patients), and
rhabdomyolysis (12 patients). Forty-five patients had complications
of chronic medical illness and eight patients had dementia with by
psychosis.
Conclusions Although serious medical illnesses and injuries
occurred, there was a low rate of medical and surgical illness that
required admission. There was a high rate of psychiatric admission.
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Introduction Untreated mild heat illness (heat exhaustion) becomes
progressively more severe (heat stroke). Although the prognosis and
risk factors for hospital mortality in patients with severe heat illness
are often reported, the epidemiologic data for mild heat illness have
been rarely reported. We therefore investigated the hospitalization
predictive factors in the patients with mild heat illness.
Methods Questionnaire sheets were sent to our affiliated hospitals
in Yamaguchi prefecture, located at 34° north latitude with a popula-
tion of 1.5 million, to identify the patients who received medical
attentions with heat illness from 1 July to 31 August 2007. The
questionnaire included symptoms, vital signs, laboratory data and
presence or absence of hospitalization (decided by each doctor).
Results We analyzed the data from 114 of the 126 patients with
mild heat illness. Twelve patients were excluded because of
insufficient description. The total number of hospitalizations was
44 (35%) and all patients were discharged without subsequent
complications. The significant differences were shown in body
temperature, consciousness disturbance, dysfunction of central
nerve system including convulsion or cerebellar ataxia, age, levels
of serum C-reactive protein, blood urea nitrogen (BUN) and white
blood cell count between hospitalized and nonhospitalized patients
with mild heat illness. Independent predictive factors for
hospitalization were Glasgow Coma Scale < 15 (P = 0.04, OR =
3.56, 95% CI = 1.05–12.01), age ≥ 60 years (P < 0.01, OR =
4.44, 95% CI =1.50–13.08), and BUN ≥21 mg/dl (P = 0.03,
OR = 3.35, 95% CI = 1.16–9.67).
Conclusions Based on the present findings, the factors of
hospitalization for mild heat illness were identified as presence of
consciousness disturbance, seniority and high BUN level. These
factors did not directly show the severity of heat illness, but they do
help us to determine the patients who should be hospitalized.
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Introduction We have been aware that colon cancer in our public
institution is too often diagnosed at a late stage. We evaluated the
pattern of visits of these patients to the emergency department
(ED) prior to the diagnosis of cancer.
Methods All patients in the hospital cancer registry with a diagnosis
of colon cancer between January 2001 and December 2004 were
evaluated. The prior ED visits were tracked in the searchable ED
electronic medical record back to January 1999. Chief complaints
and hematocrits were recorded. Anemia was defined as a hematocrit
<37%. Symptoms were unexplained anorectal or abdominal pain or
bleeding, chronic constipation, diarrhea or vomiting.
Results Two hundred and thirteen patients (116 men and 97
women) with colon cancer diagnosed during the 3-year period had
visited the ED at least once prior to diagnosis. 37.6% were
diagnosed within 1 week of the first symptomatic ED visit and 50%
within the first 40 days. The median time to diagnosis after the first
symptomatic ED visit was 46 days while the average was 256
days. Diagnoses were delayed more than 1 year in 51 patients.
The median time to diagnosis after the first detection of anemia
was 84 days. Forty-one patients were diagnosed at greater than 1
year. Women with anemia (n = 27) were nearly twice as likely as
men (n = 16) to have ≥1-year delays in diagnosis following the
detection of anemia.
Conclusions Opportunities to facilitate early diagnosis of colon
cancer were missed in some cases. Focused interaction of ED
providers with outpatient care providers to facilitate evaluation of
suspected colon cancer is necessary to improve early detection.
Women with anemia are less likely to be evaluated for a
gastrointestinal source of blood loss.
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Introduction This study was designed to demonstrate use of chest
X-ray scans in a district general hospital emergency department
and to highlight areas of inappropriate use.
Methods A retrospective chart review of 62 consecutive chest X-
ray exposures from emergency patients in the department. The
frequency of temperature, pulse, respiratory rate and oxygen
saturation parameters were recorded, and those subsequently
abnormal. The indication for the X-ray scan, information about
previous chest X-ray scans and the record of the observed result
were reviewed, as well as whether the patient’s management was
altered by the result of the X-ray scan.
Results Only 50% of the X-ray scans provided information that
would potentially change the patient’s management, although 68%
had positive findings recorded. Twenty-nine per cent were
requested for investigation of chest pain (pleuritic in 8.1%), 11.3%
for investigation of abdominal pain, and 5% for transient ischemic
attacks.
Conclusions Approximately 50% of chest X-ray scans requested
from the emergency department are inappropriate. They are often
requested unnecessarily for chest pain, transient ischaemic
attacks, mild chest infections, head injury, haematemesis and minor
injuries.
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Introduction Organophosphorus (OP) insecticides are widely
used in agriculture, usually as pesticides, and frequently cause ill
Available online http://ccforum.com/supplements/12/S2
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health and death for hundreds of thousands of people each year.
The majority of deaths occur following deliberate self-poisoning.
They are common suicidal agents in Pakistan, India, Sri Lanka and
other South Asian countries. The Accident & Emergency
Department of Liaquat University Hospital Hyderabad routinely
receives victims of OP poisoning from the farming communities all
around. Our objective was to document the management, complica-
tions and subsequent outcome of patients with acute organo-
phosphorus poisoning in the ICU of Liaquat University Hospital.
Methods All victims of OP poisoning admitted to the ICU of
Liaquat University Hospital admitted from May 2004 to October
2006 were included in the study. Diagnosis of OP poisoning was
confirmed from history and clinical findings. Management,
complications and subsequent outcome were noted. Statistical
analysis was performed using SPSS 10.
Results A total of 111 patients of OP poisoning were admitted to
the ICU during the study period; 60.4% of patients were males.
The mean age was 25.26 ± 8.52 years; 85.6% were within the
age limit of 12–30 years. Of patients, 89.2% were a suicidal
attempt. In 94.6% of patients, ingestion was the route of exposure.
The mean ICU stay was 2.3 ± 3.2 days. Twenty (18%) patients
needed mechanical ventilatory support. The overall mortality ratio
was 9% (n = 10). The mortality rate for the patients who required
mechanical ventilation was 40% (n = 8), but the rate was 2.2%
(n = 2) for the patients who were not mechanically ventilated.
Conclusions Because of widespread use of OP pesticides by
farming communities of the developing world, it is very difficult to
reduce mortality by primary prevention. Immediate shifting of the
victim to a well-equipped and well-staffed ICU, careful resusci-
tation with appropriate use of antidotes and good supportive care
and observation can help reduce the number of deaths in the
period after admission to the hospital. Awareness and education of
general practitioners in the rural areas regarding emergency
management, as well as prompt referral to an appropriate facility, is
also recommended to reduce the mortality rate.
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Introduction Paraphenylenediamine (PPD) is frequently used by
women in certain countries such as Tunisia, Morocco, India,
Pakistan and Sudan to dye their hair black. Knowledge of its
systemic toxicity led to use for a purpose of autolysis, but global
studies including a medico-legal and toxicological investigation
remain very rare. In Tunisia the sporadic cases of suicide by the
ingestion of this substance were recorded in the regions of the
south and the center.
Methods A retrospective study concerning a series of 10 cases of
voluntary acute intoxications with PPD brought together in the
Laboratory of Toxicology of CHU Farhat Hached Sousse. The
samples of blood, urine and gastric contents were realized during
the clinical examination and autopsy in the hospitals of Sfax,
Sousse and Kairouan. The characterization of PPD in the aqueous
biological circles was able to be made after the clarification of a
separation technique.
Results The sex ratio (male/female) was equal to 0.25. The
average age was 28 years. Seven subjects were single and three
were married. The socioeconomic level was low in all of the cases.
Death was noted in 9/10 cases. The most common clinical
evidence was cervicofacial oedema (nine cases), diffuse myalgia
(three cases), and blackish urine (six cases). The analysis
toxicology brought conclusive evidence of the ingestion of PPD by
revealing the level of the gastric contents and the urine in almost all
of the cases (10 cases).
Conclusions The study shows that intoxication by the black stone
is relatively rare but there is a potentially burning absence of a fast
and effective medical intervention. The prognosis for survival
involves the initial phase characterized by cervicofacial oedema
requiring a tracheotomy of rescue for lack of intubation, often
difficult. It is this logic that makes the role for the Laboratory of
Toxicology bringing, in the shortest time period, proof of an acute
intoxication, for which the diagnosis is not to be underestimated.
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Introduction Massive drug ingestions may be associated with
refractory cardiac failure, which reversibility makes extracorporeal life
support (ECLS) promising despite prolonged arrest. Our objective
was to determine the prognosis factors of ECLS-treated patients.
Methods A prospective study including all poisoned patients treated
with ECLS during 2003–2007; surgical cannulation of femoral
vessels in the ICU to perform ECLS (Rotaflow®; Jostra-Maquet SA)
in collaboration with a cardiosurgical team of a neighboring hospital.
Descriptive analysis (median, (percentiles 10–90%)); univariate
comparisons using chi-squared and Mann–Whitney tests.
Results Fifty-seven poisoned patients (19 males/38 females, 41
years (21–59); SAPS II, 75 (49–94)) were treated with ECLS over
a 4-year period in relation to cardiac failure (26/57) and arrest
(31/57). Patients had ingested high doses of cardiotoxicants in
49/57 cases (chloroquine 19%, class I antiarrhythmic drugs 19%,
β-blockers 14%, calcium channel blockers 11%). Sixteen patients
(28%) survived, including five to prolonged cardiac arrest (maximal
duration: 180 min). Death was consecutive to multiorgan failure,
anoxic encephalopathy or capillary leak syndrome if ECLS was
performed under cardiac massage. Four patients presented
documented brain death, allowing organ donation in two cases.
Among these patients, the heart of one flecainide-poisoned patient
was successfully transplanted, after normalization of ECG and
myocardial function as well as toxicant elimination under ECLS.
Prognosis factors in ECLS-treated poisoned patients were as
follows: QRS enlargement on admission (P = 0.009), SAPS II
score on admission (P = 0.005), ECLS performance under
massage (P = 0.008), arterial pH (P < 0.001), lactate concen-
tration (10.7 (6.6–19.6) versus 15.0 mmol/l (6.2–29.5), P =
0.003), as well as red cell (P = 0.008), fresh plasma (P = 0.003),
and platelet (P = 0.03) transfusions within the first 24 hours.
Conclusions ECLS appears to be an efficient salvage technique in
cases of refractory toxic cardiac failure or arrest.
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Introduction The incidence of acute calcium-channel blocker
(CCB) poisonings is increasing. Our objectives were to describe
the CCB-poisoned patients admitted to the ICU and to determine
the prognostic factors.
Methods Retrospective collection of clinical data in three ICU in
2000–2006; determination of plasma concentration using HPLC
(REMEDI). Description (median, (25–75% percentiles)); compari-
sons using Mann–Whitney and chi-squared tests; multivariate
analysis using a step-by-step logistic regression model.
Results Eighty-four patients (47 males/36 females, 44 years
(31–56); SAPS II, 15 (8–25)) were included. Verapamil (39/83),
diltiazem (13/83), nifedipine (11/83), nicardipin (9/83), and amlo-
pdipine (8/83) were involved. On admission, systolic blood
pressure was 105 mmHg (86–118), heart rate 76/min (67–91),
QRS duration 85 ms (80–110), and plasma lactate concentration
2.86 mmol/l (1.79–5.98). Poisoning features included shock
(42/83), atrioventricular block (34/83), asystole (8/83), and/or
ventricular arrhythmia (4/83). All patients received fluid replace-
ment, 50/83 epinephrine infusion (maximal rate: 3.0 mg/hour
(1.4–8.0)), and 27/83 norepinephrine (5.0 mg/hour (2.9–15.0)).
Thirty-three out of 83 were mechanically ventilated. Treatments
included calcium salts (22/83), glucagon (18/83), dobutamine
(18./33), 8.4% sodium bicarbonate (16/83), isoprenaline (14/83),
insulin + glucose (13/83), terlipressin (4/83), electrosystolic
stimulation (2/83), and extracorporeal life support (5/83). Eleven
patients (13%) died in the ICU. The plasma verapamil concen-
tration was significantly different on admission regarding survival
(800 versus 2,522 mg/l, P < 0.05). If excluding SAPS II from the
model, multivariate analysis showed that QRS duration (>100 ms;
OR, 5.3; 95% CI, 1.1–27.0) and maximal epinephrine rate
(>5 mg/hour; OR, 27.6; 9%% CI, 5.3–144.7) were the only two
predictive factors of death (P = 0.007). Shock was refractory if
epinephrine + norepinephrine was ≥8 mg/hour with renal
(creatinine > 150 μmol/l) or respiratory failure (PaO2/FiO2 > 150
mmHg) (sensitivity, 100%; specificity, 89%).
Conclusions Despite optimal management in the ICU, the CCB
poisoning mortality remains high (13%), encouraging development
of extracorporeal life support and new antidotes.
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Introduction There is a paucity of data regarding the demo-
graphics and the type of drugs ingested by patients who require
admission to critical care following deliberate self-poisoning (DSP).
Critical care admissions place a large economic burden on the
health care system, and potential measures to prevent critical care
admissions should be taken. Ingestion of antihypertensive
medication, coma upon presentation, and presentation to the
emergency department less than 2 hours after ingestion are
predictive of ICU admission. Our aim was to establish the
incidence of DSP, to assess the demographics, and to identify
factors that may contribute to multiple admissions for DSP.
Methods Data were retrieved from the Riyadh Intensive Care
Programme (RIP) database for each case of DSP between April
2006 and October 2007 that required critical care. Case notes
were reviewed and the following data recorded: type of poison
ingested, past medical history, past psychiatric history, previous
ICU admission for DSP and demographics.
Results The RIP database identified 64 episodes of DSP involving
55 patients. The mean age was 40 years (26 males, 29 females).
Forty-eight episodes required level 3 care. Forty-one patients
required intubation. The average length of stay was 2.5 days. Nine
patients (16.3% admissions) had more than one admission to the
ICU during the study period. Of these, seven were female, average
age 35 years, and two male, mean age 50 years. The commonest
drug in multiple DSP was alcohol, followed by benzodiazepines. Six
patients (75%) had a known psychiatric history. Three patients died
during this period, one male and two female. Their average age was
46 years. None of these patients had previously presented to critical
care. One of the deceased patients had a psychiatric history.
Available online http://ccforum.com/supplements/12/S2
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Conclusions Most of the ICU admissions to Cardiff and Vale NHS
trust following multiple DSP episodes involve young females. The
most frequently ingested drug is alcohol, and then benzodia-
zepines. Further targeted psychiatric involvement with young
women with a known psychiatric history may be warranted
financially to prevent multiple critical care admissions. This may
have no impact on overall successful DSP suicides.
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Introduction The classic physiopathologic approach of the
manifestations after paraphenylenediamine (PPD) intoxication
presents many limits. Recently, the immunogenic role of PPD
(particularly its derivatives of oxidation) in the genesis of contact
dermatitis and immunologic perturbations has been revealed. Our
aim is to establish the immunologic profile of PPD-intoxicated
persons  based on monitoring of the inflammatory reaction.
Methods A prospective study of 21 patients treated in the medical
resuscitation unit in Ibn Rochd University Hospital of Casablanca
due to PPD intoxication, realized during 2005. A follow-up of the
demographic, clinical, paraclinical, therapeutic and evolutive
parameters as well as valuation of the scores of gravity (SAPS II,
APACHE II, OSF) was carried out in all our patients, and an
inflammatory check-up including the white corpuscles, C-reactive
protein, C3 and C4 fractions of complement and lymphocyte
subpopulations CD3, CD4, CD8 and CD19 were realized for all of
them. A follow-up was realized, and the kinetics compared with
those of the clinical and paraclinical evolution of the patients.
Results The monitoring of the inflammatory reaction in our patients
shows evolution at three times for this reaction, with the first time of
inflammatory stress during the first 3 days after the intoxication
characterized by a relative immunodepression, the second time from
the third day when the rhabdomyolysis exerts its proinflammatory
power, and the third time (from the sixth day) corresponds to the
immunomodulative action of PPD and to its oxidative metabolism. It is
a systemic inflammatory reaction specific to a cytotoxic cell support,
which would explain the secondary worsening of the clinical and
paraclinical parameters of our patients (the nature of the state relative
to hemodynamic shock, the cause of multivisceral failures, etc.).
Conclusions It seems that the immunological aspect may present
the answer to several questions that rhabdomyolysis alone could
not answer. This study tried to establish a first immunologic profile
of PPD-intoxicated persons, and to correlate it with their evolution.
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Introduction Hospitals in Slovenia lack an organized approach to
medical emergencies and clinical deterioration in hospitalized
patients. The Institute of Oncology (IO) is the first hospital in
Slovenia that is considering implementation of rapid response
teams (RRT) with the intention of improving patient safety and care.
The IO is a teaching hospital and tertiary national cancer centre for
Slovenia. On average, 350 outpatients and 210 inpatients are
treated every day.
Methods A cross-sectional study of emergencies and clinical deteri-
orations in our wards from August to October 2007 with intent to
access the situation and provide the optimal basis for introduction of
RRT. Data were collected through a report form that was filled out by
doctors and nurses on the ward at the time of the emergency or
clinical deterioration. All hospital wards were included.
Results A total of 3,140 patients were hospitalized during this 3-
month period and 43 reports were returned. Most emergencies
and clinical deteriorations were linked to active patient treatment –
surgical and systemic therapy (chemotherapy and target
therapies). The most common complications were: sepsis (34.8%),
serious hypersensitivity to therapy (30.2%), pulmonary embolism
(9.3%), bleeding (4.6%), followed by single cases of ileus, acute
respiratory failure, cardiac arrest, spinal cord compression, stroke,
pneumothorax, high intracranial pressure, peritonitis, and acute
renal failure. There were seven fatal outcomes (16.3%), all
transferred and treated in the ICU, caused mainly by late
identification and treatment of sepsis, and were possibly
preventable.
Conclusions The incidence of emergencies and clinical
deteriorations in the IO was somewhat lower than reported, which
can be ascribed to under-reporting [1]. The results are useful for
providing basis for planning the most efficient and appropriate form
of RRT but also to provide better education for ward staff with the
intent to improve their awareness and immediate management of
these conditions. As a result we hope to introduce RRT by the end
of 2008, as the first hospital in Slovenia. We intend to continue
with assessment of emergencies on the wards also as a part of
quality assessment after the introduction of RRT.
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Introduction Although there are many people of poor condition in
the hospital, they have not been properly managed compared with
out-of-hospital patients by the out-of-hospital emergency medical
service system. The system of an inhospital medical emergency
team (MET) is desired to be set up. Our staff of the Critical Care
and Emergency Center functioned as a voluntary MET in response
to the inhospital whole paging system. Since 2006, our hospital
has adopted the emergency call system as a regular system. The
objective of this study was to clarify the usefulness and problems
of our MET system.
Methods We examined the medical records of our MET system
(Doctor Call (DC)) for the past 1 year and 8 months.
Results The data of 34 cases were enrolled. Events occurred in
wards or diagnostic and treatment rooms in the outpatients’
department in 29% of cases, examination room in 6%, and other
nonmedical areas in 65%. Patients were found by the doctor in
21%, nurse in 18%, patients’ family in 6%, nonhospital staff
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including other patients in 12%, and other nonmedical staff in
43%. The reasons why bystanders decided to start the DC system
were cardiac arrest in 12%, unresponsiveness in 26%, convulsion
in 12%, falling down in 29%, lying in 15%, and others in 6%. In
two cases, who were inpatients in their ward, a bystander who
found their abnormality (unresponsive and no respiration) at first
called a doctor on night duty for the ward before starting up the
DC system, with hesitation for using this system because these
events occurred at night. We experienced six cases of
cardiopulmonary arrest in the DC system including these two
cases, 33% of whom were survived without any functional
disturbance, 49% died after temporary return of spontaneous
circulation, and 18% died without return of spontaneous circula-
tion because of acute aortic dissection in the outpatient depart-
ment of cardiac surgery during consultation by a specialist. Except
for these two cases, patients were managed at first by bystanding
doctors before DC in 25%, by MET in 53% within 3 minutes, and
by other generalists and specialists in 22% within 2 minutes.
Conclusions Although our MET system is thought to work well, it
needs to be helped by other doctors working nearer the scene
than the MET. It is thought necessary to educate the importance of
the emergency call and the MET system even at night for all
hospital staff.
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Introduction Cardiopulmonary resuscitation (CPR) after cardiac
arrest in cancer patients is often discouraged as it is associated
with very poor outcomes. In our 560-bed tertiary cancer hospital in
Mumbai, India, the ICU runs a cardiac arrest team (CAT). We
reviewed our data to determine outcomes in our patients and
whether it is justified to continue the CAT.
Methods All inhospital patients from June 2005 to July 2007 with
unanticipated cardiorespiratory arrests and other emergencies for
whom the CAT was called were included. Data were recorded
using the Utstein template. Patients with anticipated progression
towards arrest, and those with seizures, hypotension without
dysarrythmias or dysarrythmias without hypotension, were
excluded. The outcome studied was survival on hospital discharge
(SOHD). Binary logistic regression analysis was performed to
determine factors associated with SOHD.
Results Three hundred and sixty patients (227 males, 133 females,
mean age 45.2 ± 18.3 years) were studied. The mean time interval
between collapse and onset of resuscitation was 2.3 ± 2.1 minutes.
The overall SOHD was 25.3%. Sixteen out of 244 patients (6.6%)
with cardiac arrest and 75/116 (64.7%) patients with respiratory
arrest or other emergencies had SOHD. The initial rhythm recorded
during CPR was asystole in 189 patients, pulseless electrical
activity in 31 patients and ventricular fibrillation/tachycardia in
24patients, while 116 patients had other rhythms. SOHD for these
rhythms was 1.6%, 3.2%, 54% and 65.6%, respectively. Cardiac
arrest in medical oncology patients was associated with significantly
worse SOHD than in other patients (3/117, 2.6% vs 13/127,
10.1%, P = 0.02). On univariate analysis, the age, medical oncology
admission and monitored arrest were not associated with SOHD.
On multivariate analysis, only asystole (OR = 97.5, 95% CI =
29.0–327.5) and time to resuscitation (OR = 1.4, 95% CI =
1.17–1.67) were significantly associated with mortality (P < 0.000),
while witnessed arrest and cardiac arrest were not.
Conclusions The overall survival was 25.3%. Nearly one-third of
patients suffer from respiratory arrest or other emergencies with
good (64.7%) SOHD. A reduced response time is associated with
improved SOHD. These considerations justify the presence of a
CAT in our cancer hospital. Asystolic patients should not be
resuscitated.
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Introduction Outcome after out-of-hospital cardiac arrest is poor
[1]. We examined the records of patients admitted to the University
Hospital of Wales ICU to compare our outcomes with published
literature and to identify risk factors for poor outcome.
Methods All patients aged >18 years who were admitted between
1 January 2004 and 31 December 2006 after out-of-hospital
cardiac arrest were identified from computerised records and case
notes. Patients admitted between 1 January 2007 and 31 May
2007 were studied prospectively. Demographic and outcome data
were collected as well as information related to the cardiac arrest
episode.
Results Sixty patients were admitted over 41 months. Twenty-one
out of 60 were female (male:female ratio 2:1). The mean age was
61.8 ± 15.2 years. There were six patients >80 years old.
Bystander cardiopulmonary resuscitation (CPR) was attempted in
73% of cases. The response time of medical services ranged from
3 to 45 minutes (mean 10.5, median 7 min). The longest response
time for a surviving patient was 6 minutes. No patient survived with
a total duration of cardiac arrest >15 minutes or time without CPR
>6 minutes. There were no survivors with any initial rhythm other
than ventricular fibrillation/ventricular tachycardia (VF/VT). The
mean ICU length of stay was 3.3 days for nonsurvivors (range
1–15 days) and 12.9 days (range 1–35 days) for survivors. Mean
hospital length of stay was 4.4 days for nonsurvivors (range 1–35
days) and 31.4 days (range 1–91 days) for survivors. Overall
survivals to ICU/ home discharge were 38.3%/33.3%, respec-
tively. Survival in the >80-year-old group was 0% compared with
40% in those aged <80 years (P = 0.024). Survival in males was
38.5% and in females 23.8% (P = 0.25). Information on
neurological outcome was available for seven out of 20 survivors.
All seven received therapeutic hypothermia treatment. Five (71%)
had ‘good’ neurological outcomes. One had minor cognitive deficit
and one required long-term nursing home care.
Conclusions The high male:female ratio may reflect the higher
incidence of ischaemic heart disease in males. Gender does not
affect outcome after ICU admission. Our survival rates of 33.3%
are higher than the national average of 28.6% [1], but we have had
no survivors over the age of 80 years or with any initial rhythm other
than VF/VT. Delay to initiation of CPR (>6 min) and prolonged
CPR (>15 min) were also universally associated with death in this
patient cohort. Neurological outcomes of survivors appear good.
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Comparison of the characteristics and outcome between
patients suffering from out-of-hospital primary cardiac
arrest and drowning victims with cardiac arrest: an analysis
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S Grmec, M Strnad, D Podgorsek, A Jus
ZD dr. Adolfa Drolca Maribor, Slovenia
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Introduction In 2003, ILCOR published the Utstein Style for
Drowning (UFSD) to improve the understanding of epidemiology,
treatment and outcome prediction after drowning. Characteristics
and outcome among patients with out-of-hospital primary cardiac
arrest (OHPCA) compared with drowning victims with cardiac
arrest (DCA) patients were described with application and
evaluation of UFSD data for outcome analysis.
Methods All patients with OHPCA and DCA from February 1998
to February 2007 were included in the research and analysis. Data
on patients with OHPCA and DCA were collected prospectively
using the Utstein method. Data on patients with DCA were then
compared with data of patients with OHPCA.
Results During the study period 788 cardiac arrests with
resuscitation attempts were identified: 528 of them were OHPCA
(67%) and 32 (4%) were DCA. The differences between patients
with DCA and patients with OHPCA were: the patients with DCA
were younger (46.5 ± 21.4 vs 62.5 ±15.8 years; P = 0.01), they
suffered a witnessed cardiac arrest less frequently (9/32 vs
343/528; P = 0.03), they were more often found in a non-
shockable rhythm (29/3 vs 297/231; P < 0.0001), they had a
prolonged ambulance response time (11 vs 6 min; P = 0.001),
they had a relatively better (but not statistically significant) return of
spontaneous circulation in the field (22/32 (65%) vs 301/528
(57%); P = 0.33) and more of them were admitted to hospital
(19/32 (60%) vs 253/528 (48%); P = 0.27) and they also had a
significantly higher survival rate – discharge from hospital (14/32
(44%) vs 116/528 (22%); P = 0.01). Patients with DCA had
higher values of initial partial pressure of end-tidal carbon dioxide
(petCO2) (53.2 ± 16.8 vs 15.8 ± 8.3 mmHg; P < 0.0001) and
average petCO2 (43.5 ±13.8 vs 23.5 ± 8.2; P = 0.002). These
values of petCO2 suggest asphyxial mechanism of cardiac arrest.
The analysis showed that survived patients with DCA were
younger, had more bystander cardiopulmonary resuscitation,
shorter call–arrival interval, higher values of petCO2 after 1 minute
of cardiopulmonary resuscitation, higher average and final values of
petCO2, a lower value of initial serum K+ and more of them
received vasopressin (P < 0.05) in comparison with DCA patients
who did not survive.
Conclusions Patients with DCA had a better survival rate
(discharge from hospital) and higher initial and average petCO2
values, and more of them had a nonshockable initial rhythm.
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Introduction The objective of this study was to investigate trends
in hospital mortality for admissions to UK critical care units
following cardiopulmonary resuscitation (CPR) for the period
1998–2006.
Methods A retrospective analysis of the Intensive Care National
Audit and Research Centre Case Mix Programme Database of
480,433 admissions to 178 units in England, Wales and Northern
Ireland. Admissions, mechanically ventilated in the first 24 hours in
the critical care unit and admitted following CPR in the 24 hours
before admission, were identified for the period 1 January
1998–31 December 2006.
Results Mechanically ventilated survivors following CPR accounted
for 26,722 (5.6%) of admissions. In total 15,143 (56.7%) died on
the admitting critical care unit and 18,573 (70.7%) died before
ultimate discharge from acute hospital. Over the 9 years, relative to
all admissions, the proportion of patients admitted following CPR
decreased from 6.6% to 5.0%; this reduction occurred mainly
among those admitted following inhospital CPR. The mean age of
admissions following CPR has increased (from 62 to 65 years
following inhospital CPR (P < 0.001) and from 58 to 62 years for
out-of-hospital CPR (P < 0.001)). Hospital mortality decreased
significantly from 70.5% to 69.0% (trend analysis odds ratio (95%
confidence interval); 0.98 per year (0.97–0.99) P < 0.001). After
adjustment for case mix, the reduction in hospital mortality
following inhospital CPR remained significant (0.97 per year
(0.96–0.99) P = 0.001) but did not for out-of-hospital CPR (0.99
per year (0.97–1.01) P = 0.43).
Conclusions In the period 1998–2006, the crude hospital
mortality for admissions to UK critical care units following CPR has
decreased significantly, and for inhospital CPR this decrease
remained significant after adjustment for case mix.
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Return of spontaneous circulation after cardiac arrest using
mechanical chest compressions with the Lund Cardiac
Arrest System compared with manual chest compressions
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Introduction Experimental studies have shown improved organ
perfusion with mechanical chest compression with the Lund
Cardiac Arrest System (LUCAS) compared with conventional
cardiopulmonary resuscitation (CPR). Few data exist on the effects
on clinical outcome. From September 2006 onwards, all out-of-
hospital resuscitations for cardiac arrest in the Leiden area were
performed using the LUCAS in combination with continuous flow
insufflations of oxygen (CFI). We studied the effect of the LUCAS-
CFI on the return of spontaneous circulation (ROSC) on arrival at
the hospital compared with conventional CPR.
Methods From January 2007 to September 2007, data on ROSC
on arrival at the hospital were collected prospectively, and were
compared with historical controls, manual CPR, for January
2006–September 2006. Only patients with primary cardiac
disease (ischemia or arrhythmias) were included in the analysis.
Groups were compared using the chi-square test and the
Mann–Whitney test. Potential confounders of the effect of the
LUCAS on ROSC were tested in a univariate logistic regression
model. In a multivariate logistic regression model, the effect of
LUCAS was tested, corrected for confounders.
Results From January 2007 to September 2007, 57 patients were
resuscitated using LUCAS-CFI. Fifty-six patients were used as
historical controls. Groups were comparable (Table 1) with the
exception of bystander CPR. ROSC occurred in 20 (35%) patients
in the LUCAS-CFI group versus 14 (25%) in the control group. In
the univariate analysis, asystole significantly decreased the chance
of ROSC (OR = 0.21, 95% CI = 0.05–0.96). Corrected for
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confounders the LUCAS did not perform better than manual chest
compression with respect to ROSC (OR = 1.25, 95% CI =
0.53–2.94).
Conclusions We found no significant difference in ROSC
between LUCAS-CPR compared with conventional CPR by
manual chest compressions.
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Return of spontaneous circulation and neurological
outcome after inhospital Lund University Cardiac Arrest
System cardiopulmonary resuscitation
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Introduction We report return of spontaneous circulation (ROSC)
and neurological outcome after inhospital Lund University Cardiac
Arrest System cardiopulmonary resuscitation (LUCAS-CPR).
Methods From February 2006 onwards, we intended to use
LUCAS-CPR for all cases of adult inhospital arrest, after arrival of
the inhospital emergency team. The Glasgow Coma Scale (GCS)
was used to determine neurological outcome 24 hours after
discontinuing sedative drugs. Outcome at 3 and 6 months was
determined by the Cerebral Performance Categories (CPC) [1].
Results Seventy-two patients received inhospital LUCAS-CPR.
Twenty-two were female. The mean age was 71.46 (SD ± 11.9)
years. The location of arrest was a monitored ward in 28 cases
(emergency department, coronary care unit, ICU) and a general
ward in 44. All but three arrests were witnessed. Because of
obesity, LUCAS-CPR could not be initiated in three patients. First
rhythm was asystole in 15 patients (20.8%), pulseless electrical
activity in 40 (55.5%) and ventricular tachycardia/ventricular
fibrillation in 17 cases (23.6%). ROSC was obtained in 46 of 72
patients (63.8%). The GCS was favourable (14 or 15/15) in 25
cases (34.7%). The CPC at 3 months revealed a CPC of one in
seven patients (9.7%) and of two in 10 patients (13.9%). One
patient had a CPC of 3 and one patient a CPC of 4. The CPC at 6
months was slightly different. One patient with a CPC of 1 died,
one patient with a CPC of 3 changed to a CPC of 2 after
revalidation, and finally one patient with a CPC of 3 died.
Conclusions LUCAS-CPR is a good alternative for manual closed-
chest compression in patients with inhospital cardiac arrest. The
ROSC ratio (63,8%) and early neurologic outcome as determined
by the GCS (34.7%) are high. CPC at 3 and 6 months revealed a
good outcome (CPC 1 or 2) in 23.6%.
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Etiology of prehospital cardiac arrest largely determines
outcome in patients treated with mild hypothermia
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Introduction Clinical and experimental investigations have
demonstrated improved neurological outcome after therapeutic
mild hypothermia in patients after successful resuscitation from
prehospital cardiac arrest. In these investigations only patients with
prehospital cardiac arrest due to ventricular fibrillation were
included. After the presentation of controlled studies, therapeutic
hypothermia moved into the topical international guidelines.
Available online http://ccforum.com/supplements/12/S2
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Manual CPR LUCAS-CPR P value
Age 64 61 0.40
Ventricle fibrillation (%) 56.5 65.5
Arrival time (min) 7 6 0.27
Bystander CPR (%) 45.2 69.0 0.01
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Methods We investigated efficacy and outcome of mild thera-
peutic hypothermia in the treatment of out-of-hospital cardiac
arrest due to varied etiologies. We compared retrospectively 168
patients admitted in the years 2001–2006 to our medical ICU with
the indication for cooling therapy after cardiac arrest. Eighty-nine
patients received cooling therapy (MHT Group), 79 patients were
not cooled after cardiac arrest (NO-COOL Group). Cooling was
obtained by endovascular cooling device or surface cooling.
Survival in the two groups and factors associated with survival
were analysed.
Results In the MHT Group, survival was significantly higher (53%
versus 47%, P = 0.0012). Age and duration of resuscitation
therapeutic hypothermia were independently associated with
survival. In patients with first registered rhythm of asystole (8/25
(32%) vs 2/13 (15%), P = 0.06), prolonged resuscitation, time
from return to spontaneous circulation >20 minutes and prolonged
time to arrival on scene, cooling therapy was associated with a
significant improvement in neurological outcome.
Conclusions Therapeutic hypothermia improves significantly
survival and neurological outcome of out-of-hospital cardiac arrest
in patients independent of first registered rhythm. Patients with a
prolonged episode of hypoxia and prolonged time to return of
spontaneous circulation profit significantly from treatment with
therapeutic hypothermia.
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Introduction Induced mild hypothermia therapy (MHyT) improves
neurological outcome in postresuscitation cardiac arrest patients
with ventricular fibrillation/tachycardia (VF/VT). Patients with
asystole were excluded from earlier studies due to poor overall
outcome [1,2]. The present study enrolled both patients with
asystole or VT/VF; one of the objectives was to assess neurological
function at ICU discharge.
Methods A prospective multicenter single-arm registry in 49 patients
with witnessed cardiac arrest who were selected for MHyT. Patients
had to be ≥18 years old and unconscious at ICU/emergency room
admission (GCS < 8), with a time interval between cardiac arrest
and initiation of MHyT treatment <6 hours. Informed consent was
obtained from the patient or legal representative. Neurological status
was documented upon emergency room arrival, during MHyT
treatment, at ICU discharge and at hospital discharge as measured
by the Glasgow Outcome Scale (GOS). Temperature measure-
ments were continuously taken throughout the MHyT treatment via
bladder catheter. For the MHyT treatment the Deltatherm® device
(KCI, San Antonio, TX, USA) was used.
Results Of the 49 patients included in the registry 31 (63%) had
VF/VT and 17 (35%) had asystole as first rhythm. In one patient
(2%) the rhythm was unknown. Good neurological recovery at ICU
discharge (GOS 5 and 4) was seen in 22 (45%), three patients
(6%) were neurologically impaired (GOS 3), six patients (12%)
were in a vegetative state (GOS 2) and 16 (33%) of the patients
died. In two patients (4%) the neurologic outcome was unknown.
Good neurological recovery was seen in 48% (n = 15) of patients
with VF/VT and in 41% (n = 7) of patients with asystole.
Conclusions MHyT improves neurological outcome in patients
with witnessed cardiac arrest regardless of the initial rhythm.
Favorable results in VT/VF patients were similar to preceding
studies [1,2]. Hypothermia also appears to provide neurological
protection in patients presenting with asystole.
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Introduction Out-of-hospital cardiac arrest patients have a poor
prognosis. Recent randomised controlled trials have shown that
moderate hypothermia improves neurologic outcome and survival
in selected patients after cardiac arrest [1]. Therapeutic hypo-
thermia is now recommended by the ALS Task Force of the ILCOR
and incorporated in the American and European resuscitation
guidelines for postresuscitation care.
Methods Case notes of all OHCA patients admitted alive to our
ICU in 2006 were retrospectively analysed. All patients received
standard care including adequate sedation and mechanical
ventilation. Mild hypothermia was initiated as soon as possible and
ideally maintained at 32–34°C for 12–24 hours with a combination
of cold saline, cooling blanket and ice packs. Patients were
allowed to passively rewarm. The institution’s ethics committee
approved the study. Discharged survivors were followed up for 6
months, and neurologic outcome was evaluated using the
Glasgow Outcome Score (GOS).
Results Twenty-five patients were admitted following OHCA.
Twenty (80%) fulfilled our cooling criteria. Eight patients had
cooling initiated in A&E whereas nine had cooling initiated in the
ICU and three were not cooled. Five patients were at target
temperature on arrival in A&E. Of the 17 patients who had cooling
initiated in hospital, the target temperature was achieved in only 15
patients. In patients where cooling was initiated in A&E, the median
time to reach the target temperature from hospital admission was
4.25 hours; and when cooling was initiated in the ICU, it was 6.25
hours. A temperature above 37.5°C was noted in 12 (48%)
patients during rewarming. Seven (28%) had a favourable outcome
and were discharged from the hospital with a GCS of 15 and all
had a GOS of 5 at 6 months. Five out of seven survivors were
cooled. The cause of death was hypoxic brain injury in 15 (60%)
and cardiogenic shock in three (12%) patients. All deaths occurred
in hospital following treatment limitation decisions at (median
(range)) 41 (9.5–94) hours.
Conclusions Our mortality rate of 72% was higher than the HACA
study but the same as the Intensive Care National Audit and
Research Centre. All survivors had a good neurologic outcome.
Using this method of cooling we failed to achieve consistent
hypothermia. Preventing rebound hyperthermia was difficult and
many treatment limitation decisions were made before 72 hours.
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Therapeutic hypothermia preserves the brain by reducing
nitric oxide synthase after asphyxial cardiac arrest in rats
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Y Michotte, L Huyghens
UZ Brussels, Belgium
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Introduction Induced therapeutic hypothermia (TH) following
cardiac arrest (CA) is the only strategy that has demonstrated
improvement in outcomes. The mechanism by which TH, when
applied after reperfusion, exerts its cell protective effect during CA
remains unclear. The study aim was to elucidate the mechanisms;
dopamine, glutamate as marker of excitatory amino acid overflow
and also the citrulline/arginine ratio (CAR) as marker of nitric oxide
synthase were measured during reperfusion after asphyxial CA in a
sham operated group of rats, in a normothermic group and in a
hypothermic group. Also the effect of TH on the histological data
obtained from the rat’s brain 24 hours and 7 days post insult were
analyzed.
Methods Anesthetized rats were exposed to 8 minutes of
asphyxiation including 5 minutes of CA. The CA was reversed to
restoration of spontaneous circulation, by brief external heart
massage and ventilation within a period of 2 minutes.
Results After the insult and during reperfusion, the extracellular
concentration of glutamate and dopamine, as determined by
microdialysis in the rat striatum, increased up to 3,000% and
5,000%, respectively, compared with the baseline values in the
normothermic group. However, when TH was induced for a period
of 60 minutes after the insult and restoration of spontaneous
circulation, the glutamate and dopamine concentrations were not
significantly different from that in the sham group. The CAR
increased up to fivefold compared with the basal value in the
normothermic group and only 2.5-fold in the hypothermic group.
However, in the sham operated group this ratio remained low and
stable throughout the experiment. Histological analysis of the brain
showed that TH reduced brain damage, ischemic neurons, as well
as astroglial cell proliferation.
Conclusions TH induced after asphyxial CA mitigates the
excitotoxic process, and diminishes nitric oxide synthase activity
and brain damage as well as astroglial cell proliferation.
P376
Cerebral blood flow and cerebrovascular reactivity during
hypothermia after cardiac arrest
L Bisschops, C Hoedemaekers, K Simons, J van der Hoeven
Radboud University Nijmegen Medical Centre, Nijmegen, The
Netherlands
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Introduction Anoxic neurological injury is a major cause of
morbidity and mortality in cardiac arrest patients. After restoration
of spontaneous circulation, pathophysiological changes in cerebral
perfusion appear, known as postresuscitation syndrome. In the
delayed hypoperfusion phase, the cerebral blood flow is reduced,
resulting in a potential mismatch between cerebral oxygen supply
and demand, and secondary neurological damage. The aim of this
study was to assess cerebral blood flow and cerebrovascular
reactivity to changes in PaCO2 in patients after cardiac arrest
treated with mild hypothermia.
Methods We performed an observational study in 10 adult
comatose patients after out-of-hospital cardiac arrest. All patients
were cooled to 32–34ºC for 24 hours, followed by passive
rewarming. Blood flow velocity in the middle cerebral artery (MCA)
was measured by transcranial doppler. Oxygen saturation in the
jugular bulb (SjbO2) was measured by repeated blood sampling.
Hypocapnia and hypercapnia were induced by a 20% increase
and decrease in minute ventilation during 20 minutes. Data are
expressed as the mean ± SEM. Changes over time were analysed
by ANOVA. The relation between MCA velocity and SjbO2 was
determined by linear regression analysis.
Results We present the results of the first five patients. All patients
were male, with a mean age of 66 ± 5 years. Ventricular fibrillation
was the cause of cardiac arrest in all patients. The mean time from
collapse to return of spontaneous circulation was 25 ± 15 minutes.
At the start of the experiment, mean flow velocity in the MCA was
low (32.2 ± 9.6 cm/s), increasing significantly to 62.5 ± 11.3 cm/s
at 48 hours (P < 0.001). The SjbO2 at the start of the experiment
was 68.2 ± 4.0%, increasing significantly to 79.7 ± 3.8% at
48 hours (P < 0.001). Regression analysis showed that the
change in SjbO2 correlated significantly with the change in PaCO2
(P < 0.001). A 1 kPa decrease in PaCO2 resulted in a 9.5%
decrease in SjbO2. A decrease in PaCO2 also resulted in
decreased flow velocities in the MCA (P = 0.09).
Conclusions During mild hypothermia after cardiac arrest, MFV in
the MCA is low, suggesting active cerebral vasoconstriction.
Cerebrovascular reactivity to changes in PaCO2 is preserved in
comatose cardiac arrest patients during mild hypothermia. Hyper-
ventilation may induce cerebral ischemia in the postresuscitation
period.
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Early therapeutic hypothermia in sudden cardiac death and
following return of spontaneous circulation
A Luzzani, E Polati, G Larosa, F Righetti, G Castelli
Osp Maggiore Borgo Trento, Verona, Italy
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Introduction The aim of this study is to assess the role of
therapeutic hypothermia on neurological outcome in patients who
experienced sudden cardiac death (SCA) with ensuing return of
spontaneous circulation.
Methods Thirty adult patients, aged between 18 and 85 years,
referred to our ICU after SCA due to cardiac disease with
following return of spontaneous circulation were randomly
allocated to the following treatment groups: patients in group 1
were treated immediately after admission with therapeutic
hypothermia plus standard treatment, patients in group 2 received
only standard treatment. All patients at entry presented with GCS
3. Neurological outcome was assessed on discharge and after
6 months, by means of the GOS scale (0 = dead, 1 = vegetative,
2 = severely disabled, 3 = moderately disabled, 4 = good recovery).
We consider scores 0–1 as unfavourable outcome, scores from 2
to 4 as favourable outcome. To compare the two groups we used
the Mann–Whitney U test of for continuous variables, the chi-
square test for qualitative variables.
Results Patients in group 1 (15 patients) and in group 2 (15
patients) were statistically comparable for sex (P = 0.16) and age
(P = 0.77) and presentation ECG rhythm (P = 0.63). Median GOS
values at discharge from the ICU were 2 (interquartile range
25–75% (IR) 1–3) in group 1 and 1 (IR 0–1) in group 2 (P =
0.06). Median GOS values at 6 months were 3 (IR 1–4) in group 1
and 1(IR 1–2) in group 2 (P = 0.09). The patients who improved
their GOS values were 9/15 (60%) in group 1 and 2/15 (13.3%)
in group 2 (P < 0.003).
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Conclusions Our study demonstrated that early treatment with
therapeutic hypothermia in the patient who had SCA improves
neurological outcome.
P378
Effect of therapeutic mild hypothermia initiated by cold
fluids after cardiac arrest on haemostasis as measured by
thrombelastography
A Spiel, A Kliegel, A Janata, T Uray, C Wandaller, F Sterz, 
A Laggner, B Jilma
Medical University of Vienna, Austria
Critical Care 2008, 12(Suppl 2):P378 (doi: 10.1186/cc6599)
Introduction Application of mild hypothermia (32–33°C) has been
shown to improve neurological outcome in patients with cardiac
arrest, and is therefore a class IIa recommendation in the treatment
of those patients. However, hypothermia affects haemostasis, and
even mild hypothermia has been found to be associated with
bleeding and increased transfusion requirements in patients under-
going surgery [1]. On the other hand, crystalloid hemodilution has
been shown to enhance the coagulation onset [2]. Currently, it is
unknown in which way the induction of mild therapeutic
hypothermia by a bolus infusion of cold crystalloids affects the
coagulation system of patients with cardiac arrest.
Methods This was a prospective pilot study in 18 patients with
cardiac arrest and return of spontaneous circulation. Mild
hypothermia was initiated by a bolus infusion of cold 0.9% saline
fluid (4°C; 30 ml/kg/30 min) and maintained for 24 hours. At 0
hours (before hypothermia), 1 hour, 6 hours and 24 hours we
assessed the prothrombin time, activated partial thromboplastin
time (aPPT) and platelet count, and performed thrombelastography
(ROTEM®) after in vitro addition of heparinase. Thrombelasto-
graphy yields information on the cumulative effects of various blood
compounds (for example, coagulation factors, haematocrit,
platelets, leukocytes) involved in the coagulation process.
Results A total amount of 2,527 (± 527) ml of 0.9% saline fluid
was given. Platelet counts dropped by 27% (P < 0.01) after 24
hours. The haematocrit significantly decreased after 1 hour (P <
0.05) due to hemodilution and returned thereafter to baseline
values. The aPTT increased 2.7-fold after 1 hour (P < 0.01), mainly
due to administration of heparins. All ROTEM® parameters did not
significantly change in the time course. None of the patients
developed bleeding complications during the observation period.
Conclusions Despite significant changes in haematocrit, platelet
count and APTT, thrombelastographic parameters were not altered
during the course of mild hypothermia. Therapeutic hypothermia
initiated by cold crystalloid fluids therefore has only minor overall
effects on the coagulation system in patients with cardiac arrest.
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Immunomodulatory effects of esmolol in a septic animal
model due to multidrug-resistant Pseudomonas
aeruginosa pyelonephritis
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Introduction The infusion of esmolol (a hypelective β1-blocker) is
associated with immunomodulatory effects [1].
Methods Eighty white rabbits underwent pyelonephritis (multidrug-
resistant Pseudomonas aeruginosa) induction and classification in
pretreatment (PT) (n = 40) (infusion of esmolol immediately after
pyelonephritis induction) and treatment (T) (n = 40) (initial infusion
of esmolol 2 hours after pyelonephritis induction) group. PT =
group A (n = 10, control, N/S 0.9% infusion), group B (n = 10,
esmolol infusion), group C (n = 10, amikacin infusion) and group D
(n = 10, esmolol and amikacin infusion) and T = groups E, F, G
and H having similar treatment. Serum malondialdehyde (MDA)
was estimated at serial time intervals by the thiobarbiturate assay
followed by HPLC analysis. The animals were under survival follow-
up every 12 hours for the next 21 days. After death, quantitative
organ cultures were performed.
Results Median (IQR) MDA at 24 hours was 1.95 (0.75), 0.78
(1.79), 1.55 (1.60) and 0.12 (0.24) μmol/ml in groups A, B, C and
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D, respectively. Respective values at 48 hours were 2.60 (2.00),
1.40 (2.36), 3.15 (3.00) and 0.25 (0.20) μmol/ml. At 24 hours, the
median (IQR) MDA of groups E, F, G and H were 2.80 (5.74), 0.32
(0.87), 0.61 (5.83) and 0.19 (2.75) μmol/ml, respectively. Tissue
bacterial load was similar within groups. See Figures 1 and 2.
Conclusions In the present septic model, esmolol prolonged
survival probably by exerting an immunomodulatory effect as
assessed by reduced oxidative stress without any effect on tissue
bacterial load.
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Applying the 2003 SCCM/ESICM/ACCP/ATS/SIS instead
of the 1992 ACCP/SCCM sepsis definitions increases the
numbers of patients with systemic inflammatory response
syndrome shock and septic shock but decreases mortality
rates
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Introduction To compare the prevalence of patients suffering from
different stages of systemic inflammatory response syndrome (SIRS)
and sepsis applying the original 1992 ACCP/SCCM and the revised
2003 SCCM/ESICM/ACCP/ATS/SIS sepsis definitions.
Methods Set in a university adult ICU. Patients were
postoperative/post-traumatic critically ill patients admitted to the
ICU from October 2006 to October 2007. No interventions were
used. From October 2006 to October 2007, 714 patients were
surveyed using computer assistance with respect to different
stages of SIRS and sepsis using the 1992 and the 2003 sepsis
definitions, respectively.
Results Within the same patient collective, applying the 2003
definitions instead of the 1992 definitions, the prevalence of no
SIRS (11 vs 110, respectively), no SIRS due to infection (sepsis)
(0 vs 12), SIRS (129 vs 169) and sepsis (18 vs 52) decreased,
and the prevalence of severe SIRS (169 vs 86), SIRS shock (121
vs 65) and septic shock (216 vs 168) increased. Prevalence of
severe sepsis was comparable with both definitions (50 vs 52).
Applying the 2003 definitions in patients with SIRS shock and
septic shock, the mortality rates of 17% and 25% were markedly
lower than those of 23% and 30%, respectively, under the 1992
definitions. Compared with the patients classified to be without
SIRS shock and septic shock, the risk of mortality of those patients
was markedly elevated that were classified to be in SIRS shock or
septic shock with the 2003 definitions but not with the 1992
definitions (odds ratio = 5.0, CI = 2.2–11.2, P < 0.0001).
Conclusions Replacing the original 1992 sepsis definitions with
the 2003 revised sepsis definitions may result in increased
prevalence of severe SIRS, SIRS shock and septic shock.
However, the mortality rates of patients with SIRS shock and
septic shock will be lower.
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Introduction The term systemic inflammatory response syndrome
(SIRS) was introduced in 1992 [1] and has frequently served as a
criterion for enrollment in sepsis trials. In the present study, the
prevalence of SIRS in patients with significant bacterial infections
and in patients with septic shock was assessed.
Methods A cohort of 404 adult patients admitted to the
Department of Infectious Diseases from the emergency room (ER)
for suspected severe infection was studied prospectively. Of the
SIRS variables, white blood cells (WBC) were measured on arrival
while the physiological variables (temperature, heart rate (HR) and
respiratory rate (RR)) were recorded on arrival to the ER and every
4 hours for 24 hours. In another cohort of 36 consecutive adults
with vasopressor-dependent septic shock, the presence of SIRS
criteria during 24 hours around the start of vasopressors was
evaluated.
Results Bacterial infections requiring antibiotic treatment were
diagnosed in 306 patients in the ER cohort. Nonbacterial infection
or noninfection was diagnosed in 82 patients. In 16 patients, no
diagnosis could be verified. Significant bacteremia was detected in
68 patients; the most common pathogens were pneumococci and
Escherichia coli. Of the 306 patients with a verified bacterial
infection and of the 68 with verified bacteremia, 26% and 21%,
respectively, failed to meet two or more of the SIRS criteria on
arrival in the ER. SIRS on arrival correlated significantly with
bacterial infection, but not with bacteremia. Only RR and WBC
contributed significantly to this finding, HR and temperature did not.
In the septic shock group, all patients eventually fulfilled the HR
and RR criteria but only 23/36 (64%) reached the temperature
criterion and 25/36 (69%) the WBC criterion during 24 hours.
Conclusions SIRS correlated with a subsequently verified
bacterial infection requiring antibiotic treatment, but only the RR
and WBC criteria contributed to this finding. As a tool for defining
sepsis and selecting patients for enrollment in clinical sepsis trials,
SIRS is nonspecific, and for ≥3 fulfilled criteria it lacks sensitivity. It
may be time to abandon the SIRS criteria in selecting patients for
sepsis trials and instead focus on more strict definitions of
underlying infections in association with sepsis-related
hypoperfusion and organ dysfunction.
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Introduction Several randomized prospective studies showed some
beneficial protective effects of exogenous human purified C1-
esterase inhibitor (C1INH) in patients with sepsis [1,2]. Our purpose
was to evaluate influence of systemic inflammation on the pharmaco-
kinetic–pharmacodynamic of C1INH in patients with sepsis.
Methods C1INH (Bicizar®; BioGenius LLC, Russia) was
administered at the total dosage of 12,000 U in 48 hours (scheme
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of infusion: 6,000 U, 3,000 U, 2,000 U, 1,000 U every 12 hours) to
13 patients meeting ACCP/SCCM sepsis criteria during the first 24
hours after hospitalization. C1INH activity and C3, C4, IL-6 and
procalcitonin levels were measured at baseline, 5 minutes, 30
minutes, 1 hour, 2 hours, 4 hours, 6 hours, 8 hours and 10 hours
after C1INH intravenous infusion. The ratio of Cinitial to Cmax 0–10 hours
reflected changes in C1INH activity after 6,000 U infusion. AUC
0–10 hours was calculated after correction of the C1INH
activity–time curve to baseline.
Results The median C1INH maximal shift after the first infusion was
55% (38–75%), as reflected by Cinitial/Cmax 0–10 hours. The calculated
AUC 0–10 hours was 8.8 U-hours/ml (4.6–14.5 U-hours/ml). In
patients with lower Cinitial 1.69 U/ml (0.96–2.65 U/ml), levels of C3
(r = 0.69, P < 0.01) and C4 (r = 0.67, P < 0.05) at baseline were
likely to be decreased. A direct correlation between C3 level and
Cinitial/Cmax 0–10 hours (r = 0.49, P < 0.05) as well as inverse
correlation with AUC 0–10 hours (r = –0.613, P < 0.05) were
found. The significant correlation of Cinitial/Cmax 0–10 hours with the
baseline procalcitonin was also observed (r = 0.57, P < 0.05).
Conclusions The shift in C1INH activity after 6,000 U infusion of
purified protein was likely to be connected with baseline
compliment activity in sepsis. Initial C3 and C4 depletion was
associated with increased C1INH activity. The pharmacokinetic–
pharmacodynamic profile of human purified C1INH might also be
influenced by the severity of systemic inflammatory response.
These factors could have some implication in the dosage-
adjustment strategy.
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Introduction Nitrite (NO2–) is reduced to nitric oxide (NO) by
deoxyhemoglobin, and resynthesized in blood by oxidation of NO in
the presence of ceruloplasmin. The central circulation seems a
probable site for nitrite consumption and repletion during periods
of oxidative stress and recovery such as that seen in hemorrhagic
shock and resuscitation (HSR). We asked whether NO2– is
consumed in the central circulation during hemorrhage, and
reconstituted during resuscitation.
Methods Male Sprague–Dawley rats (n = 13) were anesthetized,
ventilated via tracheostomy, and then underwent HSR by
withdrawing venous blood to a target systolic pressure of 40% of
baseline, waiting 30 minutes and then resuscitating with saline to
prebleed mean arterial pressure. Whole blood NO2– (arteriovenous
NO2–) and exhaled NO (NOexh) (measured by chemilumi-
nescence), blood gases and hemodynamics were sampled at
baseline, at the end of hemorrhage, after 20 minutes auto-
resuscitation, and after saline resuscitation. Mass flow of NO2–
(mass NO2–) across the central circulation was calculated as the
product of arteriovenous difference and blood flow.
Results Figure 1 shows changes (± SEM) in hemodynamics,
arterial and venous whole blood nitrite, and NOexh during HSR.
Mass flow of NO2– decreased acutely with hemorrhage and NOexh
increased, suggesting consumption of NO2– to NO across the
central circulation. Conversely, during autoresuscitation, mass flow
increased and NOexh decreased – suggesting production of NO2–.
Conclusions Our findings are consistent with the hypothesis that
NO2– consumption to NO is involved in the hemodynamic
response to HSR. We also provide evidence that the lung is a
major site of repletion of the NO2– pool, presumably by oxidation of
NO to NO2– during both autoresuscitation and saline resuscitation.
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Introduction Ischemic postconditioning has been shown to
protect several organs (heart, brain, liver) from prolonged ischemia-
reperfusion-induced damages. However, an eventual protecting
effect of postconditioning after gut ischemia-reperfusion remains to
be demonstrated. In this study, we evaluated an ischemic
postconditioning protocol on a rat model of gut ischemia
reperfusion.
Methods Wistar male rats (300 g) were randomized in three
groups of eight rats: control (C), gut ischemia-reperfusion (IR) and
gut IR plus postconditioning (IR-postC) groups. A laparotomy was
performed under ketamine anesthesia for all rats. Then, the
superior mesenteric artery (SMA) was occluded during 60 minutes
and then reperfused during 60 minutes in both the IR and IR-postC
groups. Postconditioning consisted of a succession of three
ischemia (30 seconds) and reperfusion (120 seconds) periods. At
the end of reperfusion, mesenteric and systemic bloods were
sampled for lactate measurement. Lactate levels were compared
using a Student test.
Results All animals survived the duration of study. Gut IR provided
a significant increase in mesenteric lactate (LacM), 3.9 versus 1.34
mmol/l (P < 0.0001), and in systemic lactate (LacS), 4.2 versus
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0.9 mmol/l (P = 0.007). There was no significant difference in
terms of lactate between the IR and IR-postC groups: LacM: 3.4
mmol/l (P = 0.35); LacS: 3.4 mmol/l (P = 0.66). See Figure 1.
Conclusions This protocol of postconditioning was not efficient in
terms of hyperlactatemia reduction in our rat model of gut IR.
Further studies will be needed to determine whether post-
conditioning might be a therapeutic alternative in cases of gut
ischemia-reperfusion.
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1α in cultured human hepatocytes and monocytes: impact
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Introduction Hypoxia-inducible factor 1α (HIF1α) is a
transcriptional factor activated by hypoxia. HIF1α coordinates cell
adaptation to hypoxia and modulates cellular metabolism and
respiration. Recent data suggest that HIF1α may also be activated
via proinflammatory mediators and Toll-like receptors under
normoxic conditions. The aim of this study was to evaluate whether
lipopolysaccharide (LPS) could increase HIF1α expression in a
time-dependent and dose-dependent manner in cultured human
hepatocytes and monocytes, and to determine a possible role in
the modulation of cellular respiration.
Methods Cultured human hepatocytes (HepG2) and monocytes
(MM6) were exposed to cobalt chloride, hypoxia (1.5% oxygen)
and different concentrations of LPS. The time-course expression of
HIF1α was determined by western blotting. Mitochondrial
respiration was assessed after cell permeabilization with a protocol
of stimulation-inhibition of each mitochondrial complex using the
Oxygraph 2K (Oroboros Instruments, Innsbruck, Austria) and
Datlab 4.2 software for data acquisition.
Results Hypoxia, cobalt chloride and LPS induced accumulation of
HIF1α in both cell lines in comparison with controls. In monocytes,
HIF1α was detected after 4 hours of normoxic LPS incubation at a
concentration of 1 mg/ml. In cultured hepatocytes, HIF1α was
detected after 2 hours of normoxic LPS incubation at a
concentration of 1 mg/ml. Cellular respiration of permeabilized
cultured hepatocytes was not affected after 6 hours (complex I and
II respiratory control ratio (RCR)-dependent respiration: controls:
1.7 ± 0.4 vs LPS: 2.2 ± 0.4 and controls: 2.4 ± 1 vs LPS: 3.4 ±
0.5, respectively, P > 0.05, n = 5) or after 24 hours (complex I and
II RCR-dependent respiration: controls: 2 ± 0.4 vs LPS: 1.9 ± 0.5
and controls: 3.9 ± 1.7 vs LPS: 4.5 ± 2.6, respectively, P > 0.05,
n = 6) of normoxic LPS 1 mg/ml incubation (P > 0.05 for both).
Conclusions LPS induces the expression of HIF1α in human
monocytes and hepatocytes under normoxic conditions. Exposing
hepatocytes to LPS (1 mg/ml) for 6 and 24 hours does not impair
their cellular respiration.
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Introduction Nonhypoxic stimuli can induce the expression of
hypoxia-inducible factor 1α (HIF1α). Only recently has it been
demonstrated that lipopolysaccharide (LPS) induces the
expression of HIF1α in macrophages and that the induction of
hypoxic genes in macrophages is also Toll-like receptor 4 (TLR4)-
dependent. We hypothesized that HIF1α expression is induced in
dendritic cells in a TLR-dependent manner, plays a crucial role in
linking the innate with the adaptive immune system and may also
influence mitochondrial respiration.
Methods Human monocyte-derived immature dendritic cells (iDC)
were stimulated with different TLR ligands (hyaluronic acid (HA),
LPS or lipoteichoic acid) under normoxia. Furthermore, iDC were
incubated under hypoxic conditions (1.5% oxygen) at the same
time points with or without additional stimulation with LPS. HIF1α
expression was examined by western blot at 2 hours, 4 hours, 6
hours, 8 hours, 12 hours and 24 hours after TLR stimulation. In
parallel, the cells were analyzed for the expression of the
costimulatory molecules and maturation markers CD80 and CD86
by flow cytometry (FACScan; B&D). Finally, iDC were incubated in
the presence or absence of 1mg/ml LPS, and mitochondrial
respiration of digitonin-permeabilized iDC was determined using
the Oxygraph 2K (Oroboros Instruments, Innsbruck, Austria) and
DatLab 4.2 software for data acquisition and analysis.
Results All tested TLR ligands stimulated the expression of HIF1α
in a time-dependent manner. Interestingly, TLR induced HIF1α
expression levels in normoxia were even higher than in hypoxia.
Hyaluronic acid, LPS and lipoteichoic acid led to dendritic cell
maturation, as shown by CD80 and CD86 induction. LPS also
increased complex II-dependent mitochondrial respiration of iDC
(complex II respiratory control ratio: 1.5 ± 0.5 for controls vs 3.8 ±
1.2 for LPS, P < 0.05; n = 3).
Conclusions The current data demonstrate that HIF1α expression
in dendritic cells is induced under normoxic conditions via TLR2
and TLR4 agonists in a time-dependent manner. LPS also
increases complex II-dependent mitochondrial respiration of
dendritic cells.
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Introduction Undisturbed generation of ATP, produced through
NADH dehydrogenase in the respiratory chain, is required for the
homeostasis of aerobic metabolism. In the case of a failing heart,
excess production of reactive oxygen species (ROS) can cause an
oxidative modification of mtDNA, such as 8-oxo-dGTP, which can
lead to defects in DNA replication. On the other hand, free radical
scavengers, such as polyethyleneglycole catalase (PEG-CAT), have
been considered with improvement of defection in DNA replication
through hydrolyzing 8-oxo-dG by the human functional homologue of
the MutT protein (hMTH1 for mutt homologue 1; MTH-1) in the rat
caecal ligation and puncture (CLP) model. However, associations
between oxidative mtDNA damage and ATP production have not
been well isolated clearly in the rat CLP heart injury model.
Methods Sepsis was induced by CLP. Adult male Sprague–
Dawley rats (n = 20) after 4 hours of CLP were administrated with
or without free radical scavengers (H2O2 scavenger: PEG-CAT).
We measured cardiomyocyte generation of MTH-1 by RT-PCR,
NAD/NADH ratio, ATP production and 8-oxo-dG by HPLC with or
without inhibition of ROS by PEG-CAT in the rat CLP heart injury
model.
Available online http://ccforum.com/supplements/12/S2
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Results Both the NAD/NADH ratio and ATP production level of the
PEG-CAT(+) group were significantly increased compared with the
PEG-CAT(–) group (P < 0.05), but these level had not normalized.
The 8-oxo-dG level of the PEG-CAT(–) group were increased
compared with the PEG-CAT(+) group (P < 0.05). The mRNA of
MTH-1 level of PEG-CAT(+) group was significantly higher
compared with the PEG-CAT(–) group (P < 0.05). See Table 1.
Conclusions ATP production of the mitochondria may be inhibited
by mtDNA damage of ROS through the respiratory chain.
Reference
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Introduction Sepsis-induced acute respiratory distress syndrome
is generally accepted to be caused by neutrophil sequestration in
the lung microvasculature with resultant pulmonary endothelial
damage from neutrophilic enzymes and metabolites. Developing
models to study this condition accurately is crucial if therapeutic
goals are to be achieved. Currently, endotoxemia models such as
systemic lipopolysaccharide (LPS) injection predominate in the
study of this condition due to the poor reproducibility of septic
models such as cecal ligation and perforation (CLP).
Methods A method of CLP designed to inhibit proper abscess
formation was compared against intraperitoneal injection of 0.5 mg/kg
LPS using C57B/6 mice at various time points up to 24 hours.
Outcomes included circulating leukocyte counts, lung myeloperoxi-
dase levels, and a multitude of cytokines and chemokines using
Luminex technology. Septic human plasma from patients in the ICU
was also analyzed for comparison using Luminex technology.
Results LPS-treated mice consistently demonstrated earlier and
greater peak MPO, TNFα, IL-1α, IL-5, IL-6, IL-10, MIP-1α, MCP-1, and
Rantes levels that were shorter lasting in duration when compared with
our CLP model, which consistently demonstrated steadily increasing
levels over time. Interestingly, IL-17 levels were observed to peak at
424.3 ± 7.0 pg/ml in our CLP model but only reached a level of 31.7 ±
17.8 pg/ml in the LPS model, which was comparable with the control
value. Our CLP model demonstrated multiple comparable trends in
cytokine and chemokine levels with the septic human plasma data
taking into account the differences in time-point collection. The most
apparent trend was the highest and consistently elevated IL-6 levels
found to be 11,528.7 ± 955.3 pg/ml in septic C57B/6 mice and
11,718.7 ± 4511.0 pg/ml in septic human patients.
Conclusions Systemic LPS effects are very robust and short-lived;
therefore, this model is not as relevant as CLP with respect to
human sepsis. Furthermore, septic effects such as those seen with
IL-17 are not observed in LPS models. Here, we demonstrate that
CLP with abscess impairment can be highly reproducible and
comparable with human data.
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Introduction Pharmacological and biological actions of the
gaseous biological mediator hydrogen sulfide include vasodila-
tation, cytoprotection, inhibition of mitochondrial respiration as well
as induction of a state akin to suspended animation.
Methods Rodent models of ischemia and reperfusion of the heart
and the liver were employed, as well as a model of acute respiratory
distress syndrome. A dog model of cardiopulmonary bypass, an
ovine model of acute respiratory distress syndrome induced by burn
and smoke inhalation as well as a pig model of myocardial infarction
were used. Hydrogen sulfide was administered to the animals in a
stable, iso-osmolar, pH-neutral intravenous injectable formulation
(IK-1001; sodium sulfide for injection).
Results In a rat study of myocardial infarction, a significant
protection was seen in terms of reduction of myocardial infarct
size. In a mouse model of myocardial infarction, IK-1001 reduced
infarct size, reduced neutrophil infiltration, attenuated the inflam-
matory response, and improved contractility. The cardiac
protection was also confirmed in large animal models: in a porcine
model of myocardial ischemia, reduction of infarct size and
improvement of cardiac contractility was seen. Improvement of
cardiac contractility and preservation of endothelium-dependent
relaxant responses were seen in a dog cardiopulmonary bypass
model. Protection was also seen in a mouse model of liver
ischemia-reperfusion injury. The protective effect of IK-1001 was
also demonstrated in a mouse and in a sheep model of acute
respiratory distress syndrome, evidenced by improved survival rate,
and downregulation of the inflammatory response.
Conclusions The current presentation overviews some of the recent
data demonstrating the organ protective effects of hydrogen sulfide.
The mechanism of protection probably involves multiple effects
including metabolic effects, antioxidant mechanisms, activation of
KATP channels, as well as inhibition of inflammatory cell activation.
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Introduction Sepsis and systemic inflammatory response
syndrome have been assumed to disturb wound healing. However,
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Effects of PEG-CAT on myocarditis
Control CLP/PEG-CAT(+) CLP/PEG-CAT(–) 
group group group
NAD/NADH 148.1 ± 0.48 128.5 ± 1.05 90.2 ± 1.03
ATP 2,560 ± 2.3 1,960 ± 2.2 1,127 ± 1.8
8-oxo-dG 1.06 ± 0.83 1.07 ± 0.62 1.71 ± 0.20
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the effect of sepsis in maintaining epithelial barriers and in the
restoration of barrier function is only partly understood [1]. To date
there are no controlled human studies looking at wound healing in
severe sepsis.
Methods Suction blisters were induced on 35 patients with severe
sepsis and 15 healthy controls [2]. The first set of suction blisters
were made within 48 hours of the first organ failure and the second
set on the fourth day of the study. The healing of the suction
blisters were studied by measuring transepidermal water loss
(TEWL) and blood flow with a Laser-Doppler flowmeter (BF).
These measurements were also made on the intact skin.
Results The average age in the whole study population was 62
years (SD 12). Fifty-four percent of (n = 19) patients were surgical,
and an intra-abdominal focus of infection was the most common in
these patients. In medical patients the most common focus of
infection was lungs. The mean APACHE II score on admission was
25. In the surgical group 68% and in the medical group 63%
developed MOF (P = not significant). The healing of the blister
wound was not affected during the first 4 days of the study. After
the first set of blisters, septic patients had significantly higher BF
compared with controls. However, on the eighth day of the study
the SOFA scores correlated positively with TEWL and negatively
with BF (Figures 1 and 2).
Conclusions The epidermal barrier function remains intact for the
first 4 days of severe sepsis but subsequently, following increasing
organ dysfunction, leads to impaired barrier function and
decreasing BF.
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Introduction In this study the effect of the endotoxin dose on
production of an F2-isoprostane, 8-iso-PGF2α, a free radical-
mediated lipid peroxidation product, and 15-keto-dihydro-PGF2α, a
major metabolite of PGF2α and cyclooxygenase (COX)-mediated
inflammatory response, was investigated. Oxidative injury and
COX-mediated inflammation play a central role in the manifestation
of endotoxaemic shock. These eicosanoids are therefore markers
of key processes in the pathophysiology of endotoxaemic shock.
However, their relationship to the endotoxin dose has not been
established.
Methods Twenty pigs were anesthetised and given endotoxin at
logarithmically increasing doses (0.063–16 μg/kg/hour). Three
nonendotoxaemic pigs served as controls. 8-Iso-PGF2α and 15-keto-
dihydro-PGF2α were measured in plasma at baseline and hourly for 6
hours. The dose–response to increasing doses of endotoxin was
determined using the two-sided Jonckheere–Terpstra test.
Results Endotoxin induced the formation of both 8-iso-PGF2α and
15-keto-dihydro-PGF2α. Increases in the endotoxin dose induced
significant log-linear responses in 8-iso-PGF2α and 15-keto-
dihydro-PGF2α (P < 0.001, P < 0.05, respectively) as depicted in
Figure 1.
Conclusions Our findings indicate that free radical-mediated lipid
peroxidation and COX-mediated inflammatory response are
dependent on the endotoxin dose in a log-linear fashion in this
model.
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Figure 1 (abstract P390)
Correlation between TEWL and SOFA scores on the eighth day of study.
Figure 2 (abstract P390)
Correlation between BF and SOFA scores on the eighth day of study.
Figure 1 (abstract P391)
Relative changes in 8-iso-PGF2α and 15-keto-DH-PGF2α (values are
mean ± SEM).
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Nitric oxide synthase 2-derived NO in endotoxemia is not
sufficient to cause hemodynamic effects
P Brouckaert, J Bultinck, E Rogge, A Cauwels
Ghent University/VIB, Gent, Belgium
Critical Care 2008, 12(Suppl 2):P392 (doi: 10.1186/cc6613)
Introduction Inducible nitric oxide synthase (NOS2)-derived NO is
considered a central mediator of the cardiovascular collapse in
endotoxemia and sepsis. Nevertheless, NOS2 mice display
enhanced morbidity and mortality after administration of endotoxin
or TNF. This is probably due to the documented indispensable
antioxidant and anti-inflammatory properties of NO [1,2].
Methods We used TLR4–/– mice (natural mutants and induced
mutants) and control mice, lipopolysaccharide (LPS) from Sigma
and Invivogen, measured NOx using Griess reagents, followed the
blood pressure using tail cuff techniques, performed immunohisto-
chemistry and monitored lethality and body temperature.
Results We observed in TLR4–/– mice resistant to the inflam-
matory and lethal effects of endotoxin that various LPS
preparations obtained from Sigma – but not Invivogen – were able
to induce as much NOS2 and NOx as control mice but without
resulting in hemodynamic effects, measured as changes in blood
pressure. This is dependent on non-LPS bacterial products in this
preparation. These contaminants do not induce cytokine
production nor cause suffering. Further immunohistochemical
investigations showed that NOS2 was induced in a similar way in
TLR4–/– mice as previously described in wildtype mice [3], namely
predominantly in the liver and gut. In addition, dose–response
experiments showed that the amount of NOx produced in wildtype
mice was similar after low doses of LPS to that after lethal doses of
LPS.
Conclusions We conclude that NOS2-derived NO is not sufficient
to cause hemodynamic effects and that the cardiovascular
collapse is dependent on an extra stimulus.
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Introduction The role of gap junctional intercellular communication
between endothelial cells and vascular smooth muscle cells during
the inflammatory process is not well understood. In particular, the
role of vascular connexins (gap junction proteins) in regulating
blood flow in response to inflammatory agents such as lipo-
polysaccharide (LPS) has not been fully investigated. We have
previously demonstrated that the endothelium modulates the LPS
response in microvessels via an unknown mechanism. Our
hypothesis is that LPS modulation of agonist-mediated vaso-
constriction is dependent on the presence of connexin 40 (Cx40)
within the microvessel wall.
Methods Wildtype (WT) and Cx40 knockout (Cx40–/–) animals
were treated with LPS (15 mg/kg intraperitoneally) or saline for 18
hours. Small mesenteric resistance arteries (190–220 μm) were
isolated, mounted on glass cannulae, pressurized at 60 mmHg
with no lumen flow and placed on the stage of an inverted
microscope. The external arteriolar diameter was measured and
concentration–response curves to phenylephrine (PE, 10–9 to 10–4 M)
and to extracellular Ca2+ (0–2 mM) under depolarizing conditions
(120 mM K+) were conducted. The half-maximal effect (EC50) was
determined for each dose–response curve.
Results LPS treatment resulted in hyporesponsiveness to PE in
WT mice (EC50 2.07 ± 0.45 mM vs 0.56 ± 0.15 mM in shams) but
resulted in hyperresponsiveness in Cx40–/– mice (EC50 0.27 ±
0.03 mM vs 3.15 ± 1.50 mM in shams). However, LPS treatment
resulted in hyporesponsiveness to Ca2+ in both WT mice (EC50
0.39 ± 0.03 mM vs 0.23 ± 0.01 mM in shams) and Cx40–/– mice
(EC50 0.75 ± 0.24 mM vs 0.23 ± 0.03 mM in shams).
Conclusions We conclude that agonist-mediated but not Ca2+-
mediated vasoconstriction is modulated by the presence of Cx40.
This suggests an important role for intercellular communication
during LPS-mediated inflammation.
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Introduction Recent animal studies have demonstrated that
pretreatment with inhaled carbon monoxide (iCO) may exert anti-
inflammatory effects in various models of septic tissue injury. In all
of these injury models, iCO was administered before the develop-
ment of injury, and there is no information about whether iCO might
act therapeutically (after the disease process has started) to treat
established injury. We therefore investigated for the first time the
potential beneficial effects of iCO in a porcine sepsis model and
the administration of CO after the onset of septic damage because
this model is close to clinical reality.
Methods Five groups of six pigs each (30 pigs), under anaesthesia
and mechanical ventilation, were studied. In 24 pigs (four groups),
a sepsis model and acute lung injury was created by continuous
(20 μg/kg/hour) intravenous infusion of lipopolysaccharide (LPS)
for 6 hours. After 2.5 hours of LPS infusion, other groups with six
pigs in each either received LPS infusion, received 250 ppm iCO
for 3.5 hours continuously, received 3 mg/kg hydrocortisone bolus
(steroid), or received both steroid and iCO. For comparison,
another healthy control group was studied under anaesthesia and
mechanical ventilation. Measurements of haemodynamics, blood
gases, respiratory mechanics and biochemistry of organ function
(liver, kidney, myocardial) were made intermittently during time
course of the experiment. At the end of the 6-hour period, the
animals were killed and lung tissue was taken for quantitative
histological evaluation (inflammatory cells, edema, haemorrhage)
and inflammatory markers (glucocorticoid receptors, TNFα, NF-κB,
activator protein 1).
Results LPS administration induced a dramatic inflammatory injury
in lungs, a marked expression in TNFα, NF-κB, activator protein 1,
downregulation of glucocorticoid receptors, acute lung injury with
pulmonary hypertension and severe deterioration on organ
function, respiratory mechanics, and oxygenation. Treatment with
steroid and to greater extent with iCO significantly improved the
microscopic appearance of the lung while it had no effect on
inflammatory markers. In terms of haemodynamics, iCO
significantly decreased pulmonary hypertension induced by LPS,
without an obvious protective effect on organ function and
respiratory mechanics.
Conclusions The major findings in the current study are that iCO
administered after LPS infusion significantly decreased pulmonary
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hypertension, and attenuated the histological appearance of the
lung damage, without an obvious protective effect on organ
function and respiratory mechanics.
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Introduction Sepsis induces a hypermetabolic state and impairs
energy metabolism. In this preliminary small animal study, we used
recently developed metabolomics technology to test the hypo-
thesis that metabolic shifts in glucose and amino acid metabolism
in the heart and liver occur during the onset of endotoxemia.
Methods Sepsis was modeled in C57BL/6 mice via administration
of lipopolysaccharide (LPS) (intraperitoneally, 40 mg/kg). Five hours
post LPS, the left lobe of the liver and the heart were harvested.
High-throughput capillary electrophoresis–mass spectrometry was
used to identify and quantify metabolite levels based on their unique
mass/charge ratio. The advantage of this metabolomics approach is
that over 1,000 charged species can be detected in a single
sample, generating a unique metabolic profile or readout.
Results Figure 1 shows relative changes in glucose and glycolytic
metabolites, Kreb’s cycle intermediates, NADH, ATP and amino
acids between 5-hour LPS (n = 2) and control mice (n = 2).
Metabolomic analysis suggested that endotoxemia caused an early
increase in glucose metabolism in the heart, but a decrease in the
liver. NADH levels increased in the liver, but not the heart, while
ATP levels decreased in both the liver and the heart. Amino acid
levels increased in the liver, with the exception of alanine and
glycine, but were more variable in the heart.
Conclusions Five hours after LPS administration, we found
differential glucose and amino acid metabolism in the heart and
liver, indicating that profound shifts in metabolism occurred during
the onset of endotoxemia.
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Introduction The optimal mean arterial blood pressure (MAP) for
sepsis resuscitation remains unclear. Growing evidence suggests that
mitochondrial dysfunction plays a role in the pathogenesis of sepsis-
induced organ failures. The aim of this study was to evaluate the effect
of progressively increasing levels of MAP, achieved by the use of
noradrenaline (NA) on liver mitochondrial function during sepsis.
Methods Thirteen anesthetized pigs received endotoxin
(Escherichia coli LPS B0111:B4, 0.4 μg/kg/hour until the mean
pulmonary arterial pressure reached 35 mmHg) and were
subsequently randomized to placebo or NA administration for 10
hours. The NA dose was adjusted every 2 hours to achieve 15
mmHg increases in MAP up to 95 mmHg. Systemic (thermodilution)
and hepatosplanchnic blood flow (ultrasound Doppler) were
measured at each step. At the end of the experiment, hepatic
mitochondrial oxygen consumption (high-resolution respirometry)
and citrate synthase activity (spectrophotometrically) were assessed,
using the Oxygraph 2K (Oroboros Instruments, Innsbruck, Austria)
and DatLab 4.2 software for data acquisition and analysis.
Results The MAP, cardiac output and systemic DO2 increased in
the NA group to 95 ± 7 mmHg (controls: 64 ± 3 mmHg), 8.7 ±
3.1 l/min (controls: 5.7 ± 1.4 l/min), and 33 ± 8 ml/min/kg
(controls: 17.6 ± 3.4 ml/min/kg; all P < 0.05). Systemic and
hepatosplanchnic VO2 were not different between groups. Hepatic
lactate uptake decreased significantly in both groups, but without
differences between the groups. At the end of the experiment, liver
mitochondrial function in the NA group exhibited a significant
improvement in terms of maximal complex I-dependent mito-
chondrial respiration (from 329 ± 83 to 587 ± 195 pmol/s/mg),
and of respiratory control ratio for complex I (from 3.8 ± 1.3 to
5.7 ± 0.5) and complex II (from 3.2 ± 0.5 to 3.9 ± 0.6; all P < 0.05).
There were no differences in citrate synthase activity between the
groups (13.9 ± 3 vs 16.8 ± 4 μmol/min/mg).
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Figure 1 (abstract P395)
Metabolic profiles for glucose (left) and amino acid (right) metabolism.
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Conclusions The use of NA to increase the MAP during
endotoxemic shock was associated with an improvement in
hepatic mitochondrial respiration, but was not associated with
higher levels of hepatic oxygen consumption or improved hepatic
lactate clearance.
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Introduction Catheter-related septic shock is an increasingly
common entity in the ICU. Current recommendations for early line
removal and rapid administration of appropriate antibiotics are
largely based upon expert opinion. No study of line-related septic
shock has been reported.
Methods A retrospective review of 5,715 cases of septic shock
from 24 adult ICUs revealed 217 cases thought to be catheter
related. Time from onset of hypotension to both appropriate
antibiotic therapy and line removal were assessed, and mortality
differences observed.
Results The most commonly recovered organisms were
Staphylococcus aureus, Candida albicans, and Klebsiella sp.
Overall, 31% of infections were Gram-negative, 31% were Gram-
positive, and 34% were fungal. Survival to hospital discharge was
51.6%, and the average hospital stay was 26.09 days. The
average APACHE II score was 26.12 (SD ±7.6). Survival among
patients who received initiation of antibiotics within 0–3 hours of
hypotension was 82.4%, but declined to 62.9% from 3 to 6 hours
and then to 55.9% from 6 to 12 hours. Survival among patients
given antibiotics from 12 to 24 hours and then >24 hours was
48% and 13%, respectively. Discontinuation of the infected central
venous catheter before 6 hours after the onset of hypotension
resulted in a survival of 90%. However, survival was 79% if
catheter removal occurred from 6 to 12 hours, 63% from 12 to 24
hours, and 21% if removal happened at any time after 24 hours.
Multivariate analysis demonstrated that delays from onset of
hypotension to both appropriate antimicrobials and line removal
exerted independent adverse effects on survival.
Conclusions This study clearly demonstrates the mortality benefit
of both early appropriate antibiotics and rapid line removal in
catheter-related septic shock.
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Introduction Guidelines for early goal-directed therapy (EGDT) in
sepsis include target values of mean arterial pressure (MAP) ≥65
mmHg, central venous pressure (CVP) ≥8 mmHg, and central
venous oxygen saturation (ScvO2) ≥70%. It is unclear whether a
similar goal-directed approach is applicable to general ICU patients.
Methods Prospectively collected data were analyzed in order to
determine whether there are differences in hemodynamics and in
clinical decision-making in patients in whom these target values
had been met versus those in whom they had not. One hundred
and twelve critically ill patients in whom a PiCCO catheter was
inserted were assigned into one of two groups: Group A (n = 54) –
all EGDT goals were present; Group B (n = 58) – either MAP,
CVP and/or ScvO2 values were below target.
Results The MAP, CVP and ScvO2 were significantly higher in
Group A as well as the cardiac index (4.2 ± 1.4 vs 3.5 ± 1.3
l/min/m2, P < 0.0031). Lactate, pH, heart rate, systemic vascular
resistance, global end-diastolic volume, extravascular lung water,
PO2/FiO2, hemoglobin, and the number of patients with lactate >4
mmol/l (12 in group A and nine in B) were not different between
the two groups. There was no difference between the therapeutic
decisions that were made for Group A and Group B, respectively:
fluid loading – 31 versus 30; blood – 3 versus 10; inotropic agents –
12 versus 15; vasoconstrictor – 19 versus 15; diuretic – 9 versus
11; dialysis/ filtration – 7 versus 10. ScvO2 was ≥70% in 76% of
the patients with lactate >4 (n = 21) and in 66% of the patients
with lactate <4 (n = 89). No correlation was found between lactate
levels and ScvO2 or between cardiac index and ScvO2.
Conclusions Patients in which all EGDT goals were present had a
similar incidence of hyperlactatemia and a similar need for
hemodynamic interventions as the ones in which these goals were
not met. This suggests that hemodynamic management of critically
ill patients in the ICU not be based solely on the parameters and
goals that are recommended by the sepsis guidelines.
P399
Outcome and mortality risk factors of patients presenting
to the ICU with severe sepsis and septic shock
R Bhurayanontachai, B Khwannimit
Prince of Songkla University, Hat Yai, Songkhla, Thailand
Critical Care 2008, 12(Suppl 2):P399 (doi: 10.1186/cc6620)
Introduction This study investigated clinical characteristic,
outcome and risk factors for hospital mortality of patients who were
admitted with severe sepsis and septic shock to the ICU in single
tertiary referral university teaching hospital in Thailand.
Methods A retrospective analysis of prospectively collected data
of patients with an ICU admission between 1 July 2004 and 30
June 2006.
Results A total of 390 patients, with a mean age of 55.5 ± 19
years, were admitted during the study period. Three hundred and
three (77.7%) of these patients had septic shock. The mean
APACHE II score was 26.8 ± 9.4. Overall ICU and hospital
mortality rates were 39.2% and 49.7%, respectively. Comorbid
diseases were found in 157 patients (40.3%), the most common
being hemotologic malignancy (15.4%), immunocompromised
(7.4%) and AIDS (4.9%). One hundred and seventy-three patients
(44.4%) had a community-acquired infection. Respiratory tract
infection was the most common site of infection (50%). Positive
blood cultures were found in 106 (27.5%) patients and there were
positive cultures in all 241 (61.8%) patients. The most common
organisms were Klebsiella pneumoniae (19.9%), Escherichia coli
(14.5%) and Pseudomonas species (9.8%). Acute respiratory
distress syndrome (ARDS) had been identified in 80 patients
(20.5%). Septic patients with ARDS had significant higher
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mortality than those patients without ARDS (68.8% vs 31.3%, P <
0.001, respectively). A pulmonary artery catheter was used in 31
(7.9%) patients. In a multivariate analysis, ARDS (OR, 2.59; 95%
CI, 1.29–5.12, P = 0.007), pulmonary artery catheter placement
(OR, 4.12; 95% CI, 1.21–14.08, P = 0.024), comorbid diseases
(OR, 1.85; 95% CI, 1.03–3.33, P = 0.04), hospital-acquired
infection (OR, 2.12; 95% CI, 1.21–3.17, P = 0.009), APACHE II
score (OR, 1.10 per point increase; 95% CI, 1.05–1.16, P <
0.001) and maximum LOD score (OR, 1.34 per point increase;
95% CI, 1.21–1.49, P < 0.001) were independent risk factors for
hospital mortality.
Conclusions This study identifies that outcome for patients with
severe sepsis and septic shock is closely related to ARDS,
pulmonary artery catheter placement, hospital-acquired infection
and high severity score. These groups of patients require special
attention to reduce mortality.
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Introduction Blood cultures are considered the golden standard in
the diagnosis of this disease entity, with fever being the most
common reason for culturing blood. The aim of this study was to
evaluate the relative value of potential indications for performing
blood cultures in ICU patients.
Methods A prospective interventional pilot study. A new validated
and reliable protocol including an extended list of indications for
sampling blood for culture was developed and introduced at the
ICU of a university hospital (July–October 2006). Culturing ‘after
physicians’ request’ was retained as an indication to cover all other
possible signs suggestive for a beginning sepsis that were not
included in the protocol, and to keep it manageable. Educational
sessions for the staff were organized to draw attention to the
indications, and for a procedure to follow when performing blood
cultures. Indications were recorded in an electronic ICU data
management system and linked to the results of the micro-
biological laboratory.
Results During the 4-month period, 444 blood cultures were
sampled from 180 patients (57.8 ± 15.0 years) of which 66.2%
were male. Of these, 79 cultures yielded a microorganism;
however, after correction for contaminants (n = 31), 48 cultures
(10.8%) were considered a true bloodstream infection. Fever was
found the most common reason for culturing (56.8%), followed by
physicians’ request (15.1%), and central venous catheter change
after secondary transfer (10.6%), respectively. Coagulase-negative
staphylococci (n = 12), Escherichia coli (n = 9), and Staphylo-
coccus aureus (n = 8) were isolated most frequently. Of cultures
sampled because of fever, 9.2% led to the diagnosis of true
bacteremia, whereas this number increased up to 35.0% and
25.0% in cases where cultures were sampled because of
hypotension or unexplained altered mental status. When blood was
drawn because of the simultaneous presence of different indica-
tions, in the combinations ‘hypotension and fever’, ‘hypotension
and central venous catheter change’, and ‘hypotension and altered
mental status’, the culture yielded the causative pathogen in 33.3%
(n = 9), 60.0% (n = 5), and 75.0% (n = 4), which was statistically
significant when compared with the other indications (all P < 0.01).
The monocentric setting and the small sample size concerns the
major limitations of this pilot study.
Conclusions Beside fever, other indications suggestive for
systemic infection should be considered for blood culturing in ICU
patients. However, further evaluation is needed to confirm these
preliminary findings.
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Introduction Dopexamine hydrochloride is a synthetic dopaminergic
agent with predominant DA-1 and β-2 agonist properties. Studies
using dopexamine in the perioperative period have yielded conflicting
results. One published systematic review discussed only the effect
of dopexamine on renal and hepatosplanchnic perfusion. Hence, we
conducted a meta-analysis to investigate the effect of dopexamine
on mortality in patients undergoing major abdominal surgery.
Methods Embase (1974–July 2007), Medline (1950–July 2007),
CINAHL, PubMed, and CENTRAL were searched using the MeSH
term ‘Dopexamine’. Four out of the 42 potentially eligible studies
fulfilled the inclusion criteria. A total of 851 patients were included
in these four studies. The data were pooled and entered into
Revman 4.2 for further analysis. A random effects model was used
and the results are reported as relative risks (RR) with 95% CI.
Results Mortality was not significantly different with dopexamine
treatment (RR = 0.61, 95% CI = 0.32–1.18; P = 0.14). Subgroup
analysis involving the studies that used low-dose (≤1 μg/kg/min)
dopexamine failed to show any benefit. See Figure 1.
Available online http://ccforum.com/supplements/12/S2
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Conclusions Dopexamine does not improve mortality in patients
undergoing major abdominal surgery. The benefits of a particular
dose of administration remain uncertain because of the limited
number of studies included in this meta-analysis. Further well-
powered multicentre randomised controlled clinical trials will be
needed to address this.
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Introduction In septic shock, arginine–vasopressin (AVP) infusion
efficiently maintains the mean arterial pressure (MAP), but may
compromise hepatosplanchnic perfusion due to excessive
vasoconstriction and, thus, depress whole-body and regional
substrate metabolism. In this context, the underlying hemodynamic
status is crucial [1]. We therefore compared the effects of
noradrenaline (NA) and AVP on hepatosplanchnic blood flow,
whole body glucose oxidation and hepatic gluconeogenesis during
resuscitated, hyperdynamic septic shock.
Methods After intraperitoneal faeces inoculation [2], anesthetized,
mechanically ventilated and instrumented pigs were randomly
assigned to NA (increments of 0.06 μg/kg/min until maximal heart
rate of 160/min; n = 8) or AVP (1–5 ng/kg/min, supplemented by
NA if the maximum AVP dosage alone failed to maintain MAP; n =
9) to treat sepsis-associated hypotension. During continuous
infusion of stable, nonradioactively labeled 1,2,3,4,5,6-13C6-
glucose, blood isotope (gas chromatography–mass spectrometry)
and expiratory gas 13CO2 (nondispersive infrared spectrometry)
enrichment was measured to derive gluconeogenesis and direct
aerobic glucose oxidation [2] together with portal venous (Qpv)
and hepatic arterial (Qha) blood flows (ultrasound flow probes).
Data are the median (quartiles), and P < 0.05 was regarded as
significant for AVP versus NA.
Results At 24 hours of sepsis AVP resulted in significantly lower
cardiac output and Qpv (20 (11–36) vs 26 (15–35) ml/kg/min),
while Qha was comparable (3.0 (0.1–6.0) vs 2.1 (0.1–5.1)
ml/kg/min). Despite significantly lower NA infusion rates (0.08
(0.0–0.64) vs 0.56 (0.05–4.36) μg/kg/min), AVP did not affect the
parameters of energy expenditure (O2 uptake (5.8 (3.9–8.1) vs 4.7
(4.2–6.6) ml/kg/min), CO2 production (3.4 (2.3–4.9) vs 3.5
(2.9–4.7) ml/kg/min)), nor glucose metabolism (glucose oxidation
3.9 (0.6–4.6) vs 3.7 (0.6–4.6) mg/kg/min; gluconeogenesis 6.8
(4.6–8.5) vs 7.2 (4.9–11.0) mg/kg/min).
Conclusions Given the markedly lower NA infusion rates, the
unchanged parameters of substrate utilization suggest improved
cellular energy metabolism during AVP infusion.
Acknowledgements Supported by Ferring Pharmaceuticals A/S
and the Deutscher Akademischer Austauschdienst.
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Introduction The results of the Vasopressin in Septic Shock Trial
suggest that early administration of vasopressin may be superior to
a last resort treatment. However, it is still unknown whether
vasopressin is superior to terlipressin. We therefore performed a
randomized study to compare the efficacy and safety of continuous
infusions of either vasopressin or terlipressin as first-line therapy in
patients with septic shock.
Methods We enrolled 45 septic shock patients requiring
vasopressor support to maintain mean arterial pressure between 65
and 75 mmHg despite adequate volume resuscitation. Patients were
randomly allocated to be treated either with a continuous terlipressin
infusion (1.3 μg/kg/hour), with vasopressin (0.03 U/min), or with
titrated norepinephrine (control; each n = 15). In both the terlipressin
and vasopressin groups, norepinephrine was additionally
administered to achieve a mean arterial pressure between 65 and 75
mmHg, if necessary. Data from right heart catheterization, a
thermodye dilution catheter, gastric tonometry and organ function
were obtained at baseline and after 12, 24, 36 and 48 hours.
Results No differences were found in terms of cardiac index, mixed-
venous oxygen saturation, gastric mucosal-to-arterial carbon dioxide
partial pressure and the plasma disappearance rate of indocyanine
green. Compared with vasopressin and norepinephrine, terlipressin
infusion allowed a marked reduction in catecholamine requirements
at 48 hours (Table 1) and was associated with significantly less
rebound hypotension as compared with vasopressin. Only one-half
of the patients receiving terlipressin or vasopressin needed renal
replacement therapy as compared with control patients.
Table 1 (abstract P403)
Norepinephrine requirements
Dose at 24 hours Dose at 48 hours 
Group (μg/kg/min) (μg/kg/min)
Terlipressin 0.16 ± 0.3* 0.17 ± 0.4* 
Vasopressin 0.8 ± 1.2 0.8 ± 1.3 
Norepinephrine 1 ± 1.3 1.2 ± 1.4 
Data presented as mean ± SD. *P < 0.05 versus vasopressin and
norepinephrine.
Conclusions Continuous low-dose terlipressin infusion (1.3
μg/kg/hour) represents an efficacious first-line treatment of septic
shock patients. The hypothesis that terlipressin may be superior to
vasopressin in septic shock needs to be confirmed in large-scale
clinical trials.
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Introduction Patients in septic shock (SS) produce inappropriately
low amounts of vasopressin [1]. The purpose of our study was to
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analyze hemodynamic effects of association of exogenous arginine
vasopressin (VP) and low doses of norepinephrine (NE) in critically
ill patients with septic shock.
Methods We included patients in SS receiving NE (>0.2 μg/kg/min),
and patients with high risk for cardiovascular complications were
excluded. VP was given by continuous infusion at a starting dose
between 0.01 and 0.04 U/min during 48 hours. VP was titrated to
maintain mean arterial pressure (MAP) ≥ 70 mmHg. The following
hemodynamic data were recorded at different time points during 2
days: MAP, heart rate, cardiac index (CI) (monitored by Swan–Ganz
catheter), arterial lactate, NE doses and creatinine clearance.
Statistical analysis was performed using SPSS software for
windows version 13 and the Wilcoxon test. P < 0.05 was
considered significant.
Results Seventeen patients were included in this study. Numerical
results are presented as means (Table 1). NE was weaned to
0 μg/min in 47% of cases within 44 ± 25 hours. A significant
increase in platelet amount was found within 48 hours of starting
VP (231 ±28 vs 134 ± 28, P = 0.009). Creatinine clearance
increased at day 3 of therapy (49 ± 7 vs 70 ± 30, P = 0.04).
Modifications of lactates were not significant. Reversible cardiac
ischemia was noted in two cases.
Conclusions These preliminary results showed that VP
administration increases the MAP, decreases the CI, gradually
decreases the NE dose and improves creatinine clearance in
patients with septic shock.
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Introduction Vasopressinergic V1 receptor agonists, such as
arginine vasopressin (AVP) and terlipressin (TP), are increasingly
used to stabilize haemodynamics in catecholamine-refractory
hyperdynamic septic shock [1]. In the current sepsis guidelines,
however, norepinephrine (NE) and dopamine are still recom-
mended as vasopressors of choice [2]. The present study was
designed as a prospective, randomized, controlled laboratory
experiment to elucidate the effects of AVP and TP (when given as
first-line therapy) on mesenteric blood flow (Qma) and mortality in
an established model of ovine septic shock.
Methods Twenty-four ewes were anaesthetized and instrumented
for chronic study. A median laparotomy was performed to place a
flow-probe around the superior mesenteric artery and to take
faeces from the caecum under sterile conditions. After baseline
measurements (BL1) had been performed, the faeces were
injected into the peritoneal cavity. A second set of measurements
(BL2) was taken after the onset of septic shock (defined as mean
arterial pressure (MAP) <60 mmHg). The animals were then
randomly assigned to receive either AVP (0.5 mU/kg/min; n = 8) or
TP (1 μg/kg/hour; n = 8). The control group (n = 8) received only
the vehicle (normal saline). NE was titrated to maintain MAP at 70
± 5 mmHg in all groups.
Results There were no differences between groups at baseline.
Qma and electrolytes were similar between groups. However,
systemic haemodynamics and global oxygen transport were
stabilized more effectively in animals receiving AVP or TP versus
control animals. In addition, continuous TP infusion prolonged
survival as compared with the control and AVP group (P < 0.05).
Conclusions In fulminant ovine septic shock, infusion of AVP or TP
as first-line therapy is safe and efficacious. The notion that low-
dose TP infusion may be superior to NE or AVP therapy needs to
be confirmed in prospective clinical trials.
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Introduction Norepinephrine is favored in the treatment of
hyperdynamic shock after cardiac surgery because of its reliable
effectiveness to achieve an adequate medium arterial pressure. In
some patients, however, norepinephrine may fail to restore blood
pressure. Terlipressin can be used to reverse hypotension in patients
with norepinephrine-resistant shock. We sought to determine the
effects of terlipressin on hemodynamics, perfusion parameters and
renal function in shock patients after cardiac surgery not responsive
to high-dose norepinephrine (>0.5 μ/kg/min).
Methods A prospective open-label study was carried out in 49
patients. The cause of shock was a documented infection in 34
patients, and a suspected one in 15 patients. After volume
resuscitation, patients who needed norepinephrine in a higher
dose than 0.5 μ/kg/min received 1 mg terlipressin in four doses
with a 6-hour interval. The mean arterial pressure, heart rate,
cardiac index, pulmonary artery occlusion pressure, mean
pulmonary artery pressure, systemic vascular resistance index,
pulmonary vascular resistance index, central venous pressure,
lactate, and central venous saturation were measured before
terlipressin, and 2 hours, 6 hours and 24 hours later.
Available online http://ccforum.com/supplements/12/S2
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Changes of hemodynamic parameters after arginine vasopressin
Pre VP VP 4 hours VP 12 hours VP 24 hours VP 48 hours
MAP (mmHg) 64 ± 4 74 ± 8* 74 ± 8* 75 ± 9* 80 ± 9*
HR (beats/min) 106 ± 15 97 ± 27* 98 ± 15* 101 ± 18 98 ± 11*
CI (l/min/m2) 4.1 ± 1,5 4.1 ± 1,5 3.6 ± 1.1 3.7 ± 1.4* –
NE (μg/kg/min) 0.47 ± 0.27 0.3 ± 0.28* 0.30 ± 0.28* 0.29 ± 0.27* 0.22 ± 0.29*
Tropinine (μg/l) 0.09 ± 0.03 – – 0.07 ± 0.02 0.14 ± 0.07
*P < 0.05.
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Results Terlipressin induced a significant increase in mean arterial
pressure (P < 0.001), systemic vascular resistance (P < 0.001)
and pulmonary vascular resistance (P < 0.001), and a significant
decrease in heart rate (P < 0.001) and cardiac index (P < 0.001),
without compromising central venous saturation (P = 0.65). Blood
lactate concentrations significantly decreased over the study
period (P < 0.001). Renal function, assessed by urine flow and
creatinine clearance, was significantly improved (P < 0.001). A
significant reduction in norepinephrine infusion rates was observed
(P < 0.001).
Conclusions In patients with hyperdynamic shock after cardiac
surgery who need high doses of norepinephrine, terlipressin is
effective to restore hemodynamic parameters and to reduce dose
of vasoactive drugs, with no compromise in organic perfusion.
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Introduction Platelet-activating factor (PAF) is a phospholipid
autacoid inducing peripheral vasodilation and vascular leak, both
pathophysiological hallmarks of sepsis-induced cardiovascular
dysfunction resulting in hypotension [1]. Indeed, PAF has been
implicated in various animal models of sepsis and in septic humans
[2]. A deficiency in the vasopressor hormone arginine vasopressin
(AVP), a mixed V1a/V2 receptor agonist, also contributes to the
cardiovascular dysfunction of septic shock, leading to clinical use
of AVP for this condition [3,4]. These various findings led us to
hypothesize that the selective V1a receptor agonist FE 202158
would be effective in a rat model of PAF-induced hypotension.
Methods Male Wistar rats were anesthetized with thiobutabarbital,
surgically instrumented, and put on assisted ventilation. After
obtaining baseline data, the mean arterial pressure (MAP) was
reduced to 40 mmHg by titration of an intravenous infusion of PAF.
Once this level of hypotension was reached, test animals were
given an intravenous infusion of FE 202158, titrated to raise and
maintain MAP at 70 mmHg for 3 hours while the PAF infusion was
continued. Control rats received only an equal infusion of vehicle in
addition to the continued PAF infusion.
Results FE 202158 dramatically reduced mortality in PAF-treated
animals compared with PAF + vehicle controls. Survival was 80% in
the FE 202158-treated group (8/10) versus 9% in the vehicle-treated
group (1/11). Improvements were also observed in other hemo-
dynamic parameters related to vascular leak and tissue perfusion.
Conclusions This rat model of PAF-induced hypotension
reproduced the pathophysiological hallmarks of sepsis-induced
cardiovascular dysfunction. The selective V1a receptor agonist FE
202158 was not only able to reverse the associated mortality, but
also other manifestations of this dysfunction including vascular leak.
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Introduction The study objective was to review the current use of
vasoactive medications in our ICU and to compare vasoactive
medications with respect to therapeutic end points and the choice
of agent. The second objective was to determine prognostic
factors that effect survival in critically ill pediatric patients.
Methods The data of patients admitted to the Istanbul Faculty of
Medicine Pediatric ICU between January 2004 and January 2005
were investigated retrospectively.
Results During the study period, vasoactive medications
(dobutamine and/or dopamine, epinephrine) were used in 63
patients. The median age of the patients was 96.5 months (1–192)
and 52.4% (n = 33) of the patients were male. Of the patients,
28.6% (n = 18) died. The patients in the epinephrine treatment
group were sicker than those in the dobutamine and/or dopamine
groups. The pH and base deficit levels improved earlier in the
epinephrine therapy than in the dobutamine and/or dopamine
therapies. In the patients treated with epinephrine, the lactate
concentration initially increased, but decreased to the basal level in
the 8-hour observation period. The heart rate was higher at
admission and during the follow-up in nonsurvivors than survivors
but was not statistically significant. The relationship between
increasing lactate concentration and mortality was statistically
significant (P < 0.01).
Conclusions Early initiation of epinephrine may offer survival
benefit to critically ill pediatric shock patients. The lactate
concentration may increase transiently in patients treated with
epinephrine. The decrease in the heart rate and lactate
concentration are important determinants of outcome.
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Introduction Evolution of hemodynamic monitoring revealed many
septic shock patients on high catecholamines without proper fluid
loading before. The aim of our study was to show that it is possible
in quite a few cases to reduce these agents by a forced volume
resuscitation combined with active reduction of catecholamines.
Methods We studied 21 patients (15 males, six females; mean ±
SE age, 72 ± 11 years) with septic shock on high catecholamines
(norepinephrine 19.77 (range 6.7–56.7) mg/min (21 patients);
dobutamine 294.17 (0–666.7) mg/min (14 patients); epinephrine
13.97 (0–33.3) mg/min (11 patients)), mottled-marbled cold
extremities, a monitor showing sufficient blood pressure, central
venous pressure 15 ± 7 mmHg and lactate 3.58 ± 2.24 mmol/l
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after major surgery (surgical ICU, university hospital). Intervention:
forced volume challenge combined with an active induced
reduction of catecholamines to achieve an adequate fluid loading
status guided by passive leg-raising test, course of central venous
pressure and in 14 cases by hemodynamic monitoring (Vigilance II
n = 12; Vigileo n = 2 (Edwards)). It was stopped after clinical
improvement with rewarmed extremities, increasing diuresis and
lack of improvement by passive leg-raising test. Data collection:
baseline characteristics, individual hemodynamic parameters,
PAO2/FiO2, course of catecholamines, administered volume,
lactate, time needed to wean from catecholamines, and outcome.
Results Mean catecholamine doses decreased significantly in all
patients: norepinephrine 2.0 ± 0.17 (0–10); dobutamine 166.7 ±
15.83 (0–333.3); epinephrine 1.8 ± 0.28 (0–6.7) mg/min (mean ±
SEM, range; P < 0.05 (t test)). Volume challenge: 4,476 ± 2,976
ml Ringer (range up to 12,500 ml) and 1,062 ± 946 ml
hydroxyethyl starch (range up to 3,500 ml) (mean ± SE), fluid
balance during intervention 6,724 ± 3,971 ml (range 2,040–18,410
ml). Mean weaning time from catecholamines: 10.35 ± 6.57 hours
(range 3–23 hours). All patients showed rewarmed extremities,
decrease of mean lactate levels (2.44 ± 1.33 mmol/l (1.10–5.4)).
Hemodynamic constellations were dishomogeneous without
cardiac deterioration or mean PAO2/FiO2 deterioration (253 ± 122
to 284 ± 86 mmHg). Fifteen patients survived, six died.
Conclusions It is possible to wean quite a few septic shock
patients from high catecholamines. Adequate fluid loading
preceding the use of high catecholamine doses should be a main
subject of discussion in patients with severe septic shock.
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Introduction Cardiac dysfunction is an important organ
manifestation of severe sepsis, and its occurrence increases with
disease severity. Similarly, patients suffering from acute heart
failure are characterised by a poor cardiac performance and a high
mortality. We compared the cardiac function index (CFI), a marker
of myocardial contractility and other hemodynamic variables, in
patients with acute heart failure and severe sepsis or septic shock
and studied their relationship with ICU mortality.
Methods Twenty-one patients requiring invasive hemodynamic
monitoring were included. Diagnoses were severe sepsis or septic
shock in nine patients (with no history of impaired ventricular
function) and acute heart failure in 12 patients. In each patient, four
hemodynamic measurements were performed during 24 hours of
combined monitoring with a pulmonary artery catheter and a
PiCCO catheter. The following parameters were simultaneously
assessed: cardiac index by pulmonary artery catheter, CFI,
pulmonary artery occlusion pressure, right atrial pressure, and
global end-diastolic volume index. A nonparametric Mann–Whitney
U test and Fisher’s exact test were performed, as appropriate.
Results presented as the median (interquartile range). Statistical
significance defined as P < 0.05.
Results The ICU length of stay was 17 (14–30) days in septic
patients and 12 (5–19) days in heart failure patients (P = 0.13).
Overall ICU mortality was 44% among patients with sepsis and
25% among those with heart failure (P = 0.40). In septic patients,
the cardiac index in survivors was 5.2 (4.4–6.3) l/min/m2
compared with 3.6 (3.3–3.8) l/min/m2 in nonsurvivors (P < 0.001).
In patients with heart failure, the cardiac index in survivors and
nonsurvivors was 2.6 (2.1–3.0) l/min/m2 and 2.8 (2.3–3.3)
l/min/m2, respectively (P = 0.54). The CFI in septic survivors was
6.7 (6.0–7.4) min–1 compared with 3.5 (3.0–5.4) min–1 in
nonsurvivors (P < 0.001). The CFI in patients with heart failure who
survived was 2.6 (2.0–3.0) min–1 and 2.9 (2.3–3.2) min–1 in those
who died (P = 0.46). In both septic and heart failure patients, the
pulmonary artery occlusion pressure, right atrial pressure and
global end-diastolic volume index did not differ between survivors
and non-survivors.
Conclusions The cardiac index and CFI both provide prognostic
information in patients with severe sepsis or septic shock. No
relationship with ICU mortality was found in patients with acute
heart failure.
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Introduction The role of early-goal directed therapy (EGDT) in
severe sepsis (SS) is unclear. A 3-month prospective, multicentre,
ANZICS CTG-endorsed observational study supported by the
ANZIC Research Centre was performed to determine current
resuscitation practices and outcomes in patients presenting to the
emergency department (ED) with SS in 32 Australian and New
Zealand (ANZ) hospitals from September 2006 to January 2007.
Methods Adult patients with ≥2 systemic inflammatory response
criteria and either hypotension (systolic blood pressure <90 mmHg
or mean arterial pressure <65 mmHg after a 500 ml fluid challenge
or the requirement for vasoactive agents) or metabolic acidosis
(blood lactate >4.0 mmol/l or anion gap >20 mEq/l) presenting to
the ED were identified.
Results Three hundred and twenty-four patients (52.5% male) of
median age 66 years (IQR 50, 79) and APACHE II score 18.0
(IQR 13.0, 24.5) were enrolled. Pneumonia (42.6%) and urinary
tract infection (30.2%) were the commonest causes of severe
sepsis. Between T0 (enrolment) and T+6 hours, 44.4% received
an intra-arterial, 37% a central venous and no patients a
continuous central venous oxygen saturation catheter. Between T0
and T+6 hours, a vasoactive infusion was commenced in 30.2%, a
red blood cell transfusion in 7.7%, and a dobutamine infusion in
2.5%. In the same time period, 52.6% were admitted to the ICU
and 18.8% had invasive ventilation. Overall hospital mortality was
20.1% and was not different between patients admitted to the ICU
(18.9%) and the general ward (20.4%).
Conclusions The management of patients presenting to the ED
with SS in ANZ does not include EGDT. Hospital mortality was
lower than previously reported and the baseline mortality in ANZ
was much lower than in Rivers and colleagues’ trial [1]. Reliable
estimates of sample size and recruitment rate for a proposed
multicentre trial in ANZ were obtained, confirming that there are
sufficient patient numbers to perform a randomised controlled trial
in ANZ. The present observational study has resulted in a
successful NHMRC grant application to fund a large multicentre
trial of EGDT in SS in Australasia.
Acknowledgements Supported by Intensive Care Foundation and
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Introduction Sepsis is a major problem in healthcare, with high
mortality. Application of surviving sepsis campaign evidence-based
recommendations is a way of improving quality of care.
Methods Concurrent data collection for all patients admitted to an
ICU with the diagnosis of community-acquired severe sepsis
(including septic shock), between 2005 and 2007. Time zero was
defined as the hospital arrival time.
Results During that period 228 patients were admitted to the
study, median age was 60 years, 62% were male, the median
SAPS II score was 45 and 63% had septic shock. The overall
mortality rate was 36%. Compliance with 6-hour bundles was:
54% for serum lactate measurement, 39% for blood cultures 18%
for antibiotic administration in 1 hour, 98% for fluid challenge, 34%
for central venous pressure >8 cmH2O and 4% for SvcO2 >70%.
The overall compliance was 1%. The median time from hospital to
ICU admission was 6 hours (P25 = 1; P75 = 25). Compliance with
24-hour bundles was 59% for steroids in refractory septic shock,
51% for glucose control < 150 mg/dl and 98% for plateau
pressure < 30 cmH2O. The overall compliance was 37%. Logistic
regression was built with 28-day outcome as the end point,
adjusted for age (OR = 1.035; 95% CI = 1.017–1.054), gender
and severity of sepsis (septic shock OR = 3.241; 95% CI =
1.734–6.056) and SAPS II (OR = 1.046; 95% CI = 1.026–1.067),
for each of the 6-hour and 24-hour bundles. Only the use of
corticoids, in refractory shock had a significant reduction on 28-
day mortality (adjusted OR = 0.45; 95% CI = 0.214–0.946).
Lactacidemia was found to be an independent risk factor for 28-
day mortality (adjusted OR = 1.276; 95% CI = 1.083–1.504).
Conclusions The rate of compliance with the 6-hour sepsis bundle
was very low and the main reasons were the early antibiotic
administration and the measurement of central venous saturation.
This compliance rate would probably be better if we had
considered time zero the time of the diagnosis but objectivity
would be lost. In conclusion, there is a large need for improvement
in the care of the severe septic patient in our hospital, mainly in the
emergency department where compliance is lower. Lactacidemia
seems to be a good index of prognosis.
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Introduction The concept of the Surviving Sepsis Campaign (SSC)
bundles integrates evidence-based and time-sensitive issues to
ensure that all eligible patients receive the right treatment at the
right time. A course on sepsis and severe infection was developed
in our hospital in 2004 addressed at doctors and nurses working in
the emergency department and in medical and surgical wards.
Methods To determine whether our performance towards septic
patients improved, a retrospective comparison of compliance with
SSC in the periods between December 2004 and November
2005 and July 2006 and June 2007 after implementation of sepsis
and severe infection courses was done.
Results During both periods 173 patients were admitted with
community-acquired severe sepsis, 107 in the first and 66 in the
second. The mean age was 62 and 60 years (P = 0.758); 61%
and 70% were male (P = 0.233); mean SAPS II was 45 and 47
(P = 0.896); and 72% and 50% had septic shock (P = 0.004).
See Figure 1.
Conclusions Our intervention with sepsis and severe infection
courses seems to have produced a slight improvement in the care
of the septic patient.
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Introduction The purpose of the study was to describe the
effectiveness of the Surviving Sepsis Campaign (SSC) bundles
with regard to both implementation and outcome in patients with
septic shock.
Methods A single-centre prospective observational study of
patients admitted to the medical–surgical ICU with septic shock.
Patients were admitted from September 2005 to March 2007.
After an educational program, implementation of the SSC
Resuscitation Bundles (RB) and Management Bundles (MB) was
accomplished.
Results We analyzed 186 consecutive patients. Global hospital
mortality was 43%. The rate of compliance with the RB was 36%.
The compliance rate with the MB was only 20%. When the
influence of age, severity, emergency department origin, and ICU
admission delay was controlled by multivariate analysis,
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compliance with the RB was independently associated with
survival (OR = 0.42, 95% CI = 0.20–0.89, P = 0.02). We only
found differences in mortality between C and NC groups in four
bundle elements: serum lactate measured before 6 hours (36.5%
vs 56.7%; P < 0.01), early broad-spectrum antibiotics (31.1% vs
51.4%; P < 0.01), mean arterial pressure ≥65 mmHg before 6
hours (36.3% vs 60.8%; P < 0.01), and treatment with activated
protein C when indicated (20% vs 59.5%; P < 0.01). In the
multivariate analysis, activated protein C, complete RB, age, SOFA
score, and mechanical ventilation were associated independently
with mortality. Compliance rates with RB during three consecutive
6-month time periods were 33.3%, 43.1% and 27.9%,
respectively; inhospital mortality rates in those periods were
41.7%, 35.4% and 52.5%, respectively (P = 0.14). Compliance
with the MB decreased from 26.1% (first period) to 8.7% (third
period).
Conclusions Implementation of the RB was associated with
decreased mortality in patients with septic shock. However,
compliance with the SSC bundles decreased in the third period of
study, making us alert to the need to continue the efforts to keep
the SSC active and updated. The poor adherence to management
bundles probably shows the many uncertainties that remain within
this group of interventions.
Acknowledgements Supported by IFIMAV Expte PRF/07/04 and
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Introduction Four years after release of the Surviving Sepsis
Campaign (SSC) guidelines, doctors’ approaches to early sepsis
resuscitation are unknown. We sought to understand the strategies
used in Australasia (ANZ), the United Kingdom and the USA.
Methods In 2007 we invited members of the UK, US and ANZ
intensive care, emergency medicine (EM) and, in the UK, acute
internal medicine (AM) societies to answer an anonymous online
questionnaire. Respondents described their management of a
severe sepsis patient, with multiple choice questions based around
eight decision nodes in the SSC 6-hour resuscitation bundle.
Results The response rate was 21% (2,461/11,795). Guideline
compliance was low (Figure 1): 0.1% (n = 2) complied with all
recommendations; 2% (n = 32) implemented all but intubation for
a persistently low central venous oxygen saturation (ScvO2); 21%
(n = 356) complied with all but intubation plus any one of the other
elements. The most marked interspecialty and intercountry
differences were as follows. In ANZ, 57% of intensivists and 31%
of EM doctors checked lactate at presentation, and 15% and 65%
respectively transfused blood for a haematocrit <30% and ScvO2
<70%. In the UK, 89% of intensivists and 44% of AM doctors
placed an arterial catheter. In the USA, 76% of intensivists inserted
a central line; 44% in EM did so. Among EM doctors, in the USA
30% checked lactate compared with 79% in the UK. Among
intensivists, only 15% in ANZ targeted central venous pressure
(CVP) 8–12 mmHg, compared with 55% in the USA; 15% versus
52% respectively transfused blood when indicated; and 20% and
49% started an inotrope for SvcO2 <70%. Time concerns
prevented 40% of EM doctors implementing the 6-hour bundle,
and 40% of intensivists expressed concern at the transfusion
threshold. More than 20% of all respondents felt evidence
supporting SSC lacking and preferred tailored care.
Conclusions Despite 4 years of guideline dissemination, the SSC
6-hour resuscitation bundle is not well supported. Management
varies between specialties and countries. Concerns relate to
knowledge, attitudes and resources, and differ markedly between
groups.
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Introduction The Surviving Sepsis Campaign (SSC) guidelines
were established to improve outcomes for patients with severe
sepsis. Early goal-directed therapy (EGDT) forms a key part of the
SSC guidelines and has been shown to reduce mortality rates in
septic shock. However, implementation of EGDT requires specific
knowledge and skills. Provision of optimal emergency care for
patients with severe sepsis necessitates provision of these skills in
the emergency department (ED). In the United Kingdom, all
patients must be treated in the ED and discharged or admitted
within a 4-hour time target.
Methods We sought to establish the availability of these skills in
Emergency Specialist Registrars working in Scottish emergency
departments. An Internet-based questionnaire was sent to all 49
emergency registrars.
Results Forty-two responses were obtained (86%). The majority of
respondents (95%) were aware of EGDT and the SSC. While
98% felt able to insert arterial and central venous lines, only 43%
had inserted more than five central venous lines in the 12 months
before the study. Only 45% of ED registrars possessed the full
complement of skills and knowledge to implement EGDT. The fact
that two-thirds of registrars stated that their preference was for
EGDT to be started in the ED with referral to critical care for
completion may be a reflection of this deficiency. In addition, the 4-
hour time-to-admission target was seen by 78% of registrars to be
a barrier to the implementation of EGDT in the ED.
Conclusions This study has shown that less than one-half of ED
registrars have the skills and knowledge to deliver EGDT. If EGDT
Available online http://ccforum.com/supplements/12/S2
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is to be implemented within the ED, appropriately skilled personnel
and equipment must be available. Early referral to critical care is
essential if the SSC aim of reducing mortality from sepsis is to be
achieved.
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Introduction The use of early goal-directed therapy (EGDT) in
severe sepsis and septic shock has been shown to decrease
morbidity and mortality rates significantly when given to patients
prior to ICU admission, especially in the emergency department
(ED). The aim of this study was to assess the efficacy of EGDT in
severe sepsis and septic shock patients in the ICU.
Methods A muticentre, prospective, randomized and controlled
study. We randomly assigned patients admitted to the ICU with
severe sepsis or septic shock to receive either 6 hours of EGDT or
standard therapy (as a control). The primary end point (28-day
mortality for any cause) and secondary end points (ICU stay days,
mechanical ventilation duration, APACHE II scores and MODS
scores) were obtained serially for 28 days and compared between
the two groups.
Results Of the 313 enrolled patients, 162 were randomly
assigned to EGDT and 151 to standard therapy; there were no
significant differences between the groups with respect to
baseline characteristics. The 28-day mortality was 24.8% in the
group assigned to EGDT, as compared with 42.5% in the group
assigned to standard therapy (P = 0.001). During the interval from
the first hour to 28 days stay in the ICU, the patients assigned to
EGDT had a significantly lower APACHE II score (14.44 ± 8.46 vs
18.00 ± 7.04, P = 0.043) and MODS score (4.53 ± 3.55 vs 7.09
± 4.95, P = 0.009) than those assigned to standard therapy; there
were no differences in ICU stay days (20.6 ± 1.9 vs 19.9 ± 2.2, P
= 0.82) and mechanical ventilation duration (13.2 ± 1.5 vs 14.4 ±
1.6, P = 0.6) between the two groups.
Conclusions EGDT provides significant benefits with respect to
outcome and scores in patients with severe sepsis and septic
shock in the ICU.
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Introduction With overcrowding in our emergency departments
and an access block issue, the emergency department (ED) length
of stay (LOS) is becoming a growing concern. Over the past
decade, despite decreasing mortality in sepsis and septic shock in
Australia and NZ hospitals, the reported incidence of sepsis and
septic shock in ICU patients presenting to the ED has increased. In
this study we postulated that, in severe sepsis and septic shock
patients, prolonged ED LOS is associated with increased ICU and
hospital LOS as well as increased inhospital mortality.
Methods A retrospective observational study. Data were collected
from 1 July 2004 to 31 October 2007. The setting was a cosmo-
politan 360-bed teaching hospital with a nine-bed general ICU.
The ED has 50,000 presentations per year.
Results There were 120 patients with diagnosis of severe sepsis
and septic shock admitted to the ICU. They were equally
distributed males and females with a mean age of 64.75 years. We
excluded three patients due to incomplete data. The mean ED LOS
was 10.05 hours and the median was 8.33 hours. The mean ICU
LOS and hospital LOS were 5.54 and 15.02 days, respectively.
Twenty-six patients (22.2%) died in the hospital. Based on ED
LOS, the patients were divided into three groups of <6 hours, 6–8
hours and >10 hours. There was no association between ED LOS
and inhospital mortality (P = 0.23) between the three groups.
Similarly, no association was found between ED LOS and ICU
LOS or hospital LOS (P = 0.31 and P = 0.28, respectively).
Gender, age and SAP score did not affect outcomes. However, a
significant association was found between APACHE II score and
ICU LOS (P = 0.009), with no effect on hospital LOS or mortality.
Conclusions Our study showed that, in the severe sepsis and
septic shock patient group, a prolonged ED LOS had no effect on
ICU and hospital LOS or on inhospital mortality.
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Introduction Recent published literature supports the
recommendations of early antibiotic administration for patients with
sepsis. However, certain patients with suspected sepsis do not
manifest typical symptoms, such as perturbations in blood
pressure and heart rate. To identify these high-risk patients,
surrogate evidence of hypoperfusion such as hyperlactatemia and
decreased central venous oxygen saturation may be employed.
These patients are described as being in compensated or ‘cryptic
shock’. The current study investigates whether early administration
of antibiotics affects the ICU or hospital length of stay (LOS) in
patients with ‘cryptic shock’.
Methods The current investigation is a retrospective analysis
(January 2000–December 2005) of patients evaluated in the
emergency department with evidence of cryptic shock. Two
hundred and sixty patients were identified. Cryptic shock diagnosis
was based upon the lactate level, central venous oxygen saturation
and mean arterial pressure (MAP) at the time of presentation to
evaluate the impact of early antibiotic administration (antibiotics <1
hour, or antibiotics <3 hours) on disposition and length of stay.
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Forty-eight patients were found with a complete set of data with
MAP > 65 mmHg and lactate > 4 mmol/l and ScvO2 < 65 mmHg.
Of these, 32 patients were identified with MAP > 90 mmHg,
lactate > 4 mmol/l and ScvO2 < 65 mmHg. Using chi-square and
Fisher’s exact method, data for the presence of cryptic shock and
ICU LOS were analyzed. All tests were two-sided and assessed at
the 0.05 type-I error rate.
Results Patients with MAP > 90 mmHg and elevated lactate had a
mean time until antibiotics of 174 minutes, MAP = 95 mmHg and
lactate = 7.5 mmol/l, respectively. For patients admitted to the ICU
the mean LOS = 5.5 days, and for those admitted to a general
ward the mean LOS = 11.1 days. There was no association
between early administration of antibiotics (antibiotics <1 hour, or
antibiotics <3 hours, P = 0.86 and P = 0.89 respectively) and ICU
LOS. When the degree of cryptic shock was stratified based upon
a level of lactate > 2.5 mmol/l or lactate > 4 mmol/l, again there
was no association with LOS (P = 0.47 and P = 0.33, respectively).
Conclusions In patients with cryptic shock, with early
administration of antibiotics whether administered in <1 hour or
< 3 hours there was no statistically significant impact on total
hospital LOS or ICU LOS.
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Introduction Patients with septic shock have a mortality rate of
50–60% and require timely and directed interventions. The aim of this
study was to use the Cooper Surviving Sepsis Campaign database
[1] to compare characteristics, treatments and outcomes of septic
shock (SS) patients diagnosed in the emergency department (ED)
with patients developing SS in medical wards (MW) and the ICU.
Methods The studied population included patients admitted to
Cooper Hospital during March 2006–August 2007. Seventy SS
patients were diagnosed in the ED, 27 SS patients were
diagnosed in the MW and 12 SS patients were diagnosed in the
ICU. APACHE II scores, the infection source, time from SS
presentation to transfer to the ICU, achieving central venous
pressure (CVP) and ScvO2 targets, need for mechanical ventilation
(MV) and inhospital mortality were reviewed.
Results ICU SS patients had APACHE II scores of 30.9 ± 5.6,
compared with 23.2 ± 6.1 for the MW patients and 21.8 ± 7.7 for
the ED patients (P < 0.01). Pneumonia was the primary infection
for the ICU group and urinary tract infection for the ED and MW
groups. ICU patients had a higher percentage of MV (100%) use
during the first 24 hours after shock onset, compared with 70% for
the MW patients and 45% for the ED patients (P = 0.01). ICU
mortality was 83%, compared with 59% for the MW patients and
25% for ED patients (P = 0.01). There was a median 9.8 hours
from SS presentation to transfer to the ICU in ED patients,
compared with 3.1 hours in the MW patients (P < 0.01). In the ED
group the median was 7.9 hours for achieving CVP ≥8 mmHg and
8.2 hours for vena cava oxygen saturation (ScVO2) ≥70%; in the
MW group it was 6.3 hours for CVP ≥8 mmHg and 10.8 hours for
ScVO2 ≥70%; and in the ICU group it was 1.8 hours for CVP ≥ 8
mmHg (P < 0.05 vs ED and MW) and 7.8 hours for ScVO2 ≥70%.
Conclusions The APACHE II score, use of MV in the first 24 hours
and mortality were higher in ICU-diagnosed SS patients. The data
suggest that patients who develop SS in the ICU are at higher risk
of death compared with those presenting with SS to the ED and or
developing SS in the MW.
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Introduction Posttraumatic distress disorder (PTSD) and impaired
heath-related quality of life (HRQoL) are important outcome
parameters of ICU treatment. There is evidence that PTSD is
associated with dysregulation of the hypothalamus pituitary adrenal
axis [1]. Administration of hydrocortisone (HC) during ongoing
trauma might be protective for PTSD [2]. PTSD and HRQoL were
prospectively evaluated in septic shock patients enrolled in a
substudy of the CORTICUS trial.
Methods Eighty-four patients enrolled in the randomized controlled
study of HC in septic shock who received HC (50 mg every 6 hours
for 5 days, tapered until day 11) or placebo (PL) [3] were screened
for eligibility. Mental disorders (SKID 1, BDI), PTSD (PTSS-10,
KPS), and HRQoL (SF-36) were investigated 1 year after discharge
from the ICU. Baseline SAPS II values were calculated. Adrenal
function (cortisol before/after 250 μg adrenocorticotrophic
hormone) was tested at the time of the interview.
Results Eighteen out of 84 patients were interviewed (44 dead,
20 rejected participation, two dropouts). Nine of them had
received HC and nine PL; six (30%) suffered from PTSD. Vitality
and mental health (subscales of HRQoL) were significantly
reduced in patients with PTSD (P < 0.05). There was no
correlation between the severity of disease (SAPS II) and
development of PTSD, and no difference in the physical dimension
between patients with and without PTSD. The incidence of PTSD
did not differ between patients in the HC and PL groups.
Conclusions PTSD and the mental dimension of HRQoL is a
relevant factor for long-term outcome after septic shock.
Application of HC did not reduce development of PTSD. Adrenal
function did not differentiate between patients with and without
PTSD. The interpretation of the results is limited due to the small
sample size, and further prospective studies are warranted.
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Introduction It is usual practice in ICUs to infuse several drugs
and fluids over a limited number of lines. The danger of drug
incompatibility is imminent to this regimen.
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Methods Four ICUs of a university hospital with 28 patients
altogether were surveyed regarding the number of intravenous
lines per patient and the infused drugs and fluids. No prior
information was given to the ICU personnel. The results were
stored and analyzed in a computer program. Possible in vitro
interaction was defined as known physical or chemical
incompatibility (for example, different pH, oxidative potential).
Results In 18 of 28 patients (64%), two or more drugs were
infused over the same line. In 10 of these patients (36%), serious
drug interaction had to be expected according to the drug
software, dependent on the pH and resulting from the arrangement
of drug application.
Conclusions The possible danger of serious drug interaction in
36% of the surveyed ICU patients seems alarming. The risk of drug
incompatibility rises with the number of applied drugs and with a
lack of pharmacologic knowledge in ICU personnel. We anticipate
that optimized arrangement of drug infusion could improve the
situation. Possibly, often observed missed therapeutic effects
could have been induced by mixed drug application, and thereby
provoked chemical reactions. However, the sample size of this
survey is too small to achieve universal evidence – additional
studies have to follow. Further details of possible drug interactions
and their chemical and pharmacological effects must be evaluated.
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Introduction Although requirements of human resources in the
ICU are well defined (six nurses per bed in level III and four nurses
per bed in level II ICUs), these guidelines are not followed in many
countries and evidence is also lacking [1]. The aim of this study
was to investigate the effect of the number of nurses on the
survival in multiple system organ failure (MSOF) on an eight-bed
level-III ICU.
Methods As the number of nurses was doubled in 2003 (from 14
to 29, increasing the ICU bed/nurse ratio from 1.7 to 3.6) we
screened the records of all patients from 2001 to 2005 admitted
to the ICU. Those suffering from at least two organ failures as
defined by the multiple organ dysfunction score were selected for
analysis [2]. In addition to demographic and outcome variables,
data were also collected on practice variations, such as timing of
tracheostomy, invasive monitoring and antimicrobial management.
Mortality and yearly demographic data were compared with
Fisher’s exact test and independent-sample t tests, respectively.
Multivariate, forward stepwise logistic regression was performed to
evaluate the independent predictors of survival.
Results Out of 2,169 patients, 449 were found to have MSOF.
There was no significant difference in demographics over the
years. Mortality significantly decreased after 2003: 2001, 92.8%;
2002, 89.9%; 2003, 84% (not significant); 2004, 75.3%; 2005,
65.4% (P = 0.001). Survival was significantly influenced by the
number of qualified nurses (OR = 1.20 (95% CI: 1.10–1.31), P <
0.001), simplified acute physiology score II (OR = 0.98 (95% CI:
0.96–0.99), P = 0.014), and the number of blood cultures (OR =
1.13 (95% CI: 1.05–123), P = 0.002).
Conclusions These results suggest that although the ICU
bed/nurse ratio is still far from ideal, the number of nurses do play
an important role in the survival of patients in MSOF. According to
these data, optimising the nurse:patient ratio is not only a
professional goal but also a moral duty for those who are in charge
of providing healthcare resources.
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Introduction In population-based studies, blacks had higher risk of
severe sepsis and mortality compared with whites, but the reasons
for these differences are unknown. We examined racial differences
in quality of care and outcomes in subjects hospitalized with
community-acquired pneumonia (CAP).
Methods We analyzed 352 blacks and 1,738 whites enrolled in an
observational cohort study of subjects with CAP. We used
Medicare and American Thoracic Society (ATS) guidelines to
assess the quality of care, comparing timing of initial antibiotics and
whether initial antibiotic therapy was compliant with ATS guidelines.
Results Whites were older than blacks (mean age 68 years vs 53
years, P < 0.0001), had a higher burden of chronic disease
(69.2% vs 63.1% Charlson score > 0, P = 0.02), and had higher
severity of illness (mean APACHE III score 53.9 vs 47.4, P <
0.001; mean Pneumonia Severity Index (PSI) 97.7 vs 78.6, P <
0.0001). Blacks were more likely to go to large (>500 beds)
teaching hospitals (87.5% vs 46.4%, P < 0.0001 went to teaching
hospitals, and 37.6% vs 10.5%, P < 0.0001 went to large
hospitals). Blacks were less likely to receive ATS-guideline
compliant antibiotics and less likely to receive antibiotics within 4
hours (Figure 1). These differences persisted when analyses were
stratified by PSI class, but were not significant in multivariable
analyses with hospital characteristics as random effects to account
for clustering of racial groups. No differences were seen in risk of
severe sepsis and 90-day mortality.
Conclusions Blacks receive lower quality of care when
hospitalized for CAP.
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Racial disparities in quality of care.
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Introduction We conducted research to assess simultaneously
patient-related and ICU-related determinants of performance.
Methods A prospective study involving 26 ICUs from a regional
network in the Paris area, France (CubRéa), 33,471 patients
treated in 1999 and 2000, and 1,000 caregivers (doctor, nurse)
from these ICUs. Severity was evaluated by a revised version of
SAPS II [1]. Organisational performance was assessed through a
composite score related to coordination, communication, conflict
management, organizational learning, and skills developed in
relationship with patients [2]. We studied the association between
clinical performance, measured standardised mortality ratio (SMR),
and ICU factors (organisational performance, volume, specialisation,
team cultural values and caregiver well-being) by multilevel logistic
regression, to account for correlation within ICUs.
Results The ICUs were heterogeneous (severity, mean workload,
volume, specialisation, caregiver/bed ratios). The revised SAPS II
gave SMRs between 0.64 and 1.37. Higher values of
organisational score were related to team satisfaction-oriented
culture, a high workload, and a high level of satisfaction at work. In
univariate screening, a higher volume (all patients, ventilated
patients) and a higher organisational score were associated with
lower SMRs, while the nurse/bed ratio had a rising then
decreasing relationship. Multivariate regression retained SAPS II
(P < 10–4) then volume (P < 10–3), which were respectively related
to upper and lower mortality. The organisational score was
borderline (P = 0.09). Sensitivity analysis proved robustness of the
results. See Figure 1.
Conclusions Performance is mainly related to the case mix and
volume. Outcomes other than death may be more sensible to
organisational factors.
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Introduction This poster guides us through the process of
understanding how the Acute Illness Management Course (AIM)
originated and its effectiveness in enabling practitioners to provide
quality care to acutely ill adult patients in noncritical care
environments, thus reducing hospital standardised mortality rates
(SMRs). Early detection of critical illness in patients on general
wards and the initiation of appropriate care reduces mortality and
length of stay in the hospital [1,2]. However, there is evidence to
suggest that basic management of patients considered acutely ill is
often substandard [3-5]. These findings led to the Greater Man-
chester Critical Care Network undertaking a study aimed at identi-
fying levels of knowledge regarding acute illness management. The
outcome provided a case to support the development of the AIM, a
1-day programme for practitioners designed to equip them with a
structured approach to the recognition, assessment and manage-
ment of acutely ill adults.
Methods A gap analysis determined deficits in acute illness
knowledge. Following the introduction of the AIM, a precourse and
postcourse questionnaire established whether attendance
increased knowledge. A further study is presently trying to
establish retention of knowledge at 3 months.
Results The gap analysis demonstrated a lack of knowledge in the
care of acute illness, resulting in the AIM. The AIM was introduced
in 2003. To date 6,200 multidisciplinary staff have been trained.
The study in 2006 examined precourse and postcourse knowledge
of acute illness. This study confirmed that practitioners who
attended the AIM had improved knowledge. Data have shown a
significant reduction in hospital SMRs across Manchester that
correlates with the introduction of the AIM [6]. The present study is
trying to establish a link between the reduction in SMRs and the
implementation of AIM.
Conclusions The introduction of the AIM has enriched the care of
patients who are acutely ill. Manchester is ‘AIMing’ to save lives –
the AIM is helping us do that.
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Relation between volume and revised standardised mortality ratio
(SMR).
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Introduction Clinical and experimental investigations have demon-
strated improved outcome following therapeutic mild hypothermia
after successful resuscitation. In septic shock, implementation of
‘standard operating procedures’ improves outcome. To advance
treatment and outcome in patients after successful prehospital
resuscitation, we established in August 2005, at our medical ICU
at the Heart Centre Freiburg, an evidence-based standard
operating procedures in postresuscitation care. To evaluate
enforcement and quality of postresuscitation care in daily practice
we compared achievement and realisation of our standard
operating procedure before and after introduction.
Methods During 2001–2006 a total of 229 patients, after
successful prehospital resuscitation, were assigned to our medical
heart centre. One hundred and seventy-seven (77%) patients
fulfilled the inclusion criteria and 89 (39%) of the patients were
treated with mild hypothermia. In August 2005, we established at
our medical ICU standard operating procedures in post-
resuscitation care. We compared retrospectively patients treated
with mild hypothermia before (control group) and after August 2005
(SOP group) concerning inclusion and realisation of therapeutic
hypothermia and achievement of the target temperature.
Results There were no differences in age and number of patients
with cooling indication. After the implementation of the standard
operating procedure, significantly more patients were cooled
(52/132, 39% versus 37/46, 80%; P < 0.05). In the SOP group, the
target temperature could be reached significantly faster compared
with patients treated without SOP after admission to the hospital
(372 ± 187 min versus 1,117 ± 761 min, P < 0.05) and after admis-
sion to the ICU (264 ± 188 min versus 940 ± 607 min, P < 0.05).
Conclusions Standard operating procedures in postresuscitation
care could facilitate realisation of therapeutic measures in daily
practice. Here we showed that the implementation of an evidence-
based standard reduced the time to achieve the target temperature
and decreased the number of patients treated with mild
hypothermia after successful resuscitation. Although time course
and duration to achieve the target temperature is known to play a
crucial role in this therapeutic concept, this will be a step to
improve outcome of these patients.
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Introduction Practice variation refers to how identical patients with
exactly the same comorbidities and clinical presentation are
managed differently by clinicians. It is increasingly recognized as a
major contributor to inefficiencies in healthcare delivery as well as
medical errors. The ICU is a place where significant practice
variation exists. In this project, the concept of extracting information
from a large database in order to reduce practice variation and
facilitate care customization is explored. Calculation of
maintenance fluid requirement was selected to investigate the
feasibility of this approach.
Methods The Multi-parameter Intelligent Monitoring for Intensive
Care (MIMIC II) database consists of >18,000 ICU patients
admitted to the Beth Israel Deaconess Medical Center since 2003.
Patients who were on vasopressors >6 hours during the first 24
hours of admission were identified. Demographic and physiologic
variables that might affect fluid requirement or reflect the
intravascular volume were extracted. We represented the variables
by learning a Bayesian network from the underlying data.
Results The network generated has a threshold Bayes factor of 7
representing the posterior probability of the model given the
observed data. This minimum Bayes factor translates into P <
0.05. The variables from day 1 that correlated with the fluid intake
on day 2 are the number of vasopressors, mean blood pressure,
mean heart rate, mean creatinine and day 1 fluid intake. The
probability that a patient will require a certain amount of fluid on
day 2 can be predicted based on the values of the five variables. In
the presence of a larger database, analysis may be limited to
patients with good clinical outcomes; that is, resolution of lactic
acidosis, improvement in organ dysfunction, survival to discharge.
Conclusions By better predicting maintenance fluid requirements
based on the previous day’s physiologic variables, one might be
able to prevent hypotensive episodes requiring fluid boluses during
the course of the following day. The application of machine
learning to a large high-resolution database may also facilitate a
more evidence-based customization of care by limiting the analysis
to patients of certain demographics and/or those with specific
clinical presentations.
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Introduction A 24-hour flow chart has been used for prescribing
and documenting medication administration in the intensive
therapy unit/high-dependency unit for many years. Transcription
errors arising from rewriting inpatient drug charts have been
recognised as a major factor contributing to medication errors. A
project was undertaken to assess these errors in order to devise a
new chart that would minimise them and improve patient safety.
Methods An interdisciplinary group of medical, nursing and
pharmacy staff designed a new drug chart for the pilot. Audit data
were collected before and after the introduction of the new drug
chart using categories from a similar study [1]. The errors recorded
included: transcription errors (for example, transcription omission,
or drug name, dose or dose frequency transcribed/altered
incorrectly); administration errors (for example, doses given after
prescription discontinued or prescribed dose not given); and
patient’s allergies not documented. Data were collected for 10
days. The number of patient-days was used as the denominator.
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Transcription and administration errors before and after the new
chart
Flow chart New chart P value 
Error type (n = 273) (n = 243) (χ2)
Transcription 102 12 <0.01
Administration 17 6 <0.05
Allergy  120 13 <0.01
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Results The audit showed that the new drug chart led to
significant reductions in transcription errors and drug adminis-
tration errors. There was an improvement in the documentation of
allergies (Allergy) on patients’ charts (Table 1).
Conclusions The introduction of a drug chart designed by the
interdisciplinary team has led to a substantial reduction in
prescribing and administration errors and has improved patient
safety. An audit cycle has been implemented and the team will
continue to assess audit data and feedback from users to ensure
that the design meets the evolving requirements of the intensive
therapy unit/high-dependency unit and that reduction in
prescribing and administration errors are sustained.
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Introduction The Northern Ireland Incident Monitoring Study is a
prospective regional audit study designed to analyse occurrence of
adverse events in ICUs. The project is based on the Australian
Incident Monitoring Study. The aim of the study is to foster a
culture of incident reporting and analysis in the ICU using an
anonymous unified system across Northern Ireland to identify
patterns amenable to change.
Methods A database specifically designed for the collection of
incident data anonymously in the ICU environment was developed.
An incident was defined as ‘an event that led to, or could have led
to, patient harm if it had been allowed to proceed’. Data from each
unit were analysed, by a central coordinator, in cycles of 4–6
weeks, and a collated report for the whole region generated
periodically.
Results A total of 227 incidents were reported in the first data
cycle across the seven ICUs, the mean cycle duration being 36.5
days and the median unit size nine beds (range 6–25). Table 1
shows the majority of events were drug related, followed by unit or
patient management issues, incidents related to procedures,
equipment issues and airway-related events. Patterns were
identified across the units.
Table 1 (abstract P430)
Breakdown of total reported incidents in Northern Ireland
Incident  Number of reports % of total
Drug 105 46
Management 48 21
Procedural 34 15
Equipment 20 15
Airway 20 9
Conclusions The project demonstrated that reporting statistics
were enhanced with this unified anonymous, speciality-specific
system than with previously used systems. The project has
established the means to benchmark data between units and to
identify patterns across the region.
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Introduction The quality of intensive care (QIC) can be defined by
several dimensions: structure, process and outcomes [1]. All
Finnish ICUs contribute to the Finnish Intensive Care Quality
Consortium (FICQC) with shared reports over the Internet. The
FICQC chose to describe the quality of intensive care by four
dimensions: patient outcome, patient selection, resource utilization
and data completeness. The aim of this work was to develop a
continuous, comprehensive and compact view of the quality of
intensive care and to describe the effects of organizational
changes on the performance.
Methods The four most significant dimensions and elements for
each dimension were selected by an expert panel (Figure 1).
Briefly on the elements of each dimension: Outcome describes
patient survival after the ICU stay; Patient selection consists of the
ratio of high-risk patients to low-risk patients; Resource utilization
indicates ICU productivity and use of resources; and Data
completeness describes the missing data ratio. Data completeness
indicates also the quality of data collection and recording proce-
dures. Element values are weighed by arbitrarily defined
coefficients and the dimension scores are calculated. Dimension
scores are adjusted with a data transformation algorithm to index
values. Indexes are reported every 3 months as part of FICQC
routine reporting.
Results Members of the FICQC see the indexes as a valuable
reporting method. Organizational changes are reflected in the
indexes. Examples will be shown.
Conclusions Quality indexes are powerful when defined and
designed properly. The indexes provide the user with a rapid,
comprehensive view of performance in a compact format. The
indexes help the ICU management to monitor and thereby even
improve the unit’s performance and quality.
Reference
1. Curtis et al.: Intensive care unit quality improvement: a
how-to guide for the interdisciplinary team. Crit Care Med
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Four fundamental dimensions of the quality of intensive care.
S170
P432
Quality improvement: reducing ventilator-associated
pneumonia
C Hawe, K Ellis, C Cairns, A Longmate
Stirling Royal Infirmary, NHS Forth Valley, UK
Critical Care 2008, 12(Suppl 2):P432 (doi: 10.1186/cc6653)
Introduction Ventilator-associated pneumonia (VAP) is associated
with increased morbidity in intensive care [1]. Education and
checklists may improve adherence to preventative interventions [2].
Methods A ‘VAP prevention bundle’ was introduced in November
2005. Bundle compliance was assessed 1 year later (50 patients)
and twice again (59 and 50 patients) after introduction of an
educational package. The incidence of VAP was concurrently
measured using HELICS definitions [3].
Results VAP rates and bundle compliance were unaffected by
passive bundle introduction. However, compliance increased
following the intervention. The quarterly VAP incidence fell from 24
to 6/1,000 patient-ventilated days. There was a significant increase
in the number of ‘at-risk ventilated patient-days’ between each
incidence of VAP. See Table 1 and Figure 1.
Table 1 (abstract P432)
Bundle compliance
Compliance (%) Ineligible (%) Patients (%)
November 2006 May 2007 October 2007
Head up 54 79 95
Oral wash 2 100 100
Subglottic tube 55 89 93
Daily weaning plan 54 64 65
Daily sedation break 56 90 82
Conclusions Passive introduction of the bundle had limited effect
as demonstrated by initial compliance. Compliance improved
following education. Improved compliance was associated with a
decreased incidence of VAP.
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Introduction Ventilator-associated pneumonia (VAP) is the most
frequent ICU-related infection in patients requiring mechanical
ventilation, who have a mortality rate ranging from 20% to 50%,
prolonging the duration of mechanical ventilation and the ICU
length of stay, and increasing costs. We describe the impact of
VAP bundle use in an intermediate respiratory care unit (IRCU) to
prevent VAP in patients requiring prolonged mechanical ventilation.
Methods A prospective observational study enrolled all
tracheotomized patients admitted to a seven-bed IRCU of a tertiary
care hospital between March 2005 and October 2007. The daily
VAP bundle checklist as described by the Institute for Healthcare
Improvement [1] was performed since March 2006 to evaluate
compliance. VAP diagnosis was supported by the Clinical
Pulmonary Index Score and microbiological quantitative criteria.
The mean duration of mechanical ventilation and VAP rate per
1,000 ventilator-days pre and post the bundle period was
evaluated and compared using the likelihood ratio for VAP from a
Poisson distribution. P < 0.05 was considered significant.
Results Eighty-eight patients were studied, 40 females and 48
males. The mean age and APACHE II score were 76 ± 12 years
and 14 ± 5, respectively. We analyzed 3,727 records during the
study period. There were a total of 53 VAP episodes. The
compliance rate was 97%. The mean duration of mechanical
ventilation pre and post bundle was similar (17.8 and 17.78 days,
respectively). The VAP rate decreased from 22 cases per 1,000
ventilator-days to 9.76 cases per 1,000 ventilator-days: a 55.78%
reduction at the end of 20 months of bundle use (P < 0.05).
Conclusions The application of the VAP bundle in chronic
ventilated patients resulted in a significant reduction in the
incidence of VAP.
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Introduction In an effort to decrease the gap between the current
management of pneumonia in the ICU and the recommendations
by the 2005 American Thoracic Society/Infectious Diseases
Society of America (ATS/IDSA), we developed, implemented and
evaluated an ICU hospital-acquired pneumonia performance
improvement (PI) project by adapting these guidelines in four
academic hospitals.
Methods PI indicators were developed and assessed. PI1
evaluated the initial microbiological work-up (lower airway and
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Ventilator-associated pneumonia (VAP) geometric distribution chart.
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blood cultures within 48 hours). PI2 assessed empiric antibiotics in
patients with risk factors for multidrug-resistant organisms. PI3
evaluated patients for short-course therapy (clinical pulmonary
infection score ≤6 on day 0 and day 3 and no hemodynamic
instability or severe sepsis). PI4 assessed whether patients were
candidates for de-escalation and had their antibiotics adjusted on
day 3. Data were collected prospectively and reviewed by the
principal investigators prior to submission to the database.
Results Analysis was performed on the first 164 patients meeting
the clinical criteria of pneumonia. Respiratory cultures were obtained
in 94% and blood cultures were obtained in 88% of patients. One
hundred and twenty-five patients received empiric therapy. The
empiric therapy was compliant with the ATS/IDSA guidelines in only
31% of the patients, with failure to use a second agent to cover
multidrug-resistant Gram-negative pathogens in 55% patients.
Nineteen patients were candidates for short-course therapy, and this
was implemented in one patient. De-escalation criteria was met in
106 patients and occurred in 75% of candidates.
Conclusions Adherence to ATS/IDSA guidelines for diagnosis
and management of hospital-acquired pneumonia was less than
expected, but initial work-up with appropriate cultures was
performed in the majority of patients. In patients at risk for
multidrug-resistant organisms, empiric antibiotics were compliant
with the guidelines only one-third of the time. De-escalation of
antibiotic therapy, while not optimal, did occur in most candidates.
In patients who were candidates for short-course therapy, this
option was rarely chosen.
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Introduction Unplanned extubations (UEs) can be accidental or
intentional (autoextubation). The incidence of UE is 1–4/100
ventilator-days and is considered a quality indicator for nursing
care in the ICU. We studied the effect of a predominantly nurse-
driven endotracheal tube care (ETTC) protocol on incidence,
circumstances, and outcome of UEs in orotracheally intubated
mechanically ventilated patients.
Methods A 1-year prospective observational study in a 24-bed
mixed medicosurgical ICU in a university hospital. The ETTC protocol
includes: endotracheal tube (ETT) fixation with waterproof adhesive
plaster and/or adapted tubeholder; wrist fixation in all patients;
nurse-driven sedation and analgesia supervised by a dedicated ICU
physician; pressure support weaning using a flow trigger and tube
compensation when possible, actively steered by a nurse and a
respiratory physiotherapist; special care to avoid ETT dislocation
during mobilisation or transport of the patient; and prompt
pharmacological treatment of the restless or agitated patient.
Results Six hundred and eighty-eight patients were ventilated
during 4,605 days. The incidence of UE was 0.32/100 ventilation-
days. Autoextubation occurred in 11 (73%) patients, mostly (82%)
during the evening or night shift, and in the absence of a nurse in
the patient’s room. All patients had been successfully weaned and
were free of sedation. No patient had to be reintubated. All
accidental extubations (n = 4; 27%) occurred in the immediate
postoperative phase following cardiac bypass surgery and in the
presence of a nurse and/or physiotherapist at the bedside.
Seventy-five percent took place during morning shifts in full-
sedated patients and were due to ETT dysfunction. All patients
were promptly reintubated. UEs never occurred during patient
mobilisation or transport. No patient died as a result of UE.
Conclusions The implementation of a nurse-driven ETTC protocol
for prevention of UE resulted in a very low incidence of UE, in a low
number of accidental UEs occurring in relatively controlled
circumstances, in no UEs during patient mobilisation, and in no
excess morbidity and mortality.
P436
Evidence-based guidelines for preventing ventilator-
associated pneumonia: results of a knowledge test among
3329 European intensive care nurses
SO Labeau1, DM Vandijck2, J Rello3, S Adam4, 
KH Vandewoude2, SI Blot2
1University College Ghent, Belgium; 2University Hospital Ghent,
Belgium; 3Joan XXIII University Hospital, Tarragona, Spain;
4University College London Hospitals Trust, London, UK
Critical Care 2008, 12(Suppl 2):P436 (doi: 10.1186/cc6657)
Introduction Although evidence-based guidelines for preventing
ventilator-associated pneumonia (VAP) are available, non-
adherence by ICU clinicians seems common. This may, at least
partly, be due to a lack of knowledge of the recommendations. Our
study aimed to assess ICU nurses’ knowledge of evidence-based
VAP prevention recommendations.
Methods A European survey by means of a validated and reliable
multiple-choice questionnaire concerning nine evidence-based
strategies for VAP prevention [1,2]. Data gathered were gender,
years of ICU experience (<1 years, 1–5 years, 6–10 years, >10
years), number of ICU beds (<8 beds, 8–15 beds, >15 beds), and
whether they hold a specialized qualification in intensive care.
Results Between November 2006 and April 2007, 3,329
questionnaires were gathered from 22 European countries. The
nurses’ mean score was 4.06/9 (45.1%). No differences were
found between males and females. Nurses with a longer ICU
working experience scored significantly better than their less
experienced colleagues (P < 0.001 for <1 year vs >1 year and for
<5 years vs >5 years of experience; P = 0.001 for <10 years vs
>10 years of experience). Respondents from larger ICUs obtained
significantly lower scores than those from smaller units (P < 0.001
for <8 beds vs >8 beds and P = 0.048 for <15 beds vs >15
beds). Linear regression analysis demonstrated knowledge to be
independently associated with years of ICU experience, and with
the number of ICU beds (both P < 0.001).
Conclusions European nurses’ knowledge of VAP prevention
guidelines is poor. We recommend including VAP prevention
guidelines in the core nurse education curriculum and in continuing
refresher nursing education programs.
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Introduction Controversy exists around the use of total plasma
cortisol and the high-dose adrenocorticotrophic hormone (ACTH)
test for diagnosing relative adrenal insufficiency in sepsis [1,2].
Our aim was to examine the response of bioactive free cortisol
levels to stimulation with 1 μg synthetic ACTH in a cohort of
patients with septic shock.
Methods A prospective observational study at a tertiary intensive
care facility. Patients with septic shock (n = 14) were enrolled.
Measurements of free cortisol and total plasma cortisol were
performed at baseline and at 30 and 60 minutes following injection
of 1 μg synthetic ACTH (synacthen).
Results Free plasma cortisol and total plasma cortisol at baseline
on day 1 were 39.7 (±44.7) and 424.6 (±232.8) nmol/l, respec-
tively. The mean increments at 30 minutes of total cortisol and free
cortisol were 157.3 (±106) and 54.4(±36) nmol/l, respectively.
The mean percentage changes in total and free cortisol were
29.6% and 82.8%, respectively; P = 0.07. Relative adrenal insuffi-
ciency diagnosed by a total plasma cortisol response <250 nmol/l
was present in 12 patients (85%), and in 13 patients (92%) by a
free cortisol increment of less than 110 nmol/l.
Conclusions To our knowledge these data represent the first set
of information on free cortisol response to 1 μg synacthen.
Although preliminary, the proportionally larger change in free
cortisol in response to a low-dose synacthen stimulus may indicate
a greater sensitivity for secondary adrenal insufficiency, and is
consistent with previous observations [1]. These data support the
suggestion that the traditional relative adrenal insufficiency criteria
might need reconsideration. Further study is warranted to
determine the clinical utility of this investigation.
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Introduction Arginine vasopressin (AVP) is a peptide hormone that
is released in response to osmotic and haemodynamic changes in
order to maintain fluid volume and vascular tone. As a ‘stress
hormone’, AVP is significantly increased in acute haemodynamic
instability [1]. Copeptin is a stable fragment of pre-pro-vasopressin
that is released in equimolar quantities as AVP, and thus reflects
levels of released AVP. Unlike AVP, copeptin is highly stable ex
vivo and is thus used for analysis. We aimed to study whether
copeptin is elevated in any form of acute haemodynamic instability
(that is, shock state) and whether copeptin is a predictor of
outcome in critically ill patients.
Methods A total of 352 consecutive patients (65% male, 64 ± 15
years, SAPS 2 52 ± 23) admitted to the ICU of the Department of
Cardiology/Medical University of Vienna were included. Blood
samples were obtained on admission in all patients. Copeptin was
determined using a recently developed immunoassay in the
chemiluminescence/coated tube format [2].
Results Two hundred and seventy-seven patients survived to ICU
discharge and 75 patients died. Copeptin plasma levels were
significantly higher in ICU nonsurvivors than in ICU survivors (194
± 205 pmol/l vs 101 ± 100 pmol/l; P < 0.0001). The area under
the ROC curve for prediction of ICU survival was 0.678 for
copeptin. Patients with diagnosis of shock (n = 132) had
significantly higher copeptin plasma levels than patients without
shock (174 ± 169 pmol/l vs 93 ± 100 pmol/l; P < 0.0001). There
was no statistically significant difference in copeptin plasma levels
between patients with different shock forms. Using a Kaplan–Meier
model for 28-day survival, patients with copeptin plasma levels
above the mean had significantly lower survival rates compared with
patients with copeptin plasma levels below the mean (P = 0.03).
Conclusions In critically ill patients, elevated plasma levels of
copeptin are a strong and independent predictor of adverse
outcome. Copeptin is significantly increased in shock patients,
independent of the shock category.
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Introduction Acute renal failure (ARF) is a common problem in
critically ill patients and associated with an adverse prognosis [1].
Vasopressin is a peptide hormone that is released in response to
osmotic and haemodynamic changes. An elevation of vasopressin
has been suggested to decrease the glomerular filtration rate [2].
In the present study we aimed to assess whether an elevation of
vasopressin is associated with the development of ARF in critically
ill patients. As vasopressin is highly unstable, copeptin – a stable
fragment of the precursor molecule pre-pro-vasopressin that is
secreted in equimolar quantities [3] – is used for analysis.
Methods Three hundred and fifty-two consecutive patients (228
males, age 64 ± 15 years, SAPS 2 52 ± 23) admitted to the ICU
of the Department of Cardiology/Medical University of Vienna were
included. In addition to routine laboratory assessment, blood
samples for determination of copeptin were obtained in all patients
on admission. Copeptin was determined by use of the
chemiluminescence/coated tube format [3].
Results Two hundred and seventy-seven patients survived to ICU
discharge and 75 patients died. There was a significant inverse
correlation between copeptin and glomerular filtration rate
(–0.266; P < 0.0001). Patients who developed ARF (n = 114) had
higher copeptin plasma levels (180 ± 167pmol/l vs 95 ± 107
pmol/l; P < 0.0001), a lower mean blood pressure (48 ± 28
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mmHg vs 60 ± 24 mmHg; P < 0.0001), were more often in need
of vasopressor support (81% vs 63%; P < 0.001) and were more
often in shock (72% vs 20%; P < 0.0001) than patients with
preserved renal function. Entering all these variables in a stepwise
logistic regression model, only shock (P < 0.0001) and copeptin
(P < 0.005) were independent predictors for development of ARF.
Conclusions In critically ill patients, an elevation of plasma
copeptin is strongly associated with development of ARF. The
therapeutic impact of this observation is still to be elucidated.
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Introduction Patients undergoing major surgery are at high risk of
postoperative sepsis. Early markers of septic complications would be
useful for diagnosis and therapy of patients with sepsis. In contrast
to the rather uniform results of studies dealing with other markers of
sepsis such as C-reactive protein (CRP), the impact of raised n-
terminal B-type natriuretic peptide (BNP) levels in the postoperative
period is less clear. Furthermore, growing evidence supports the
hypothesis that BNP could be an early predictor of sepsis in the ICU.
We evaluated the time courses of BNP, CRP and APACHE II score
and investigated their role as early markers of systemic inflammatory
response syndrome (SIRS)/sepsis after major surgery.
Methods Twenty-nine patients were prospectively included: 20
patients had major oncological surgery of the head and neck
(Group 1). The second group included patients with manifest
cardiovascular disease (n = 9) undergoing cardiac surgery. The
APACHE II score and serum concentrations of BNP and CRP
were determined before and daily after surgery. The American
College of Chest Physicians Classification was used to diagnose
SIRS, and organ system failure to define sepsis.
Results Mean baseline levels of BNP were different in both groups
(Group 1: 435.2 ± 906.1 ng/ml vs Group 2: 2,083.4 ± 3,694.9
ng/ml). The maximum values of BNP achieved at postoperative day
3 were significantly higher compared with the baseline levels. There
was also a significant difference between both groups (Group 1:
1,500.0 ± 1,963.8 ng/ml vs 3,806.6 ± 3,822.0 ng/ml; P < 0.05;
r2 = 0.84). The APACHE II score was significantly higher at the
maximum time point (day 3) for all patients (P < 0.05, r2 = 0.45).
However, the CRP levels were not significantly different within this
period. Six patients developed SIRS. The average maximum BNP
was 2,286.98 ± 2,943.58 ng/ml. Within this group, two patients
died of severe sepsis and had significantly higher BNP levels as
compared with the maximum postoperative values (P < 0.05).
Conclusions Our results show that BNP levels are significantly
higher in patients after undergoing major surgery at risk of
SIRS/sepsis. We also observed significantly higher BNP levels in
patients developing SIRS/sepsis. BNP may therefore be an
appropriate prognostic marker indicating the early development of
postoperative severe sepsis after major surgery.
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Introduction Brain natriuretic peptide (BNP) is a biochemical
marker for risk stratification in heart failure, and carbohydrate (CA)
125 has been shown to correlate with heart failure severity.
However, few data are available about the combination of these
two biomarkers in the evaluation of short-term mortality in patients
admitted for acute heart failure (AHF).
Methods We studied 184 consecutive patients admitted to our
ICU for AHF. The CA 125 and BNP levels were measured, and four
categories were formed: CI = BNP < 350 ng/l, CA 125 < 65 U/ml;
CII = BNP ≥ 350 ng/l, CA 125 < 65 U/ml; CIII = BNP < 350 ng/l,
CA 125 ≥ 65 U/ml; and CIV = BNP ≥ 350 ng/l, CA 125 ≥ 65 U/ml.
The independent association between the aforementioned
categories and survival was assessed with Cox regression analysis.
Results At 6 months follow-up, 39 deaths (21.2%) were identified.
The mortality rate was lower in CI (8.2%), intermediate in CII and
CIII (27% and 25.2%, respectively) and higher in CIV (41.8%).
After adjusting for age, gender, NYHA class, ejection fraction,
systolic blood pressure on admission, sodium and creatinine, the
mortality rate remained unaltered. The higher mortality was
observed when both biomarkers were elevated (CIV vs CI: heart
rate = 3.6, 95% CI: 1.5–8.84). Intermediate risk when only one of
them was elevated (CII vs CI: heart rate = 2.2, 95% CI: 0.94–6.4).
The lower mortality was observed in the group with none of the
biomarkers elevated (CI = control group).
Conclusions CA 125 added prognostic value to BNP, and the
combination of these biomarkers affords a better risk stratification
in patients admitted with AHF.
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Introduction Pulmonary embolism (PE) is frequently under-
diagnosed and associated with high lethality despite progress in
prophylaxis and treatment. Aggressive management may improve
outcome in patients with high risk of right ventricle (RV) failure
secondary to pulmonary hypertension. CT scan angiography,
cardiac echo and biomarkers (pro-brain natriuretic peptide
(proBNP) and troponin) have been used to identify these high-risk
patients. We wanted to evaluate relationship between inter-
ventional treatment of acute PE with cardiac biomarkers changes.
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Methods Patients with PE < 24 hours confirmed by thoracic CT
scan angiography, pulmonary circulation obstruction > 50% and
echographic or CT evidence of RV dysfunction underwent invasive
angiography and thrombolysis with r-tPA. Reperfusion was
evaluated by Miller–Walsh’s score and a second angiograph was
performed 6 hours later to re-evaluate. Plasmatic proBNP and
troponin were measured before and 6 hours after angiography.
Results Thirteen patients, four men (31%), age 60.4 ± 19.2 years.
ProBNP pre/post angiography in whole group = 3,672 ± 2,894/
2,954 ± 2,648 (P = 0.055); in successful reperfusion group =
4,225 ± 3,050/3,233 ± 2,910 (pre/post) (P < 0.013) and in
unsuccessful reperfusion group = 1,830 ± 1,320/2,024 ± 1,512
(pre/post) (P = not significant). Troponin pre/post angiography =
0.31 ± 0.27/0.23 ± 0.28 (P = not significant), without a significant
lowering with regards to reperfusion. A significant lowering was
seen in pulmonary arterial mean pressure before and after
angiography in the whole group = 34.5 ± 8.9/23.4 ± 6.9 (P <
0.002), as in successfully reperfused patients (P < 0.005). No
complications were derived from the procedure. Twenty-eight-day
mortality was 8.3% (one patient from the reperfused group).
Conclusions Biomarkers may help to define a high-risk PE group,
susceptible to benefit from more aggressive management. ProBNP
has a dynamic and sensitive correlation with pulmonary bed
circulatory status, and with major variations in pulmonary
hemodynamics, as we observed. Cardiopulmonary overload
improves after successful direct thrombolysis. Angiographic reper-
fusion correlates directly with a significant lowering in proBNP
levels and a significant improvement on pulmonary pressures. We
think this aggressive approach may be recommended: if indirect
evidence of reperfusion is present (for example, significant
lowering on plasmatic proBNP levels), a control invasive
angiography could be avoided. Also, these results could be
extrapolated to intravenous thrombolysis.
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Introduction Elevated serum N-terminal pro-brain natriuretic
peptide (NT-proBNP) levels occur in severe sepsis or septic
shock. Studies on the value of NT-proBNP testing among septic
patients revealed conflicting results. The aim of the study was to
investigate NT-proBNP among septic patients admitted to the ICU.
Methods Serum NT-proBNP measurements were carried out in 10
consecutive patients (seven males/three females, age 66 ± 10.67
years) with sepsis within 6 hours of admission to the IXU. NT-
proBNP was determined with a sandwich immunoassay on an
Elecsys 2010 (Roche Diagnostics, Mannheim, Germany). Logarith-
mic transformation of data was required because of the skewed
distributions of the NT-proBNP.
Results Elevated levels of NT-proBNP were found in eight
patients, while two were in the ‘grey’ zone (NT-proBNP < 400
pg/l). The median NT-proBNP level was 3,930 pg/ml (range,
307–16,800 pg/ml). Inhospital mortality was high, five patients
died (50%). NT-proBNP showed a weak and inverse correlation
with systolic blood pressure (r = –0.49, P < 0.05) and with body
temperature (r = –0.57, P < 0.02), while no correlation was found
for other analyzed parameters (age, diastolic blood pressure, body
temperature, leucocytes, C-reactive protein, fibrinogen, lactates,
procalcitonin). At admission, the mean log NT-proBNP levels were
significantly higher in hospital nonsurvivors (3.66 ± 0.63 pg/ml)
compared with survivors (3.36 ± 0.65 pg/ml), but without
statistical significance (P < 0.54). Mean baseline levels of log NT-
proBNP were different in septic patients with proved bacterio-
logical infection than in patients without proved infection. Higher
concentrations were found in proved infection (X ± SD) (3.66 ±
0.71 pg/ml) than in the bacteriological negative patients (3.24 ±
0.52 pg/ml), but were statistically insignificant (P < 0.32).
Conclusions Our results showed that NT-proBNP levels can be
elevated in critically ill patients presenting with sepsis. Values are
higher in nonsurvivors than in survivors and in the patients with
proved bacteriological infection, but with no statistical significance.
More research is needed to accentuate the positive value of NT-
proBNP in the ICU.
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Introduction B-type natriuretic peptide (BNP) and troponin levels
can predict outcome after acute myocardial infarction and after
acute heart failure. The purpose of this study was to evaluate the
prognostic implication of high postoperative BNP and cardiac
troponin I concentrations in adult patients undergoing cardiac
surgery.
Methods A prospective study was carried out in a total of 181
consecutive patients undergoing elective coronary artery bypass or
valve surgery patients. BNP and cardiac troponin I concentrations
were measured immediately after surgery (day 0), and at day 1
after surgery (day 1). Postoperative cardiac dysfunction was
defined as low output cardiac or hemodynamic instability requiring
inotropic support for >24 hours. Pulmonary dysfunction was
defined as postoperative hypoxemia (rate PO2/FiO2 < 200) or time
to extubation longer than 360 minutes. Univariate and multivariate
analyses were performed.
Results A significant secretion of BNP was observed after cardiac
surgery. Independent predictors of cardiac dysfunction were
higher values of BNP and troponin measured on day 0 and on day
1 (P = 0.0001), higher levels of CKMB (P = 0.006), and lower
ejection fraction (P = 0.05). Independent predictors of pulmonary
dysfunction were elevation of BNP on day 0 (P = 0.0005) and on
day 1 (P = 0.02). BNP levels higher than 300 pg/ml were
associated with higher rates of renal failure (P = 0.0001). A BNP
level higher than 300 pg/ml and a troponin level higher than 15
ng/ml was associated with a higher risk of mortality (P = 0.0001).
Conclusions Postoperative BNP and cardiac troponin are
independent predictors of mortality and cardiac and pulmonary
dysfunction after cardiac surgery. Higher levels of BNP are also
correlated with higher rates of renal failure after cardiac surgery.
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Introduction We sought to determine whether amino-terminal pro-
brain natriuretic peptide (NT-proBNP) predicts ICU outcome in a
representative cohort of mechanically ventilated, critically ill patients.
Methods A total of 234 consecutive patients (109 men – median
age: 60 years) with a wide range of admitting diagnoses (medical,
surgical, and multiple trauma cases) were included in this
prospective study that was conducted in two ICUs of tertiary
hospitals over an 18-month period. The following data were
recorded upon ICU entry: age, sex, admitting diagnosis, severity of
critical illness according to the APACHE II score, degree of organ
dysfunction quantified by the SOFA score and the presence of
sepsis using established criteria. Exclusion criteria included
chronic heart failure defined by a left ventricular ejection fraction
<50% on admission echocardiography, and pre-existent renal
insufficiency (history of serum creatinine >1.8 mg/dl before ICU
entry). The primary end point was ICU outcome.
Results Nonsurvivors (n = 98) had significantly higher NT-proBNP
levels on ICU admission (2,074 vs 283 pg/ml, P < 0.001), on day
1 (2,197 vs 221 pg/ml, P < 0.001) and on day 2 (2,726 vs 139
pg/ml, P < 0.001) than survivors (n = 135). Receiver operated
characteristics (ROC) analysis showed that the area under the
ROC curve with regard to ICU mortality prediction was 0.70 for
APACHE II and 0.77 for admission NT-proBNP. The cutoff value in
admission NT-proBNP that best predicted outcome was 941
pg/ml. Multiple logistic regression analysis revealed that APACHE
II score (OR = 1.06, 95% CI = 1.01–1.11, P = 0.007) and the
best cutoff point in NT-proBNP (OR = 7.74, 95% CI = 4.00–14.9,
P < 0.0001) independently predicted ICU outcome.
Conclusions In a representative mixed ICU population, non-
survivors have consistently higher NT-proBNP levels compared
with survivors. Admission NT-proBNP concentrations provide
independent prognostic information for ICU mortality.
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Introduction Elevated levels of B-type natriuretic peptides are
reported in hypo-osmolal hyponatraemia with natriuresis in cerebral
salt wasting (CSW) syndrome. The aim of our study was to
evaluate serum N-terminal pro-B-type natriuretic peptide (NT-
proBNP) and its relationship with renal function parameters in
patients with acute brain diseases who developed CSW.
Methods We prospectively measured NT-proBNP in 12 patients
(mean age 46 ± 17 years, seven men) with acute brain diseases
(four subarachnoid haemorrhage, five tumour, three trauma, mean
Glasgow Coma Scale 13 ± 2.7). All patients were classified as
New York Heart Association (NYHA) I and none had pulmonary
oedema. The mean Glasgow Outcome Scale upon discharge from
the neurologic–neurosurgical ICU was 4 ± 1.2. Diagnoses of CSW
(mean serum sodium 129 ± 3.6 mmol/l) were stated by evaluation
of renal function parameters – only with clearance of creatinine
above 1.15 ml/s. Urine was collected within 24 hours. The control
group was made up of patients with acute brain diseases,
normonatraemia, NYHA I and normal renal parameters (n = 20
patients).
Results We found significantly higher levels of NT-proBNP in
patients with CSW (430.4 ± 706.4 pg/ml) compared not only with
the reference range (125 pg/ml, P = 0.001) but also with the
control group (268.3 ± 203.9, P < 0.001). There were no
differences in fluid intake (P = 0.440) between the two groups, but
patients with CSW had higher sodium intake per kilogram of body
weight (P = 0.024), diuresis (P = 0.019), daily sodium output (P =
0.036), electrolyte clearance (P = 0.001) and sodium clearance
(P = 0.007). Further analysis of the control group did not show any
relationship between NT-proBNP and measured parameters, in
contrast to CSW, where we found a negative relation between NT-
proBNP and serum sodium (P = 0.022), fluid intake (P = 0.047),
osmotically active substances clearance (P = 0.031) and electro-
lyte clearance (P = 0.047). No further correlations were found.
Conclusions Our results showed that natriuresis with hypo-
osmolal hyponatraemia in CSW were related to significant higher
serum levels of NT-proBNP with a negative correlation to serum
sodium and fluid intake, compared with patients with acute brain
disease and normonatraemia.
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Introduction Plasma B-type natriuretic peptide concentration
(BNP) is a marker of cardiac dysfunction [1]. It is unclear why
extremely high concentrations have been reported in sepsis with
preserved systolic function [2]. This study sought to evaluate
relationships between BNP and in vivo diastolic function in a rat
cecal ligation and perforation (CLP) model of sepsis.
Methods With institutional ethics committee approval (UQ AEC
Protocol 675/05), 24 male Sprague–Dawley rats (518 ± 56 g)
were studied. Rats were assigned to CLP (n = 12), sham surgery
(sham, n = 6) or anaesthesia without surgery (control, n = 6).
Echocardiography (15 MHz rodent probe) and venous blood
sampling (BNP enzyme immunoassay) were performed prior to
intervention (baseline; T0) and 18–22 hours following intervention
(final; T2).
Results Prior to final evaluation, three CLP rats (25%) and one
sham rat (during anaesthesia) died. Baseline differences between
groups (ANOVA) were demonstrated for heart rate (HR) (CLP 340
± 36 bpm, sham 351 ± 19 bpm, control 300 ± 12 bpm; P = 0.02),
peak passive to active diastolic transmitral velocity ratio (E/A) (CLP
1.7 ± 0.65, sham 1.26 ± 0.27, control 2.34 ± 0.59; P = 0.048)
and A velocity (CLP 0.574 ± 0.13 m/s, sham 0.733 ± 0.33 m/s,
control 0.411 ± 0.07 m/s; P = 0.03). BNP was not significantly
different between groups (CLP 0.676 ± 0.179 ng/ml; sham
0.719 ± 0.202 ng/ml; control 0.503 ± 0.006 ng/ml; P = 0.07). At
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T2, CLP was compared with sham and control (ANCOVA with
adjustment for baseline values). Compared with control rats, CLP
rats demonstrated higher HR (CLP 402 ± 46 bpm, control 305 ±
11 bpm; P = 0.003), higher A velocity (CLP 0.802 ± 0.152 m/s,
control 0.501 ± 0.103 m/s; P = 0.01), and lower E/A (CLP 1.02 ±
0.23, control 1.74 ± 0.46; P = 0.004). BNP was not significantly
different in the CLP group (CLP 0.743 ± 0.225 ng/ml, sham 0.756
± 0.213 ng/ml (P = 0.3), control 0.509 ± 0.026 ng/ml (P = 0.7)).
At T2, multiple linear regression with backward elimination yielded
HR as the only independent predictor of BNP (adjusted r2 = 0.56,
P < 0.001).
Conclusions In this model, sepsis was associated with
echocardiographic evidence of diastolic dysfunction resembling
clinical sepsis without an associated increase in BNP. HR was an
independent predictor of BNP, accounting for 56% of variation.
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Introduction The objective of our study was to investigate how
methemoglobin (MetHb) levels reflect the occurrence and severity
of sepsis. MetHb is generated of nitric oxide (NO) through
interaction with hemoglobin in a variety of patients [1]. This
includes patients in sepsis with a potentially higher NO generation.
Methods Six hundred and sixty-five patients of a university ICU
were included in a retrospective study to analyze data after onset
of sepsis (day 0) and 24 hours later (day 1). Eligible for inclusion
were sepsis or severe sepsis patients as defined by ACCP/SCCM
consensus conference and control ICU patients, both with
measured MetHb levels and age >18 years. The recorded SOFA
score on day 0 was used to stratify the study population in less
severely (≤10 points) and more severely (>10 points) patients.
After verification of skewness, septic and nonseptic patients and
SOFA groups were compared using the Mann–Whitney U test.
P < 0.05 was considered significant.
Results Of 665 patients, 71% (n = 469) had a SOFA score ≤10.
Forty-five percent (n = 211) of them had sepsis. One hundred and
sixty-four out of 196 severely ill patients (SOFA score > 10) had
sepsis. MetHb levels were significantly higher in patients with
sepsis compared with nonseptic patients on day 0 (SOFA ≤ 10:
0.72 ± 0.27% vs 0.65 ± 0.15% (P < 0.01); SOFA > 10: 0.79 ±
0.21% vs 0.62 ± 0.17% (P < 0.01)). On day 1 similar results
comparing septic and nonseptic patients were obtained (SOFA
≤ 10: 0.73 ± 0.24% vs 0.63 ± 0.16% (P < 0.01); SOFA > 10:
0.80 ± 0.24% vs 0.69 ± 0.20% (P < 0.01)). If sepsis was more
severe, as defined by SOFA score > 10, significantly higher MetHb
levels were observed compared with sepsis patients with SOFA
scores ≤10 on day 0 and day 1 (P < 0.01).
Conclusions Our data suggest that increased MetHb levels reflect
the severity of disease defined by SOFA score. Furthermore,
MetHb levels may have the potential to contribute to the diagnosis
of sepsis. This potential of MetHb levels needs prospective
validation.
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1. Kosaka H, et al.: Free Radic Biol Med 1989, 7:653-658.
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Introduction Lactate is one of the most crucial intermediates of
carbohydrate and nonessential amino acid metabolism. Moderate
hyperlactatemia in the immediate postoperative cardiac surgical
period is associated with a high risk of major complications [1,2].
Methods We audited 246 unselected, consecutive postoperative
patients who were admitted post cardiac surgery over 3 months via
interrogation of the blood gas analysis machine at the London
Chest Hospital. Patients were divided into three groups according
to lactate levels for their first 24 hour stay on the intensive therapy
unit (ITU): normal up to 2 mmol/l (NoHL), moderate 2.1–4.9 mmol/l
(MHL), severe hyperlactatemia >5 mmol/l (SHL) [3]. The length of
stay in the ITU was also identified.
Results See Tables 1 and 2.
Table 1 (abstract P449)
Normal, moderate and severe hyperlactatemia groups
Lactatemia Average age 
level Total Male (%) Female (%) (years)
NoHL 121 100 (40.6) 21 (8.5) 66
MHL 112 89 (36.2) 23 (9.3) 68
SHL 13 10 (4) 3 (1.2) 72
Table 2 (abstract P449)
Patient length of stay in ITU related to maximum lactate levels in
the first 24 hours
Length of stay NoHL (%) MHL (%) SHL (%)
≤24 hours 100 (82.6) 72 (64.3) 4 (30.7)
≤48 hours 14 (11.6) 23 (20.5) 3 (23.1)
>48 hours 7 (5.7) 17 (15.1) 6 (46.2)
Conclusions We can confirm that hyperlactatemia during the first 24
hours post cardiac surgery is associated with a prolonged ITU stay.
References
1. Micheal JM, et al.: Frequency, risk factors and outcome of
hyperlactatemia after cardiac surgery. Chest 2003, 123:
1361-1366.
2. Iqbal M, et al.: Effect of cardio pulmonary bypass on lactate
metabolism. Intensive Care Med 2003, 29:1279-1285.
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Introduction Perfusion parameters are goals of standard treatment
in shock states and have prognostic significance in critically ill
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patients. After cardiac surgery, factors such as a low ejection
fraction, longer duration of pump and perioperative ischemia may
prolong the stay in the ICU. We sought to determine whether
perfusion parameters as lactate and base excess may predict
duration of stay in the ICU after cardiac surgery.
Methods We performed a consecutive observational study in a
university hospital. A total of 98 patients undergoing elective
coronary artery bypass graft surgery were evaluated. Samples of
lactate, arterial gases, and central venous saturation (ScVO2) were
collected 60 minutes after the beginning of surgery (initial) and at
the end of procedure (final). Perfusion parameters were analyzed:
central venous saturation (low <70%, normal >70%), base excess
(low <–3 mol/l, normal >–3 mol/l), lactate (high >2.2 mmol/l,
normal <2.2 mmol/l), carbon dioxide gap (abnormal >5, normal
<5). A long ICU stay was considered more than 7 days. Univariate
and multivariate analyses were performed.
Results Risk factors for a longer time of ICU stay were a high initial
carbon dioxide gap (P = 0.004) and a low level of initial base
excess (P = 0.004). In a multivariate analysis, a low level of initial
base excess is an independent predictor of a longer time of ICU
stay after cardiac surgery (OR = 4.7; 95% CI, 3.45–47). Neither
lactate nor ScVO2 showed correlation with longer duration of ICU
stay after cardiac surgery.
Conclusions In this observational study, high postoperative carbon
dioxide gap and low base excess predicted the length of ICU stay
after cardiac surgery. These findings suggest that these parameters
may be markers of prognosis after cardiac surgery and support the
role of hemodynamic optimization in reducing complications.
References
1. Baker J, Coffernils M, et al. Blood lactate levels are superior
to oxygen-derived variables in predicting outcome in
human septic shock. Chest 1991, 99:956-962.
2. Rivers E, Nguyen B, et al. Early goal-directed therapy in the
treatment of severe sepsis and septic chock. N Engl J Med
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Introduction In cardiorespiratory failure there is an oxygen-
metabolism imbalance mirrored in a timely fashion by a rise in
blood lactate associated with a lowering of blood pH. If the
therapeutic approach were able to repay this oxygen debt and to
restore an adequate blood flow to the lactate-remover organs,
effective lactate clearance (LC) should be observed. The study aim
was to evaluate whether a short-term (2 hour) LC could be used as
a prognostic marker to tailor the therapy in cardiorespiratory
insufficiencies.
Methods Ninety-seven consecutive admissions to our emergency
department for acute cardiorespiratory insufficiency were included.
Exclusion criteria were sepsis, GCS < 8 and need for immediate
intubation. Arterial blood gas analysis (BGA) and lactatemia were
assessed at emergency department arrival and 2, 6, and 24 hours
later. LC was calculated as:  [lactate start - lactate 2 hours] x 100 /
lactate start. The 7-day mortality or orotracheal intubation (negative
outcome) versus discharge or downward transfer (positive
outcome) was evaluated. A logistic regression model was
performed taking into account different risk factors.
Results Of the 97 patients enrolled (54 females, 43 males; age
76.5 ± 9.6 years; APACHE II score 19.3 ± 4.5), 70.1% had a
positive outcome and 29.9% had a negative outcome (7-day
mortality 15.5%), 86.2% of patients with negative outcome had LC
< 25% versus 17.6% in those with positive outcome. The mean
LC in the positive outcome group was 43.6 ± 30.1 versus –12.2 ±
46.9 in that with negative outcome (P < 0.0001). Arterial lactate at
2 hours also correlated with outcome (2.2 ± 0.9 vs 4.7 ± 2.8
mmol/l in positive vs negative outcomes, respectively; P < 0.0001),
but when a cutoff value of 25% was used, LC showed a stronger
significance (Table 1). LC < 25% had a better specificity than
lactate at 2 hours > 2 mmol/l (83.3 vs 73.0%), with higher negative
predictive value (93.3 vs 53.3%).
Conclusions The systematic monitoring of 2-hour LC could be
used in cases of acute cardiorespiratory insufficiencies to identify
high-risk patients who require more aggressive therapy/monitoring.
On the other hand, 2-hour LC > 25% is highly predictive of
positive outcome and may confirm the therapeutic approach.
P452
Interpretation of serum lactate levels in septic
hyperlactatemic patients with acute respiratory distress
syndrome
S Milanov, G Georgiev, V Todorova, M Milanov
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Introduction Increased serum lactate levels are used as a
surrogate marker of tissue hypoxia in critically ill patients [1]. The
aim of this study was to define the significance and the origin of
hyperlactatemia in septic acute respiratory distress syndrome
(ARDS) patients.
Methods We prospectively observed 21 consecutive septic
ARDS patients (standardized criteria) with a hyperlactatemia for a
period of 24 months in a general ICU (17 beds, Pirogov
Emergency Institute, Sofia, Bulgaria). Parameters of oxygen
transport, haemodynamics and metabolism were defined with the
aid of pulmonary artery catheterization and indirect calorimetry for a
10-day period. In addition, the transpulmonary lactate gradient
(LACTtp = LACT(v) – LACT(a) (mmol/l)) and transpulmonary
lactate flux (LACTtf = LACTtp x COtd (mmol/min, mmol/hour))
were calculated to assess the presence of intrapulmonary lactate
production/consumption.
Results We found positive values of transpulmonary lactate flux
and transpulmonary lactate gradient in all patients, which
determines the pulmonary lactate kinetics as pulmonary lactate
production. There were statistically significant epidemiological
differences in pulmonary lactate kinetics. The mortality in this study
was 47%, higher in patients with direct lung injury. We did not
observe pathological supply dependency of oxygen consumption
using the method of indirect calorimetry.
Conclusions These results define the lung as the main lactate-
producing organ in septic hyperlactatemic patients with ARDS, which
in the absence of a pathological supply dependency of oxygen
Available online http://ccforum.com/supplements/12/S2
Table 1 (abstract P451) 
Negative Positive 
outcome outcome 
(n = 29) (n = 68) OR (95% CI)
LC at 2 hours < 25% 25 12 29 (8.6–99), 
P < 0.0001
Lactate at 2 hours 26 32 7.7 (2–28), 
> 2 mmol/l P = 0.0006
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consumption outlines the risk of wrong interpretation of serum lactate
levels as a surrogate marker of tissue hypoxia in these patients.
Reference
1. Leverve XM, et al.: Lactate: a key metabolite in the intercel-
lular metabolic interplay. Crit Care 2002, 6:284-285.
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Introduction Sensory neurons release calcitonin gene-related
peptide (CGRP) upon activation. We have previously reported that
activation of sensory neurons increases insulin-like growth factor-I
(IGF-I) production, thereby reducing ischemia/reperfusion (I/R)-
induced liver injury in mice. Although immunoglobulin has been
shown to reduce organ failures by attenuating inflammatory
responses in various animal models of sepsis, its therapeutic
molecular mechanism(s) is not fully understood. Since sensory
neurons have an Fcγ receptor, it is possible that intravenous
immunoglobulin reduces reperfusion-induced renal injury by
increasing IGF-I production through sensory neuron activation. We
examined this possibility in the present study.
Methods The right renal vessels were clamped in wildtype (WT)
and congenital αCGRP-deficient mice (CGRP–/–) for 45 minutes
after left nephrectomy. Intravenous immunoglobulin (IVIg) (100 mg/kg)
was administered immediately before ischemia (pretreatment) or
15 minutes after reperfusion (post-treatment).
Results Both pretreatment and post-treatment with IVIg reduced
I/R-induced renal injury and enhanced increases in renal tissue
levels of IGF-I in WT mice. In contrast, neither pre-treatment nor
post-treatment with IVIg showed any therapeutic effects in
CGRP–/– mice. Reperfusion-induced apoptosis of renal tubular
cells was markedly suppressed by IVIg in WT mice, but not by IVIg
in CGRP–/– mice. Pretreatment with anti-IGF-I antibody completely
reversed the therapeutic effects of IVIg in WT mice. Both CGRP
and IGF-I showed therapeutic effects similar to those of IVIg in WT
and CGRP–/– mice. Although the F(ab′) fragment of IgG did not
increase CGRP release from cultured dorsal root ganglion
neurons, the Fcγ fragment increased CGRP release from cultured
dorsal root ganglion neurons in vitro. Administration of the Fcγ
fragment significantly reduced renal injury in WT mice, while the
F(ab′) fragment of IgG did not.
Conclusions These observations strongly suggested that IVIg
might reduce reperfusion-induced renal injury by enhancing IGF-I
production through prevention of renal tubular cell apoptosis. The
therapeutic effects of IVIg might mainly depend on the Fcγ
fragment that is capable of activating sensory neurons.
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Introduction The use of intravenous immunoglobulins (IVIG) in the
treatment of human sepsis remains controversial. The aim of this
study was to assess the effects of IVIG in patients with severe
sepsis with or without septic shock on mortality and morbidity
compared with standard treatment of sepsis.
Methods This prospective controlled study included 32 patients
randomized according to the type of sepsis treatment into: 16
patients with standard treatment of sepsis plus IVIG, and 16
patients with standard treatment of sepsis as controls. IgM-
enriched IVIG was given at a dose of 5 ml/kg/day for three
consecutive days. APACHE II and SOFA scores were calculated
on days 1 and 4 and then day 14. Recording of any side-effect
related to IVIG therapy was done to test the drug tolerability. Serial
levels of serum TNFα, IL-1, IL-6, L-10 and serum CD14 were
measured daily.
Results Compared with conventional treatment of sepsis, IVIG
reduced APACHE II and SOFA scores significantly on day 14 of
hospitalization. The serum procalcitonin (PCT) level showed a
significantly consistent decline from day 1 to day 14 in IVIG-treated
patients of the entire group as well as the severe sepsis and septic
shock subgroups. The PCT level always showed a rise in
conventionally treated patients from day 1 to day 14 in the entire
group and severe sepsis and septic shock subgroups. Significant
decline in the serial CD14 and IL-I levels from day 1 to day 5
occurred in the IVIG-treated entire group of patients as well as the
severe sepsis and septic shock subgroups of patients. The
mortality rate was significantly lower in IVIG-treated patients with
severe sepsis compared with conventionally treated patients (40%
vs 70%). In IVIG-treated patients with septic shock, the mortality
rate was 100% just like that of the conventionally treated patients
with septic shock.
Conclusions Used early enough, IVIG therapy induces substantial
improvement in morbidity and mortality in patients with severe
sepsis, but could not demonstrate any beneficial effect on the
morbidity or mortality rate in patients with septic shock. The
improvement in the clinical course and ultimate outcome of severe
sepsis is paralleled by a consistent decline in serum levels of IL-6,
PCT and CD14.
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Introduction Sepsis is a serious problem of ICUs due to high
mortality. Adsorption of lipopolysaccharide (LPS) circulating in
blood at Gram-negative infections may prevent systemic inflam-
matory cascade progressing. The aim was to study LPS adsorption
efficacy in combined therapy of patients with severe Gram-
negative sepsis.
Methods Nine surgical patients with severe sepsis were enrolled
into the study: six patients underwent cardiac surgery with
cardiopulmonary bypass, three patients with severe pancreatitis.
The mean age was 50.8 ± 4.7 years. All patients required inotropic
support, eight patients were on mechanical ventilation. The mean
APACHE II score was 21.1 ± 3.8 points. Each patient received
two LPS adsorption procedures (LPS-adsorber; Alteco Medical
AB, Sweden). Each session takes 120 minutes. The blood flow
rate was 100–150 ml/min, anticoagulation was heparin 4–10
U/kg/hour. In addition to routine tests, detection of LPS (LAL-test;
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Cembrex, USA), proinflammatory cytokines TNFα, IL-1β, IL-6 (IFA;
Bends Med. Systems, Austria) and procalcitonin (PCT) concen-
trations (PCT LIA; BRAHMS AG, Germany) were performed. The
data are expressed as the median and 25th and 75th percentiles
and were compared by Mann–Whitney U test; P < 0.05 was
considered statistically significant.
Results Decreasing LPS, proinflammatory cytokines and PCT
concentrations after LPS adsorption were observed (see Figure 1).
Insignificant and short-term (10–15 min) depression of the arterial
pressure and systemic vascular resistance with unchanged cardiac
output was noted at the beginning of the first procedure of LPS
adsorption. Stabilization of hemodynamics was reached by
temporary increasing inotropic support. Despite the combined
treatment 6/9 (67%) patients died due to cardiac failure (n = 3)
and multiorgan failure (n = 3) progressing.
Conclusions Our experience of LPS adsorption shows evidence
of potential efficacy of this method in combined therapy for severe
Gram-negative sepsis. Further investigations are required.
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Introduction Septic shock remains a major cause of multiple organ
failure, with a high mortality rate, and severe pneumonia is one of
the major causes of septic shock. The existence of a relationship
between lung injury and the serum level of F2-isoprostane, as a
known oxidative stress marker, was recently reported. The
technique of direct hemoperfusion (DHP) with a polymyxin B-
immobilized fiber column (PMX; Toray Industries Inc., Tokyo Japan)
was developed in Japan in 1994, and it has been used for the
treatment of endotoxemia in septic shock. Reduction of the serum
levels of several endotoxins following PMX has been recognized.
Methods We treated 12 patients with severe pneumonia
complicated by septic shock by direct hemoperfusion with PMX.
The patients were divided into two groups based on the results of
analysis of the oxygenation status immediately after DHP-PMX
(Group A, increase of the PaO2/FiO2 ratio by more than 20% (six
cases); Group B, increase of the PaO2/FiO2 ratio by 20% or less
(six cases)). The serum levels of inflammatory mediators (high
mobility group box-1 protein, N-arachidonoylethanolamine, 2-
arachidonoyl glycerol, plasminogen activator inhibitor 1 and F2-
isoprostane) were measured at four time points; before,
immediately after, and 1 and 3 days after the DHP-PMX. During the
same period, as compared with cases of septic shock of other
causation (n = 26) that were treated by DHP-PMX, the pneumonia
cases showed significantly higher SOFA scores (15.2 ± 5.2 vs 9.9 ±
3.6; P = 0.0331) and low survival rates (25% vs 73%; P = 0.0017).
Results The average patient age was 60.4 years; six of the
patients were men and six were women. The average APACHE II
score was 32.2 ± 9.9, and the average SOFA score was 15.2 ±
5.2 before DHP-PMX. Three patients survived and nine died. Only
the serum levels of F2-isoprostane, a marker of oxidative stress,
were significantly increased in Group B (P = 0.0331).
Conclusions The existence of a relationship between the serum
levels of F2-isoprostane and rebellious cases by a poor result of
DHP-PMX in severe pneumonia patients became evident. Further-
more, cases of septic shock associated with severe pneumonia
showed a more serious general condition, and suggested
prediction of a poor outcome. The results suggest that therapy
targeted against oxidative stress may be important in cases of
septic shock caused by severe pneumonia.
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Introduction Septic shock is a condition associated with diffuse
coagulopathy and multiple organ failure, and frequently ends in
death. The effectiveness of continuous venovenous hemodia-
filtration (CVVHDF) using a polymethylmethacrylate membrane
hemofilter (PMMA) for critically ill patients has also been reported.
Methods We treated 18 septic shock patients by CVVHDF. The
patients were divided into two groups: namely, a group in which
CVVHDF using PMMA therapy was added (11 cases), and a
group in which CVVHDF using a polyacrylonitrile membrane
hemofilter (CVVHDF using PAN) therapy was added (seven
cases). The outcomes in the two groups were compared.
Results The average APACHE II score and the average SOFA
score were not significantly different between the two groups. The
CVVHDF using PMMA group showed significantly better out-
comes, with significant improvements of the serum plasminogen
activator inhibitor 1 (PAI-1), protein C, IL-6 and N-arachidonoyl-
ethanolamine (AEA) levels.
Conclusions Therapies aimed at blood purification, such as
CVVHDF, continuous hemofiltration and plasma exchange have
been reported to be effective for the removal of inflammatory
cytokines and various mediators. Few reports have shown the
influence of the column used for CVVHDF on the removal
efficiency of the abovementioned factors, although several columns
have been used in CVVHDF. CVVHDF using PMMA has been
reported to be effective for cytokine removal. Our findings suggest
removal of IL-6, AEA and PAI-1 by CVVHDF using PMMA; and
CVVHDF using PMMA resulted in better outcomes and an
improved survival rate in septic shock patients.
Reference
1. Matsuda K, et al.: Current topics on cytokine removal tech-
nologies. Ther Apher 2001, 5:306-314.
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Figure 1 (abstract P455)
Dynamics of lipopolysaccharide (LPS), cytokines and procalcitonin
(PCT).
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Introduction The aim of the study was to evaluate the clinical
impact of polymyxin-B hemoperfusion (HP-PMX) as adjuvant therapy
versus conventional treatment in septic shock (SS) patients with
high endotoxemia.
Methods A retrospective analysis of the clinical profile and
evolution related to the treatment strategy of SS patients with a
high endotoxin activity (EA) level (>0.6 units) attending our ICU
from January to August 2007. All patients (n = 16) were treated
with standard therapy (ST) according to the Surviving Sepsis
Campaign. According to our ICU practice, adjuvant therapy with
HP-PMX (twice, 2 hours/session with an interval of 24 hours) was
performed only in SS patients with known or presumed Gram-
negative and Gram-positive infections, worsening of haemo-
dynamic instability in the next 6 hours of diagnosis and ≥3 organ
failures (PMX group, n = 8). The clinical profile was evaluated in
the two groups (ST vs PMX group) at T0 (SS diagnosis, start of
HP-PMX) and at T1 (at 48 hours). The Student t test for paired
values was used for statistical purpose (P < 0.05 significant).
Results At T0, the clinical profile of the two groups of high EA level
SS patients was similar (EA level, age, SOFA score, mean arterial
pressure, norepinephrine, lactates, PaO2/FiO2, continuous renal
replacement therapy, used of activated protein C). Otherwise the
PMX group showed a significant improvement of clinical conditions
compared with the ST group at T1 (Table 1). The ICU length of
stay was significantly longer in the PMX group versus the ST group
(21.5 ± 21.3 vs 53.6 ± 67 days, P < 0.05). Further PMX-HP
resulted in a reduction of ICU mortality when compared with ST in
high EA level SS patients, probably due to endotoxin removal
(45% vs 16%, not significant due to small sample size).
Table 1 (abstract P458)
Evolution of high endotoxin activity level in septic shock patients
T0 T1 P value
Norepinephrine, ST group 0.58 0.33 Not significant
Norepinephrine, PMX group 0.85 0.28 <0.05
SOFA score, ST group 11.5 11.1 Not significant
SOFA score, PMX group 14.15 12.17 <0.05
Lactate, ST group 5.41 4.71 Not significant
Lactate, PMX group 7.94 5.35 <0.05
Conclusions We can question whether the EA level could be a
useful guide to early institution of specific anti-lipopolysaccharide
treatments.
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Introduction Despite developing therapeutic strategies, mortality
of sepsis and septic shock has actually remained at a level of about
35–50%. The objective was to study the safety and effectiveness
of a newly developed cytokine adsorption column in patients with
sepsis and septic shock.
Methods This study was a prospective, randomized, controlled
clinical trial. The newly developed column contains microporous
cellulose beads with a hexadecyl alkyl chain as the ligand. Eighteen
patients with early septic shock or septic organ dysfunction were
enrolled. Nine of 18 patients were randomized to direct
hemoperfusion (DHP). All patients received supportive intensive
care, and those randomized to DHP received direct hemoperfusion
for 4 hours more than two times up to 14 times during 14 days.
Results The decrease of the APACHE II score from the
pretreatment level at the seventh day was significantly larger in the
treatment group than in the control group (P = 0.0189;
Mann–Whitney test). Adsorption-column-related serious adverse
events were not observed in the DHP group. The concentration of
IL-6 and IL-8 in the plasma decreased from the pretreatment level
in the DHP group significantly (P = 0.0464 and P = 0.0464,
respectively; Wilcoxon test).
Conclusions The newly developed DHP column improved the
septic shock better than the ordinary supportive intensive care.
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Introduction Extracorporeal blood purification techniques for the
treatment of sepsis remain conceptually sound but are still an
unresolved issue. Coupled plasma filtration adsorption (CPFA)
enabling higher nonselective elimination of septic mediators
represents a promising concept [1]. Its efficacy, however, has not
been tested in a clinically relevant large animal model of septic
shock. We therefore evaluated the biological effects of CPFA in a
porcine long-term, hyperdynamic, peritonitis-induced septic shock
model.
Methods In 16 mechanically ventilated and instrumented pigs,
fecal peritonitis was induced by inoculating autologue feces.
Twelve hours after induction of sepsis, the pigs were randomly
allocated to 10 hours of either CPFA (n = 8) or standard treatment
(Control, n = 8). Before, 12, 18 and 22 hours after the induction of
peritonitis, we measured, in addition to systemic and regional
hemodynamics, ileal mucosal and renal cortex microvascular
perfusion (OPS and laser Doppler flowmetry). Energy metabolism
was determined by measuring arterial, hepatic, portal and renal
venous lactate/pyruvate (L/P) ratios and hepatic venous ketone
body (KBR) ratios. Plasma IL-6 and TNFα levels were also
determined.
Results All animals in both groups required noadrenaline infusion
to maintain the mean arterial pressure above 70 mmHg. Neither the
dose of vasopressor support nor the median time to development
of arterial hypotension differed between the groups. In the control
group, hyperdynamic septic shock resulted in a progressive
deterioration of intestinal mucosal and renal cortex microvascular
perfusion despite well-maintained regional blood flows. Altered
microcirculation was paralleled by gradually increased systemic
and regional L/P and KBR. Although CPFA blunted the otherwise
progressive increase in plasma TNFα levels, it failed to beneficially
influence sepsis-induced alterations in microvascular perfusion and
energy metabolism.
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Conclusions In our experimental model, CPFA did not afford
protection against septic shock-induced hemodynamic,
microcirculatory and metabolic disturbances.
Acknowledgement Supported by research project MSM
0021620819.
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Introduction Septic shock remains the main cause of late death of
patients admitted to the ICU. Despite recent advances in medical
support and treatment, this mortality has not changed significantly.
The treatment of direct hemoperfusion using polymyxin-B
immobilized fiber (PMX-DHP) has shown that an increase of blood
pressure was observed in patients with septic shock caused by
Gram-negative infection. The performance time of PMX-DHP is
usually 2 hours in Japan. In this study, we investigated the clinical
efficacy of the long-term performance of PMX-DHP.
Methods We treated 10 patients with septic shock caused by
Gram-positive infection including MRSA as well as Streptococcus
pneumonia and Clostridium using the PMX-DHP treatment.
Results An increase of blood pressure was observed in eight out
of 10 (80%) patients with septic shock. The average performance
time of PMX-DHP was 6.5 hours to improve the blood pressure.
Conclusions Our results suggest that septic shock caused by
Gram-positive infection seems to be improved by long-term
performance with PMX-DHP treatment.
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Introduction IL-6 is a multifunctional cytokine that plays an
essential role in the pathogenesis of severe sepsis. The G/C
polymorphism at position –174 of the IL-6 gene is associated with
an adverse outcome in a number of inflammatory diseases,
although its association with outcome in adult patients with severe
sepsis remains unclear. We tested the hypothesis that IL-6
promoter polymorphism –174 C/G is associated with increased
mortality among ICU patients with severe sepsis.
Methods The study was conducted in the mixed medical–surgical
adult ICU of Stradins University Hospital in Riga in 2007. A total of
69 critically ill patients who met the proposed severe sepsis criteria
were included. The IL-6 –174 G/C polymorphism was genotyped
by sequencing. Patients were followed up throughout their stay in
the ICU to their clinical outcome. The frequency distribution of the
genotypes in the patient subgroups were compared using the
Pearson χ2 test. P < 0.05 was considered to indicate statistical
significance.
Results Of the 69 severe sepsis patients observed, 18 (26%) had
G/G at position –174 of IL-6 gene, 41 (59%) were heterozygous
C/G, and 10 (14%) were homozygous C/C. ICU mortality in the
G/G group was eight patients (44%), in the C/G group 14
patients (34%) and in the C/C group seven patients (70%). There
was no statistically significant difference between groups (P > 0.05).
Conclusions We found no association between IL-6 gene
promoter polymorphism –174 C/G and ICU mortality in severe
sepsis patients.
P463
Association of (CCTTT)10, a nitric oxide synthase 2
promoter polymorphism, with death due to acute lung
injury
D Perez, C Manzon, J Navellou, C Patry, G Capellier
CHU Besançon, France
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Introduction Nitric oxide via inducible nitric oxide synthase
(NOS2) is believed to be a molecule central to the pathogenesis of
acute lung injury (ALI). (CCTTT)n, a polymorphism within the NOS2
gene promoter, has been associated with outcome in some
pathologies. The study objective was to investigate the frequency
of the (CCTTT)n alleles in patients with ALI and to determine
whether their occurrence affects the outcome of ALI.
Methods A monocenter cohort study conducted from June 2006
to February 2007 in a medical ICU in a university hospital. Two
hundred and sixty-four patients were included in the cohort, and
112 patients with ALI. The main outcome measures were the
frequency of the (CCTTT)n alleles among patients with ALI and
among those who died.
Results The polymorphism frequencies of the survivors in the
cohort and the patients with ALI differed only at the (CCTTT)10
allele (10 repetitions) (83% vs 17% in the survivor and nonsurvivor
patients in the cohort, respectively, P = 0.034; 90% vs 10% in the
survivor and nonsurvivor patients with ALI, respectively, P =
0.026). The frequency of the (CCTTT)10 allele among the cohort
and patients with ALI was 15% and 13%, respectively, consistent
with the Caucasian population frequency. A multiple logistic
regression analysis showed that patients with the (CCTTT)10 allele
had a 0.5-fold risk of death in the cohort (P = 0.035) and a 0.22-
fold risk of death in the ALI group (P = 0.029). A Kaplan–Meier
study showed that survival was significantly enhanced among
patients with ALI who had the (CCTTT)10 allele (P = 0.006).
Conclusions The (CCTTT)10 allele, a NOS2 promoter polymor-
phism, is strongly associated with survival in ALI.
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Tranexamic acid effects on postoperative bleeding in
cardiopulmonary bypass surgery according to the
plasminogen activator inhibitor-1 polymorphism
M Brouard, J Iribarren, J Jiménez, L Lorente, R Perez, 
R Santacreu, M Santana, J Rodriguez, P Machado, R Martinez,
M Mora
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Introduction The objective was to determine the effects of
tranexamic acid (TA) on postoperative bleeding in cardiopulmonary
bypass (CPB) surgery according to the 4G/5G plasminogen
activator inhibitor-1 (PAI-1) gene polymorphism, the main
endogenous regulator of fibrinolysis.
Methods We performed a prospective analysis on the
postoperative bleeding effect of TA prophylaxis (2 g), administered
before and after CPB, according to the PAI-1 polymorphism. We
recorded data related to coagulation, fibrinolysis and bleeding,
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preoperatively, at admission (0 hours) to the ICU, and 4 hours and
24 hours postoperatively. SPSS version 15 was used.
Results We studied 50 patients (24 with TA and 26 without TA).
In patients not receiving TA, significant differences were found
between PAI-1 genotype groups (4G/4G; 4G/5G; 5G/5G) in
chest-tube blood loss at 0 hours (P = 0.03), at 4 hours (P =
0.001) and at 24 hours (P = 0.009). Fresh frozen plasma was
required during the ICU stay in 50% of 5G/5G, 25% of 4G/5G
and none of the 4G/4G carriers (P = 0.021). 4G/4G patients did
not show significant differences in blood loss between the TA and
placebo groups. 4G/5G patients receiving TA had lower blood
loss than the placebo group at 0 hours (P = 0.012) and at 24
hours after surgery (P = 0.014). In contrast, 5G/5G patients
receiving TA had significantly lower blood loss compared with the
placebo group at 0 hours (P = 0.028), at 4 hours (P = 0.008) and
at 24 hours (P = 0.004) after surgery. Fifty-five percent of 5G/G
patients in the placebo group received fresh frozen plasma during
the ICU stay compared with no patients in the TA group (P =
0.014).
Conclusions PAI-1 5G/5G homozygotes who did not receive TA
showed significantly greater postoperative bleeding than patients
with other PAI-1 genotypes. The 5G/5G homozygotes who
received TA showed the greatest blood-sparing benefit.
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risk and outcome of pneumonia
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Introduction IL-6 is a pleiotropic cytokine expressed in many
tissues. A polymorphism in the IL-6 gene, associated with differ-
ences in the IL-6 transcription rate, has been recently described
[1]. The influence of genetic polymorphisms of IL-6 gene promoter
–174 G/C on the severity of systemic inflammatory response
syndrome associated with community-acquired pneumonia (CAP)
was studied.
Methods A prospective, multicentric case–control study in three
university hospitals in Spain. In 852 consecutive patients who
presented with CAP and 923 controls, using PCR-RFLP analysis,
we analyzed the –174G/C single nucleotide polymorphism of the
IL-6 gene. The pneumonia severity was assessed on the day of
admission and stratified according to the PORT score and
complications recorded such as respiratory failure, renal
impairment, severe sepsis, shock and multiorgan failure. Outcomes
evaluated were the duration of hospital stay, ICU admittance, and
inhospital and 28-day mortality.
Results See Table 1. The distribution of the G/C 174 genotype
was similar in CAP patients and controls. The genotype distribution
of the polymorphism was 45.07% for GG and 43.89% and
11.03% for GC and CC, respectively. In patients who were
admitted with CAP, no significant differences were observed
compared with progression between groups.
Multivariate analysis (which included genotype, age, sex, and
classical risk factors for CAP) identified the C/C genotype as the
only independent predictor of renal failure.
Conclusions Our findings show that the 174G/C polymorphism is
not associated with risk and outcome of CAP in the Spanish white
Caucasian population.
Reference
1. Schluter B, Raufhake C, Erren M, et al.: Effect of the inter-
leukin-6 promoter polymorphism (-174 G/C) on the inci-
dence and outcome of sepsis. Crit Care Med 2002, 30:
32-37.
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Introduction It has been postulated that genetic predisposition
may influence the susceptibility to infection and disease outcome.
The D allele of the angiotensin-converting enzyme (ACE) gene is
associated with many diseases. However, there are only few
reports available about infection. We have investigated the
association between ACE I/D polymorphism and sepsis, its clinical
features such as shock, acute respiratory distress syndrome
(ARDS), multiorgan dysfunction syndrome (MODS) and mortality.
Methods Ninety-eight patients who had been diagnosed with
sepsis and 100 healthy individuals were included. The patients
were divided into groups based on the presence of shock, ARDS,
MODS and mortality. The ACE gene polymorphism was analyzed
by PCR.
Results There was no statistical difference between the controls’
and patients’ genotype (P = 0.29). No evidence emerged
regarding the association of the ACE I/D polymorphism with
MODS, but there was evidence of an association with sepsis-
related hypotension, mortality and ARDS. While the I/I genotype
was observed to increase the sepsis-related mortality risk 11.5-fold
(P = 0.008), it increased the risk for hypotension 9.5-fold (P <
0.001). On the other hand, it was found that carrying D/D
genotypes increased the risk of the having ARDS 4.5-fold (0R =
4.5, 95% CI 1.15–19.6) (P = 0.028). Meanwhile, in multivariate
logistic analysis, shock is the only factor associated with mortality.
Conclusions The insertion polymorphism in angiotensin-converting
enzyme gene is associated with an increase in the risk of sepsis-
related mortality and shock, but the deletion polymorphism is
associated with an increase in the risk of sepsis-related ARDS.
P467
Incidence of renal failure following orthotopic liver
transplantation is lower in the Asian population
J Read, P Bearfield, B Agarwal
Royal Free Hospital, London, UK
Critical Care 2008, 12(Suppl 2):P467 (doi: 10.1186/cc6688)
Introduction Renal failure is reported as a frequent complication
following orthotopic liver transplantation (OLT) and is associated
with a higher morbidity and mortality [1]. Acute kidney injury and
the need for renal replacement therapy (RRT) are known to be
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Table 1 (abstract P465) 
C/C genotype G/C genotype G/G genotype
No sepsis 10 (13.51%) 32 (43.24%) 32 (43.24%)
Sepsis 53 (10.08%) 236 (44.87%) 237 (45.06%)
Severe sepsis 18 (13.14%) 56 (40.88%) 63 (45.99%)
Septic shock 13 (11.30%) 50 (43.48%) 52 (45.22%)
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generally greater in the Asian population for a number of proposed
reasons, such as higher incidence of diabetes mellitus and
hypertension. In our study the incidence of renal failure and the
need for RRT in the early postoperative period following OLT was
actually lower in this group.
Methods A retrospective case-note review was undertaken on
348 consecutive elective OLTs performed in the period
2000–2007 at our institution. The primary outcome was the
requirement for RRT and renal impairment as per the RIFLE and
AKIN criteria. Patients on RRT pretransplant, acute hepatic failure,
regraft and combined organ transplant were excluded.
Results Two hundred and seventy-one patients fulfilled the
inclusion criteria, of which 45 (17%) were of Asian ethnicity. A total
of 32 patients required RRT in the early postoperative period, of
which only three (9.4%) were Asian. The change in serum
creatinine in the first 48 hours was also examined and is presented
in Table 1. The baseline pretransplant serum creatinine was similar
between the groups: The median serum creatinine was 86 μmol/l
for both the Asian (range 60–179) and non-Asian groups (range
34–264).
Table 1 (abstract P467)
Change in serum creatinine following OLT as per RIFLE/AKIN
criteria
Non-Asian Asian 
ΔCr 48 hours group (n = 22) group (n = 45)
Creatinine > 150% 77 (34%) 19 (42%)
Creatinine > 200% 57 (25%) 11 (24%)
Creatinine > 300%/RRT 36 (16%) 3 (7%)
Conclusions The burden of RRT following liver transplantation
was less in the Asian population. Examination of perioperative
serum creatinine showed that the Asian group actually suffered
mild renal dysfunction to a greater extent (42% vs 34%) but did
not progress to ‘failure’ stage as often as non-Asians (7% vs 16%,
P < 0.05). The reason for this reversal may be partly due to far
fewer Asian transplant recipients with alcoholic liver disease, a
known predisposing risk factor.
Reference
1. Bilbao I, et al.: Risk factors for acute renal failure requiring
dialysis after liver transplantation. Clin Transplant 1998,
12:123-129.
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Introduction Acute renal failure (ARF) is one of the most common
problems of the critical patient, often resulting in acute tubular
necrosis following an impairment in renal hemodynamics. Fenoldo-
pam is a selective dopaminergic agonist specific for dopaminergic
receptor DA-1 that, provoking an increase in renal blood flow,
diuresis and natriuresis, seems to prevent ARF – exerting a nephro-
protective effect.
Methods Patients in the ICU without ARF but at risk of renal
damage (sepsis, nephrotoxic drug administration) were recruited.
Fenoldopam was administered by intravenous infusion (0.05–0.1
μg/kg/min) for 24 hours. Specific tubular enzymatic biomarkers
(β2-microglobulin, microalbuminuria, retinal binding protein, γGT,
alkaline phosphatase, n-acetyl-glucosaminidase) have been dosed
in urine before fenoldopam administration (basal value), at the end
of the infusion (T1) and 24 hours later (T2). Diuresis, blood
creatinine and cystatin C were also measured in the same interval.
All data were compared using a t test and logistic regression
analysis.
Results See Figure 1. Of the 23 patients studied, after informed
written consent, 10 patients received fenoldopam. At T1 a
statistically significant reduction of the tubular biomarkers, cystatin
C and creatinine, and an increase in diuresis were found compared
with basal. At T2 a nonstatistically significant reduction of γGT and
microalbumin and cystatin C associated with an increased urinary
output were observed, showing a benefit on kidney function lasting
even after 48 hours.
Conclusions Our study shows a significant protective effect of
fenoldopam measured by tubular biomarkers after a 24 hour infusion.
Reference
1. Morelli A: Crit Care Med 2005, 33:2451-2456.
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Renal hemodynamic, microcirculatory and metabolic
responses to peritonitis-induced acute kidney injury in pigs
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Introduction The widely held paradigm that renal vasoconstriction
may not be a prerequisite for septic acute kidney injury (AKI) has
recently been challenged [1]. Further research is needed to
establish whether this concept is valid in other clinically relevant
models of sepsis-induced AKI [2]. The aim of our study was
therefore to dynamically assess the pattern of renal hemodynamics,
microcirculation and energy balance during a hyperdynamic
porcine model of progressive septic shock.
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Figure 1 (abstract P468)
Markers of renal function. NAG, n-acetyl-glucosaminidase; B2M, β2-
microglobulin; Microalb, microalbuminuria; PLR, retinal binding protein;
ALP, alkaline phosphatase; GGT, γGT.
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Methods In eight anesthetized, mechanically ventilated and
instrumented pigs, fecal peritonitis was induced by inoculating
autologous feces. Six sham-operated animals served as time-
matched controls. Hyperdynamic circulation was achieved using
hydroxyethylstarch, and norepinephrine was administered to
maintain mean arterial pressure ≥70 mmHg. Before and at 12, 18
and 24 hours of peritonitis, we measured, in addition to systemic
hemodynamics, renal blood flow, renal cortex microvascular
perfusion, renal venous pressure, renal oxygen kinetics and
regional acid–base balance and lactate/pyruvate (L/P) ratios.
Results All pigs developed hyperdynamic septic shock associated
with the development of AKI as evidenced by increased plasma
creatinine levels to 30% of baseline. Although the renal blood flow
slightly decreased by the end of the experiment, renal vascular
resistance remained unchanged. Despite maintained regional
hemodynamics, there was significant and early decline in renal
cortex microvascular perfusion. Although renal oxygen consump-
tion did not change, renal venous acidosis and an increased L/P
ratio developed.
Conclusions Septic AKI was not associated with renal
vasoconstriction. While early alterations in renal cortex
microcirculation preceded a minor decline in renal blood flow,
unchanged renal oxygen consumption together with signs of
significant metabolic stress suggests that the basis for septic AKI
may be attributable not only to changes in microcirculatory
perfusion, but also to disturbed cellular energy machinery
independent of tissue oxygen availability.
Acknowledgement Supported by MSM 0021620819.
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Introduction Rhabdomyolysis is a dissolution of skeletal muscles
causing extravasation of toxic intracellular contents from the
myocytes into the circulatory system. It leads to electrolyte distur-
bances, hypovolemia, and renal failure. The incidence of rhabdo-
myolysis after cardiac surgery and the impact on prognosis are not
known. The purpose of this study was to determine the incidence of
rhabdomyolysis, the associated risk factors and to assess the
prognostic impact in patients undergoing cardiac surgery.
Methods We performed a prospective, observational study in a
tertiary surgical ICU in a university hospital. A total of 200 patients
undergoing elective surgery were evaluated. Creatine kinase (CK)
samples were collected daily (rhabdomyolysis, CK > 2,500 U/l) as
plasma creatinine, CK-MB and troponin. Patients were followed
during the ICU stay and clinical outcomes were evaluated. Renal
failure was defined as >50% increase in serum creatinine from
baseline, and myocardial ischemia as an increase of CK-MB or
troponin greater than five times.
Results Rhabdomyolysis was present in 38 patients (19%). There
were no relations between rhabdomyolysis and hypothermia, sex,
age, cardioprotection or use of vasoactive drugs. Risk factors
were: previous use of statin (P = 0.002), intraoperative
hemodynamic instability (P = 0.045), longer duration of surgery
(P < 0.001), and longer duration of pump (P < 0.0001). The
previous use of statin and a longer duration of surgery were
independent predictors of rhabdomyolysis (statin OR = 3.68, 95%
CI = 1.38–9.83 and longer duration of surgery (minutes) OR =
1.01, 95% CI = 1.006–1.02). The occurrence of rhabdomyolysis
was not associated with higher incidence of renal failure,
myocardial ischemia, mortality and longer time of ICU stay.
Conclusions In this observational study, rhabdomyolysis was a
frequent event after cardiac surgery, present most in patients with
previous use of statin or who presented hemodynamic instability in
the intraoperative period. However, this had no implications with
respect to midterm prognosis.
References
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orthotopic liver transplantation in adults is associated with
prolonged mechanical ventilation and higher incidence of
pneumonia.
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Introduction Acute renal failure requiring renal replacement
therapy (RRT) is common following orthotopic liver transplantation
(OLT) and is associated with increased morbidity and mortality [1].
Prolonged mechanical ventilation in intensive therapy unit (ITU)
patients (>3 days) is associated with increases in length of stay,
costs, mortality, risk of ventilator-associated pneumonia and
sedation requirements [2].
Methods A retrospective cohort study was conducted on 348
consecutive OLTs in adults performed at the Royal Free Hospital
(London, UK) between January 2000 and January 2007. Patients
on RRT pretransplant, acute or fulminant hepatic failure, regraft or
combined organ transplant were excluded. Primary outcomes were
postoperative RRT and renal impairment as defined by the RIFLE
criteria. Data also examined included the number of ventilated
postoperative days, and the presence of a clinical diagnosis of
pneumonia by the ITU physician.
Results Two hundred and seventy-one patients were included.
Thirty-two of them required postoperative RRT. The mean duration
of ventilation, prolonged ventilation, length of ITU stay, incidence of
pneumonia, and ITU mortality were higher in the RRT group (Table 1).
Table 1 (abstract P471)
RRT Non-RRT
n 32 239
MV days (mean (SD)) 20 (19) 5 (12)
Prolonged MV (>3 days) 30 (94%) 51 (21%)
ITU days (median (IQR)) 13(7–24) 2 (1–4)
Pneumonia 15 (47%) 29 (12%)
ITU mortality 34% 4%
MV, mechanical ventilation.
Conclusions RRT after OLT is associated with prolonged mechanical
ventilation, increased risk of pneumonia, and higher ITU mortality.
References
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Introduction Slow continuous ultrafiltration (SCUF) is known to
reduce extravascular water [1,2]. We hypothesized that, in acute
decompensated heart failure, SCUF may reduce both the cardiac
preload and the respiratory workload.
Methods Ten patients (six males, four females; age 76 ± 4 years,
NYHA classes III–IV) admitted to our medical ICU for acute
decompensated heart failure were treated with SCUF (Aquadex-
flex flow; CHF USA). The heart rate (HR), mean arterial pressure
(MAP), arterial blood gas analysis and inferior vena cava (IVC)
diameter with M-mode subcostal echocardiography were
evaluated before (T0) and immediately after (T1) SCUF.
Results The mean ultrafiltration time was 25.5 ± 5 hours with a
mean volume of 259 ml/hour and a total ultrafiltrate production of
6.6 ± 2 l. Differences between T0 and T1 parameters are presen-
ted in Table 1. No hemodynamic instability was observed. A
significant reduction of IVC diameters and PCO2 was founded,
with a near 30% PCO2 reduction in hypercapnic patients (4/10).
Table 1 (abstract P472) 
T0 T1 P value
MAP (mmHg) 85 ± 9 88 ± 12 Not significant
HR (bpm) 86 ± 7 85 ± 14 Not significant
IVC diameter (mm) 25.5 ± 1.7 22 ± 2.8 <0.04
PCO2 (mmHg) 55.5 ± 31 42.7 ± 17 0.01
Conclusions In our preliminary report, SCUF seems to improve
cardiac preload in congestive heart failure and to correct carbon
dioxide in those patients who are hypercapnic too. The latter is
probably due to both lung water [3] and respiratory workload
reduction.
References
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Introduction Chronic obstructive pulmonary disease (COPD) and
heart disease are often associated. Cardiorespiratory decom-
pensation can be related to fluid overload status with increased
LVEDVI, LVEDP, airway resistance and work of breathing. This
often requires tracheal intubation with a difficult weaning from
mechanical ventilation (MV). The basis to treat an overload status
consists of diuretic administration, which has been demonstrated
to be able to reduce airway edema and resistance. Loop diuretics
can induce tolerance. Their use may be associated with increased
morbidity due to deleterious effects, particularly on neurohormonal
activation of the renin–angiotensin–aldosterone system with
increase of sympathetic renal tone, sodium and water retention,
progression of cardiac dysfunction and maintenance of
cardiorespiratory decompensation.
Methods An alternative approach to remove sodium and water is
slow continuous ultrafiltration (SCUF), which has been demon-
strated to be effective in congestive heart failure (CHF) treatment.
The major hindrance to an extensive early application of SCUF is
the requirement of a central venous large-bore catheter and the
involvement of specialized medical and paramedical staff. Recently,
a new device (Aquadex Flex Flow) for mini-SCUF able to overcome
the drawbacks of traditional devices has been developed. It
operates with peripheral small-bore venous catheters and does not
require specialized staff. We present two cases of our initial
experience.
Results Case 1 An 82-year-old female admitted to the ICU for
anasarca, dyspnea and decompensated COPD underwent mini-
SCUF. A negative fluid balance of 16 l was obtained in 55 hours,
diuresis was maintained, blood gas exchanges (BGE) improved
and tracheal intubation and MV was avoided. Case 2 A 78-year-old
male was admitted to the ICU for respiratory failure and
decompensated CHF. Anasarca, obesity and OSAS were
associated. He was treated with MV, dobutamine, diuretics and
mini-SCUF. A negative fluid balance of 18 l was obtained in 60
hours without diuresis reduction; edema was markedly reduced,
BGE improved and weaning from MV was obtained 3 days after
admission.
Conclusions We suggest that early aggressive fluid removal
through mini-SCUF in severe cardiorespiratory failure could avoid
tracheal intubation or could accelerate MV weaning.
Reference
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Introduction Renal failure following cardiac surgery prolongs the
ICU stay [1]. We developed a service in this tertiary cardiothoracic
centre to provide intermittent renal replacement therapy (RRT) in
designated high-dependency units (HDU) outside the ICU for
cardiothoracic patients who have isolated renal failure. This has
reduced the ICU length of stay and costs, and allowed other patients
to be admitted to the ICU. The service is provided by ICU nurses and
supported by the Outreach team, whose remit is to facilitate ICU
discharge and to educate ward nurses in critical care skills.
Methods A retrospective analysis of the ICU database identified all
patients who had received intermittent RRT outside critical care
during an 18-month period in 2006–2007. We reviewed patient
demographics, diagnosis, number of episodes of RRT performed
outside the ICU; daily SOPRA scores and RRT-related complica-
tions. The discharge from the ICU and the institution of RRT were
led by an intensivist. An established nurse-led Outreach team was
responsible for the daily assessment and nursing supervision of
these patients. Each episode of RRT was provided by an ICU
nurse on a 12-hour shift. The clinical risk management database
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was reviewed to identify any patient safety incidents (PSI) relating
to this service.
Results There were 127 episodes in the study period of RRT in
ward areas (111 episodes in transplant HDU, 15 episodes in
cardiac surgery HDU and one episode in cardiology HDU). There
were two PSIs with minor patient impact only.
Conclusions The 127 episodes of RRT outside the ICU reduced
the demand for ICU beds. These patients were successfully
discharged from the ICU (critical care level 3) to HDU (level 2)
beds with the support of the critical care Outreach team. There
was a low rate of complications. We believe that an established
critical care Outreach service can facilitate early and safe
discharge from the ICU of cardiothoracic patients with isolated
renal failure requiring intermittent RRT.
Reference
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Introduction Increasing the dose of renal replacement therapy has
been shown to improve survival in critically ill patients with acute
kidney injury. The study objective was to assess mortality and renal
recovery of patients with acute kidney injury receiving either
standard or intensified dialysis therapy in the ICU.
Methods A prospective randomized parallel group study (from
2003 to 2006). Investigators were blinded for initial group
assignment; the follow-up period was 28 days. In seven ICUs of a
tertiary university hospital, we studied 157 patients (570 screened)
with acute kidney injury requiring renal replacement therapy
without pre-existing chronic kidney disease. No patient withdrawal
occurred due to adverse effects; 146 patients qualified for final
intention-to-treat analysis. Participants were randomly assigned to
receive either standard (that is, currently recommended) dialysis
dosed to maintain plasma urea levels between 120 and150 mg/dl
(20–25 mmol/l), or intensified dialysis dosed to maintain plasma
urea levels below 90 mg/dl (<15 mmol/l). In the former group
patients received daily dialysis, whereas in the latter group they
received at least two treatments daily after initiation of renal
replacement therapy. Outcome measures were survival at day 14
(primary), and survival and renal recovery at day 28 (secondary)
after initiation of renal replacement therapy. Outcome measures
were defined before inclusion of the first participant.
Results The treatment intensity differed significantly already after
24 hours (P < 0.01 for plasma urea and applied dialysis dose). No
significant differences between intensified and standard treatment
were seen for survival at day 14 (74.4% vs 70.0%) and day 28
(56.5% vs 60.0%), and for renal recovery amongst the survivors at
day 28 (60.5% vs 59.5%).
Conclusions Increasing the dose of renal replacement therapy
above the currently recommended dose neither reduces mortality
nor improves renal recovery in critically ill patients with acute
kidney injury.
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High-volume continuous venovenous hemofiltration
reduces mortality in critically ill patients with acute renal
failure
R Van Ketel, I Meynaar, L Dawson, S Sleeswijk Visser, 
M Van Spreuwel-Verheijen, P Tangkau
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Introduction Renal replacement therapy is used in critically ill
patients to treat acute renal failure. The most frequently used
technique is continuous venovenous hemofiltration (CVVH). The
appropriate dose of CVVH is currently a matter of debate. We
compared hospital survival in patients receiving low-volume CVVH
with patients receiving high-volume CVVH.
Methods The ICU is an intensivist-led unit in a 500-bed teaching
hospital. We performed a retrospective cohort study of all patients
admitted to the ICU who were treated with renal replacement
therapy between 1 January 2005 and 1 July 2007. Patients with
acute renal failure only were treated with low-volume CVVH (35
ml/kg ultrafiltrate). Patients with acute renal failure and sepsis or
multiorgan dysfunction syndrome were treated with high-volume
CVVH (4 l/hour ultrafiltrate). All data were collected from the ICU
database or from patient records.
Results A total of 58 patients were included in the study (Table 1).
Eighty-eight percent of patients received at least 80% of the
prescribed dose. We found a trend towards a higher mortality in
patients who received low-volume CVVH compared with patients
who were treated with high-volume CVVH. In a logistic regression
model with age, APACHE II score and CVVH dose as independent
parameters, the age and CVVH dose were significant predictors of
mortality (Table 2).
Table 1 (abstract P476)
Patient characteristics and crude hospital mortality
Low volume High volume 
(n = 37) (n = 21) P value
Mean age (SD) 65.7 (14.6) 71.2 (9.5) 0.136
Mean APACHE II score (SD) 21.9 (7.3) 24.0 (7.4) 0.310
Hospital mortality 17 (46%) 5 (24%) 0.095, 
OR 0.37
Table 2 (abstract P476)
Logistic regression model for hospital mortality (reference = low-
dose CVVH) 
OR (95% CI) P value
Age 0.91 (0.85–0.98) 0.012
APACHE II score 0.95 (0.88–1.03) 0.242
CVVH dose 0.20 (0.05–0.79) 0.021
Conclusions High-volume CVVH decreases hospital mortality in
critically ill patients with acute renal failure in this study. This is in
agreement with the literature.
Reference
1. Ronco C, Bellomo R, Homel P, et al.: Effects of different
doses in continuous veno-venous haemofiltration on out-
comes of acute renal failure: a prospective randomised
trial. Lancet 2000, 356:26-30.
Critical Care    March 2008 Vol 12 Suppl 2 28th International Symposium on Intensive Care and Emergency Medicine
S187
P477
High fluid volume removal with continuous renal
replacement therapy as a therapeutic option for early
posttraumatic acute respiratory distress syndrome
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RA De Blasi
University of Rome Sapienza II, Rome, Italy
Critical Care 2008, 12(Suppl 2):P477 (doi: 10.1186/cc6698)
Introduction The increase in vascular permeability, due to capillary
leakage, seems to be responsible for high density on CT lung
examination and worsening of gas exchange in acute respiratory
distress syndrome (ARDS) patients. An improvement of the
PaO2/FiO2 ratio and ARDS reversal following lung water removal
has been shown. The aim of our study was to investigate whether
hourly depletion of high fluid volume through continuous renal
replacement therapy (CRRT) could reverse posttraumatic ARDS.
The body water redistribution in different compartments can lead
to a rapid decrease in extravascular lung water (EVLW).
Methods Three trauma patients, fulfilling ARDS criteria within 48
hours since traumatic nonbrain injury (early posttraumatic ARDS),
underwent protective lung ventilation with moderate to high
positive end-expiratory pressure, maintaining end-tidal CO2
< 60 mmHg. All patients developed acute renal failure. The
patients were treated with CRRT with 45 ml/kg/hour ultrafiltration
and 500 ml/hour fluid volume removal. Modified Swan–Ganz and
arterial catheters (Picco) were inserted for cardiovascular and
EVLW index (EVLWI) monitoring.
Results The haemodynamic variables, the gas exchange values
and the fluid balance are reported in Figures 1 and 2. Rapid high
fluid volume depletion decreased the EVLWI, providing a complete
resolution of ARDS and leading to extubation of all three patients
within 72 hours from the beginning of CRRT. The treatment was
uneventful and all the patients showed haemodynamic stability.
Conclusions This approach seems to be a possible treatment
option for early posttraumatic ARDS. In our opinion this study
could introduce a new therapeutic choice that might decrease
days of mechanical ventilation.
References
1. Compton F, et al.: Hemodial Int 2007, 11:231-237.
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Introduction There is no consensus on the criteria for initiation of
renal replacement therapy (RRT) for acute kidney injury (AKI).
Traditionally, serum urea levels are used as a surrogate marker for
timing. In the past, higher levels were associated with increased
hospital mortality. There is no consensus on the exact level of
serum as a cutoff to start RRT, in order to impact on outcome. We
want to evaluate urea cutoff criteria as described in the literature
for initiation of RRT for AKI, in relation to outcome.
Methods A retrospective study of 342 ICU patients with AKI who
were started on RRT in the period 2004–2007, and who were
captured in the electronic ICU database. The APACHE II score
was calculated at admission to the ICU. The SOFA and nonrenal
SOFA scores, blood levels of urea, creatinine, sodium and
potassium were recorded at the start of RRT. Data are presented
as the proportion and median (IQR).
Results Three hundred and forty-two patients were included. The
median age was 65 years (56, 73), 67.9% were male. The
APACHE II score was 20 (15.26), and the nonrenal SOFA and
SOFA scores were 5 (4, 8) and 8 (6, 11), respectively. Inhospital
mortality was 58.2%. At the start of RRT, serum creatinine was 3.7
mg/dl (2.6, 4.9), urea was1.4 g/dl (0.9, 2.0). Intermittent RRT was
the initial mode of RRT for 53.2% of patients, continuous dialysis in
22.5%, continuous venovenous hemofiltration in 14.9%, and slow
low-efficiency daily dialysis in 8.5%. The traditionally used serum
urea cutoff levels (1.0, 1.2, 1.4, 2, and 3 g/dl) were not associated
with increased hospital death. Factors associated with inhospital
death were APACHE II score (OR = 1.06, P < 0.001), continuous
RRT (OR = 2.63, P < 0.001), nonrenal SOFA score at start of
RRT (OR = 1.14, P < 0.001), and age (OR = 1.03, P = 0.001).
Inhospital death was inversely correlated with creatinine at the start
of RRT (OR = 0.63, P < 0.001). A multivariate logistic regression
model demonstrated that, after correction for age, nonrenal SOFA
and creatinine at the start of RRT, increasing urea levels were
associated with mortality (OR = 1.50, P = 0.023), as were urea
cutoff levels of 1.2 g/dl (OR = 2.28, P = 0.009) and 1.4 g/dl
(OR = 2.36, P = 0.003). Higher and lower cutoff values were not
associated with mortality.
Available online http://ccforum.com/supplements/12/S2
Figure 1 (abstract P477)
PaO2/FiO2 ratio and extravascular lung water index (EVLWI).
Figure 2 (abstract P477)
Water balance and cardiac index (CI).
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Conclusions Traditional cutoff values for initiation of RRT based
on serum urea levels were not useful in assessing the prognosis.
After correction for severity of illness and serum creatinine, serum
urea was associated with mortality. Future models for initiation of
RRT should include nonrenal indicators for outcome.
P479
Initiation of renal replacement therapy in patients with
acute kidney injury and severe lactic acidosis
S Vuylsteke, A Dhondt, C Danneels, J De Waele, S Blot, E Hoste
Ghent University Hospital, Ghent, Belgium
Critical Care 2008, 12(Suppl 2):P479 (doi: 10.1186/cc6700)
Introduction Both severe lactic acidosis (sLA) and acute kidney
injury (AKI) with need for renal replacement therapy (RRT) are
strong risk factors for mortality. The decision to initiate RRT in AKI
patients with sLA is often a matter of dispute, and, because of lack
of data, an anecdotal experience. The aim of the study was to
describe the epidemiology of this specific cohort of ICU patients,
and to evaluate specific risk factors for mortality.
Methods A single-center, retrospective study on all adult ICU
patients with AKI and sLA at initiation of RRT, during the 3-year
period from August 2004 to July 2007. sLA was defined as serum
lactate > 5mmol/l. Data are presented as the proportion or median
(interquartile range).
Results Of 454 ICU patients with AKI-RRT, 89 (19.6%) had sLA
at initiation of RRT. RRT was started 2.1 days (1.4, 3.1) after ICU
admission. Continuous hemodialysis was used in 55.1%, slow low-
efficiency daily dialysis in 11.2%, intermittent hemodialysis in
11.2%, and continuous venovenous hemofiltration (CVVH) in
22.5% of patients. The median age was 65.6 years (53.4, 72.8),
64% were male, and the APACHE II score at admission was 25
(19, 30). The majority were in the surgical ICU (67.4%), followed
by the medical ICU (16.9%), cardiac surgery ICU (12.4%) and
burn unit (3.4%). At the start of RRT, lactate was 13.1 mmol/l (7.6,
20.7), urea 0.92 g/dl (0.60, 1.22), creatinine 2.54 mg/dl (1.70,
3.47), pH 7.23 (7.11, 7.33), and HCO3– 16.6 (13.6, 21.0). ICU
mortality was 80.9% (vs 56% for all RRT patients). The decrease
of lactate was greater with hemodialysis compared with CVVH
during the first 4 hours of RRT (23.9% vs 2.1%; P = 0.018).
However, it was comparable after 24 hours (29.8% vs 38.1%; P =
0.267). Nonsurvivors were older (67.2 years vs 51.9 years; P =
0.003), had lower HCO3– (16.1 mmol/l vs 19.3 mmol/l; P =
0.039), higher urea (0.98 g/dl vs 0.57 g/dl; P < 0.001), and higher
creatinine (2.6 mg/dl vs 1.8 mg/dl; P = 0.022). There was no
difference in the serum lactate level between survivors and
nonsurvivors. In addition, mortality was comparable in different
ICUs, and in different RRT modalities. Finally, on multivariable
analysis, only age and urea level were associated with mortality.
Conclusions As much as one-fifth of ICU patients with AKI
present with sLA at the start of RRT. This subgroup has a
particularly high mortality. Serum lactate levels decreased faster
with a dialysis modality compared with CVVH; however, this did
not result in better outcomes. Surprisingly, lactate levels at the start
of RRT were not predictive for mortality.
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Introduction Ranitidine, a histamine-2 receptor antagonist, is
frequently used in intensive care patients requiring stress ulcer
prophylaxis. Continuous venovenous hemodiafiltration (CVVHDF)
is an important extracorporeal renal replacement therapy in
critically ill patients suffering from multiple organ failure. This study
investigates the pharmacokinetics of ranitidine in anuric critically ill
patients undergoing CVVHDF.
Methods Ranitidine 50 mg was administered intravenously in five
intensive care patients with acute renal failure undergoing
CVVHDF who required stress ulcer prophylaxis. The concentration
of ranitidine in serum and ultradiafiltrate was determined by high-
performance liquid chromatography.
Results The mean peak serum level of ranitidine was 1.95 ± 0.55
mg/l. The mean trough serum level was 0.50 ± 0.29 mg/l. The
mean AUC 0–8 was 5.47 ± 2.83 mg.hour/l. The volume of
distribution and the half-life were 73.72 ± 33.25 l and 14.54 ±
9.82 hour, respectively. Total clearance and hemodiafiltration
clearance were 5.05 ± 3.92 l/hour and 1.28 ± 0.39 l/hour,
respectively.
Conclusions Pharmacokinetics of a single dose of ranitidine in
anuric critically ill patients undergoing CVVHDF is comparable with
reported results in healthy volunteers. No dose adaptation of
ranitidine therefore seems necessary in critically ill patients
undergoing CVVHDF. However, prior to translation of these
findings to the clinical arena, multiple dose studies are required.
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Ceftriaxone pharmacokinetic properties during continuous
venovenous haemofiltration using an in vitro model
B Harvey, D Yeomanson, H Mulla, TN Johnson, A Mayer
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Critical Care 2008, 12(Suppl 2):P481 (doi: 10.1186/cc6702)
Introduction During continuous venovenous haemofiltration (CVVH),
drug clearance is dependent on the extracorporeal blood flow,
ultrafiltration rate, albumin binding, molecular weight and the volume
of distribution of the drug [1]. Doses are adjusted assuming reduced
drug clearance by the renal system and CVVH. Variation in filtration
practice, including predilution, high-volume haemofiltration and filters,
greatly alters the removal of drugs. Assessing the adequacy of
cephalosporin dosing during CVVH is complex; underdosing or
overdosing may occur. We studied the pharmacokinetics properties
of ceftriaxone during CVVH using an in vitro model.
Methods Renoflow HF1200 filters were used to model a 50 kg
patient. After completion of priming, each circuit and reservoir was
then prepared with a known volume of Hartmann’s solution, 4.5%
albumin or whole blood using the Infomed 400. The blood pump
speed and exchange rate for each of the circuit was 6 ml/kg/min
and 30 ml/kg/hour, respectively. Haemasol BO was used as the
replacement fluid, with 70% predilution. Following paired sampling
from circuit (CS) and ultrafiltrate (UF) fluid, ceftriaxone (80 mg/kg)
was injected into the postfilter port (time 0). Paired samples were
taken at 5-minute, 10-minute, 15-minute, 30-minute, 60-minute, 90-
minute, 120-minute, 240-minute, 480-minute, and 720-minute
intervals. Ceftraxione concentrations were determined using HPLC.
Results The maximum circuit concentration at 2 minutes for
albumin, blood and Hartmann’s solution was 4.8 ng/ml, 5.5 ng/ml
and 3.6 mg/ml, respectively. The sieving coefficient (ratio of mean
concentrations in the UF/CS) for albumin, blood and Hartmann’s
solution was 0.7 mg/ml, 0.96 mg/ml and 0.84 mg/ml, respectively.
The mean residence time (average amount of time a molecule of
the drug remains in the CS) and the half-life (calculated from the
mean residence time) were 35 minutes and 24 minutes,
respectively, for the blood circuit.
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Conclusions Estimates of a high sieving coefficient and short
circuit half-life from this in vitro model suggest ceftriaxone is rapidly
cleared during CVVH (almost entirely cleared by 240 min). This
has important implications for dosing schedules during in vivo
haemofiltration. Overall the albumin circuit had the lowest sieving
coefficient and longest terminal half-life, reflecting protein binding
of drug and suggesting ceftriaxone clearance may increase in
hypoalbuminaemic patients. The maximum circuit concentration
was lower in circuits primed with Hartmann’s solution. This may
reflect precipitation of the drug with calcium in this solution.
Reference
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Introduction The exact dosage of anticoagulation during continuous
venovenous hemofiltration (CVVH) is crucial for maximal effect and
safety of the procedure. Enoxaparine is one possible choice of
anticoagulant drug. The aim of our study was to compare the mean
dose of enoxaparine depending on whether a bolus or continuous
administration scheme was used.
Methods We performed retrospective analysis of prospectively
collected data for 36 consecutive patients (24 male and 12
female) receiving CVVH in the ICU of East Tallinn Central Hospital.
Twenty-three patients received boluses of enoxaparine every 6
hours, and 13 patients received continuous infusion of
enoxaparine. The dosage of anticoagulation was guided according
to the results of anti-Xa measurements.
Results The mean age of the patients (61.4 ± 15.7 years) and the
mean duration of the procedure (76.2 ± 29.2 hours) did not differ
significantly between the two groups. The mean dose of
enoxaparine was 0.12 ± 0.05 mg/kg/hour in the bolus group and
0.08 ± 0.03 mg/kg/hour in the continuous group (P = 0.027). The
mean anti-Xa did not differ significantly between the groups
(1.03 ± 0.42 vs 0.88 ± 0.24 units/ml, respectively, P = 0.252).
Filter clotting was observed 0.39 ± 0.58 times per procedure in
the bolus group and 0.38 ± 0.77 times in the continuous group
(P = 0.977). One patient in the bolus group developed cerebral
hemorrhage.
Conclusions Continuous administration allows the maintenance of
a necessary level of anticoagulation with lower doses of
enoxaparine during CVVH as compared with bolus dosing. It still
needs to be clarified whether this difference in the mean dose of
the anticoagulant may be important in reducing the complications.
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Introduction Patients requiring mechanical ventilation (MV) have
high mortality rates. In Latin America, the knowledge of mortality risk
factors in patients on MV is scarce. Identification of such factors is
essential to improve outcomes. The objective of our study was to
determine the mortality risk factors in patients that required MV in
the ICU of a general university hospital in southern Brazil.
Methods A prospective cohort study of 1,115 adult patients
admitted to the ICU who needed MV for at least 24 hours,
between March 2004 and April 2007. Data were collected on
each patient at the inclusion in the study and daily during the
course of MV for up to 28 days. Multivariate analysis by logistic
conditional regression was used.
Results The frequency of MV was 46%; the overall and specific
mortality rates were 23% and 51%, respectively. The mean (±SD)
age was 57 ± 18 years; 52% were males; the mean APACHE II
score was 22 ± 8.3; 69% were medical patients; the mean
duration of MV was 10 ± 7.9 days; 93% were on invasive MV. The
variables independently associated with increased mortality were
(1) conditions present at beginning of MV: age (P = 0.04),
APACHE II score (P < 0.001), acute lung injury/acute respiratory
distress syndrome (ALI/ARDS) as cause of MV (P = 0.04), and
gastrointestinal failure (P = 0.01); and (2) conditions occurring
over the course of MV: ALI/ARDS (P < 0.001), sepsis (P = 0.007),
cardiovascular (P = 0.002), renal (P < 0.001), and hepatic failure
(P = 0.009), use of vasoactive drugs (P < 0.001) and opioids (P =
0.04), and duration of MV (P < 0.001). It is of note that ventilatory
monitored variables included in the multivariate model were not
associated with mortality.
Conclusions In our study, the risk factors for mortality 28 days
after the beginning of MV were conditions present at the beginning
of MV (age, APACHE II score, ALI/ARDS as a cause of MV, and
gastrointestinal failure) and conditions occurring over the course of
MV (ALI/ARDS, sepsis, cardiovascular, renal and hepatic failure,
use of vasoactive drugs and opioids, and duration of MV). The
survival of patients on MV therefore involves conditions present at
the start of MV, and conditions that occur during the MV period,
including aspects related to patient management. Knowledge of
these factors may permit the evolvement of early interventions that
might decrease poor outcomes of patients that require MV.
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Introduction Long-stay critically ill patients represent a small
subgroup of ICU patients with huge resource consumption. The
goal of this study was to identify outcomes and characteristics of
these patients.
Methods Data were collected retrospectively from consecutive
patients requiring at least 60 days of ICU care admitted over seven
calendar years (2000–2006) to a general ICU in a university-
affiliated 427-bed hospital.
Results A total of 27 patients met the inclusion criteria. Long-stay
ICU patients represented 1.2% of total admissions. The mean age
was 69 years (26–92 years). The median ICU stay in overall ICU
patients was 7 days, while in long-stay ICU patients it was 98 days
(62–202 days). General ICU mortality was 17.4%, in the studied
group the mortality rate was 44.4%. A further eight patients died in
the hospital after discharge from the ICU, representing an
additional 26% of all long-stay ICU patients. Two years after the
discharge 22.2% of these patients were alive, and 14.8% are alive
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until now. We found no obvious differences between the ones that
died in ICU or in the hospital, or were discharged from the hospital,
whether looking at APACHE II score, preadmission heart failure,
obesity, diabetes mellitus or lung disease. One prominent factor in
long-stay ICU patients that died in the unit was the occurrence of
acute respiratory distress syndrome (83%) as opposed to the two
other groups of patients (25% and 26%). Consequently, the
median length of mechanical ventilation was greater in this group
(101.8 days). Catecholamine requirement was also greater
(83.3%) as well as the duration of the support (median 57.3 days).
End-stage renal disease and immunosuppression had a negative
impact and lead to prolonged ICU stay. The data regarding
immunosuppression are supported by other authors [1].
Conclusions End-stage renal disease and immunosuppression
increase the risk of long-stay in ICU. The patients that died in the
unit had a greater incidence of acute respiratory distress
syndrome, needed more ventilation days and were more
dependent on catecholamines and for longer time.
Despite the severity of the illness these patients still has favorable
chances of 22.2% two years survival. More studies are needed to
explore long stay ICU patient’s population.
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Introduction In spite of decreasing case fatality attributable to
improved clinical management, patients with severe sepsis or
septic shock still have a high mortality rate. This study aimed to
describe the impact of respiratory and cardiovascular organ
dysfunction (OD) on the outcome of patients with severe sepsis or
septic shock (SS).
Methods We conducted a retrospective study based on hospital
discharge and charge master information of ~5 million discharges
from ~500 hospitals in the USA during 2006 (Premier Pers-
pective™ Database). SS was defined via ICD-9 coding and
required infection and organ dysfunction (six systems as defined in
[1]). We created four mutually exclusive OD groups by focusing on
respiratory (Resp) and cardiovascular (CV) organ dysfunction
because of their relative greater reliability in database analysis: (1)
both Resp and CV OD (Resp&CV OD); (2) respiratory OD without
cardiovascular OD (Resp/noCV), (3) cardiovascular OD without
respiratory OD (CV/noResp), and (4) neither OD. Outcome
measures include inhospital mortality, use of the ICU, length of
hospital stay (LOS), and total costs during hospitalization.
Results A total of 89,033 cases were identified as severe sepsis
or septic shock, resulting in a SS rate of 1.7% discharges. Among
all SS cases, hospital mortality was 31.1%, 68.4% were admitted
to the ICU, the mean LOS was 14.9 days, and mean costs of
hospitalization were $33,000. Each of the four OD groups
consisted of 20.4–29.2% SS patients. Among the four OD
groups, the hospital mortality and ICU use were greatest in the
Resp&CV OD group and least in the neither OD group with the
following trend: both Resp&CV OD > Resp/noCV > CV/noResp >
neither OD (mortality: 52% > 34% > 26% > 15%; ICU use: 92%
> 79% > 68% > 39%) (P < 10–7 for all pairwise comparisons).
The two groups with respiratory OD (that is, both the Resp&CV
OD group and the Resp/noCV group) had a similar LOS (mean:
16.7 days and 18.7 days, respectively) and similar costs (mean:
$44,000 and $43,000), which were greater than the CV/noResp
OD group (LOS: 12.2 days; costs: $26,000) and the neither OD
group (LOS: 13.2 days; costs: $25,000).
Conclusions Respiratory organ dysfunction increases the risk of
death and consumption of healthcare resource in patients with
severe sepsis or septic shock.
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Introduction Mortality risk prediction models are used worldwide
as a means of benchmarking ICU quality. Most models use logistic
regression, with a cardinal assumption being linearity in the
relationship between continuous predictors (for example, blood
pressure) and the log odds of outcome (death). However, such
linear relationships rarely exist in clinical practice. Several new
statistical methods are available that allow nonlinear modelling for
continuous predictors. We have applied one such method,
multivariable fractional polynomials (MFP), to a paediatric ICU risk
score (PIM2), to investigate whether this would improve the
performance of PIM2.
Methods All admissions to a single paediatric ICU over a 6-year
period (2000–2006) were examined (n = 7,472, deaths = 380).
PIM2 comprises 10 variables, of which three are continuous (base
excess, systolic blood pressure, and FIO2/PO2); these were
examined via a customised MFP macro [1] using SAS 9.1.
Results Application of the MFP approach resulted in improved
model discrimination (c statistic = 0.843 versus 0.835 for the
standard model), as well as excellent fit (Hosmer–Lemeshow P =
0.71). The MFP algorithm demonstrated a nonlinear relationship for
all three continuous predictors, which also altered between the
univariable and multivariable logistic models (Figure 1). A hitherto
unsuspected interaction between blood pressure and ‘high-risk’
diagnostic category was revealed. Bootstrapping showed that
similar nonlinear relationships were preserved across a range of
datasets.
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Figure 1 (abstract P486)
Univariable (left) and multivariable (right) risk profile for base excess.
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Conclusions The MFP approach offers several advantages over
linear modelling, both in model fit and a better elucidation of risk
profiles for individual predictors. This requires confirmation in a
national dataset.
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Introduction Almost one-half of patients with septic shock develop
acute lung injury (ALI). The understanding of why some patients do
and others do not develop ALI is limited. The objective of this study
was to test the hypothesis that delayed treatment of septic shock
is associated with the development of ALI.
Methods An observational cohort study in a medical ICU in a
tertiary medical center. Patients were prospectively identified with
septic shock who did not have ALI at the outset, excluding those
who denied research authorization. There were no interventions.
Results High-frequency cardiorespiratory monitoring, arterial gas
analysis and portable chest radiographs were reviewed to identify
the timing of ALI development. Risk factors present before ALI
development were identified by review of electronic medical
records and were analyzed in univariate and multivariate analyses.
Seventy-one out of 160 patients (44%) developed ALI at a median
of 5 (range 2–94) hours after the onset of septic shock.
Multivariate logistic regression analysis identified the following
predictors of ALI development: delayed goal-directed resuscitation
(OR = 3.55, 95% CI = 1.52–8.63, P = 0.004), delayed antibiotics
(OR = 2.39, 95% CI = 1.06–5.59, P = 0.039), transfusion (OR =
2.75, 95% CI = 1.22–6.37, P = 0.016), alcohol abuse (OR =
2.09, 95% CI = 0.88–5.10, P = 0.098), recent chemotherapy
(OR = 6.47, 95% CI = 1.99–24.9, P = 0.003), diabetes mellitus
(OR = 0.44, 95% CI = 0.17–1.07, P = 0.076) and baseline
respiratory rate (OR 2.03 per standard deviation, 95% CI =
1.38–3.08, P < 0.001).
Conclusions When adjusted for known modifiers of ALI
expression, delayed treatment of shock and infection were
associated with development of ALI.
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Introduction Developing severe sepsis or septic shock after
chemotherapeutic treatment is commonly perceived as the worst-
case scenario in hematological patients. This study compared the
characteristics and outcome of patients with hematological
malignancies who were referred to the ICU because of severe
sepsis and septic shock who had received versus those who had
not received intravenous chemotherapeutic treatment within 3
weeks prior to ICU admission.
Methods A prospective observational cohort study was conducted
at the medical ICU of a tertiary care centre. All consecutive
patients with hematological malignancies admitted to this unit
between 2000 and 2006, and who were diagnosed with either
severe sepsis or septic shock, were considered for analysis.
Results Seventy-seven patients were admitted with severe sepsis
and 109 with septic shock. Ninety-one patients (49%) had
received recent intravenous chemotherapy within 3 weeks prior to
ICU admission. As compared with those without, patients with
recent chemotherapy more often had a high-grade malignancy (P <
0.001), were more often neutropenic (P < 0.001), less often had
pulmonary infiltrates (P = 0.007), and less often required
mechanical ventilation (P = 0.04). The ICU, 28-day, inhospital, and
6-month mortality rates were 33% versus 48.4% (P = 0.037),
40.7% versus 57.4% (P = 0.027), 45.1% versus 58.9% (P =
0.076), and 50.5% versus 63.2% (P = 0.103), in patients with and
without recent chemotherapy, respectively. Logistic regression
identified four variables independently associated with 28-day
mortality: SOFA score at ICU admission (P < 0.001), pulmonary
site of infection (P = 0.005), and fungal infection (P = 0.003) were
associated with worse outcome, whereas intravenous chemo-
therapy within 3 weeks prior to ICU admission was protective at
borderline significance (P = 0.049). After more complete adjust-
ment with a propensity score for recent chemotherapy, chemo-
therapy was no longer associated with outcome (P = 0.079).
Conclusions Patients referred to the ICU with severe sepsis and
septic shock complicating active chemotherapeutic treatment have
an overall crude mortality that is comparable with septic shock in
general ICU patients, and have a better prognosis than commonly
perceived.
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Introduction Previous studies have demonstrated a widely variable
prognosis in critical illness amongst patients with haematological
neoplastic disease; with inhospital mortality documented as high as
78% [1]. We sought to describe the outcomes in our population.
Methods We conducted a retrospective study of consecutive
admissions with a primary diagnosis of haematological malignancy
over a 4-year period. Patients admitted recurrently as separate
admissions were recorded as multiple events. Neutropenia was
defined as <1.5 x 109/l [2]. Outcome was defined as ICU mortality,
inhospital mortality, length of ICU stay and requirement for
mechanical ventilation or renal replacement therapy (RRT).
Results Of 5,142 admissions, 33 had a primary diagnosis of
haematological neoplasm (24 males). The average age was 55.8 ±
13.6 years. The median length of ICU stay was 5.4 days. The ICU
mortality rate of all ICU admissions was 15.2%, compared with
39.4% in patients with haematological malignancy (P < 0.01). The
inhospital mortality was 63.6%. Eleven patients were neutropenic
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on admission. In the neutropenic subgroup, ICU mortality was
45.5% (vs 36.3% in non-neutropenic patients, P = 0.46) and
inhospital mortality was 45.5% (vs 72.7% in non-neutropenic
patients). Of 22 patients requiring mechanical ventilation, the ICU
mortality was 50% (vs 18.1%, P = 0.13) and inhospital mortality
was 72.7% (vs 45%, P = 0.44). Of six patients requiring RRT, the
ICU mortality was 50% (vs 37% in those patients not requiring
RRT, P = 0.65) and inhospital mortality was 66.7% (vs 63%).
Conclusions The mortality rate is high amongst patients in whom
haematological malignancy is complicated by critical illness.
Although significantly higher than our remaining ICU population, it
was lower than reported elsewhere in the literature. Neutropenia
on admission was not significantly associated with a poorer
outcome. Although mortality was higher in those requiring
mechanical ventilation or RRT, this did not reach statistical
significance. This may be a result of our small sample size.
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Introduction The objective of this study was to identify mortality in
critically ill oncologic patients.
Methods Data were collected prospectively from 120 consecutive
patients who were admitted to the combined medical and surgical
ICU. The primary outcome studied was overall ICU mortality.
Results Overall, 49.2% of patients were older than 66 years old
(our study median) and 55.8% were men. The median time for the
length of stay was 3 days and the median time for the follow-up
was 8 days. The ICU mortality and the hospital mortality were
35.8% and 46.7%, respectively. Through the Kaplan–Meier
survival curve, there was significant difference among the patients’
mortality with terminal stages of cancer and the patients’ mortality
with response to treatment. The median survival times were 13.47
and 29.4 days, respectively. The survival of patients with a need for
invasive mechanical ventilation was fourfold to fivefold lower (P =
0.005). Through the Cox multiple regression, the variables related
to ICU mortality were a higher length of hospital stay before the
ICU admission (P = 0.003) and coagulopathy over the ICU stay
(P = 0.035) (Table 1).
Conclusions Our study suggest that patients in terminal stages of
cancer who presented a higher length of hospital stay before ICU
admission, coagulopathy and mechanical ventilation over the ICU
stay have higher ICU mortality.
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Introduction In a previous audit, patients with ≤1 organ failure
(OF) on day 1 or day 2 had high ICU mortality (63% and 52%,
respectively). We examined the impact of organ dysfunction (OD)
patients with ≤1 OF.
Methods One hundred and seventy-nine consecutive adult
admissions (111 males, 68 females) from February 2006 to June
2007 with an ICU stay ≥3 days were prospectively studied. The
APACHE II score, day 1 SOFA score, highest SOFA score of the
first three days (MAX3), and changes in SOFA score between day
2 and day 1 (Δ1) and between day 3 and day 1 (Δ2) were
calculated. For each organ, a SOFA score of 1–2 or 3–4 defined
OD or OF, respectively. The total number of ODs and OFs on ICU
days 1–3 was calculated. Binary logistic regression (backward
conditional) was used to determine factors associated with
mortality.
Results The mean age was 44.8 ± 15.4 years, APACHE II score
20.1 ± 6.5 and SOFA score 16.8 ± 3.8. The ICU mortality was
66%. On days 1 and 2, 65% and 77% patients had ≤1 OF. On
days 1–3, an increasing number of ODs were significantly
associated with increasing mortality in patients with ≤1 OF, but not
in patients with ≥2 OFs (Table 1). On multivariate analysis, Δ2
(OR = 1.26, 95% CI = 1.12–1.41, P = 0.000), ODs on day 1
(OR = 1.54, CI = 1.06–2.23, P = 0.03) and OFs on day 2 (OR =
2.67, CI = 1.76–4.06) were independently associated with ICU
mortality.
Table 1 (abstract P491) 
Number Day 1, Day 1, Day 2, Day 2, 
of ODs ≤1 OF ≥2 OF ≤1 OF ≥2 OF 
0 9/16, 56% 8/14, 57% 13/47, 28% 8/11, 73%
1–2 40/72, 56% 31/40, 78% 36/67, 54% 46/54, 87%
>2 23/28, 82%* 7/9, 78%† 12/17, 71%** 11/13, 85%††
Data presented as (deaths/ total patients, %). *P = 0.04; †P = 0.31; 
**P = 0.002; ††P = 0.59.
Conclusions An increasing number of ODs worsens the outcome
in critically ill medical oncology patients with ≤1 OF. Worsening
OD scores are associated with mortality. Early recognition and
management of OD before the onset of multiple OF may help
improve outcome.
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Results of the final model of the Cox multiple regression (n = 120)
P value in 95% CI of 
Variable β β standard likelihood ratio Hazard ratio hazard ratio
Length of hospital stay before ICU admission 1.226 0.473 0.003 2.930 0.161–0.534
Coagulopathy 1.565 0.686 0.035 4.785 1.867–12.260
S193
P492
Causes and risk factors of maternal mortality in the ICU
C Kaddour, R Souissi, Z Haddad, Z Zaghdoudi, M Magouri, 
M Soussi, S Abbassi
Institute of Neurology, La Rabta, Tunisia
Critical Care 2008, 12(Suppl 2):P492 (doi: 10.1186/cc6713)
Introduction Maternal mortality is considered a basic health
indicator that reflects the adequacy of healthcare; in our country
the overall maternal mortality is 69.8 per 100,000 live births
(Tunisian National Enquiry into Maternal Deaths 1993–1994). In
this study we tried to identify causes of maternal death in our ICU.
Methods A prospective study of patients first managed in a tertiary
referral maternity center for high-risk pregnancies. Collected data
were age, gravity, parity, admission diagnosis and delivery mode.
The APACHE II score, APACHE III score and SAPS Obst score
were calculated. The study period was January 2004–December
2004. The outcome measure was mortality. We used the
International Classification of Diseases definition of a maternal
death: ‘the death of a woman while pregnant or within 42 days of
termination of pregnancy, from any cause related to or aggravated
by the pregnancy or its management, but not from accidental or
incidental causes’.
Results From 131 obstetrics admissions, 18 patients died (14%).
Advanced age (33 ± 9), high gravity (2.8 ± 1.7) and high parity
(2.77 ± 1.7) scores are common to all death. As compared with
vaginal delivery (n = 9), caesarean delivery (n = 9) was not
associated with a significantly increased risk for postpartum
maternal death; the majority of maternal deaths are due to direct
obstetric causes (16–89%). At admission all patients had high
severity of illness scores, APACHE II (18.76 ± 16.65), APACHE III
(71.58 ± 30.19) and SAPS Obst (30.29 ± 8.24), which indicates
how grave our patients’ health condition is. The most common
cause of death was hypertensive disorders in five patients,
infection in four patients and hemorrhage in three cases, other
causes were pulmonary embolisms in two cases, one case of
amniotic fluid embolism, one patient with peripartum cardio-
myopathy, one patient with intracerebral hemorrhage and one
patient with anaphylactic shock.
Conclusions The knowledge of the specific causes involved in the
maternal mortality risk could help to elaborate adequate preventive
strategies to reduce maternal death.
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Introduction Acute respiratory failure (ARF) is the most common
organ failure in the ICU, and mortality is high. The outcome
worsens in association with any other organ failure. The objective
of this study was to describe the aetiology, mortality rate and
causes of ARF and to evaluate the outcome of ARF with/without
concomitant organ failure.
Methods A prospective cohort study that includes all patients
admitted to the ICU of a tertiary hospital from January to July 2007.
ARF was defined based on the SOFA score criteria, SOFA
respiratory ≥3, PaO2/FiO2 <200 and mechanical ventilation.
Results Two hundred and ninety-six patients were admitted, 48%
with ARF (142 patients), 59.6% males. Primary diagnoses were
52.5% respiratory insufficiency, 27.7% neurological disease,
14.2% cardiologic/septic shock, and 5.7% cardiac arrest. Causes
of ARF were 47.5% pneumonia, 11.5% pulmonary oedema, 11.5%
chronic pulmonary disease, 10.8% nonpulmonary ARDS, 7.9%
atelectasis, 3.5% bronchospasm, 3.5% pleural effusion, 2.1%
pulmonary fibrosis. Severity was APACHE II score 23.17 ± 7.1,
SAPS II score 50.5 ± 15.4, SAPS III score 66.5 ± 15.5, SOFA
score at admission 8.6 ± 4.1, SOFA maximum score 10.23 ± 4.7,
lactic acid 4.01 ± 3.3, and lung injury score (LIS) 1.7 ± 0.7
(0.66–3.5). Of patients, 21.6% received noninvasive ventilation
and 78.4% invasive ventilation. The mean stay in the ICU was 9.6
± 10.5 days, hospital stay was 19.8 ± 18.29 days. In the ICU,
73.8% developed multiorgan failure syndrome (MOFS). The
mortality rate in the ICU was 39.7% and in the hospital was
50.4%. Mortality in patients without ARF was 15.6%, and in
patients with ARF was 50.4% (RR = 5.53, 95% CI, 3.2–9.5). The
mortality rate was lowest in the subgroup with ARF as a single
organ failure (16.7%) and it increased with additional organs in
failure (ARF + 1, 37.8%; ARF + 2, 69%; ARF + 3, 90%; ARF + 4
or 5, 91%; χ2 test P = 0.000). The mortality rate of those with ARF
at admission was 55.5%, versus 30% for those who developed
ARF (RR = 2.95, 95% CI = 1.2–6.8). Patients with invasive
ventilation had 2.45 times more risk to die than noninvasive
ventilation (55% vs 33.3%). The mortality rate in acute respiratory
distress syndrome (ARDS) was 77.8% vs 40.8% without ARDS
(RR = 5.1, 95% CI = 2.1–12.2). The mortality rate in MOFS was
62.7% versus 16.2% only with ARF. Multivariant logistic
regression showed there is no association with mortality rate and
age, Barthel, PaO2, HCO3, and PaCO2. The mortality rate
associates with lactic acid, APACHE II and III scores, acute
physiological score, SAPS II and III scores, MODS, SOFA score at
admission, pH, LIS and PaO2/FiO2. Developing MOFS and the LIS
score are independent predictors of mortality in ARF patients.
Conclusions ARF has a high mortality rate especially if it is
associated with severe failure of other organs. Developing MODS
and the LIS score are good predictors of outcome in patients with
ARF.
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Introduction The incidence and prevalence of immuno-
compromised patients has increased (higher number of trans-
plantations and improved management of primary immuno-
deficiencies). Nevertheless, the management strategies of these
patients in the pediatric ICU (PICU) remain a challenge because of
their important death rate. The study objective was to analyse the
morbimortality and prognosis of immunosuppressed patients
requiring critical care due to a medical cause.
Methods A retrospective study (January 2004–July 2007) in a 15-
bed PICU at a university hospital. Chi-square and Fisher exact test
analysis was performed.
Results One hundred and thirty-nine immunocompromised patients
were admitted 186 times, which comprised 10% of the total
number of admissions to the PICU in this period. The median age
was 63 months (range, 1 month–23 years); male predominance
(60.2%). Cause of immunosuppression: postchemotherapy neutro-
penia or hematopoietic stem cell transplantation (HSCT; 65.1%),
solid organ transplantation (15.6%), primary immunodeficiency
(9.7%) and miscellany (8.6%). Initial problem: haemodynamic
(43.5%), respiratory (34.4%), neurological (14.0%), other (8.1%).
PRISM 24-hour score was 8 (0–40). Evolutive failures (% patients):
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hematologic (50.5%), respiratory (40.5%), cardiovascular (40.5%),
renal (30.6%), hepatic (19.4%), neurological (14%), gastrointestinal
(5.6%). Multisystem organ failure (MOF; ≥3 organs) in 32.2%.
Critical care support (% patients): mechanical ventilation (50.5%),
sympathicomimetic drugs (36.6%), renal depuration (12%),
extracorporeal life support with membrane oxygenator (0.5%). Mean
stay in the PICU was 7.3 days (median 3 (1–49)). Mortality was
22%; higher in HSCT (26.2%) but without significant differences
among groups (P = 0.529). Mortality according to initial problem:
respiratory (31.2%), neurological (23%), cardiovascular (17.5%),
other (6.6%) (P = 0.012). Mortality of patients who underwent
mechanical ventilation was 40.4%; if respiratory and haematologic
failure association it was 63.8%; if MOF it was 55% (P > 0.0001).
Conclusions Regarding immunocompromised patients in the
PICU, respiratory failure at admission or during the evolution
involves a high risk of death, especially when associated with
haematological failure. The impact on the policy of admission in the
PICU must be investigated in new studies.
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Introduction Acute respiratory failure (ARF) in immunocompro-
mised patients is associated with a high mortality rate. The aim of
this investigation is to study these patients’ behavior patterns to
collect data that can allow us to improve their survival rate.
Methods A retrospective study (January 2004–July 2007) in a
pediatric ICU. We analyse the morbimortality, the reasons for ARF
and the critical care support required. We included medical
inmunocompromised patients with ARF (Wilkinson criteria). Exclusion
factors: postoperative mechanical ventilation; 15 were ruled out due
to upper obstruction airway, pulmonary cardiogenic edema,
pulmonary thromboembolism and limitation of therapeutic effort (LTE).
Results Fifty-seven patients (64 admissions) were enrolled in the
study. Median age was 66 months (1 month–17 years). Reason for
inmunodepressed situation: haematological 41 (64.1%): postchemo-
therapy neutropenia 20, hematopoietic stem cell transplantation
(HSCT) 21, primary immunodeficiencies 10 (15.6%); solid organ
transplantation 7 (10.9%), miscellany 6 (9.4%). PRISM 24-hour score
was 12 (0–40). Reason for ARF: infectious pulmonary disease 23
(36%), noninfectious pulmonary disease 8 (13%), secondary
pulmonary injury 28 (43%), neurological disorders 5 (8%). Evolutive
organ failures (% patients): hematopoietic (68.8%), cardiovascular
(65.6%), renal (54.7%), hepatic (37.5%), neurologic (28.1%),
gastrointestinal (6.3%). Multiorgan failure (MOF) in 70.3%. Critical
care support: conventional mechanical ventilation (96.8%),
noninvasive positive pressure ventilation (7.8%; exclusive 2), high
frequency ventilation (HFV)  (20.3%), extracorporeal life support with
membrane oxygenator (1.5%) (positive end-expiratory pressure
(PEEP) > 7 (62.5%), PaFiO2 < 150 (57.8%), oxygenation index (OI)
> 15 (42.2%), barotrauma: 18.8%), sympathomimetic drugs (64.1%),
renal replacement therapy (25%). Length of stay was 10 days (1–47).
Mortality was 51.6%; greater if PaFiO2 < 150 (67.5%; p = 0.004),
PEEP > 7 (65%; P = 0.006), OI > 15 (64%; P = 0.008), HSCT
(71.4%; P = 0.024), MOF (60%; P = 0.035), HFV (76.9%; P =
0.039). Death with LTE was 91%, and by respiratory failure was 40%.
Conclusions Immunocompromised patients with ARF have a high
mortality rate, especially if they have undergone HSCT and present
MOF. Assessing the kind of lung injury by a biopsy sample to begin an
early direct treatment is necessary to improve their survival. Although
the respiratory index associated with the risk of mortality is known, this
does not allow one to predict these patients’ prognosis with certainty.
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Introduction The aim of our study was to compare the
characteristics of older patients (Group A, age ≥65 years) and
younger ones (Group B, age <65 years) admitted to the seven-bed
multidisciplinary ICU of our hospital, during a 9-year period.
Methods A retrospective observational study of the records of all
patients who were admitted to the ICU from 1998 to 2006. Data
collected included age, gender (male, female), reason for
admission (medical or surgical), APACHE II score on admission,
length of ICU stay (LOS) in days and ICU mortality. Data were
analyzed using Pearson correlation.
Results In total, 1,981 patients were admitted to the ICU during
the aforementioned period. Group A included 1,216 patients
(61.4% of total) and Group B 765 patients (38.6%). The annual
percentage of elderly patients ranged from 53.3% (in 1999) to
67.2% (in 2005). Male patients outnumbered female ones in all
age groups with the exception of the over-90 years age group.
Surgical admissions outweighed medical ones only for patients
aged 55–74 years of age. See Table 1.
Table 1 (abstract P496)
Characteristics of the ICU population from 1998 to 2006
Number APACHE Surgical 
of Male II LOS patients ICU 
Age patients (%) score (days) (%) mortality
<65 years 765 63.5 13.1 10.2 50.3 13.3
≥65 years 1,216 57.1 18.3 9.8 52.1 24.1
Conclusions Elderly patients represented the majority of ICU-
admitted patients. No correlation was found between ICU LOS
and age or severity of disease as measured by APACHE II score
on admission. ICU mortality was found to be consistently higher in
older patients compared with the younger ones (P < 0.001).
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Introduction Outcomes research suggests that neurological
patients cared for in specialized neuro-ICUs have lower mortality
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and better outcomes compared with general ICUs. However, little
is known about how the process of care differs in these two types
of units.
Methods The Greater New York Hospital Association conducted a
city-wide 24-hour ICU prevalence survey on 15 March 2007. Data
were collected on all patients admitted to 141 ICUs in 68 different
hospitals.
Results Of 1,906 ICU patients surveyed, 231 with a primary
neurological diagnosis were analyzed; 52 (22%) were admitted to
a neuro-ICU and 179 (78%) to a general ICU. Patients in neuro-
ICUs were more likely to have been transferred from an outside
hospital (37% vs 11%, P < 0.0001). Hemorrhagic stroke was
more frequent in neuro-ICUs (46% vs 16%, P < 0.0001), whereas
traumatic brain injury (2% vs 24%, P < 0.0001) and ischemic
stroke (0% vs 19%, P = 0.001) were less common. Despite a
slightly lower rate of mechanical ventilation (39% vs 50%, P =
0.15), the ICU length of stay (LOS ≥10 days) was longer in neuro-
ICUs (40% vs 17%, P < 0.0001). Neuro-ICU patients had more
often undergone tracheostomy (35% vs 15%, P = 0.043), invasive
hemodynamic monitoring (40% vs 20%, P = 0.002), and external
ventricular drain placement (14% vs 1%, P < 0.001) than patients
cared for in general ICUs; the use of intracranial pressure bolts
(15% vs 9%, P = 0.18) and electroencephalogram monitoring was
similar (4% vs 6%, P = 1.00). There was no difference in the use
of intravenous insulin (4% vs 9%, P = 0.37) or analgesics (14% vs
12%, P = 0.82), but intravenous sedation was less prevalent in
neuro-ICUs (12% vs 30%, P = 0.009). Fewer neuro-ICU patients
had received blood transfusions (0% vs 8%, P = 0.03) and more
were receiving nutritional support compared with general ICUs
(67% vs 39%, P < 0.001). The frequency of Do-Not-Resuscitate
orders was also somewhat lower in neuro-ICUs (3.8% vs 8.4%,
P = 0.37).
Conclusions Neurological patients cared for in specialty neuro-
ICUs had longer ICU LOS, underwent more invasive intracranial
and hemodynamic monitoring, tracheostomy, and nutritional
support, and received less intravenous sedation than patients in
general ICUs. These differences in care may explain previously
observed disparities in outcome between neuro-ICUs and general-
ICUs.
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Introduction Multiorgan dysfunction syndrome (MODS) is often
the final complication in critical patients. The increasing incidence
of MODS has been linked to development of resuscitation and
support techniques. The study aims were to describe the etiology,
morbimortality rate and mortality causes of MODS, and to find
factors associated with this syndrome.
Methods A prospective cohort study including 296 nonselected
medical critically ill patients diagnosed with multiorgan failure
(SOFA score ≥3 in at least two organs) and admitted to a 24-bed
ICU of a tertiary hospital from January to June 2007.
Results Two hundred and ninety-six patients were admitted, 124
suffered from MODS and 72% of them had it at admission. Fifty-
nine percent came from the emergency room. The mean age was
59 ± 16.2 years, and 60% were male. Causes of admission: 26%
neurologic pathology, 23% sepsis and 17% respiratory pathology.
Most frequent cause of MODS was sepsis (55%). Other causes
were respiratory pathology (13%) and neurologic impairment
(14%). At admission, 66.2% showed one (19.4%) or two (46.8%)
failing organs. Four or more failing organs were found in 10% of
patients at admission. During their stay in the ICU, 24.4% showed
four or more failing organs and almost 50% of them showed two
failing organs. Severity: APACHE II score 24.6 ± 7, APACHE III
score 79.4 ± 29, SAPS II score 55.57 ± 15, SAPS III score 72 ±
14; SOFA score at admission 10 ± 3, SOFA score in 24 hours 9.3
± 4, SOFA score in 48 hours 8.3 ± 3; SOFA score in 72 hours 7.6
± 3.7, SOFA maximum score 12.4 ± 3.8. Outcome complications
in 62%. Mean stay in the ICU was 9.7 ± 11.1 days and in the
hospital was 20 ± 19 days. The mortality rate in the ICU was 50%
and in hospital was 59%. Patients with severe respiratory failure
had higher mortality rates (63% vs 40%, χ2 P = 0.05). The
mortality rate in the hospital increased with the number of failing
organs (patients with four or more failing organs showed 90%
mortality, χ2 P = 0.000). Patients who developed complications
had higher mortality rates (76.3% vs 30.4%, χ2 P = 0.000), except
for nosocomial pneumonia. Severity score systems and sequential
SOFA scores were found to be independent predictor factors of
mortality.
Conclusions Critically ill patients who show MODS have a high
mortality rate, especially if they suffer from respiratory failure or had
four or more failing organs. In this study, severity score shows a
good discriminatory power.
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Determination of SpO2/FiO2 thresholds to impute for
PaO2/FiO2 ratios in the Sequential Organ Failure
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Introduction The Sequential Organ Failure Assessment (SOFA)
score is a well-validated and effective method by which to measure
organ dysfunction in critically ill patients and is a good indicator of
prognosis. However, repeated arterial blood gas data are often
lacking for calculating the respiratory component of the SOFA
score on a daily basis. The aim of this study was to derive
SpO2/FiO2 (S/F) ratio correlations with the PaO2/ FiO2 (P/F) ratio
in assessing the respiratory parameters of the SOFA score, incor-
porating the level of positive end-expiratory pressure (PEEP).
Methods Matched measurements of SpO2 (limited to values
≤98%) and PaO2 from patients admitted with acute respiratory
distress syndrome were used to determine the relationship
between S/F and P/F, using three separate linear regression
models, for patients on <8 cmH2O PEEP, 8–12 cmH2O PEEP and
>12 cmH2O PEEP. S/F threshold values correlating with P/F ratios
of 100, 200, 300 and 400 were determined, using the equation
derived from the model.
Results The linear regression coefficients of determination (R2) for
the three models (PEEP < 8 cmH2O, n = 1,107; PEEP 8–12 cmH2O,
Available online http://ccforum.com/supplements/12/S2
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Variable SF ratio SF ratio SF ratio
PF ratio PEEP <8 cmH2O PEEP 8–12 cmH2O PEEP >12 cmH2O
100 115 130 129
200 240 259 234
300 370 387 332
400 502 515 425
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n = 1,404 and PEEP >12 cmH2O, n = 405) were 0.58, 0.61 and
0.59, respectively. S/F threshold values correlating with P/F ratios
of 100, 200, 300 and 400, according to PEEP, are presented in
Table 1.
Conclusions S/F ratios categorized by the level of PEEP can be
used to impute for P/F ratios in the calculation of the respiratory
component of the SOFA score.
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Introduction Scoring systems represent classification systems or
point systems that have been designed for making quantitative
statements regarding the severity of a disease, its prognosis, and
its course. These systems are based on physiologic abnormalities
and have been successful in measuring severity of illness among
critically ill patients. Furthermore, scores may serve the purposes of
assessing therapies, of quality control and of quality assurance,
and of an economic evaluation of intensive care. We validated the
APACHE IV benchmark for a subset of patients with severe acute
pancreatitis (SAP).
Methods Twenty consecutive patients of SAP (as per Balthazar’s
CT classification of SAP) admitted to a surgical ICU between
February 2007 and December 2007 were enrolled in the study.
The length of stay and mortality percentages was predicted using
APACHE IV and later both the variables were compared with the
observed data.
Results Predictive ICU length of stay was 4.69 days (2.6–6.04)
whereas the exact ICU length of stay of patients was 25 (9.5–103)
days. Observed mortality was 20% (four patients) in our study, as
compared with 0% predicted mortality.
Conclusions APACHE IV could not be validated in our subset of
patients of SAP. The predictive ICU length of stay and mortality
percentage did not correlate with our experience in such patients.
Reference
1. Zimmerman JE, et al.: Acute Physiology and Chronic Health
Evaluation (APACHE) IV: hospital mortality assessment
for today’s critically ill patients. Crit Care Med 2006, 34:
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Introduction The critically ill obstetric population still search for a
model that accurately predicts mortality. The study hypothesis was
that APACHE IV [1] predicts ICU mortality better than APACHE III
[2] and APACHE II [3].
Methods A prospective collection of data concerning APACHE II
and APACHE III, and a retrospective analysis of complimentary
data necessary for APACHE IV mortality calculation. Discrimination
was assessed by the area under the receiver operator curve (ROC)
and calibration by the Hosmer–Lemeshow (HL) goodness-of-fit
test. Results are expressed as the mean ± SD. P < 0.05 was
considered significant.
Results The mean age was 31.2 ± 5.9 years. Seventy-five percent
were delivered by caesarean section. Seventy-eight percent
needed mechanical ventilation. Overall mortality was 11.23% (n =
71/641). Acute physiology scores (APS) of APACHE II and
APACHE III were significantly different between survivors and
nonsurvivors, respectively (7.2 ± 5 vs 20 ± 9 and 23.5 ± 18 vs
76 ± 39) (P < 0.001). See Table 1.
Table 1 (abstract P501)
Performance of the scores concerning mortality prediction
formulas and acute physiology scores
System ROC HL
APACHE II mortality 0.79 ± 0.033 0.07
APACHE III mortality 0.91 ± 0.018 0.012
APACHE IV mortality 0.93 ± 0.015 0.056
APACHE II APS 0.89 ± 0.02 0.27
APACHE III APS 0.9 ± 0.022 0.75
Conclusions APACHE II mortality prediction is out of date.
APACHE III and APACHE IV mortality have excellent discrimination
but poor calibration. Considering the APS alone, the APACHE
systems discriminate and calibrate well. APACHE IV can therefore
be considered the best mortality prediction model. Incorporation of
new predictor variables such as mechanical ventilation and
importance of respiratory dysfunction explains part of this
improvement. Regular recalibration of mortality prediction formulas
is important and helps improve calibration for aggregate patient
samples. For specific subgroups of patients, however, this
measure is probably insufficient; we need to incorporate new
specific variables.
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Introduction The aim of this study was to assess the comparative
performance of the SAPS 3 score with that of the APACHE II and
SAPS II scores in surgical ICU patients.
Methods In a cohort, observational study in a 51-bed
postoperative ICU of a university hospital, we included all
consecutive patients admitted to the ICU between August 2004
and December 2005. The SAPS 3 score was retrospectively
calculated from prospectively collected data. The probability of ICU
mortality was calculated for SAPS II, APACHE II, adjusted
APACHE II (adjAPACHE II), SAPS 3, and customized SAPS 3 for
West Europe (C-SAPS3 (Eu)) using standard formulas. A first-level
customization was performed using logistic regression on the
original scores, and the corresponding probability of ICU death
was calculated for the customized scores (C-SAPS II, C-SAPS 3,
and C-APACHE II).
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Results The study group constituted 1,851 patients; 1,173 males
(63.4%) and 678 females (36.6%), mean age 62 years. Patients
were mostly admitted after cardiac surgery (26.4%). Gastro-
intestinal, neurosurgery, vascular, and trauma surgeries contributed
to 18.7%, 8.1%, 5.7%, and 7.5%. The overall ICU and hospital
mortality rates were 6.4% and 9%. Hosmer and Lemeshow (H–L)
statistics showed poor calibration for SAPS II, APACHE II,
adjAPACHE II, SAPS 3, and C-SAPS 3 (Eu) (H–L C-statistics and
H-statistics: P > 0.05), whereas C-SAPS II, C-APACHE II, and C-
SAPS 3 showed good calibration. Discrimination was generally
good for all models (area under the receiver operator curve
(aROC) ranged from 0.78 (C-APACHE II score) to 0.89 (C-SAPS
3). APACHE II and C-APACHE II scores had significantly lower
aROC compared with other scores. C-SAPS 3 score appears to
have the best calibration curve by visual inspection.
Conclusions In this group of surgical ICU patients the perfor-
mance of the SAPS 3 score was similar to that of the APACHE II
and SAPS II scores. Customization improved calibration of all
prognostic models.
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Introduction Prognostic indicators have been identified in critically
ill patients with haematological malignancies [1,2]. Locally
developed risk-prediction models have proven to be equally or
more accurate in predicting hospital mortality for these patients
than models constructed for the general ICU population such as
the APACHE II or SAPS II [1,2]. The objective of this study is to
compare the accuracy of predicting hospital mortality in patients
with haematological malignancies admitted to the ICU between a
risk-prediction model based on multiple logistic regression (MLR)
and a support vector machine (SVM)-based risk prediction model.
Methods Three hundred and fifty-two patients with haematological
malignancies that were admitted to the ICU between 1997 and
2006 for a life-threatening complication were included. Two
hundred and fifty-two patient records were used for training and
100 were used for validation. In a first model, 12 input parameters
were included for comparison between MLR and SVM. In a
second, more complex model, 17 input parameters were used.
MLR and SVM analyses were performed independently from each
other. Discrimination was evaluated using the area under the
receiver operating characteristic (ROC) curves (±SE).
Results The area under the ROC curve for the MLR and SVM in
the validation set were 0.836 (±0.04) versus 0.802 (±0.04) in the
first model (P = 0.21) and 0.891 (±0.03) versus 0.808 (±0.04) in
the second, more complex model (P = 0.01), respectively.
However, SVM only needed four variables to make its prediction in
both models, whereas MLR needed seven and eight variables,
respectively, in the first and second models.
Conclusions MLR had better discriminative power for prediction of
hospital mortality in critically ill patients with haematological
malignancy as compared with SVM, but to the expense of inclusion
of more input variables. The discriminative power in both models
was sufficient for clinical use. After further validation and
optimization, the application of SVM algorithms might contribute in
the near future to the development of new risk-prediction models in
the ICU.
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Introduction Venous thromboembolism (VTE) during pregnancy
remains a significant cause of obstetric morbidity and mortality,
presenting the leading cause of maternal mortality in the USA and
Europe. In the present study we tried to determine the prevalence
of VTE, risk factors and mortality associated with VTE in critically ill
obstetric patients.
Methods A retrospective analysis of data collected prospectively.
Charts were reviewed for maternal characteristics of age, parity,
body mass index (BMI), presenting clinical symptoms and signs,
biological disturbances (deficiencies of protein S, protein C,
antithrombin III, etc.), obstetric management modalities and diag-
nosis of ICU admission. Objective modalities used to diagnose
VTE included Doppler ultrasound, computed tomography, and
magnetic resonance imaging scanning. High-probability ventilation
and perfusion scans were considered confirmatory of pulmonary
embolism, patients with low or intermediate probability scans had
pulmonary angiography for confirmation. SAPS Obst and APACHE
III scores were collected. The main outcome of interest was the
vital status at ICU discharge.
Results From January 1996 to July 2004, 541 obstetrics patients
were hospitalized in our ICU; 31 presented venous thrombo-
embolism (5.73%), 27 of them in the postpartum period (87%).
The mean age was 28.7 ± 6.2 (20–40) years, mean gravidity was
2.5 ± 1.5 (1–8), mean parity was 1.97 ± 1.27 (0–5) and BMI was
>27 in 17 cases. One patient presents a history of intracranial
venous thrombosis, another one with a history of ischemic stroke
and a third with Behçet disease. Two patients had haematological
abnormalities (deficiencies of protein C, antiphospholipid
antibodies). Delivery was vaginal in 15 cases and caesarean in 16
cases (P = 0.025). Two patients had deep-vein thrombosis
(6.45%), 15 with pulmonary embolism (48.3) and 14 with
intracranial venous thrombosis (45.1). The APACHE III score was
19.4 ± 13.8 and SAPS Obst was 13 ± 6. Five deaths (16.1%)
occurred in this study and three patients left the hospital with
neurologic deficits, requiring chronic care or rehabilitation.
Conclusions We found that vaginal delivery is a risk factor for
thromboembolic events in pregnancy. This indicates that we need
to review our antithrombotic strategy for preventing VTE events in
pregnancy for this mode of delivery.
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Quality of life after prolonged ICU stay: preliminary results
of a prospective survey in critically ill patients
R Nakahara, L Weibel, A Zollinger, C Hofer
Triemli City Hospital, Zurich, Switzerland
Critical Care 2008, 12(Suppl 2):P505 (doi: 10.1186/cc6726)
Introduction Prolonged ICU stay contributes largely to the overall
ICU costs. However, only limited data are available on outcome
Available online http://ccforum.com/supplements/12/S2
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measurement in patients with prolonged ICU stay. The aim of this
prospective survey was to assess quality of life in this patient
group.
Methods During a 1-year period, patients with a length of stay
(LOS) > 7 days in an interdisciplinary ICU were contacted by
telephone. A structured interview was performed to determine
patient satisfaction via a four-item Likert scale and quality of life
using the SF-36® health survey [1]. Norm-based SF-36® scorings
(transformed to a mean ± SD = 50 ± 10) were analysed
considering patient data at admission and during the ICU stay.
These data were obtained from the hospital main database.
Multivariate analysis was done for identification of risk factors
related to reduced quality of life, and a t test for subgroup analysis.
P < 0.05 was considered significant. Data are presented as the
mean ± SD.
Results A total of 1,618 patients received ICU treatment during a
1-year period (mortality rate: 4.8%). Sixty-six patients (4.1%) with a
LOS > 7 days were identified (general surgery: 34.8%, cardiac
surgery: 27.3%, internal medicine: 27.3%). Age was 63.9 ± 12.7
years (63.4% of patients >60 years), SAPS score was 34.9 ±
15.7 and LOS = 33.2 ± 21.7 days. Ventilatory support was
needed in 58 patients (87.9%), haemodiafiltration was performed
in 12 patients (18.2%). The mortality rate 6 months after discharge
was 9.1%. Fifty-five patients (91.7%) responded to the
questionnaire. Patients satisfaction was high (Likert scale = 1.3 ±
0.6). SF-36® physical and mental health components ranged from
39.1 ± 12.9 to 53.1 ± 12.4. The physical and mental component
summaries (PCS and MCS) were 46.2 ± 9.0 and 49.2 ± 10.9,
respectively. Multivariate analysis revealed no significant risk factor
for reduced PCS and MCS. Subgroup analysis showed a trend to
a decreased PCS for SAPS > 37 (P = 0.07), and MCS was
significantly decreased for LOS > 33 days (P = 0.002).
Conclusions These preliminary results indicate that prolonged ICU
length of stay is associated with a high survival rate after 6 months.
Quality of physical and mental health with only minor limitations can
be achieved in these patients.
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Introduction Assessment of health-related quality of life (HRQOL)
using the Short Form-36 (SF-36) has been recommended and
used in the ICU, particularly in subpopulations of ICU survivors [1].
We assessed the HRQOL of general ICU survivors at 4 months
post discharge and investigated any correlation with age, illness
severity and hospital or ICU length of stay (LOS).
Methods Following ethical approval, from November 2004 to
October 2005 all adult patients admitted for level 3 care for longer
than 48 hours to a 16-bed university hospital general ICU were
identified. Those surviving to 4 months post ICU discharge were
sent a questionnaire that included the SF-36 to complete.
Standard outcome and demographic data were also collected.
Results Eighty-six questionnaires were returned, 65 allowed
calculation of mental and physical summary components. Results
were compared (t test) between the lower 50% and higher 50% of
patients for each discriminator (P < 0.05 = significant). See Table 1.
Conclusions At 4 months after ICU discharge, the more elderly
have significantly higher psychological HRQOL as compared with
younger patients. Prolonged hospital LOS is associated with a
persisting significant reduction in the physical domains of HRQOL.
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Introduction Survivors of prolonged critical illness (requiring ≥14
days ventilation) experience the highest prevalence and severest
forms of critical illness-related morbidity. This study examines the
degree to which generic questionnaires reflect the quality of
survivors’ lives following critical illness.
Methods Twenty patients took part in semistructured interview at
≤6 months post ICU discharge. Patients discussed in detail the
aspects of their physical and psychological recovery that
concerned them most. Interviews were transcribed verbatim and
were thematically analysed. Patients also completed recom-
mended quality of life questionnaires (SF-36 and Euroqol 5D).
Using ‘think aloud’ techniques, patients described the ways in
which their responses to the fixed-choice categories of the
questionnaires were constructed. Interview data were also mapped
on to the developers’ definitions of the domains of the SF-36,
providing rich contextual information.
Results Impaired mobility and fatigue were major concerns.
Patients experienced a range of morbidity and expressed a number
of concerns not captured by questionnaire. Patients often provided
counter-intuitive scores by questionnaire; ‘thinking aloud’ revealed
that individuals process and construct their responses in
unanticipated ways. Patients under-reported many aspects of
morbidity not considered a matter of ‘health’ (for example, muscle
wasting), and under-reported morbidity overall because a life of
impairment was ‘better than being dead’. Interviews revealed the
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Discriminator Age (years) APACHE II score ICU LOS Hospital LOS
Mental summary component Mean below median value 39.32* 44.04 42.12 44.99
Mean above median value 46.78 42.21 44.07 41.28
Physical summary component Mean below median value 35.04 35.85 36.08 39.31*
Mean above median value 36.36 35.60 35.35 32.22
*Significant at P < 0.05.
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nature and extent of patients’ reliance on informal carers and,
importantly, the diverse adaptive processes used to minimise the
interference of morbidity in everyday life. These patients, although
self-selecting, presented a positive outlook akin to the survivor
‘persona’ known to influence the meaning and subjective
evaluation of quality of life among cancer patients.
Conclusions This research raises important questions about the
use of generic quality of life measures among survivors of critical
illness. Qualitative and mixed methods approaches, although
analytically laborious, may yield experientially important information
and clinically useful insights into the quality of survivors’ lives that
are inaccessible by questionnaire alone.
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Introduction The objective was to estimate differences in long-
term outcomes and resource use (RU) and to determine the
marginal cost-effectiveness (CE) ratio of care using a liberal (LIB)
or conservative (CON) fluid strategy for acute lung injury (ALI) in
the NHLBI ARDS Network multicenter Fluid and Catheter
Treatment Trial.
Methods We used data on RU and outcomes from a subset of
655 participating in postdischarge follow-up. We estimated costs
using Medicare cost-to-charge ratios and fee schedules. CE ratios
and 95% confidence ellipses were generated by Monte-Carlo
simulation (Figure 1). We estimated the postdischarge RU and
utility up to 1 year from interviews, post-1-year survival from age-
matched, sex-matched and race-matched life tables, and post-1-
year costs from the Medical Expenditure Survey. We assumed
mean utility at 1 year to be constant thereafter. We projected costs
to the year 2008 and discounted future costs and outcomes at 3%
per annum. Costs are in 2007 US$.
Results Hospital costs were available for 633 subjects and were
similar for LIB (n = 310, $97,100) and CON (n = 323, $89,000)
(P = not significant). Post discharge to 1 year costs of LIB (n =
208) were similar to those of CON (n = 221) ($53,600 vs
$52,600, P = not significant) for those discharged alive, and
$41,100 vs $39,000 for all subjects. Post 1 year costs were
similar. Mortality increased from 26.9% (LIB) and 24.5% (CON) at
60 days to 35.6% and 32.1% at 1 year (P = 0.31). Home oxygen
use was 32.2% and 28.5% for LIB and CON (P = not significant)
and 15.4% and 14.0% at 1 year (P = not significant). Admission to
a rehabilitation facility (34.1% and 29.4%) and rehospitalization
(44.2% and 46.2%) were common in year 1 (P = not significant).
Quality of life was low throughout follow-up, but did improve from
60 days (0.50 and 0.48) to 1 year (0.67 and 0.59) (P = not
significant between LIB and CON).
Conclusions Subjects surviving ALI have considerable
postdischarge RU and impaired quality of life. No single domain of
outcome was significantly affected by the fluid strategy but
observed values were generally better with CON. CON had a
better CE profile than LIB.
Acknowledgement Sponsorship from R01-HS-11620 and N01-
HR-46064.
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Introduction Chronic thoracic pain after sternotomy has an overall
incidence of 28–38%. It has been suggested that excessive and
persistent postoperative pain may be a precursor to chronic pain.
The aim of this study was to determine the incidence of chronic
poststernotomy pain, the use of analgetics to minimize this pain
and its effect on daily function and sleeping. We investigated
whether unacceptable acute pain after sternotomy is an
independent predictor for the occurrence of chronic thoracic pain.
Methods A cohort study of 146 patients (older than 18 years)
submitted to intensive care after cardiac surgery through
sternotomy in the period 28 June 2006–18 August 2006 was
performed. From all patients, the pain was measured using the
Numeric Rating Scale (NRS ranging from 0 to 10). One or more
pain measurements of a NRS >4 during the first postoperative
week was considered unacceptable acute pain. After 10–12
months the patients were contacted by telephone and questioned
about thoracic pain in the 2 weeks prior to the interview. The main
outcome variable was unacceptable chronic thoracic pain.
Multivariable logistic regression was used to control for potential
confounders and to calculate the adjusted odds ratio of
unacceptable chronic thoracic pain for patients who experienced
unacceptable acute pain.
Results From a total of 146 patients we contacted 120 (82.2%)
by telephone. The incidence of chronic thoracic pain was n = 42
(35%). Of the patients with chronic pain most patients, n = 31
(73%), rated this pain as unacceptable. Of the patients with
chronic thoracic pain, disturbed sleeping was mentioned by 16
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(38%) patients, use of analgetics for thoracic pain by 15 (36%)
patients and disturbed daily function by six (14%) patients. Almost
all of these patients rated their chronic pain unacceptable. The
adjusted odds ratio of unacceptable chronic thoracic pain for
patients who experienced unacceptable acute pain was 4.6 (95%
CI: 1.26–16.4).
Conclusions The results of this study confirmed that chronic pain
is an important complication after sternotomy. Unacceptable acute
pain is a strong predictor for the development of chronic thoracic
pain.
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Introduction The study was designed to evaluate the pharmaco-
kinetics of oral melatonin in patients recovering from critical illness.
To re-enforce a patients’ circadian rhythm it is necessary to
administer an appropriate dose at the correct time. However, data
are currently unavailable to guide effective dosing in this population.
Methods A randomised double-blind placebo controlled trial was
performed in 24 critically ill patients weaning from mechanical
ventilation. Melatonin 10 mg was administered as an oral solution
at 21:00 hours each night for four nights. Pharmacokinetic analysis
of plasma melatonin concentrations was undertaken in the first
nine patients in the active group. Twelve blood samples were
collected from each patient at appropriately spaced intervals. After
sample dilution, plasma melatonin was measured in duplicate using
a melatonin radioimmunoassay. Plasma concentrations were
corrected for endogenous plasma melatonin concentration by
subtracting the 21:00-hour baseline value. Pharmacokinetic data
from mean values were described using noncompartmental analysis.
Nocturnal sleep quantity was measured using the bispectral index
(BIS) and expressed as the sleep efficiency index (SEI) and BIS area
under the curve (AUC) between 22:00 and 07:00 hours.
Results Melatonin was rapidly and extensively absorbed with a
mean (SD) time to maximum plasma concentration of 0.5 (0) hours,
a maximum plasma concentration (Cmax) of 14,974 (3,200) pg/ml
and the area under the plasma concentration time curve 0–24
hours (AUC(0–24)) was 29,979 (8,205) ng.hour/l. Plasma concen-
trations declined biexponentially with an overall plasma half-life of
1.47 (0.28) hours. Clearance of this liver-metabolised drug
resembled cirrhotic patients [1] rather than healthy individuals [2].
Both Cmax and AUC(0–24) had a moderately strong correlation with
plasma ALT concentrations; r = 0.7 (P = 0.04) and r = 0.62 (P =
0.07), respectively. No such association was found with age,
gender, weight, creatinine or bilirubin. Morning plasma levels
(plasma concentration at 08:00 hours) remained supraphysio-
logical at 84 (64) pg/ml. No association was found between the
pharmacokinetic parameters Cmax, AUC(0–24) or plasma concen-
tration at 08:00 hours and the mean SEI or BIS AUC measure-
ments of nocturnal sleep.
Conclusions The 10 mg nocturnal dose is excessive in this
population, and reduced doses should be used in future
chronotherapeutic studies of exogenous melatonin.
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Introduction Delirium in the ICU can compromise the recovery
process, prolong the ICU and hospital stays and increase mortality.
Therefore, recognition of delirium is of utmost importance.
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Methods To ascertain current attitude pertaining to delirium in
critically ill patients, a simple questionnaire was sent to ICUs with
≥5 beds throughout The Netherlands.
Results From the number of units responding (n = 40, 53%), a
delirium protocol was present in the majority of cases (n = 31,
78%), although implementation had occurred in only 16 ICUs
(40%). Treatment of delirium was judged clinically important by
75% of the medical teams. The reported general incidence of
delirium varied widely (<10% to 75%), but most participants
thought it to occur in >25% of ventilated patients (n = 28, 70%)
and in patients older than 50 years (n = 34, 85%). Most
participating centers reported that they could certainly (n = 8, 20%)
or most certainly (n = 21, 53%) identify delirium. A geriatrician or a
psychiatrist predominantly diagnosed delirium (n = 27, 68%), while
a screening instrument like the Dutch Confusion Assessment
Method for the Intensive Care Unit was used in a minority of cases
(n = 13, 33%). A geriatrician or a psychiatrist was consulted when
patients were agitated (n = 32, 80%), or when routine
pharmacological treatment had failed (n = 30, 75%). The frequency
of checking for the presence of delirium varied from never (n = 12,
30%) to >3 times a day (n = 8, 20%). Delirium was predominantly
treated with haloperidol (n = 30, 75%), while nonpharmacological
measures were also taken frequently (n = 24, 60%).
Conclusions In The Netherlands, delirium is considered an
important problem in the ICU, although its incidence is thought to
be low. Delirium is most frequently established by a geriatrician or
psychiatrist after consultation. Efforts should be undertaken to
implement delirium protocols and a routinely applied screening
instrument in the ICU.
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Introduction Delirium is an increasing complication of the ICU
patient. We estimated the incidence of delirium using the Confusion
Assessment Methods for the Intensive Care Unit (CAM-ICU) in a
cohort of general ICU patients. We also investigated the value of
S-100 protein to reflect this clinical condition.
Methods Adult consecutive patients admitted to the ICU for more
than 72 hours were entered in the study. The CAM-ICU was
performed at admission and subsequently twice a day, by medical
staff. Clinical data were evaluated in a univariate and multivariate
analysis with STATA/10. S-100 protein in patients who experienced
delirium was compared with patients not experiencing delirium.
Results Twenty-two patients entered into the study. Delirium
occurred in 36.4%. The risk of delirium was independently
associated with sepsis and use of vasoactive drugs during the ICU
stay, but not with age, sex, SAPS II, benzodiazepine or opiate use
(Figure 1). Delirium was linked to a longer ICU stay (16.25 vs 6.28
days) and mechanical ventilation period (20.4 vs 8.4 days). Patients
that experienced delirium showed a higher level of S-100 protein
(0.19 ± 0.06 μg/l) than control (0.05 ± 0.03 μg/l) (Figure 1).
Conclusions In our study, delirium increases the ICU stay and
duration of mechanical ventilation. Perturbation of the thalamic filter
associated with the use of vasoactive drugs with anticolinergic
properties and hypotension seems to be a predisposing factor for
the incidence of delirium. Delirium represents an early symptom of
cerebral dysfunction, and an increased level of S-100 protein can be
an early marker of brain injury in sepsis-associated encephalopathy.
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Introduction Recently published literature suggests that the use of
nicotine replacement therapy in critically ill smokers may lead to
increased mortality in the ICU [1]. The objective of this study was
to test this hypothesis retrospectively in a single, combined
medical and surgical ICU in a community-based academic hospital.
Methods We retrospectively reviewed all of the admissions to our
ICU in the period 1 July 2006 and 30 June 2007. Our ICU is a 16-
bed, combined medical and surgical ICU at a community-based
academic hospital with a critical care medicine fellowship. Critically
ill, active cigarette smokers were identified as our study group, and
demographic information, the use of nicotine replacement, ICU
length of stay, and ICU mortality were collected and analyzed.
Results We reviewed 874 charts, 420 females (48.1%) and 454
males (51.9%); there were 688 nonsmokers (78.7%) and 186
(21.3%) smokers. There was a statistically significant reduction in
mortality in the nicotine replacement group compared with smokers
who did not receive nicotine replacement. (10.1% vs 23.7%, P <
0.05). The ICU length of stay was longer in the smokers versus
nonsmokers overall, although not statistically significant (156.4 hours
vs 109.2 hours, P > 0.1). The length of stay was longer in the
smokers who received nicotine replacement versus those who did
not receive it. (315.4 hours vs 273.0 hours, P < 0.003).
Conclusions While there was a trend to worse outcome in
critically ill smokers versus nonsmokers, this was not found to be
statistically significant. In the main study group of smokers, nicotine
replacement was clearly associated with decreased mortality. The
increased length of stay found in smokers receiving nicotine
replacement therapy may have been directly attributable to their
decreased mortality. This finding is in direct contrast with a recently
published study of similar size and suggests that there is a role for
a prospective study to determine the appropriate management with
regard to nicotine replacement therapy in critically ill patients.
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Introduction Delirium is a common problem in hospital settings,
and the prevalence of delirium varies among different hospital
inpatient populations (42–87%). As in other patient populations,
early detection of delirium in the ICU is a necessary first step for
successful treatment and prevention. The Dutch Confusion
Assessment Method for the Intensive Care Unit (CAM-ICU) is a
rapid and easily administrated screening instrument to detect
delirium and is based on the DSM-IV. The aim of this study was to
translate, retranslate and validate the CAM-ICU for use in Dutch
ICU settings.
Methods The translation of the CAM-ICU was done by standard
translation guidelines, which include preparation, forward
translation/reconciliation, retranslation by an official translator,
harmonization and validation. Secondly, the validation study of the
Dutch CAM-ICU version itself was performed in a large Dutch
community hospital with a mixed ICU. The patients were tested by
a geriatrician or a psychiatrist for symptoms of delirium according
to the DSM-IV criteria. The CAM-ICU testing was done indepen-
dently by a trained research nurse but within the same hour in
which the geriatrician or psychiatrist tested the patient, as to
minimise the bias of fluctuations in delirium symptoms during the
day. Agreement was calculated using crosstabs analysis and the
Kappa statistic.
Results Thirty consecutive adult patients with a Richmond Agitation
and Sedation Score –3/+4 were included in the study, 60 paired
tests for delirium were carried out and 30 CAM-ICU instruments
were completed. Only three patients were diagnosed differently by
the geriatrician or psychiatrist and the CAM-ICU; two had a
psychiatric disorder and one had been sedated between the two
measurements. Overall agreement was 90% (Κ > 0.81, P < 0.001).
Conclusions The translation of the Dutch CAM-ICU showed good
correlation with the original English version developed by W Ely
and can therefore be used in a Dutch intensive care setting. The
results of the validation study showed very good agreement
between the clinical diagnoses made by the geriatrician or
psychiatrist and the detection of delirium using the Dutch CAM-
ICU. It therefore provides the means for early and reliable detection
of ICU delirium in a Dutch ICU setting.
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Introduction Critically ill patients are characterized by increased
loss of muscle mass, partially attributed to sepsis and multiple
organ failure, as well as immobilization. Recent studies have shown
that electrical muscle stimulation (EMS) may be an alternative to
active exercise in chronic obstructive pulmonary disease and
chronic heart failure patients with myopathy. The role of EMS for
the preservation of muscle mass of critically ill patients has not
been studied. The aim of our study was to investigate the EMS
effects on muscle mass preservation of critically ill patients with the
use of ultrasonography (US).
Methods Ten consecutive critically ill patients (age: 69 ± 16 years,
APACHE score: 22 ± 5, SOFA score: 10 ± 3) were randomly
assigned upon admission to receive daily EMS sessions (45-min
session, 5 days per week) of the vastus lateralis, vastus medialis
and peroneus longus muscles of both lower extremities (EMS
group) or to the control group (non-EMS group). Muscle mass was
evaluated with US, by measuring the cross-sectional diameter
(CSD) of the quadriceps muscle (rectus femoris–vastus inter-
medius). US images were obtained using a GE Vivid 7 model
ultrasound scanner with a 7.5 MHz linear probe. The position of
the probe was selected as midway between the anterior superior
iliac spine and the midpoint of the patella, and was placed ventral
to the transverse plane and perpendicular to the skin. To
standardize the measurements of the US, the position that was
selected was marked for the following measurement. The
measurements were performed on the second and seventh day
following admission.
Results The rectus femorist CSD decreased in both groups (EMS
group: from 1.24 ± 0.33 to 1.16 ± 0.35 cm, non-EMS group: from
1.52 ± 0.51 to 1.25 ± 0.43 cm) (P < 0.05); however, the EMS
group (–0.08 ± 0.05 cm, –7.2 ± 4.1%) was observed to decrease
significantly less (P < 0.05) than the non-EMS group (–0.26 ± 0.13
cm, –17.3 ± 7.6%). The vastus intermedius CSD decreased in both
groups (EMS group: from 0.87 ± 0.43 to 0.79 ± 0.42 cm, non-EMS
group: from 1.65 ± 0.65 to 1.23 ± 0.47 cm) (P < 0.05), and there
was a significant difference (P < 0.05) between the EMS group
(–0.08 ± 0.02 cm, –10.0 ± 5.0%) and the non-EMS group (–0.41
± 0.21 cm, –24.6 ± 5.1%).
Conclusions The preliminary data presented suggest that EMS
may preserve the muscle mass of critically ill patients. These
results as well as the potential use of EMS as a preventive and
rehabilitation tool in ICU patients with polyneuromyopathy need to
be further investigated.
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Introduction ‘End of life’ (EOL) decisions in ICUs are influenced
by numerous factors such as patient’s disease severity and
reversibility, religious and cultural traits, education and awareness
of the patient’s family and legal provisions. The majority of
published studies on EOL reflect either a European or an American
ethos; that is, either the physician’s paternalistic approach about
the patient or the patient’s autonomy and self-determination about
this sensitive process. Studies that reflect the influence and pivotal
role of a closely knit Indian family in EOL decision-making are
scant. We retrospectively analysed the EOL decisions taken by the
family in our ICU.
Methods The setting was a 50-bed multidisciplinary ICU of a 400-
bed tertiary care teaching hospital in Pune in India. Case papers of
all ICU admissions during 1 year (1 January–31 December 2006)
where the EOL decision was documented were reviewed. Data
collected included demographics, underlying disease process,
duration of aggressive treatment until EOL consent, duration
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between EOL decision and death, consenting person’s relation
with the patient, organ failure and level of life-sustaining supports
at decision.
Results During the study period 524 patients died in our ICU, of
which EOL decision and consent was explicitly documented in 95
cases, which constitute the study population. The average age of
the patient was 63 years (range 17–91), the average duration of
active treatment until EOL consent was 83.35 hours (range
1–960), and the average duration between consent and death was
29.03 hours (range 1–168). A total of 92.7% consents were
signed by close relatives (son/daughter, brother/sister, spouse,
father/mother) and 7.3% were by other relatives (cousins, son in
law/daughter in law). No EOL decision was signed by the patient
or his/her legal representative as well as the physician. No EOL
decision was taken as per a patient’s self-documented own ‘Death
Will’ or ‘Advanced Directive’.
Conclusions Withholding nonbeneficial life-sustaining therapies
as an EOL process was practised in 18.12% of the total ICU
deaths. All 95 (100%) EOL decisions as well as directive requests
and consents were signed by patients’ relatives, reflecting the
importance of close family ties in Indian EOL practices.
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Introduction Approximately one in five patients in the USA dies in
the ICU. The majority of these deaths are following withholding or
withdrawal of treatment. Communication between the healthcare
team and the relatives of the patient constitutes a very important
aspect of the end of life care. We conducted a retrospective
survey to assess the quality of communication in terms of duration
and content of the interview and spiritual care.
Methods The next of kin of patients who died over a period of 1
year from April 2003 were identified. Those with ongoing
complaints and no fixed abode were excluded. Seventy-three
patients had died during this period. Sixty-one questionnaires were
sent out by post and 32 responses were received. Nine were
incomplete and 23 were analysed.
Results Were you given sufficient information? – 74% and 78% of
the responders were satisfied with the amount of information given
by medical and nursing staff, respectively. Awareness of what was
happening to your relative? – 65% were aware of what was
happening to their relative. Were questions and concerns
answered? – 74% replied positively. Was the duration of interview
sufficient? – 87% replied yes. Was there overall satisfaction with
the content of interview? – 70% were overall satisfied. Was
spiritual care offered? – spiritual care was not offered to 56% of
responders; if it was offered, 85% of them would have accepted it.
Conclusions Medical and nursing staff appear to have given
sufficient information and answered questions and concerns of the
next of kin. The duration of the interview was also sufficient. The
next of kin appear to have comprehended the information given. It
does appear that spiritual care was not offered to the majority of
responders. We could improve our quality of communication by
offering spiritual care to relatives. A structured interview with the
relatives can improve family understanding and satisfaction of the
quality of end of life care!
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Introduction There is no formal guideline on end of life care issues
in the Middle East. We hypothesize that decisions are influenced
by personal belief, culture and background training. The purpose of
the present study was to compare the opinion of healthcare
providers on the care of terminally ill patients.
Methods An anonymous questionnaire was sent by email to
members of the Pan Arab Society of Critical Care with a grace
period of 6 months.
Results The response rate was 46.2%. The findings were as
follows: males 91.8%, Muslims 86%, physicians 96%, consultants
70.9%, and aged between 40–50 years 47.7%. Most of the
responders had a Middle Eastern training background (33.8%),
followed by North American (29.2%) and European (17.6%). There
is no formal Do Not Resuscitate (DNR) policy in 62.2% of the
participants’ institutions. Religion played a major role for 59.3%
responders in making the DNR decision. DNR was equivalent to
comfort care in 39.5%. In a futile case scenario, Do Not Escalate
Therapy was the preferred response (54.7%). The likelihood of a
patient once labeled DNR being clinically neglected was a concern
among 46.5%. The importance of comfort during dying was a priority
for 45.3%, while religious concerns were important in 52.3%.
Admission of DNR patients to the ICU was acceptable for 47.7%,
and to continue feeding DNR patients for 94%. For 60.5% the best
time to discuss end of life issues was prior to the patient getting
severely ill. Almost one-half of the responders (46.5%) wanted
physicians to have the ultimate authority in the DNR decision. There
was no significant effect of place of training and seniority on the
management plan, neglect of the patient, right to override the right of
the family, the best defining conditions for the patient’s death or
abuse of the code. Nevertheless, the place of training had a
significant effect on the meaning of the code (P < 0.08).
Conclusions Despite a different training background, the majority of
members of the Pan Arab Critical Care Society have a general agree-
ment on care of terminally ill patients. Further studies are needed to
form a consensus and formalize a DNR policy for the region.
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Introduction The world’s population is becoming older, which
affects the ICU population. Elderly patients constitute 42–52% of
all admissions to the ICU. It is therefore necessary to establish the
risks of this group of patients, aiming to offer proper treatment. The
aim of this study was to identify risk factors of an elderly population
of patients admitted to the ICU.
Methods A prospective longitudinal cohort study in a general ICU
of a tertiary hospital, between 1 December 2006 and 30 April
2007. Inclusion criteria were patients above or equal to 65 years
old, admitted to the ICU for at least for 24 hours. Exclusion criteria
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were moribund patients, patients with terminal diseases and
patients readmitted to the ICU.
Results One hundred and ninety-nine patients were enrolled, with
mean age of 75.4 years, 58.8% female. The ICU and inhospital
mortalities of this population were 28.1% and 57.3% respectively.
Mean values of APACHE II, SOFA, MODS and Katz index
(Activities of Daily Living Scale) were, respectively, 20.0 ± 5.8, 6.8
± 3.9, 2.4 ± 1.9 and 5.3 ± 1.6. A total 61.1% of the patients were
in postoperative status; of them, 41.6% were under mechanical
ventilation and 39.1% required vasoactive drugs. Independent risk
factors of a high mortality rate (death versus ICU discharge) were:
advanced age (76.9 ± 6.7 years vs 73.3 ± 6.5 years; OR = 1.08;
95% CI = 1.01–1.16; P < 0.001), Katz index (4.9 ± 1.9 vs 5.7 ±
0.9; OR = 0.66; 95% CI = 0.45–0.98; P = 0.001), hyperglycemia
(158.1 ± 69.0 vs 139.6 ± 48.5; OR = 1.02; 95% CI = 1.01–1.03;
P = 0.041) and requirement for mechanical ventilation at ICU
admission (57.0% vs 20.5%; OR = 3.57; 95% CI = 1.24–10.3);
P < 0.001).
Conclusions Prognosis was more dependent on severity of illness
and functional status before admission than on high age itself.
Traditional prognostic models such as APACHE II, SOFA and
MODS were not discriminative. We need a new prognostic score
validated in elderly ICU patients that predicts not only survival but
also functional and cognitive status after discharge.
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Introduction The purpose of the study was to focus on factors that
affected outcome of very elderly patients (≥75 years) in a 10-bed
polyvalent ICU.
Methods A retrospective database analysis of admissions from
January 2003 to June 2006. The variables recorded were: age,
admission diagnosis, severity of illness scores, mechanical
ventilation days, ventilator-acquired pneumonia, and ICU length of
stay. According to the ICU outcome, patients were divided into
survivors and nonsurvivors. Statistics were performed by Mann–
Whitney, chi-square, multivariate logistic regression and ROC
curve analyses.
Results Very elderly patients comprised 10.7% (n = 131) of the
study population (n = 1,223). The mean age was 78 ± 4 years
(range 75–96). Patient data according to outcome and statistical
significance are presented in Tables 1 and 2. The APACHE II (OR:
1.153, 95% CI: 1.011–1.315, P = 0.033) and SOFA scores (OR:
1.724, 95% CI: 1.189–2.499, P = 0.004) upon ICU admission
were determined as independent risk factors affecting outcome.
ROC curve analysis revealed that admission APACHE II (>23) and
SOFA (>4) scores presented a sensitivity of 77.4% and 96.8%,
respectively, with a specificity of 95% and 74%, respectively, for
the prediction of poor outcome. The total mortality rate was 23.7%
(n = 31).
Conclusions It is not age per se but concomitant factors that
appear to be responsible for the poorer prognosis. Among them,
severity of illness and premorbid functional status are identified as
strong predictors of adverse ICU outcome.
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Introduction ‘Doctor. Do whatever necessary to save her life’. This
is a challenge for doctors in daily practice, mainly when it deals
with attempts to prolong life and admission to the ICU should be
denied. The objective of the present study is to determine attitudes
and practices of newly graduated physicians in Brazil about end of
life care and to evaluate the new set of skills they have to be
prepared to deal with.
Methods A multiple-choice cognitive test was applied to
physicians as part of a selection process for a residency program.
The question was about a 77-year-old woman, with dementia, who
has lived in long-term geriatric care for the past 5 years. She was
transferred to the hospital with acute respiratory failure and
pneumonia. The lung image showed disseminated malignancy. The
granddaughter (GD), although unaware of the prognosis, asked
the doctor to do ‘everything to save the life’. The candidates were
asked for the appropriate behavior. Option (A) to treat, including
performing advanced life support at the ICU, independent of a
previous quarrel with the GD; Option (B) to not perform any
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Table 1 (abstract P521)
Patient data 1
Survivors Nonsurvivors P value
Age (years) 78.4 ± 4 78 ± 3 NS
SOFA score 3.4 ± 2.7 6 ± 3 0.000
APACHE II score 15 ± 6 27.5 ± 6.7 0.000
GCS 12.4 ± 4 8,3 ± 5 0.000
Mechanical ventilation (days) 10 ± 14 12 ± 13.5 NS
ICU length of stay (days) 10 ± 15 13 ± 14.5 NS
Data presented as mean ± SD. NS, not significant.
Table 2 (abstract P521)
Patient data 2
Survivors Nonsurvivors P value
Medical 26 (26%) 19 (61%) 0.000
Surgical 69 (69%) 7 (23%) 0.000
Trauma 5 (5%) 5 (16%) 0.000
Inotropes 33 (33%) 16 (51.6%) 0.05
Ventilator-acquired pneumonia 14 (14%) 14 (45%) 0.001
Data presented as n (%).
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diagnostic or therapeutically measure and inform the GD that this
will no longer bring benefit to her grandmother; Option (C) to
define, together with the GD, possible palliative interventions; or
Option (D) to apply protocols based on evidence related to
palliative care, independently of the GD’s opinion. The correct
answer was based on two skills: the concern about futile treatment
and ethical issues – Option (C).
Results A total of 1,133 physicians participated in the selection
process for medical residency and answered the questionnaire. Of
the respondents, 698 (61.61%) would rather define with the family
possible palliative interventions (correct option – (C)); 312
respondents (27.54%) would treat the patient even without the
family’s opinion (option (A)); 122 respondents (10.77%) would
apply protocols, again independent of the GD’s opinion (option
(D)); and one candidate (0.08%) chose option (B).
Conclusions Although the concept of palliative care and the
importance to share decisions with the family has been chosen by
the majority of the newly graduating physicians, 38.31% would still
make decisions independently of the family’s opinion. Medical
students have to be prepared for a new set of skills.
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Introduction Interdisciplinary ethics consultation (EC) on the ICU
can be requested by the clinical team as a result of a subjective
assessment of the patient’s situation. The aim of this study was to
objectify the initiation of EC by means of the SOFA score and to
examine its impact on the clinical course.
Methods Over a 2-year period, all patients receiving an EC on the
ICU were recorded. The age, hospital stay and mortality were
compared with ICU patients who did not receive an EC. SOFA
score values of EC patients at the time of admission to the ICU and
at the time of EC were compared. Furthermore, the effect of
different EC decisions (maximization/limitation of treatment) on
hospital stay and mortality were defined.
Results An EC was carried out in 52 patients out of the total 764
patients (6.8%). Age (76.6 years; range 40–99), hospital stay
(20.5 days; range 5–286) and ICU mortality (92.3%) were
significantly higher in EC patients compared with patients without
EC (68.3 years; range 10–100; P ≤ 0.001) (3 days; range 2–106;
P ≤ 0.001) (7.6%; P ≤ 0.001). The mean SOFA score at the time
of EC (7.52; ±0.48 SEM) was significantly higher compared with
the time of admission to the ICU (4.29; ±0.42 SEM) (P ≤ 0.001).
Following maximization of treatment (n = 9), the median hospital
stay was significantly longer (13 days; range 4–254) compared
with other EC decisions (n = 43) (P ≤ 0.007).
Conclusions In critically ill patients, the interdisciplinary EC
provides a meaningful tool for decision-making between
maximization and reduction of treatment – facilitating improved end
of life care and dignified dying. Indication of an EC at the bedside
should be supported by the SOFA score.
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Introduction In conjunction with the Electronic Medical Record’s
Computerised Physician Order Entry project, KK Hospital has
participated in the SingHealth Wireless Local Area Network
(WLAN) Infrastructure project to evaluate the CISCO® Wireless
network technology product. The vendor, medical device
manufacturers and local medical equipment distributors would not
guarantee in writing that there would be no radiofrequency or
electromagnetic interference (EMI) from the 2.4 GHz and 5 GHz
direct sequencing spread spectrum system (DSSS) with medical
devices. The Standards, Productivity and Innovation Board are able
to conduct onsite electric field measurements but could not
guarantee any EMI on medical devices. Senior management at KK
Hospital requested an EMI test to be conducted inhouse to
determine the potential effects of the WLAN on medical devices.
Methods The test was conducted within a vacant room in the
women’s ICU. Selected medical devices were representative of
technology used in KK Hospital ICUs and wards. The WLAN and
medical devices were set up to replicate the actual environment as
closely as possible. The test was conducted on both the 2.4 GHz
and 5 GHz direct sequencing frequency bandwidth at a power
setting of 50 mW with two PC Notebooks. A command was
executed on the two PC Notebooks to generate continuous
wireless transmission between the WLAN card of the PC
Notebooks and the access point in the room. One women’s ICU
nurse was deployed to chart and monitor the parameters of each
medical device under test. The project team also checked the
equipment under test at 1 or 2 hour intervals.
Results No electromagnetic interference was detected on any of
the devices under test.
Conclusions The EMI test was only a sampling, bench-top test
and should not be taken as conclusive for EMI effects of the DSSS
WLAN on each medical device within the hospital. However, due
diligence was exercised in conducting the EMI test and there
appears to be no evidence to suggest adverse EMI effects on the
medical devices tested.
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Introduction The steady increase of expected lifetime and mean
age of man in the western world can only be accompanied by an
increase in medical care and inherent use of ICU resources. Now-
adays, one in five Americans dies using ICU care. We explored
whether the use of ICU resources by long-stay patients has
increased over time.
Methods Data from all patients admitted to a 10-bed
medical–surgical ICU in a university-affiliated teaching hospital in a
10-year period were analyzed. In the study period, organizational
aspects such as the nurse-per-patient ratio and the number of
intensivists remained stable. In the first 24 hours, the type of
admission and medical history was recorded and APACHE II
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scores were calculated. After discharge, patients were divided into
four groups with ICU length of stay (LOS) <3 days, 3–6 days,
7–13 days and ≥14 days. Data are shown as the median
(interquartile range (IQR)).
Results Over the years, the number of patients admitted per year
was stable at a median 578 (IQR 535–588). Age (69 (65–76)
years) was stable over the years and did not differ between LOS
groups. APACHE II scores (12 (8–17)) were stable as well, while a
longer ICU LOS was associated with higher scores. Hospital
mortality was 18.5% (range 16.6–19.1%). The proportion of
patients per year in the different LOS groups did not change over
the years; that is, LOS <3 days: 62.5% (range 61.4–64.1%), LOS
3–6 days: 19.1% (range 18.9–20.1%), LOS 7–13 days: 9.8%
(range 9.2–10.9%), and LOS ≥14 days: 8.6% (range 7.5–9.6%).
The relatively small group of long-stay patients (≥14 days; n = 44
(39–51) per year) comprised predominantly medical admissions
(65.5%) and consumed 54.6% of the yearly ICU treatment days.
Mortality in this group (35.1%) was higher than in the groups with
shorter length of ICU stay (14.2% in LOS <3 days, 17.1% in LOS
3–6 days and 27.0% in LOS 7–13 days; P < 0.001).
Conclusions Consumption of ICU resources by long-stay patients
was considerable, but did not change over time in our setting.
Long-stay patients were predominantly medical admissions and
showed the highest mortality. These findings are important in view
of futility and costs.
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Introduction A recently published study by Negrini and colleagues
in 2006 suggested strongly diverging patient-related costs per ICU
day between Western European countries. We tried to verify these
results by performing a cost analysis in three European countries.
Methods We conducted a retrospective cost study in one
German, one Italian and three Dutch adult medical–surgery ICUs,
from the hospital perspective. A microcosting approach was used;
that is, all relevant resources were identified and valued at the most
detailed level. Resource use was divided into patient-related and
nonpatient-related care. Patient-related care comprised diagnostics,
consumables, inpatient stay and labour, while nonpatient care
included overheads and capital. Resource use was primarily
derived from hospital administrative databases, while unit costs
were acquired from financial hospital databases and hospital
pharmacy databases, using 2006 as the reference year.
Results Average patient-related care costs per ICU day were
€1,040 in Germany, €1,333 in Italy and €1,243 in The
Netherlands. Hence these costs are similar in all three countries,
although there are differences between the considered patient-
related care categories (for example, nursing and medical staff).
The total average ICU cost per day (patient-related care +
nonpatient-related care) amounted to €1,225 in Germany, €1,472
in Italy, and €1,911 in The Netherlands. Variations in overheads
and capital costs might be (partly) caused by differences in the
accounting and financing systems. For example, unlike in Italy and
The Netherlands, in Germany most capital costs of public hospitals
are paid by the states and hence do not represent any cost to the
hospital.
Conclusions Our results indicate that the patient-related care
costs of intensive care in Germany, Italy, and The Netherlands are
similar from the hospital perspective.
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Introduction Chest X-ray scans are frequently performed in ICUs.
It is uncertain how much clinical information all chest X-ray scans
provide. There are currently no guidelines or protocols on this
subject. We believe some of the chest X-ray scans performed were
avoidable, limiting the cost for hospitals and radiation exposure to
patients.
Methods All chest X-ray scans performed in our 23-bed ICU and
high dependency unit were monitored by asking the person
ordering the X-ray scan to fill in the form confirming the indication
for the chest X-ray scan. At the end of 1 month all forms were
collected and analysed.
Results A total of 112 X-ray scans were performed in a 4-week
period but only 102 forms were completed. Eighty-four out of 102
chest X-ray scans were taken for only one indication, with 36/84
for diagnosis of chest pathology. Fourteen X-ray scans were taken
without completing the indication. Twenty-five per cent of X-ray
scans were performed looking for two or more parameters, making
them more cost-effective.
Conclusions Routine chest X-ray scans are debatable. Post-
procedure X-ray scans are not required if done by an experienced
clinician. The presence of protocols for ordering the chest X-ray
scan may reduce the total number of chest X-ray scans performed
and so reduce the cost and radiation exposure. A picture archiving
and communication system may reduce the overall cost.
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Introduction The objective of this study is to gain a view on how
intensive care staff thinks of technology in the ICU. The study
investigates the acceptance of technology by intensive care nurses
and tries to determine the advantages and disadvantages of the
equipment in use in ICUs at this moment.
Methods After reviewing some earlier publicised studies on this
topic, an online survey was set up to investigate the nurse’s view
on technology in the ICU. As this survey was set to reach as many
respondents from Flemish hospitals, it was set up in Dutch.
Results The survey was taken by 116 ICU staff members from 12
Flemish hospitals, including three academic hospitals, with ages
ranging from 22 to 58 years. The working experience ranges from
<1 year to 38 years. Educational records vary from bachelor
nursing degrees to specialized nurses and master degrees. Some
interesting results of the survey were the following: 91% of the
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respondents perceived an increase of technology in the ICU during
the time they were working in the unit. Sixty-six percent find that
the complexity of these technological devices is increasing. Only
62% think that the devices they have to work with are rather user-
friendly. Seventy-seven percent think that the technological
evolution of the ICU gives them a better view on the patients status.
Twenty-five percent say it gives them a better overview on nursing
tasks. On the other hand, 22% disagree with this statement and
thinks that the technological evolution of the ICU complicates this
overview. Even more alarming is the fact that 41% of the
respondents say that they are kept from giving essential care to the
patient because they have to control and adjust too many devices.
Conclusions The results of the survey imply that there is much room
for improvement of the technological equipment and processes in an
ICU. Technology seems to have a duality between its advantages
and disadvantages. For example, this survey made clear that some
devices are too complicated, so the advantage they create by giving
good feedback on the patients status results in the disadvantage
that too much attention is kept away from the patient because of the
complexity of the device and the time spent to set it up.
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Introduction In the United Kingdom there is evidence of
inadequate intensive care provision [1], causing delays in critical
care admission [2] and interhospital transfer. Recovery rooms are
often used as overflow critical care units.
Methods In 2006 an audit was undertaken of critically ill patients
admitted to recovery. Data were collected on the demography,
time/source of admission, duration of stay, destination and
mortality. The audit was repeated in 2007, following an expansion
from 17 to 19 beds in critical care.
Results Despite the increase in beds, the number of patients
admitted to recovery doubled with more medical admissions from
wards/A&E during 2006–2007 (40% versus 31%). The reason for
use of the facility remains a lack of intensive therapy unit (ITU)
beds. The majority were ventilated (>70%) and admitted after-
hours. There is significantly higher mortality in emergency patients
admitted to the ITU via the overflow facility (Table 1).
Conclusions There is increasing use of the overflow facility
especially out of hours and for the nonsurgical population. These
patients have a higher mortality than those admitted directly to the
ITU. We recommend earlier interhospital transfer of critical care
patients when an internal bed is not available.
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Introduction Until recently no studies had been carried out
concerning visiting policies in adult ICUs in Italy [1]. Moreover,
today no data are as yet available on visiting policies in Italy’s
pediatric ICUs (PICUs). We carried out a national survey to
evaluate visiting policies in Italian PICUs.
Methods An email questionnaire was sent to the heads of all 34
Italian PICUs asking about their visiting policies.
Results The response rate was 100%. The median daily visiting
time was 300 minutes (range 30 min–24 hours). Only 12% of
surveyed PICUs have unrestricted policies where one parent is
allowed to be present both day and night, while 59% of PICUs do
not allow the constant presence of a parent even during the day.
Children were not permitted to visit in 76% of PICUs. In the case
of a dying patient, 6% of PICUs did not alter their policy; 71%
extended visiting hours; 62% increased the number of slots; and
44% allowed more visitors. A gowning procedure was compulsory
for visitors in 94% of PICUs. No waiting room was provided by
32% of PICUs. In 16 units (48%) a formal process of revision of
the ward’s visiting policies was underway.
Conclusions Despite the widely held conviction that there is no
sound scientific basis for restricting visitors in ICUs [2-4], our findings
show a clear tendency in Italian PICUs to apply restrictive visiting
policies. They are nevertheless slightly more liberal than policies in
Italian adult ICUs [1]. In addition, it should be noted that in about one-
half of ICUs a revision of current policies is underway. Our survey
could contribute towards liberalizing visiting policies in Italian PICUs
and promoting more attentive care for the patient and his/her family.
Acknowledgement The study was supported by Associazione per
il Bambino Nefropatico (Milan, Italy).
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Table 1 (abstract P529) 
Number of Out-of-hours Length of stay 
Year admissions admissions (minutes) Mode of admission Died Survived Mortality
2005–2006 51 22 (43%) 60–1464 (438) Recovery 25 24 51%
Direct ITU admission 191 543 26%, P < 0.009*
2006–2007 105 65 (62%), P = 0.039* 20–1,650 (391) Recovery 38 58 39.6%
Direct ITU admission 149 501 22.9%, P < 0.0001*
*P < 0.05 by χ2 test.
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Introduction Performing a needs assessment is essential to
ensure that educational interventions and materials created will
address areas of deficit in the learners knowledge/skills. The goal
of this Ministry-funded project was to determine the educational
needs of healthcare professionals from community hospitals in the
context of Ontario’s Critical Care Strategy (CCS). The study
hypothesis was that a novel model, applying sound principles of
education research, must be created to concomitantly assess the
needs of multiple disciplines.
Methods A mixed-methods design was employed, combining both
qualitative and quantitative data collection techniques. Numerous
sources were triangulated, including a comprehensive literature
review, expert consultation, questionnaires, and multidisciplinary
and discipline-specific focus groups. Interviews were held with the
CCS and Local Health Integrated Networks (LHIN) leaders.
Selective sampling was used to ensure greater validity and allow
for a smaller sample. Qualitative data were audio recorded and
coded. Quantitative data were analyzed using descriptive statistics
(frequencies, cross-tabulations and gap analysis).
Results A high proportion of LHIN (10/13) and CCS leaders (6/7)
were sampled. Physicians, nurses, respiratory therapists and
pharmacists were represented in seven focus groups. The ABCs
of critical care figured prominently in educational needs, as did
sepsis, pediatric emergencies, codes, trauma, medications and
technical skills. The common denominator expressed by profes-
sionals was the infrequency of these events, resulting in lack of
exposure, experience, and training through which they could
become confident. There was no statistically significant difference
between educational needs identified between physicians, nurses
and respiratory therapists.
Conclusions We conducted a multidisciplinary needs assessment
to identify perceived and nonperceived educational needs of
healthcare providers working in community hospitals. No
differences in needs were identified between the major disciplines.
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Introduction The redevelopment of the ICU at Westmead Hospital
in 2006 required each of the 39 new bedspaces to have a
transportable system that utilised bedside mechanical ventilation
and patient monitoring equipment. Clinicians at Westmead ICU felt
that there were certain limitations in patient care with the use of
transport ventilators and monitors. When patients were transferred
out of the ICU to other departments (for example, for CT scan,
etc.), it was proposed that enhancements to care could be
achieved using more sophisticated bedside equipment in place of
basic transport ventilators and monitors.
Methods A specialised multidisciplinary team was assembled for
the planned project. It was envisaged that the new system would
be on a detachable trolley, connected to an articulating ceiling-
mounted service pendant. It would be mobile, with the equipment
mounted in such a way that it would also be capable of docking to
the ICU bed. This concept would therefore allow uninterrupted
monitoring and mechanical ventilation of the patient by the unit’s
bedside equipment, thereby allowing seamless transfer out of the
ICU for radiological investigations.
Results The decision on the final configuration for the mounting of
the selected equipment for the trolleys required comprehensive
strategic planning. This was to ensure that the bulky equipment be
manageable during patient transfers. Following installation and
implementation, 826 patients have been transferred to
CT/radiology, with some patients transferred multiple times. There
have been improvements in patient care experienced with the use
of the system during these transfers, which include greater patient
respiratory and haemodynamic stability, maintenance of lung-
protective strategies, advances in infection control and reduced
preparation times.
Conclusions The staff have become extremely competent in the
use of the equipment and confident in the system. The patient-
centred benefits observed have justified the expense and time
invested. After experience in the use of this model, new ideas that
could be implemented to enhance patient management with use of
the system have also been gained.
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Introduction The National Confidential Enquiry into Patient
Outcome and Death (NCEPOD) published a report in 2005
criticising the care of medical patients being admitted to ICUs in
the United Kingdom. In particular it criticised the low level of
consultant involvement in management of patients being admitted
to the ICU. Little is known, however, about patients referred to the
ICU but not admitted. These referrals, whether for advice only,
requests for practical skills or for decisions on suitability of a
patient for the ICU, reflect a large proportion of work done by
intensive care doctors outside the ICU.
Methods Data on all referrals were collected prospectively from all
24 ICUs in Scotland over 2 weeks. All referrals for admission, from
all specialties, were included. Referrals not resulting in admission
were stratified into five groups: advice only; too well; too sick; skill
sought; and other. These data were anonymised and analysed from
a national perspective.
Results Of the 857 referrals made during the study period, the
majority (585, 68%) were not admitted. The reasons for referral
and the rationale for nonadmission are shown in Figure 1. Of those
132 patients deemed too sick for admission, 43% were cardiac
arrest calls. Excluding the cardiac arrest calls, the referring team
consultant was aware of 60% of cases compared with the ICU
consultants’ 87%.
Critical Care    March 2008 Vol 12 Suppl 2 28th International Symposium on Intensive Care and Emergency Medicine
S209
Conclusions This study demonstrates that the majority of work
done by ICU doctors is underestimated by counting admissions
alone. This has important manpower planning implications. The low
rates of consultant involvement from the referring team in patients
deemed too sick for ICU admission is a significant concern. The
results of this study suggest that there is similar room for
improvement in this patient group as well as the group who are
admitted to the ICU as highlighted in the NCEPOD report.
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Introduction The importance of information management is
increasingly recognized as having a major role in supporting quality
improvement and safety initiatives, and outcomes research in the
ICU.
Methods A program description of the current information
management framework within all adult ICUs in Calgary, Canada.
Results Calgary Health Region is a large Canadian health region
providing acute care to 1.2 million residents in four ICUs
(approximately 4,000 annual admissions) within the Department of
Critical Care Medicine. An information management framework
developed during the past decade is composed of three tightly
integrated components: (1) data collection system – electronic
bedside charting system and its related interfaces including direct
data transfer from bedside monitoring devices and linkages to
other regional databases; (2) data analysis and reporting system –
a data warehouse and its interfaces for producing information from
the data; and (3) knowledge communication system – intranet
website, to feed back the information to the users and to increase
knowledge. By routinely collecting and reporting detailed, valid,
consistent, and complete information on all admissions to adult
ICUs, this information has proven to be a value in providing
outcome measures and indicators for numerous quality
improvement initiatives. A web-based surveillance system for
ventilator-associated pneumonia is only one example of system
effectiveness. Data obtained from this information system have also
been utilized to support tens of published research projects
investigating the determinants and outcomes of critical illness.
Conclusions The Critical Care information management
framework in Calgary has been proven an effective tool for quality
and safety, and research efforts. This framework can serve as a
model for ICUs to consider adopting elsewhere.
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Introduction Multiple organ dysfunction is common cause of death
in critically ill patients. The aim of this study is to perform a serial
assessment of the Multiple Organ Dysfunction Score (MODS),
Sequential Organ Failure Assessment (SOFA) score and Logistic
Organ Dysfunction (LOD) score and to compare their ability in
predicting ICU mortality.
Methods All of the data were collected prospectively on
consecutive ICU admissions over 24 months at a tertiary referral
university hospital in Thailand. The MODS, SOFA and LOD scores
were calculated on initial admission and repeated every 48 hours.
Discrimination was evaluated by the area under the receiver
operating characteristic curve (AUC). The Δ score was defined as
the difference between the score at the reference time and the
initial score.
Results See Figure 1. A total of 2,054 patients were enrolled in
the study. The initial, maximum and Δ scores of all the organ
dysfunction scores correlated well with ICU mortality. The
maximum all-model scores up to six correlated with a mortality rate
less than 5%, while those higher than 10 and 14 were associated
with a mortality rate greater than 55% and 77%, respectively.
When Δ LOD-48 increased more than four points, the ICU
Available online http://ccforum.com/supplements/12/S2
Figure 1 (abstract P533)
Reasons for referral and rationale for nonadmission. Data complete
583/585.
Figure 1 (abstract P535)
Correlation of the Δ-48 score of the MODS, SOFA and LOD scores
with ICU mortality.
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mortality went up to 79%. The maximum score of all models had
better ability for predicting ICU mortality than the initial or Δ score.
The AUCs for maximum scores were 0.892 (95% CI =
0.872–0.911) for the MODS, 0.907 (95% CI = 0.890–0.924) for
the SOFA and 0.920 (95% CI = 0.903–0.936) for the LOD. The
AUC of the Acute Physiology and Chronic Health Evaluation
(APACHE) II score was 0.905 (95% CI = 0.867–0.923). No
statistical difference existed between the maximum score and the
APACHE II score.
Conclusions Serial assessment of organ dysfunction during the
ICU stay is reliable with ICU mortality. The maximum scores is the
best discrimination power comparable with APACHE II score in
predicting ICU mortality.
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Introduction Noninvasive ventilation (NIV) is now the accepted
first-line treatment for acidotic exacerbations of chronic obstructive
pulmonary disease (COPD). Many hospitals perform NIV in a ward-
based unit outside the ICU. Patients are still admitted to the ICU
when failure of NIV may lead to mechanical ventilation, or for bed
resource reasons. The impact of the opening of a ward-based NIV
unit at University Hospital Aintree in July 2004 is described.
Methods Patients admitted to the ICU with acute exacerbations of
COPD were identified from the ICU database for the 3 years either
side of the NIV unit opening and their case notes examined by a
single person (JG).
Results Fifty-seven patients admitted to the ICU were identified for
the 6-year period (51% male, mean age 68.5 years), 32 from
before the NIV unit opened and 25 after. There were no statistically
significant differences in sex, age, forced expiratory volume in
1 second, percentage predicted forced expiratory volume in
1 second, WHO performance status and admission pH before and
after the NIV unit opened. There was a trend towards a worse
admission pCO2 after the unit opened (P = 0.065). Forty out of 57
patients were deemed ‘not for intubation’ at the time of ICU
admission. In all of these cases, the decision was made by the
admitting intensivist rather than the referring physician. Ten
patients were intubated before the NIV unit opened and three
patients after (P = 0.004). The mean length of stay in critical care
was 3.5 days (SD 5.2) and the mean hospital stay was 13.9 days
(SD 12.0). Overall the ICU mortality rate was 23% and inpatient
mortality was 30%. There were no statistically significant
differences before and after the NIV unit opened.
Conclusions The opening of a ward-based NIV unit had little
impact on the workload of the ICU. Patients admitted to the ICU
and markers of their disease and exacerbation severity were very
similar before and after the unit opened. This may be explained by
patients who would have previously been managed conservatively
being admitted to the NIV unit, but the ICU population remaining
similar. It is clear that most patients come to the ICU without a
predefined intubation decision. Significantly fewer patients were
intubated after the NIV unit opened, and the reasons for this are
unclear. Comparison with NIV unit data is now required to
establish their patient population and outcome.
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Introduction In one of our ICUs, we started a two-intensivist coverage
system during the day, with each intensivist admitting new patients
every other day. The purpose of this study was to test the hypothesis
that the increased mortality associated with round-time ICU
admissions will disappear with the two-intensivist coverage system.
Methods This retrospective study involves analyses of data from
the APACHE III database of three ICUs (medical, surgical, and
mixed). The study period was from January 2001 through
December 2006. A daytime two-intensivist coverage was
introduced in the medical ICU in April 2002. Daily morning patient
rounds were usually performed from 8:00 to 11:00 a.m. Data
collected included the Acute Physiology Score, APACHE III score,
predicted mortality, and hospital mortality. Comparisons were
made between round-time and nonround-time ICU admissions. The
odds ratio and 95% confidence intervals were calculated. P <
0.05 is considered statistically significant.
Results There were 25,209 ICU admissions during the study
period (41.3% medical ICU, 31.6% mixed ICU, and 27.2% surgical
ICU). Of the 25,206 admissions, 2,160 (8.6%) were admitted
during morning rounds. Differences between round-time and
nonround-time admissions are presented in Table 1. A logistic
regression analysis showed that both predicted probability of death
(OR, 95% CI = 187, 159–220) and round-time admission (OR,
95% CI = 1.589, 1.386–1.821) were independently associated
with increased mortality. Round-time admission was an independent
risk factor for mortality in each of the three ICUs. For the medical
ICU, the implementation of two-intensivist coverage did not improve
the independent association of round-time admission with
increased mortality (OR, 95% CI = 1.611, 1.326–1.957).
Table 1 (abstract P537)
Differences between round-time admissions and nonround-time
admissions
Round-time Nonround-time 
Variable admissions admissions P value
Age 63.2 62.9 0.428
Acute Physiology Score 45.0 42.0 <0.001
APACHE III score 59.8 55.6 <0.001
Predicted death (%) 22 16 <0.001
Real death (%) 19.9 11.9 <0.001
Conclusions ICU admission during round time is independently
associated with increased mortality. Appropriate allocation of
staffing during round time may improve patient outcome.
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Introduction When admission to the ICU is deemed necessary in
patients with haematological malignancy, prognosis is extremely
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poor, with reported ICU mortality rates of 38–73% and even higher
inhospital and long-term mortality. In the presence of conditions
associated with 100% mortality, cessation of or negation to initiate
therapy would be justified. The aim of this study was to evaluate
the outcome, and to identify clinically useful prognostic parameters
in this group of patients.
Methods The study retrospectively included 86 patients with
haematological malignancy, admitted to the ICU of the University
Hospital Maastricht between December 1999 and December 2005.
Demographic data, characteristics of haematological disease, therapy
and complications, indication for ICU admission, clinical parameters,
laboratory values, interventions on the ICU, APACHE II and SOFA
scores, as well as ICU and hospital mortality were collected.
Results ICU mortality was 56% and inhospital mortality was 65%.
Nonsurvivors had higher APACHE II and SOFA scores than
survivors (32 ± 8.0 vs 25 ± 6.5 and 11.5 ± 3.1 vs 8.5 ± 3.0,
respectively). Mortality was higher in patients with invasive
mechanical ventilation, in patients with inotropic/vasopressor
therapy and in cardiopulmonary resuscitated patients. Patients with
an increasing SOFA score over the first week (≥2 points) had
significantly higher mortality rates, and patients with a decrease
(≥2 points) had significantly lower mortality rates (P = 0.005).
Subgroups with 100% mortality included patients with
myeloablative allogeneic stem cell transplantation in the past year
(n = 9), reactivation of cytomegalovirus (n = 6) and acute
lymphoblastic leukaemia (n = 5). Presence of neutropenia was not
associated with higher mortality, neither were disease status,
indication for ICU admission, graft-versus-host disease, chronic
use of immunosuppressive medication, left ventricular ejection
fraction ≤40% or bacteraemia.
Conclusions The mortality of patients with haematological
malignancies admitted to the ICU is high and mainly associated
with severity of illness, reflected in organ failure scores, need for
mechanical ventilation and inotropic or vasopressor therapy.
Although several factors are associated with poor outcome, no
absolute predictors of mortality were identified.
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Introduction In recent years, cellphones have gradually replaced
pagers as the main mode of communication among healthcare
workers. The rapid, effective two-way communication with cell-
phones can potentially translate into improved patient care,
especially in an intensive setting such as the operating room and
critical care unit. However, electromagnetic interference (EMI)
between cellphones and life-supporting devices may potentially
result in patient harm. The survey aims to collate the anaesthe-
siologists’ experience with cellphones and pagers in the workplace.
Methods One hundred and forty survey forms were distributed to
anaesthesiologists working in the National Health Group
institutions and to members of the Singapore Society of
Anaesthesiologists. The survey includes questions on the primary
mode of communication at work, efficiency of communication with
each device, problems with network transmission and experience
with EMI, whether cellphones help to reduce medical error and
avoid adverse outcomes, and what was judged to be a reasonable
minimum operating distance for cellphones. In addition, cellphone
users were polled on whether they will welcome such a change.
Results One hundred and nineteen anaesthesiologists responded.
Fifty-nine respondents were pager users. No significant EMI was
reported by all the participants. Among the pager users, 69%
reported an experience with significant communication delay and
the majority will prefer their pagers to be replaced with cellphones.
Ninety-three percent of cellphone users responded positively
towards the change in communication device, with the majority
reporting a facilitation of communication. However, in the
responders’ opinion this did not directly translate into a reduction
or avoidance of critical incidents or adverse outcome.
Conclusions The recent transition from pagers to cellphones in
Singapore hospitals has improved communication at work for
anaesthetists. No instances of clinically significant EMI were
reported. However, network coverage in operating theaters could
be further improved to ensure prompt and effective communication
among healthcare workers.
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Introduction BMJ Learning is an online learning website for health
professionals [1]. It produces interactive learning resources to
enable them to update their knowledge and skills [2]. One of its
main target audiences is primary care professionals. These users
have consistently requested learning resources in emergency
medicine to better care for such patients in the community. To help
meet these needs, BMJ Learning produced a series of learning
modules in emergency medicine.
Methods BMJ Learning produced a series of seven modules on
common emergency medicine conditions. These included
epistaxis, accidental hypothermia, acute gastrointestinal haemor-
rhage, anaphylaxis, deliberate self-harm, uncomplicated first
generalised seizure and paracetamol overdose.
Results A total of 5,082 users completed these modules.
Feedback was overwhelmingly positive. Specific examples of
feedback are as follows: ‘good update of management plan
reinforces need for taking into account concurrent medication
when resuscitating patients’, ‘nice simple messages with good
starting points for trying to deal with these complicated patients’,
‘useful data on risk of recurrence as this is a question often asked
by patients’. This feedback was particularly encouraging as it
showed how the primary care professionals planned to change
their practice to improve patient outcomes as a result of the
learning.
Conclusions We feel that the results show that online learning
modules are effective at helping primary care professionals learn
about emergency medicine. We encourage other providers of
online learning to increase the amount of learning resources that
are available in this area.
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Introduction Emergencies in cardiology are among the key
demands of therapy in emergency and critically ill patients. The
study objectives were to address the use of medical simulation as
a way for medical learners to acquire and maintain skills needed to
manage emergencies in cardiology, and to evaluate the students’
satisfaction with the course.
Methods Between March 2002 and December 2006, a total of
497 trainees received a baseline evaluation (n = 283) followed by
an 8 hour-training session that involved an introductory lecture,
skills management with a mannequin simulator (Figure 1), clinical
scenarios for the training ACLS algorithm, and instructor-facilitated
debriefings. After finishing the course, they were retested and
completed a numerical scale survey (n = 497) of their perceptions
about the course (1 = poor, 2 = fair, 3 = good, and 4 = excellent).
Results Performance improved significantly after simulator training
(76.7% vs 58.1%, P < 0.001); 75% of participants scored less
than 70% in the baseline evaluation while only 25% scored less
than 70% in the retest. The course was considered excellent by
63% of the participants and good by 36%.
Conclusions The extremely positive response to simulation-based
training on emergencies in cardiology found in the present study
suggests that this training modality may be valuable in the training
of medical students and physicians. Most students considered the
course excellent. Simulation-based training is expected to become
routine in many healthcare settings in the coming decade.
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Figure 1 (abstract P541)
Defibrillation in a cardiac arrest.
